Citrus Sinensis ID: 007361
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.919 | 0.711 | 0.542 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.953 | 0.709 | 0.538 | 1e-178 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.978 | 0.697 | 0.496 | 1e-172 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.962 | 0.691 | 0.512 | 1e-172 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.978 | 0.700 | 0.490 | 1e-169 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.980 | 0.693 | 0.471 | 1e-160 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.985 | 0.716 | 0.472 | 1e-157 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.991 | 0.711 | 0.477 | 1e-155 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.960 | 0.682 | 0.481 | 1e-154 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.932 | 0.665 | 0.461 | 1e-146 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 639 bits (1649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/608 (54%), Positives = 419/608 (68%), Gaps = 51/608 (8%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
MP L+PNP+Y +EYV E EV+Y + L SV + M +NP G QR TW++ Q W ++
Sbjct: 225 MPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYL 284
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
++D CD Y LCG+Y CN+N + A C CL+GFV K+P W D S+GCVRR +L
Sbjct: 285 ---SAMMDSCDQYTLCGSYGSCNINESPA-CRCLKGFVAKTPQAWVAGDWSEGCVRRVKL 340
Query: 121 DCEHG-DGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCL 179
DC G DGFLK +KLPDTR S D + L ECK++C +NC+C+AY+ D+R GG GC+
Sbjct: 341 DCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCI 400
Query: 180 LWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGG 239
LWF DLID++E +E+GQDL+VR+A+SE++ ++R+ +
Sbjct: 401 LWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSRVSS-------------------- 440
Query: 240 FVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGG 299
RKQ EE++ELP D ++ AT FS NKLG+GG
Sbjct: 441 ---------RKQ----------------EEEDLELPFLDLDTVSEATSGFSAGNKLGQGG 475
Query: 300 FGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359
FGPVYKG L GQE+A KRLS++S QG+EEF+NE+ LIAKLQHRNLVK++G C +ERM
Sbjct: 476 FGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERM 535
Query: 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419
LIYEY PNKSL+ FIFD R + LDW KR +II GIARG+LYLH+DSRLRIIHRDLKASN
Sbjct: 536 LIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASN 595
Query: 420 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 479
VLLD++MN KISDFG+AR G D+TEANT RVVGTYGYM PEY IDG FS+KSDVFSFGV
Sbjct: 596 VLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGV 655
Query: 480 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS-LSEVLRCIQV 538
LVLEIV G+RNRGF + +H NLLGHAWR ++E++ E+I++++ S + +SEVLR I +
Sbjct: 656 LVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHI 715
Query: 539 GLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEI 598
GLLCVQQ P+DRPNMS VVLMLS E L P+QPGFF ERN S + S + S N
Sbjct: 716 GLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQ 775
Query: 599 TISLIEGR 606
T+S+I+ R
Sbjct: 776 TMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1608), Expect = e-178, Method: Compositional matrix adjust.
Identities = 325/604 (53%), Positives = 422/604 (69%), Gaps = 26/604 (4%)
Query: 7 NPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLI 66
N ++ +++ S+ EV Y + + + S +V+N G R +Q Q ++ +
Sbjct: 234 NSLFDYKFTSSAQEVNYSWT-PRHRIVSRLVLNNTGKLHRFIQSKQNQ----WILANTAP 288
Query: 67 LDQCDNYALCGAYAVCNMNS-NSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHG 125
D+CD Y++CGAYAVC +NS N+ C CL+GF PKS +W++ + GCV +CE
Sbjct: 289 EDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKK 348
Query: 126 DGFLKRESVKLPDTRFSLVD--NKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFH 183
D F+K +KLPDT +S D N+++L +CK CS NCSCTAYAN D+R GG GCLLWF
Sbjct: 349 DAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFG 408
Query: 184 DLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYL 243
DL+DM+E S GQD+++RM ++++ K ++ + + + V V++ F
Sbjct: 409 DLVDMREYSSFGQDVYIRMGFAKIE----FKGREVVGMVVGSVVAIAVVLVVVFACFRKK 464
Query: 244 WKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPV 303
+R+R + +G EE+++LPIFD I+ AT++FS N LG GGFGPV
Sbjct: 465 IMKRYRGENFR----------KGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPV 514
Query: 304 YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363
YKG L +GQEIA KRLS +SGQG+EEF+NEV LIAKLQHRNLV+L+GCC Q +E MLIYE
Sbjct: 515 YKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYE 574
Query: 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423
Y+PNKSL+ FIFD RS LDW KR II G+ARG+LYLHQDSRLRIIHRDLKA NVLLD
Sbjct: 575 YMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLD 634
Query: 424 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 483
N+MNPKISDFG+A++FG DQ+E++TNRVVGTYGYMPPEYAIDG FSVKSDVFSFGVLVLE
Sbjct: 635 NDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLE 694
Query: 484 IVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS-LSEVLRCIQVGLLC 542
I+ GK NRGF HADH NLLGH W++W+E+R +E+ + S + EVLRCI V LLC
Sbjct: 695 IITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLC 754
Query: 543 VQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISL 602
VQQ+PEDRP M+SVVLM + SLP P QPGFFT RN P+ SS S R S NE++I++
Sbjct: 755 VQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRNVPDISSSLSLR---SQNEVSITM 811
Query: 603 IEGR 606
++GR
Sbjct: 812 LQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 604 bits (1558), Expect = e-172, Method: Compositional matrix adjust.
Identities = 315/634 (49%), Positives = 429/634 (67%), Gaps = 41/634 (6%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPF- 59
+P++QP F + +++ EV Y F + KS V S + ++ G QR TW+E Q W F
Sbjct: 230 VPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFW 289
Query: 60 -VPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRT 118
P DQCD Y CG Y C+ N+ S C C++GF P++P W L D SDGCVR+T
Sbjct: 290 YAP-----KDQCDEYKECGVYGYCDSNT-SPVCNCIKGFKPRNPQVWGLRDGSDGCVRKT 343
Query: 119 QLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGC 178
L C GDGF++ + +KLPDT + VD I + EC++ C ++C+CTA+AN D+RG GSGC
Sbjct: 344 LLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGC 403
Query: 179 LLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLG 238
+ W +L D++ ++ GQDL+VR+AA++L+D K+ + A +I S + V+ ++LL
Sbjct: 404 VTWTGELFDIRNYAKGGQDLYVRLAATDLED-------KRNRSAKIIGSSIGVSVLLLLS 456
Query: 239 GFVY-LWKRRHRKQGKTDG--------SSKLDYND----------RGNREEEMELPIFDW 279
++ LWKR+ ++ + S L N+ R N +++ELP+ ++
Sbjct: 457 FIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEF 516
Query: 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK 339
+A AT NFS+ NKLG+GGFG VYKG L++GQE+A KRLSK+S QG +EF+NEV LIA+
Sbjct: 517 EEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIAR 576
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 399
LQH NLV+L+ CC E+MLIYEYL N SL+ +FD +R+ L+W R II GIARGL
Sbjct: 577 LQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGL 636
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 459
LYLHQDSR RIIHRDLKASN+LLD M PKISDFGMAR FG D+TEANT +VVGTYGYM
Sbjct: 637 LYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMS 696
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519
PEYA+DG+FS+KSDVFSFGVL+LEI+ KRN+GFY++D NLLG WR W E + +E+I
Sbjct: 697 PEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEII 756
Query: 520 NKSLGGSYSL---SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER-SLPQPKQPGFF 575
+ + S S E+LRCIQ+GLLCVQ+R EDRP MS V+LML E ++PQPK PG+
Sbjct: 757 DPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYC 816
Query: 576 TERNPPESGSSSSKR---SLLSTNEITISLIEGR 606
ER+ ++ SSSSK+ + N+IT+S+++ R
Sbjct: 817 LERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 604 bits (1557), Expect = e-172, Method: Compositional matrix adjust.
Identities = 318/621 (51%), Positives = 430/621 (69%), Gaps = 38/621 (6%)
Query: 12 FEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAP--FVPFSGLILDQ 69
+ + +++ EV Y + + K+++ S + +N G QRLTW E TQ W + P D
Sbjct: 235 YNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSP-----KDL 289
Query: 70 CDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFL 129
CDNY +CG + C+ NS C C++GF P + WDL D S GC+R+T+L C+ DGF
Sbjct: 290 CDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFT 348
Query: 130 KRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMK 189
+ + +KLPDT ++VD +I L CKE C ++C+CTA+ANAD+R GGSGC++W +++DM+
Sbjct: 349 RLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMR 408
Query: 190 ELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHR 249
++ GQDL+VR+AA+EL+D +R K +K +I ++ +LL++ VI + WKR+ +
Sbjct: 409 NYAKGGQDLYVRLAAAELED-KRIKNEKIIGSSIGVSILLLLSFVIF-----HFWKRKQK 462
Query: 250 K----------QGKTDGS-------SKLDYNDRGNREEEMELPIFDWMAIANATENFSDK 292
+ Q ++ S S+ Y + + E +ELP+ + A+A AT NFS+
Sbjct: 463 RSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSND 522
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
NKLG+GGFG VYKG L++G+EIA KRLSK S QG +EF NEV LIAKLQH NLV+L+GCC
Sbjct: 523 NKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCC 582
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
+ E+MLIYEYL N SL+ +FD TRS L+W KR II GIARGLLYLHQDSR RIIH
Sbjct: 583 VDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIH 642
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 472
RDLKASNVLLD M PKISDFGMAR FG ++TEANT RVVGTYGYM PEYA+DG+FS+KS
Sbjct: 643 RDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKS 702
Query: 473 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN----KSLGGSYS 528
DVFSFGVL+LEI+ GKRN+GFY+++ NLLG WR W E +E+++ SL +
Sbjct: 703 DVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFP 762
Query: 529 LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPESGSSS 587
E+LRCIQ+GLLCVQ+R EDRP MSSV++ML E + +PQPK+PGF R+P E+ SSS
Sbjct: 763 THEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSS 822
Query: 588 SKR--SLLSTNEITISLIEGR 606
S + + N+IT+S+I+ R
Sbjct: 823 STQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 596 bits (1536), Expect = e-169, Method: Compositional matrix adjust.
Identities = 310/632 (49%), Positives = 422/632 (66%), Gaps = 39/632 (6%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAP-- 58
+P ++P + N +V Y + + K+++ S++ ++ G QRLTWME Q W
Sbjct: 229 VPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLW 288
Query: 59 FVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRT 118
+ P D CDNY CG Y C+ N+ S C C++GF P + + L D S GCVR+T
Sbjct: 289 YSP-----KDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMN-EQAALRDDSVGCVRKT 341
Query: 119 QLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGC 178
+L C+ DGF++ + ++LPDT + VD I L EC+E C K C+CTA+AN D+R GGSGC
Sbjct: 342 KLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGC 401
Query: 179 LLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLG 238
++W L D++ ++ GQDL+VR+AA +L+D +R K KK +I ++ +LL++ +I
Sbjct: 402 VIWSGGLFDIRNYAKGGQDLYVRVAAGDLED-KRIKSKKIIGSSIGVSILLLLSFIIF-- 458
Query: 239 GFVYLWKRRHRKQGKTDG-----------------SSKLDYNDRGNREEEMELPIFDWMA 281
+ WKR+ ++ + Y + N+ + +ELP+ +W A
Sbjct: 459 ---HFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKA 515
Query: 282 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 341
+A AT NFS NKLG+GGFG VYKG+L++G+EIA KRLSK S QG +EF NEV LIAKLQ
Sbjct: 516 LAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQ 575
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
H NLV+L+GCC + E+MLIYEYL N SL+ +FD TRS L+W KR II GIARGLLY
Sbjct: 576 HINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLY 635
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LHQDSR RIIHRDLKASNVLLD M PKISDFGMAR FG ++TEANT RVVGTYGYM PE
Sbjct: 636 LHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPE 695
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN- 520
YA+DG+FS+KSDVFSFGVL+LEI+ GKRN+GFY+++ NLLG WR W E + +E+++
Sbjct: 696 YAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDP 755
Query: 521 ---KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFT 576
+L + E+LRCIQ+GLLCVQ+R EDRP MSSV++ML E + +PQPK+PGF
Sbjct: 756 INIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCV 815
Query: 577 ER--NPPESGSSSSKRSLLSTNEITISLIEGR 606
R +S SS+ + + N++T+S+I+ R
Sbjct: 816 GRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 565 bits (1455), Expect = e-160, Method: Compositional matrix adjust.
Identities = 301/638 (47%), Positives = 407/638 (63%), Gaps = 44/638 (6%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
+P+ Q + ++ N EV Y F + +S S + + G QRLTW + W F
Sbjct: 232 IPEDQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRF- 290
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
+S + QCD Y +CG YA C++N+ S C C++GF P++ +WD + GC+RRTQL
Sbjct: 291 -WSSPVDPQCDTYIMCGPYAYCDVNT-SPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQL 348
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
C GDGF + + +KLP+T + VD I + ECK+ C +C+CTA+ANAD+R GGSGC++
Sbjct: 349 SCS-GDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVI 407
Query: 181 WFHDLIDMKELSES---GQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILL 237
W L D++ + GQDL+VR+AA+++ KK+ + I S+ + V+LL
Sbjct: 408 WTERLEDIRNYATDAIDGQDLYVRLAAADI--------AKKRNASGKIISLTVGVSVLLL 459
Query: 238 GGFVYLWKRRHRKQ-------GKTDGSSKLDYND---RGNRE-------EEMELPIFDWM 280
LWKR+ ++ T + L N+ RE EE+ELP+ +
Sbjct: 460 LIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEME 519
Query: 281 AIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
+ ATENFS NKLG+GGFG VYKG L++G+EIA KRLSK+S QG +EF NEV LIA+L
Sbjct: 520 TVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARL 579
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
QH NLV+++GCC + DE+MLIYEYL N SL+ ++F TR L+W++R I G+ARGLL
Sbjct: 580 QHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLL 639
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
YLHQDSR RIIHRDLK SN+LLD M PKISDFGMAR F D+TEANT +VVGTYGYM P
Sbjct: 640 YLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSP 699
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
EYA+ G+FS KSDVFSFGV+VLEIV GK+NRGFY+ D+ ++LL + W W E R +E+++
Sbjct: 700 EYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVD 759
Query: 521 KSLGGSYSL-------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQP 572
+ S S EVL+CIQ+GLLCVQ+ E RP MSSVV M E + +PQPK P
Sbjct: 760 PVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPP 819
Query: 573 GFFTERNPPESGSSSS----KRSLLSTNEITISLIEGR 606
G+ R+P E SSS + + N+ T S+I+ R
Sbjct: 820 GYCVRRSPYELDPSSSWQCDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 556 bits (1433), Expect = e-157, Method: Compositional matrix adjust.
Identities = 295/625 (47%), Positives = 406/625 (64%), Gaps = 28/625 (4%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPF- 59
+P++ ++ +V+NE+EV + + + +SV + ++N G R TW+ + ++W F
Sbjct: 218 VPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTMHRFTWIARDKRWNDFW 277
Query: 60 -VPFSGLILDQCDNYALCGAYAVCNM-NSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRR 117
VP +QCDNYA CG C+ +S + +C CL GF PK P W L D S GC ++
Sbjct: 278 SVP-----KEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGCTKK 332
Query: 118 TQLD-CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANA--DVRGG 174
+ C DGF+K + +K+PDT + VD I+L ECK+ C KNCSC AYA+A + + G
Sbjct: 333 KRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVAYASAYHESKRG 392
Query: 175 GSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGV 234
GCL W ++D + SGQD ++R+ EL R K++V +++ S L+ V
Sbjct: 393 AIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRRVLLILIS--LIAAV 450
Query: 235 ILLGGFVYLWKRRHRKQGKTDGSSK------LDYNDRGNREEE----MELPIFDWMAIAN 284
+LL ++ R RK + SS D+++ E++ ELP+FD I
Sbjct: 451 MLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNRELPLFDLNTIVA 510
Query: 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 344
AT NFS +NKLG GGFGPVYKGVL EIA KRLS++SGQGMEEF+NEV LI+KLQHRN
Sbjct: 511 ATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRN 570
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
LV+++GCC + +E+ML+YEYLPNKSL+ FIF + LDW KR +I+ GIARG+LYLHQ
Sbjct: 571 LVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQ 630
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
DSRLRIIHRDLKASN+LLD+EM PKISDFGMAR FG +Q E T+RVVGT+GYM PEYA+
Sbjct: 631 DSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAM 690
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
+G FS+KSDV+SFGVL+LEI+ GK+N F+ + NL+GH W LW E+I+ +
Sbjct: 691 EGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVGHIWDLWENGEATEIIDNLMD 748
Query: 525 G-SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS-GERSLPQPKQPGFFT-ERNPP 581
+Y EV++CIQ+GLLCVQ+ DR +MSSVV+ML +LP PK P F + R
Sbjct: 749 QETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGG 808
Query: 582 ESGSSSSKRSLLSTNEITISLIEGR 606
E+G+ ++ +S N++T S I+GR
Sbjct: 809 ENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 548 bits (1412), Expect = e-155, Method: Compositional matrix adjust.
Identities = 301/630 (47%), Positives = 399/630 (63%), Gaps = 29/630 (4%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
+P++ ++ +V+N +EV + ++ +SV + MV+N G QR W + +KW +
Sbjct: 221 VPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVLNETGTLQRFRWNGRDKKW---I 277
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSA-KCECLEGFVPKSPSEWDLLDKSDGCVR-RT 118
F D+CD Y CG C+ S +C CL G+ PK+P +W L D SDGC R +
Sbjct: 278 GFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKTPRDWFLRDASDGCTRIKA 337
Query: 119 QLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANA--DVRGGGS 176
C +GF K + VK+P+T VD I+L EC++ C KNCSC AYA+A + + G
Sbjct: 338 DSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKNCSCVAYASAYHESQDGAK 397
Query: 177 GCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVIL 236
GCL W +++D + SGQD ++R+ SEL KK++ +++ S++ V ++L
Sbjct: 398 GCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGASGKKRLVLILISLIAVVMLLL 457
Query: 237 LGGFVYLWKRRHRKQGK-------TDGSSKLDYNDRGNREE------EMELPIFDWMAIA 283
+ YL KRR R Q + S D D EE ELP+F+ IA
Sbjct: 458 ISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRELPLFELSTIA 517
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 343
AT NF+ +NKLG GGFGPVYKGVL G EIA KRLSKSSGQGMEEF+NEV LI+KLQHR
Sbjct: 518 TATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHR 577
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
NLV+++GCC + +E+ML+YEYLPNKSL+ FIF + LDW KR II GI RG+LYLH
Sbjct: 578 NLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLH 637
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
QDSRLRIIHRDLKASNVLLDNEM PKI+DFG+AR FG +Q E +TNRVVGTYGYM PEYA
Sbjct: 638 QDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYA 697
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+DG FS+KSDV+SFGVL+LEI+ GKRN FY + NL+ H W W +E+I+K +
Sbjct: 698 MDGQFSIKSDVYSFGVLILEIITGKRNSAFY--EESLNLVKHIWDRWENGEAIEIIDKLM 755
Query: 524 G-GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER-SLPQPKQPGFFT--ERN 579
G +Y EV++C+ +GLLCVQ+ DRP+MSSVV ML LP PK P F RN
Sbjct: 756 GEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFTAGRRRN 815
Query: 580 PPESGSSS---SKRSLLSTNEITISLIEGR 606
GSS S + + N++T++ ++GR
Sbjct: 816 TKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 547 bits (1409), Expect = e-154, Method: Compositional matrix adjust.
Identities = 301/625 (48%), Positives = 399/625 (63%), Gaps = 43/625 (6%)
Query: 12 FEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCD 71
+ + N EV Y F + + S + +N +G + W Q+W F D CD
Sbjct: 242 YNFTENREEVAYTFRVTDHNSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMPK---DTCD 298
Query: 72 NYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKR 131
Y +CG YA C+M S S C C++GF P SP +W D + C R+TQL C D F +
Sbjct: 299 LYGICGPYAYCDM-STSPTCNCIKGFQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRL 356
Query: 132 ESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKEL 191
++K+P T ++VD +I L EC+E C +C+CTAYAN+D+R GGSGC++W + D++
Sbjct: 357 MNMKIPATTAAIVDKRIGLKECEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNY 416
Query: 192 SESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQ 251
+ GQDLFVR+AA+E ER+ + K I+ S++LV I+ WK++ ++
Sbjct: 417 AADGQDLFVRLAAAEFG--ERRTIRGKIIGLIIGISLMLVLSFIIY----CFWKKKQKRA 470
Query: 252 GKTDGSSKLDYNDR--------------GNREEEMELPIFD----WMAIANATENFSDKN 293
T ++ + Y DR G R E + + + ATENFSD N
Sbjct: 471 RAT--AAPIGYRDRIQELIITNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSN 528
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
LG GGFG VYKG L++GQEIA KRLS+ S QG EF+NEV LIA+LQH NLV+L+ CC
Sbjct: 529 ILGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCI 588
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
DE++LIYEYL N SL+ +F+ T+S L+W R II GIARGLLYLHQDSR +IIH
Sbjct: 589 YADEKILIYEYLENGSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIH 648
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 472
RDLKASNVLLD M PKISDFGMAR F D+TEANT +VVGTYGYM PEYA++G+FSVKS
Sbjct: 649 RDLKASNVLLDKNMTPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKS 708
Query: 473 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS------ 526
DVFSFGVLVLEIV GKRNRGF+++ +NLLG+ W W E + +E+++ + S
Sbjct: 709 DVFSFGVLVLEIVSGKRNRGFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSL 768
Query: 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPESG- 584
+ EVLRCIQ+GLLCVQ+R EDRP MSSVVLML E+ +PQPK+PG+ R+ ++
Sbjct: 769 FQPHEVLRCIQIGLLCVQERAEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTAD 828
Query: 585 -SSSSKRS--LLSTNEITISLIEGR 606
SSS+KR L+ N+IT+S+I R
Sbjct: 829 SSSSTKRDSESLTVNQITVSVINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1339), Expect = e-146, Method: Compositional matrix adjust.
Identities = 297/644 (46%), Positives = 394/644 (61%), Gaps = 79/644 (12%)
Query: 2 PQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV- 60
P + VY F YV ++ V RF ++ + G + L W E +KW F
Sbjct: 246 PPDETGSVY-FTYVPSDPSVLLRFKVLYN-----------GTEEELRWNETLKKWTKFQS 293
Query: 61 -PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQ 119
P S +CD Y CG + +C+M ++ C C+ G+ S W S GC RRT
Sbjct: 294 EPDS-----ECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTP 343
Query: 120 LDCEHG-----DGFLKRESVKLPDTRF---SLVDNKISLLECKELCSKNCSCTAYANADV 171
L CE D FL +SVKLPD +LVD + +C+E C +NCSC AY+
Sbjct: 344 LKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPE----DCRERCLRNCSCNAYSLV-- 397
Query: 172 RGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLV 231
GG GC++W DL+D+++ G L +R+A SE+ + +K K+A+++ ++
Sbjct: 398 --GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVGE------NRKTKIAVIVA---VL 446
Query: 232 TGVILLGGFVYLWKRRHRKQ-------GKTDGSS------------------KLDYNDRG 266
GVIL+G F L R RK+ GK +S +D G
Sbjct: 447 VGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEG 506
Query: 267 NREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG 326
ELP+F AIA AT +F +N+LG GGFGPVYKGVL +G+EIA KRLS SGQG
Sbjct: 507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566
Query: 327 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 386
++EF+NE++LIAKLQHRNLV+L+GCC + +E+ML+YEY+PNKSL+ F+FD T+ +DW
Sbjct: 567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626
Query: 387 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446
R II GIARGLLYLH+DSRLRIIHRDLK SNVLLD EMNPKISDFGMAR FG +Q EA
Sbjct: 627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686
Query: 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506
NT RVVGTYGYM PEYA++GLFSVKSDV+SFGVL+LEIV GKRN + H +L+G+A
Sbjct: 687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL-RSSEHGSLIGYA 745
Query: 507 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML-SGERS 565
W L+ R EL++ + + S E LRCI V +LCVQ +RPNM+SV+LML S +
Sbjct: 746 WYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTAT 805
Query: 566 LPQPKQPGFF-TERNPPESGSS--SSKRSLLSTNEITISLIEGR 606
L P+QP F T RN + + SS++ ++S+NEIT +++ GR
Sbjct: 806 LAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | ||||||
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.978 | 0.713 | 0.644 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.976 | 0.729 | 0.616 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.981 | 0.727 | 0.603 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.980 | 0.722 | 0.602 | 0.0 | |
| 224122974 | 729 | predicted protein [Populus trichocarpa] | 0.985 | 0.818 | 0.610 | 0.0 | |
| 224115106 | 755 | predicted protein [Populus trichocarpa] | 0.948 | 0.761 | 0.628 | 0.0 | |
| 302143143 | 910 | unnamed protein product [Vitis vinifera] | 0.957 | 0.637 | 0.605 | 0.0 | |
| 302143165 | 657 | unnamed protein product [Vitis vinifera] | 0.978 | 0.902 | 0.599 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.991 | 0.723 | 0.586 | 0.0 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.985 | 0.246 | 0.575 | 0.0 |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2032), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/597 (64%), Positives = 466/597 (78%), Gaps = 4/597 (0%)
Query: 2 PQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVP 61
PQL+PN +YT+ ++S E++Y+F+LI SSV S +VMN G QR TW+ +T WA F
Sbjct: 224 PQLEPNMLYTYGFISTATEMYYKFDLINSSVASRIVMNSSGAAQRFTWITRTNSWARF-- 281
Query: 62 FSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLD 121
S ++LDQCD+YALCGAY CN+N C CLEGF+PKSP +W + + SDGCVRRT+LD
Sbjct: 282 -SAVLLDQCDDYALCGAYGSCNVNKQPV-CACLEGFIPKSPKDWSIQEWSDGCVRRTKLD 339
Query: 122 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLW 181
C+ GD FL+ VKLPD S VD L ECK+LC KNCSC AYAN+D+RGGGSGCLLW
Sbjct: 340 CDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKDLCLKNCSCVAYANSDIRGGGSGCLLW 399
Query: 182 FHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFV 241
F +LID +EL+ GQDL++R+AASEL +IE+ + KK++ I++ +++ + GV++L +
Sbjct: 400 FDELIDTRELTTGGQDLYIRIAASELYNIEKNRSSDKKQLGIIVGTIITIVGVLVLAFIL 459
Query: 242 YLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFG 301
Y +++ +KQ S +Y D R+E+MELP FD IANAT+NFS +NKLGEGGFG
Sbjct: 460 YARRKKLKKQANMKTSHLQNYEDEDQRKEDMELPTFDLSTIANATDNFSSRNKLGEGGFG 519
Query: 302 PVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361
VYKG LIEGQE+A KRLSK+SGQG+ EF+NEV+LIAKLQHRNLVKL+GCC + DER+LI
Sbjct: 520 SVYKGTLIEGQEVAVKRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDERILI 579
Query: 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 421
YEY+PNKSL+ FIFD DW I+GGIARGLLYLHQDSRLRIIHRDLKA+NVL
Sbjct: 580 YEYMPNKSLDYFIFDKKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKAANVL 639
Query: 422 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLV 481
LDN MNPKISDFG+AR FG DQTEANTN++VGTYGYM PEYA+DG FSVKSDVFSFGVLV
Sbjct: 640 LDNGMNPKISDFGLARTFGGDQTEANTNKIVGTYGYMSPEYAVDGFFSVKSDVFSFGVLV 699
Query: 482 LEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLL 541
LEIV GK+NRGF H DHHHNLLGHAWRLW E P+ELIN+ S +LSE++RCI VGLL
Sbjct: 700 LEIVSGKKNRGFNHPDHHHNLLGHAWRLWNEGMPLELINEPEQDSCTLSEIIRCIHVGLL 759
Query: 542 CVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEI 598
CVQ+RPEDRPNMSSV++MLS SLPQPKQPGFFTERN PE SSSS + STNEI
Sbjct: 760 CVQKRPEDRPNMSSVIVMLSSGISLPQPKQPGFFTERNLPERESSSSNQKSFSTNEI 816
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/607 (61%), Positives = 452/607 (74%), Gaps = 15/607 (2%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
P+L+P+P+YTFE+V N NEV+++F L SSV S + + P G Q TW QT W
Sbjct: 220 FPELKPDPIYTFEFVFNRNEVYFKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDW---Y 276
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
F+ ++D+C+NYALCGA A C+ NS S C+CL+GF+ KSP+EW+ + + GC+RRT L
Sbjct: 277 VFATAVVDRCENYALCGANARCDSNS-SPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPL 335
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
DC DGF VKLPDT S D+ SL+EC+ LC +NCSC AYAN D RG GSGCL
Sbjct: 336 DCTDKDGFQSYTGVKLPDTSSSWYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLR 395
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGF 240
WF DLID + L+E GQD+++R+AAS+ KK KKK ++ +V+L + +++LG
Sbjct: 396 WFGDLIDTRRLAEGGQDIYIRLAASQSGVTGEKKRKKKTHAGVIGGAVILGSSILILGIV 455
Query: 241 VYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGF 300
+ +R+HRK G ++ DR +EEEMELP+ D I +AT+NFS KLGEGGF
Sbjct: 456 FCIRRRKHRKNG--------NFEDR--KEEEMELPMLDLTTIEHATDNFSSSKKLGEGGF 505
Query: 301 GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360
G VYKG LIEGQEIA KRLSKSSGQG+ EF+NEVLLIAKLQHRNLVKL+GCC DE+ML
Sbjct: 506 GAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKML 565
Query: 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 420
IYEY+PN+SL+ FIFD TR KFLDWSKR II GIARGLLYLHQDSRLRIIHRD+KASN+
Sbjct: 566 IYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNI 625
Query: 421 LLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
LLDNE+NPKISDFG+AR FG DQTEANT RVVGTYGYM PEYA+DG FSVKSDVFSFGVL
Sbjct: 626 LLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVL 685
Query: 481 VLEIVCGKRNRGFYHADHHH-NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVG 539
VLEIV GK+NRGF H D++ NLLGHAW LW P+ELI++ S + SE LRCI V
Sbjct: 686 VLEIVSGKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSCTPSEALRCIHVA 745
Query: 540 LLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEIT 599
LLCVQQRPEDRPNMSSVVLML E LPQPKQPGFF NPPE +SS+K S NE+T
Sbjct: 746 LLCVQQRPEDRPNMSSVVLMLGSENPLPQPKQPGFFMGSNPPEKDTSSNKHQSHSANEVT 805
Query: 600 ISLIEGR 606
++L++ R
Sbjct: 806 VTLLQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1947), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/608 (60%), Positives = 466/608 (76%), Gaps = 13/608 (2%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
P+L+PNPV+ + +V NE E+++ + L+ SSV S +V+NP G+ QRL W+ +T+ W +
Sbjct: 222 FPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVY- 280
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
S D CD+YALCGAY+ CN++ S +C C++GFVPK P +WD +D S+GCVR+T L
Sbjct: 281 --STAYKDDCDSYALCGAYSTCNIH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSL 337
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
DC+ GDGF K VKLPDTR S + ++L EC LC +NCSC+AY N+D++GGGSGCLL
Sbjct: 338 DCQKGDGFAKYSGVKLPDTRNSWFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLL 397
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGF 240
WF DLID+KE +E+GQD ++RMAASELD I + ++ VI S + + G+ILL
Sbjct: 398 WFGDLIDIKEFTENGQDFYIRMAASELDAISKVTKRR-----WVIVSTVSIAGMILLSLV 452
Query: 241 V--YLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEG 298
V YL K+R +++G T+ ++ + + R+E++ELP+F I NAT NFS NKLGEG
Sbjct: 453 VTLYLLKKRLKRKGTTELNN--EGAETNERQEDLELPLFXLDTILNATHNFSRNNKLGEG 510
Query: 299 GFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358
GFGPVYKG+L +G+EIA KRLSK S QG++EF+NEV+ I+KLQHRNLVKL+GCC +E+
Sbjct: 511 GFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEK 570
Query: 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKAS 418
MLIYEY+PNKSLN FIFD +S LDW KR II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 571 MLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKAD 630
Query: 419 NVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG 478
NVLLDNEMNP+ISDFGMAR+FG ++T A T RVVGTYGYM PEYAIDG++SVKSDVFSFG
Sbjct: 631 NVLLDNEMNPRISDFGMARSFGGNETIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFG 690
Query: 479 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQV 538
VL LEI+ GKRNRGF H DH NLLGHAW L++E P+ELI+ S+G +Y+ SEVLR + V
Sbjct: 691 VLXLEIISGKRNRGFNHPDHDLNLLGHAWTLYMEGTPLELIDASVGYTYNQSEVLRALNV 750
Query: 539 GLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEI 598
GLLCVQ+ P+DRPNMSSVVLMLS E +LPQPK+PGFFTERN E+ S K ++ S NE
Sbjct: 751 GLLCVQRHPDDRPNMSSVVLMLSSEGALPQPKEPGFFTERNMLEADSLQCKHAVFSGNEH 810
Query: 599 TISLIEGR 606
TI+++EGR
Sbjct: 811 TITILEGR 818
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/626 (60%), Positives = 462/626 (73%), Gaps = 32/626 (5%)
Query: 2 PQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVP 61
PQL PNPV+ F +VSN++E++Y + L +SV S ++++ G +R W+++TQ W F
Sbjct: 208 PQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVSRLIVSEKGALERHNWIDRTQSWTLF-- 265
Query: 62 FSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLD 121
FS + DQCD Y LCGAYA CN+NS C CLEGFVPKSP++W D SDGCVRRT+L
Sbjct: 266 FS-VPTDQCDTYLLCGAYASCNINSYPV-CSCLEGFVPKSPTDWSASDWSDGCVRRTELS 323
Query: 122 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLW 181
C GDGF K + +KLPDT S VD + L EC+ +C +NCSC AYAN+D+RG SGCLLW
Sbjct: 324 CHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCLRNCSCLAYANSDIRG--SGCLLW 381
Query: 182 FHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFV 241
F LIDM++ +E GQDL++R+AASEL K K+VAI+++ +++ G+ LG +
Sbjct: 382 FDHLIDMRKFTEGGQDLYIRIAASEL----AKGKSHGKRVAIIVSCLIIGMGMTALGSLL 437
Query: 242 YLWKRRHRKQGKT-----------------DGSSKL----DYNDRGNREEEMELPIFDWM 280
Y KR+ G+ G +K +Y D G +E+ EL FD +
Sbjct: 438 YTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKETYIENYGDNGAKED-TELIAFDLI 496
Query: 281 AIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
I NAT NFS+ NKLGEGGFGPVYKG L++GQEIA KRLS++SGQG +EF+NEV+LIA+L
Sbjct: 497 TIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSETSGQGGKEFKNEVILIARL 556
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
QHRNLVKL+GCC DE+MLIYEY+PNKSL+ FIFD RS LDW +IIGGIARGLL
Sbjct: 557 QHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSMLLDWHMCFRIIGGIARGLL 616
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
YLHQDSRLRIIHRDLKASN+LLD +MNPKISDFG+AR FG DQ ANT RVVGTYGYM P
Sbjct: 617 YLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGKDQNAANTKRVVGTYGYMSP 676
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
EYA+DGLFSVKSDVFSFGVLVLEIV GKRNRGF H DH NLLGHAWRLW+EER +EL +
Sbjct: 677 EYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDHSLNLLGHAWRLWMEERALELFD 736
Query: 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNP 580
K YS+S+VLRCIQVGLLCVQ+ P DRP+MS+VV+ML E SLPQPKQPGF+TER+P
Sbjct: 737 KFSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAVVVMLGSESSLPQPKQPGFYTERDP 796
Query: 581 PESGSSSSKRSLLSTNEITISLIEGR 606
E+ SS+SK + S NEI+ +LIE R
Sbjct: 797 FEADSSTSKERVWSRNEISSTLIEPR 822
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122974|ref|XP_002330410.1| predicted protein [Populus trichocarpa] gi|222871795|gb|EEF08926.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/606 (61%), Positives = 456/606 (75%), Gaps = 9/606 (1%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
+P N VY ++VS NE +YRF+L+ SS+PS +V++P G PQRLTW+ QT W +
Sbjct: 133 VPDTVSNTVYREQFVSTPNESYYRFDLLNSSIPSRLVISPAGIPQRLTWIPQTNLWGSY- 191
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
S + +DQCD Y LCG +C++N + A C CLE FVPK+P W+ D GCVRRTQL
Sbjct: 192 --SVVQIDQCDTYTLCGVNGICSIN-DQAVCSCLESFVPKTPDRWNSQDWFGGCVRRTQL 248
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
C +GDGFLK VKLPD S V+ +SL EC ++C NCSC AY+N+D+RGGGSGC L
Sbjct: 249 GCNNGDGFLKHTGVKLPDMSDSWVNTSMSLNECGDMCLSNCSCVAYSNSDIRGGGSGCYL 308
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGF 240
WF +L D K+L + G+DL++RMAASEL R+K ++ I++ ++ V++LG
Sbjct: 309 WFSELKDTKQLPQGGEDLYIRMAASELRISSRRKLRR-----IIVGILIPSVVVLVLGLI 363
Query: 241 VYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGF 300
+Y+ ++ R+Q T +Y D +R++ MELP FD+ I NAT+ FS KLGEGGF
Sbjct: 364 LYMRRKNPRRQAFTPSIRIENYKDESDRKDGMELPAFDFTTIENATDCFSFNKKLGEGGF 423
Query: 301 GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360
G VYKG L +GQEIA KRLSK SGQG+ EF+NEV+LIAKLQHRNLVKL+GCC + +ERML
Sbjct: 424 GSVYKGTLSDGQEIAVKRLSKDSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGNERML 483
Query: 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 420
IYEY+PNKSL++FIFD T + LDW R IIGGIARGLLYLHQDSRLRIIHRDLKASNV
Sbjct: 484 IYEYMPNKSLDNFIFDQTNTNILDWQTRLNIIGGIARGLLYLHQDSRLRIIHRDLKASNV 543
Query: 421 LLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
LLD+ MNPKISDFGMAR FG DQ EANT+R+VGTYGYM PEYA+DGLFS+KSDVFSFGVL
Sbjct: 544 LLDDSMNPKISDFGMARTFGGDQIEANTSRIVGTYGYMSPEYAVDGLFSIKSDVFSFGVL 603
Query: 481 VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGL 540
VLEIV K+NRGF+H DH+HNLLGHAWRLW E RP+EL+NK + S SLSEV+RCIQVGL
Sbjct: 604 VLEIVSAKKNRGFFHPDHNHNLLGHAWRLWNEGRPLELMNKKIDDSSSLSEVIRCIQVGL 663
Query: 541 LCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITI 600
LCVQQRPEDRP+MS+VV+MLS E SLPQPKQPGF+TER+ E +SSS S N I+
Sbjct: 664 LCVQQRPEDRPSMSTVVVMLSSEISLPQPKQPGFYTERSFSEQETSSSSIRSASRNNISF 723
Query: 601 SLIEGR 606
++ E R
Sbjct: 724 TVFEPR 729
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115106|ref|XP_002316941.1| predicted protein [Populus trichocarpa] gi|222860006|gb|EEE97553.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/582 (62%), Positives = 448/582 (76%), Gaps = 7/582 (1%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
+P+ N VY ++VS E +Y F+L+ SSVPS +V+NP PQRLTW+ QT W +
Sbjct: 180 VPETISNTVYGEQFVSTATESYYTFDLLNSSVPSRLVINPSSIPQRLTWITQTNLWGSY- 238
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
S + +DQCD Y LCGA +C+ NSN A C CLE F+P++P W+ D S GCVRRTQL
Sbjct: 239 --SVVQIDQCDTYTLCGANGICS-NSNGAVCSCLESFIPRTPESWNKQDWSGGCVRRTQL 295
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
C++GDGFL+ VKLPD S V+ +SL+EC+ +C NCSC AY N+D+R G SGC L
Sbjct: 296 GCKNGDGFLQITGVKLPDMSDSWVNTSMSLVECRNMCLSNCSCVAYGNSDIRRGASGCYL 355
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGF 240
WF DL D K L GQDL++RMAASEL E+K K+K+ I+I +++ +++LG
Sbjct: 356 WFDDLWDTKHLPLGGQDLYIRMAASELSIYEKKSSSKRKRRRIIIGTLISAVVLLVLGFM 415
Query: 241 VYLWKRRHRKQGKTDGSSKLD-YNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGG 299
+Y+ +RR +QGK S ++D D R+++MELP FD++ I NAT+ FS NKLGEGG
Sbjct: 416 LYMRRRRKTRQGKK--SIRIDNLKDESGRKDDMELPAFDFITIKNATDYFSYNNKLGEGG 473
Query: 300 FGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359
FG VYKG L +GQEIA KRLSK+SGQG++EF+NEV+LIAKLQHRNLVKL+GCC + DERM
Sbjct: 474 FGSVYKGTLTDGQEIAVKRLSKNSGQGLKEFKNEVILIAKLQHRNLVKLLGCCIEGDERM 533
Query: 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419
LIYEY+PNKSL++FIFD LDW IIGGIARGLLYLHQDSRLRIIHRDLKASN
Sbjct: 534 LIYEYMPNKSLDNFIFDKKSRNLLDWQTHMNIIGGIARGLLYLHQDSRLRIIHRDLKASN 593
Query: 420 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 479
VLLDN MNPKISDFGMAR FG DQ EANTNR+VGTYGY+ PEYA+DGLFS+KSDVFSFGV
Sbjct: 594 VLLDNSMNPKISDFGMARIFGGDQIEANTNRIVGTYGYISPEYAVDGLFSIKSDVFSFGV 653
Query: 480 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVG 539
LVLEIV GK+NRGFYH DH+HNLLGHAW+LW E RP+EL++ ++ S SLSE+LR IQVG
Sbjct: 654 LVLEIVSGKKNRGFYHPDHNHNLLGHAWKLWNEGRPLELMDITIDDSSSLSEILRHIQVG 713
Query: 540 LLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPP 581
LLCVQQRP+DRP+MS+VV+MLS E SLPQPKQPGF+TERN P
Sbjct: 714 LLCVQQRPDDRPSMSTVVVMLSSEISLPQPKQPGFYTERNFP 755
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143143|emb|CBI20438.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/593 (60%), Positives = 457/593 (77%), Gaps = 13/593 (2%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
P+L+PNPV+ + +V NE E+++ + L+ SSV S +V+NP G+ QRL W+ +T+ W +
Sbjct: 204 FPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVY- 262
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
S D CD+YALCGAY+ CN++ S +C C++GFVPK P +WD +D S+GCVR+T L
Sbjct: 263 --STAYKDDCDSYALCGAYSTCNIH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSL 319
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
DC+ GDGF+K VKLPDTR S + ++L EC LC +NCSC+AY N+D++GGGSGCLL
Sbjct: 320 DCQKGDGFVKCSGVKLPDTRNSWFNESMNLKECASLCLRNCSCSAYTNSDIKGGGSGCLL 379
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGF 240
WF DLID+KE +E+GQD ++RMAASELD I + ++ VI S + + G+ILL
Sbjct: 380 WFGDLIDVKEFTENGQDFYIRMAASELDAISKVTKRR-----WVIVSTVSIAGMILLSLV 434
Query: 241 V--YLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEG 298
V YL K+R +++G T+ ++ + + R+E++ELP+FD I NAT NFS NKLGEG
Sbjct: 435 VTLYLLKKRLKRKGTTELNN--EGAETNERQEDLELPLFDLDTILNATHNFSRNNKLGEG 492
Query: 299 GFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358
GFGPVYKG+L +G+EIA KRLSK S QG++EF+NEV+ I+KLQHRNLVKL+GCC +E+
Sbjct: 493 GFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEK 552
Query: 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKAS 418
MLIYEY+PNKSLN FIFD +S LDW KR II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 553 MLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKAD 612
Query: 419 NVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG 478
NVLLDNEMNP+ISDFGMAR+FG ++T+A T RVVGTYGYM PEYAIDG++SVKSDVFSFG
Sbjct: 613 NVLLDNEMNPRISDFGMARSFGGNETQARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFG 672
Query: 479 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQV 538
VL+LEI+ GKRNRGF H DH NLLGHAW L++E P+ELI+ S+G +Y+ SEVLR + V
Sbjct: 673 VLLLEIISGKRNRGFNHPDHDLNLLGHAWTLYMERTPLELIDASVGDTYNQSEVLRALNV 732
Query: 539 GLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRS 591
GLLCVQ+ P+DRPNMSSVVLMLS E +L QPK+PGFFTERN E+ S K +
Sbjct: 733 GLLCVQRHPDDRPNMSSVVLMLSSEGALRQPKEPGFFTERNMLEADSLQCKHA 785
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143165|emb|CBI20460.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/607 (59%), Positives = 452/607 (74%), Gaps = 14/607 (2%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
PQL+PN VY++ ++ N+ E +Y F L+ SSV + +V++P G QR TW+++T W +
Sbjct: 64 FPQLRPNSVYSYAFIFNDKETYYTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDW---I 120
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
+S D CD+YALCG Y +C +N S KCEC++GF PK S WD+ D SDGCVR T +
Sbjct: 121 LYSSAQTDDCDSYALCGVYGICEIN-RSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPM 179
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
C+ +GFLK VKLPDTR S + ++L EC LC NCSCTAY N+D+RGGGSGCLL
Sbjct: 180 VCQKSNGFLKYSGVKLPDTRNSWFNESMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLL 239
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKK-KKVAIVITSVLLVTGVILLGG 239
WF DLID++E +E+GQD ++RMA SELD K K VI S + + G+ILL
Sbjct: 240 WFGDLIDIREYTENGQDFYIRMAKSELDAFAMTNSGSKGAKRKWVIVSTVSIVGIILLSL 299
Query: 240 FVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGG 299
+ L+ R ++ L + REE++ELP+FD I NAT+NFS+ NKLGEGG
Sbjct: 300 VLTLYVLRKKR---------LRRKEINEREEDLELPLFDLDTILNATDNFSNDNKLGEGG 350
Query: 300 FGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359
FGPVYKG+L +G+EIA KRLSK S QG++EF+NEV I+KLQHRNLVKL+GCC +E+M
Sbjct: 351 FGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVKLLGCCIHGEEKM 410
Query: 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419
LIYEY+PNKSL+ FIFD +S LDW KR II GIARGLLYLHQDSRLRIIHRDLKA N
Sbjct: 411 LIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADN 470
Query: 420 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 479
VLLDNEMNP+ISDFGMAR+F +++EA T RVVGTYGYM PEYAIDG++S+KSDVFSFGV
Sbjct: 471 VLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGYMSPEYAIDGVYSIKSDVFSFGV 530
Query: 480 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVG 539
LVLEIV GKRNRGF H DH NLLGHAW L++E +P+ELI+ S+G S + SEVLR + VG
Sbjct: 531 LVLEIVTGKRNRGFNHPDHALNLLGHAWTLYMEGKPLELIDASMGDSCNQSEVLRALNVG 590
Query: 540 LLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEIT 599
LLCVQ+ P+DRP+MSSVVLMLS E +L QPK+PGFFTERN E SS+SK ++ S NE T
Sbjct: 591 LLCVQRSPDDRPSMSSVVLMLSSESALHQPKEPGFFTERNMLEGSSSASKHAIFSGNEHT 650
Query: 600 ISLIEGR 606
I+LIEGR
Sbjct: 651 ITLIEGR 657
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/609 (58%), Positives = 460/609 (75%), Gaps = 8/609 (1%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
M L+PNP+YTFE+V N+ E++Y++ + SSV S MV++P G QR TW+++TQ W ++
Sbjct: 228 MINLKPNPIYTFEFVFNQEEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYL 287
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
+ +D CD +ALCGA+ VCN+N NS C+CL+ F PKS EW D S GCVR+ L
Sbjct: 288 TAN---MDNCDRFALCGAHGVCNIN-NSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPL 343
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
DC +G+GF+K +K+PDTR S + I+L EC+E+C KNCSCTAYAN DVR GGSGC+L
Sbjct: 344 DCSNGEGFIKYTGIKVPDTRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVL 403
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGF 240
WF DLID+++ +E+GQD+++R+AAS +D + + KK+ ++ IVI L+ ++ L F
Sbjct: 404 WFGDLIDIRQYNENGQDIYIRIAASVIDKPVKSRGKKRVRI-IVIPVSLVAFSLLALCLF 462
Query: 241 VYLWKRRHRKQGKTDGSSKLD-YNDRG--NREEEMELPIFDWMAIANATENFSDKNKLGE 297
+ ++ ++Q +G+ + DR +R E++ELP+FD + +AT FS NKLG+
Sbjct: 463 LRFLRKNKQQQLTREGNVVTNPEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQ 522
Query: 298 GGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357
GGFGPVYKG+L +GQEIA KRLSK S QG+ EF NEV+ IAKLQHRNLVKL+GCC + +E
Sbjct: 523 GGFGPVYKGILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEE 582
Query: 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA 417
RMLIYEY+PNKSL+ FIFD R+ LDW+KR II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 583 RMLIYEYMPNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKA 642
Query: 418 SNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSF 477
SN+LLD EMNPKISDFGMAR+FG D+T ANT+R+VGTYGYM PEYAIDGLFSVKSDVFSF
Sbjct: 643 SNILLDYEMNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSF 702
Query: 478 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQ 537
GVLVLEIV G++NRGF HA+H NLLGHAW L E RP++LI++S+ + +SEVLR I+
Sbjct: 703 GVLVLEIVSGRKNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIE 762
Query: 538 VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNE 597
V LLCVQ+ PEDRP MS VVLMLS + LPQPK+PGFFTER+ SS+ K + S NE
Sbjct: 763 VALLCVQKSPEDRPKMSIVVLMLSSDIVLPQPKEPGFFTERDLSNDSSSTIKHEISSVNE 822
Query: 598 ITISLIEGR 606
+T +L+E R
Sbjct: 823 LTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/638 (57%), Positives = 460/638 (72%), Gaps = 41/638 (6%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
PQL+PN VY++ ++ N+ E +Y F L+ SSV + +V++P G QR TW+++T W +
Sbjct: 218 FPQLRPNSVYSYAFIFNDKETYYTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDW---I 274
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
+S D CD+YALCG Y +C +N S KCEC++GF PK S WD+ D SDGCVR T +
Sbjct: 275 LYSSAQTDDCDSYALCGVYGICEIN-RSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPM 333
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
C+ +GFLK VKLPDTR S + ++L EC LC NCSCTAY N+D+RGGGSGCLL
Sbjct: 334 VCQKSNGFLKYSGVKLPDTRNSWFNESMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLL 393
Query: 181 WFHDLIDMKELSESGQDLFVRMAASEL------------DDIERKKPK------------ 216
WF DLID++E +E+GQD ++RMA SEL + ++ K
Sbjct: 394 WFGDLIDIREYTENGQDFYIRMAKSELGMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTN 453
Query: 217 ---KKKKVAIVITSVLLVTGVILLGGFVYLW---KRRHRKQGKTDGSSKLDYNDRG---- 266
K K VI S + + G+ILL + L+ K+R R++G S +N +G
Sbjct: 454 SGSKGAKRKWVIVSTVSIVGIILLSLVLTLYVLRKKRLRRKGNNLYSK---HNCKGAEIN 510
Query: 267 NREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG 326
REE++ELP+FD I NAT+NFS+ NKLGEGGFGPVYKG+L +G+EIA KRLSK S QG
Sbjct: 511 EREEDLELPLFDLDTILNATDNFSNDNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQG 570
Query: 327 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 386
++EF+NEV I+KLQHRNLVKL+GCC +E+MLIYEY+PNKSL+ FIFD +S LDW
Sbjct: 571 LDEFKNEVTHISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWP 630
Query: 387 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446
KR II GIARGLLYLHQDSRLRIIHRDLKA NVLLDNEMNP+ISDFGMAR+F +++EA
Sbjct: 631 KRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEA 690
Query: 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506
T RVVGTYGYM PEYAIDG++S+KSDVFSFGVLVLEIV GKRNRGF H DH NLLGHA
Sbjct: 691 RTKRVVGTYGYMSPEYAIDGVYSIKSDVFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHA 750
Query: 507 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 566
W L++E +P+ELI+ S+G S + SEVLR + VGLLCVQ+ P+DRP+MSSVVLMLS E +L
Sbjct: 751 WTLYMEGKPLELIDASMGDSCNQSEVLRALNVGLLCVQRSPDDRPSMSSVVLMLSSESAL 810
Query: 567 PQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIE 604
QPK+PGFFTERN E SS+SK ++ S NE TI+LIE
Sbjct: 811 HQPKEPGFFTERNMLEGSSSASKHAIFSGNEHTITLIE 848
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.567 | 0.439 | 0.631 | 3.2e-173 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.953 | 0.709 | 0.529 | 1.9e-163 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.925 | 0.665 | 0.507 | 4.4e-155 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.938 | 0.669 | 0.495 | 1.2e-152 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.942 | 0.674 | 0.493 | 7.6e-151 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.965 | 0.694 | 0.425 | 1e-128 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.910 | 0.650 | 0.454 | 3.7e-126 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.947 | 0.676 | 0.435 | 4.3e-125 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.963 | 0.703 | 0.420 | 1.1e-121 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.854 | 0.636 | 0.449 | 4.7e-119 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 3.2e-173, Sum P(2) = 3.2e-173
Identities = 218/345 (63%), Positives = 263/345 (76%)
Query: 263 NDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS 322
+ R EE++ELP D ++ AT FS NKLG+GGFGPVYKG L GQE+A KRLS++
Sbjct: 439 SSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRT 498
Query: 323 SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF 382
S QG+EEF+NE+ LIAKLQHRNLVK++G C +ERMLIYEY PNKSL+ FIFD R +
Sbjct: 499 SRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRE 558
Query: 383 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442
LDW KR +II GIARG+LYLH+DSRLRIIHRDLKASNVLLD++MN KISDFG+AR G D
Sbjct: 559 LDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGD 618
Query: 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 502
+TEANT RVVGTYGYM PEY IDG FS+KSDVFSFGVLVLEIV G+RNRGF + +H NL
Sbjct: 619 ETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNL 678
Query: 503 LGHAWRLWIEERPVELINKSLGGSYS-LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
LGHAWR ++E++ E+I++++ S + +SEVLR I +GLLCVQQ P+DRPNMS VVLMLS
Sbjct: 679 LGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLS 738
Query: 562 GERSLPQPKQPGFFTERNPPEXXXXXXXXXXXXTNEITISLIEGR 606
E L P+QPGFF ERN N T+S+I+ R
Sbjct: 739 SEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1591 (565.1 bits), Expect = 1.9e-163, P = 1.9e-163
Identities = 320/604 (52%), Positives = 413/604 (68%)
Query: 7 NPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLI 66
N ++ +++ S+ EV Y + + + S +V+N G R +Q Q W + +
Sbjct: 234 NSLFDYKFTSSAQEVNYSWTP-RHRIVSRLVLNNTGKLHRFIQSKQNQ-W---ILANTAP 288
Query: 67 LDQCDNYALCGAYAVCNMNS-NSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHG 125
D+CD Y++CGAYAVC +NS N+ C CL+GF PKS +W++ + GCV +CE
Sbjct: 289 EDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKK 348
Query: 126 DGFLKRESVKLPDTRFSLVD--NKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFH 183
D F+K +KLPDT +S D N+++L +CK CS NCSCTAYAN D+R GG GCLLWF
Sbjct: 349 DAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFG 408
Query: 184 DLIDMKELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXFVYL 243
DL+DM+E S GQD+++RM ++++ R V F
Sbjct: 409 DLVDMREYSSFGQDVYIRMGFAKIEFKGRE-------VVGMVVGSVVAIAVVLVVVFA-C 460
Query: 244 WKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPV 303
++++ K+ + + K G EE+++LPIFD I+ AT++FS N LG GGFGPV
Sbjct: 461 FRKKIMKRYRGENFRK------GIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPV 514
Query: 304 YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363
YKG L +GQEIA KRLS +SGQG+EEF+NEV LIAKLQHRNLV+L+GCC Q +E MLIYE
Sbjct: 515 YKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYE 574
Query: 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423
Y+PNKSL+ FIFD RS LDW KR II G+ARG+LYLHQDSRLRIIHRDLKA NVLLD
Sbjct: 575 YMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLD 634
Query: 424 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 483
N+MNPKISDFG+A++FG DQ+E++TNRVVGTYGYMPPEYAIDG FSVKSDVFSFGVLVLE
Sbjct: 635 NDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLE 694
Query: 484 IVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS-LGGSYSLSEVLRCIQVGLLC 542
I+ GK NRGF HADH NLLGH W++W+E+R +E+ + L + + EVLRCI V LLC
Sbjct: 695 IITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLC 754
Query: 543 VQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPEXXXXXXXXXXXXTNEITISL 602
VQQ+PEDRP M+SVVLM + SLP P QPGFFT RN P+ NE++I++
Sbjct: 755 VQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRNVPDISSSLSLRSQ---NEVSITM 811
Query: 603 IEGR 606
++GR
Sbjct: 812 LQGR 815
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1512 (537.3 bits), Expect = 4.4e-155, P = 4.4e-155
Identities = 301/593 (50%), Positives = 399/593 (67%)
Query: 12 FEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCD 71
+ + +++ EV Y + + K+++ S + +N G QRLTW E TQ W +S D CD
Sbjct: 235 YNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLW-YSPK--DLCD 291
Query: 72 NYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKR 131
NY +CG + C+ NS C C++GF P + WDL D S GC+R+T+L C+ DGF +
Sbjct: 292 NYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRL 350
Query: 132 ESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKEL 191
+ +KLPDT ++VD +I L CKE C ++C+CTA+ANAD+R GGSGC++W +++DM+
Sbjct: 351 KRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNY 410
Query: 192 SESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXFVYLWKRRHRK- 250
++ GQDL+VR+AA+EL+D +R + WKR+ ++
Sbjct: 411 AKGGQDLYVRLAAAELED-KRIKNEKIIG-----SSIGVSILLLLSFVIFHFWKRKQKRS 464
Query: 251 ---------QGKTDGS-------SKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNK 294
Q ++ S S+ Y + + E +ELP+ + A+A AT NFS+ NK
Sbjct: 465 ITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNK 524
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 354
LG+GGFG VYKG L++G+EIA KRLSK S QG +EF NEV LIAKLQH NLV+L+GCC
Sbjct: 525 LGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVD 584
Query: 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 414
+ E+MLIYEYL N SL+ +FD TRS L+W KR II GIARGLLYLHQDSR RIIHRD
Sbjct: 585 KGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRD 644
Query: 415 LKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDV 474
LKASNVLLD M PKISDFGMAR FG ++TEANT RVVGTYGYM PEYA+DG+FS+KSDV
Sbjct: 645 LKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDV 704
Query: 475 FSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK----SLGGSYSLS 530
FSFGVL+LEI+ GKRN+GFY+++ NLLG WR W E +E+++ SL +
Sbjct: 705 FSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTH 764
Query: 531 EVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPE 582
E+LRCIQ+GLLCVQ+R EDRP MSSV++ML E + +PQPK+PGF R+P E
Sbjct: 765 EILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLE 817
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1489 (529.2 bits), Expect = 1.2e-152, P = 1.2e-152
Identities = 298/601 (49%), Positives = 398/601 (66%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
+P++QP F + +++ EV Y F + KS V S + ++ G QR TW+E Q W F
Sbjct: 230 VPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFW 289
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
++ DQCD Y CG Y C+ N+ S C C++GF P++P W L D SDGCVR+T L
Sbjct: 290 -YAPK--DQCDEYKECGVYGYCDSNT-SPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLL 345
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
C GDGF++ + +KLPDT + VD I + EC++ C ++C+CTA+AN D+RG GSGC+
Sbjct: 346 SCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVT 405
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXF 240
W +L D++ ++ GQDL+VR+AA++L+D +R
Sbjct: 406 WTGELFDIRNYAKGGQDLYVRLAATDLED-KRNRSAKIIG-----SSIGVSVLLLLSFII 459
Query: 241 VYLWKRRHRKQGKTDG--------SSKLDYND----------RGNREEEMELPIFDWMAI 282
+LWKR+ ++ + S L N+ R N +++ELP+ ++ +
Sbjct: 460 FFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEV 519
Query: 283 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 342
A AT NFS+ NKLG+GGFG VYKG L++GQE+A KRLSK+S QG +EF+NEV LIA+LQH
Sbjct: 520 AMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQH 579
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
NLV+L+ CC E+MLIYEYL N SL+ +FD +R+ L+W R II GIARGLLYL
Sbjct: 580 INLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYL 639
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
HQDSR RIIHRDLKASN+LLD M PKISDFGMAR FG D+TEANT +VVGTYGYM PEY
Sbjct: 640 HQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEY 699
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
A+DG+FS+KSDVFSFGVL+LEI+ KRN+GFY++D NLLG WR W E + +E+I+
Sbjct: 700 AMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPI 759
Query: 523 LGGSYSL---SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTER 578
+ S S E+LRCIQ+GLLCVQ+R EDRP MS V+LML E + +PQPK PG+ ER
Sbjct: 760 ITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLER 819
Query: 579 N 579
+
Sbjct: 820 S 820
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1472 (523.2 bits), Expect = 7.6e-151, P = 7.6e-151
Identities = 298/604 (49%), Positives = 398/604 (65%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV 60
+P ++P + N +V Y + + K+++ S++ ++ G QRLTWME Q W
Sbjct: 229 VPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLW 288
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
+S D CDNY CG Y C+ N+ S C C++GF P + + L D S GCVR+T+L
Sbjct: 289 -YSPK--DLCDNYKECGNYGYCDANT-SPICNCIKGFEPMN-EQAALRDDSVGCVRKTKL 343
Query: 121 DCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLL 180
C+ DGF++ + ++LPDT + VD I L EC+E C K C+CTA+AN D+R GGSGC++
Sbjct: 344 SCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVI 403
Query: 181 WFHDLIDMKELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXF 240
W L D++ ++ GQDL+VR+AA +L+D +R
Sbjct: 404 WSGGLFDIRNYAKGGQDLYVRVAAGDLED-KRIKSKKIIG-----SSIGVSILLLLSFII 457
Query: 241 VYLWKRRHRKQ----------GKTDGS--SKL-----DYNDRGNREEEMELPIFDWMAIA 283
+ WKR+ ++ ++ S ++L Y + N+ + +ELP+ +W A+A
Sbjct: 458 FHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALA 517
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 343
AT NFS NKLG+GGFG VYKG+L++G+EIA KRLSK S QG +EF NEV LIAKLQH
Sbjct: 518 MATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHI 577
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
NLV+L+GCC + E+MLIYEYL N SL+ +FD TRS L+W KR II GIARGLLYLH
Sbjct: 578 NLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLH 637
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
QDSR RIIHRDLKASNVLLD M PKISDFGMAR FG ++TEANT RVVGTYGYM PEYA
Sbjct: 638 QDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYA 697
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK-- 521
+DG+FS+KSDVFSFGVL+LEI+ GKRN+GFY+++ NLLG WR W E + +E+++
Sbjct: 698 MDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPIN 757
Query: 522 --SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTER 578
+L + E+LRCIQ+GLLCVQ+R EDRP MSSV++ML E + +PQPK+PGF R
Sbjct: 758 IDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGR 817
Query: 579 NPPE 582
+ E
Sbjct: 818 SSLE 821
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1245 (443.3 bits), Expect = 1.0e-128, Sum P(2) = 1.0e-128
Identities = 266/625 (42%), Positives = 374/625 (59%)
Query: 7 NPVYTFEYVS---NENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKW--APFVP 61
N +Y F+ S + V++ + SS + P G ++ W + + W + P
Sbjct: 233 NYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKP 292
Query: 62 FSGLILDQCDNYALCGAYAVCNMNS--NSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQ 119
+ +C+ Y CG Y+VC+ + +S KC C++GF P +W+ D S GC RR
Sbjct: 293 ST-----ECEKYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVP 347
Query: 120 LDCEHG------DGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRG 173
L+C DGF + +K+PD ++ N CK++C+++CSC AYA
Sbjct: 348 LNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHNNSET--CKDVCARDCSCKAYALVV--- 402
Query: 174 GGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXX 233
G GC++W DLIDM+ G + +R+A S+L + V
Sbjct: 403 -GIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGG-GKENSTLWIIVFSVIGAFLLGLC 460
Query: 234 XXXXXXF-----VYLWKRRHRKQGKTDGSSKLDYNDR------GNREEEMELPIFDWMAI 282
F +LWK++ +D DY+ G++ + +LPIF + ++
Sbjct: 461 IWILWKFKKSLKAFLWKKKDITV--SDIIENRDYSSSPIKVLVGDQVDTPDLPIFSFDSV 518
Query: 283 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 342
A+AT +F+++NKLG+GGFG VYKG EG+EIA KRLS S QG+EEF+NE+LLIAKLQH
Sbjct: 519 ASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQH 578
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
RNLV+L+GCC + +E+ML+YEY+PNKSL+ F+FD ++ LDW KR ++IGGIARGLLYL
Sbjct: 579 RNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYL 638
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H+DSRL+IIHRDLKASN+LLD EMNPKISDFGMAR F Q ANT RVVGTYGYM PEY
Sbjct: 639 HRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEY 698
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
A++G+FS KSDV+SFGVL+LEIV G++N F DH +L+G+AW LW + + E+I+
Sbjct: 699 AMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGYAWHLWSQGKTKEMIDPI 757
Query: 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPP 581
+ + ++E +RCI VG+LC Q RPNM SV+LML + S LP P+QP F + N
Sbjct: 758 VKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSG 817
Query: 582 EXXXXXXXXXXXXTNEITISLIEGR 606
+ N++T + I GR
Sbjct: 818 DIELNFDGHDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1239 (441.2 bits), Expect = 3.7e-126, P = 3.7e-126
Identities = 277/609 (45%), Positives = 364/609 (59%)
Query: 4 LQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPL---GDPQRLTWMEQTQKWAPFV 60
L N +Y F+ S +E + S PS+++ + G + L W E +KW F
Sbjct: 233 LLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQ 292
Query: 61 PFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
+CD Y CG + +C+M ++ C C+ G+ S W S GC RRT L
Sbjct: 293 SEPD---SECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTPL 344
Query: 121 DCEHG-----DGFLKRESVKLPDTRFSLVD-NKISLLECKELCSKNCSCTAYANADVRGG 174
CE D FL +SVKLPD F + + N + +C+E C +NCSC AY+ G
Sbjct: 345 KCERNISVGEDEFLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNAYSLV----G 398
Query: 175 GSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXX 234
G GC++W DL+D+++ G L +R+A SE+ + + V
Sbjct: 399 GIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFA-- 456
Query: 235 XXXXXFVYLWKRRHRKQ------GK-TDGS--------SK---------LDYNDRGNREE 270
+ LW+ + +K GK TD S SK +D G
Sbjct: 457 ------LLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVN 510
Query: 271 EMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEF 330
ELP+F AIA AT +F +N+LG GGFGPVYKGVL +G+EIA KRLS SGQG++EF
Sbjct: 511 TSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEF 570
Query: 331 ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 390
+NE++LIAKLQHRNLV+L+GCC + +E+ML+YEY+PNKSL+ F+FD T+ +DW R
Sbjct: 571 KNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFS 630
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
II GIARGLLYLH+DSRLRIIHRDLK SNVLLD EMNPKISDFGMAR FG +Q EANT R
Sbjct: 631 IIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVR 690
Query: 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510
VVGTYGYM PEYA++GLFSVKSDV+SFGVL+LEIV GKRN + H +L+G+AW L+
Sbjct: 691 VVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL-RSSEHGSLIGYAWYLY 749
Query: 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQP 569
R EL++ + + S E LRCI V +LCVQ +RPNM+SV+LML + + L P
Sbjct: 750 THGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAP 809
Query: 570 KQPGFFTER 578
+QP F + R
Sbjct: 810 RQPTFTSTR 818
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 4.3e-125, P = 4.3e-125
Identities = 263/604 (43%), Positives = 358/604 (59%)
Query: 22 FYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAV 81
+Y + +S+ +V+ P G + +Q W V + ++C+ YA CG A
Sbjct: 256 YYTYTATNTSLQRFVVL-PNGTDICYMVRKSSQDWE-LVWYQPS--NECEYYATCGPNAK 311
Query: 82 CNMNSNS-AKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCE---HGDGFLKRESVKLP 137
C + + AKC CL+GF PK +W+ + S GC+R L CE GDGFL ++K P
Sbjct: 312 CTASQDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCETNQSGDGFLPMGNIKWP 371
Query: 138 DTRF--SLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESG 195
D + S V ++ C+ +C NCSC AY V +GCL W ++LIDM EL
Sbjct: 372 DFSYWVSTVGDEPG---CRTVCLNNCSCGAY----VYTATTGCLAWGNELIDMHELQTGA 424
Query: 196 QDLFVRMAASEL---DDIERXXXXXXXXVAXXXXXXXXX--XXXXXXXXFVY-LWKRRHR 249
L +++ ASEL I + V V+ W+ RH
Sbjct: 425 YTLNLKLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHGRNIKDAVHGSWRSRHS 484
Query: 250 KQGKTDGSSKLD------YNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPV 303
S+ LD ++D + EL ++ I AT NFSD NKLGEGGFGPV
Sbjct: 485 STQSQQNSAMLDISQSIRFDDDVEDGKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPV 544
Query: 304 YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363
Y G L G+E+A KRL ++SGQG+EEF+NEV+LIAKLQHRNLV+L+GCC R+E++L+YE
Sbjct: 545 YMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYE 604
Query: 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423
Y+PNKSL+ F+F+ + + LDW KR II GIARGLLYLH+DSRLR++HRDLKASN+LLD
Sbjct: 605 YMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLD 664
Query: 424 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 483
+M PKISDFGMAR FG DQ + NTNRVVGT+GYM PEYA++G+FSVKSDV+ FGVL+LE
Sbjct: 665 ADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILE 724
Query: 484 IVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCV 543
I+ GKR F+ + N+ G+AWR W E+ ELI+ + S S+ +VLRCI + LLCV
Sbjct: 725 IITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCV 784
Query: 544 QQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPEXXXXXXXXXXXXTNEITISL 602
Q ++RP++ +V+LMLS + S LP P+ P E +T++
Sbjct: 785 QDHADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREIESSKSSEKDRSHSIGTVTMTQ 844
Query: 603 IEGR 606
+ GR
Sbjct: 845 LHGR 848
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1197 (426.4 bits), Expect = 1.1e-121, P = 1.1e-121
Identities = 263/626 (42%), Positives = 367/626 (58%)
Query: 6 PNPVYT---FEY-VSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVP 61
PN Y FE +S++N + +++ +++ G + W Q+W ++
Sbjct: 222 PNMDYRINLFELTLSSDNRGSVSMSYAGNTLLYHFLLDSEGSVFQRDWNVAIQEWKTWLK 281
Query: 62 FSGLILDQCDNYALCGAYAVCNMNSNSAK-CECLEGFVPKSPSEWDLLDKSDGCVRRTQL 120
+CD YA CG +A C N S C C+ GF P+S +EW+ + + GCVR+ L
Sbjct: 282 VPST---KCDTYATCGQFASCRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPL 338
Query: 121 DCEH---------GDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADV 171
CE DGF++ + +K+P N+ +C E C KNCSCTAY+ D
Sbjct: 339 QCESRDNNDGSRKSDGFVRVQKMKVPHNPQRSGANE---QDCPESCLKNCSCTAYS-FD- 393
Query: 172 RGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXX 231
RG GCLLW +L+DM+E S +G ++R+A SE +R V
Sbjct: 394 RG--IGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFK--KRTNRSIVITVTLLVGAFLFA 449
Query: 232 XXXXXXXXFVYLWK-RRHRKQGKT-----DGSSKLDYNDRG----NREEEMELPIFDWMA 281
LWK +HR++ + + L ND G N+ + ELP+F++
Sbjct: 450 GTVVLA-----LWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQV 504
Query: 282 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 341
+A AT NFS NKLG+GGFG VYKG L EG +IA KRLS++SGQG+EEF NEV++I+KLQ
Sbjct: 505 LAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQ 564
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
HRNLV+L+G C + +ERML+YE++P L+ ++FD + + LDW R II GI RGL+Y
Sbjct: 565 HRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMY 624
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH+DSRL+IIHRDLKASN+LLD +NPKISDFG+AR F ++ E +T RVVGTYGYM PE
Sbjct: 625 LHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPE 684
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521
YA+ GLFS KSDVFS GV++LEIV G+RN FY+ + NL +AW+LW + L++
Sbjct: 685 YAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDP 744
Query: 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNP 580
+ +E+ RC+ VGLLCVQ DRP++++V+ MLS E S LP+PKQP F R
Sbjct: 745 VIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGT 804
Query: 581 PEXXXXXXXXXXXXTNEITISLIEGR 606
E N ++++ I GR
Sbjct: 805 SEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1172 (417.6 bits), Expect = 4.7e-119, P = 4.7e-119
Identities = 249/554 (44%), Positives = 338/554 (61%)
Query: 67 LDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCE--- 123
+ CD Y CG + +C + SN KCECL+GFVPKS EW+ + + GC+RRT L C+
Sbjct: 283 VSSCDVYNTCGPFGLC-IRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNS 341
Query: 124 -------HGDGFLKRESVKLPD--TRFSLVDNKISLLECKELCSKNCSCTAYANADVRGG 174
+GD F +VK PD SL++ + +C++ C NCSCTA++ +
Sbjct: 342 SATAQANNGDIFDIVANVKPPDFYEYLSLINEE----DCQQRCLGNCSCTAFSYIEQ--- 394
Query: 175 GSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXX 234
GCL+W +L+D+ + G+ L +R+A+SEL R V+
Sbjct: 395 -IGCLVWNRELVDVMQFVAGGETLSIRLASSELAGSNRVKIIVASIVSISVFMILV---- 449
Query: 235 XXXXXFVYLWKRRHRKQGKTDGSSKLDYNDRGNREE--EMELPIFDWMAIANATENFSDK 292
F W R++ + L+ + RE+ ++ FD I T NFS +
Sbjct: 450 -----FASYWYWRYKAKQNDSNPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSME 504
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
NKLG+GGFGPVYKG L +G+EIA KRLS +SGQG+EEF NE++LI+KLQHRNLV+L+GCC
Sbjct: 505 NKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCC 564
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
+ +E++LIYE++ NKSLN FIFD T+ LDW KR +II GIA GLLYLH+DS LR++H
Sbjct: 565 IEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVH 624
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 472
RD+K SN+LLD EMNPKISDFG+AR F Q +ANT RVVGT GYM PEYA G+FS KS
Sbjct: 625 RDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKS 684
Query: 473 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEV 532
D+++FGVL+LEI+ GKR F + LL AW W E +L+++ + S S SEV
Sbjct: 685 DIYAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEV 744
Query: 533 LRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPEXXXXXXXXXX 592
RC+Q+GLLC+QQ+ DRPN++ V+ ML+ LP+PKQP F + +
Sbjct: 745 ARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKPKQPVFAMQVQESDSESKTMYS-- 802
Query: 593 XXTNEITISLIEGR 606
N IT + I GR
Sbjct: 803 --VNNITQTAIVGR 814
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5427 | 0.9191 | 0.7113 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 606 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-27 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-23 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-10 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-05 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 5e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-53
Identities = 99/297 (33%), Positives = 134/297 (45%), Gaps = 74/297 (24%)
Query: 294 KLGEGGFGPVYKGVLI-----EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVK 347
KLGEG FG VYKG L + E+A K L + S Q +EEF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
L+G CT+ + M++ EY+P L D++ R K L S IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAI 464
IHRDL A N L+ + KISDFG++R D + + +V G +M PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
+G F+ KSDV+SFGVL+ EI +LG
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIF------------------------------------TLG 201
Query: 525 GSY----SLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLML 560
S +EVL ++ G L C + PEDRP S +V +L
Sbjct: 202 EEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 93/282 (32%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 292 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNL 345
KLGEG FG VYKG L + E+A K L + +S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
VKL+G CT+ + ++ EY+ L ++ L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEY 462
IHRDL A N L+ + KISDFG++R D + + R G +M PE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
+G F+ KSDV+SFGVL+ EI G + + E++
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIF----TLGE--------------QPYPGMSNEEVLEYL 216
Query: 523 LGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 560
G Y L + C + L C + PEDRP S +V +L
Sbjct: 217 KNG-YRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-51
Identities = 91/305 (29%), Positives = 127/305 (41%), Gaps = 81/305 (26%)
Query: 293 NKLGEGGFGPVYKGVLIEGQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVK 347
KLGEG FG VYKG L E+A K L + S + ++F E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIGGIARGLLY 401
L+G CT+ + L+ EY+ L D++ F L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG----- 456
L + +HRDL A N L+ ++ KISDFG++R + T G
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516
+M PE DG+F+ KSDV+SFGVL+ EI
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIF------------------------------- 201
Query: 517 ELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSS 555
+LG + S EVL ++ G L C Q PEDRP S
Sbjct: 202 -----TLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSE 256
Query: 556 VVLML 560
+V L
Sbjct: 257 LVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
LGEGGFG VY G+++A K + K S +EE E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
+ L+ EY SL D + + L + +I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 413 RDLKASNVLLDN-EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSV 470
RDLK N+LLD+ K++DFG+++ + ++ +VGT YM PE + G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 471 KSDVFSFGVLVLEI 484
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 4e-47
Identities = 73/200 (36%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 294 KLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLI 349
KLG G FG VYK G+ +A K L K S + ++ + E+ ++ +L H N+V+LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409
+D L+ EY L D++ +R L + +I I RGL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-F 468
IIHRDLK N+LLD KI+DFG+A+ + T VGT YM PE + G +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176
Query: 469 SVKSDVFSFGVLVLEIVCGK 488
K DV+S GV++ E++ GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 24/265 (9%)
Query: 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLV 346
+ KLGEG FG VY + G+ +A K + K + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L D+ L+ EY L D + + L + + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
I+HRDLK N+LLD + + K++DFG+AR + VGT YM PE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 467 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526
+ D++S GV++ E++ GK + D L I + S
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKP---PFPGDDQLLELFKK----IGKPKPPFPPPEWDIS 224
Query: 527 YSLSEVLRCIQVGLLCVQQRPEDRP 551
+++R + + PE R
Sbjct: 225 PEAKDLIRK------LLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 93/297 (31%), Positives = 127/297 (42%), Gaps = 74/297 (24%)
Query: 294 KLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVK 347
KLGEG FG VYKG L ++A K L + + + EEF E ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
L+G CTQ + ++ EY+P L DF+ + L Q+ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG---YMPPEYAI 464
+HRDL A N L+ + KISDFG++R I + + R G +M PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKR-GGGKLPIKWMAPESLK 177
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
DG F+ KSDV+SFGVL+ EI +LG
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIF------------------------------------TLG 201
Query: 525 GS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLML 560
S EVL ++ G L C PEDRP S +V L
Sbjct: 202 EQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 25/209 (11%)
Query: 293 NKLGEGGFGPVYKGVLIE-GQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 349
LG G FG VY + + G+ +A K LS S + +E E E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 350 GCCTQRDERML-IY-EYLPNKSLNDFI--F-----DVTRSKFLDWSKRCQIIGGIARGLL 400
G ++ L I+ EY+ SL+ + F V R +++ QI+ GL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK----YTR--QIL----EGLA 115
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
YLH I+HRD+K +N+L+D++ K++DFG A+ G +T T V GT +M P
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKR 489
E + +D++S G V+E+ GK
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 289 FSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 347
F K+G+GGFG VYK G+E+A K + S + E+ NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL----YLH 403
G ++DE ++ E+ SL D + T + I + + LL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTE-----SQIAYVCKELLKGLEYLH 115
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
IIHRD+KA+N+LL ++ K+ DFG++ N +VGT +M PE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVI 169
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGK 488
+ K+D++S G+ +E+ GK
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 90/296 (30%), Positives = 138/296 (46%), Gaps = 45/296 (15%)
Query: 293 NKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLV 346
+LGEG FG V G+++A K L+ S Q +FE E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 347 KLIGCCTQRDER--MLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLL 400
K G C + R LI EYLP+ SL D++ + + L +S + I +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMD 123
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT--EANTNRVVGTYGYM 458
YL R IHRDL A N+L+++E KISDFG+A+ D+ + Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN-------LLGHAWRLWI 511
PE FS SDV+SFGV + E+ F + D + ++G A I
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYEL--------FTYGDPSQSPPAEFLRMIGIAQGQMI 231
Query: 512 EERPVELI--NKSLGGSYSL-SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564
R +EL+ + L S EV ++ LC + P+DRP+ + ++L++ R
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 87/288 (30%), Positives = 119/288 (41%), Gaps = 54/288 (18%)
Query: 293 NKLGEGGFGPVYKGVLIE--GQEI--AAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVK 347
+LG G FG V KGV + G+E+ A K L + G +EF E ++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFD---VTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
LIG C + + ML+ E P L ++ + S + + + +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP----- 459
+HRDL A NVLL N KISDFGM+RA G T G P
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517
PE G FS KSDV+S+GV + E K A+
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------------------- 206
Query: 518 LINKSLGGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSVVLMLS 561
+ L L C Q + L C + RPEDRP S +
Sbjct: 207 -VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 80/255 (31%), Positives = 115/255 (45%), Gaps = 37/255 (14%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
E+ + KLG G FG V+ G ++A K L K E F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L C++ + ++ EY+ SL DF+ K L + + IA G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE--- 120
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 461
IHRDL A N+L+ + KI+DFG+AR D+ A P PE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG------AKFPIKWTAPE 174
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVC-------GKRN--------RGFY------HADHHH 500
A G F++KSDV+SFG+L+ EIV G N RG+ + +
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234
Query: 501 NLLGHAWRLWIEERP 515
+L+ W EERP
Sbjct: 235 DLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 344
N+ + +G G FG VYKG+ +E G +A K++S + ++ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYL 402
+VK IG D +I EY N SL I KF + + + + +GL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII-----KKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H+ +IHRD+KA+N+L + K++DFG+A ++ + VVGT +M PE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEV 170
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
S SD++S G V+E++ G
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 73/211 (34%), Positives = 108/211 (51%), Gaps = 25/211 (11%)
Query: 295 LGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVK 347
LGEG FG VYKG L +A K L ++ + +EF E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQIIGG 394
L+G CT+ +++EYL + L++F+ D T LD S I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRVVG 453
IA G+ YL S +HRDL A N L+ + KISDFG++R + D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 454 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+MPPE + G F+ +SD++SFGV++ EI
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 7e-31
Identities = 86/329 (26%), Positives = 133/329 (40%), Gaps = 25/329 (7%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQH-R 343
++ KLGEG FG VY + +A K L+K S + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
N+VKL L+ EY+ SL D + + R L S+ I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 404 QDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEAN----TNRVVGTYGYM 458
IIHRD+K N+LLD + K+ DFG+A+ + ++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 459 PPEYAIDGLF---SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515
PE + S SD++S G+ + E++ G + + P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233
Query: 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF 575
S +S+ + LL P++R + SS + L K
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKD--PKNRLSSSSDLSHD----LLAHLKLKESD 287
Query: 576 TERNPPESGSSSSKRSLLSTNEITISLIE 604
S+ + SL + E IS +
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 63/292 (21%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKR--LSKSSGQGMEEFENEVLLIAKLQHRN 344
+ ++G+G FG VY ++ K LS S + E+ NEV ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI---------FDVTRSKFLDWSKRCQIIGGI 395
++K ++ + ++ EY L+ I F + LDW Q+
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF--PEEQILDWF--VQL---- 112
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
L YLH SR +I+HRD+K N+ L + K+ DFG+++ A T VVGT
Sbjct: 113 CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTP 167
Query: 456 GYMPPE------YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509
Y+ PE Y + KSD++S G ++ E+ K H NLL
Sbjct: 168 YYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLK------HPFEGENLL------ 209
Query: 510 WIEERPVELINKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
EL K L G Y S LR + LL Q+ PE+RP+++ +
Sbjct: 210 -------ELALKILKGQYPPIPSQYSSELRNLVSSLL--QKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 72/235 (30%), Positives = 113/235 (48%), Gaps = 41/235 (17%)
Query: 292 KNKLGEGGFGPVYKG---VLIEGQE---IAAKRLSKSSGQGMEE-FENEVLLIAKLQHRN 344
K +LGEG FG V+ G L + +A K L +++ + FE E L+ QH N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------------FDVTRSKFLDWSK 387
+VK G CT+ D ++++EY+ + LN F+ ++T S+ L
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL---- 125
Query: 388 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447
QI IA G++YL + +HRDL N L+ ++ KI DFGM+R D +
Sbjct: 126 --QIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTD 176
Query: 448 TNRVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
RV G +MPPE + F+ +SDV+SFGV++ EI + + ++
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 283 ANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 341
+ E + + K+GEG G VYK G+E+A K++ + Q E NE+L++ +
Sbjct: 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCK 73
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI---IGGIARG 398
H N+V DE ++ EY+ SL D I + QI + +G
Sbjct: 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRM----NEPQIAYVCREVLQG 128
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR--VVGTYG 456
L YLH +IHRD+K+ N+LL + + K++DFG F T+ + R VVGT
Sbjct: 129 LEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPY 181
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
+M PE + K D++S G++ +E+ G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRN 344
+ LG+G G VYK G+ A K++ + ++ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR----GLL 400
+VK G + E ++ EY+ SL D + K + ++ IAR GL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPE--PVLAYIARQILKGLD 113
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
YLH IIHRD+K SN+L++++ KI+DFG+++ ++ T N VGT YM P
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSP 169
Query: 461 EYAIDG-LFSVKSDVFSFGVLVLEIVCGK 488
E I G +S +D++S G+ +LE GK
Sbjct: 170 E-RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 23/207 (11%)
Query: 295 LGEGGFGPVYKGVLI-EGQ----EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 348
LG G FG VYKGV I EG+ +A K L + + + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 349 IGCC-TQRDERMLIYEYLPNKSLNDFIF---DVTRSK-FLDWSKRCQIIGGIARGLLYLH 403
+G C + + LI + +P L D++ D S+ L+W + IA+G+ YL
Sbjct: 75 LGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
+ R++HRDL A NVL+ + KI+DFG+A+ +D+ E + +M E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 464 IDGLFSVKSDVFSFGVLVLEIVC-GKR 489
+ +++ KSDV+S+GV V E++ G +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 6/199 (3%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
E F+ + KLG G FG V++G+ +A K L ++F+ EV + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
L C+ + +I E + SL F+ + L + + +A G+ YL +
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
IHRDL A N+L+ ++ K++DFG+AR D ++ ++ Y + PE A G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179
Query: 467 LFSVKSDVFSFGVLVLEIV 485
FS KSDV+SFG+L+ E+
Sbjct: 180 TFSTKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 85/299 (28%), Positives = 130/299 (43%), Gaps = 56/299 (18%)
Query: 285 ATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRL-SKSSGQGMEEFENEVLLI 337
++ + LG G FG VY+G+ ++A K L S Q +F E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 338 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIG 393
+K H+N+V+LIG +R R ++ E + L F+ + R L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTN 449
+A+G YL ++ IHRD+ A N LL + P KI+DFGMAR D A+
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR----DIYRASYY 175
Query: 450 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYHADH 498
R G +MPPE +DG+F+ K+DV+SFGVL+ EI G+ N+
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---- 231
Query: 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557
+ RL + P ++ C Q PEDRPN ++++
Sbjct: 232 --EFVTGGGRL---DPPKGCPG-------------PVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
+G+G FG V G GQ++A K L K + F E ++ L+H NLV+L+G
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG--IARGLLYLHQDSRLR 409
Q + ++ EY+ SL D++ R+ + Q+ + G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI---TLAQQLGFALDVCEGMEYLEEK---N 122
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDGL 467
+HRDL A NVL+ ++ K+SDFG+A+ EA+ + G + PE +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKK 175
Query: 468 FSVKSDVFSFGVLVLEI 484
FS KSDV+SFG+L+ EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 65/233 (27%), Positives = 97/233 (41%), Gaps = 45/233 (19%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEF---ENEVLLIAKL 340
++F +GEG F V E +E A K L K + ++ E EVL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59
Query: 341 QHRNLVKLIGCCTQRDERML--IYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIG 393
H ++KL T +DE L + EY PN L +I D ++F
Sbjct: 60 GHPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAA 109
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-- 451
I L YLH IIHRDLK N+LLD +M+ KI+DFG A+ + + +
Sbjct: 110 EILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 452 ----------------VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
VGT Y+ PE + SD+++ G ++ +++ GK
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-27
Identities = 39/67 (58%), Positives = 50/67 (74%), Gaps = 1/67 (1%)
Query: 122 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLW 181
C GDGFL+ ++KLPDT ++VD I L EC++ C NCSCTAYA AD+R GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 182 FHDLIDM 188
+L+DM
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
KLG G FG V++G+ +A K L K ++F E ++ KL+H L++L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
CT + ++ E + SL +++ L + + +A G+ YL + I
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YI 125
Query: 412 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLF 468
HRDL A NVL+ K++DFG+AR D EA G + PE A+ F
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRF 181
Query: 469 SVKSDVFSFGVLVLEIV 485
S+KSDV+SFG+L+ EIV
Sbjct: 182 SIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPF- 59
+P++Q Y + + N EV+Y + + +S+ S + ++ G +R TW+ +Q W F
Sbjct: 14 IPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERFTWIPNSQDWNLFW 73
Query: 60 -VPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKS 101
P DQCD Y CG Y C++N S KC C++GFVPK+
Sbjct: 74 SAP-----KDQCDVYGRCGPYGYCDVN-TSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 73/199 (36%), Positives = 106/199 (53%), Gaps = 21/199 (10%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
KLG G FG V+ G ++A K L K E F E L+ +LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 354 QRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
Q + +I EY+ N SL DF+ +T +K +D + + IA G+ ++ R
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAFIE---RK 121
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDG 466
IHRDL+A+N+L+ + KI+DFG+AR I+ E T R + + PE G
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEY-TAREGAKFPIKWTAPEAINYG 178
Query: 467 LFSVKSDVFSFGVLVLEIV 485
F++KSDV+SFG+L+ EIV
Sbjct: 179 TFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 39/215 (18%)
Query: 293 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE----NEVLLIAKLQHRNLVK 347
++GEG +G VYK G+ +A K++ + + E F E+ L+ KL+H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 348 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYL 402
L T + + +++EY+ + L + D KF + +C Q++ GL YL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIKCYMKQLL----EGLQYL 116
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE- 461
H + I+HRD+K SN+L++N+ K++DFG+AR + + TNRV+ T Y PPE
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPEL 172
Query: 462 --------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ D++S G ++ E+ GK
Sbjct: 173 LLGATRYGPEV--------DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 40/218 (18%)
Query: 289 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--------EVLLIAKL 340
+ KLGEG +G VYK + EI A + + ++ E E+ L+ +L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKEL 55
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKR--CQIIGGIAR 397
+H N+VKL+ + L++EY + L ++ D + K Q++ R
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLL----R 109
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
GL Y H RI+HRDLK N+L++ + K++DFG+ARAFGI T+ VV T Y
Sbjct: 110 GLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWY 164
Query: 458 MPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE Y+ +V D++S G + E++ GK
Sbjct: 165 RAPEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 10/203 (4%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
E F KLGEG +G VYK + E GQ +A K + + ++E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYI 60
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
VK G + + ++ EY S++D + +K L + I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS- 117
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
+ IHRD+KA N+LL+ E K++DFG+ + + T A N V+GT +M PE +
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 466 GLFSVKSDVFSFGVLVLEIVCGK 488
++ K+D++S G+ +E+ GK
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
K+KLG G +G VY+GV + A + K +EEF E ++ +++H NLV+L+G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
CT+ +I E++ +L D++ + R + ++ + I+ + YL + + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 412 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 471
HRDL A N L+ K++DFG++R D A+ + PE FS+K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 185
Query: 472 SDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530
SDV++FGVL+ EI G + LL +R+ ERP G +
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM---ERPE-------GCPPKVY 235
Query: 531 EVLRCIQVGLLCVQQRPEDRPNMSSV 556
E++R C Q P DRP+ + +
Sbjct: 236 ELMRA------CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 295 LGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 349
LG+G FG V Y + G+ +A K+L S+ + + +FE E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 350 GCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
G C R L+ EYLP SL D++ R + LD K I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQK-HRER-LDHRKLLLYASQICKGMEYL---GS 126
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEY 462
R +HRDL N+L+++E KI DFG+ + D+ V G P PE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY----YKVREPGESPIFWYAPES 182
Query: 463 AIDGLFSVKSDVFSFGVLVLEI 484
+ FSV SDV+SFGV++ E+
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 66/197 (33%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLVKLIGCC 352
K+G+G FG VYKGVL E+A K + + +F E ++ + H N+VKLIG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
Q+ ++ E +P SL F+ + L K Q+ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEYAIDGL 467
RDL A N L+ KISDFGM+R + E V +P PE G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 468 FSVKSDVFSFGVLVLEI 484
++ +SDV+S+G+L+ E
Sbjct: 172 YTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 71/212 (33%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 295 LGEGGFGPVYKGVLI-------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLV 346
LG G FG VY+G +A K L K ++ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF----LDWSKRCQIIGGIARGLLYL 402
KL+G C + + +I E + L ++ D +F L + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 403 HQDSRLRIIHRDLKASNVLL-----DNEMNPKISDFGMARAFGIDQTEANTNRVVGT--- 454
Q + IHRDL A N L+ D + KI DFG+AR D +++ R G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLL 175
Query: 455 -YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
+M PE +DG F+ +SDV+SFGVL+ EI+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLIG 350
LG+G FG V + G+ A K L K +E E E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 351 CCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
Q +E++ L+ EY P L + F R++F I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEYLH- 110
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
L II+RDLK N+LLD + + K++DFG+A+ + + NT GT Y+ PE +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 499
+ D +S GVL+ E++ GK FY D
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP--FYAEDRK 199
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 74/248 (29%), Positives = 119/248 (47%), Gaps = 38/248 (15%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
++G G FG V+ G +E +++A K + + E+F E ++ KL H LV+L G CT
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC--QIIGGIARGLLYLHQDSRLRII 411
+R L++E++ + L+D++ R++ +S+ + + G+ YL + +I
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 412 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLF 468
HRDL A N L+ K+SDFGM R DQ ++T GT + PE +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKY 178
Query: 469 SVKSDVFSFGVLVLEI---------------VCGKRNRGF------YHADHHHNLLGHAW 507
S KSDV+SFGVL+ E+ V N GF + + L+ H W
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238
Query: 508 RLWIEERP 515
+ E+RP
Sbjct: 239 KERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 70/197 (35%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
KLG G FG V+ G ++A K L K ++ F E L+ LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 354 QRDERMLIYEYLPNKSLNDFIFD-----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
+ + +I EY+ SL DF+ V K +D+S + IA G+ Y+ R
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---RK 122
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468
IHRDL+A+NVL+ + KI+DFG+AR ++ A + PE G F
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSF 181
Query: 469 SVKSDVFSFGVLVLEIV 485
++KSDV+SFG+L+ EIV
Sbjct: 182 TIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 35/282 (12%)
Query: 288 NFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRN 344
+F NK+G+G FG V+K V + + A K+ LSK + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARGLLY 401
+++ + + ++ EY N L+ + + W QI+ GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL----LGLAH 116
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH +I+HRD+K+ N+ LD N KI D G+A+ + ANT +VGT Y+ PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521
D ++ KSDV++ GV++ E GK + A++ L+ + + +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP---FDANNQGALI---------LKIIRGVFP 219
Query: 522 SLGGSYS--LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
+ YS L++++ C+ + RP+ ++ S
Sbjct: 220 PVSQMYSQQLAQLID------QCLTKDYRQRPDTFQLLRNPS 255
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 71/226 (31%), Positives = 117/226 (51%), Gaps = 32/226 (14%)
Query: 294 KLGEGGFGPVYKGVLI------EGQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQHRNLV 346
+LGE FG VYKG L + Q +A K L K+ G EEF++E ++ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQIIG 393
L+G T+ +I+ Y + L++F+ D T L+ + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRVV 452
IA G+ +L S ++H+DL NVL+ +++N KISD G+ R + D + N ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 453 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV-------CGKRNR 491
+M PE + G FS+ SD++S+GV++ E+ CG N+
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 39/216 (18%)
Query: 295 LGEGGFGPVYKGVLI------EGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLV 346
LG+G FG VY+G+ +A K +++ S + +E F NE ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72
Query: 347 KLIGCCTQRDERMLIYEYL-------------PNKSLNDFIFDVTRSKFLDWSKRCQIIG 393
+L+G + +++ E + P N + T KF+ +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA------A 126
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
IA G+ YL + +HRDL A N ++ ++ KI DFGM R D E + R G
Sbjct: 127 EIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGG 179
Query: 454 T----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
+M PE DG+F+ KSDV+SFGV++ E+
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-23
Identities = 41/89 (46%), Positives = 51/89 (57%), Gaps = 8/89 (8%)
Query: 118 TQLDCEHG---DGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGG 174
T L+C DGFLK VKLPD + ISL EC+E C NCSCTAYA + G
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNN---G 55
Query: 175 GSGCLLWFHDLIDMKELSESGQDLFVRMA 203
GCLLW L +++ LS G L++R+A
Sbjct: 56 SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 20/200 (10%)
Query: 295 LGEGGFGPVYKGVL-IEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVKLI 349
+G G FG V +G L + G++ +A K L + SS + +F E ++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409
G T+ M+I EY+ N SL+ F+ KF + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL-RENDGKF-TVGQLVGMLRGIASGMKYL---SEMN 126
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEYAI 464
+HRDL A N+L+++ + K+SDFG++R + T G +P PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG-----GKIPIRWTAPEAIA 181
Query: 465 DGLFSVKSDVFSFGVLVLEI 484
F+ SDV+SFG+++ E+
Sbjct: 182 YRKFTSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 37/219 (16%)
Query: 292 KNKLGEGGFGPVYKGV---LIEGQE---IAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
K +LGEG FG V+ L+ Q+ +A K L ++S ++F+ E L+ LQH+++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS-----KFLDWSK-----------RC 389
V+ G CT+ ++++EY+ + LN F+ RS K L +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFL----RSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 390 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449
I IA G++YL + L +HRDL N L+ + KI DFGM+R D +
Sbjct: 126 AIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYY 178
Query: 450 RVVG----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
RV G +MPPE + F+ +SD++SFGV++ EI
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 354
LG G FG V+ G ++A K + + + ++F E ++ KL H NLV+L G CT+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 414
+ ++ EY+ N L +++ R L + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 415 LKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLFSVK 471
L A N L+ + K+SDFG+AR DQ ++ GT + PPE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 472 SDVFSFGVLVLEI-VCGK 488
SDV+SFGVL+ E+ GK
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 65/198 (32%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 294 KLGEGGFGPVYKG----VLIEGQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKL 348
KLG+G FG V +G + +A K L M++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
G M++ E P SL D + FL S C IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESK--- 116
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGI--DQTEANTNRVVGTYGYMPPEYAIDG 466
R IHRDL A N+LL ++ KI DFG+ RA D + V + + PE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTR 175
Query: 467 LFSVKSDVFSFGVLVLEI 484
FS SDV+ FGV + E+
Sbjct: 176 TFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 76/245 (31%), Positives = 116/245 (47%), Gaps = 32/245 (13%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
KLG G FG V+ G ++A K L K E F E ++ KL+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 413
+ ++ EY+ SL DF+ D + L + +A G+ Y+ R+ IHR
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 414 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDGLFSVK 471
DL+++N+L+ + + KI+DFG+AR I+ E T R + + PE A+ G F++K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL--IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 472 SDVFSFGVLVLEIVC-------GKRNRGFYHADHH--------------HNLLGHAWRLW 510
SDV+SFG+L+ E+V G NR H L+ W+
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243
Query: 511 IEERP 515
EERP
Sbjct: 244 PEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 294 KLGEGGFGPVYKGVLI-----EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 347
+LGE FG +YKG L Q +A K L ++ Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIF--------------DVTRSKFLDWSKRCQIIG 393
L+G TQ +++EYL L++F+ D T LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGIDQTEANTNRVV 452
IA G+ YL S +H+DL A N+L+ +++ KISD G++R + D ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 453 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+MPPE + G FS SD++SFGV++ EI
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 5e-23
Identities = 73/243 (30%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
KLG+G FG V+ G +A K L K E F E ++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 413
+ + ++ EY+ SL DF+ K+L + + IA G+ Y+ R+ +HR
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 414 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 473
DL+A+N+L+ + K++DFG+AR ++ A + PE A+ G F++KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185
Query: 474 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWIE 512
V+SFG+L+ E+ R RG+ + H+L+ WR E
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 245
Query: 513 ERP 515
ERP
Sbjct: 246 ERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRNL 345
F+ +G+G FG VYK + Q +A K L ++ + +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
K G + + +I EY S D+ + LD + I+ + GL YLH++
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
IHRD+KA+N+LL E + K++DFG++ ++ NT VGT +M PE
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 466 GLFSVKSDVFSFGVLVLEIVCGK 488
+ K+D++S G+ +E+ G+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 70/227 (30%), Positives = 119/227 (52%), Gaps = 13/227 (5%)
Query: 288 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHRN 344
+++ K+GEG +G VYKG GQ +A K++ +S +G+ E+ L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+V L Q LI+E+L + L ++ + + +++D + I +G+L+ H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
R++HRDLK N+L+DN+ K++DFG+ARAFGI T+ VV T Y PE +
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLL 174
Query: 465 DG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510
+S D++S G + E+ + +H D + L +R+
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT---KKPLFHGDSEIDQLFRIFRIL 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQG---------MEEFENEVLLIAKLQHRN 344
+G G FG VY G+ G+ +A K++ S ++ E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+V+ +G D + EY+P S+ + + + + I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNR--VVGTYGYMPP 460
IIHRD+K +N+L+DN+ KISDFG+++ T+ N R + G+ +M P
Sbjct: 125 RG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
E ++ K+D++S G LV+E++ GK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QH 342
+ T F +GEG +G VYK + ++ A ++ EE + E ++ K H
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 343 RNLVKLIGCCTQR------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ------ 390
N+ G ++ D+ L+ E S+ D + KR +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
I+ RGL YLH++ ++IHRD+K N+LL K+ DFG++ +D T N
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172
Query: 451 VVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+GT +M PE D + +SDV+S G+ +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 295 LGEGGFGPVYKGV---LIEGQE---IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 347
+G+G FG V++ L+ + +A K L + +S +F+ E L+A+ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGG---------- 394
L+G C L++EY+ LN+F+ + + + G
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 395 ------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEAN 447
+A G+ YL S + +HRDL N L+ M KI+DFG++R + D +A+
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
N + +MPPE ++ +SDV+++GV++ EI
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 24/205 (11%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLS-----KSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG G FG VY+G+ L +G A K +S ++ + +++ E E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 349 IGCCTQRDERML-IY-EYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+G T+R+E L I+ E +P SL + + + R QI+ G+ YLH
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHD 120
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-A 463
+HRD+K +N+L+D K++DFGMA+ + G+ +M PE A
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIA 174
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGK 488
G + + +D++S G VLE+ GK
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 27/208 (12%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKR-----LSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+G FG VY ++ G+E+A K+ S + + + E E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLY 401
GC + + EY+P S+ D + VTR ++++ I G+ Y
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK----YTRQ------ILEGVEY 119
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA-RAFGIDQTEANTNRVVGTYGYMPP 460
LH + I+HRD+K +N+L D+ N K+ DFG + R I + V GT +M P
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
E + K+DV+S G V+E++ K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 68/206 (33%), Positives = 120/206 (58%), Gaps = 30/206 (14%)
Query: 295 LGEGGFGPVYKGVLI-EGQEI----AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 348
LG G FG VYKG+ + EG+ + A K L++++G + EF +E L++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+G C + L+ + +P+ L D++ + + L+W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-A 463
R++HRDL A NVL+ + + KI+DFG+AR D+ E N + G MP ++ A
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG-----GKMPIKWMA 179
Query: 464 IDGL----FSVKSDVFSFGVLVLEIV 485
++ + F+ +SDV+S+GV + E++
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 47/289 (16%)
Query: 295 LGEGGFGPVYKGVLIEG----QEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LGEG FG V +G L + ++A K +L + +EEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 349 IGCCTQRDER------MLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGGIARGL 399
IG C + M+I ++ + L+ F+ + L + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGID---QTEANTNRVVGTY 455
YL S IHRDL A N +L +M ++DFG+++ + D Q V
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179
Query: 456 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH---NLLGHAWRLWIE 512
++ E D +++ KSDV++FGV + EI R + Y +H + L H RL
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA--TRGQTPYPGVENHEIYDYLRHGNRL--- 234
Query: 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
++P + +++ YS C + P+DRP + + +L
Sbjct: 235 KQPEDCLDELYDLMYS-------------CWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 34/209 (16%)
Query: 295 LGEGGFG--------PVYKGVLIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNL 345
LGEG FG P G G+ +A K L + GQ ++ E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 346 VKLIGCCTQRDER--MLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLY 401
VK GCC+++ + LI EY+P SL D++ + ++ L ++++ I G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAY 122
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-- 459
LH IHRDL A NVLLDN+ KI DFG+A+A E + V G P
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVF 175
Query: 460 ---PEYAIDGLFSVKSDVFSFGVLVLEIV 485
E + FS SDV+SFGV + E++
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 69/223 (30%), Positives = 104/223 (46%), Gaps = 46/223 (20%)
Query: 295 LGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVL-LIAKL------- 340
LGEG FG V K + E +A K L + E ++ L++++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK------DDATEKDLSDLVSEMEMMKMIG 73
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------ 394
+H+N++ L+G CTQ ++ EY + +L DF+ R S
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRA-RRPPGEYASPDDPRPPEETLTQK 132
Query: 395 --------IARGLLYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAF-GIDQ 443
+ARG+ +L + IHRDL A NVL+ D+ M KI+DFG+AR ID
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDY 187
Query: 444 TEANTN-RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
TN R+ +M PE D +++ +SDV+SFGVL+ EI
Sbjct: 188 YRKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-21
Identities = 60/221 (27%), Positives = 119/221 (53%), Gaps = 10/221 (4%)
Query: 269 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM 327
+EE+ + ++I + + ++ K+G+G G V+ + + GQE+A K+++
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60
Query: 328 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 387
E NE+L++ +L++ N+V + DE ++ EYL SL D + + +D ++
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQ 116
Query: 388 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447
+ + L +LH + ++IHRD+K+ NVLL + + K++DFG +Q++ +
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
T +VGT +M PE + K D++S G++ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 287 ENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLIAK 339
N + LG G FG V+ KG+ EG E + K L K+ + ++ EF E+ + K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIG 393
L H+N+V+L+G C + + +I EY L F+ + + L ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
IA G+ +L S R +HRDL A N L+ ++ K+S +++ + N ++
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 454 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
++ PE + FS KSDV+SFGVL+ E+
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 39/223 (17%)
Query: 288 NFSDKNKLGEGGFGPVYKGV---LIEGQE---IAAKRLSKSSGQGMEEFENEVLLIAKLQ 341
N K +LGEG FG V+ L Q+ +A K L +S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI----------------FDVTRSKFLDW 385
H ++VK G C + D ++++EY+ + LN F+ ++T+S+ L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 386 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445
+++ IA G++YL + +HRDL N L+ + KI DFGM+R D
Sbjct: 126 AQQ------IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYS 172
Query: 446 ANTNRVVG----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+ RV G +MPPE + F+ +SDV+S GV++ EI
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
K +LGEG FG V+ + +A K L + ++F+ E L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQII 392
VK G C D ++++EY+ + LN F+ L S+ I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
IA G++YL + +HRDL N L+ + KI DFGM+R D + RV
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182
Query: 453 G----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
G +MPPE + F+ +SDV+SFGV++ EI
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIEGQ-EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 344
+ ++ LG+G +G VY + Q IA K + + + ++ E+ L + L+HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG----GIARGLL 400
+V+ +G ++ + E +P SL+ + RSK+ Q I I GL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMA-RAFGIDQTEANTNRVVGTYGYM 458
YLH +I+HRD+K NVL++ KISDFG + R GI+ T GT YM
Sbjct: 123 YLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYM 176
Query: 459 PPEYAIDGL--FSVKSDVFSFGVLVLEIVCGK 488
PE G + +D++S G ++E+ GK
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
KLG+G FG V+ G ++A K L K E F E ++ KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 413
+ + ++ E++ SL DF+ + K+L + + IA G+ Y+ R+ IHR
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 414 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 473
DL+A+N+L+ + + KI+DFG+AR ++ A + PE A+ G F++KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185
Query: 474 VFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVL 533
V+SFG+L+ E+V + R Y + +L R + P G SL E++
Sbjct: 186 VWSFGILLTELV--TKGRVPYPGMVNREVLEQVERGYRMPCP-------QGCPESLHELM 236
Query: 534 RCIQVGLLCVQQRPEDRPNMSSV 556
+ LC ++ P++RP +
Sbjct: 237 K------LCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 43/226 (19%)
Query: 292 KNKLGEGGFGPVY--KGVLIEGQEIAAKRLSKSSGQ----------------GMEEFENE 333
KLGEG FG V+ + ++ A + ++ E+F E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 334 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI--------FDVTRSKFLDW 385
V ++++L N+ +L+G CT +I EY+ N LN F+ SK L +
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 386 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445
S + IA G+ YL L +HRDL N L+ KI+DFGM+R
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR-------N 179
Query: 446 ANTN-------RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
++ R +M E + G F+ KSDV++FGV + EI
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 71/269 (26%), Positives = 128/269 (47%), Gaps = 32/269 (11%)
Query: 295 LGEGGFGPVYK------GVLIEGQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVK 347
LG G F Y+ G L+ +++ R + S + +E E+ L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI--IGGIARGLLYLHQD 405
++G + L E++ S++ + SK+ + + I + RGL YLH++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL-----SKYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 406 SRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEAN--TNRVVGTYGYMPPEY 462
+IIHRD+K +N+L+D+ +I+DFG A T A +++GT +M PE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
+ DV+S G +++E+ K ++A+ H N L +++ +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLALIFKIASATTAPSI---- 232
Query: 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRP 551
LS LR V L C++ +PEDRP
Sbjct: 233 ---PEHLSPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 48/271 (17%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
KLG G FG V+ + ++A K + K +E F E ++ LQH LVKL T
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 354 QRDERMLIYEYLPNKSLNDFIFD-----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
++ +I E++ SL DF+ K +D+S + IA G+ ++ Q +
Sbjct: 72 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN-- 122
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDG 466
IHRDL+A+N+L+ + KI+DFG+AR + + T R + + PE G
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 467 LFSVKSDVFSFGVLVLEIVCGKRN--RGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
F++KSDV+SFG+L++EIV R G + + + ++L
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------------------VIRALE 217
Query: 525 GSYSLSEVLRCIQ----VGLLCVQQRPEDRP 551
Y + C + + + C + RPE+RP
Sbjct: 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFE-----NEVLLIAKLQHRNLV 346
+G+G FG V K +I K + + M E E +EV ++ +L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIV 62
Query: 347 KLIGCCTQRD-ERMLIY-EYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGLLYLH 403
+ R + + I EY L I + K+++ +I+ + L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 404 --QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
D ++HRDLK +N+ LD N K+ DFG+A+ G D + A T VGT YM PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180
Query: 462 YAIDGLFSVKSDVFSFGVLVLEI 484
+ KSD++S G L+ E+
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 78/284 (27%), Positives = 138/284 (48%), Gaps = 50/284 (17%)
Query: 295 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 349
+G G FG V++G+L + G++ +A K L + + ++F +E ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 406
G T+ M+I EY+ N +L+ ++ R ++S Q++G GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSS-YQLVGMLRGIAAGMKYL---S 124
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 461
+ +HRDL A N+L+++ + K+SDFG++R D T + G +P PE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRWTAPE 180
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
F+ SDV+SFG+++ E++ G+R W + E +
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPY---------------WDMSNHE-----VM 220
Query: 521 KSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 560
K++ + L + C Q+ L C QQ RP +V +L
Sbjct: 221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 17/196 (8%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
+LG G FG V+ G ++A K +++ + E+F E ++ KL H LV+L G CT
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR-----CQIIGGIARGLLYLHQDSRL 408
Q+ ++ E++ N L +++ R + SK CQ + G+ YL ++S
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQ---DVCEGMEYLERNS-- 120
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468
IHRDL A N L+ + K+SDFGM R + +D +++ + PPE +
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 469 SVKSDVFSFGVLVLEI 484
S KSDV+SFGVL+ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 57/210 (27%), Positives = 112/210 (53%), Gaps = 10/210 (4%)
Query: 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIA 338
+++ + + ++ K+G+G G VY + + GQE+A K+++ E NE+L++
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 398
+ +H N+V + DE ++ EYL SL D + + +D + + +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQA 127
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
L +LH + ++IHRD+K+ N+LL + + K++DFG +Q++ +T +VGT +M
Sbjct: 128 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 182
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE + K D++S G++ +E+V G+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 31/219 (14%)
Query: 295 LGEGGFGPVYKGVLIEGQ------EIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVK 347
LGEG FG V K + +A K L +++ + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFI------------FDVTRSKFLDWS--KRCQIIG 393
L G C+Q +LI EY SL F+ D R+ + +R +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 394 G-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446
I+RG+ YL + ++++HRDL A NVL+ KISDFG++R + +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
++ +M E D +++ +SDV+SFGVL+ EIV
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLS------KSSGQGMEEFENEVLLIAKLQHRNLV 346
LG+G +G VY G+ +GQ IA K++ ++ + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+ +G C + + E++P S++ + R L C+ I G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF---GIDQTEANTNRVV-GTYGYMPPEY 462
++HRD+K +NV+L K+ DFG AR G+ T +N + + GT +M PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ + KSD++S G V E+ GK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 13/194 (6%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
+LG G FG V G GQ A ++ K +EF E ++ KL H LV+L G CT
Sbjct: 11 ELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 413
++ ++ EY+ N L +++ + + S+ ++ + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 414 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLFSV 470
DL A N L+D++ K+SDFG++R D+ ++ VG+ + PPE + FS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180
Query: 471 KSDVFSFGVLVLEI 484
KSDV++FGVL+ E+
Sbjct: 181 KSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
E++ ++G G +G VYK I E+ A K + G E + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR----GLLY 401
V G +RD+ ++ EY SL D I+ VTR + I + R GL Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-----LQIAYVCRETLKGLAY 116
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH+ IHRD+K +N+LL + + K++DFG++ + T A +GT +M PE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPE 171
Query: 462 YA---IDGLFSVKSDVFSFGVLVLE 483
A G + K D+++ G+ +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 60/204 (29%), Positives = 108/204 (52%), Gaps = 11/204 (5%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRN 344
E F+ ++G+G FG VYKG+ +E+ A ++ + + +E+ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+ + G + + +I EYL S D+ + L+ + I+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ R IHRD+KA+NVLL + + K++DFG+A Q + NT VGT +M PE
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGK 488
+ K+D++S G+ +E+ G+
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 25/270 (9%)
Query: 293 NKLGEGGFGPVYKGVLIEGQE-IAAKR--LSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 349
+G G VY + + E +A KR L K ++E EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409
DE L+ YL SL D + LD + ++ + +GL YLH + +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYAIDGL 467
IHRD+KA N+LL + + KI+DFG++ + G D+T VGT +M PE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 468 -FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526
+ K+D++SFG+ +E+ G A + L ++ P L +
Sbjct: 183 GYDFKADIWSFGITAIELATG-------AAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235
Query: 527 YSLS--EVLRCIQVGLLCVQQRPEDRPNMS 554
YS S +++ LC+Q+ P RP
Sbjct: 236 YSKSFRKMIS------LCLQKDPSKRPTAE 259
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRN 344
E F+ K+G+G FG V+KG+ Q++ A ++ + + +E+ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+ K G + + +I EYL S D+ LD ++ I+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ + IHRD+KA+NVLL K++DFG+A + T+ N VGT +M PE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGK 488
+ K+D++S G+ +E+ G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRN 344
E + ++LGEG G V K L I A + + + ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 345 LVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSKFLDWSKRC--QIIGGIA---- 396
+VK G + EY SL D I+ + + R +++G IA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKR----GGRIGEKVLGKIAESVL 115
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
+GL YLH +IIHRD+K SN+LL + K+ DFG++ A T GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSF 168
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
YM PE +S+ SDV+S G+ +LE+ +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR----NLVKL 348
+LG G G V K + +I A + + E + ++L + H+ +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGF 64
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA----RGLLYLHQ 404
G + + EY+ SL D I + + + +I+G IA +GL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPE-----RILGKIAVAVLKGLTYLH- 117
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ +IIHRD+K SN+L+++ K+ DFG++ ++ + A T VGT YM PE I
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSYMAPE-RI 171
Query: 465 DGL-FSVKSDVFSFGVLVLEIVCGK 488
G +SVKSD++S G+ ++E+ G+
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAKLQHRNLVKLIG 350
K+GEG +G VYK + G+ +A K++ E+ L+ +L H N++KL+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
+ + L++E++ + L I D R + L S + + +GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-DGLFS 469
+HRDLK N+L++ E K++DFG+AR+FG T+ VV T Y PE + D +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 470 VKSDVFSFGVLVLEIVCGK 488
D++S G + E++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 38/266 (14%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQH---RNLVKLI 349
+G G +G VY+G + G+ +A K ++ + + + + EV L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL----YLHQD 405
G + +I EY S+ T K +++ I I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVR------TLMKAGPIAEKY--ISVIIREVLVALKYIHKV 120
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
+IHRD+KA+N+L+ N N K+ DFG+A + ++ +T VGT +M PE +
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITE 175
Query: 466 G-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
G + K+D++S G+ + E+ G ++D A L + +P L + G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP----YSDVD---AFRAMMLIPKSKPPRLEDN--G 226
Query: 525 GSYSLSEVLRCIQVGLLCVQQRPEDR 550
S L E + C+ + P++R
Sbjct: 227 YSKLLREFV------AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 292 KNKLGEGGFGPVY----KGVL---------IEGQE--IAAKRL-SKSSGQGMEEFENEVL 335
K KLGEG FG V+ +G+ +GQ +A K L + + +F E+
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD-VTRSKF--------LDWS 386
++++L++ N+++L+G C D +I EY+ N LN F+ S F + +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 387 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446
+ IA G+ YL + L +HRDL N L+ N KI+DFGM+R
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
R V +M E + G F+ SDV++FGV + E+
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 11/204 (5%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRN 344
E F+ ++G+G FG V+KG+ Q++ A ++ + + +E+ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+ K G + + +I EYL S D+ R+ D + ++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ + IHRD+KA+NVLL + + K++DFG+A Q + NT VGT +M PE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGK 488
+ K+D++S G+ +E+ G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT 353
+G G +G VYKG ++ ++AA ++ +G EE + E+ ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 354 QR------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
++ D+ L+ E+ S+ D I + T+ L I I RGL +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI--- 464
++IHRD+K NVLL K+ DFG++ +D+T N +GT +M PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 465 --DGLFSVKSDVFSFGVLVLEIVCG 487
D + KSD++S G+ +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 59/221 (26%), Positives = 117/221 (52%), Gaps = 10/221 (4%)
Query: 269 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM 327
+EE+ + +++ + + ++ K+G+G G VY + I GQE+A K+++
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60
Query: 328 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 387
E NE+L++ + ++ N+V + DE ++ EYL SL D + + +D +
Sbjct: 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 116
Query: 388 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447
+ + L +LH + ++IHRD+K+ N+LL + + K++DFG +Q++ +
Sbjct: 117 IAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
T +VGT +M PE + K D++S G++ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLS---------KSSGQGM-EEFENEVLLIAKLQHR 343
+G+G +G VY + + G+ +A K++ S + M + +E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARG 398
N+V+ +G T + + EY+P S+ + F+ +F Q++ G+A
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT----EQVLEGLA-- 122
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR----AFGIDQTEANTNRVVGT 454
YLH I+HRDLKA N+L+D + KISDFG+++ + DQ + G+
Sbjct: 123 --YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ----NMSMQGS 173
Query: 455 YGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKR 489
+M PE I +S K D++S G +VLE+ G+R
Sbjct: 174 VFWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 71/262 (27%), Positives = 108/262 (41%), Gaps = 28/262 (10%)
Query: 295 LGEGGFGPVY------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+GGFG V G + +++ KRL K G+ M E ++L K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL--EKVSSRFIVSL 58
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
+D+ L+ + L I++V F ++ I GL +LHQ
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGF-PEARAIFYAAQIICGLEHLHQ---R 114
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468
RI++RDLK NVLLD+ N +ISD G+A + GT GYM PE ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVY 171
Query: 469 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS 528
D F+ G + E++ G R + + + E VE
Sbjct: 172 DFSVDWFALGCTLYEMIAG---RSPFR-QRKEKVEKEELKRRTLEMAVEY-------PDK 220
Query: 529 LSEVLRCIQVGLLCVQQRPEDR 550
S + + LL + PE R
Sbjct: 221 FSPEAKDLCEALLQ--KDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 87/317 (27%), Positives = 142/317 (44%), Gaps = 70/317 (22%)
Query: 275 PIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEG---QEIAAKRLSKSSGQG-MEEF 330
P+ +W I F D +GEG FG V K + + + A KR+ + + + +F
Sbjct: 2 PVLEWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 54
Query: 331 ENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVT 378
E+ ++ KL H N++ L+G C R L EY P+ +L DF+ F +
Sbjct: 55 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 379 RS--KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436
S L + +ARG+ YL Q + IHRDL A N+L+ KI+DFG++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 437 RAFGIDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV------ 485
R + V T G +P + AI+ L ++ SDV+S+GVL+ EIV
Sbjct: 172 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
Query: 486 -CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQ 544
CG Y L +RL E+P+ + EV ++ C +
Sbjct: 224 YCGMTCAELYEK------LPQGYRL---EKPLNCDD----------EVYDLMR---QCWR 261
Query: 545 QRPEDRPNMSSVVLMLS 561
++P +RP+ + +++ L+
Sbjct: 262 EKPYERPSFAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRL-----SKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+G FG VY ++ G+E+AAK++ S + + + E E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 349 IGCCTQRDERML--IYEYLPNKSLNDFIFD---VTRSKFLDWSKRCQIIGGIARGLLYLH 403
GC R E+ L EY+P S+ D + +T S ++++ I G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNRVVGTYGYMPPEY 462
+ I+HRD+K +N+L D+ N K+ DFG ++ I + V GT +M PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA 496
+ K+DV+S G V+E++ K Y A
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 79/270 (29%), Positives = 122/270 (45%), Gaps = 34/270 (12%)
Query: 289 FSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN---EVLLIAKLQHRN 344
FSD ++G G FG VY + E+ A K++S S Q E++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
++ GC + L+ EY S +D + K L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ +IHRD+KA N+LL K+ DFG A A N VGT +M PE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 465 ---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521
+G + K DV+S G+ +E+ +R ++ N + + + E P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM----NAMSALYHIAQNESPALQSGH 238
Query: 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP 551
SE R C+Q+ P+DRP
Sbjct: 239 -------WSEYFRNFVDS--CLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 13/193 (6%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGME-EFENEVLLIAKLQHRNLVKLIGCCT 353
LG+G FG V+KG L + +A K + Q ++ +F +E ++ + H N+VKLIG CT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDSRLRI 410
QR ++ E +P DF+ + + K D K Q++ A G+ YL +
Sbjct: 63 QRQPIYIVMELVPG---GDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 470
IHRDL A N L+ KISDFGM+R D +++ + PE G +S
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 471 KSDVFSFGVLVLE 483
+SDV+S+G+L+ E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 37/212 (17%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN-------EVLLIAKLQHRNL 345
K+GEG +G VYK + G+ +A K++ + E E E+ L+ +L H N+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLET-----EDEGVPSTAIREISLLKELNHPNI 60
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC----QIIGG----IAR 397
V+L+ ++ L++E+L D+ K++D S +I + +
Sbjct: 61 VRLLDVVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
G+ Y H R++HRDLK N+L+D E K++DFG+ARAFG+ T+ VV T Y
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWY 165
Query: 458 MPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK 488
PE + +S D++S G + E+V +
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 67/293 (22%)
Query: 288 NFSDKNKLGEGGFGPVYK-GVLIEGQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRN 344
+F KLG+G +G VYK L + Q A K L S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 345 LVK-----LIGC--CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--------WSKRC 389
++ L G C + EY P D +++ K W
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAP---FGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 390 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449
Q+ RGL LH+ +I+HRDLK++N+LL KI D G+++ + + A T
Sbjct: 111 QL----LRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT- 160
Query: 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509
+GT YM PE +S KSD++S G L+ E+ +
Sbjct: 161 -QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA--------------------TFAP 199
Query: 510 WIEERPV-ELINKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
E R + +L K G Y S+ L +Q +P+ RPN +
Sbjct: 200 PFEARSMQDLRYKVQRGKYPPIPPIYSQDL--QNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFE-NEVLLIAKLQHRNL 345
NF KLGEG + VYKG EI A K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
V+L ++ ML++EY+ +K L ++ LD + + +G+ + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT--NRVVGTYGYMPPEYA 463
R++HRDLK N+L++ K++DFG+ARAFGI NT N VV T Y P+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI---PVNTFSNEVV-TLWYRAPDVL 172
Query: 464 IDG-LFSVKSDVFSFGVLVLEIVCGK 488
+ +S D++S G ++ E++ G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 69/214 (32%), Positives = 113/214 (52%), Gaps = 28/214 (13%)
Query: 295 LGEGGFGPVYK----GVLIEGQE----IAAKRLS-KSSGQGMEEFENEVLLIAKL-QHRN 344
LGEG FG V + G+ + +A K L ++ + + + +E+ L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTRS--KFLDWSKRCQI 391
++ L+G CTQ +I EY +L +F+ FD+T+ + L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 450
+ARG+ YL +SR R IHRDL A NVL+ + KI+DFG+AR ID + +N
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+ +M PE D +++ +SDV+SFG+L+ EI
Sbjct: 197 RLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 20/201 (9%)
Query: 295 LGEGGFGPVYKGVLIEGQE-----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG G FG VYKG+ I E +A K L + +S + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+G C + L+ + +P L D++ + + L+W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+R++HRDL A NVL+ + + KI+DFG+AR ID+TE + + +M E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 465 DGLFSVKSDVFSFGVLVLEIV 485
F+ +SDV+S+GV V E++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 27/267 (10%)
Query: 293 NKLGEGGFGPVYKGV-LIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 349
NK+G G FG VY V L G+ +A K R+ + + ++E +E+ ++ L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409
G R++ + EY +L + + + LD + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEEL---LEHGRILDEHVIRVYTLQLLEGLAYLHSH---G 119
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT--NRVVGTYGYMPPEYAIDGL 467
I+HRD+K +N+ LD+ K+ DFG A + T + GT YM PE G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 468 FSVK---SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
+D++S G +VLE+ GKR D+ ++ H + +P I SL
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSEL--DNEFQIMFH---VGAGHKPP--IPDSLQ 232
Query: 525 GSYSLSEVLRCIQVGLLCVQQRPEDRP 551
S E + C++ P+ RP
Sbjct: 233 LS---PEGKDFLD---RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 295 LGEGGFGP--VYK----GVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+G FG +Y+ L+ +E+ RLS+ + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYL 402
+ ++ EY +L D I R K + + QI+ ++ Y+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVS----YI 117
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H+ I+HRD+K N+ L K+ DFG+++ G + + A T VVGT YM PE
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPEL 172
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
++ KSD+++ G ++ E++ KR + A N L ++ +
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRT---FDAT---NPLNLVVKIVQGNYTPVV---- 222
Query: 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
YS SE+ I + +QQ PE RP V+
Sbjct: 223 --SVYS-SEL---ISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 21/216 (9%)
Query: 280 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQGMEEFENE 333
+ I TE F LG G FG VYKG+ I EG+++ A K L + +S + +E +E
Sbjct: 1 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59
Query: 334 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRC 389
++A + + ++ +L+G C + LI + +P L D++ + + L+W +
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ- 117
Query: 390 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449
IA+G+ YL + R++HRDL A NVL+ + KI+DFG+A+ G D+ E +
Sbjct: 118 -----IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
+M E + +++ +SDV+S+GV V E++
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 25/205 (12%)
Query: 295 LGEGGFGPVYKGVLI--EGQEI--AAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVKLI 349
+G+G FG VY G LI +GQ+I A K L++ + + +E+F E +++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 350 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 405
G C + +++ Y+ + L +FI T + + +IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 464
+ +HRDL A N +LD K++DFG+AR + + N T +P ++ A+
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH---TGAKLPVKWMAL 171
Query: 465 DGL----FSVKSDVFSFGVLVLEIV 485
+ L F+ KSDV+SFGVL+ E++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 295 LGEGGFGPVYKGVLI-EGQEI----AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 348
LG G FG V+KG+ I EG I A K + SG Q +E + +L + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+G C L+ + P SL D + + + L+W + IA+G+ YL +
Sbjct: 75 LGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
R++HR+L A N+LL ++ +I+DFG+A D + + +M E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 465 DGLFSVKSDVFSFGVLVLEIV 485
G ++ +SDV+S+GV V E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 27/219 (12%)
Query: 285 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKS-SGQGMEEFENEVLLI 337
A E + +LG+G FG VY KGV+ + E +A K ++++ S + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 338 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--------WSKRC 389
+ ++V+L+G +Q ++I E + L ++ + R + + K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVQAPPSLKKMI 122
Query: 390 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449
Q+ G IA G+ YL+ + + +HRDL A N ++ + KI DFGM R D E +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 175
Query: 450 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
R G +M PE DG+F+ SDV+SFGV++ EI
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 55/221 (24%), Positives = 116/221 (52%), Gaps = 10/221 (4%)
Query: 269 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM 327
+EE+ + +++ + + ++ K+G+G G VY + + GQE+A ++++
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 328 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 387
E NE+L++ + ++ N+V + DE ++ EYL SL D + + +D +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117
Query: 388 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447
+ + L +LH + ++IHRD+K+ N+LL + + K++DFG +Q++
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ +VGT +M PE + K D++S G++ +E++ G+
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 342
N + + +LG+G FG VYK E G AAK + S + +E+F E+ ++++ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N+V L ++ ++ E+ +L+ + ++ R L + + + L +L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H ++IHRDLKA N+LL + + K++DFG++ A T + +GT +M PE
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKS-TLQKRDTFIGTPYWMAPEV 174
Query: 463 AI-----DGLFSVKSDVFSFGVLVLEI 484
D + K+D++S G+ ++E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 69/308 (22%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAA--KRLSK-SSGQGMEEFENEVLLIAKL-Q 341
E+ ++ +GEG FG V + ++ +G ++ A K L + +S +F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS--------------- 386
H N++ L+G C R + EY P +L DF+ +S+ L+
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTS 118
Query: 387 -KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445
+ Q +A G+ YL S + IHRDL A NVL+ + KI+DFG++R +
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV---- 171
Query: 446 ANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV-------CGKRNRGF 493
V T G +P + AI+ L ++ KSDV+SFGVL+ EIV CG
Sbjct: 172 ----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227
Query: 494 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553
Y L +R+ E+P ++ + E++R C + RP +RP
Sbjct: 228 YEK------LPQGYRM---EKPRNCDDE-------VYELMR------QCWRDRPYERPPF 265
Query: 554 SSVVLMLS 561
+ + + LS
Sbjct: 266 AQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 343
+ + K+GEG +G VYK + + IA K++ + +G+ E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD----WSKRCQIIGG----I 395
N+V+L L++EYL D+ K +D ++K ++I I
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL----------DLDLKKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGT 454
RG+ Y H R++HRDLK N+L+D N K++DFG+ARAFGI T+ VV T
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-T 166
Query: 455 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIV 485
Y PE + +S D++S G + E+V
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV---LIEGQ---EIAAKRL-SKSSGQGMEEFENEVLLIAK 339
N S LG G FG V + L + ++A K L + E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 340 L-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 398
L H N+V L+G CT ++I EY L +F+ R FL +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKG 153
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
+ +L + IHRDL A NVLL + KI DFG+AR D +N VV +
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMND-----SNYVVKGNARL 205
Query: 459 P-----PEYAIDGLFSVKSDVFSFGVLVLEI 484
P PE + +++ +SDV+S+G+L+ EI
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 19/194 (9%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
+GEG FG V +G GQ++A K + + F E ++ KL H+NLV+L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
++ E + +L +F+ TR + L + Q +A G+ YL +++H
Sbjct: 70 HNG-LYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 413 RDLKASNVLLDNEMNPKISDFGMARA--FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 470
RDL A N+L+ + K+SDFG+AR G+D ++ + PE FS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSS 176
Query: 471 KSDVFSFGVLVLEI 484
KSDV+S+GVL+ E+
Sbjct: 177 KSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 289 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---EVLLIAKLQHRN 344
F+D ++G G FG VY + + +A K++S S Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
++ GC + L+ EY S +D I +V + K L + I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLG-SASD-ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--Y 462
R IHRD+KA N+LL K++DFG A + N VGT +M PE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVIL 184
Query: 463 AID-GLFSVKSDVFSFGVLVLEI 484
A+D G + K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQH 342
N E+F ++G G +G VYK + E+AA ++ K G+ + E++++ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N+V G +RD+ + E+ SL D I+ VT L S+ + +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H + +HRD+K +N+LL + + K++DFG++ I T A +GT +M PE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEV 177
Query: 463 AI---DGLFSVKSDVFSFGVLVLEI 484
A G ++ D+++ G+ +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 6e-18
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 289 FSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN---EVLLIAKLQHRN 344
F+D ++G G FG VY + E+ A K++S S Q E++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
++ GC + L+ EY S +D + K L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ +IHRD+KA N+LL K++DFG A + N VGT +M PE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 465 ---DGLFSVKSDVFSFGVLVLEI 484
+G + K DV+S G+ +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 295 LGEGGFGPVY------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+GGFG V G L +++ KRL K G E +L AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRIL--AKVHSRFIVSL 58
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLLYLHQDSR 407
+ + L+ + L I++V + C I GL +LHQ
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 467
RII+RDLK NVLLDN+ N +ISD G+A Q++ T GT G+M PE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 468 FSVKSDVFSFGVLVLEIVCGK---RNRG 492
+ D F+ GV + E++ + R RG
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 288 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRN 344
NF K+GEG +G VYK + G+ +A K RL + E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL--YL 402
+VKL+ ++ L++E+L ++ L KF+D + GI L+ YL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLK---------KFMD----ASPLSGIPLPLIKSYL 106
Query: 403 HQ-------DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
Q R++HRDLK N+L++ E K++DFG+ARAFG+ T+ VV T
Sbjct: 107 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 164
Query: 456 GYMPPEYAIDG-LFSVKSDVFSFGVLVLEIV 485
Y PE + +S D++S G + E+V
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 295 LGEGGFGPVYK-GVLIEGQEIAAKRLSKSS--GQGMEEF---ENEVLLIAKLQHRNLVKL 348
LG GGFG V V + + A K + K G +E E E+L + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEIL--EECNHPFIVKL 58
Query: 349 IGCCTQRDER---MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
T +D++ ML+ EY L + D R F +++ R I + YLH
Sbjct: 59 Y--RTFKDKKYIYMLM-EYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLH-- 110
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
II+RDLK N+LLD+ K+ DFG A+ Q T GT Y+ PE ++
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166
Query: 466 GLFSVKSDVFSFGVLVLEIVCGK 488
+ D +S G+L+ E++ G+
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQE------------------IAAKRL-SKSSGQGMEEFEN 332
K KLGEG FG V+ EG E +A K L ++ +F
Sbjct: 10 KEKLGEGQFGEVHL-CEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 333 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI--------FDVTRSKFLD 384
E+ ++++L+ N+++L+ C D +I EY+ N LN F+ + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 385 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444
+S + IA G+ YL S L +HRDL N L+ KI+DFGM+R
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
R V +M E + G F+ SDV++FGV + EI
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
+ K+GEG G V G+++A K++ Q E NEV+++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
V++ DE ++ E+L +L D VT ++ ++ + + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLAVLKALSFLHAQ 134
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMPPEY 462
+IHRD+K+ ++LL ++ K+SDFG Q R +VGT +M PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ + D++S G++V+E+V G+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 294 KLGEGGFGPVYKGVL-IEGQEI--AAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLVKLI 349
+LG G FG V KGV + ++I A K L + + + +E E ++ +L + +V++I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409
G C + + ML+ E LN F+ + + S +++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDGL 467
+HRDL A NVLL N+ KISDFG+++A G D + R G + + PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174
Query: 468 FSVKSDVFSFGVLVLE 483
FS +SDV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 43/286 (15%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS---KSSGQGMEEFENEVLLIAKLQ 341
NF + K+G+G F VYK + L++G+ +A K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL-----DWSKRCQIIGGIA 396
H N++K + + +E ++ E L+ I + K L W Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
L ++H RI+HRD+K +NV + K+ D G+ R F T A++ +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516
YM PE + ++ KSD++S G L+ E+ + FY G L+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY---------GDKMNLY------ 214
Query: 517 ELINKSLGGSYS------LSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
L K Y SE LR + C+ PE RP++S V
Sbjct: 215 SLCKKIEKCDYPPLPADHYSEELR--DLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 70/282 (24%), Positives = 124/282 (43%), Gaps = 32/282 (11%)
Query: 213 KKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEM 272
K+ +K IT L V+ L F +++ R L+ N +
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN---------LELKRVENEDGTW 670
Query: 273 ELPIFDW-----MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG 326
EL FD + I + + ++N + G G YKG I+ G + K ++ +
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730
Query: 327 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 386
+E+ + KLQH N+VKLIG C LI+EY+ K+L+ +V R+ L W
Sbjct: 731 ----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS----EVLRN--LSWE 780
Query: 387 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446
+R +I GIA+ L +LH ++ +L +++D + P + + D
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839
Query: 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
++ Y+ PE + KSD++ FG++++E++ GK
Sbjct: 840 ISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-----EVLLIAKLQHRNLV 346
KLGEG + VYK E G+ +A K++ + ++ N E+ L+ +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
L+ + L++E++ L I D +S L + + RGL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH--- 119
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
I+HRDLK +N+L+ ++ K++DFG+AR+FG T++VV T Y PE
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYRAPEL---- 173
Query: 467 LFSVKS-----DVFSFGVLVLE 483
LF + D++S G + E
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAA-KRLS-KSSGQGMEEFE-NEVLLIAKLQHRNLVKLIG 350
K+GEG +G V+K E EI A KR+ +G+ E+ L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
+ L++EY ++ L + FD +D + + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFS 469
+HRDLK N+L++ K++DFG+ARAFGI + VV T Y PP+ L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 470 VKSDVFSFGVLVLEIVCGKR 489
D++S G + E+ R
Sbjct: 179 TSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 29/210 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI---AAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 349
LGEG FG V +G L + I A K +++ + ME+F +E + + + H N+++LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 350 GCCTQRDER------MLIYEYLPNKSLNDFIFDVTR----SKFLDWSKRCQIIGGIARGL 399
G C Q E ++I ++ + L+ F+ +R ++L + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 459
YL S IHRDL A N +L+ MN ++DFG+++ + R G MP
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI----YNGDYYR-QGRIAKMP 177
Query: 460 PEY-AIDGL----FSVKSDVFSFGVLVLEI 484
++ AI+ L ++ KSDV+SFGV + EI
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 63/213 (29%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFEN---EVLLIAKLQHR 343
+F +G+G FG V + +++ A K ++K N E ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 344 NLVKLIGCCT-QRDERM-LIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 396
LV L + Q +E M L+ + L L + F + KF I I
Sbjct: 61 FLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIV 110
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
L YLH IIHRD+K N+LLD + + I+DF +A + T GT G
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPG 164
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 489
YM PE +SV D +S GV E + GKR
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 70/294 (23%)
Query: 295 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 349
+G G FG V G L + G+ +A K L + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIG---GIARGLL 400
G T+ M++ EY+ N SL+ F+ F V Q++G GIA G+
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI-----------QLVGMLRGIASGMK 120
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP- 459
YL S + +HRDL A N+L+++ + K+SDFG++R D A T R G +P
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPI 173
Query: 460 ----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515
PE F+ SDV+S+G+++ E++ ERP
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------------------------YGERP 209
Query: 516 V-ELIN----KSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 560
E+ N K++ Y L + C Q+ L C Q+ +RP +V +L
Sbjct: 210 YWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 295 LGEGGFGPVYKGVLI--------EGQEIAAKRLS-KSSGQGMEEFENEVLLIAKL-QHRN 344
LGEG FG V + E +A K L ++ + + + +E+ ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 391
++ L+G CTQ +I EY +L +++ +D+ R + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 450
+ARG+ YL + + IHRDL A NVL+ KI+DFG+AR ID + TN
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+ +M PE D +++ +SDV+SFGVL+ EI
Sbjct: 200 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 295 LGEGGFGPVY--------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
+G G FG V+ K V+I ++I ++++K + NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+ + M++ EY P +L ++I S + + I+ + LL LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----ILHFFVQILLALHHVH 118
Query: 407 RLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
I+HRDLK N+LLD ++M KI DFG+++ +++ VVGT Y+ PE
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEG 175
Query: 466 GLFSVKSDVFSFGVLVLEIVCGKR 489
++ KSD+++ G ++ E+ KR
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 60/197 (30%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 294 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
+LG+G FG VYK E G AAK + S + +E++ E+ ++A H +VKL+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
+ ++ E+ P +++ + ++ R L + I + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIH 133
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 467
RDLKA NVLL + + K++DFG++ A + +T + +GT +M PE + D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS-AKNV-KTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 468 FSVKSDVFSFGVLVLEI 484
+ K+D++S G+ ++E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT 353
+G G +G VYKG ++ ++AA ++ + EE + E+ ++ K HRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 354 QR------DERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDS 406
++ D+ L+ E+ S+ D + + + DW I I RGL +LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGLAHLHAH- 140
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-- 464
++IHRD+K NVLL K+ DFG++ +D+T N +GT +M PE
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 465 ---DGLFSVKSDVFSFGVLVLEIVCG 487
D + +SD++S G+ +E+ G
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 42/224 (18%)
Query: 285 ATENFSD---KNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME-EFENEVLLIAK 339
A ++ S+ N++G G G VYK + G+ A K + + + + E+ ++
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND-------FIFDVTRSKFLDWSKRCQII 392
+ H N+VK E ++ E++ SL F+ DV R QI+
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----------QIL 178
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
GIA YLH R I+HRD+K SN+L+++ N KI+DFG++R + QT N V
Sbjct: 179 SGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSV 229
Query: 453 GTYGYMPPEY--------AIDGLFSVKSDVFSFGVLVLEIVCGK 488
GT YM PE A DG D++S GV +LE G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN---EVLLIAKLQH 342
E F +++G G FG VY E+ A K++S S Q E++++ EV + +L+H
Sbjct: 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N ++ GC + L+ EY S +D + K L + I G +GL YL
Sbjct: 81 PNTIEYKGCYLKEHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H + +IHRD+KA N+LL K++DFG A + N VGT +M PE
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEV 188
Query: 463 AI---DGLFSVKSDVFSFGVLVLEI 484
+ +G + K DV+S G+ +E+
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQH 342
N ++ ++G G +G VYK + E+AA ++ K G + E+ ++ + +H
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI---IGGIARGL 399
N+V G R++ + EY SL D I+ VT QI +GL
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPL-----SELQIAYVCRETLQGL 119
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 459
YLH ++ HRD+K +N+LL + + K++DFG+A I T A +GT +M
Sbjct: 120 AYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMA 174
Query: 460 PEYAI---DGLFSVKSDVFSFGVLVLEI 484
PE A +G ++ D+++ G+ +E+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
E + +KLGEG + VYKG L+ +EI RL G EV L+ L
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
+H N+V L L++EYL +K L ++ D S + K + + RGL
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK--LFLFQLLRGLN 118
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
Y H R +++HRDLK N+L++ K++DFG+ARA I T+ +N VV T Y PP
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPP 173
Query: 461 EYAIDGL-FSVKSDVFSFGVLVLEIVCGK 488
+ + +S + D++ G + E+ G+
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRL-----SKSSGQGMEEFENEVLLIAKL 340
N+ LG G FG VY + G+E+A K++ S+ + + + E E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 341 QHRNLVKLIGCCTQRDERML--IYEYLPNKSLND-------FIFDVTRSKFLDWSKRCQI 391
+H +V+ GC +E+ L EY+P S+ D +VTR ++++
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR----YTRQ--- 114
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA-RAFGIDQTEANTNR 450
I +G+ YLH + I+HRD+K +N+L D+ N K+ DFG + R I +
Sbjct: 115 ---ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
V GT +M PE + K+DV+S V+E++ K
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 8e-17
Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 35/210 (16%)
Query: 295 LGEGGFGPVYKGVL-IEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVKLI 349
+G G FG V +G L + G+ +A K L S + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIG---GIARGLL 400
G T+ M+I E++ N +L+ F+ F V Q++G GIA G+
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI-----------QLVGMLRGIAAGMK 120
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP- 459
YL S + +HRDL A N+L+++ + K+SDFG++R D ++ +G G +P
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPI 175
Query: 460 ----PEYAIDGLFSVKSDVFSFGVLVLEIV 485
PE F+ SDV+S+G+++ E++
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 48/199 (24%)
Query: 294 KLGEGGFGPVYKGVLIE-GQEIAAKR-LSKSSGQGME-EFENEVLLIAKLQHRNLVKLIG 350
KLGEG FG VYK I+ G+ +A K+ L + G E+ ++ KL+H N+V LI
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 351 CCTQRDERMLIYEYLPN--KSLNDF-------------IFDVTRSKFLDWSKRC---QII 392
+ E + + + K + +C Q++
Sbjct: 75 ---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF----------GID 442
GI YLH++ I+HRD+KA+N+L+DN+ KI+DFG+AR + G
Sbjct: 126 EGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 443 QTEANTNRVVGTYGYMPPE 461
T TN VV T Y PPE
Sbjct: 179 GTRKYTNLVV-TRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 58/210 (27%), Positives = 108/210 (51%), Gaps = 29/210 (13%)
Query: 293 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE----NEVLLIAKLQHRNLVK 347
++GEG +G VYK G+ +A K++ + + E F E+ ++ +L HRN+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70
Query: 348 LIGCCTQRDERM----------LIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGI 395
L T + + + L++EY+ + + + S + +S+ + +
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFMKQL 125
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
GL Y H+ + L HRD+K SN+LL+N+ K++DFG+AR + +++ TN+V+ T
Sbjct: 126 LEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 456 GYMPPEYAI-DGLFSVKSDVFSFGVLVLEI 484
Y PPE + + + DV+S G ++ E+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 68/205 (33%), Positives = 110/205 (53%), Gaps = 24/205 (11%)
Query: 295 LGEGGFGPVY------KGVLIEGQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQHRNLVK 347
LGEG FG V +G G+++A K L +S G + + + E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 348 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLLYLHQ 404
G CT+ LI E+LP+ SL +++ R+K ++ ++ + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ----TEANTNRVVGTYGYMPP 460
SR + +HRDL A NVL+++E KI DFG+ +A D+ + + + V Y P
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA---P 181
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIV 485
E I F + SDV+SFGV + E++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 294 KLGEGGFGPVYKGVLIE-GQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 350
++GEG G V+K E G+ +A K+ L + G + E+ + QH +VKL+
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYLHQDSR 407
+L+ EY+P+ L++ + D R + + ++ G+A Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVKSYMRMLLKGVA----YMHA--- 117
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
I+HRDLK +N+L+ + KI+DFG+AR F ++ +++ V T Y PE
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 13/191 (6%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 354
+G+G FG V G G ++A K + + + F E ++ +L+H NLV+L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 355 RDERMLIY-EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 413
+ I EY+ SL D++ RS L + + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 414 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 473
DL A NVL+ + K+SDFG+ + Q + PE + FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 181
Query: 474 VFSFGVLVLEI 484
V+SFG+L+ EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 31/209 (14%)
Query: 293 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSG-QGMEEFE-NEVLLIAKLQ---HRNLV 346
++GEG +G VYK L G+ +A K++ +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 347 KLIGCC-TQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
+L+ C R +R L++E++ ++ L ++ + + + ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDF 122
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH RI+HRDLK N+L+ ++ KI+DFG+AR + + A T+ VV T Y PE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWYRAPE 176
Query: 462 ------YAIDGLFSVKSDVFSFGVLVLEI 484
YA V D++S G + E+
Sbjct: 177 VLLQSSYA----TPV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRL-----SKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+G FG VY + G+E+A K++ S + + + E E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 349 IGCCTQRDERML--IYEYLPNKSLND-------FIFDVTRSKFLDWSKRCQIIGGIARGL 399
GC ER L E++P S+ D +VTR ++++ I G+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK----YTRQ------ILEGV 119
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNRVVGTYGYM 458
YLH + I+HRD+K +N+L D+ N K+ DFG ++ I + V GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE + K+D++S G V+E++ K
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 45/232 (19%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQE-----------------IAAKRL-SKSSGQGMEEFENE 333
K KLGEG FG V+ ++ Q+ +A K L ++ +F E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 334 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--------- 384
V ++++L+ N+++L+G C D +I EY+ N LN F+ S LD
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL----SSHHLDDKEENGNDA 125
Query: 385 -----------WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433
+S + IA G+ YL S L +HRDL N L+ + KI+DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
GM+R R V +M E + G F+ SDV++FGV + EI+
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE-----NEVLLIAKLQHRNLVKL 348
LG+G FG V L E G+ A K L K ++ E +L +A+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
CC Q +R+ N D +F + +S+ D ++ I L++LH
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468
II+RDLK NVLLD+E + K++DFGM + GI T+ GT Y+ PE + L+
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GI-FNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 469 SVKSDVFSFGVLVLEIVCG 487
D ++ GVL+ E++CG
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 295 LGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+GGFG V G + +++ KRL K SG+ M E E+L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
+ L+ + L I++V + L+ + I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468
I++RD+K NVLLD++ N ++SD G+ A + + T R GT GYM PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQR-AGTNGYMAPEILKEEPY 171
Query: 469 SVKSDVFSFGVLVLEIVCGK 488
S D F+ G + E+V G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 34/217 (15%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVL------LIAKLQ------- 341
LGEG FG V V+ E I + +K ++ +++ L+++++
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKR 388
H+N++ L+G CTQ ++ EY +L +++ FD + + L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 389 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEAN 447
+ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR ID +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
TN + +M PE D +++ +SDV+SFGVL+ EI
Sbjct: 194 TNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 74/278 (26%), Positives = 124/278 (44%), Gaps = 31/278 (11%)
Query: 288 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS---KSSGQGMEEFENEVLLIAKLQHR 343
NF + K+G G F VY+ L++G +A K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD-----WSKRCQIIGGIARG 398
N++K + +E ++ E L+ I + K L W Q+ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
H SR R++HRD+K +NV + K+ D G+ R F T A++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
PE + ++ KSD++S G L+ E+ FY G L+ + +E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFY---------GDKMNLYSLCKKIEQ 222
Query: 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
+ S SE LR Q+ +C+ PE RP+++ V
Sbjct: 223 CDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 63/296 (21%)
Query: 295 LGEGGFGPVYKGVLI-EGQEI-AAKRLSK--SSGQGMEEFENEVLLIAKL-QHRNLVKLI 349
+GEG FG V K + +G + AA + K +S +F E+ ++ KL H N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA-----RGLLYLHQ 404
G C R L EY P+ +L DF+ +S+ L+ I A + LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 405 D--------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
D S+ + IHRDL A N+L+ KI+DFG++R + V T G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMG 171
Query: 457 YMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV-------CGKRNRGFYHADHHHNLLG 504
+P + AI+ L ++ SDV+S+GVL+ EIV CG Y L
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LP 225
Query: 505 HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+RL E+P+ ++ + +++R C +++P +RP+ + +++ L
Sbjct: 226 QGYRL---EKPLNCDDE-------VYDLMR------QCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 292 KNKLGEGGFGPVYKGVLI--EGQEIA-AKRLSK--SSGQGMEEFENEVLLIAKLQHRNLV 346
+GEG FG VY+GV + E ++IA A + K +S E+F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
KLIG T+ + ++ E P L ++ LD + ++ L YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
R +HRD+ A NVL+ + K+ DFG++R D++ ++ +M PE
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183
Query: 467 LFSVKSDVFSFGVLVLEI 484
F+ SDV+ FGV + EI
Sbjct: 184 RFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 294 KLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGME-EFENEVLLIAKLQHRNLVKLIGC 351
++G G FG V+ G L + +A K ++ ++ +F E ++ + H N+V+LIG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
CTQ+ ++ E + F+ T L + Q++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 412 HRDLKASNVLLDNEMNPKISDFGMAR--AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 469
HRDL A N L+ + KISDFGM+R G+ + ++ + PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 470 VKSDVFSFGVLVLE 483
+SDV+SFG+L+ E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 21/200 (10%)
Query: 294 KLGEGGFGPVYKGVL--IEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNLVKL 348
+LG G FG V KG+ + ++ A ++ K+ +E E ++ +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
IG C + + ML+ E LN F+ ++K + +++ ++ G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-YAIDGL 467
+HRDL A NVLL + KISDFG+++A G D+ T+G P + YA + +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPECM 170
Query: 468 ----FSVKSDVFSFGVLVLE 483
FS KSDV+SFGVL+ E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 289 FSDKNKLGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 342
F LG+GGFG V G + +++ KR+ K G+ M E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQIL--EKVNS 59
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
R +V L +D L+ + L I+ + + F + + I GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
HQ+ RI++RDLK N+LLD+ + +ISD G+A QT VGT GYM PE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEV 172
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ ++ D ++ G L+ E++ G+
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 298 GGFGPVY---KGVLIEGQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKLI 349
G +G V+ K G A K + K+ + E ++L + Q +VKL
Sbjct: 4 GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKLY 59
Query: 350 GCCTQRDERM-LIYEYLPN---KSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
Q + + L+ EYLP SL + + D ++ I I L YLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLH 110
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFG------MARAFGIDQTEANTNRVVGTYGY 457
IIHRDLK N+L+D+ + K++DFG + R ++ E R+VGT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 458 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
+ PE + S D +S G ++ E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 295 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 341
LGEG FG V V+ E ++A K L S ++ + + + +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG-------- 393
H+N++ L+G CTQ +I EY +L +++ R +++ +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 394 ------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 446
+ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR ID +
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
TN + +M PE D +++ +SDV+SFGVL+ EI
Sbjct: 199 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE-NEVL-------LIAKLQHR 343
+ +LG+G FG VY ++ + + +A +RL + E NE + L++KL H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGLLYL 402
+VK +RD +I EY + L+ + ++ + K L ++ C+ + G+ Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
HQ RI+HRDLKA N+ L N + KI DFG++R A T GT YM PE
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVC 486
+ KSD++S G ++ E+ C
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 30/218 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQH-R 343
E+ D ++G G FG V K + G +A KR+ S + + ++ ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF---IFDVTRSKFLDWSKRCQIIGGIA---- 396
+VK G R+ I L + SL+ F +++V +S + +I+G IA
Sbjct: 64 YIVKFYGA-LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE-----EILGKIAVATV 117
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGT 454
+ L YL ++ L+IIHRD+K SN+LLD N K+ DFG++ I +T R G
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT-----RDAGC 170
Query: 455 YGYMPPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
YM PE A DG + V+SDV+S G+ + E+ GK
Sbjct: 171 RPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 27/210 (12%)
Query: 294 KLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLV 346
+LG+G FG VY+G +I+G+ +A K +++S S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQIIGGIARG 398
+L+G ++ +++ E + + L ++ + R + + R Q+ IA G
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---- 454
+ YL+ + +HRDL A N ++ ++ KI DFGM R D E + R G
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+M PE DG+F+ SD++SFGV++ EI
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 288 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS---KSSGQGMEEFENEVLLIAKLQHR 343
NF + K+G G F VY+ L++ + +A K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD-----WSKRCQIIGGIARG 398
N++K + + +E ++ E L+ I + K L W Q+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
H SR R++HRD+K +NV + K+ D G+ R F T A++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEI 484
PE + ++ KSD++S G L+ E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 71/280 (25%), Positives = 130/280 (46%), Gaps = 38/280 (13%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIEGQE------IAAKRLSKSSGQGMEEFENEVLLIAKLQ 341
+ K+GEG FG +Y L + + I L+K + E + EV+L+AK++
Sbjct: 1 RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK 57
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARG 398
H N+V + ++ EY D + + R + + +S+ QI+ I+ G
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDG---GDLMKRINRQRGVLFSED-QILSWFVQISLG 113
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
L ++H +I+HRD+K+ N+ L N M K+ DFG+AR A T VGT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168
Query: 458 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517
+ PE + ++ K+D++S G ++ E+ K + ++ H L+ + + P+
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP---FEGNNLHQLVLKICQGYFA--PI- 222
Query: 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557
S S L ++ + + P DRP+++S++
Sbjct: 223 ----SPNFSRDLRSLISQL------FKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 294 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
K+GEG G V G+++A K + Q E NEV+++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
+E ++ E+L +L D + L+ + + + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 472
RD+K+ ++LL + K+SDFG D + + +VGT +M PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198
Query: 473 DVFSFGVLVLEIVCGK 488
D++S G++V+E+V G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
E + KLGEG + V+KG L+ +EI RL G EV L+ L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
+H N+V L L++EYL +K L ++ D + + I RGL
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLA 118
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
Y H R +++HRDLK N+L++ K++DFG+ARA + T+ +N VV T Y PP
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPP 173
Query: 461 EYAI-DGLFSVKSDVFSFGVLVLEIVCGK 488
+ + +S + D++ G + E+ G+
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 41/193 (21%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFE----NEVLLIAKLQHRNLVK 347
K+G+G FG V+K + ++I A K++ E F E+ ++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITALREIKILQLLKHENVVN 75
Query: 348 LIGCCTQ--------RDERMLIYEY--------LPNKSLNDFIFDVTRSKFLDWSKRCQI 391
LI C + L++E+ L NK++ F ++ K ++
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK--------KV 124
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN---T 448
+ + GL Y+H R +I+HRD+KA+N+L+ + K++DFG+ARAF + + T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 449 NRVVGTYGYMPPE 461
NRVV T Y PPE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEF------ENEVLLIAK 339
+ + N++ EG +G VY+ + EI A K+L E F E +LL K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILL--K 60
Query: 340 LQHRNLVKL--IGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRC---QII 392
LQH N+V + + + D+ ++ EY+ + KSL + + FL +C Q++
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFLQSEVKCLMLQLL 116
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
G+A +LH + I+HRDLK SN+LL+N KI DFG+AR +G + T VV
Sbjct: 117 SGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV 168
Query: 453 GTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 488
T Y PE + +S D++S G + E++ K
Sbjct: 169 -TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
+LG+G FG VYK E +AA K + S + +E++ E+ ++A H N+VKL+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
+ ++ E+ +++ + ++ R L + + L YLH++ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 467
RDLKA N+L + + K++DFG++ +T + +GT +M PE + D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 468 FSVKSDVFSFGVLVLEI 484
+ K+DV+S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 294 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
K+GEG G V V G+ +A K++ Q E NEV+++ QH N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
DE ++ E+L +L D VT ++ ++ + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 472
RD+K+ ++LL ++ K+SDFG + + +VGT +M PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 473 DVFSFGVLVLEIVCGK 488
D++S G++V+E+V G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 294 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
K+GEG G V G+++A K++ Q E NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
DE ++ E+L +L D VT ++ ++ + + + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 472
RD+K+ ++LL ++ K+SDFG + + +VGT +M PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 473 DVFSFGVLVLEIVCGK 488
D++S G++V+E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 68/311 (21%)
Query: 282 IANATENFSDKNKLGEGGFGPVYKGVLIEG-----QEIAAKRLSKSSGQ-GMEEFENEVL 335
IA + + + + L EG FG ++ G+LI+ +E+ K + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 336 LIAKLQHRNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG 394
L+ L H+N++ ++ C + E ++Y Y+ +L F+ ++C++
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL------------QQCRLGEA 108
Query: 395 -----------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437
IA G+ YLH + +IH+D+ A N ++D E+ KI+D ++R
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
Query: 438 -AFGIDQ--TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494
F +D N NR V +M E ++ +S SDV+SFGVL+ E++
Sbjct: 166 DLFPMDYHCLGDNENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT-------- 214
Query: 495 HADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDR 550
LG ++E P E+ G Y L++ + C V C PE+R
Sbjct: 215 --------LGQT--PYVEIDPFEMAAYLKDG-YRLAQPINCPDELFAVMACCWALDPEER 263
Query: 551 PNMSSVVLMLS 561
P+ S +V L+
Sbjct: 264 PSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 52/148 (35%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN--EVLLIAKLQ-HRNLVKLI 349
+LG+G FG VY E E+ A K++ K EE N EV + KL H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409
+ DE ++EY+ +L + D F + R II I +GL ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH---KHG 119
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMAR 437
HRDLK N+L+ KI+DFG+AR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--FENEVLLIAKLQHR 343
E + + +GEG +G V K E GQ +A K+ +S M + E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF---LDWSKRCQIIGGIARGLL 400
NLV LI ++ L++E++ + L+D K+ LD S+ + + I RG+
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDL------EKYPNGLDESRVRKYLFQILRGIE 114
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
+ H + IIHRD+K N+L+ K+ DFG AR E T+ V T Y P
Sbjct: 115 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAP 169
Query: 461 EYAI-DGLFSVKSDVFSFGVLVLEIVCG 487
E + D + D+++ G LV E++ G
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 41/105 (39%), Positives = 64/105 (60%), Gaps = 10/105 (9%)
Query: 388 RCQIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443
+I+G IA GL YL+ + RI+HRD+K SN+L+++ K+ DFG++ +
Sbjct: 101 PVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE--LIN 156
Query: 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ A+T VGT YM PE G ++VKSDV+S G+ ++E+ GK
Sbjct: 157 SIADT--FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 68/203 (33%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKS---SGQGMEEFENE--VLLIAKLQHRNLVKL 348
LG+G FG V L E+ A K L K +E E VL +A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 349 IGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
C Q +R+ + EY+ D +F + RS D + I GL +LH+
Sbjct: 62 H-SCFQTKDRLFFVMEYVNG---GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG- 116
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI--DQTEANTNRVVGTYGYMPPEYAID 465
II+RDLK NVLLD+E + KI+DFGM + GI T T+ GT Y+ PE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVT---TSTFCGTPDYIAPEILSY 170
Query: 466 GLFSVKSDVFSFGVLVLEIVCGK 488
+ D ++ GVL+ E++ G+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 34/281 (12%)
Query: 295 LGEGGFGPVYK-------GVLIEGQEI-----AAKRLSKSSGQGMEEFENEVLLIAK-LQ 341
LG G FG VYK L+ +EI A + + + + + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC-QIIGGIARGLL 400
H N+V+ + D ++ + + L + + K +R I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
YLH++ R I+HRDL +N++L + I+DFG+A+ Q E+ VVGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSCP 182
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
E + + K+DV++FG ++ ++ FY N+L A + I E E +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMC--TLQPPFYST----NMLSLATK--IVEAVYEPLP 234
Query: 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
+ G YS +V I C+ E RP++ V M+S
Sbjct: 235 E---GMYS-EDVTDVITS---CLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN--------EVLLIA 338
F N++GEG +G VY+ EI A K++ M+ + E+ L+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLL 61
Query: 339 KLQHRNLVKLIGCCT--QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 396
L+H N+V+L D L+ EY + L + ++ F + +C ++ +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTP-FSESQVKC-LMLQLL 118
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
RGL YLH++ IIHRDLK SN+LL ++ KI+DFG+AR +G+ T +VV T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV-TLW 173
Query: 457 YMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 488
Y PE L + D+++ G ++ E++ K
Sbjct: 174 YRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 294 KLGEGGFGPVYKGVLIE---GQEIAAKRL--SKSSGQGMEEFE-NEVLLIAKLQHRNLVK 347
+G G +G VYK G+E A K+ K G+ + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 348 LIGCCTQRDERM--LIYEYLPNKSLNDF--IFDVTRSKFLDWSKRCQIIGGIAR------ 397
L+ + ++ L+++Y + +D I R +KR I + +
Sbjct: 67 LVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQI 117
Query: 398 --GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGID-QTEANTNR 450
G+ YLH + ++HRDLK +N+L+ E KI D G+AR F + A+ +
Sbjct: 118 LNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 451 VVGTYGYMPPE 461
VV T Y PE
Sbjct: 175 VVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 285 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE--NEVLLIAKLQ 341
A ++ + KLGEG + VYKG+ I GQ +A K +S + +G+ F E L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI------ 395
H N+V L+++ + K F+F+ + + Q GG+
Sbjct: 62 HANIV-------------LLHDIIHTKETLTFVFEYMHTDLAQY--MIQHPGGLHPYNVR 106
Query: 396 ------ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449
RGL Y+H I+HRDLK N+L+ K++DFG+ARA I ++ ++
Sbjct: 107 LFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSS 162
Query: 450 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 488
VV T Y PP+ + +S D++ G + +E++ G+
Sbjct: 163 EVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 295 LGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+GGFG V G + +++ KR+ K G+ M NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL--NEKRILEKVNSRFVVSL 65
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
+D L+ + L I+++ F D + + GL L ++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDLQRE--- 121
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR-VVGTYGYMPPEYAIDGL 467
RI++RDLK N+LLD+ + +ISD G+A + E T R VGT GYM PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEK 177
Query: 468 FSVKSDVFSFGVLVLEIVCGK 488
++ D + G L+ E++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE------FENEVLLIAKLQHRNLVKL 348
LG+G FG V+ L + A + K M++ E VL +A +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 349 IGCCTQRDERML-IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
C Q E + + EYL D +F + D + I GL +LH
Sbjct: 62 Y-CTFQTKENLFFVMEYLNG---GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 467
I++RDLK N+LLD + + KI+DFGM + + +A T GT Y+ PE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQK 172
Query: 468 FSVKSDVFSFGVLVLEIVCGK 488
++ D +SFGVL+ E++ G+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 295 LGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+GGFG V G + +++ KR+ K G+ M NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL--NEKQILEKVNSRFVVSL 65
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDSR 407
+D L+ + L I+++ F + +R I GL LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--ERAVFYAAEITCGLEDLH---R 120
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 467
RI++RDLK N+LLD+ + +ISD G+ A I + E R VGT GYM PE +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGL--AVEIPEGETIRGR-VGTVGYMAPEVVKNER 177
Query: 468 FSVKSDVFSFGVLVLEIVCGK 488
++ D + G L+ E++ GK
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE------FENEVLLIAKLQHRNLVKL 348
LG+G FG V L E A + K ++ E VL +A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHL 61
Query: 349 IGCCTQRDERML-IYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYL 402
C Q E + + EYL L I FD R++F +II G L +L
Sbjct: 62 F-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG----LQFL 112
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H+ II+RDLK NVLLD + + KI+DFGM + + +A+T GT Y+ PE
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEI 167
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
++ D +SFGVL+ E++ G+
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 289 FSDKNKLGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 342
F LG+GGFG V G + + + KR+ K G+ M E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQIL--EKVNS 59
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
+ +V L +D L+ + L I+++ F + + I GL L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-EEERALFYAAEILCGLEDL 118
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H+++ ++RDLK N+LLD+ + +ISD G+ A I + E+ R VGT GYM PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGL--AVKIPEGESIRGR-VGTVGYMAPEV 172
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ +++ D + G L+ E++ G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 51/218 (23%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVLLIAKLQHRN 344
+G G +G V + G+++A K+LS F++ E+ L+ + H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVT-----------RSKFLDWSKRCQI 391
++ L+ T P SL DF ++ VT + + L +
Sbjct: 76 VIGLLDVFT------------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451
+ I RGL Y+H IIHRDLK SN+ ++ + KI DFG+AR T+
Sbjct: 124 VYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGY 175
Query: 452 VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 488
V T Y PE ++ + ++ D++S G ++ E++ GK
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHR 343
E + +KLGEG + V+KG + +A K RL G EV L+ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA------- 396
N+V L L++EYL D ++LD + +
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL----------DSDLKQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
RGL Y H + +I+HRDLK N+L++ + K++DFG+ARA + T+ +N VV T
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLW 168
Query: 457 YMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 488
Y PP+ + +S D++ G ++ E+ G+
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 295 LGEGGFGPVYKGVLIE----GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+G FG V + L Q++A K L S +EEF E + + H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 349 IGCCTQRDER------MLIYEYLPNKSLNDFIF--DVTRSKF-LDWSKRCQIIGGIARGL 399
IG + + M+I ++ + L+ F+ + F L + + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGY 457
YL S IHRDL A N +L+ M ++DFG+++ G + +++ +
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKW 181
Query: 458 MPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
+ E D +++ SDV++FGV + EI+
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 38/272 (13%)
Query: 295 LGEGGFGPVYKGVLIE----GQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348
+GEG FG + +L++ Q+ A K RL KSS +E+ E +L+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
++ EY L I R K Q + G+ ++H+
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK--- 119
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468
R++HRD+K+ N+ L K+ DFG AR A T VGT Y+PPE + +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177
Query: 469 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS 528
+ KSD++S G ++ E+ K H ++W+ LI K GSY
Sbjct: 178 NNKSDIWSLGCILYELCTLK-----------HPFQANSWK--------NLILKVCQGSYK 218
Query: 529 LSEVLRCIQVGLLCVQ---QRPEDRPNMSSVV 557
++ L Q + P RP+ ++++
Sbjct: 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 53/218 (24%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN-------EVLLIAKLQHRNL 345
KLGEG + VYKG + GQ +A K + +E E E L+ L+H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIR------LEHEEGAPFTAIREASLLKDLKHANI 65
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC-----------QIIGG 394
V L + L++EYL D +++D Q++
Sbjct: 66 VTLHDIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL-- 113
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
RGL Y HQ R++HRDLK N+L+ K++DFG+ARA + ++ +N VV T
Sbjct: 114 --RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-T 166
Query: 455 YGYMPPEYAIDGL-----FSVKSDVFSFGVLVLEIVCG 487
Y PP D L +S D++ G + E+ G
Sbjct: 167 LWYRPP----DVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 21/199 (10%)
Query: 298 GGFGPVY--KGVLIEGQEIAAKRLSKSSGQGMEEFEN----EVLLIAKLQHRNLVKLIGC 351
G FG VY K G A K L KS + N +++ + + + KL
Sbjct: 7 GAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
+D L+ EYL I DW+ Q I + G+ LHQ II
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWA--KQYIAEVVLGVEDLHQRG---II 119
Query: 412 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 471
HRD+K N+L+D + K++DFG++R ++ + VGT Y+ PE I G+ K
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDK 172
Query: 472 -SDVFSFGVLVLEIVCGKR 489
SD +S G ++ E + G
Sbjct: 173 MSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 65/244 (26%), Positives = 99/244 (40%), Gaps = 85/244 (34%)
Query: 289 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVLLIA 338
+ +G G +G V V G+++A K++S F++ E+ L+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLR 54
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVT-----------RSK---- 381
L+H N++ L+ + L S DF ++ VT +S
Sbjct: 55 HLRHENIIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT 101
Query: 382 ------FLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435
FL QI+ RGL YLH +IHRDLK SN+L+++ + KI DFG+
Sbjct: 102 DDHIQYFL-----YQIL----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGL 149
Query: 436 ARAFGIDQTEAN--TNRVVGTYGYMPPE---------YAIDGLFSVKSDVFSFGVLVLEI 484
AR D+ E T VV T Y PE AI D++S G + E+
Sbjct: 150 ARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAEL 200
Query: 485 VCGK 488
+ K
Sbjct: 201 LTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 287 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHR 343
+++ KLGEG + VYKG + G+ +A K RL + G E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
N+V L ++ L++EY+ + L ++ + K + + RGL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVK--LFLFQLLRGLSYIH 120
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
Q I+HRDLK N+L+ + K++DFG+ARA + + +N VV T Y PP+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVL 175
Query: 464 IDGL-FSVKSDVFSFGVLVLEIVCG 487
+ +S D++ G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 59/223 (26%), Positives = 111/223 (49%), Gaps = 23/223 (10%)
Query: 294 KLGEGGFGPVYKGVLIE--GQEIAAKRLS-KSSGQGME-EFENEVLLIAKLQ---HRNLV 346
++GEG +G V+K ++ G+ +A KR+ ++ +GM EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 347 KLIGCCT-QRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
+L CT R +R L++E++ ++ L ++ V + + ++ + RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDF 125
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH R++HRDLK N+L+ + K++DFG+AR + + VV T Y PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 504
+ ++ D++S G + E+ R + + + LG
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLG 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 281 AIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
++ + T+ + +G+G +G VYK + +AA ++ EE E E ++ L
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL 75
Query: 341 -QHRNLVKLIGCCTQRDERM-----LIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIG 393
H N+VK G + D+ + L+ E S+ + + + + LD + I+
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
G GL +LH + RIIHRD+K +N+LL E K+ DFG++ + NT+ VG
Sbjct: 136 GALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VG 190
Query: 454 TYGYMPPEY-----AIDGLFSVKSDVFSFGVLVLEIVCG 487
T +M PE D + + DV+S G+ +E+ G
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 55/242 (22%), Positives = 108/242 (44%), Gaps = 44/242 (18%)
Query: 280 MAIANATENFSDKNK-LGEGGFGPVYKGV-LIEGQEIAAKR--LSKSSGQGMEEFEN--- 332
+ +E + K LGEG +G V K + G+ +A K+ + + S ++ +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60
Query: 333 ---------EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN---KSLNDFIFDVTRS 380
E+ ++ +++H N++ L+ + D L+ + + + K ++ I
Sbjct: 61 CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR----- 115
Query: 381 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440
+ +C I+ I GL LH+ +HRDL +N+ ++++ KI+DFG+AR +G
Sbjct: 116 -LTESQVKC-ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170
Query: 441 ID-------------QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVC 486
+ E T++VV T Y PE + + D++S G + E++
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
Query: 487 GK 488
GK
Sbjct: 230 GK 231
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 41/107 (38%), Positives = 61/107 (57%), Gaps = 15/107 (14%)
Query: 391 IIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446
I+G IA + L YLH S+L +IHRD+K SNVL++ K+ DFG++ + +D A
Sbjct: 104 ILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSV-A 159
Query: 447 NTNRVVGTYGYMPPEYAIDGL-----FSVKSDVFSFGVLVLEIVCGK 488
T G YM PE I+ + VKSDV+S G+ ++E+ G+
Sbjct: 160 KTID-AGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 51/280 (18%)
Query: 294 KLGEGGFGPVYKGVLIEGQE------IAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 347
K+GEG FG K +L++ +E I +SK S + EE EV +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-----LDWSKRCQIIGGIARGLLYL 402
+ ++ +Y L I F LDW + I L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHV 117
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H +I+HRD+K+ N+ L + K+ DFG+AR A T +GT Y+ PE
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
+ ++ KSD+++ G ++ E+ K HA N+ L+ K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK------HAFEAGNM-------------KNLVLKI 213
Query: 523 LGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557
+ GSY S LR + L ++ P DRP+++S++
Sbjct: 214 IRGSYPPVSSHYSYDLRNLVSQLF--KRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVK 347
++G+GG+G V+ + EI A KR+ KS + E E ++L K LVK
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVK 65
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDS 406
L+ + L EY+P DF + L + R + + LH
Sbjct: 66 LLYAFQDDEYLYLAMEYVPG---GDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH--- 118
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
L IHRDLK N L+D + K++DFG+++ T AN+ VVG+ YM PE
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMAPEVLRGK 173
Query: 467 LFSVKSDVFSFGVLVLEIVCG 487
+ D +S G ++ E +CG
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
LG+G FG V L E+ A K L K ++ E +L +A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 349 IGCCTQRDERML-IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
CC Q +R+ + EY+ D +F + RS+ D + + L++LH+
Sbjct: 62 H-CCFQTKDRLFFVMEYVNG---GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 467
+I+RDLK N+LLD E + K++DFGM + GI T GT Y+ PE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILN-GVTTTTFCGTPDYIAPEILQELE 172
Query: 468 FSVKSDVFSFGVLVLEIVCGK 488
+ D ++ GVL+ E++ G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 46/221 (20%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN---------EVLLIAKL-Q 341
KLG+G +G V+K + +E+ A L K + F N E++ + +L
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVA--LKKI----FDAFRNATDAQRTFREIMFLQELGD 65
Query: 342 HRNLVKLIGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIA 396
H N+VKL+ + E L++EY+ L+ I R+ L D KR I+ +
Sbjct: 66 HPNIVKLLN--VIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLL 117
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV----V 452
+ L Y+H S +IHRDLK SN+LL+++ K++DFG+AR+ + E N V V
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDYV 173
Query: 453 GTYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 488
T Y PE L D++S G ++ E++ GK
Sbjct: 174 ATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 295 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 349
LG G FG + +G L + + +A L S + F E L + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
G T+ + M++ EY+ N +L+ F+ + + + ++ G+A G+ YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA--NTNRVVGTYGYMPPEYA 463
S + +H+ L A VL+++++ KIS F + D++EA T + PE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 464 IDGLFSVKSDVFSFGVLVLEIVC-GKR 489
FS SDV+SFG+++ E++ G+R
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 41/252 (16%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 343
E + + + +G G +G V + G +A K+LS+ S + E+ L+ ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--------- 390
N++ L+ T P +SL +F ++ VT D + +CQ
Sbjct: 77 NVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
+I I RGL Y+H IIHRDLK SN+ ++ + KI DFG+AR T+
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176
Query: 451 VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509
V T Y PE ++ + ++ D++S G ++ E++ G R + H + L RL
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 233
Query: 510 WIEERPVELINK 521
+ EL+ K
Sbjct: 234 -VGTPGAELLKK 244
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 41/210 (19%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLVKLI 349
LG G FG V + A K LSK+ Q +E NE ++ ++H LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 350 GCCTQRDERML--IYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYL 402
G + +D+ L + EY+P L + F ++F + L YL
Sbjct: 68 G--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--------AAQVVLALEYL 117
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H L I++RDLK N+LLD++ KI+DFG A+ + + T + GT Y+ PE
Sbjct: 118 HS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPE- 168
Query: 463 AIDGLFSVK-----SDVFSFGVLVLEIVCG 487
+ K D ++ G+L+ E++ G
Sbjct: 169 ----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 28/220 (12%)
Query: 295 LGEGGFGPVYKGVLI-EGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKL 348
LG+G FG V L +G+ A K L K E VL +A ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTHL 61
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
++ + E+L L I FD+ R+ F C GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--------GLQFLH 113
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
II+RDLK NV+LD + + KI+DFGM + A+T GT Y+ PE
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEIL 168
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 503
++ D +SFGVL+ E++ G+ +H D L
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 295 LGEGGFGPV----YKGVLIEGQEIAAKRLSKSSGQGMEEFEN-----EVLLIA-KLQHRN 344
LG G FG V YK G+ A K L K +E E+ + A +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSL----NDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
LV L C D + EY L + +F R+ F C ++G L
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY---AACVVLG-----LQ 115
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRVVGTYGYMP 459
YLH++ +I++RDLK N+LLD E KI+DFG+ + G T+ GT ++
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLA 169
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
PE + ++ D + GVL+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 53/169 (31%), Positives = 74/169 (43%), Gaps = 21/169 (12%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+ARG+ +L SR + IHRDL A N+LL KI DFG+AR D
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI--VCGKRNRGFYHADHHHNLLGHAWRLWIE 512
+M PE D +++ +SDV+SFGVL+ EI + G + L R+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP 298
Query: 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
E Y+ E+ + L C PEDRP S +V +L
Sbjct: 299 E-------------YATPEIY---SIMLDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 295 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFEN---EVLLIAKLQHRNLVK 347
LG+G FG V +L+ G+ A K L K +E + E ++ +H L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 406
L +D + EY+ L F ++R + R + G I L YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG- 114
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPPEYAID 465
+I++RDLK N++LD + + KI+DFG+ + GI T+A T + GT Y+ PE D
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKE-GI--TDAATMKTFCGTPEYLAPEVLED 169
Query: 466 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
+ D + GV++ E++CG+ FY+ DH
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAKLQ---HRNLVK 347
++G G +G VYK G +A K + + + EV L+ +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 348 LIG-CCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
L+ C T R +R L++E++ ++ L ++ D L ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H + I+HRDLK N+L+ + K++DFG+AR I + VV T Y PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPEV 178
Query: 463 AIDGLFSVKSDVFSFGVLVLEI 484
+ ++ D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 295 LGEGGFGPVYKGVLIE---------GQEIAAKR-LSKSSGQGMEEFENEVLLIAKLQHRN 344
LG+G F +YKGVL GQE++ + S + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
LVKL G C RDE +++ EY+ L+ F+ + L W + + +A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 405 DSRLRIIHRDLKASNVLL----DNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGY 457
+++H ++ N+L+ NE K+SD G+ E R+ +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--SREERVERI----PW 170
Query: 458 MPPEYAIDGLFSVKS--DVFSFGVLVLEIVCG 487
+ PE +G S+ D +SFG +LEI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 294 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-------EVLLIAKLQHRNL 345
K+GEG +G V+K E GQ +A K+ +S E+ E+ ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
V LI ++ + L++EY + LN+ + + +II + + + H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK- 118
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI- 464
IHRD+K N+L+ + K+ DFG AR + + V T Y PE +
Sbjct: 119 --HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVG 174
Query: 465 DGLFSVKSDVFSFGVLVLEIVCG 487
D + DV++ G + E++ G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 55/239 (23%), Positives = 106/239 (44%), Gaps = 39/239 (16%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------E 333
+ + + + +GEG +G V G ++A K++S FE+ E
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--------FEHQTFCQRTLRE 53
Query: 334 VLLIAKLQHRNLVKLIGCCTQRD-ERM----LIYEYLPNKSLNDFIFDVTRSKFLDWSKR 388
+ ++ + +H N++ ++ E ++ E + ++ + +++ L
Sbjct: 54 IKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHI 108
Query: 389 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448
+ I RGL Y+H + ++HRDLK SN+LL+ + KI DFG+AR D +T
Sbjct: 109 QYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHT 163
Query: 449 NRV---VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 503
+ V T Y PE ++ K+ D++S G ++ E++ + F D+ H L
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL--FPGKDYLHQLN 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 295 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFEN---EVLLIAKLQHRNLVK 347
LG+G FG V +L+ G+ A K L K +E + E ++ +H L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 406
L D + EY L F ++R + +R + G I L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 115
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
+++RD+K N++LD + + KI+DFG+ + GI A GT Y+ PE D
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDN 170
Query: 467 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
+ D + GV++ E++CG+ FY+ DH
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 33/187 (17%)
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
LL +H +IHRD+K++N+LL + K+ DFG ++ + ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
PE +S K+D+FS GVL+ E++ KR F + E+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP--FDGENME-----------------EV 253
Query: 519 INKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRP------NMSSVVLMLSGERSLP 567
++K+L G Y S+S ++ I LL P+ RP NM L +SG +
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNMPICKLFISGLLEIV 311
Query: 568 QPKQPGF 574
Q QPGF
Sbjct: 312 Q-TQPGF 317
|
Length = 496 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 38/103 (36%), Positives = 64/103 (62%), Gaps = 10/103 (9%)
Query: 390 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445
I+G I+ RGL YL + + +I+HRD+K SN+L+++ K+ DFG++ ID +
Sbjct: 99 NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-ID-SM 154
Query: 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
AN+ VGT YM PE ++V+SD++S G+ ++E+ G+
Sbjct: 155 ANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 295 LGEGGFGPVYKGVLIE-------GQEIAAKRLSKSSGQGMEEF--ENEVLLIAKLQHRNL 345
LG+G FG V+ L+ GQ A K L K++ + + + E ++A++ H +
Sbjct: 4 LGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
VKL + LI ++L L + +F KF + +A L
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALD 112
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
+LH L II+RDLK N+LLD E + K++DFG+++ ID E GT YM P
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAP 167
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCG 487
E + +D +SFGVL+ E++ G
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLIG 350
+G G FG V+ I A K ++ +++ + NE ++ ++ H +++L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 351 CCTQRDERML--IYEYLPNKSLNDFIFDVTRSKFLDWSKR---CQIIGGIARGLLYLHQD 405
T+ D+R L + EY+P L F + +F + + +I+ + YLH
Sbjct: 68 -WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALE----YLHS- 119
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
I++RDLK N+LLD E + K++DFG A+ D+T + GT Y+ PE
Sbjct: 120 --KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT----LCGTPEYLAPEVIQS 172
Query: 466 GLFSVKSDVFSFGVLVLEIVCGK 488
+ D ++ G+L+ E++ G
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 295 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNL 345
LG+G FG V +L++ G+ A K L K +E EN VL ++ H L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFL 57
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQ 404
L D + EY L F ++R + R + G I L YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLHS 113
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ +++RDLK N++LD + + KI+DFG+ + GI + A GT Y+ PE
Sbjct: 114 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKTFCGTPEYLAPEVLE 169
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
D + D + GV++ E++CG+ FY+ DH
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN--EVLLIAKLQ-HRNLVKL 348
K+GEG F V K + G+ A K + K + +E+ N E+ + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 349 I--------GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
I G L++E L + +L + I R + L + + + + L
Sbjct: 64 IEVLFDRKTGRLA------LVFE-LMDMNLYELIKG--RKRPLPEKRVKSYMYQLLKSLD 114
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
++H++ I HRD+K N+L+ ++ K++DFG R GI T + T Y P
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT-EYISTRWYRAP 167
Query: 461 EYAI-DGLFSVKSDVFSFGVLVLEIV 485
E + DG + K D+++ G + EI+
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQH 342
T + D +G G FG V + GQ +A K++ K S+ + E+ L+ L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N++ L E + L L+ + S+ L+ + I RGL Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H ++HRDLK SN+L++ + KI DFG+AR Q T V Y Y PE
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YRAPEI 176
Query: 463 AID-GLFSVKSDVFSFGVLVLEIVCGK 488
+ + V+ D++S G + E++ GK
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
IA GL +LH II+RDLK NV+LD E + KI+DFGM + T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGT 164
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y+ PE + D ++FGVL+ E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 58/283 (20%)
Query: 295 LGEGGFGPVYKGVLI----EGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRNLVK- 347
+G+G +G V L+ +G++ K+L+ +S + + E E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 348 -------------LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG 394
++G C D +Y L + + K L ++ +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQ----------KGKLLPENQVVEWFVQ 110
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
IA L YLH+ I+HRDLK NV L K+ D G+AR A+T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514
YM PE + ++ KSDV++ G V E+ K HA + ++ +R+ IE +
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRI-IEGK 218
Query: 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557
+ S L E++ +L +RPE RP++ S++
Sbjct: 219 LPPMPKDY---SPELGELIA----TMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 36/209 (17%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRL------SKSSGQGMEEFENEVLLIAKLQHRNL 345
+ LG G G VYK + + I A ++ + Q M E E ++ K +
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE----ILYKCDSPYI 61
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA----RGLLY 401
+ G + + E++ SL+ + ++G IA +GL Y
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTY 110
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMP 459
L L+I+HRD+K SN+L++ K+ DFG++ I +T VGT YM
Sbjct: 111 LWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT------YVGTNAYMA 161
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE + + SDV+S G+ +E+ G+
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 39/158 (24%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 333 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYE-----YLPNKSLNDFIFDVTRSKFLDWSK 387
E +L+ + H +++++ + L+ LP+ S + + + RS+ L +
Sbjct: 107 EAMLLQNVNHPSVIRM--------KDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 388 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447
I I GL YLH RIIHRD+K N+ +++ I D G A+ F +
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV--VAPA 212
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
+ GT PE ++ K+D++S G+++ E++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 343
E + + +G G +G V Q++A K+LS+ S E+ L+ ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--------- 390
N++ L+ T P S+ +F ++ VT D + +CQ
Sbjct: 75 NVIGLLDVFT------------PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
+I + RGL Y+H IIHRDLK SNV ++ + +I DFG+AR Q +
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTG 174
Query: 451 VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 488
V T Y PE ++ + ++ D++S G ++ E++ GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIEGQE----IAAKRLSKSS----GQGMEEFENEVLLIAK 339
NF LG G +G V+ + G + A K L K++ + E E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 340 LQHRNLVKLIGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI-IGGIAR 397
++ + + Q D ++ LI +Y+ L F R +F + + QI G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKE--QEVQIYSGEIVL 116
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
L +LH +L II+RD+K N+LLD+ + ++DFG+++ F D+ E GT Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172
Query: 458 MPPEYAI--DGLFSVKSDVFSFGVLVLEIVCG 487
M P+ DG D +S GVL+ E++ G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 294 KLGEGGFGPVYKG-VLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 350
+GEG +G V K G+ +A K+ S+ + EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 351 CCTQRDERMLIYEYLPN-------KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
++ L++EY+ S D RS W Q++ IA Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS--YIW----QLLQAIA----YCH 117
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
IIHRD+K N+L+ K+ DFG ARA T+ V T Y PE
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELL 173
Query: 464 I-DGLFSVKSDVFSFGVLVLEIVCG 487
+ D + DV++ G ++ E++ G
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 33/228 (14%)
Query: 276 IFDWMAIANATENFSDKNKLGEGGFGPVYKGVL--IEGQEIAAKRLSKSSGQGMEEFENE 333
IFD + + ++ + +G+G +G V+K VL G + A K L EE E E
Sbjct: 9 IFD--SFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEIEAE 64
Query: 334 VLLIAKLQ-HRNLVKLIGCCTQRDER-----MLIYEYLPNKSLNDFIFDVTRSKFLDWSK 387
++ L H N+VK G ++D + L+ E S+ D + FL +
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGE 119
Query: 388 RCQ--IIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441
R + II I GL +LH + + IHRD+K +N+LL E K+ DFG++ +
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--L 174
Query: 442 DQTEANTNRVVGTYGYMPPEY-----AIDGLFSVKSDVFSFGVLVLEI 484
T N VGT +M PE +D + + DV+S G+ +E+
Sbjct: 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 390 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445
+I+G ++ RGL YL + + +I+HRD+K SN+L+++ K+ DFG++ +
Sbjct: 103 EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 156
Query: 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ N VGT YM PE +SV+SD++S G+ ++E+ G+
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 293 NKLGEGGFGPVYK------GVLIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHR-- 343
++LG+G +G VYK GV + +EI RL ++E + N++++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 344 --NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
+V G + EY+ SL+ ++ + +I + +GL +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
L ++ IIHRD+K +NVL++ K+ DFG++ + + A TN +G YM PE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPE 171
Query: 462 Y------AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ ++V+SDV+S G+ +LE+ G+
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 390 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445
QI+G ++ +GL YL + + +I+HRD+K SN+L+++ K+ DFG++ +
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 156
Query: 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ N VGT YM PE +SV+SD++S G+ ++E+ G+
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+ARG+ +L SR + IHRDL A N+LL KI DFG+AR D
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+M PE D +++ +SDV+SFGVL+ EI
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 45/268 (16%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEE---FENEVLLIAKL 340
++F K+ +G G FG V V+ E G A K + KS E FE E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSL------NDFIFDVTRSKFLDWSKRCQIIGG 394
+ +L +D L+ EY P L + FD ++F
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY----------- 107
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A +L +H ++ +HRD+K NVL+D + K++DFG A ++ N+ VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166
Query: 455 YGYMPPEY--AIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH----NLLG 504
Y+ PE ++G + V+ D +S GV+ E++ G R +H N++
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG---RSPFHEGTSAKTYNNIMN 223
Query: 505 HAWRLWIEERP------VELINKSLGGS 526
L E P ++LI L G
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLLCGQ 251
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 33/285 (11%)
Query: 293 NKLGEGGFGPVYKG---VLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 348
+++G G FG V G + + K L S+ F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ--IIGGIARGLLYLHQDS 406
+G C + +L+ E+ P L +++ K + +A GLL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGIDQTEANTNRVVGTYGYMPPEYAI- 464
IH DL N L +++ KI D+G+A + D V ++ PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 465 --DGLFSVK----SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL--WIEERPV 516
L S+++S GV + E+ F AD + L L + E+ +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL--------FTAADQPYPDLSDEQVLKQVVREQDI 228
Query: 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
+L L YS R +V C PE RP V +L+
Sbjct: 229 KLPKPQLDLKYS----DRWYEVMQFCWLD-PETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A+G+ +L SR + IHRDL A N+LL KI DFG+AR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+M PE D +++++SDV+SFGVL+ EI
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451
I I L +LHQ L II+RD+K N+LLD+E + ++DFG+++ F ++ E
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSF 166
Query: 452 VGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLEIVCG 487
GT YM PE G D +S GVL E++ G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 287 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 343
+ + + +G G G V Y +L + +A K+LS+ F+N+ AK +R
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 391
LV L+ C ++ L+ + P KSL +F + D + LD + +
Sbjct: 73 ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451
+ + G+ +LH IIHRDLK SN+++ ++ KI DFG+AR G + T V
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYV 186
Query: 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
V Y Y PE + + D++S G ++ E++ G
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 13/95 (13%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A+G+ +L + IHRD+ A NVLL + KI DFG+AR ++N VV
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272
Query: 455 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+M PE D +++V+SDV+S+G+L+ EI
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-10
Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 566 LPQPKQPGFFTERNPPESGSSSSK--RSLLSTNEITISLIEGR 606
+PQPKQPGF R+P E+ SSSS + N++T+S+I+ R
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
L +L C D + EY+ + D ++ + + + I+ GL +LH+
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYV---NGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
II+RDLK NV+LD+E + KI+DFGM + +D T GT Y+ PE
Sbjct: 120 RG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTPDYIAPEIIA 174
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGK 488
+ D +++GVL+ E++ G+
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKR-LSKSSGQGMEEFE-NEVLLIAKLQHR 343
+ + K+GEG +G VYK G+ +A K+ + +G+ E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 344 N-LVKLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSKF---LDWSKRCQIIG 393
+V+L+ +E+ L++EYL + L F+ D L +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVV 452
+ +G+ + H + ++HRDLK N+L+D + KI+D G+ RAF I ++ T+ +V
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV 173
Query: 453 GTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIV 485
T Y PE + +S D++S G + E+
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN---EVLLIAKLQHRNLVKLIGC 351
+GEG +G V K E +EI A + K S + E E E+ ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
+R + L++EY+ K++ + + ++ + K I + + + + H++ I+
Sbjct: 69 FRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPE--KVRSYIYQLIKAIHWCHKND---IV 122
Query: 412 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 471
HRD+K N+L+ + K+ DFG AR + + AN V T Y PE + +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 472 SDVFSFGVLVLEIVCGK 488
D++S G ++ E+ G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 37/108 (34%), Positives = 60/108 (55%), Gaps = 15/108 (13%)
Query: 390 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445
I+G + + L YL + +IHRD+K SN+LLD N K+ DFG++ +D ++
Sbjct: 114 DILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS-GRLVD-SK 169
Query: 446 ANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGK 488
A T R G YM PE ID + +++DV+S G+ ++E+ G+
Sbjct: 170 AKT-RSAGCAAYMAPE-RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 64/211 (30%)
Query: 308 LIEGQEIAAKRLSKSSGQGMEEFEN---------EVLLIAKLQHRNLVKLIGCCTQRDER 358
+ GQ +A K+LS+ F+N E++L+ + H+N++ L+ T
Sbjct: 38 TVTGQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT----- 85
Query: 359 MLIYEYLPNKSLNDF--------------------IFDVTRSKFLDWSKRCQIIGGIARG 398
P KSL +F D R +L + C G
Sbjct: 86 -------PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC--------G 130
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
+ +LH IIHRDLK SN+++ ++ KI DFG+AR G T VV Y Y
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YR 184
Query: 459 PPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 488
PE I G+ + D++S G ++ E++ G
Sbjct: 185 APE-VILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 311 GQEIAAKRLSKSSGQGMEE---FENEVLLIAKLQHRNLVKLIGCCTQRDERML-IYEYLP 366
G E+A K L + + + F E L A+L H N+V L+ + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---D 423
++L + + L + +++ + L H I+HRDLK N+++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 424 NEMNPKISDFGMARAFGIDQTEAN------TNRVVGTYGYMPPEYAIDGLFSVKSDVFSF 477
+ K+ DFG+ +A+ T V+GT Y PE + SD++++
Sbjct: 117 VRPHAKVLDFGIG-TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 478 GVLVLEIVCGKR 489
G++ LE + G+R
Sbjct: 176 GLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+ARG+ +L + +HRDL A NVLL KI DFG+AR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+M PE D L++ SDV+S+G+L+ EI
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
IA GL +LH II+RDLK NV+LD+E + KI+DFGM + D T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y+ PE + D ++FGVL+ E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 295 LGEGGFGPVYKGVLIE----GQ----EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
LG+G F ++KG+ E G+ E+ K L KS E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
G C DE +++ EY+ SL+ ++ ++ S + ++ +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 407 RLRIIHRDLKASNVLLDNEM-----NP---KISDFGMARAFGIDQTEANTNRVVGTYGYM 458
+ H ++ A NVLL E NP K+SD G++ + E R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT--VLPKEILLERI----PWV 171
Query: 459 PPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 487
PPE + S+ +D +SFG + EI G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
I RGL YLH I+HRD+K N+L+++ KI DFG+AR D+++ T VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 455 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 488
Y Y PE + ++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 295 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNL 345
LG+G FG V +L+ G+ A K L K +E E+ VL +H L
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVL--QNTRHPFL 57
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQ 404
L D + EY L F ++R + R + G I L YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALGYLH- 112
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPPEYA 463
+++RDLK N++LD + + KI+DFG+ + ++ T + GT Y+ PE
Sbjct: 113 --SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEYLAPEVL 167
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
D + D + GV++ E++CG+ FY+ DH
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 37/210 (17%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 353
+G G G V + G +A K+LS+ F+N+ AK +R LV L+ C
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVN 78
Query: 354 QRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQIIGGIARGLLY 401
++ L+ + P KSL +F + D + LD + ++ + G+ +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKH 138
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY----GY 457
LH IIHRDLK SN+++ ++ KI DFG+AR A TN ++ Y Y
Sbjct: 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-------ACTNFMMTPYVVTRYY 188
Query: 458 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
PE + + D++S G ++ E+V G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 343
+ + D ++G G +G V + G ++A K+L + S + E+ L+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKFLDWSK----RCQ- 390
N++ L+ T P+ SL+ F K + K R Q
Sbjct: 75 NVIGLLDVFT------------PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
++ + +GL Y+H IIHRDLK N+ ++ + KI DFG+AR QT++
Sbjct: 123 LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTG 174
Query: 451 VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 488
V T Y PE ++ + ++ D++S G ++ E++ GK
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 51/231 (22%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEE---FENEVLLIAKLQHRNLVKLIG 350
+G G FG V+ + ++ A K L KS + E ++A +VKL
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 351 CCTQRDERML--IYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
+ +DE L + EY+P L +F ++F IA +L L
Sbjct: 68 -YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IAELVLALD 115
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------------------- 440
+L IHRD+K N+L+D + + K++DFG+ +
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 441 ----IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
Q N VGT Y+ PE + ++ D +S GV++ E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 9/149 (6%)
Query: 294 KLGEGGFGPVYKGVLIEG---QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLI 349
++G G FG V G + G ++ K L S+ Q +F E LQH NL++ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL--DWSKRCQIIGGIARGLLYLHQDSR 407
G CT+ +L+ E+ P L ++ +++ + D + ++ IA GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMA 436
IH DL N LL ++ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
H LV L C + EY+ D +F + R + L I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH+ II+RDLK NVLLD+E + K++D+GM + G+ + T+ GT Y+ PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD-TTSTFCGTPNYIAPE 166
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ D ++ GVL+ E++ G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
IA +L L + I++RDLK N+LLD + + DFG+++A D TN GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGT 159
Query: 455 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 487
Y+ PE +D ++ D +S GVLV E+ CG
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVLLIAKLQHRN 344
+G G +G V E +++A K+++ + F+N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 345 LVKLIGCC--TQRD---ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ-IIGGIARG 398
++ + R+ + ++YE L + L+ I RS CQ + + RG
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQII----RSSQTLSDDHCQYFLYQLLRG 120
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
L Y+H + ++HRDLK SN+LL+ + KI DFG+AR ++ + T VV +
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRA 176
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 502
P ++ DV+S G + E++ R F D+ H L
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL--GRKPLFPGKDYVHQL 218
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 287 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 343
+ + + +G G G V Y VL + +A K+LS+ F+N+ AK +R
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 65
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 391
LV L+ C ++ L+ + P KSL +F + D + LD + +
Sbjct: 66 ELV-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451
+ + G+ +LH IIHRDLK SN+++ ++ KI DFG+AR G + T V
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYV 179
Query: 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
V Y Y PE + + D++S G ++ E+V
Sbjct: 180 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
I GL ++H +++RDLK +N+LLD + +ISD G+A F + A+ VGT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
Query: 455 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 487
+GYM PE G+ + +D FS G ++ +++ G
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-08
Identities = 25/81 (30%), Positives = 36/81 (44%), Gaps = 6/81 (7%)
Query: 123 EHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSK-NCSCTAYANADVRGGGSGCLLW 181
+ D F++ + KLP ++ SL EC C NCSC ++ G GCLLW
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVISV-ASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56
Query: 182 -FHDLIDMKELSESGQDLFVR 201
L D + G DL+ +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 46/140 (32%), Positives = 72/140 (51%), Gaps = 13/140 (9%)
Query: 352 CTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
C Q + R+ + E++ D +F + R + L I+ L +LH+ I
Sbjct: 64 CFQTESRLFFVIEFVSG---GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---I 117
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY--AIDGLF 468
I+RDLK NVLLD E + K++D+GM + GI + T+ GT Y+ PE D F
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDT-TSTFCGTPNYIAPEILRGEDYGF 175
Query: 469 SVKSDVFSFGVLVLEIVCGK 488
SV D ++ GVL+ E++ G+
Sbjct: 176 SV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 15/102 (14%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT--NRVV 452
+ RGL Y+H + +IHRDLK SN+L++ + +I DFGMAR TE V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 453 GTYGYMPPEYAIDGLFSV-----KSDVFSFGVLVLEIVCGKR 489
T Y PE L S+ D++S G + E++ G+R
Sbjct: 173 ATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLVKLIGCC 352
K+G G +G VYK +G++ L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 353 TQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY-----LHQD 405
+R L+++Y + + I R+ + K Q+ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWH--IIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 406 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGID-QTEANTNRVVGTYGYMP 459
++HRDLK +N+L+ E P KI+D G AR F + A+ + VV T+ Y
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 460 PEYAIDGLFSVKS-DVFSFGVLVLEIV 485
PE + K+ D+++ G + E++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
I GL ++H +R +++RDLK +N+LLD + +ISD G+A F + A+ VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
Query: 455 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 487
+GYM PE G + +D FS G ++ +++ G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 343
E ++ ++G G +G V + G+++A K+LS+ S + E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK---------RCQ-I 391
N++ L+ T S ++F + V D K + Q +
Sbjct: 75 NVIGLLDVFT------------SAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL 122
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451
+ + GL Y+H IIHRDLK N+ ++ + KI DFG+AR +A
Sbjct: 123 VYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGY 174
Query: 452 VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 488
V T Y PE ++ + ++ D++S G ++ E++ GK
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 40/173 (23%)
Query: 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 347
+ D LG G G V+ V + + +A K++ + Q ++ E+ +I +L H N+VK
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 348 LIGCCTQRDERMLIYEYLPNKS--LNDFIFDVTR-------SKFLDWSKRCQIIGG---- 394
+YE L L + + +T ++++ + G
Sbjct: 67 -------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113
Query: 395 ---------IARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 437
+ RGL Y+H + ++HRDLK +NV ++ E + KI DFG+AR
Sbjct: 114 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
LV L C L+ EY+ D +F + R + L I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNG---GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
II+RDLK NVLLD + + K++D+GM + G+ + T+ GT Y+ PE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILR 169
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGK 488
+ D ++ GVL+ E++ G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 295 LGEGGFGPVYKGVLIEGQE----IAAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLV 346
LG+GG+G V++ + G + A K L K+ + + + E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
LI + LI EYL L F+ F++ C + I+ L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFME-DTACFYLSEISLALEHLHQ-- 118
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
II+RDLK N+LLD + + K++DFG+ + + T +T GT YM PE +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEILMRS 175
Query: 467 LFSVKSDVFSFGVLVLEIVCG 487
D +S G L+ +++ G
Sbjct: 176 GHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 288 NFSDKNKLGEGGFGPV----YKGVLIEGQEIAAKRLSKSSGQGMEEFEN---EVLLIAKL 340
+F LG G FG V +KG G+ A K L K M++ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 341 QHRNLVKLIGCCTQRDERM-LIYEYLPN-------KSLNDFIFDVTRSKFLDWSKRCQII 392
H +V ++ C Q + R+ + E++ + F DV +KF
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV--AKFYH-------- 124
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
+ YLH II+RDLK N+LLDN+ + K++DFG A+ + T +
Sbjct: 125 AELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC 176
Query: 453 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
GT Y+ PE D ++ GVL+ E + G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
G I L +LH +L I++RD+K N+LLD+E + ++DFG+++ F + + + T
Sbjct: 112 GEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFC 167
Query: 453 GTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 487
GT YM PE K+ D +S G+L+ E++ G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLVKLIGCC 352
K+G G +G VYK +G++ L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 353 TQRDERM--LIYEYLPNKSLNDFIFDVT-----RSKFLDWSKRCQIIGGIARGLLYLHQD 405
+R L+++Y + + F + L S ++ I G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 406 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGID-QTEANTNRVVGTYGYMP 459
++HRDLK +N+L+ E P KI+D G AR F + A+ + VV T+ Y
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 460 PEYAIDGLFSVKS-DVFSFGVLVLEIV 485
PE + K+ D+++ G + E++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A G+ +L + +HRDL A NVL+ KI DFG+AR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+M PE + L++ SDV+SFG+L+ EI
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQ--EIAAKRLSKSS---GQGMEEFENEVLLIAKLQ 341
E+F+ LG G FG V +A KR KS + ++ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
H V L G L+ E++ F+ R+K C I Y
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL---RRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
L L I++RDLK N+LLD + K++DFG A+ + T + GT Y+ PE
Sbjct: 147 LQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCG 487
++ +D ++ G+ + EI+ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 13/95 (13%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A+G+ +L + IHRDL A N+LL + KI DFG+AR D +N VV
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND-----SNYVVKG 274
Query: 455 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+M PE + +++ +SDV+S+G+L+ EI
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 20/145 (13%)
Query: 352 CTQRDERML--IYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
C +D++ L + EY+P L + + +DV W+K A +L L
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIHS 160
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT-EANTNRVVGTYGYMPPEY---- 462
+ +IHRD+K N+LLD + K++DFG +D+T + VGT Y+ PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCG 487
DG + + D +S GV + E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 13/113 (11%)
Query: 375 FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434
FD++R++F A L L + +I+RDLK N+LLD + + + DFG
Sbjct: 90 FDLSRARFY-----------TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
+ + + + TN GT Y+ PE + ++ D ++ GVL+ E++ G
Sbjct: 139 LCK-LNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 15/173 (8%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
+G+G FG V +G+ A K L K + +E E VLL ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL-KNVKHPFLVGL 61
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
D+ + +Y+ L F + R + + IA L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---L 115
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
II+RDLK N+LLD++ + ++DFG+ + GI + T+ GT Y+ PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GI-EHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 316 AKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI---YEYLPNKSLND 372
AKR+ K+ + + ENE+L + +L H N++K+ +I Y++ + D
Sbjct: 197 AKRV-KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 373 FIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD 432
FD L R I+ + + Y+H ++IHRD+K N+ L+ + + D
Sbjct: 256 EAFDWKDRPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGD 310
Query: 433 FGMARAFGIDQTEANTNRVVGTYGYMPPE-YAIDGLFSVKSDVFSFGVLVLEIV 485
FG A F + EA VGT PE A DG + +D++S G+++L+++
Sbjct: 311 FGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN---TNRV 451
I GL Y+H + ++HRDLK N+L++ + KI DFG+AR F + E T
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-Y 169
Query: 452 VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 488
V T Y PE + K+ DV+S G ++ E++ K
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 40/182 (21%), Positives = 63/182 (34%), Gaps = 37/182 (20%)
Query: 323 SGQGMEEFENEVLLIAKLQHRNLVKLIG--------CCTQRDERMLIYEYLPNKS---LN 371
+ G + E+ ++ + HR ++ LI C + ++ Y+ L
Sbjct: 126 AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLE 185
Query: 372 DFIFDVTRSKFLDWSKRCQIIGGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNEMN 427
I I R LL YLH IIHRD+K N+ LD N
Sbjct: 186 QAIT-------------------IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPEN 223
Query: 428 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
+ DFG A GT PE + K+D++S G+++ E+
Sbjct: 224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK 283
Query: 488 KR 489
Sbjct: 284 NV 285
|
Length = 392 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 295 LGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEE-----FENEVLLIAKLQHRNLVKL 348
+G+G FG V ++G+ A K L K +E E VLL ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL-KNVKHPFLVGL 61
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
++ + +++ L F + R + + IA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468
I++RDLK N+LLD++ + ++DFG+ + GI Q++ T GT Y+ PE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTT-FCGTPEYLAPEVIRKQPY 173
Query: 469 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 499
D + G ++ E++ G FY D
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP--FYCRDVA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 48/212 (22%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKR--LSKSSGQG-MEEFENEVLL------I 337
++F KLGEG FG VYK L+ Q + L K++ G +E + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSC 191
Query: 338 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND------FIFDVTRSKFLD------- 384
A + L + + DE L++ Y +L D F ++V
Sbjct: 192 ADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG 249
Query: 385 WSKRCQIIGGIARGLLY----LHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMAR-- 437
+ +II I R +L+ LH I+HRD+K N++ KI D G A
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306
Query: 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 469
GI+ Y+P E+ +D ++
Sbjct: 307 RVGIN--------------YIPKEFLLDPRYA 324
|
Length = 566 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 67/258 (25%), Positives = 119/258 (46%), Gaps = 39/258 (15%)
Query: 249 RKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDK--NKLGEGGFGPVYKG 306
K D + N+ G E+E ++ D N + N S K N +G G FG VY+
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEKMIDND----INRSPNKSYKLGNIIGNGSFGVVYEA 85
Query: 307 VLIEGQE-IAAKRLSKSSGQGMEEFENEVLLIAK-LQHRNLVKLIGC----CTQRDERML 360
+ I+ E +A K++ + +++N LLI K L H N++ L C +++E+ +
Sbjct: 86 ICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140
Query: 361 ----IYEYLPNKSLNDFIFDVTRSK-----FLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
+ E++P ++++ ++ R+ FL Q+ R L Y+H I
Sbjct: 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQL----CRALAYIHSKF---IC 192
Query: 412 HRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FS 469
HRDLK N+L+D N K+ DFG A+ Q + + + Y PE + ++
Sbjct: 193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS---YICSRFYRAPELMLGATNYT 249
Query: 470 VKSDVFSFGVLVLEIVCG 487
D++S G ++ E++ G
Sbjct: 250 THIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 35/97 (36%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRVVGTY 455
R L Y+H + + HRDLK N+L + + KI DFG+AR AF T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 456 GYMPPEYAIDGLFSVKS----DVFSFGVLVLEIVCGK 488
Y PE G F K D++S G + E++ GK
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 29/148 (19%), Positives = 55/148 (37%), Gaps = 17/148 (11%)
Query: 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV--K 347
S L G VY + + ++ K S + + E EV ++ L + L K
Sbjct: 1 SSIKLLKGGLTNRVYL-LGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPK 57
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 406
++ L+ E++ ++L + + + +A+ LHQ
Sbjct: 58 VLASGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAK----LHQLP 106
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFG 434
L + H DL N+L+D+ I D+
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
IA +L +H +L +HRD+K NVLLD + +++DFG D T ++ VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGT 166
Query: 455 YGYMPPEY--AID---GLFSVKSDVFSFGVLVLEIVCGK 488
Y+ PE A++ G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 14/159 (8%)
Query: 333 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQII 392
E ++ + H ++++L G T LI LP + + + + C I+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI----AICDIL 185
Query: 393 G---GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449
+ R + YLH++ RIIHRD+KA N+ +++ + + DFG A F +D
Sbjct: 186 AIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYY 241
Query: 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
GT PE + D++S G+++ E+
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 40/148 (27%), Positives = 64/148 (43%), Gaps = 13/148 (8%)
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
+ N +KL T +LI +Y+ + L D + + L ++ +II + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL---LKKEGKLSEAEVKKIIRQLVEALND 124
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
LH + IIH D+K NVL D + + D+G+ + G GT Y P
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSP 175
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
E + V D ++ GVL E++ GK
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 65/247 (26%), Positives = 106/247 (42%), Gaps = 40/247 (16%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN-----EVLLIAKLQHRNLVKL 348
K+G G FG V+ QE + S +G++E E EV ++ +L+H+N+V+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL----YLHQ 404
I + + L Y + D ++ + + I I R LL Y H
Sbjct: 78 IDRFLNKANQKL-YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 405 ----DSRLRIIHRDLKASNVLLD-------------NEMN----PKISDFGMARAFGIDQ 443
+ R++HRDLK N+ L N +N KI DFG+++ GI
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI-- 194
Query: 444 TEANTNRVVGTYGYMPPEYAIDGLFSV--KSDVFSFGVLVLEIVCGKRNRGFYHADHHHN 501
E+ + VGT Y PE + S KSD+++ G ++ E+ GK F+ A++
Sbjct: 195 -ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP--FHKANNFSQ 251
Query: 502 LLGHAWR 508
L+ R
Sbjct: 252 LISELKR 258
|
Length = 1021 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A + YLH L II+RDLK N+LLD++ + ++DFG+ + G++ E T+ GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGT 159
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
Y+ PE + D + G ++ E++ G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A +L + +L +HRD+K NVLLD + +++DFG D T +N VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGT 166
Query: 455 YGYMPPEY--AID---GLFSVKSDVFSFGVLVLEIVCGK 488
Y+ PE A++ G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 18/141 (12%)
Query: 355 RDERML--IYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
+D+R L + EY+P L + + +DV W++ A +L L +
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT-----AEVVLALDAIHSMGF 163
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY----AIDG 466
IHRD+K N+LLD + K++DFG + + VGT Y+ PE DG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 467 LFSVKSDVFSFGVLVLEIVCG 487
+ + D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN--TNRVV 452
IA L YLH L I++RDLK N+LLD++ + ++DFG+ + + E N T+
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFC 157
Query: 453 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
GT Y+ PE + D + G ++ E++ G
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 50/280 (17%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIA---AKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLI 349
++G G FG V + +A K L ++ + EF + LQH N+++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR-----------CQIIGGIARG 398
G C + +L++EY L ++ + W +R C+ IA G
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL----SQE--QWHRRNSQLLLLQRMACE----IAAG 111
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGIDQTEANTNRVVGTYGY 457
+ ++H + +H DL N L +++ K+ D+G+ + + D E ++ V +
Sbjct: 112 VTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRW 167
Query: 458 MPPEYAI---DGLFSVK----SDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRL 509
+ PE GL + + S+V++ GV + E+ + Y +L H
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP---YSHLSDREVLNHV--- 221
Query: 510 WIEERPVELINKSLGGSYS--LSEVLRCIQVGLLCVQQRP 547
I+++ V+L L YS EVL Q L ++R
Sbjct: 222 -IKDQQVKLFKPQLELPYSERWYEVL---QFCWLSPEKRA 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 21/46 (45%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437
I +A L YLH+ IIHRDLK N+L+ NE + K++DFG+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEE---FENEVLLIAK 339
E+F +G G FG V L+ Q A K LSK + F E ++A
Sbjct: 43 EDFDVIKVIGRGAFGEVQ---LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99
Query: 340 LQHRNLVKLIGCCTQRDERML--IYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGI 395
+V+L +D++ L + EY+P L + + +D+ W++
Sbjct: 100 ANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE----KWARFY-----T 148
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID-QTEANTNRVVGT 454
A +L L + IHRD+K N+LLD + K++DFG + +T VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGT 206
Query: 455 YGYMPPEY----AIDGLFSVKSDVFSFGVLVLEIVCG 487
Y+ PE DG + + D +S GV + E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKS-SGQGM--EEFENEVLLIAKLQHRNLVKLI 349
+G+GG G VY + + +A K++ + S + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ----------IIGGIARGL 399
C+ D Y+ +L + V + + L SK I I +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATI 126
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA--------FGIDQTEANT--- 448
Y+H S+ ++HRDLK N+LL I D+G A ID E N
Sbjct: 127 EYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 449 -----NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
++VGT YM PE + S +D+++ GV++ +++
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 49/161 (30%), Positives = 71/161 (44%), Gaps = 34/161 (21%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFEN------EVLLIAKLQHRNLVK 347
+G G FG V + I A K+L KS M E E E ++A+ + +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSE---MLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 348 LIGCCTQRDER--MLIYEYLPNKSL-------NDFIFDVTRSKFLDWSKRCQIIGGIARG 398
L + +DE LI EYLP + + F + TR F IA
Sbjct: 66 LY--YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FY-----------IAET 110
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439
+L + +L IHRD+K N+LLD + + K+SDFG+
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-05
Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 13/84 (15%)
Query: 122 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKN---CSCTAYANADVRGGGSGC 178
C+ L + ++K+ T+ + D EC C KN SC A+ A R C
Sbjct: 5 CKSAGTTLIKIALKIKTTKANTAD------ECANRCEKNGLPFSCKAFVFAKARK---QC 55
Query: 179 LLW-FHDLIDMKELSESGQDLFVR 201
L + F+ + +++ G DL+
Sbjct: 56 LWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 35/181 (19%), Positives = 70/181 (38%), Gaps = 34/181 (18%)
Query: 327 MEEF---ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL 383
E+ + E++ +LQH N++ + E ++ + S D + ++ F
Sbjct: 40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFP 95
Query: 384 DWSKR---CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440
+ I+ + L Y+H IHR +KAS++LL + +S + +
Sbjct: 96 EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM- 151
Query: 441 IDQTEANTNRVVGTYGYMPPEYAIDGL--------------FSVKSDVFSFGVLVLEIVC 486
RVV + P+ ++ L ++ KSD++S G+ E+
Sbjct: 152 --IKHGKRQRVV----HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205
Query: 487 G 487
G
Sbjct: 206 G 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 41/178 (23%), Positives = 80/178 (44%), Gaps = 2/178 (1%)
Query: 312 QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLN 371
+++ AK + + + +E+ +A H +VK D+ +LI EY LN
Sbjct: 94 EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153
Query: 372 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431
I + ++ + +L L + +++HRDLK++N+ L K+
Sbjct: 154 KQIKQRLKEHLPFQEYEVGLL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211
Query: 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 489
DFG ++ + + + GT Y+ PE +S K+D++S GV++ E++ R
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 65/265 (24%), Positives = 99/265 (37%), Gaps = 85/265 (32%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 342
E+F +G+G FG V L++ G+ A K L KS E F+ + L K +
Sbjct: 1 EDFHTVKVIGKGAFGEVR---LVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52
Query: 343 RNL--------VKLIGCCTQRDERMLIYEYLPNKSL-------NDFIFDVTRSKFLDWSK 387
L V L LI E+LP L + F DVTR F
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR--FY---- 106
Query: 388 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-------- 439
+A +L + +L IHRD+K N+L+D + K+SDFG++ F
Sbjct: 107 -------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 440 --GIDQTEANTNRV-----------------------------------VGTYGYMPPEY 462
+ Q ++N NR+ VGT Y+ PE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCG 487
+ + + D +S G ++ E + G
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 39/180 (21%), Positives = 77/180 (42%), Gaps = 20/180 (11%)
Query: 317 KRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG----CCTQRDERMLIYEYLPNKSLND 372
K+ K ++ ENE+ + ++ N++K+ G LI EY L +
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 373 FIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKIS 431
+ + K L + + + +GL L++ ++ +++L + + L+ KI
Sbjct: 112 VL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKII 165
Query: 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS---VKSDVFSFGVLVLEIVCGK 488
G+ + + N N +V Y + D +FS +K D++S GV++ EI GK
Sbjct: 166 CHGLEKILSSPPFK-NVNFMV----YFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY--AI 464
+L +HRD+K N+L+D + +++DFG D T ++ VGT Y+ PE A+
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM 178
Query: 465 D---GLFSVKSDVFSFGVLVLEIVCGK 488
+ G + + D +S GV + E++ G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 34/126 (26%), Positives = 54/126 (42%), Gaps = 33/126 (26%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----------------RA 438
IA +L + +L IHRD+K N+LLD++ + K+SDFG+ +
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 439 FGIDQTEANTN-----------------RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLV 481
D T N N VGT Y+ PE + ++ D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 482 LEIVCG 487
E++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.52 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.52 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.45 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.33 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.03 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.91 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.89 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.88 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.86 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.7 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.53 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.37 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.2 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.02 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.93 | |
| PLN02236 | 344 | choline kinase | 96.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.65 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.57 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.45 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.06 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.81 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.6 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.58 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.52 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.52 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.28 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.9 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.72 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.51 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.5 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-57 Score=467.11 Aligned_cols=290 Identities=44% Similarity=0.741 Sum_probs=257.7
Q ss_pred ccCccCHHHHHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEE
Q 007361 273 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352 (606)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 352 (606)
....|++.++..+|++|+..+.||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999999999999998765544256699999999999999999999999
Q ss_pred eeCC-eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 353 TQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 353 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
.+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 89999999999999999999999998899999999999999999999999
Q ss_pred ecCCccccCCCccccccccc-ccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh
Q 007361 432 DFGMARAFGIDQTEANTNRV-VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....++.|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999664321 1111112 89999999999999999999999999999999999999987665555566899999999
Q ss_pred hhcCcchhcccccC-CCCCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 511 IEERPVELINKSLG-GSYSL-SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 511 ~~~~~~~l~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
.+....+++|+.+. +.... .++.++++++++|++.+|++||+|.+|+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99999999999987 55554 688899999999999999999999999999965443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=392.86 Aligned_cols=255 Identities=31% Similarity=0.476 Sum_probs=208.7
Q ss_pred CCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccC--HHHHHHHHHHHhhccCCCcceEEEEEeeCC-eeEEEEecC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG--MEEFENEVLLIAKLQHRNLVKLIGCCTQRD-ERMLIYEYL 365 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~ 365 (606)
+...+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33446699999999999999544449999997643222 569999999999999999999999999988 799999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCccccCCCcc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQT 444 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~~~~~~ 444 (606)
++|+|.++++.. +...+++..++.++.+||+||.|||++++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999764 46679999999999999999999999874 99999999999999997 99999999998764332
Q ss_pred cccccccccccCccCccccc--cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 445 EANTNRVVGTYGYMPPEYAI--DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.......||+.|||||++. ...|+.|+|||||||+||||+||+.||..... ...+......+
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~--------- 262 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGG--------- 262 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC---------
Confidence 2222368999999999999 56999999999999999999999999865432 11111111111
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.....+......+..++.+||+.||+.||++.+++.+|+.+
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 11222222456778889999999999999999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=385.63 Aligned_cols=255 Identities=31% Similarity=0.477 Sum_probs=213.6
Q ss_pred CCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+...+.||+|.||.||.|.++....||+|.++.. ....++|.+|+.+|++|+|+|||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4455889999999999999988889999999654 455688999999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 448 (606)
+|.+||.. ..+..++..+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+......
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999965 34566999999999999999999999998 999999999999999999999999999965544443332
Q ss_pred cccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 449 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
...-+..|.|||.+....|+.|||||||||+||||+| |+.|++..... +..+.++...+-..
T Consensus 363 -~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 363 -GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLERGYRLPR 425 (468)
T ss_pred -CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHhccCcCCC
Confidence 2345779999999999999999999999999999998 66665432211 12223333333334
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
+...+..+.+|+..||..+|++|||+..+...|+....
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 44566788899999999999999999999999987644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=357.79 Aligned_cols=248 Identities=27% Similarity=0.365 Sum_probs=204.2
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-eeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-ERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~ 364 (606)
+++..+.||+|..|+|||+++.. ++.+|+|.+... .....+++.+|+++++..+||+||.++|.|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 44556899999999999999976 677889988544 3445678999999999999999999999999998 59999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
|++|||++++... +.+++...-+|+.+|++||.|||+.. +||||||||+|||++..|.+||+|||.++.+-..
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999999543 45999999999999999999999632 3999999999999999999999999999887433
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
..+..+||..|||||.+.+..|+.++||||||++++|+.+|+.|+......... ..++++..+.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~--------------~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD--------------IFELLCAIVD 296 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC--------------HHHHHHHHhc
Confidence 445689999999999999999999999999999999999999998654211111 1122222221
Q ss_pred CC---CCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GS---YSL-SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~---~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+. .+. ....++.+++..||+.||.+||++.++++
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 111 23456789999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=395.87 Aligned_cols=260 Identities=29% Similarity=0.443 Sum_probs=215.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
.+....+.||+|.||.||+|+... .+.||||.++...+. ...+|++|+++++.++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 455566899999999999999643 467999999877655 7889999999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 360 LIYEYLPNKSLNDFIFDVT-------R----SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
+|+|||..|+|.+||.... . ..+|+..+.+.||.|||.||.||-++. +|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999996321 1 234889999999999999999999987 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+||||++.....+.........-+.+|||||.+..++||.+||||||||+|||+++ |+.|+.....++ +.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VI 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VI 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HH
Confidence 9999999998766555544333445789999999999999999999999999999997 778865443321 11
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
.....++ + -+.+...+.+++.|++.||+.+|++||+++||-..|+....
T Consensus 716 e~i~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 1111111 1 23455566789999999999999999999999999986433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=375.56 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=209.7
Q ss_pred cCCCcCCeecccCcccEEEEEE-eCCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..|...+.||+|||..+|+++. ..|..||+|.+.+. .....+.+.+|+++.++|+|||||+++++|.+.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 56999999999774 3345677899999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|+|++++|..++. +++.+++.++..++.||+.||.|||+.+ |+|||||..|+||++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 6778999999999999999999999998 999999999999999999999999999988655
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.... .+.+||+.|.|||++....++..+||||+|||+|-||.|++||+...- .+..+..
T Consensus 172 ~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-------------------kety~~I 230 (592)
T KOG0575|consen 172 GERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-------------------KETYNKI 230 (592)
T ss_pred cccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-------------------HHHHHHH
Confidence 4433 448999999999999999999999999999999999999999864321 1111111
Q ss_pred cCCCCCH--HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSL--SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~--~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...++.. .......+|+..+|+.+|.+|||+.+|+.
T Consensus 231 k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 231 KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122211 22235678999999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=356.73 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=200.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc-------CHHHHHHHHHHHhhccCCCcceEEEEEeeCC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-------GMEEFENEVLLIAKLQHRNLVKLIGCCTQRD 356 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 356 (606)
..+.|.+.+.||+|+||.|-+|.... |+.||||++++.... ......+|+++|++|+|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567788999999999999999754 999999999764211 2334579999999999999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CceEEeec
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDF 433 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~ki~DF 433 (606)
..|||+||++||.|.+++. ..+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999984 3455788888889999999999999999 9999999999999765 78999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccCC---CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
|+|+..+ ......+.+||+.|.|||++.+.. +..|+|+||+||+||-+++|..||.....+..
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------- 389 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------- 389 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----------
Confidence 9999876 233455689999999999998665 34588999999999999999999864433221
Q ss_pred hhcCcchhcccccCCCCC------HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 511 IEERPVELINKSLGGSYS------LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~------~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+.+....+.+. ..-..+..+++.+||+.||++|||+.|+++
T Consensus 390 -------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 -------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11111122111 122346788999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=355.19 Aligned_cols=199 Identities=30% Similarity=0.510 Sum_probs=180.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..+|...++||+|.||+||+|++.. +..||||.+.+. .....+.+..|+.+|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4578888999999999999999875 889999999776 5556778899999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC------CceEEeecCCc
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE------MNPKISDFGMA 436 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~------~~~ki~DFGla 436 (606)
|||.+|+|.+|++. .+.+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 346999999999999999999999998 9999999999999764 56899999999
Q ss_pred cccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
+.+.. .......+|++-|||||++..++|+.|+|+||+|+|||++++|+.||+.
T Consensus 163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99863 3334558999999999999999999999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=342.29 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=207.5
Q ss_pred hcCCCcCCeecccCcccEEEEEE-eCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEE-EEeeCCe-eEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIG-CCTQRDE-RML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~l 360 (606)
..+|.+.++||+|.||+|||+.. .+|..+|.|++.-. +.+..++...|+.+|++|+|||||++++ .+.+..+ +++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34677889999999999999985 46899999998643 3455677899999999999999999999 4555555 899
Q ss_pred EEecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 361 IYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSR-LRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
||||+..|+|..++... ...+.+++..+++++.|++.||..+|++-+ ..|+||||||.||+|+.+|.+||+|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999999653 345679999999999999999999999421 2399999999999999999999999999999
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
+....... ...+||+.||+||.+.+.+|+.|+||||+||++|||..-+.||... ++. ++
T Consensus 178 l~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-------------~L 236 (375)
T KOG0591|consen 178 LSSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-------------SL 236 (375)
T ss_pred hcchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-------------HH
Confidence 87654443 3479999999999999999999999999999999999999997543 221 11
Q ss_pred cccccCCCCC----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 519 INKSLGGSYS----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 519 ~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
-.+.-.++++ .-....+.+|+..|+..||+.||+...+++.+..
T Consensus 237 ~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 237 CKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1122222221 2345578889999999999999986555555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=342.89 Aligned_cols=239 Identities=26% Similarity=0.348 Sum_probs=200.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|++.++||+|+||.||.++..+ ++.+|+|.+++. .....+...+|..+|.+++||.||+++-.|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 5789999999999999999999876 788999999775 234567889999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+.||.|..+|. +...+++..+.-++..|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999994 3455899999999999999999999999 99999999999999999999999999986432
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
....+...+||+.|||||++.+..|+..+|.||+|+++|||++|..||...+.. +..+.
T Consensus 178 --~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------------------~~~~~ 236 (357)
T KOG0598|consen 178 --DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------------------KMYDK 236 (357)
T ss_pred --CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------------------HHHHH
Confidence 223345589999999999999999999999999999999999999997643221 11111
Q ss_pred ccCCC---CCHHHHHHHHHHHhhcccCCCCCCC
Q 007361 522 SLGGS---YSLSEVLRCIQVGLLCVQQRPEDRP 551 (606)
Q Consensus 522 ~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RP 551 (606)
.+.+. .+.-......+++...++.+|++|-
T Consensus 237 I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 237 ILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11111 1111223566788899999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=372.57 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=213.2
Q ss_pred CCCcCCeecccCcccEEEEEEeC----CcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
...+.++||.|.||.|++|+++- ...||+|.++.. .+....+|+.|+.||.+.+||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34567899999999999999864 357999999765 4556789999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|||+||+|+.||.. +...+++.+..-++.+||.||.||-+.+ +|||||.++|||++.+..+||+|||+++.+..+
T Consensus 710 EyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999965 3355899999999999999999999988 999999999999999999999999999987554
Q ss_pred cccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 443 QTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 443 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.... .+..-.-+.+|.|||.+...++|.++||||||+|+||.++ |.+|+=.. ...+...-++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm----------------SNQdVIkaIe 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----------------SNQDVIKAIE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc----------------chHHHHHHHH
Confidence 4221 1111223679999999999999999999999999999885 88984211 1112223333
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+-..+++.+..|.+|++.|||+|-.+||.+.+|+.+|+..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 3444456677788999999999999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=351.73 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=203.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD 356 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 356 (606)
..++|.+.++||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467888999999999999999752 246799999865432 3346789999999999 8999999999887644
Q ss_pred -eeEEEEecCCCCCchhhhcccCC--------------------------------------------------------
Q 007361 357 -ERMLIYEYLPNKSLNDFIFDVTR-------------------------------------------------------- 379 (606)
Q Consensus 357 -~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 379 (606)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccC
Q 007361 380 ---SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456 (606)
Q Consensus 380 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 456 (606)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134888999999999999999999988 99999999999999999999999999987543322222333456788
Q ss_pred ccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHH
Q 007361 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRC 535 (606)
Q Consensus 457 y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l 535 (606)
|+|||++.+..++.++||||||++||||++ |..|+....... ........+.... .+......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMR---------APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCC---------CCCCCCHHH
Confidence 999999999999999999999999999997 999876432211 0111111111100 111123467
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 536 IQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 536 ~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.+|+.+||+.+|++||++.+|+++|+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 7899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=375.20 Aligned_cols=258 Identities=31% Similarity=0.473 Sum_probs=211.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC--Cc----EEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE--GQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~--g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
++.+..+.||+|.||.||+|...+ |. .||+|.+.+. +.+...+|..|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 455667899999999999999765 43 4899999775 4566789999999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 360 LIYEYLPNKSLNDFIFDVT----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
+++|||++|+|..||.+.+ +...+...+.+.++.+||+|+.||+++. +|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997642 2456999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
|+.+...+.........-+..|||||.+.++.|+.|+|||||||+||||+| |..|++..+..+ ....+.++-
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhCC
Confidence 996654444433333344679999999999999999999999999999998 667765433221 111111111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+ -..+...+..+++|+..||+.+|++||++..+++.+..+
T Consensus 922 -------R--L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 -------R--LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred -------c--cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1 122334456788999999999999999999999988765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=334.97 Aligned_cols=255 Identities=28% Similarity=0.416 Sum_probs=201.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC--eeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--ERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 363 (606)
.++...+.||+|.||+||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+.++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346667899999999999999876 8999999987664444677999999999999999999999865555 6899999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCccccCC-
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGI- 441 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~~~~- 441 (606)
|+++|||.+++..... .+++..+..+..||++||+|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965332 5999999999999999999999998 999999999999999 79999999999987754
Q ss_pred CcccccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
...........||+.|||||++.++. ...++||||+||++.||+||+.|+... . ....+..........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~----~~~~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F----EEAEALLLIGREDSL----- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c----chHHHHHHHhccCCC-----
Confidence 11222334478999999999999643 345999999999999999999997543 0 011111111111111
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
+ ..+..-.....+++..|++.+|+.|||+.++++--
T Consensus 242 P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1 12222334567899999999999999999998754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.74 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=203.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 360 (606)
.+.|+..++||+|.||.||+++... |+.||+|++.... +.......+||.+|++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4567888999999999999999754 8999999997654 44456678999999999999999999999887 68999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+|||++ +|.-++.. ..-.+++.++..++.|++.||.|+|+.+ |+|||||.+|||||++|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 77777743 3345899999999999999999999999 9999999999999999999999999999887
Q ss_pred CCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH-----HHHhhhcC
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA-----WRLWIEER 514 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-----~~~~~~~~ 514 (606)
.......++ .+-|..|.|||+++|. .|+.++|+||.||||.||++|+..+.....-+....+-.. -..|...+
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 665554444 5679999999999875 6999999999999999999999987654332221111110 00111111
Q ss_pred cc--hhcccccCCCCCHHH-----HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PV--ELINKSLGGSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~--~l~d~~l~~~~~~~~-----~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ..+.+...-.....+ ....++|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 111111000001111 124578888999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=351.23 Aligned_cols=260 Identities=30% Similarity=0.401 Sum_probs=205.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeCC----cE-EEEEEccc---ccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEG----QE-IAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g----~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
++....++||+|+||.||+|++... .. ||+|.... .......+|.+|+++|++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 4455569999999999999998652 23 89998874 3456678999999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|||+++||+|.++|.... ..++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999996432 25999999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
-. ..........-+..|+|||.+....|+.++|||||||++||+++ |..|+...... . ... ..
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~----v~~-kI------ 375 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---E----VKA-KI------ 375 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---H----HHH-HH------
Confidence 43 11111112245679999999999999999999999999999998 77776533221 0 001 11
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCC
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 568 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~~~ 568 (606)
+........+...+..+..++..||+.+|++||+|.++.+.|+.+.....
T Consensus 376 -~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 -VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 01111112222334566678889999999999999999999987644433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=320.49 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=202.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-c-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-Q-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
+.|+...++|+|+||.|||++.++ |+.||||++..+.+ . ..+-.++|+++|++++|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457778899999999999999877 89999999976543 2 23457799999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|++..-|.++=. ....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||.|+.+..
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 998866655432 2334889999999999999999999998 99999999999999999999999999998854
Q ss_pred ccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHHHHHhhhcC
Q 007361 444 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLWIEER 514 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~~ 514 (606)
.....+..+.|..|.|||.+.+ .+|...+||||+||++.||++|..-|+..+.-....++ ......+....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2334455788999999999987 68999999999999999999999887765433222221 22222222211
Q ss_pred cc-hhcccccCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 515 PV-ELINKSLGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 515 ~~-~l~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
.- .+.-+......+. ....-+++++..|++.||.+|++-++++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 10 0000000000000 1112568899999999999999999887
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.92 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=207.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
...|....+||+|..|.||.+.... ++.||+|++........+-+.+|+.+|+..+|+|||.+++.+..++++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3567777899999999999998654 889999999877777778899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
|++|+|.+.+. ...+++.++..|+.++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+...+.
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999883 344999999999999999999999999 99999999999999999999999999998765554
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.....+||+.|||||++....|.+|+||||||++++||+-|+.|+=...+ +...+. .......++
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyL-Ia~ng~P~l------ 489 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYL-IATNGTPKL------ 489 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHH-HhhcCCCCc------
Confidence 34458999999999999999999999999999999999999999643211 111111 111111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.........+.++..+||+.|+++||++.|+|+
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 011112235678899999999999999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.33 Aligned_cols=264 Identities=26% Similarity=0.386 Sum_probs=202.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-----------------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-----------------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKL 348 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 348 (606)
++|...++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999998643 3369999886543 3345679999999999999999999
Q ss_pred EEEEeeCCeeEEEEecCCCCCchhhhcccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 007361 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVT----------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412 (606)
Q Consensus 349 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 412 (606)
++++.+.+..++||||+++++|.+++.... ....++|..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885321 1235788999999999999999999998 999
Q ss_pred ccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhcc--CC
Q 007361 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK--RN 490 (606)
Q Consensus 413 ~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~--~p 490 (606)
|||||+|||++.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998764333322233345678999999999999999999999999999999754 45
Q ss_pred CCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 491 RGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 491 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
+..... ..........+... .... ....+......+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQ-GRQV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhc-cccc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 433221 11111111111110 0000 000111223467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=340.80 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=206.7
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
....+.+.+...||+|.||+||+|.+. ..||||++... ..+..+.|++||..+++-+|.||+-+.|+|..... .+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 334566778899999999999999984 47999998654 34467899999999999999999999999998877 99
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+.+++|.+|+.+|+... ..++..+.+.|++|||+||.|||.++ |||||||..||||.++++|||+|||++..-.
T Consensus 465 iTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999997533 45899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCcccccccccccccCccCcccccc---CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
.-..........|...|||||+++. .+|+..+||||||+|+|||+||..|+.....+.-. |.-++-.-
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi---------fmVGrG~l 610 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII---------FMVGRGYL 610 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE---------EEeccccc
Confidence 2222223334567789999999974 36999999999999999999999997632222111 11111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
..|... ........+.+|+..||..++++||.+.+|+.+|+.+.
T Consensus 611 ~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 611 MPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred Cccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 111111 11123346677888999999999999999999887653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.90 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=210.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..+.|+..+.||.|..++||+|+.. .+..||||++.-.. ....+.+..|+..++.++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3467888999999999999999964 48899999986442 334689999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
.||.+||+.++++..-... +++..+..|..++++||.|||++| .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999997544333 899999999999999999999999 999999999999999999999999988765332
Q ss_pred ccc--ccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 443 QTE--ANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 443 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
... ...+..+||+.|||||++.. ..|+.|+||||||++..||.+|..||..+.+.. ....-..+.+..+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------vLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------VLLLTLQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhcCCCCCc
Confidence 222 12256789999999999653 469999999999999999999999987665421 1111223333333
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
....+..+........+.+++..|++.||.+|||+++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 322222222222233677889999999999999999998
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=346.34 Aligned_cols=259 Identities=26% Similarity=0.373 Sum_probs=203.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 357 (606)
.++|...++||+|+||.||+|++. .+..||+|+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457888999999999999999742 25689999986543 23456788999999999 89999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCC----------------------------------------------------------
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTR---------------------------------------------------------- 379 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 379 (606)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999854211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 380 --------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 380 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 125789999999999999999999988 999999999999999999999999999876433222
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+. ........+..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~--------- 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYR--------- 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCcc---------
Confidence 22222345678999999999999999999999999999998 777765332111 11111111100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
...+......+.+|+.+||+.+|++||++.+|+++|+.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00011112467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=340.49 Aligned_cols=241 Identities=28% Similarity=0.437 Sum_probs=198.9
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
..++-||.|+.|.||+|++ .++.||||++..-. ..+++-|++|+|+||+.+.|+|.....+++|||||..|.
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3457899999999999998 68999999985433 357888999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccccc
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 449 (606)
|...|. ....+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++..... ....
T Consensus 199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 999994 4456888889999999999999999998 999999999999999999999999999876533 2233
Q ss_pred ccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCH
Q 007361 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL 529 (606)
Q Consensus 450 ~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 529 (606)
.+.||..|||||++...+.++|+|||||||||||||||..|+...+.. . ..|. ...+ .+.-..+.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--A----IIwG--VGsN-------sL~LpvPs 334 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--A----IIWG--VGSN-------SLHLPVPS 334 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--e----eEEe--ccCC-------cccccCcc
Confidence 478999999999999999999999999999999999999996433221 0 0010 0011 11112233
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 530 SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 530 ~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+.-+.-|+..||+..|.+||++++++.-|+-
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 445566678899999999999999999998864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.78 Aligned_cols=246 Identities=20% Similarity=0.295 Sum_probs=198.2
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccccccC---HHHHHHHHHHHhhccCCCcceEEEEEee----CCeeEEEEec
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERMLIYEY 364 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~ 364 (606)
...||+|++|.||+|.+ +|+.||+|++....... .+.|.+|+.++.+++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 78999999997654333 5778899999999999999999999877 3467999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
+++|+|.+++.. .+.+++.....++.+++.||.|||+. + ++||||||+||++++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999954 34589999999999999999999985 5 7899999999999999999999999998654321
Q ss_pred ccccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .+. ........
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~----~~i~~~~~------ 239 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIY----DLIINKNN------ 239 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhcCC------
Confidence 12467889999999976 68999999999999999999999998643211 111 11111100
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
....+......+.+++.+||+.||++|||+.++++.|+...
T Consensus 240 --~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 --SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01111123346788999999999999999999999997643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=336.26 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=206.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHH--HHHHHHHHhhcc-CCCcceEEEEEeeCC-eeE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--FENEVLLIAKLQ-HRNLVKLIGCCTQRD-ERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~ 359 (606)
..++|...++||.|.||.||+|+... |..||||++++.-.. .++ =.+|++.|++|+ |||||+|..++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678888999999999999999765 889999999765433 333 347999999998 999999999999888 899
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+|||||+ .+|..++.+ +++.+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||+|+..
T Consensus 87 fVfE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999995 589998865 3778999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCcccccccccccccCccCccccc-cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHH-----HHHHhhhc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH-----AWRLWIEE 513 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~-----~~~~~~~~ 513 (606)
.. ....+..+.|..|.|||+++ .+.|+.++|||++|||++||.+-+..|+.........-+-. .+..|.++
T Consensus 161 ~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 53 33455678999999999986 56799999999999999999999988765443211100000 01111111
Q ss_pred -Ccchhccccc---CC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 514 -RPVELINKSL---GG----SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 514 -~~~~l~d~~l---~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
.....+.-.+ .+ ..-.....++++++..|++.||.+|||+.+.++.-
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0000111111 00 01112445788999999999999999999999753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=335.23 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=207.1
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 359 (606)
..++|..++.||+|+|++|++++..+ ++++|||++.+. .+...+-+..|-.+|.+| .||.|++|+-.|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 45688999999999999999999766 889999999765 334455677889999999 8999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+|+||.++|+|.++|.. .+.+++.....++.+|+.||+|||+.| ||||||||+|||||++|++||.|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999954 456999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCccc---------ccc--cccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH
Q 007361 440 GIDQTE---------ANT--NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 508 (606)
Q Consensus 440 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 508 (606)
...+.. ... ...+||..|.+||++.+...++.+|+|+||||||.|+.|+.||.....- +. ++
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----li---Fq 297 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LI---FQ 297 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HH---HH
Confidence 543222 111 4489999999999999999999999999999999999999998543211 00 00
Q ss_pred HhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 509 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
++ .-++-.+...++ ..+.+|+.+.|..||.+|++..+|-+-
T Consensus 298 -----kI-~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 -----KI-QALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----HH-HHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 00 111222223333 456688889999999999999888753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=325.23 Aligned_cols=270 Identities=26% Similarity=0.412 Sum_probs=204.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhh--ccCCCcceEEEEEeeCC----eeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQRD----ERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~l 360 (606)
......++||+|+||.||||.+ +++.||||++... ..+.|.+|-.+.+. ++|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445568899999999999999 5699999999544 34567777777665 58999999999876555 8999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
|+||.++|||.+|| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 455699999999999999999999976 35789999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCC-CC-----ccccchhHHHHHHHHHhccCCCCCCCCCCc---------
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FS-----VKSDVFSFGVLVLEIVCGKRNRGFYHADHH--------- 499 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DV~S~Gvvl~elltG~~p~~~~~~~~~--------- 499 (606)
+|..+........+-.-+||.+|||||++.+.. +. .+.||||+|.|||||++.-.-.......+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999987666655555589999999999997653 22 368999999999999986544321111111
Q ss_pred -cchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCC
Q 007361 500 -HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 567 (606)
Q Consensus 500 -~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~~ 567 (606)
+.-++..+......+..-.+-...... ..+.-+.+.+..||..||+-|.|+.-|.+.+..+..+.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 011122222222222221111111111 34556778899999999999999999999998765444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=377.23 Aligned_cols=263 Identities=25% Similarity=0.464 Sum_probs=211.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
....+...+.||+|+||.||+|+.. ++..||+|++....... ..|++++++++|||||+++|+|.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3456778899999999999999974 68899999986543222 356889999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.+++.. ++|..+.+++.||++||+|||+....+|+||||||+||+++.++.+++. ||.+......
T Consensus 764 y~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 9999999999942 8999999999999999999997655679999999999999999988876 6665433211
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
....+|..|+|||++.+..++.++|||||||++|||+||+.|++.... ....+..+....+........+++.+
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence 123678999999999999999999999999999999999999853322 22334444443333333444556655
Q ss_pred CCC--CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 524 GGS--YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 524 ~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
... .+.++..++.+++.+||+.+|++||+|.+|+++|+....
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 432 345677788999999999999999999999999987543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=345.44 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=203.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 357 (606)
.++|.+.+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999998853 23579999996543 23356788999999999 89999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccC-----------------------------------------------------------
Q 007361 358 RMLIYEYLPNKSLNDFIFDVT----------------------------------------------------------- 378 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 378 (606)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccc
Q 007361 379 --------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450 (606)
Q Consensus 379 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 450 (606)
....+++..+++++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1134788999999999999999999988 99999999999999999999999999987643322222222
Q ss_pred cccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCH
Q 007361 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL 529 (606)
Q Consensus 451 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 529 (606)
..++..|+|||++.+..++.++||||||+++|||++ |+.|+....... . ........ .....+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~---------~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRG---------YQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcc---------cCccCCC
Confidence 345678999999999999999999999999999997 999975432211 0 11111110 0000011
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 530 SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 530 ~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.....+.+++..||+.+|++||++.+|+++|+.+
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1124677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=335.09 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=212.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccC-HHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.....+.++||+|-||.|..+....+..||||+++...... ..+|..|+++|.+++|||||+|+|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34556779999999999999999888999999998876554 48999999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
|++|+|..|+..... ..+....-..|+.||+.||+||.+.+ ++||||.++|+|++.++++||+|||+++-+.....
T Consensus 617 mEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999965322 22456667789999999999999988 99999999999999999999999999998766666
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh--ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.......+-+.+|||||.+.-++++.++|||+||+++||+++ .++|+.....+. .+...-..+ .......+
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~-~~~~~~~~--- 765 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFF-RDQGRQVV--- 765 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhc-CCCCccee---
Confidence 555556677899999999999999999999999999999875 566754332211 111111111 11111110
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+.-.+..++++++.||..+-++||+++++...|+..
T Consensus 766 --l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 --LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112233455788999999999999999999999988753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.39 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=202.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc----cc-cCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS----SG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 357 (606)
....|...+.||+|+||+|+.|.... +..||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45688899999999999999998754 799999976553 12 33556778999999998 9999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CceEEeecCCc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMA 436 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~ki~DFGla 436 (606)
.++||||+.+|+|.+++.+ .+.+.+..+..++.|++.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 455888999999999999999999998 9999999999999999 99999999999
Q ss_pred cccCCCcccccccccccccCccCccccccCC-CC-ccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ....... ...+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~k-i~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRK-IRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHH-HhcCC
Confidence 9874 1223344579999999999999987 85 78999999999999999999986511 1111111 11110
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
..+..... ...+..++.+|++.+|.+|+++.+|+
T Consensus 240 ------~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 ------FKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------ccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00111111 35677899999999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=304.77 Aligned_cols=274 Identities=25% Similarity=0.357 Sum_probs=208.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-c-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-Q-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|...++||+|.||.||+|+... |+.||+|+++.... + ......+|++.|+.++|+||+.|++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356777899999999999999755 89999999975422 2 23467899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
||+ .+|...+.+ +...+...++..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+|+.++.+.
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 488888865 4567999999999999999999999998 9999999999999999999999999999987665
Q ss_pred ccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc------c
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP------V 516 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~ 516 (606)
..... .+-|..|.|||.+.|. .|+..+||||.|||+.||+-|..-+.....-+. +....+.+-.... .
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ---L~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ---LSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH---HHHHHHHcCCCCcccCcccc
Confidence 44333 2678999999999875 599999999999999999998876554332111 1111111111110 0
Q ss_pred hhcccc--------cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCCCCCC
Q 007361 517 ELINKS--------LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQP 572 (606)
Q Consensus 517 ~l~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~~~p~~p 572 (606)
++.|.. .....-......+++++..++..||.+|++++|++++= .....|.|..|
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~ 293 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPP 293 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCCh
Confidence 111110 00112222334568999999999999999999998753 33445555444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.13 Aligned_cols=198 Identities=30% Similarity=0.390 Sum_probs=179.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|+..+.||.|+||.|.+++.+. |..+|+|.+++.. -...+...+|..+|+.+.||+++++.+.+.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3578888999999999999999876 7789999997653 23456778999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||.+||.|..+|.. .+.+++..+..++.+|+.||+|||+.+ |++|||||+|||||.+|.+||.|||.|+...
T Consensus 123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 999999999999954 445999999999999999999999998 9999999999999999999999999999753
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
..+.+.+||+.|+|||++...+|..++|.|||||++|||+.|..||...
T Consensus 196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 2355689999999999999999999999999999999999999997543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=324.43 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=205.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeCC------cEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEG------QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g------~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
++|...+.||+|+||.||+|..... ..+++|.+..... .....|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4678889999999999999987542 5789998865432 33567899999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 007361 360 LIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 426 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~ 426 (606)
+++||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864211 145889999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHH
Q 007361 427 NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH 505 (606)
Q Consensus 427 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 505 (606)
.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~--- 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV--- 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---
Confidence 999999999986643333223334456789999999999999999999999999999998 98886532211 01
Q ss_pred HHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 506 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 506 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
........ ....+......+.+|+.+||+.+|.+||++.+|++.|+.
T Consensus 236 -~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 -IEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 111122334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.39 Aligned_cols=250 Identities=33% Similarity=0.514 Sum_probs=193.2
Q ss_pred cCCeecccCcccEEEEEEe-----CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 291 DKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..+.||.|.||.||+|.+. .+..|+||.+.... ....+.|.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999987 25789999996543 33478999999999999999999999999988889999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++|+|.++|... ....+++..++.|+.||++||.|||+.+ ++|+||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999754 2455899999999999999999999988 99999999999999999999999999987633322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
............|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+ .....+....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~----~~~~~~~~~~------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EI----IEKLKQGQRL------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HH----HHHHHTTEET-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc----cccccccccc-------
Confidence 233333456789999999999999999999999999999999 67775432111 11 1111111110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
..+......+.+++..||+.+|++||++.++++.|
T Consensus 225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11111234677899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=330.84 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=200.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-Cc----EEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.+|+..+.||+|+||.||+|++.. +. .+|+|.+.... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468889999999999999999754 33 38999986543 34456889999999999999999999999864 5789
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998642 345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|++..... .+ .. ...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~-~~~~~~-~~- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SS-ILEKGE-RL- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HH-HHhCCC-CC-
Confidence 4333222222345678999999999999999999999999999998 88887532111 01 11 111000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+......+.+++..||+.+|.+||++.+++..|...
T Consensus 231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111224577899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=327.91 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=207.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..|+..+.||+|.||.||||.... ++.||+|.+.-. .....+++.+|+.++.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456777999999999999999866 778899998643 455678899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+.+|++.+.|. ....+++..+.-|+.+++.||.|||+++ .+|||||+.|||+..+|.+|++|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999983 3445688888899999999999999998 99999999999999999999999999988755444
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.. ...+||+.|||||++....|+.|+||||||++.+||.+|..|+...++.....+ +-+...
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------------Ipk~~P 228 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------------IPKSAP 228 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------------ccCCCC
Confidence 33 568999999999999988999999999999999999999999766555322211 111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..........+.+++..|++.+|+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1122222345778899999999999999999883
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.35 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=205.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|+..+.||+|++|.||+|...+++.+|+|.+.... ...+++.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998788899999986543 34678999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 345899999999999999999999988 999999999999999999999999999876532211
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .......... .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~---------~ 222 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGY---------R 222 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC---------C
Confidence 1111233468999999999999999999999999999999 88886532211 1111111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
...+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01111223567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.51 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=201.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|+..+.||+|+||.||++.+.++..+|+|.+... ....+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778999999999999999988889999987543 3445789999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|+|.+++... ...+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988542 235899999999999999999999998 9999999999999999999999999998654322211
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...... ...... ..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~----i~~~~~--~~------ 221 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM----ISRGFR--LY------ 221 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCC--CC------
Confidence 122345668999999998899999999999999999999 8888643221 111111 111100 00
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.+......+.+++.+||+.+|++||++.+++++|.
T Consensus 222 -~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 -RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=322.04 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=201.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEe----CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.++|.+.+.||+|+||.||+|.+. .+..+|+|.+..... ...+.|.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788899999999999999864 256899999876432 334678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998542 345899999999999999999999998 9999999999999999999999999876542
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. ....+...
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~----~~~~~~~~---- 226 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVI----KAVEDGFR---- 226 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCCCC----
Confidence 2211 11112345678999999999999999999999999999875 99987533211 011 11111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
...+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 227 -----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 -----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01112233467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.30 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=204.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEcccccc-cCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 357 (606)
.++|.+.++||+|+||.||+|+... +..||+|++..... ...+.+.+|+.++.++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 5678889999999999999998632 34699999965433 33467999999999996 9999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccC-----------------------------------------------------------
Q 007361 358 RMLIYEYLPNKSLNDFIFDVT----------------------------------------------------------- 378 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 378 (606)
.++||||+++|+|.++|....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999885321
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC
Q 007361 379 ----------------------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 424 (606)
Q Consensus 379 ----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~ 424 (606)
....+++..+..++.||++||.|||+.+ |+|+||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124788899999999999999999988 999999999999999
Q ss_pred CCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchh
Q 007361 425 EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLL 503 (606)
Q Consensus 425 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 503 (606)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----- 347 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence 99999999999987643332222333456788999999999999999999999999999997 888875322110
Q ss_pred HHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 504 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 504 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.......... ....+......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 348 -~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 348 -TFYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -HHHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0111111110 0011112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.50 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=198.4
Q ss_pred CCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 289 FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999975 58899999986532 22345678999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999998875432 335899999999999999999999998 9999999999999999999999999998753221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......||..|+|||++.+..++.++||||||+++|||++|+.||......... ......... . .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~--------~--~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKE--------D--Q 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhc--------c--c
Confidence 122357899999999999999999999999999999999999998643321110 000000000 0 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
...+......+.+|+..||+.+|++||+ +.++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122346678999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.48 Aligned_cols=256 Identities=29% Similarity=0.470 Sum_probs=205.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
++|.+.+.||+|+||.||+|...+ +..+|+|.+...... ..+.+.+|++++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467788999999999999998744 478999998765444 4578999999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 360 LIYEYLPNKSLNDFIFDVT-----------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986422 2345889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~--- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIE--- 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---
Confidence 9999999986543322222223445788999999999999999999999999999998 99886432211 1111
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
....+... ..+......+.+++..||+.+|++||++.+|++.|+
T Consensus 236 -~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 -CITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111110 111122346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.08 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=210.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
...+|+..++||.|+||.||+|...+++.+++|.+.........++..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34678888999999999999999988999999999777665677899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++... ....+++..+..++.+|+.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999653 3455899999999999999999999988 99999999999999999999999999987643222
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.. ....++..|+|||.+.+..++.++||||||+++++|++ |+.|+...... ..... .... .
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~----~~~~---------~ 221 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQ----ITAG---------Y 221 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH----HHhC---------C
Confidence 11 12345778999999999999999999999999999998 78887543211 11111 1110 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111112233567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.14 Aligned_cols=243 Identities=22% Similarity=0.267 Sum_probs=198.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.+.||+|+||.||+++... ++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 578888999999999999999865 7899999986542 234567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999853 345889999999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ........... .
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~------~ 233 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRL------K 233 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCc------C
Confidence 12357899999999999999999999999999999999999997532210 11111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVV 557 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl 557 (606)
+.... ...+.+++..||+.||.+||+ +.+++
T Consensus 234 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 234 FPNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 11111 235678999999999999997 56665
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=336.12 Aligned_cols=255 Identities=27% Similarity=0.372 Sum_probs=211.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.-|..++.||.|+-|.|-.|++.. |+..|||.+.+.. ......+..|+.+|+-+.|||+++|++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 456778999999999999999765 9999999997652 233456789999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|.|.+++. +.+.+.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||||..-..+
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999994 4566999999999999999999999998 999999999999999999999999999864322
Q ss_pred cccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
....+.+|.+.|+|||++.|.+| ..++||||.|||||.|+||+.||+. +++..++.+
T Consensus 166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-------------------dNir~LLlK 223 (786)
T KOG0588|consen 166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-------------------DNIRVLLLK 223 (786)
T ss_pred ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-------------------ccHHHHHHH
Confidence 23345799999999999999998 5789999999999999999999862 222333333
Q ss_pred ccCCCCCHH--HHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCCCCCCC
Q 007361 522 SLGGSYSLS--EVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERSLPQP 569 (606)
Q Consensus 522 ~l~~~~~~~--~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~~~~~~~p 569 (606)
...|.+.++ -..++.+|+.+|+..||+.|.|+.+|++ .|.+-..++.+
T Consensus 224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 333433322 2346678999999999999999999997 45555555544
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.96 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=203.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
.+++|+..+.||+|+||.||+|.+.. +..+|+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45779999999999999999998632 4679999885432 2334578899999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTR-------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
.++|+||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234688999999999999999999987 999999999999999999999
Q ss_pred eecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHH
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 99999986543332222222345778999999999999999999999999999999 67776432211 11111
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
........ .+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 111123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.85 Aligned_cols=199 Identities=26% Similarity=0.358 Sum_probs=174.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|+..+.||+|+||.||+++... +..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 3678889999999999999999865 7788888886542 2345679999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 345899999999999999999999863 3999999999999999999999999999765322
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
......||..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12335789999999999999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.78 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=202.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.++||+|+||.||+|+..+ ++.||+|++.+.. ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368888999999999999999875 7899999986542 234567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 345899999999999999999999998 99999999999999999999999999986533
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... . +...... ...+...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~----~~~i~~~--~~~~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---T----WENLKYW--KETLQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---H----HHHHHhc--cccccCC
Confidence 2234678999999999999999999999999999999999999986432211 0 0000000 0000000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
............+.+++..||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001123456788999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.60 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=199.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
..++|+.+..||+|+||.||.++..+ |..+|+|++.+.. ....+.++.|-.+|...++|.||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999876 8899999998763 4456778899999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||++||++..+|. +...|++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999994 4566999999999999999999999999 9999999999999999999999999985431
Q ss_pred CC---------------------cccc------------------------cccccccccCccCccccccCCCCccccch
Q 007361 441 ID---------------------QTEA------------------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVF 475 (606)
Q Consensus 441 ~~---------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~ 475 (606)
.. .... .....+||+.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0000 01135799999999999999999999999
Q ss_pred hHHHHHHHHHhccCCCCCCCCCCcc-chhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 007361 476 SFGVLVLEIVCGKRNRGFYHADHHH-NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 552 (606)
Q Consensus 476 S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 552 (606)
|+|||+||||.|-+||....+.+.- .++.| +.... .........+..+||.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~------------fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNW--RETLK------------FPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhcc------------CCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999998755443221 11111 11000 00001111466788889988 9999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.89 Aligned_cols=244 Identities=25% Similarity=0.376 Sum_probs=205.4
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|.+.+.||+|.||.||||+.+. .+.||+|.+.+.. +...+.+.+|+++++.++|||||.++++|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568888999999999999999765 7788999887653 3456779999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+.| +|..+|. ....++++.+..|+.++..||.|||+.. |+|||+||+|||++.++.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999995 3455999999999999999999999998 9999999999999999999999999999875432
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.....+.||+.|||||++.+++|+..+|.||+||||||+++|++||-. ..+.+++...+
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------------------~si~~Lv~~I~ 213 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------------------RSITQLVKSIL 213 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------------------HHHHHHHHHHh
Confidence 233457899999999999999999999999999999999999999632 12223333332
Q ss_pred CCC--CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGS--YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ++......+..++.-.++.||.+|.+..+++.
T Consensus 214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 221 22234456677888899999999999999873
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.54 Aligned_cols=255 Identities=29% Similarity=0.419 Sum_probs=205.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|...++||+|+||.||+|...+++.+|+|++.... ...+.+.+|+.++++++|+||+++++.+.+.+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45788889999999999999998888899999986533 34678999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ....+++..++.++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998543 3345889999999999999999999987 999999999999999999999999999876433221
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
. .....++..|+|||.+....++.++||||||+++|||++ |+.|+...... ... .........
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~-------- 223 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVM----SALQRGYRM-------- 223 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHH----HHHHcCCCC--------
Confidence 1 222345678999999998999999999999999999998 88887532211 111 111111000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.........+.+++.+|++.+|++||++.+++++|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011122467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.26 Aligned_cols=242 Identities=25% Similarity=0.368 Sum_probs=206.2
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
...++|...++||+|.||+|+++.++. ++.+|||.+++. .....+..+.|..++... +||.|++|+.++...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999876 778999999876 355677888899988888 599999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||+.||++..+. +...+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954443 4456999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
--. ....+.+.+||+.|||||++.+..|+..+|.|||||+||||+.|+.||...+.+ ++
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------e~ 576 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------EV 576 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HH
Confidence 421 233567799999999999999999999999999999999999999998754433 34
Q ss_pred cccccCCC--CCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 519 INKSLGGS--YSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 519 ~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
+|..+..+ ++.-...+.+.|+...+..+|++|--+
T Consensus 577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 44444332 333445577889999999999999876
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=318.38 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=204.4
Q ss_pred cCCCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
++|+..+.||+|+||.||+|.+.. ...+|+|.+.... .....+|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999999753 3578999886543 33456789999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998542 236899999999999999999999988 99999999999999999999999999998753
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~----- 226 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---D----VIKAVEDGYR----- 226 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---H----HHHHHHcCCC-----
Confidence 222222222345678999999999999999999999999999998 88886432211 0 1111111100
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 ----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112234678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=320.40 Aligned_cols=257 Identities=30% Similarity=0.449 Sum_probs=202.5
Q ss_pred cCCCcCCeecccCcccEEEEEEe-----CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|+..++||+|+||.||+|... .+..+++|.+.... ......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45777899999999999999852 35789999986533 3344678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 007361 361 IYEYLPNKSLNDFIFDVT--------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 426 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~ 426 (606)
||||+++++|.+++.... ....+++...+.++.+++.||.|||+.+ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235889999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHH
Q 007361 427 NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH 505 (606)
Q Consensus 427 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 505 (606)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... .+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~-- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVI-- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence 999999999987644333333333456778999999998899999999999999999998 88776432110 011
Q ss_pred HHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 506 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 506 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
......... ..+......+.+++.+||+.+|++||++.+|.+.|..
T Consensus 237 --~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 --EMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111000 0111123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.73 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=207.6
Q ss_pred cCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.+|...+.||+|+||.||+|+.. ++..+++|++........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777899999999999999853 245688898876665556789999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc
Q 007361 361 IYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 427 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 427 (606)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985422 1235899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHH
Q 007361 428 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA 506 (606)
Q Consensus 428 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 506 (606)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999986544332222233456789999999999999999999999999999999 888865432210 1
Q ss_pred HHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 507 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
........... ........+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 235 IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11111111111 11112346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=313.19 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=195.5
Q ss_pred CeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 293 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
+.||+|+||.||+|++. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999986 58889999876543 33456799999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccc
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 450 (606)
.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999853 2345899999999999999999999998 99999999999999999999999999876532211111111
Q ss_pred cccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCH
Q 007361 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL 529 (606)
Q Consensus 451 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 529 (606)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+....... .... +........+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~---------~~~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREA---------IEQGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHH---------HHcCCCCCCcc
Confidence 223457999999999999999999999999999998 777764321110 0000 00111111111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 530 SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 530 ~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.....+.+++.+|++.+|++||++.+|.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.90 Aligned_cols=265 Identities=21% Similarity=0.247 Sum_probs=200.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|++.+.||+|+||.||+++... ++.+|+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 368888999999999999999865 7889999986542 3345678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH--------HHHHHhhhcC-
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWRLWIEER- 514 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~~- 514 (606)
. .......||..|+|||++.+..++.++|||||||++|||++|+.|+............. ..+..+....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12233578999999999999999999999999999999999999986432211100000 0001000000
Q ss_pred cchhcccccCCCCC------HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSYS------LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~~------~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
......+....... ......+.+++..||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 011235789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.57 Aligned_cols=259 Identities=29% Similarity=0.437 Sum_probs=206.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeC------CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|.+.+.||+|+||.||++...+ +..+|+|.+........+.+.+|+.++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 578888999999999999998522 45688998876665667789999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 361 IYEYLPNKSLNDFIFDVT----------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
|+||+++++|.+++.... +...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999985322 2235899999999999999999999988 999999999999999999999
Q ss_pred eecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHH
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+...... .....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHH
Confidence 99999986643322222233445778999999999999999999999999999998 88886433211 01111
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
...+.... .... ....+.+++..||+.+|.+||++.+|++.|+.+.
T Consensus 235 i~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11111111 1111 2245789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.05 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=210.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.+....++||.|-||.||.|.|+. .-.||||.++ .+....++|+.|+.+|+.++|||+|+|+|+|......|+|.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 455667899999999999999987 6789999994 45567899999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
..|+|.+||.+..+ ..++--..+.++.||+.||+||..++ +|||||.++|+|+.++..+||+|||+++++..+...
T Consensus 346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 99999999976443 44777788899999999999999998 999999999999999999999999999998665444
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.... ..-++.|.|||-+....++.|+|||+|||+||||.| |..|+...+- .. +..+++...+
T Consensus 422 AHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------Sq---------VY~LLEkgyR 484 (1157)
T KOG4278|consen 422 AHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQ---------VYGLLEKGYR 484 (1157)
T ss_pred cccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HH---------HHHHHhcccc
Confidence 3332 234678999999999999999999999999999997 6666543221 11 2233333333
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
..-+.-.+..+++|++.||+.+|.+||++.|+-+.++
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 3334445568889999999999999999999887764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=318.54 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=199.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-Cc----EEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|...+.||+|+||.||+|.+.. ++ .+++|++..... ....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 467788999999999999999754 44 477777754332 334678888999999999999999998864 55788
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999954 2345899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... + ......+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcCC--
Confidence 3332223334567789999999999999999999999999999998 888875332111 0 01111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
.+ . .....+.+++..||+.+|++||++.++++.|....
T Consensus 232 ~~---~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 QP---Q----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC---C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00 0 11235677899999999999999999999997744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.34 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=202.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC-C
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR-D 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 356 (606)
.++|.+.+.||+|+||.||+|...+ ++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3578889999999999999997532 46899999865432 2345678899999999 899999999988654 5
Q ss_pred eeEEEEecCCCCCchhhhcccCC---------------------------------------------------------
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTR--------------------------------------------------------- 379 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 379 (606)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998853211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCcc
Q 007361 380 -SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458 (606)
Q Consensus 380 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ 458 (606)
...++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 126899999999999999999999988 9999999999999999999999999998764433323333455677899
Q ss_pred CccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHH
Q 007361 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQ 537 (606)
Q Consensus 459 aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~ 537 (606)
|||++.+..++.++|||||||+||||++ |..|+......+ ........... ...+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTR---------MRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCC---------CCCCccCCHHHHH
Confidence 9999999999999999999999999998 988875322111 01111111100 0011122346789
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 538 VGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 538 l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
++.+||+.+|++||++.+|++.|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=343.39 Aligned_cols=252 Identities=18% Similarity=0.196 Sum_probs=202.3
Q ss_pred CCCcCCeecccCcccEEEEEEeC--CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.|...+.||+|+||.||++.... ++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 47888999999999999998654 5678888775555555567888999999999999999999999999999999999
Q ss_pred CCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 366 PNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 366 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 23456899999999999999999999988 99999999999999999999999999987654333
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
........||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .+. .....+...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~----~~~~~~~~~-------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIM----QQVLYGKYD-------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCCC--------
Confidence 22334467999999999999999999999999999999999999997532110 011 111111110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++..||+.+|++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011112246788999999999999999999864
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=315.01 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=201.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|...+.||+|+||.||+|...++..+|+|.+... ....++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 457778999999999999999877778999988643 3345789999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++....+....
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998542 235899999999999999999999998 9999999999999999999999999998654332211
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ..........
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~--------- 220 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ET----VEKVSQGLRL--------- 220 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HH----HHHHhcCCCC---------
Confidence 112345678999999998899999999999999999998 88886532211 01 1111111000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.........+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112357789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.86 Aligned_cols=244 Identities=21% Similarity=0.245 Sum_probs=197.9
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|...+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999986 48899999986432 234567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999853 345899999999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .+ ......... .
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~----~~~i~~~~~------~ 216 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GI----YEKILAGKL------E 216 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCc------C
Confidence 22356899999999999999999999999999999999999997543211 00 111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
+ +......+.+++.+||+.||.+||+ +.++++
T Consensus 217 ~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 217 F----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred C----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1 1111235678999999999999995 677663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.31 Aligned_cols=241 Identities=23% Similarity=0.292 Sum_probs=193.7
Q ss_pred CeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 293 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+.||+|+||.||+++.. +|+.+|+|.+.+.. ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 48899999986542 233456788999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 448 (606)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 99998853 346899999999999999999999998 999999999999999999999999998753221 1122
Q ss_pred cccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCC
Q 007361 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS 528 (606)
Q Consensus 449 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~ 528 (606)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+. ....... .. .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~----~~~~~~~------~~----~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----ELILMEE------IR----FP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHH----HHHHcCC------CC----CC
Confidence 3457999999999999999999999999999999999999997532111 010 0011010 01 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 529 LSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 529 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
......+.+++..||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11234577899999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.28 Aligned_cols=241 Identities=21% Similarity=0.252 Sum_probs=192.4
Q ss_pred ecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
||+|+||.||+++..+ ++.+|+|.+.+. .......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999865 788999998653 234456788999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccc
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 450 (606)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 999853 345899999999999999999999998 9999999999999999999999999998643221 12334
Q ss_pred cccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH
Q 007361 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530 (606)
Q Consensus 451 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 530 (606)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .. .......... . .+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~-~~~~~~~~~~------~----~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NE-MYRKILQEPL------R----FPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HH-HHHHHHcCCC------C----CCCc
Confidence 6789999999999999999999999999999999999999753211 11 1111111100 0 1111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 531 EVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 531 ~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
....+.+++..||+.+|++||++..+.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 224567889999999999998754444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=316.17 Aligned_cols=252 Identities=26% Similarity=0.354 Sum_probs=201.1
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc--------------cCHHHHHHHHHHHhhccCCCcceE
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--------------QGMEEFENEVLLIAKLQHRNLVKL 348 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l 348 (606)
...++|++.+.||+|.||.|-+++.. +++.||+|++.+... ...+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999965 488999999965421 124688999999999999999999
Q ss_pred EEEEeeC--CeeEEEEecCCCCCchhhhcccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC
Q 007361 349 IGCCTQR--DERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 425 (606)
Q Consensus 349 ~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~ 425 (606)
+.+..+. +..|||+||+..|.+...= ..+. ++..++++++.++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998765 5689999999998876532 3344 999999999999999999999999 9999999999999999
Q ss_pred CceEEeecCCccccCCC---cccccccccccccCccCccccccCC----CCccccchhHHHHHHHHHhccCCCCCCCCCC
Q 007361 426 MNPKISDFGMARAFGID---QTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498 (606)
Q Consensus 426 ~~~ki~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 498 (606)
|++||+|||.+..+... .........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-.
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~----- 321 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD----- 321 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-----
Confidence 99999999999876322 1112233478999999999998743 35689999999999999999999632
Q ss_pred ccchhHHHHHHhhhcCcchhcccccCCC----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 499 HHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
+...++.++.+... ...+.-..+.+|++.+|+.||+.|.+..+|..-.-
T Consensus 322 --------------~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 322 --------------DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred --------------chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 12223333333221 22234567789999999999999999999876553
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=319.42 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=202.1
Q ss_pred CCCcCCeecccCcccEEEEEEeC------CcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
+|.+.+.||+|+||.||+|+... ...+++|.+..... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998642 35688888765432 335678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 007361 361 IYEYLPNKSLNDFIFDVT---------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N 419 (606)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCC
Q 007361 420 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH 498 (606)
Q Consensus 420 Ill~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 498 (606)
||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222223445678999999998999999999999999999998 88887432211
Q ss_pred ccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+...... .....+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 237 ------~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 ------RLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ------HHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111111111 00111112234677999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=314.12 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=203.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.+|...++||+|+||.||+|...+ ++.+++|.+... ....+++.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 357778999999999999999865 788999988643 344678999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998542 2345899999999999999999999988 999999999999999999999999999876433221
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
. ......+..|+|||.+.+..++.++||||||+++|||++ |..|+.....+ ..+....... .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~---------~ 223 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGY---------R 223 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCC---------C
Confidence 1 112334668999999999999999999999999999998 88886532211 1111111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+......+.+++.+||+.+|++||++.+++++|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111111234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=320.09 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=197.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|...++||+|+||.||+|.... ++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 568888999999999999999764 7899999886543 23345778999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 88888743 2345789999999999999999999998 99999999999999999999999999976532221
Q ss_pred cccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH--------HHHHHhhhc-C
Q 007361 445 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWRLWIEE-R 514 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~-~ 514 (606)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||............. ..|...... .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1223467899999999875 568999999999999999999999986433221111000 001000000 0
Q ss_pred cchhcccccCCCCC----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSYS----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
......+....... ......+.+++.+|++.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000000 011235678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=318.34 Aligned_cols=272 Identities=27% Similarity=0.394 Sum_probs=200.8
Q ss_pred cCCCcCCeecccCcccEEEEEEe-----CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEee--CCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 359 (606)
++|.+.+.||+|+||.||++... .+..+|+|++........+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999853 478999999877666667789999999999999999999998754 34688
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 440 GIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 440 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..+...........+..............+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322211 111122345699999999999999999999999999999987664321110000000000000000000001
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+...............+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111000011111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=318.71 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=201.4
Q ss_pred CCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
+|.+.++||+|+||.||+|...+ ++.+|+|++...... ..+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 45667899999999999998753 478999998754432 34678899999999999999999999999999999
Q ss_pred EEecCCCCCchhhhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc
Q 007361 361 IYEYLPNKSLNDFIFDV-------------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 427 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 427 (606)
++||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 11245889999999999999999999988 999999999999999999
Q ss_pred eEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHH
Q 007361 428 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA 506 (606)
Q Consensus 428 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 506 (606)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...... .+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~---- 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV---- 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----
Confidence 99999999887643332222333456789999999998899999999999999999998 77775432111 11
Q ss_pred HHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 507 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
......... ...+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 236 ~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111111 01111233457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=317.76 Aligned_cols=260 Identities=23% Similarity=0.371 Sum_probs=206.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-----CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEee-CCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 357 (606)
..++|...+.||+|+||.||+|.+.+ +..+++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678888999999999999999876 6789999886543 3345678899999999999999999998876 567
Q ss_pred eEEEEecCCCCCchhhhcccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEee
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRS-----KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD 432 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~D 432 (606)
.++++||+++++|.+++...... ..+++..++.++.+++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653322 56899999999999999999999988 99999999999999999999999
Q ss_pred cCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhh
Q 007361 433 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 433 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+...... .+ .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EM----AAYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HH----HHHHH
Confidence 999987643333222223456778999999999999999999999999999999 99887543211 11 11111
Q ss_pred hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.... . .........+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 234 ~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 DGYR-------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred cCCC-------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1100 0 01111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=325.01 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=173.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|++.++||+|+||.||++.+.. +..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 3678899999999999999999864 7788888876542 2334678999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.. ...+++..+..++.+++.||.|||+.. .|+|+||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 345899999999999999999999853 3999999999999999999999999999765322
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12235689999999999999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.22 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=200.5
Q ss_pred CCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe-----
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE----- 357 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 357 (606)
|.+.+.||+|+||.||+|.+.. +..+|+|++.... ....+.+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999999754 3679999986532 2335678999999999999999999999876554
Q ss_pred -eEEEEecCCCCCchhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeec
Q 007361 358 -RMLIYEYLPNKSLNDFIFDVT---RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433 (606)
Q Consensus 358 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DF 433 (606)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999985432 2346899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhh
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIE 512 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 512 (606)
|+++................+..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..+.. ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~----~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYD----YLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHc
Confidence 99987644333222222345678999999998999999999999999999999 7788643221 11111 1111
Q ss_pred cCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 513 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+... ..+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 11112334678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=317.00 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=203.3
Q ss_pred cCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.+|...++||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677899999999999999743 255788998877666667789999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 361 IYEYLPNKSLNDFIFDVTR------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAI---- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHH----
Confidence 9999999976543322222223345778999999999999999999999999999998 88886432111 000
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
......... ..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000111000 0111122457799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.67 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=201.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
.+++|.+.+.||+|+||.||+|.+.+ +..+++|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999999864 4578888876443 3334678999999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---ceEE
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTR----SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKI 430 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~ki 430 (606)
.++|+||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999864321 235899999999999999999999998 99999999999998654 6999
Q ss_pred eecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHH
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..|+...... .+. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~----~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVM----EF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HH
Confidence 99999987633222221222334568999999999999999999999999999997 88887532211 111 11
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.... .....+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 011111222346788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=312.50 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=200.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
.+|++.+.||+|+||.||+|.+..+..+|+|.+.+.. ...+++.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999998777789999885432 345678899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998542 236899999999999999999999998 9999999999999999999999999998654322111
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ....... ...
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~---------~~~ 220 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EV----VESVSAG---------YRL 220 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HH----HHHHHcC---------CcC
Confidence 111234568999999999999999999999999999999 78887532211 11 1111111 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
..+......+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111123446889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.26 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=200.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC---------------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE---------------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIG 350 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~---------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g 350 (606)
++|.+.++||+|+||.||++...+ ...+|+|++.... ....+.|.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987643 2358999886542 334567999999999999999999999
Q ss_pred EEeeCCeeEEEEecCCCCCchhhhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 007361 351 CCTQRDERMLIYEYLPNKSLNDFIFDVT---------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 421 (606)
Q Consensus 351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIl 421 (606)
++...+..++||||+++++|.+++.... ....+++..++.++.+++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999985421 1124789999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhcc--CCCCCCCCCCc
Q 007361 422 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK--RNRGFYHADHH 499 (606)
Q Consensus 422 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~--~p~~~~~~~~~ 499 (606)
+++++.+||+|||++..+.............++..|+|||.+.+..++.++||||||++++||+++. .|+......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 9999999999999998654332222223344577899999999999999999999999999999854 444322111
Q ss_pred cchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 500 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 500 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.........+..... . .....+......+.+|+.+||+.+|++||+|.+|++.|+
T Consensus 240 -~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQGR-Q-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhccc-c-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111110000 0 000011112347889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.27 Aligned_cols=260 Identities=20% Similarity=0.331 Sum_probs=206.8
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.++||+|+||.||+|+.. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999976 48899999875432 233456889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999885422 3355889999999999999999999988 99999999999999999999999999887643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... ......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~-~~~~~~------- 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQ-KIEQCD------- 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHH-HHhcCC-------
Confidence 222 122346788999999999888999999999999999999999996432111 111110 000000
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
............+.+++.+||+.+|++||++.+|++.|++.+
T Consensus 225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 001111223356789999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=319.31 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=205.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD 356 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 356 (606)
..++|+..+.||+|+||.||++.... ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44678888999999999999998753 3578999886542 23445788999999999 7999999999999999
Q ss_pred eeEEEEecCCCCCchhhhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDV-------------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~ 423 (606)
..+++|||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998532 22456899999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccch
Q 007361 424 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL 502 (606)
Q Consensus 424 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 502 (606)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence 999999999999987654332222222345678999999999999999999999999999998 88886432211
Q ss_pred hHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 503 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 503 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.......... ....+......+.+|+.+|++.+|++|||+.++++.|+.+
T Consensus 242 --~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 --ELFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --HHHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 0111111110 0111122234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.80 Aligned_cols=241 Identities=23% Similarity=0.302 Sum_probs=193.7
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+.||+|+||.||++.... ++.+|+|.+.+.. ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999754 8899999987542 334567889999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 448 (606)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99988843 345899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred cccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCC
Q 007361 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS 528 (606)
Q Consensus 449 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~ 528 (606)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+ ....... +..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~----~~~~~~~------~~~~p~~-- 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL----FELILME------DIKFPRT-- 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HH----HHHhccC------CccCCCC--
Confidence 3357899999999999999999999999999999999999997532211 00 0000000 0011111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 529 LSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 529 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
....+.+++..||+.+|++|| ++.++++
T Consensus 218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 218 --LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred --CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 223567899999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.13 Aligned_cols=266 Identities=26% Similarity=0.388 Sum_probs=207.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe--------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEee
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ 354 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 354 (606)
..++|.+.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467888899999999999999742 24578999886542 34457789999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 421 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIl 421 (606)
....++||||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999986432 1235889999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCcc
Q 007361 422 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHH 500 (606)
Q Consensus 422 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 500 (606)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--- 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 246 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence 99999999999999987654333322333455678999999999999999999999999999998 66775432111
Q ss_pred chhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 007361 501 NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP 569 (606)
Q Consensus 501 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~~~p 569 (606)
........... ...+......+.+++..||+.+|++||++.+|++.|+.+..+..+
T Consensus 247 ----~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 247 ----ELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ----HHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 11111111110 001112234677899999999999999999999999876555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.80 Aligned_cols=265 Identities=28% Similarity=0.400 Sum_probs=204.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-----------------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcce
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-----------------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVK 347 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 347 (606)
..+|.+.++||+|+||.||++...+ +..+|+|.+.... ....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999998654 2457899887553 234568899999999999999999
Q ss_pred EEEEEeeCCeeEEEEecCCCCCchhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 007361 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVT--------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419 (606)
Q Consensus 348 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N 419 (606)
+++++...+..++++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986432 1236899999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh--ccCCCCCCCCC
Q 007361 420 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHAD 497 (606)
Q Consensus 420 Ill~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt--G~~p~~~~~~~ 497 (606)
|++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999987644333333334556789999999998899999999999999999998 4555432211
Q ss_pred CccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 498 HHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 498 ~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..........+......... ..+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111111110000 0111122468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.78 Aligned_cols=192 Identities=20% Similarity=0.270 Sum_probs=166.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..+|.+.++||+|+||.||++.... ++.||+|+.. ...+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3579999999999999999999765 7889999753 23468899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 95 688888743 345899999999999999999999998 9999999999999999999999999997543221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR 491 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~ 491 (606)
........||+.|+|||++.+..++.++||||||+++|||++|+.|+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 11223357999999999999999999999999999999999999875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=323.73 Aligned_cols=241 Identities=23% Similarity=0.293 Sum_probs=192.9
Q ss_pred CeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 293 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+.||+|+||.||+++.. +|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999975 48899999986542 234456788999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 448 (606)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99988843 345899999999999999999999998 9999999999999999999999999987532221 112
Q ss_pred cccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCC
Q 007361 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS 528 (606)
Q Consensus 449 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~ 528 (606)
....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .+ ........ ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~----~~~~~~~~------~~~p~~-- 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL----FELILMEE------IRFPRT-- 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHhcCC------CCCCCC--
Confidence 2357899999999999999999999999999999999999997532211 01 11111000 011111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 529 LSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 529 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
....+.+++..||+.+|++|| ++.++++
T Consensus 218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 224567899999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.33 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=197.6
Q ss_pred CCcCCeecccCcccEEEEEEeCCc---EEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------Ce
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIEGQ---EIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------DE 357 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~g~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 357 (606)
|.+.++||+|+||.||+|++.++. .+|+|.++.. .....+.+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 346689999999999999986543 5889987654 234467789999999999999999999987532 24
Q ss_pred eEEEEecCCCCCchhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 358 RMLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
.++++||+++|+|.+++... .....+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 12345899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .. .+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~----~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SE----IYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHHcC
Confidence 9987643322222222345678999999999999999999999999999999 7777653211 11 11111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.... ........+.+++.+||+.+|++|||+.++++.|+..
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1100 0111234578999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=309.22 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=201.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|.+.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888999999865433 4567999999999999999999999875 456899999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++... ....+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.++|+|||++..+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999998642 2345899999999999999999999998 9999999999999999999999999998764322211
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .... ..... ...
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~----~~~~~---------~~~ 222 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLE----QVERG---------YRM 222 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcC---------CCC
Confidence 112345668999999998899999999999999999999 78887432111 1111 11110 011
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.13 Aligned_cols=266 Identities=28% Similarity=0.404 Sum_probs=200.1
Q ss_pred CcCCeecccCcccEEEEEE-----eCCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEEE
Q 007361 290 SDKNKLGEGGFGPVYKGVL-----IEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLI 361 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 361 (606)
...+.||+|+||.||++.. .+++.+|+|.+..... .....|.+|+.++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7779999999999988653 3477899999865432 3456788999999999999999999998654 357899
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++.. ..+++..++.++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999843 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ..+..............++++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 22211 1122345667999999998899999999999999999999999864322110 000000000000001111111
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.......+......+.+++..||+.+|++||++++|+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111222335778899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=326.36 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=206.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC--CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.++|...+.||+|+||.||+|.+.. +..+|+|++.+. .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998654 358999988653 23345678899999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999853 345899999999999999999999998 9999999999999999999999999998753
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ...........
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~----- 245 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII----- 245 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC-----
Confidence 21 22357899999999999999999999999999999999999997532211 01111111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH--hcC-------CCCCCCCCCCCCcc
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM--LSG-------ERSLPQPKQPGFFT 576 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~~--L~~-------~~~~~~p~~p~~~~ 576 (606)
...... ...+.+++.+|++.+|++|+ ++.++++- +.+ ...+..|..|.+..
T Consensus 246 -~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 246 -YFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred -CCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 011111 23467899999999999995 88888753 222 13445566666543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.54 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=203.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccc-cCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRD 356 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 356 (606)
..++|.+.++||+|+||.||+|++. .+..||+|++..... ...+.+.+|+.++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778899999999999999863 246899999976533 23457889999999997 999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccC----------------------------------------------------------
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVT---------------------------------------------------------- 378 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 378 (606)
..++|+||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986421
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 007361 379 -------------------------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 421 (606)
Q Consensus 379 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIl 421 (606)
....+++..+..++.||+.||.|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124788889999999999999999987 999999999999
Q ss_pred EcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCcc
Q 007361 422 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHH 500 (606)
Q Consensus 422 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 500 (606)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--- 348 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--- 348 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence 99999999999999986543222222223456789999999999999999999999999999998 88886533211
Q ss_pred chhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 501 NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 501 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.........+. ....+......+.+++..||+.+|.+||++++|++.|+..
T Consensus 349 ---~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 ---EQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---HHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00111111110 0001111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.71 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=205.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.++|.+.+.||+|+||.||+|.... +..+|+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999999753 3689999986543 23345788999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 359 MLIYEYLPNKSLNDFIFDVT-------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
++|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986422 1234789999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHh
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~----~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---E----VLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---H----HHHHH
Confidence 9999987644332222333456789999999998899999999999999999998 88886432211 1 11111
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....... .+......+.+++..||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 111124567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.08 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=201.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|++.++||+|+||.||+|++.++..+|+|++.... ...+.+.+|+.++++++||||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999986533 34567899999999999999999999875 456799999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++... ....+++..+..++.++++||+|||+.+ ++|+||||+||++++++.+||+|||.+..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999999542 2345799999999999999999999988 999999999999999999999999999876433221
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......++..|+|||...+..++.++||||||+++|||++ |..|+...... .+. ...... ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~----~~~~~~---------~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERG---------YRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH----HHHhcC---------CCC
Confidence 1122346678999999999999999999999999999999 77776432211 111 110000 001
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.........+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1122334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.72 Aligned_cols=246 Identities=28% Similarity=0.413 Sum_probs=194.0
Q ss_pred eecccCcccEEEEEEe---CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 294 KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+||+|+||.||+|.+. ++..+|+|++.... ....+++.+|+.+++.++||||+++++++. .+..++|+||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999753 47889999886443 234567899999999999999999999885 45678999999999
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc-c
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA-N 447 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~-~ 447 (606)
+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||.||++++++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 345899999999999999999999988 9999999999999999999999999998764432211 1
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+...... .+.. ...... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~i~~~~---------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ----MIESGE---------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCC---------CCC
Confidence 112234578999999988889999999999999999998 89887543211 1111 111111 011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.+......+.+++.+||+.+|++||++.+|++.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111223467799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=295.41 Aligned_cols=264 Identities=23% Similarity=0.263 Sum_probs=210.3
Q ss_pred HhcCCCcCCeecccCcccEEEEEE-eCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-----ee
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ER 358 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 358 (606)
..++|.+.++||+|||+-||.++. .++..+|+|++.....+..+..++|++..++++||||++++++...+. +.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 346789999999999999999994 458899999998888788899999999999999999999998875443 48
Q ss_pred EEEEecCCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 359 MLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
|++++|...|||.+.+.... ++..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999987544 3448999999999999999999999987 479999999999999999999999999987
Q ss_pred ccCCCcccc-------cccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH
Q 007361 438 AFGIDQTEA-------NTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 438 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 507 (606)
.....-... ....-..|..|.|||.+. +...++++|||||||+||+|+.|..||+..-...
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------- 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------- 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence 643211100 011134688999999984 5568999999999999999999999987532211
Q ss_pred HHhhhcCcc-hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 508 RLWIEERPV-ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 508 ~~~~~~~~~-~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+... .+....+.-..+....+.+.+++.+|+|.||.+||++.+++..++.+
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1110 11111111112223556788999999999999999999999988764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=340.81 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=203.9
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC----
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD---- 356 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 356 (606)
...++|.+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+..+..++|+|++++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34578999999999999999999865 4899999998654 2344567889999999999999999988765432
Q ss_pred ----eeEEEEecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 357 ----ERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 357 ----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999998643 23456899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~~~~~~~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-------EVMHKTL 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHh
Confidence 999998765433333344567999999999999999999999999999999999999997532210 0111111
Q ss_pred hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
..... ..+......+.+++..||+.+|.+||++.+++..
T Consensus 259 ~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11110 0111223467789999999999999999999763
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.62 Aligned_cols=261 Identities=24% Similarity=0.411 Sum_probs=203.6
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
..++|++.++||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45788999999999999999997642 45799998864432 233568899999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 358 RMLIYEYLPNKSLNDFIFDVT-------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
.++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996422 1244678889999999999999999988 999999999999999999999
Q ss_pred eecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHH
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~~~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHH
Confidence 99999986543322222222345678999999999999999999999999999998 67776432111 00011
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
....... ..+......+.+++.+|++.+|++||++.++++.|....
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111000 011112357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.33 Aligned_cols=245 Identities=23% Similarity=0.394 Sum_probs=207.1
Q ss_pred hcCCCcCCeecccCcccEEEEEE-eCCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
..+|++.+.||+|.||.|-++.. ..|+.||||.+++. +++..-.+++|+++|..|+||||++++.+|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45677889999999999999986 56999999999775 455566788999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||..+|.|.+|+.+ +..|++.+..+++.||..|+.|+|.+. ++|||||.+|||||.|+++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999954 455999999999999999999999988 99999999999999999999999999988754
Q ss_pred CcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.. ...+.+|++.|.+||++.+.+| .+.+|-|||||+||.|+.|..||+..+.. .+ +.
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l----------------vr 263 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL----------------VR 263 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH----------------HH
Confidence 32 3445899999999999999998 57899999999999999999998754321 11 11
Q ss_pred cccCCCC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSY-SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..-.+.+ .++.+....-|+.|||-.||++|.|+.+|..
T Consensus 264 QIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 264 QISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 1112222 1223345667899999999999999999974
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.17 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=192.7
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|+..++||+|+||.||++++. +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45666789999999999999976 488999999865432 3356789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+.. ..++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999987543 2567788899999999999999998 99999999999999999999999999987643211
Q ss_pred cccccccccccCccCcccccc-----CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 445 EANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||..........+.. . .....
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~-~~~~~----- 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A-ICMSQ----- 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H-HhccC-----
Confidence 1233578999999998743 234568999999999999999999986322111000000 0 00000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
...........+.+++..||+.+|++||++.++++-
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111223467889999999999999999999863
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=321.90 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=194.3
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-----eeE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ERM 359 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 359 (606)
+|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677899999999999999976 48899999986432 233456889999999999999999999885432 479
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688888743 345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-cccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH--------HHHH
Q 007361 440 GIDQT-EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWR 508 (606)
Q Consensus 440 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~ 508 (606)
..... ........||..|+|||++.+ ..++.++||||||+++|||++|+.|+...........+. ....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 112234578999999999876 678999999999999999999999985432211000000 0000
Q ss_pred HhhhcCcchhcccccCCC-CCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 509 LWIEERPVELINKSLGGS-YSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~-~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+........+....... ... .....+.+++..||+.+|++||++.++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000011111000000 000 11235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.91 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=202.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-Cc----EEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
.++|+..++||+|+||.||+|++.. ++ .||+|.+.... ....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 3567888999999999999998643 44 47899886543 3345678899999999999999999999975 4578
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+++||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998542 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
.............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .+.. .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~--- 229 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPD----LLEKGER--- 229 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCc---
Confidence 53332222222345678999999999999999999999999999998 88886532211 0110 0111100
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 567 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~~ 567 (606)
..........+.+++..||+.+|++||++.++++.|+.....+
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 ------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0111122346778999999999999999999999997664444
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.31 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=203.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 357 (606)
.++|...+.||+|+||.||++... .+..+|+|.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888999999999999999752 24579999887553 23346789999999999 79999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++|+||+++++|.+++... ....+++.++..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998542 2344899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~--- 260 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEG--- 260 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcC---
Confidence 7643322222223456778999999999999999999999999999998 888864322110 000111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.....+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0000111123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=337.97 Aligned_cols=259 Identities=24% Similarity=0.302 Sum_probs=210.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCC-cEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEE-Eee------C
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEG-QEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGC-CTQ------R 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~ 355 (606)
...++++.+.|.+|||+.||.+....+ ..+|+|++...++...+.+.+|+.+|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345667889999999999999998876 999999998888889999999999999997 9999999993 221 2
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
-+.+|+||||++|+|-+++......+ |++.++++|+.++++|+++||... ++|||||||-+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 36899999999999999996544444 999999999999999999999986 6899999999999999999999999999
Q ss_pred ccccCCCc-ccccc------cccccccCccCcccc---ccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHH
Q 007361 436 ARAFGIDQ-TEANT------NRVVGTYGYMPPEYA---IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 505 (606)
Q Consensus 436 a~~~~~~~-~~~~~------~~~~gt~~y~aPE~~---~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 505 (606)
|.-.-... ..... -...-|+.|.|||.+ .+.++++|+|||+|||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 86532221 11000 012358899999987 57889999999999999999999999986431
Q ss_pred HHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 506 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 506 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
...+++....-.....+..++..||..||+.||.+||++.+|+..+-.+.
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 11222222222223466778999999999999999999999999886653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=314.50 Aligned_cols=263 Identities=23% Similarity=0.317 Sum_probs=196.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.++||+|+||.||+|+.. +++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999986 488999999865432 334567889999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777743 2345889999999999999999999998 9999999999999999999999999997643222
Q ss_pred ccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC---cc---
Q 007361 444 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER---PV--- 516 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~--- 516 (606)
. ......+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ............... ..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchh
Confidence 1 1223567899999999875 45889999999999999999999998643211 000111000000000 00
Q ss_pred h--hccc-cc--CCCCCHH-------HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 E--LINK-SL--GGSYSLS-------EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~--l~d~-~l--~~~~~~~-------~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ..++ .. ....... ....+.+++..|++.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 0000 00 0000000 1135678999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=314.91 Aligned_cols=261 Identities=24% Similarity=0.366 Sum_probs=192.7
Q ss_pred cCCCcCCeecccCcccEEEEEEe--CCcEEEEEEccccc--ccCHHHHHHHHHHHhhc---cCCCcceEEEEEe-----e
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKL---QHRNLVKLIGCCT-----Q 354 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~ 354 (606)
++|.+.+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.++..+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999873 36789999886542 22334566777777766 6999999999985 2
Q ss_pred CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
....++|+||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999996 5898888543 2345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh---
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI--- 511 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 511 (606)
+++..... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..+........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCC
Confidence 99875432 2233457899999999999999999999999999999999999997643221 11111110000
Q ss_pred -hcCcch--hccccc--CCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 -EERPVE--LINKSL--GGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 -~~~~~~--l~d~~l--~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...... +....+ ...... .....+.+++.+|++.+|++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 000000 000011 11235678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.29 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=207.8
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|+..+.||+|+||.||+|... +|+.+|+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 6899999988642 2233568899999999999999999999999999999999
Q ss_pred ecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
||+++++|.+++... .....+++..+..++.++++||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 23455899999999999999999999988 99999999999999999999999999886543
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+... ........
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~------- 224 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKCD------- 224 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcCC-------
Confidence 2211 2234678899999999999999999999999999999999999643221 11110 00001100
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
............+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000111123346778999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=307.56 Aligned_cols=254 Identities=30% Similarity=0.426 Sum_probs=202.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|.+.++||+|+||.||+|...+++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35688889999999999999998889999999986543 34578999999999999999999999864 46789999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988543 2346899999999999999999999988 999999999999999999999999999876422211
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||.+....++.++||||||++++||++ |+.|+..... ..+. ........
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~--------- 221 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVI----QNLERGYR--------- 221 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHH----HHHHcCCC---------
Confidence 1122345678999999999999999999999999999999 8988753221 1111 11111100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..........+.+++.+|++.+|++||++.+++..|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111123468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.01 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=202.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.++|+..+.||+|+||.||++... .+..+|+|.+.... .....++.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999864 36789999886543 33456799999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 007361 359 MLIYEYLPNKSLNDFIFDVT-------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N 419 (606)
++|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234789999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCC
Q 007361 420 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH 498 (606)
Q Consensus 420 Ill~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 498 (606)
|++++++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999886543322222222344668999999999999999999999999999997 77775322111
Q ss_pred ccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
. ........... ..+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 240 --~----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --E----VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --H----HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 11111111110 0111223567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=316.61 Aligned_cols=259 Identities=28% Similarity=0.423 Sum_probs=200.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-Cc--EEEEEEcccc-cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQ--EIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 361 (606)
++|++.+.||+|+||.||+|.+.+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999999865 32 4688887643 333456789999999999 799999999999999999999
Q ss_pred EecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 362 YEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||++...... ........+..|+|||.+.+..++.++||||||+++|||++ |..|+...... .+ .
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~----~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---EL----Y 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----H
Confidence 99999998643211 11111223557999999999999999999999999999997 98887533211 11 1
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 567 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~~ 567 (606)
...... .....+......+.+++..||+.+|.+||++.++++.|+......
T Consensus 229 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EKLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111110 000111112246778999999999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=312.92 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=200.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-----------------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-----------------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKL 348 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 348 (606)
++|++.++||+|+||.||++...+ +..+|+|++.... ....++|.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 568889999999999999986432 3468899886543 3345689999999999999999999
Q ss_pred EEEEeeCCeeEEEEecCCCCCchhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 007361 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVT--------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 420 (606)
Q Consensus 349 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI 420 (606)
++++...+..++|+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999986422 1235788999999999999999999998 99999999999
Q ss_pred EEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh--ccCCCCCCCCCC
Q 007361 421 LLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADH 498 (606)
Q Consensus 421 ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt--G~~p~~~~~~~~ 498 (606)
+++.++.++|+|||+++.+.............++..|+|||...++.++.++||||||+++|||++ |..|+......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999987643322222223344678999999988899999999999999999998 55665432211
Q ss_pred ccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.........+... ..... . ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 241 --~~~~~~~~~~~~~-~~~~~---~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 --QVIENTGEFFRDQ-GRQVY---L--PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred --HHHHHHHHHHhhc-ccccc---C--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111100 00000 0 001112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.70 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=190.7
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+++... ++.+|+|.+.+. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 788999998754 223345677898888877 899999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999988743 345899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCC--ccchhHHHHHHhhhcCcchhcccccCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH--HHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+....... ......+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~--- 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R--- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C---
Confidence 234678999999999999999999999999999999999999986432211 11111122221111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
.+......+.+++..||+.+|++||+.
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111223456789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=315.75 Aligned_cols=240 Identities=27% Similarity=0.343 Sum_probs=188.7
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+|+..+ ++.||+|.+.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 7789999986542 23345556677777654 899999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999998853 345899999999999999999999988 9999999999999999999999999998643222 22
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||..|+|||.+.+..++.++||||||+++|||++|+.|+...... .+ ........ +. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~~------~~----~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---EL----FDSILNDR------PH----F 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCC------CC----C
Confidence 33467899999999999999999999999999999999999997643211 01 11111100 01 1
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMS-SVV 557 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~vl 557 (606)
+......+.+++..||+.+|++||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111223567889999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=327.19 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=201.9
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999986 48899999986542 244567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999988 999999999999999999999999999876433
Q ss_pred c---------------------------ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCC
Q 007361 443 Q---------------------------TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 495 (606)
Q Consensus 443 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 495 (606)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.|+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0112233578999999999999999999999999999999999999976432
Q ss_pred CCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 007361 496 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-MSSVVLM 559 (606)
Q Consensus 496 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~vl~~ 559 (606)
.. ..+...... ...+ .+.... .....+.+++..|++ +|.+||+ +.++++-
T Consensus 235 ~~-------~~~~~i~~~-~~~~---~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ-------ETYNKIINW-KESL---RFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-------HHHHHHhcc-CCcc---cCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 011111110 0000 000000 023456788889997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.77 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=194.2
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+++... ++.+|+|.+.+.. ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999864 7899999997542 23445688899999998 799999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999988843 345899999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCC--ccchhHHHHHHhhhcCcchhcccccCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH--HHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....||..|+|||++.+..++.++||||||+++|||++|+.|++...... ......+.......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 234678999999999999999999999999999999999999986432221 11111111221111111 1111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCC------HHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPN------MSSVV 557 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs------~~~vl 557 (606)
.. ...+.+++..||+.+|.+||+ +.+++
T Consensus 227 ~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 227 SL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 12 235678999999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.70 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=198.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.+.||+|+||.||+++... ++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468888999999999999999764 8899999987542 234567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998542 245899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccCccccc------cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAI------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.|+....... ........ .
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~--~ 225 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNF--Q 225 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcC--C
Confidence 222 222346899999999986 4567899999999999999999999975332110 01111110 0
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+. ... .......+.+++..|++ +|++||++.++++
T Consensus 226 ~~~~--~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 RFLK--FPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CccC--CCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0000 000 11122356678888998 9999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=310.22 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=202.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-C---cEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.++|+..+.||+|+||.||+|++.. + ..+++|++.... ....+++.+|+.++.+++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567788999999999999999864 3 268999886543 3345678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999854 2345899999999999999999999998 9999999999999999999999999998664
Q ss_pred CCccccc-ccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 441 IDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 441 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
....... ......+..|+|||++.+..++.++||||||+++|||++ |+.|+...... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~~~----- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDG----- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhcC-----
Confidence 3222111 111223557999999998899999999999999999997 99997432211 011111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
............+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011112235678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=327.37 Aligned_cols=252 Identities=20% Similarity=0.299 Sum_probs=193.4
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.|...+.||+|+||+||+|+... ++.+|+|++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999999998755 7899999986542 2345678999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 345889999999999999999999988 9999999999999999999999999986442110
Q ss_pred cc---------------------------------------------ccccccccccCccCccccccCCCCccccchhHH
Q 007361 444 TE---------------------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG 478 (606)
Q Consensus 444 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~G 478 (606)
.. .......||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001235799999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhh--cccCCCCCCCCHHHH
Q 007361 479 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLL--CVQQRPEDRPNMSSV 556 (606)
Q Consensus 479 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPs~~~v 556 (606)
|++|||++|+.||....... .. ........ .+ ...... .....+.+++.+ |+..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~---~~----~~i~~~~~-~~---~~~~~~--~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE---TQ----LKVINWEN-TL---HIPPQV--KLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH---HH----HHHHcccc-cc---CCCCCC--CCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999986432110 00 00000000 00 000000 111234455554 667777779999999
Q ss_pred HH
Q 007361 557 VL 558 (606)
Q Consensus 557 l~ 558 (606)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.59 Aligned_cols=243 Identities=22% Similarity=0.294 Sum_probs=192.7
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||++.... ++.+|+|.+.+.. ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 7889999997542 23455688999999888 699999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|..++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999988743 345899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........................ .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~-- 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPR-- 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCC--
Confidence 23467899999999999999999999999999999999999998654333222222222222211110 0111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
.....+.+++..||+.||++||++
T Consensus 225 --~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 --FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCC
Confidence 112456789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=308.49 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=205.4
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.+.||+|+||.||++... +++.+++|.+.... .....++.+|+.+++.++|+||+++++++.+.+..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778899999999999999964 68899999876532 233467889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
||+++++|.+++... .....+++..++.++.+|++||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988542 23456899999999999999999999998 99999999999999999999999999887643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.....+ .... ..... ....+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~-----~~~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIE-----QCDYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHH-hhhhh-----cCCCC
Confidence 3221 22346888999999999999999999999999999999999997432111 0000 00000 00000
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.. ........+.+++.+||+.+|++||||.+|+++++..
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 01 1112334677899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.01 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=210.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe-eEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE-RMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 362 (606)
++|...+++|+|+||.++..+++. ++.+++|++.-. .....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 567888999999999999998765 778999988543 34445578899999999999999999999999988 99999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
+|++||+|.+.+... +...++++++..++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+.++.+
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999653 3677999999999999999999999877 999999999999999999999999999998765
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.. ....++||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+ ...++.+.
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-------------------m~~Li~ki 218 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-------------------MSELILKI 218 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-------------------hHHHHHHH
Confidence 42 3345899999999999999999999999999999999999999875432 22222222
Q ss_pred cC---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 523 LG---GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 523 l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.. ...+..+...+..++..|++.+|..||++.+++.+
T Consensus 219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 21 22334455678889999999999999999999865
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=307.76 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=192.4
Q ss_pred CeecccCcccEEEEEEeC---CcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+.||+|+||.||+|...+ +..+++|++..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998754 35789998865432 33457889999999999999999999999999999999999999
Q ss_pred CchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 369 SLNDFIFDVT--RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 369 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|.+++.... .....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2335678888899999999999999988 9999999999999999999999999997654332222
Q ss_pred cccccccccCccCccccccC-------CCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 447 NTNRVVGTYGYMPPEYAIDG-------LFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+....... .... .........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY----TVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----HhhcccCCC
Confidence 22335578899999998642 35789999999999999996 998875432211 1111 011111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.++.+... ....+.+++..|+ .+|++|||+.+|+..|+
T Consensus 231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11221111 1234567888898 58999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=305.56 Aligned_cols=250 Identities=27% Similarity=0.348 Sum_probs=202.8
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|+..+.||+|+||.||++.... ++.+++|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 46777999999999999999864 789999988643 334567889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2456899999999999999999999987 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
. .....++..|+|||++.+..++.++||||||+++|||++|+.|+..... ... .........
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~----~~~~~~~~~--------- 218 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GAL----ILKIIRGVF--------- 218 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHHcCCC---------
Confidence 1 2335678899999999999999999999999999999999999754321 111 111111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111233567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.21 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=192.3
Q ss_pred CeecccCcccEEEEEEe----CCcEEEEEEccccc----ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 293 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++||+|+||.||+++.. .++.+|+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 47889999986532 23345678899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999998843 345788899999999999999999998 9999999999999999999999999987542221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... . .......... .+.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~-~~~~~~~~~~------~~~ 220 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------K-TIDKILKGKL------NLP 220 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCC------CCC
Confidence 1223357899999999999999999999999999999999999997543211 0 0111111100 011
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
. .....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 P----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 1224567899999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.15 Aligned_cols=251 Identities=26% Similarity=0.332 Sum_probs=198.8
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677899999999999999975 48899999986532 2233557889999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888542 2345899999999999999999999998 9999999999999999999999999998753222
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. .....|+..|+|||++.+..++.++||||+|+++|||++|+.|+....... ........ +.. .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~---------~~~-~ 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERR---------VKE-D 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHH---------hhh-c
Confidence 1 123478999999999999999999999999999999999999986432211 00000000 000 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
....+......+.+|+..||+.||++|| ++.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0111222334677899999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=308.24 Aligned_cols=267 Identities=23% Similarity=0.320 Sum_probs=202.4
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhh--ccCCCcceEEEEEeeCC----e
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQRD----E 357 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~ 357 (606)
....+....+.||+|.||.||+|.+ .|..||||++...++. .+.+|.++.+. |+|+||+.+++.-..+. .
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3456777889999999999999998 7999999999765543 45666666655 59999999998864433 5
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeccCCCCCEEEcCCCceEEee
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-----DSRLRIIHRDLKASNVLLDNEMNPKISD 432 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiH~Dlk~~NIll~~~~~~ki~D 432 (606)
++||.+|.++|||.|||. +..++....++++..+|.||++||- ++++.|.|||||+.|||+..++.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 899999999999999993 4669999999999999999999994 4889999999999999999999999999
Q ss_pred cCCccccCCC--cccccccccccccCccCccccccCC----C-C-ccccchhHHHHHHHHHhcc----------CCCCCC
Q 007361 433 FGMARAFGID--QTEANTNRVVGTYGYMPPEYAIDGL----F-S-VKSDVFSFGVLVLEIVCGK----------RNRGFY 494 (606)
Q Consensus 433 FGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-s-~k~DV~S~Gvvl~elltG~----------~p~~~~ 494 (606)
+|||...... ......+..+||.+|||||++...- + + ..+||||||+|+||+...- .||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999876543 2334556689999999999986542 2 2 2599999999999997522 222111
Q ss_pred -CCCCccchhHHHHHHhhhcCcchhcccccCC-CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 495 -HADHHHNLLGHAWRLWIEERPVELINKSLGG-SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 495 -~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
+.|+.. ..+.+---.+-+.+.+.. ..+.+.+..+.+++..||..||.-|-|+-.+-+.|..+..
T Consensus 440 Vp~DPs~-------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSF-------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCH-------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 111110 011111111222222222 2345777889999999999999999999999998876654
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=304.64 Aligned_cols=247 Identities=28% Similarity=0.374 Sum_probs=197.1
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCch
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLN 371 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 371 (606)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999876543 23457889999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccccccc
Q 007361 372 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451 (606)
Q Consensus 372 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 451 (606)
+++... ...+++..++.++.+++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988532 345899999999999999999999988 999999999999999999999999998754322111 11122
Q ss_pred ccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH
Q 007361 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530 (606)
Q Consensus 452 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 530 (606)
.++..|+|||++.+..++.++||||||+++|||++ |..|+...... . ......... ....+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~----~~~~~~~~~---------~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---Q----AREQVEKGY---------RMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---H----HHHHHHcCC---------CCCCCCC
Confidence 34668999999998899999999999999999998 88887532211 0 111111110 0111112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 531 EVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 531 ~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
....+.+++.+|++.+|++||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2356788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.39 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=202.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC--------CcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR 355 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 355 (606)
.++|.+.+.||+|+||.||+++... +..+|+|.+.... .....++.+|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578899999999999999998632 3469999987542 33456788999999999 799999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
+..++|+||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999964321 235899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 501 (606)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 9999999999999986643222222222334568999999999999999999999999999998 77776432111
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
........... ...+......+.+++..|++.+|++||+|.+|++.|+.+
T Consensus 250 ---~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 250 ---ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ---HHHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 01111111100 011112234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=310.71 Aligned_cols=246 Identities=28% Similarity=0.380 Sum_probs=193.8
Q ss_pred ecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 295 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
||+|+||+||++... +++.+|+|++.... ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999976 47899999986542 22345678899999999999999999999999999999999999999
Q ss_pred hhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccccc
Q 007361 371 NDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449 (606)
Q Consensus 371 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 449 (606)
..++... .....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9887542 23456899999999999999999999998 99999999999999999999999999986643322 123
Q ss_pred ccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCH
Q 007361 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL 529 (606)
Q Consensus 450 ~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 529 (606)
...||+.|+|||.+.+..++.++||||||+++|||++|+.|+......... ...... ...... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~--------~~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQR--------ILNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHh--------hcccCC--CCcc
Confidence 357899999999999999999999999999999999999997643221100 000000 000000 1111
Q ss_pred HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 530 SEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 530 ~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
.....+.+++..||+.+|++|| ++.++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2334677899999999999999 5666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=319.20 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=195.9
Q ss_pred CCCcCCeecccCcccEEEEEEe----CCcEEEEEEccccc----ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
+|++.++||+|+||.||+++.. .++.+|+|.+.+.. ....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999863 47899999986532 23345688899999999 599999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999853 345899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
+...... ......||..|+|||++.+. .++.++||||||+++|||++|+.|+......... ..........
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~---- 226 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC---- 226 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC----
Confidence 5332221 22335799999999999875 4789999999999999999999998643221111 1111111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
++.+.. .....+.+++.+||+.+|++|| ++.++++
T Consensus 227 --~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 --DPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111 1223567889999999999999 6666664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=307.48 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=200.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|++.++||+|+||.||+|+.. +++.+|+|++..........+.+|+.++.+++||||+++++.+...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357889999999999999999975 4788999998765555566788999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998853 345899999999999999999999988 99999999999999999999999999987642221
Q ss_pred cccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 445 EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
......++..|+|||.+. ...++.++||||||+++|||++|+.|+........... .... ....+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~---~~~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKS---NFQPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecC---CCCCC
Confidence 122356888999999884 44578899999999999999999998643221100000 0000 00000
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
.... .......+.+++..||+.+|++||++.++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0100 111234678999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=290.03 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=206.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
+.++|++++.||+|-||.||.|+.+. +-.||+|++.+. ..+...++.+|+++-..|+||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 45789999999999999999999766 668899998765 33456789999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
++||.++|+|...|.. .+.+.+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++..||+|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999964 34556889999999999999999999998 9999999999999999999999999987532
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.......+||..|.+||...+..++.++|+|++|++.||++.|..||+....+ ..... ... ++
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkr----I~k------~~ 238 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKR----IRK------VD 238 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHH----HHH------cc
Confidence 33345589999999999999999999999999999999999999998643311 11111 111 11
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
-.... .-...+.+++..|+..+|.+|.+..+|+.
T Consensus 239 ~~~p~----~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 239 LKFPS----TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ccCCc----ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11111 12235678999999999999999999874
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=316.40 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=191.3
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHH---hhccCCCcceEEEEEeeCCeeEEE
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLI---AKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
|.+.+.||+|+||.||++.... ++.+|+|.+.+.. ....+.+..|+.++ ..++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5567899999999999999764 8899999986542 23345667776655 456799999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998873 345899999999999999999999998 99999999999999999999999999875322
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ........
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~----~~i~~~~~------ 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVF----DSIVNDEV------ 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC------
Confidence 11 1223467899999999999999999999999999999999999997533211 010 11111100
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
.... .....+.+++.+||+.+|.+||+ +.++++
T Consensus 219 ~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0111 12245678999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.01 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=197.6
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|...++||+|+||.||+|+.. .++.+|+|.+... ......++.+|+.++.+++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35777899999999999999874 4788999988654 233456789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997653 3688889999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.......................... +.
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 221 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----LP 221 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----CC
Confidence 12235789999999999999999999999999999999999999864332211111101111111111100 10
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.......+.+++.+|++.+|++||++.++++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 ---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11122357789999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=318.06 Aligned_cols=259 Identities=26% Similarity=0.388 Sum_probs=202.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC--------CcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD 356 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 356 (606)
.+|.+.+.||+|+||.||++.... ...+|+|.+.... ....+++.+|+.++.++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 467888999999999999998532 2368899876543 33457899999999999 7999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~ 423 (606)
..++++||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986421 1235889999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccch
Q 007361 424 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL 502 (606)
Q Consensus 424 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l 502 (606)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 999999999999987643322222222344568999999999999999999999999999998 77776432111
Q ss_pred hHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 503 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 503 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
........... ...+......+.+++..||+.+|++||++.++++.|+...
T Consensus 244 --~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 --ELFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred --HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11111111110 0111122346778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.06 Aligned_cols=250 Identities=33% Similarity=0.478 Sum_probs=203.0
Q ss_pred CeecccCcccEEEEEEeC----CcEEEEEEcccccccC-HHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||++.... +..+++|.+....... .+.+.+|+.++..++|+||+++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999865 7789999987654433 67899999999999999999999999999999999999999
Q ss_pred CCchhhhcccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 368 KSLNDFIFDVTR------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 368 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965421 366999999999999999999999988 99999999999999999999999999988754
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
...........++..|+|||.+....++.++||||+|++++||++ |..|+...... .+ .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EV----LEYLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC-----
Confidence 432223334567889999999998899999999999999999999 58887543211 11 111111100
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
...+......+.+++.+||+.+|++||++.++++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111122357789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.59 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=200.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|.+.++||+|+||.||++.+..+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577889999999999999998777789999885433 34567899999999999999999999875 456899999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999999642 2345899999999999999999999988 999999999999999999999999999876432221
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . .......... .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~----~~~~~~~~~~---------~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---E----VLEQVERGYR---------M 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCC---------C
Confidence 1122345678999999998999999999999999999999 88886532211 1 1111111100 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+......+.+++.+||+.+|++||++.+|+++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111233567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=315.84 Aligned_cols=241 Identities=27% Similarity=0.336 Sum_probs=192.7
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||++.... ++.+|+|.+.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 7899999987542 33456677888998888 799999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999988853 335899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||..|+|||++.+..++.++|||||||++|||++|+.|+...... . .......... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~----~~~~i~~~~~------~~---- 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---E----LFQSILEDEV------RY---- 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---H----HHHHHHcCCC------CC----
Confidence 23356899999999999999999999999999999999999997533211 0 1111111100 01
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNM-----SSVVL 558 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~vl~ 558 (606)
+......+.+++.+||+.+|++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11122456789999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=305.91 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=203.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|+..+.||.|+||.||++.. .|+.+|+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35778889999999999999987 488999999976544 5678999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999985432 236899999999999999999999998 99999999999999999999999999987632221
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
....+..|+|||.+....++.++||||||+++|||++ |..|+...... .+ ........ .
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~---------~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV----VPHVEKGY---------R 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhcCC---------C
Confidence 2334668999999998899999999999999999997 88886432211 11 11111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
...+......+.+++.+|++.+|++||++.+++++|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01111223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=304.87 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=199.0
Q ss_pred CeecccCcccEEEEEEeC--C--cEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE--G--QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
++||+|++|.||+|.+.. + ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999754 2 3689999977655 566789999999999999999999999988 889999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc-c
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-A 446 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~-~ 446 (606)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865332 56899999999999999999999998 999999999999999999999999999877543221 1
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..... ... .... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~-~~~~-------~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKK----IDK-EGER-------L 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHh-cCCc-------C
Confidence 1223456789999999999999999999999999999999 99987432211 11110 000 0000 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011122356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.74 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=191.7
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+|+... ++.+|+|.+.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999865 7899999986542 33445677888888876 799999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 999988853 345899999999999999999999998 99999999999999999999999999875432211 2
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+...... .+. ........ .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~----~~i~~~~~------~~p~~- 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLF----ESILHDDV------LYPVW- 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCC------CCCCC-
Confidence 23357899999999999999999999999999999999999998643211 111 11111100 00111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-------CHHHHHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRP-------NMSSVVL 558 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RP-------s~~~vl~ 558 (606)
....+.+++..||+.+|++|| ++.++++
T Consensus 219 ---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 ---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 123567889999999999999 7777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=322.46 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=174.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|+..+.||+|+||+||++.... ++.+|+|.+.+.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999998765 7899999986542 233457888999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 346899999999999999999999998 999999999999999999999999998765321
Q ss_pred ccc---------------------------------ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccC
Q 007361 443 QTE---------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 489 (606)
Q Consensus 443 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~ 489 (606)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 007361 490 NRGF 493 (606)
Q Consensus 490 p~~~ 493 (606)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.59 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=196.4
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|+..+.||+|+||.||+++... ++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 468889999999999999999864 8899999986532 234456889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 345899999999999999999999998 999999999999999999999999998765321
Q ss_pred cccc------------------------------------cccccccccCccCccccccCCCCccccchhHHHHHHHHHh
Q 007361 443 QTEA------------------------------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC 486 (606)
Q Consensus 443 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt 486 (606)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 0112468999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 007361 487 GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN---MSSVVL 558 (606)
Q Consensus 487 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~~vl~ 558 (606)
|..||...... ... ....... ..+ ...... .....+.+++..|+. +|.+|++ +.++++
T Consensus 235 G~~Pf~~~~~~---~~~----~~i~~~~-~~~---~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQ---ETY----RKIINWK-ETL---QFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHH---HHH----HHHHcCC-Ccc---CCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99998543211 000 0010000 000 000100 112345577778886 8999998 888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.44 Aligned_cols=249 Identities=29% Similarity=0.377 Sum_probs=198.2
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCch
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLN 371 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 371 (606)
++||+|+||.||++...+++.+++|++...... ..+.+.+|+.++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765433 5568999999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccccccc
Q 007361 372 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451 (606)
Q Consensus 372 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 451 (606)
+++... ...+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998542 235789999999999999999999998 999999999999999999999999999865422221111223
Q ss_pred ccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH
Q 007361 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530 (606)
Q Consensus 452 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 530 (606)
..+..|+|||.+.+..++.++||||||++++||++ |..|+....... ....... ......+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~---------~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIES---------GYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhc---------CCCCCCCcc
Confidence 34667999999998899999999999999999999 777764332110 0000000 000011112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 531 EVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 531 ~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....+.+++.+|++.+|++||++.+|++.|+.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 23467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=310.50 Aligned_cols=271 Identities=29% Similarity=0.393 Sum_probs=204.0
Q ss_pred cCCCcCCeecccCcccEEEEEEe-----CCcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEee--CCee
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDER 358 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 358 (606)
+.|...+.||+|+||.||++++. .+..+|+|.+...... ..+.|.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667799999999999999864 2678999998765443 46789999999999999999999999877 5678
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999542 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 439 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 439 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+..........+.. ...........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHH
Confidence 6532221 11112344567999999998899999999999999999999998864322111000000 000000000001
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.+........+......+.+|+.+||+.+|++||+|.+|+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.40 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=193.2
Q ss_pred eecccCcccEEEEEEe---CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 294 KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
.||+|+||.||+|.+. .+..+|+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 245789998865533 33467999999999999999999999885 457899999999999
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc-c
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-T 448 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~-~ 448 (606)
|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+........ .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999853 2346899999999999999999999988 99999999999999999999999999986543322111 1
Q ss_pred cccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 449 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .......... ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~---------~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGK---------RLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCC---------CCCC
Confidence 11233578999999998889999999999999999996 99886532211 0111111111 1111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
+......+.+++..||+.+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 22234567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=320.18 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=199.8
Q ss_pred hcCCCcCCeecccCcccEEEEEE------eCCcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC-C
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVL------IEGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR-D 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 356 (606)
.++|.+.+.||+|+||.||+|.. ..++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999974 246789999996543 23346788999999999 689999999988654 4
Q ss_pred eeEEEEecCCCCCchhhhcccCC---------------------------------------------------------
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTR--------------------------------------------------------- 379 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 379 (606)
..++|+||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999998853210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccc
Q 007361 380 -------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452 (606)
Q Consensus 380 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~ 452 (606)
...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788899999999999999999988 9999999999999999999999999998754332222222344
Q ss_pred cccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHH
Q 007361 453 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSE 531 (606)
Q Consensus 453 gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~ 531 (606)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .+ ......+.... .... .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~~~-----~~~~----~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTRMR-----APDY----T 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH----HHHHhccCCCC-----CCCC----C
Confidence 5678999999999999999999999999999997 888865322110 01 11111111000 0011 1
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 532 VLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 532 ~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+.+++..||+.+|++||++.+|++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 23578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.34 Aligned_cols=252 Identities=28% Similarity=0.415 Sum_probs=208.9
Q ss_pred CCcCCeecccCcccEEEEEEeC-C----cEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-G----QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
+...++||+|+||+||||.+.- | -+||+|.+... ..+..+++.+|+.+|.+++||||+||+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3445899999999999999743 3 36888888654 4456789999999999999999999999998766 88999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
+||+.|+|.+|++. .+..+.-+..+.+..|||+||.|||.+. ++||||.++||||.....+||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999975 4455888999999999999999999987 999999999999999999999999999998766
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
...-......-.+.|||-|.+....|+.++|||||||.+|||+| |.+|++....++-. +++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~----------------dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP----------------DLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh----------------HHHhc
Confidence 65555554555778999999999999999999999999999997 88886554433222 22222
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
-.+-..++-...++..++.+||..|+..||+++++...+..
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 22223444556688899999999999999999999987754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.17 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=192.2
Q ss_pred CeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 293 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+.||+|+||.||++... .++.+|+|.+.+.. ......+..|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 48899999986542 233456788999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99988843 3458999999999999999999997 56 9999999999999999999999999987542221 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+.....+ .+. ....... ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~----~~i~~~~------~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----ELILMEE------IRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHH----HHHhcCC------CCCCCCC
Confidence 22357899999999999999999999999999999999999997532211 000 0000000 0111112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
...+.+++.+||+.||++|+ ++.++++
T Consensus 220 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 ----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23567889999999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.91 Aligned_cols=256 Identities=30% Similarity=0.448 Sum_probs=205.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..++|.+.++||+|+||.||++...+++.+|+|.+.... ...+++.+|+.++++++|+||+++++++......++|+||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998888899999986543 4467899999999999999999999999998999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999653 2345899999999999999999999998 99999999999999999999999999987643211
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. .......+..|+|||.+.+..++.++||||||++++||++ |+.|+...... ..... .... .
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~----~~~~---------~ 221 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQ----VERG---------Y 221 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcC---------C
Confidence 1 1112234568999999999999999999999999999999 88887432111 11111 1110 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000111113467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=308.93 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=200.0
Q ss_pred CCCcCCeecccCcccEEEEEEeC-C---cEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.|.+.+.||+|+||.||+|.+.. + ..+|+|.+... ......+|..|+.++++++||||+++++++.+....++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678999999999999999764 3 36999998654 3344578999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998542 345899999999999999999999988 999999999999999999999999998865432
Q ss_pred ccccccc-ccc--cccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 443 QTEANTN-RVV--GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 443 ~~~~~~~-~~~--gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
....... ... .+..|+|||.+.+..++.++||||||+++|||++ |..|+...... ... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~----~~i~~~----- 227 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVI----NAIEQD----- 227 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHH----HHHHcC-----
Confidence 2211111 111 2457999999999999999999999999999886 98886432211 011 100000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.....+.+....+.+++..||+.+|++||++.+|+++|+..
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00001112234577899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.93 Aligned_cols=236 Identities=27% Similarity=0.385 Sum_probs=189.2
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+++... ++.+|+|.+.+. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 789999998653 234456677888888876 699999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999998853 345899999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . .......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~----~~~~i~~~~~------~~---- 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---D----LFEAILNDEV------VY---- 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---H----HHHHHhcCCC------CC----
Confidence 23357899999999999999999999999999999999999998643211 0 1111111110 00
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
+......+.+++..|++.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11122456789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.48 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=201.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe--------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR 355 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 355 (606)
.++|.+.++||+|+||.||+++.. ....+|+|.+.... .....++.+|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357788899999999999999753 24568888886542 33456788999999999 699999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
...++|+||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999996422 1245899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 501 (606)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---E 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999987643222221222234567999999999999999999999999999999 77776432211 1
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+ .......... ..+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 245 ~----~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 L----FKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred H----HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1 1111111100 11112234677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=324.15 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=198.3
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
..++|+..++||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34678899999999999999999865 789999998643 22334567899999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34788889999999999999999998 9999999999999999999999999998754
Q ss_pred CCcccccccccccccCccCccccccC----CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
.... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... . ..........
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~- 264 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMDHKN- 264 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCCC-
Confidence 3221 122345799999999998653 4789999999999999999999997543211 0 1111111100
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVL 558 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~vl~ 558 (606)
.+ .... .......+.+++..|++.+|++ ||++.++++
T Consensus 265 ~~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 265 SL---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred cC---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00 0001 1112346678899999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.86 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=189.0
Q ss_pred CeecccCcccEEEEEEeCC---cEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 293 NKLGEGGFGPVYKGVLIEG---QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
++||+|+||.||+|....+ ..+++|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3699999999999986543 467888775443 233467889999999999999999999999999999999999999
Q ss_pred CchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 369 SLNDFIFDVTR--SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 369 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865322 234578888999999999999999998 9999999999999999999999999987543322222
Q ss_pred cccccccccCccCccccc-------cCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 447 NTNRVVGTYGYMPPEYAI-------DGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~-------~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
......++..|+|||++. ...++.++||||||+++|||++ |..|+...... .. ...........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~----~~~~~~~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV----LKQVVREQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH----HHHHhhccCccC
Confidence 223345577899999874 3457889999999999999999 66776432111 01 111111111122
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
..+.+.. .....+.+++..|+ .+|++||++++|+++|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222211 12234556777888 49999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.93 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=200.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-----ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|...+.||+|++|.||++...+ ++.+++|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 578889999999999999999754 8899999876432 1234578899999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998853 345889999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.|+..... . ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~------ 223 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFKIATQP------ 223 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----H-HHHHHHhccC------
Confidence 322111 11235678899999999999999999999999999999999999643211 0 0000000000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.....+......+.+++..||+.+|++||++.++++.
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011111223456789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=325.86 Aligned_cols=252 Identities=29% Similarity=0.402 Sum_probs=207.4
Q ss_pred CCCcCCeecccCcccEEEEEEeC--Cc--EEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE--GQ--EIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~--g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.....++||+|.||.|++|.|.. |+ .||||.+...... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34455889999999999999865 43 6899999766544 67899999999999999999999999988 7789999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|.++.|||.+.|.. ..+..+-......++.|||.||.||.++. +|||||.++|+||-....+||+||||.+.++..
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999977 45566888899999999999999999998 999999999999999999999999999988654
Q ss_pred cc-cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 443 QT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 443 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.. ........-...|.|||.+....|+.++|||+|||+||||+| |+.|+..... ..+.+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhcc
Confidence 33 233333445678999999999999999999999999999998 5567533221 12233344
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
..-.-..+....+++++++..||..+|++||++..|.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3322233445677899999999999999999999997443
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=310.34 Aligned_cols=263 Identities=26% Similarity=0.394 Sum_probs=201.5
Q ss_pred cCCCcCCeecccCcccEEEEEEe-----CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--Cee
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER 358 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 358 (606)
..|.+.++||+|+||.||+++.. .+..+|+|.+.... ....+.+.+|+.++++++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35678899999999999999842 47789999986543 33456799999999999999999999998775 568
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998532 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCC--------CCccchhHHHHHH
Q 007361 439 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA--------DHHHNLLGHAWRL 509 (606)
Q Consensus 439 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~--------~~~~~l~~~~~~~ 509 (606)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 112234567789999999988999999999999999999998765321100 0000000001111
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..... ...........+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 10000 0001112235788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.11 Aligned_cols=249 Identities=25% Similarity=0.323 Sum_probs=193.6
Q ss_pred ecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
||+|+||.||++.... |+.+|+|++.... ......+..|++++.+++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999765 8999999986532 12234566799999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccc
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 450 (606)
.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 9888543 2334899999999999999999999988 9999999999999999999999999998764322 1223
Q ss_pred cccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH
Q 007361 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530 (606)
Q Consensus 451 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 530 (606)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+......... ...... .... .+.. ... .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~-~~~~----~~~~-~~~----~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRR-TLED----EVKF-EHQ----N 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHH-hhcc----cccc-ccc----c
Confidence 46889999999999999999999999999999999999997543221110 000000 0000 0000 000 1
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 531 EVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 531 ~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....+.+++..||+.+|++||+++++++.+..
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 22356789999999999999999887654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.34 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=198.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|.+.++||+|+||.||++.... +..+|+|.+.... .....++.+|++++.+++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368889999999999999999765 6778888775442 23345688999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
+++++|.+++.. ...+++..+..++.|+++||.|||+. + ++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999854 24589999999999999999999984 5 999999999999999999999999998765322
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc----------
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE---------- 513 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 513 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+......................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1233578899999999988889999999999999999999999975322111000000000000000
Q ss_pred -------CcchhcccccCC---CC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 514 -------RPVELINKSLGG---SY-SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 514 -------~~~~l~d~~l~~---~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
...++.+..... .. .......+.+++.+||+.+|++||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 00 00123357899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.17 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=189.7
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+++... |+.+|+|.+.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999865 7899999986542 23445667788887765 899999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999998853 345899999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+...... .+ ....... .+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~----~~~~~~~------~~~~~~~- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---EL----FESIRVD------TPHYPRW- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhC------CCCCCCC-
Confidence 23467899999999999999999999999999999999999997533211 11 1111110 0111111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMS-SVV 557 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~vl 557 (606)
....+.+++..||+.||++||++. +++
T Consensus 219 ---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 123567899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.88 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=194.3
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.++||+|+||.||++... +++.+|+|++.+.. ....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999875 48899999986532 234567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999853 345889999999999999999999998 999999999999999999999999999643211
Q ss_pred ccc-----------c----------------------------------cccccccccCccCccccccCCCCccccchhH
Q 007361 443 QTE-----------A----------------------------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSF 477 (606)
Q Consensus 443 ~~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~ 477 (606)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012468999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCC---CCHH
Q 007361 478 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR---PNMS 554 (606)
Q Consensus 478 Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~ 554 (606)
||++|||++|+.||...... ... ....... ..+ .+.... .....+.+++..|++ +|.+| |++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~---~~~----~~i~~~~-~~~---~~p~~~--~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSH---ETY----RKIINWR-ETL---YFPDDI--HLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHH---HHH----HHHHccC-Ccc---CCCCCC--CCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999998543221 111 1000000 000 000100 112346678888887 66665 5888
Q ss_pred HHHHH
Q 007361 555 SVVLM 559 (606)
Q Consensus 555 ~vl~~ 559 (606)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.12 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=201.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.+|.+.+.||+|+||.||+|++.. +..+|+|.+.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467788999999999999998753 3368999886543 23456889999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998542 245899999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccccc-ccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 442 DQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 442 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |..|+...... ... ....+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~----~~~~~~~--~-- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVI----KAIEEGY--R-- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHH----HHHhCCC--c--
Confidence 322111 111233568999999999899999999999999999886 99886432211 011 1111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..........+.+++.+|++.+|.+||+|.++++.|+..
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001112234667899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.88 Aligned_cols=238 Identities=25% Similarity=0.296 Sum_probs=190.5
Q ss_pred CeecccCcccEEEEEEe----CCcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 293 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
+.||+|+||.||+++.. .|+.+|+|++.+... .....+..|+.++.+++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 67999999999998853 478999999865432 234567789999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999998843 345899999999999999999999998 9999999999999999999999999998653321 1
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ....... . .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~----~~i~~~~--------~--~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETM----TMILKAK--------L--G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHH----HHHHcCC--------C--C
Confidence 223357899999999999989999999999999999999999997542211 010 0011100 0 0
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSS 555 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 555 (606)
.+......+.+++.+||+.+|++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11112245678999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.32 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=195.4
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-----eeE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ERM 359 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 359 (606)
+|+..++||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 58999999986532 234567889999999999999999999998776 789
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+|+||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777763 3345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc---
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP--- 515 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 515 (606)
...... ......+|..|+|||.+.+. .++.++||||||+++|||++|+.||........ .............
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence 432221 12234678899999999874 479999999999999999999999864332111 0000000000000
Q ss_pred -------chhcccccCC--------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 -------VELINKSLGG--------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 -------~~l~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+...... .........+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000000 000111346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=322.57 Aligned_cols=254 Identities=20% Similarity=0.237 Sum_probs=196.1
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
..++|+..+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 45789999999999999999999865 788999988643 22334568899999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999843 24788999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccccCC----CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
.... .......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||...... .. .........
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~-~~~i~~~~~- 264 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GT-YSKIMDHKN- 264 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HH-HHHHHhCCc-
Confidence 3221 1223467999999999987543 789999999999999999999998543211 11 111111000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLM 559 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~vl~~ 559 (606)
.+...........+.+++..|++.++.+ ||++.++++-
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000011111234567788888755543 8899998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.10 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=198.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-Cc--EEEEEEcccc-cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQ--EIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 361 (606)
++|++.+.||+|+||.||+|.+.+ +. .+++|++... .......+.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 567888999999999999999754 43 4577776543 233456788999999999 899999999999999999999
Q ss_pred EecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 362 YEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||+++..... ........+..|+|||++.+..++.++||||||+++|||+| |..|+...... ...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~---- 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY---- 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHH----
Confidence 99999998643211 11111234568999999988889999999999999999998 88887432211 010
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...... .....+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000000 00001111223577899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=316.71 Aligned_cols=241 Identities=27% Similarity=0.325 Sum_probs=191.7
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCC-CcceEEEEEeeCCeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHR-NLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 362 (606)
+|++.+.||+|+||.||+|+..+ ++.+|+|.+.+. .....+.+..|..++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999765 678999998654 233456788899999999765 5888999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998853 345889999999999999999999998 999999999999999999999999998753221
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. .......||..|+|||++.+..++.++||||||+++|||++|+.|+...... .+. ....... ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~----~~i~~~~------~~ 219 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF----QSIMEHN------VS 219 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcCC------CC
Confidence 1 1223457899999999999999999999999999999999999997533211 111 1111110 00
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
... .....+.+++..||+.+|.+||+.
T Consensus 220 ~~~----~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPK----SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111 122356789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.20 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=202.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..+|+..+.||+|+||.||+|+.. +++.+++|.+........+.+.+|+.+++.+.|+||+++++.+......++|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888899999999999999964 4889999999776656667899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999842 34789999999999999999999998 99999999999999999999999999876532221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......... .. .+
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~-~~-----~~- 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNG-TP-----EL- 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCC-CC-----CC-
Confidence 122346888999999999988999999999999999999999997532211 0000000000 00 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++.+||+.+|++||++.++++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011122345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.42 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=200.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
.+|+..+.||+|+||.||++.+.+++.+|+|++.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4577789999999999999998778899999886433 345679999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999998532 235789999999999999999999988 9999999999999999999999999998654322211
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+ ......+ .....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~--~~~~~~---- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EV----VETINAG--FRLYKP---- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HH----HHHHhCC--CCCCCC----
Confidence 112234678999999998899999999999999999998 88886532211 01 1111110 000011
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
. .....+.+|+.+||+.+|++||++.++++.|.
T Consensus 224 ~---~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 R---LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred C---CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 12246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.69 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=199.8
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
+.+++++.....||+|+||.||+|++.+ +..+++|.+........+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3456667777899999999999999764 678999998776666677899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCccccC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFG 440 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~~~ 440 (606)
+||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322112378889999999999999999988 999999999999976 6799999999987653
Q ss_pred CCcccccccccccccCccCccccccCC--CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
.... ......++..|+|||++.+.. ++.++||||||+++|||++|+.|+....... ...+..-..
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~~~~~~------ 227 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMFKVGMF------ 227 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHhhhhhh------
Confidence 2221 122245788999999986644 7899999999999999999999975322110 000000000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
......+......+.+++.+||+.+|++||++.++++
T Consensus 228 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 ---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0001112222345778999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.87 Aligned_cols=240 Identities=21% Similarity=0.316 Sum_probs=188.3
Q ss_pred CeecccCcccEEEEEEeC-------------CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 293 NKLGEGGFGPVYKGVLIE-------------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
+.||+|+||.||+|++.. ...+++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998632 2258888876665555668899999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc-------eEEee
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-------PKISD 432 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~-------~ki~D 432 (606)
+|+||+++++|..++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988753 2345899999999999999999999988 999999999999987664 89999
Q ss_pred cCCccccCCCcccccccccccccCccCccccc-cCCCCccccchhHHHHHHHHH-hccCCCCCCCCCCccchhHHHHHHh
Q 007361 433 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 433 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+....... ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~~ 221 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KERF 221 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HHHH
Confidence 9998754321 2245778899999887 467899999999999999998 5777654321110 0001
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
..... . ...+....+.+|+..||+.+|++||++.+|++.|+
T Consensus 222 ~~~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEGQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HhcCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11100 0 01112346778999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=324.19 Aligned_cols=200 Identities=23% Similarity=0.379 Sum_probs=172.0
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.|...++||+|+||.||+|+... ++.+|+|++.+.. ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57788999999999999999754 7889999986542 2345678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999853 345889999999999999999999998 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------cccccccccccCccCccccccCCCCccccchhHH
Q 007361 444 T---------------------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG 478 (606)
Q Consensus 444 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~G 478 (606)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0011235789999999999999999999999999
Q ss_pred HHHHHHHhccCCCCC
Q 007361 479 VLVLEIVCGKRNRGF 493 (606)
Q Consensus 479 vvl~elltG~~p~~~ 493 (606)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.57 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=202.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|...++||+|+||.||++...++..+++|.+... ....+.+.+|+.++++++|+||+++.+.+.+ ...++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4578888999999999999999877888999988643 2345678999999999999999999999887 7789999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998542 2445889999999999999999999988 999999999999999999999999999866432221
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||.+....++.++|+||||++++||++ |+.|+...... .+. .........
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~-------- 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALERGYRM-------- 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhCCCCC--------
Confidence 1122345678999999998899999999999999999999 88886532211 111 111111010
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.........+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.06 Aligned_cols=241 Identities=27% Similarity=0.334 Sum_probs=191.9
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 362 (606)
+|...+.||+|+||.||+|+... ++.+|+|.+.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47778999999999999999865 6789999987542 23345567788888777 5899999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998853 345899999999999999999999998 999999999999999999999999999754322
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+.. .......
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~----~i~~~~~------- 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ----SIMEHNV------- 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCC-------
Confidence 1 1223467899999999999999999999999999999999999998543211 1111 1111110
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
..+......+.+++.+|++.+|++|++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111123456789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=324.58 Aligned_cols=201 Identities=22% Similarity=0.371 Sum_probs=172.8
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
+|++.++||+|+||.||+++... ++.+|+|.+.+.. ......+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999999765 7899999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999853 345889999999999999999999998 9999999999999999999999999985432100
Q ss_pred c-----------------------------------------cccccccccccCccCccccccCCCCccccchhHHHHHH
Q 007361 444 T-----------------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVL 482 (606)
Q Consensus 444 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ 482 (606)
. ........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00012357999999999999999999999999999999
Q ss_pred HHHhccCCCCCC
Q 007361 483 EIVCGKRNRGFY 494 (606)
Q Consensus 483 elltG~~p~~~~ 494 (606)
||++|+.||...
T Consensus 236 ell~G~~Pf~~~ 247 (376)
T cd05598 236 EMLVGQPPFLAD 247 (376)
T ss_pred ehhhCCCCCCCC
Confidence 999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.85 Aligned_cols=240 Identities=26% Similarity=0.360 Sum_probs=190.1
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+|+... ++.+|+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999865 7889999986542 23445667788888764 899999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999998853 345899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+...... .+ ....... .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~----~~~i~~~------~~~~~~-- 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---EL----FQSIRMD------NPCYPR-- 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhC------CCCCCc--
Confidence 23357899999999999999999999999999999999999997543211 11 1111100 011111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMS-SVV 557 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~vl 557 (606)
.....+.+++.+||+.+|++||++. ++.
T Consensus 218 --~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 --WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1223567899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=301.72 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=197.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEe-eCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT-QRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~ 365 (606)
++|.+.+.||+|+||.||++.. .|..+++|.+... ...+.+.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999986 4788999988543 23567899999999999999999999764 456789999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ....+++..++.++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998642 2345899999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+.. ...... .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~----~~~~~~---------~ 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP----RVEKGY---------K 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCC---------C
Confidence 12334568999999999999999999999999999998 8888643211 00110 000110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..........+.+++.+|++.+|++|||+.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11111223467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.56 Aligned_cols=239 Identities=21% Similarity=0.298 Sum_probs=186.6
Q ss_pred eecccCcccEEEEEEeC-------------------------CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceE
Q 007361 294 KLGEGGFGPVYKGVLIE-------------------------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 348 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 348 (606)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 13588888866555555678899999999999999999
Q ss_pred EEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC--
Q 007361 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-- 426 (606)
Q Consensus 349 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-- 426 (606)
++++.+....++||||+++|+|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998853 2345889999999999999999999988 99999999999997643
Q ss_pred -----ceEEeecCCccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHH-hccCCCCCCCCCCc
Q 007361 427 -----NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHH 499 (606)
Q Consensus 427 -----~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~ell-tG~~p~~~~~~~~~ 499 (606)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3899999988653221 12346778999998875 56899999999999999995 6888865332211
Q ss_pred cchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 500 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 500 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
... +.... ..... .....+.+++..||+.+|++||++.+|++.|+
T Consensus 230 --~~~-----~~~~~------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KER-----FYEKK------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHH-----HHHhc------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000 00000 00111 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=295.08 Aligned_cols=279 Identities=23% Similarity=0.295 Sum_probs=203.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccC--HHHHHHHHHHHhhccCCCcceEEEEEee--CCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG--MEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 360 (606)
.++|...++|++|.||.||+|+++. +..||+|+++...+.. --.-.+|+.+|.+++|||||.+-.+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4678889999999999999999865 7789999997653321 2345789999999999999999887754 356999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||++. +|..++.... ..+...++..+..|+++|++|||... |+|||||++|+|+++.|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 8888886543 46888999999999999999999998 9999999999999999999999999999987
Q ss_pred CCcccccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH--------HHHHHhh
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWRLWI 511 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~ 511 (606)
.+. ...+..+-|..|.|||++.+.+ |+..+|+||+|||+.||++++..+.........+.+- ..|..+.
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 652 2234467799999999999865 9999999999999999999998876543321111110 0111111
Q ss_pred hcCc------chhcccccCCCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCC
Q 007361 512 EERP------VELINKSLGGSYSLS-EVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPG 573 (606)
Q Consensus 512 ~~~~------~~l~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~~~p~~p~ 573 (606)
+-.. .......+...+... ....-++|....+..||.+|.|+.+.++- .-..+.|.|..|.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P~ 374 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDPS 374 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCChh
Confidence 1000 000000111111111 11234677778999999999999988642 1124444444333
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.81 Aligned_cols=249 Identities=28% Similarity=0.450 Sum_probs=193.2
Q ss_pred CeecccCcccEEEEEEeC-Cc--EEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQ--EIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+|++.+ +. .+++|.+.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999865 33 46888876432 34456789999999999 799999999999999999999999999
Q ss_pred CCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 368 KSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 368 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 1235889999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
++...... ........+..|+|||++....++.++||||||+++|||++ |..|+...... .. .......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~----~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL----YEKLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HH----HHHHhCC
Confidence 98632211 11111233567999999998899999999999999999997 88887432111 01 1111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.. ..........+.+++..||+.+|.+||++.++++.|+.+
T Consensus 228 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 001111224577999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=302.23 Aligned_cols=249 Identities=32% Similarity=0.483 Sum_probs=195.7
Q ss_pred CeecccCcccEEEEEEeC-C---cEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
++||+|+||.||+|+... + ..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++|+||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998643 2 6899999876543 24567899999999999999999999876 4568999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999543 35899999999999999999999988 99999999999999999999999999987643322211
Q ss_pred -ccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 448 -TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 448 -~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..+.. ........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~----~~~~~~~~--------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIA----MLESGERL--------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHH----HHHcCCcC---------
Confidence 111234568999999999999999999999999999998 8888754321 11111 11111100
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
..+......+.+++.+||+.+|++||++.+|++.|++..
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011112246779999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.59 Aligned_cols=241 Identities=20% Similarity=0.259 Sum_probs=188.1
Q ss_pred CeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHH-HHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVL-LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+++.. +|+.+|+|.+.+.. ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 48899999986542 223345555655 46778999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 999988843 345899999999999999999999998 999999999999999999999999998753211 112
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+...... . .......... .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~----~~~~~~~~~~------~~~~~- 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---E----MYDNILHKPL------VLRPG- 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---H----HHHHHHcCCc------cCCCC-
Confidence 23467899999999999999999999999999999999999997532211 0 1111111100 01111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
....+.+++..|++.+|.+||++.+.++
T Consensus 219 ---~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 219 ---ASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ---CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 2245678899999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.21 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=199.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC---CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..+|.+.++||+|+||.||++...+ +..|++|.+... ..+.+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997543 567899987543 23568999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|++. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 68888872 3456899999999999999999999998 999999999999999999999999999876544
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC-------c
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER-------P 515 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------~ 515 (606)
..........||..|+|||++.+..++.++|||||||++|||++|+.|+...........+....+...... .
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 333333446799999999999999999999999999999999999999854433221111111111000000 0
Q ss_pred chh------cccccCCCCCH-------HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 516 VEL------INKSLGGSYSL-------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 516 ~~l------~d~~l~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
..+ ........... .....+.+++.+|++.+|++||++.+++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 00000000110 112356788999999999999999999864
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.77 Aligned_cols=251 Identities=31% Similarity=0.472 Sum_probs=197.2
Q ss_pred CeecccCcccEEEEEEeC-------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 293 NKLGEGGFGPVYKGVLIE-------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999999754 2578888876543 24466889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-----ceEEeecCC
Q 007361 365 LPNKSLNDFIFDVT----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-----NPKISDFGM 435 (606)
Q Consensus 365 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-----~~ki~DFGl 435 (606)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996432 2345889999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH----HhcCC
Confidence 986643332222223345778999999999999999999999999999998 88886532111 11110 00000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001111223467789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=305.47 Aligned_cols=252 Identities=30% Similarity=0.463 Sum_probs=198.1
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHH--HHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGME--EFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
|+..+.||+|+||+||+++... ++.+|+|.+......... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999876 568999999766443322 3456999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++. +...+++..+..++.|+++||.+||+.+ |+|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999996 3455899999999999999999999998 9999999999999999999999999998641 122
Q ss_pred ccccccccccCccCccccc-cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.......++..|+|||++. +..++.++||||+|+++|+|++|..|+................. ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK-------RPLPSSSQ- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH-------THHHHHTT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc-------cccccccc-
Confidence 2334467899999999998 88899999999999999999999999764311111111100000 00000000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.+++..||+.+|++||++.++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001157889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=303.11 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=192.9
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-----eeEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ERMLI 361 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 361 (606)
.|...+++|.|+||.||+|++.. ++.||||++-...+-. ..|+.+|+++.|||||+|+-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45566899999999999999876 6899999986654422 46899999999999999999885432 34689
Q ss_pred EecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CceEEeecCCcccc
Q 007361 362 YEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAF 439 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~ki~DFGla~~~ 439 (606)
+|||+. +|..++... ..+..++...+.-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 788887531 22345777778889999999999999988 9999999999999976 99999999999987
Q ss_pred CCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH-----Hhhhc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR-----LWIEE 513 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~~~ 513 (606)
...+.. ....-|..|.|||.+.+. .|+.+.||||.|||+.||+-|+.-|...++.....++-.... .....
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 544333 235568899999999875 699999999999999999999988876443222111111100 00000
Q ss_pred Cc--chhcccccCCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RP--VELINKSLGGS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~--~~l~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+ .+.-.+.+... .......++++++.++++.+|.+|.++.+++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 01111111111 12233456789999999999999999999884
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=321.78 Aligned_cols=194 Identities=20% Similarity=0.271 Sum_probs=167.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..+|.+.+.||+|+||.||++.+.. ++.||+|... ...+.+|+.++++++|+|||++++++...+..++|+|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578899999999999999999876 7789999642 23457899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+. ++|.+++.. ....++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 688888743 2346999999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR 491 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~ 491 (606)
........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223467999999999999999999999999999999999988654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.90 Aligned_cols=237 Identities=22% Similarity=0.256 Sum_probs=186.4
Q ss_pred CeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHH-HHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVL-LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+++.. +|+.+|+|++.+.. .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 48899999986542 222344555544 56788999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999998853 345899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... . .......... .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~------~~~~~- 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------E-MYDNILNKPL------RLKPN- 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------H-HHHHHHcCCC------CCCCC-
Confidence 23457899999999999999999999999999999999999997532211 0 0111111100 11111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMS 554 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 554 (606)
....+.+++..|++.+|.+||++.
T Consensus 219 ---~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ---ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 234577899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.22 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=198.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-Cc----EEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|...+.||+|+||.||+|.+.. +. .+|+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 567778999999999999998754 43 468888765432 2344788999999999999999999998754 4679
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
++||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999853 2335889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ......... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~--~- 230 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EI----PDLLEKGER--L- 230 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCC--C-
Confidence 3332222233445778999999999999999999999999999997 88886432111 11 111111100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.........+.+++..||..+|++||++.++++.|+..
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00111234677899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.90 Aligned_cols=254 Identities=20% Similarity=0.335 Sum_probs=189.1
Q ss_pred CeecccCcccEEEEEEeCCc---EEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 293 NKLGEGGFGPVYKGVLIEGQ---EIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+.||+|+||.||+|...++. .+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999865543 45666665433 334578999999999999999999999999999999999999999
Q ss_pred CchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 369 SLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 369 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
+|.+++.... ....+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999996532 2344677788899999999999999988 99999999999999999999999999864322211122
Q ss_pred ccccccccCccCcccccc-------CCCCccccchhHHHHHHHHHhc-cCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 448 TNRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... ... ...........+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~----~~~~~~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REV----LNHVIKDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHhhcccccC
Confidence 233567889999998743 3467899999999999999975 456532111 111 1111122222333
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
++.+.... ...+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332222 235667888899 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.17 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=196.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|...++||+|+||.||+|+... ++.+|+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 568888999999999999999764 7789999986543 23345678899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 78887743 2345889999999999999999999998 99999999999999999999999999976533222
Q ss_pred cccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH--------HHHHHhhhcCc
Q 007361 445 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWRLWIEERP 515 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~~~ 515 (606)
. .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||............. ..|..+....
T Consensus 160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (309)
T cd07872 160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND- 236 (309)
T ss_pred c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh-
Confidence 1 222467889999999865 468999999999999999999999986443221111110 0111110000
Q ss_pred chhcccccCCC-------CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGGS-------YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+...... ........+.+++..|++.||.+|||+.++++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 -EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred -hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 00011235678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=299.19 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=202.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
++|+..++||+|+||.||+|+..+ ++.+++|.+..... .+++.+|+.++++++|+||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999876 78999999865433 678999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999853 2356899999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..... ... ..+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~-~~~----~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPN-KPP----PTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhcc-CCC----CCC--
Confidence 222345788999999999999999999999999999999999997643221100 00000 000 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011122246788999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=337.54 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=200.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.++||+|+||.||+|+... ++.||+|++..... ...+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 468889999999999999999765 88999999865422 23457899999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 363 EYLPNKSLNDFIFDVT--------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885421 1234677888999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcc----------------cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCC
Q 007361 435 MARAFGIDQT----------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498 (606)
Q Consensus 435 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 498 (606)
+++....... ........||+.|+|||.+.+..++.++||||||+++|||+||+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123569999999999999999999999999999999999999975422110
Q ss_pred ccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhcC
Q 007361 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-NMSSVVLMLSG 562 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~vl~~L~~ 562 (606)
.. .. ... ..+.. ..........+.+++.+|++.+|++|| ++.++++.|+.
T Consensus 239 ---i~---~~----~~i---~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ---IS---YR----DVI---LSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred ---hh---hh----hhc---cChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00 000 00000 000011224567899999999999996 56667766654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.63 Aligned_cols=238 Identities=23% Similarity=0.396 Sum_probs=188.4
Q ss_pred CeecccCcccEEEEEEeCCc-----------EEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 293 NKLGEGGFGPVYKGVLIEGQ-----------EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999987643 4677776544333 6789999999999999999999999988 778999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-------ceEEeecC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-------NPKISDFG 434 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-------~~ki~DFG 434 (606)
+||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986422 26899999999999999999999988 99999999999999887 79999999
Q ss_pred CccccCCCcccccccccccccCccCccccccC--CCCccccchhHHHHHHHHHhc-cCCCCCCCCCCccchhHHHHHHhh
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
++..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+....... +..+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--------~~~~~ 219 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------KERFY 219 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--------HHHHH
Confidence 9986543 1224566789999999876 789999999999999999995 55543322110 00000
Q ss_pred hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.. . ...+......+.+++..||+.+|.+||++.+|++.|+
T Consensus 220 ~~-------~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QD-------Q---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hc-------C---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 0001111157789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=304.87 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=197.3
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC------
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR------ 355 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 355 (606)
.+++.|+..+.||+|+||.||+|...+ ++.+|+|.+... .....++..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 356778888999999999999999765 778899988544 34456788999999998 799999999998753
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
...++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4579999999999999998542 2345899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
+....... .......|+..|+|||++. +..++.++||||||+++|||++|+.|+...... .. ....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~-~~~~- 228 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RA-LFLI- 228 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HH-HHHH-
Confidence 98653221 1223457889999999986 346888999999999999999999997532211 00 0000
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........ ... .....+.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~~~~~----~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPAPRL----KSK----KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCCCCC----CCC----CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000000 011 11235778999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.24 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=189.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--------
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-------- 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 355 (606)
...+|...++||+|+||.||+|...+ ++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 35679999999999999999999864 7899999885432 2345799999999999999999886432
Q ss_pred CeeEEEEecCCCCCchhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeec
Q 007361 356 DERMLIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDF 433 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DF 433 (606)
...++||||+++ +|.+++.. ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 236789999985 67666643 223456899999999999999999999998 99999999999998664 7999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhh
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 512 (606)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||....... .+. ........
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~-~i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLV-RIIQVLGT 289 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHH-HHHHHhCC
Confidence 99987643221 2235679999999998764 68999999999999999999999975432211 111 11110000
Q ss_pred cCcch-------hcc---cc-----cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 513 ERPVE-------LIN---KS-----LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 513 ~~~~~-------l~d---~~-----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
..... ..+ +. +....+......+.+|+..||+.+|.+|||+.+++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000 000 00 00001111224678999999999999999999988
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.52 Aligned_cols=264 Identities=25% Similarity=0.329 Sum_probs=201.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc--CHHHHHHHHHHHhhccCCC-cceEEEEEeeCC------
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRN-LVKLIGCCTQRD------ 356 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 356 (606)
..|...++||+|.||+||+|+... |+.||+|++.-..+. ......+|+.+++.++|+| ||+|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 456666889999999999999765 889999999765432 3455689999999999999 999999998877
Q ss_pred eeEEEEecCCCCCchhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
..++|+||++ -+|..++...... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7899999995 5899998654332 45777889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
|+.+..+... ....++|..|.|||++.+. .|+..+||||+|||+.||++++.-|+..... ..+...++..-...
T Consensus 167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCCC
Confidence 9977644332 3346789999999999987 7999999999999999999998877654431 11122222111110
Q ss_pred ---cc---hhcccc--cCCCC---CH-H-HH---HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 515 ---PV---ELINKS--LGGSY---SL-S-EV---LRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 515 ---~~---~l~d~~--l~~~~---~~-~-~~---~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.. .+.+-. ..... +. . .. ....+++.+|++.+|.+|.|++.+++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 011111 00000 00 0 01 256789999999999999999999875
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.82 Aligned_cols=237 Identities=20% Similarity=0.264 Sum_probs=185.5
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHH-HHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVL-LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
++||+|+||.||+++... ++.+|+|.+.+.. ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999864 7889999986532 222344555554 67889999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999888743 345888899999999999999999988 9999999999999999999999999987532221 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... . ........ .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-~~~~i~~~--------~~--~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------Q-MYDNILHK--------PL--QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------H-HHHHHhcC--------CC--CC
Confidence 23457899999999999999999999999999999999999997532210 0 01111111 00 11
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMS 554 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 554 (606)
+......+.+++.+|++.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112234677899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.69 Aligned_cols=193 Identities=21% Similarity=0.299 Sum_probs=164.9
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
....+|.+.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++|+||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 345689999999999999999999865 667888875332 2356899999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|++. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 688888753 3456899999999999999999999998 999999999999999999999999999753221
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCC
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR 491 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~ 491 (606)
.......||..|+|||++.+..++.++||||||+++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222356899999999999999999999999999999999876553
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.09 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=199.2
Q ss_pred CCCcCCeecccCcccEEEEEEeC--CcEEEEEEcccc----------cccCHHHHHHHHHHHhh-ccCCCcceEEEEEee
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKS----------SGQGMEEFENEVLLIAK-LQHRNLVKLIGCCTQ 354 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 354 (606)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999999876 678999987532 22234567788888875 799999999999999
Q ss_pred CCeeEEEEecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCceEEee
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISD 432 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~ki~D 432 (606)
.+..++|+||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999987532 234568999999999999999999996 45 99999999999999999999999
Q ss_pred cCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhh
Q 007361 433 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512 (606)
Q Consensus 433 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 512 (606)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ... ......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~-~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSL-ATKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHH-HHHHhh
Confidence 99998754332 22345688999999999998999999999999999999999998642211 000 001111
Q ss_pred cCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 513 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.... +.. .......+.+++.+||+.+|++||++.+|..+|+
T Consensus 228 ~~~~----~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYE----PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCC----cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1100 000 0012246778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=304.62 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=200.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-Cc----EEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.+|...+.||+|+||.||+|.+.+ |. .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788999999999999999754 32 588888765543 345678999999999999999999999987 78899
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998542 334899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
............++..|+|||.+....++.++|+||||+++|||++ |+.|+...... .+.. .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD----LLEKGER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhCCCC----
Confidence 3322222222234568999999988899999999999999999998 99987543211 0110 0111000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+......+.+++..||..+|++||++.++++.|+..
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011111224577889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.12 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=190.6
Q ss_pred CeecccCcccEEEEEEeC----CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEe-eCCeeEEEEecCC
Q 007361 293 NKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCT-QRDERMLIYEYLP 366 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~ 366 (606)
+.||+|+||.||+|.+.+ ...+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 3578999885432 334568889999999999999999999876 4556899999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc-
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE- 445 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~- 445 (606)
+++|.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 234678888999999999999999987 999999999999999999999999999865332111
Q ss_pred -ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCC-CCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 446 -ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 446 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.......++..|+|||.+.+..++.++||||||+++|||++|..| +.... ...+... ...... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~----~~~~~~-----~~- 222 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVY----LLQGRR-----LL- 222 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----HhcCCC-----CC-
Confidence 111223457789999999988999999999999999999996544 33211 1111111 111100 00
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.+......+.+++..||+.+|++||++.+|++.|+..
T Consensus 223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111124677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=302.27 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=201.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|+..+.||.|+||.||+|+... ++.+++|.+.... ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 357778999999999999999764 7899999886543 34456789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999999843 26899999999999999999999988 99999999999999999999999999987754321
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .. ..........+ .
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~----~~~~~~~~~~~-----~ 219 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL----FLIPKNNPPSL-----E 219 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH----HHhhhcCCCCC-----c
Confidence 2233567889999999999899999999999999999999999975432110 00 00011111111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. .....+.+++..||+.+|++||+++++++
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 02345778999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.68 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=188.8
Q ss_pred CeecccCcccEEEEEEeC--------CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 293 NKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998743 234788887655555567889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc--------eEEeecCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--------PKISDFGMA 436 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~--------~ki~DFGla 436 (606)
+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998542 235899999999999999999999998 999999999999987765 699999988
Q ss_pred cccCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhcc-CCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+...... .........
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~ 221 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------KKLQFYEDR 221 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------HHHHHHHcc
Confidence 754321 224678899999999874 5899999999999999999995 443221111 000011110
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
...+......+.+++..||+.+|++|||+.++++.|+
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=299.11 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=200.1
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+|++.++||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+.+..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 46778999999999999999764 788999987543 2334567889999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ....+++...+.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988532 3445889999999999999999999998 99999999999999999999999999976643221
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......++..|+|||++.+..++.++||||||+++|+|++|+.|+...... .. ... ...+....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~---~~~-~~~~~~~~-------- 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NL---ILK-VCQGSYKP-------- 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HH---HHH-HhcCCCCC--------
Confidence 122356888999999999989999999999999999999999997532110 00 010 11111100
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.+......+.+++.+||+.+|++||++.+++..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111122356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.98 Aligned_cols=242 Identities=20% Similarity=0.251 Sum_probs=187.2
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHH-HHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEV-LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+++... ++.+|+|.+.+.. ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999865 6789999986532 22233444444 456778999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
++|.+++.. ...+.+..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999998853 345788888899999999999999998 9999999999999999999999999997542221 12
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .. ........ . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~----~~~i~~~~--------~--~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM----YDNILNKP--------L--QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HH----HHHHHhCC--------c--CC
Confidence 33467999999999999999999999999999999999999997532211 01 11111110 0 01
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.......+.+++..|++.+|.+||++.+.+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 11122456788999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=302.69 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=201.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
++|.....||+|+||.||+|+... .+.+++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568888999999999999999642 457888888654433 4578999999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeec
Q 007361 360 LIYEYLPNKSLNDFIFDVTRS------KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DF 433 (606)
+|+||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643321 25899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhh
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIE 512 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 512 (606)
|++........ .......++..|+|||.+.+..++.++||||||++++||++ |..|+...... .. ......
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~----~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EV----LNRLQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HH----HHHHHc
Confidence 99875432211 12223456778999999998889999999999999999999 66776422110 01 111111
Q ss_pred cCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 513 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.... ..........+.+++.+||+.+|++||++.++++.|.
T Consensus 234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1100 0011122346788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=305.14 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=202.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
...+|...+.||+|+||.||++... +++.+|+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3467888999999999999999974 589999999976655566778999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999842 34789999999999999999999988 9999999999999999999999999987654332
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........... ..... ... .
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~~~-----~ 235 (297)
T cd06656 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPE-----L 235 (297)
T ss_pred cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-CCC-----C
Confidence 21 2234678899999999999999999999999999999999999753322110000 00000 000 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++..||+.+|++||++.++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011112235678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=299.73 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=198.1
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc---------CHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ---------GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
+|.....||+|+||.||+|.... ++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 36677899999999999998754 789999988654322 23568899999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 345889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc----ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 438 AFGIDQTE----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 438 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
........ .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFK-IGE- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHH-Hhc-
Confidence 76432111 1112345788999999999999999999999999999999999997532110 00000 000
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ....+......+.+++.+||+.+|.+||++.+|++
T Consensus 227 ----~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ----NA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----cC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 11111223356778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.20 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=198.5
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.|+..+.||+|+||.||+|.+.. ++.+|+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 45566889999999999998754 7789999876443 334567899999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999883 345899999999999999999999988 99999999999999999999999999986643221
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... . .... ......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~-----~~~~--------~~~~~~ 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---V-----LFLI--------PKNSPP 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---H-----Hhhh--------hcCCCC
Confidence 1223467889999999999999999999999999999999999965322111 0 0000 000011
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.........+.+++.+||+.+|++||++.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112233467789999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.37 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=196.9
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5667889999999999999865 677888888666556677899999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
++|..++.. ....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999988753 2346899999999999999999999998 9999999999999999999999999987653221 12
Q ss_pred ccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 448 TNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.....++..|+|||++. +..++.++|||||||++|||++|+.|+...... ..... ..........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHH-HhhcCCCCCC---
Confidence 23356889999999984 455788999999999999999999986532211 00000 0011110100
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+......+.+++..||+.+|.+||++.++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112246778999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.64 Aligned_cols=241 Identities=27% Similarity=0.348 Sum_probs=191.2
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 362 (606)
+|+..+.||+|+||.||++.... ++.||+|.+.+.. ....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36677999999999999999764 8899999987542 234456788999988885 577888999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998843 345899999999999999999999998 999999999999999999999999998754322
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.. ......||..|+|||++.+..++.++||||||+++|||++|+.|+...... .+.. .......
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~----~i~~~~~------- 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQ----SIMEHNV------- 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCC-------
Confidence 11 223356899999999999999999999999999999999999997543211 1111 1111100
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111122456789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.51 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=201.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..|+..++||.|+||.||+|.... ++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 356677899999999999999764 7889999886442 34457789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998842 35889999999999999999999988 99999999999999999999999999977643221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ . ..+.....
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~-------------~~~~~~~~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---L-------------FLIPKNNP 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---h-------------hhhhcCCC
Confidence 12234678899999999998999999999999999999999999753221100 0 00001111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
..........+.+++..||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12223345678899999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=303.33 Aligned_cols=265 Identities=26% Similarity=0.345 Sum_probs=196.9
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|+..+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.++.+++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677899999999999999986 48899999986542 23356788999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
++ ++|.+++........+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888865444567899999999999999999999998 99999999999999999999999999986543321
Q ss_pred cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHHHHHhhhc-C
Q 007361 445 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLWIEE-R 514 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~-~ 514 (606)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+..........-. ...|..+... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223568899999988754 5789999999999999999999987543211000000 0000000000 0
Q ss_pred cchhcccccCCCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSY---SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
....+........ ......++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 0011235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.49 Aligned_cols=197 Identities=25% Similarity=0.385 Sum_probs=161.1
Q ss_pred CCeecccCcccEEEEEEe---CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEee--CCeeEEEEecCC
Q 007361 292 KNKLGEGGFGPVYKGVLI---EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLIYEYLP 366 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 366 (606)
.++||+|+||.||+|+.. .++.+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 478999999999999975 35789999886432 23567889999999999999999999854 456789999986
Q ss_pred CCCchhhhccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCceEEeecCCc
Q 007361 367 NKSLNDFIFDV------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMA 436 (606)
Q Consensus 367 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~ki~DFGla 436 (606)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 787776421 12235899999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCcc-cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 437 RAFGIDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 437 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
+.+..... ........+|+.|+|||++.+. .++.++||||+|+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87653322 1223346789999999999874 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=300.96 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=197.9
Q ss_pred CCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC------
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------ 356 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 356 (606)
|.+.+.||+|+||.||+|.+.. ++.+|+|.+.... ....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567899999999999998642 6789999886542 334567899999999999999999999886542
Q ss_pred eeEEEEecCCCCCchhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeec
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVT---RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DF 433 (606)
..++++||+++|+|.+++.... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 2234789999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhh
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIE 512 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 512 (606)
|+++...............++..|++||.+.+..++.++||||||+++|||++ |+.|+..... ..+.. ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYN----YLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHH----HHHc
Confidence 99987643332222223345678999999999999999999999999999999 7777643211 11111 1111
Q ss_pred cCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 513 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
... + ..+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 231 ~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0 01112235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.60 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=197.1
Q ss_pred HHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 282 IANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 282 ~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
+....++|.+.+.||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34456899999999999999999999875 778999988642 22334567889999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999843 24788889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCccccccC----CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ... .......
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~-~~~i~~~ 262 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGT-YSKIMNH 262 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHH-HHHHHcC
Confidence 7643221 122346799999999998754 378999999999999999999999853221 111 1111110
Q ss_pred -CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 007361 514 -RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLM 559 (606)
Q Consensus 514 -~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~vl~~ 559 (606)
..... . ........+.+++..|++.++.+ ||++.++++.
T Consensus 263 ~~~~~~-----~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSLTF-----P--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcccC-----C--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00000 0 01112335667888999844433 7788888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.57 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=201.6
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.+|+..+.||.|+||.||+|... +++.+++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888899999999999999864 58899999987665556678899999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998842 35899999999999999999999998 99999999999999999999999999886543322
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... .. ..........+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~-~~~~~~~~~~~------- 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------AL-YLIATNGTPEL------- 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcCCccc-------
Confidence 1223568889999999999899999999999999999999999975432210 00 00000000000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011112235678899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.89 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=202.2
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|+..+.||.|+||.||.++... ++.+++|++... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999998654 788999987643 344567789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999985432 345899999999999999999999988 99999999999999999999999999987643332
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ....+....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~-~~~~~~~~~------- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVV-KIVQGNYTP------- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHH-HHHcCCCCC-------
Confidence 223356899999999999888999999999999999999999987532211 1110 111111100
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
........+.+++.+||+.+|++||++.++++.+
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1112234677899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.40 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=199.4
Q ss_pred HHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-----c---CHHHHHHHHHHHhhc-cCCCcceEEE
Q 007361 281 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-----Q---GMEEFENEVLLIAKL-QHRNLVKLIG 350 (606)
Q Consensus 281 ~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-----~---~~~~~~~E~~~l~~l-~H~niv~l~g 350 (606)
.-....+.|...+.||+|..++|-+..++. |++.|+|++..... . -.++-..|+.+|+++ -||+|+.+.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 334456778888999999999999988765 88999999854321 1 123455799999998 5999999999
Q ss_pred EEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
++......++|+|.|+.|.|.++|. ....+++....+|+.|+.+|++|||..+ |+||||||+|||+|++.++||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEE
Confidence 9999999999999999999999994 3456999999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCcccccccccccccCccCccccc------cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 504 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 504 (606)
+|||.|..+... ......+||++|+|||.+. ...|+..+|+|+.||++|.|+.|..||- +... ++
T Consensus 165 sDFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQ---ml- 235 (411)
T KOG0599|consen 165 SDFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQ---ML- 235 (411)
T ss_pred eccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHH---HH-
Confidence 999999987533 2344589999999999884 3458999999999999999999999952 1110 00
Q ss_pred HHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 505 HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 505 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+...++. .++-.+. .. +......+|+.+|+|.||.+|.|++|+++
T Consensus 236 -MLR~ImeGk-yqF~spe---Wa--dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 -MLRMIMEGK-YQFRSPE---WA--DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHHHHHhcc-cccCCcc---hh--hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 001111111 0110000 00 11234568899999999999999999873
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.61 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=201.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|++.++||+|+||+||++.... ++.+|+|++.... ....+.+.+|++++..++||||+++++++......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 567778999999999999999764 7889999876543 33457899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.. .+.+++.....++.+++.||.|||+.. .++|+||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999998843 345899999999999999999999742 2999999999999999999999999998754221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCcc-----chhHHHHHHhhhcCcchhc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH-----NLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~-----~l~~~~~~~~~~~~~~~l~ 519 (606)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+......... .+.... ........
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---- 230 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL-QQIVQEPP---- 230 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH-HHHhhccC----
Confidence 122357899999999998889999999999999999999999998643322110 011111 11111000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
+.+ ........+.+++.+|++.+|++||++.+++++.
T Consensus 231 -~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 -PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 0111334678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=302.33 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=198.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
++|...++||+|+||.||+++... ++.+|+|.+..........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 467778999999999999999754 7889999886655555567889999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999998843 345899999999999999999999998 9999999999999999999999999987654221
Q ss_pred ccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 446 ANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.......|+..|+|||++. ...++.++||||||+++|||++|+.|+....... . .... ..... ..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~----~~~~-~~~~~---~~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--A----LFLM-TKSNF---QPPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--h----HHhh-hccCC---CCCc
Confidence 1223357899999999974 4568899999999999999999999864322110 0 0000 00000 0000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ......+.+++..|++.+|++||++.+|++
T Consensus 231 ~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 011235678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=295.71 Aligned_cols=251 Identities=35% Similarity=0.520 Sum_probs=199.4
Q ss_pred CCcCCeecccCcccEEEEEEeC-----CcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
|++.+.||+|+||.||+++..+ +..+|+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999999865 378999998655433 5678999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854222 12899999999999999999999998 999999999999999999999999999876544
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
...... ...++..|+|||.+.+..++.++||||+|++++||++ |..|+..... ..+.. ........
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~----- 223 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE----YLKKGYRL----- 223 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCCCC-----
Confidence 222211 2336789999999988889999999999999999998 6777543211 01111 11111100
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
.........+.+++.+|++.+|++|||+.++++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111334678899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.50 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=198.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|+..+.||+|+||.||+|+... ++.+|+|++.... ....+.+.+|+.++++++|+||+++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 467888999999999999999864 8899999886542 2234568899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988887632 335899999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH--------HHhhhcC
Q 007361 444 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--------RLWIEER 514 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~ 514 (606)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+................ ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 568899999999999999999999986433211110000000 0000000
Q ss_pred c-chhcccccCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 P-VELINKSLGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~-~~l~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. .....+......+. .....+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 00000000000111 11346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.70 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=196.6
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
|+..+.||+|+||.||++.... ++.+|+|++..... ...+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 5667899999999999999764 78999999865422 2235677899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999885422 235899999999999999999999988 99999999999999999999999999876532211
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+........ ............ ....
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----~~~~~~~~~~~~-----~~~~ 225 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKEVQ-----EEYS 225 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----HHHHHhhhhhhh-----hhcC
Confidence 1234689999999999999999999999999999999999999864321110 000010100000 0011
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
.. ....+.+|+..||+.+|++||| +.++++
T Consensus 226 ~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EK----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cc----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11 2235678999999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=299.64 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=198.5
Q ss_pred CCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccc------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
+|...+.||+|+||.||+|...+++.+|+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999987899999998864321 2235688999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999853 235789999999999999999999988 99999999999999999999999999886532
Q ss_pred Cc----ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 442 DQ----TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 442 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
.. .........++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~--~~~--~~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYI--GAH--RG 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHh--hhc--cC
Confidence 11 1112233568899999999999999999999999999999999999975322110 00000 000 00
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+.+ +......+.+++.+||+.+|++||++.++++
T Consensus 226 -~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -LMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111 1122345678999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=306.64 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=196.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|...++||+|+||.||+|+... ++.||+|.+.... ......+.+|+.+++.++||||+++++++......++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 568888999999999999999764 7889999986543 33345678899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888887542 345889999999999999999999988 99999999999999999999999999976533221
Q ss_pred cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHHHHHhhhcCc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLWIEERP 515 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~~~ 515 (606)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+............ ...|..+.....
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 11224568899999998754 5789999999999999999999998643321110000 001111100000
Q ss_pred chhcc-cccCCC----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELIN-KSLGGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d-~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
....+ +..... ........+.+|+.+|++.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 000000 00011235678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.76 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=203.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
++|+..+.||.|+||.||++.... ++.+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 578888999999999999999864 6789999987666566788999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988542 245899999999999999999999988 99999999999999999999999999876543211
Q ss_pred ccccccccccCccCccccccC---CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 446 ANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .. .. .... .+....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~----~~-~~~~---~~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--AL----FL-ISKS---NFPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HH----HH-HHhc---cCCCcc
Confidence 12235678899999999877 88999999999999999999999975332110 00 00 0000 000000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+ .........+.+++.+||+.+|.+||++.+|+.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 112233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.05 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=195.6
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
|+..+.||+|+||+||++.... ++.+|+|.+.... ......+.+|+.++.+++|+|++++.+.+..++..++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5667889999999999999754 8899999986542 22345578899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998886432 345899999999999999999999988 9999999999999999999999999987653221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......|+..|+|||.+.+..++.++|+||||+++|||++|..|+........ ........... ...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~------~~~-- 223 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLET------EEV-- 223 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcc------ccc--
Confidence 12235689999999999999999999999999999999999999754321100 00000000000 000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
........+.+|+..|++.+|++||+ +.+++.
T Consensus 224 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 --YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11112235678999999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=297.57 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=196.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|.+.+.||+|+||.||+|.. .++.+|+|++.... ..+.+.+|+.++..++|||++++++++... ..++|+||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67889999986432 346789999999999999999999998754 4799999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 99999998643 2345899999999999999999999988 999999999999999999999999998764321
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......+..|+|||.+.+..++.++||||||+++|||++ |+.|+....... + ....... ...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~---------~~~ 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---V----KECVEKG---------YRM 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---H----HHHHhCC---------CCC
Confidence 112234568999999998999999999999999999998 888865332110 1 1111111 001
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.........+.+++.+||+.+|++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111223567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.79 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=199.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568888999999999999999865 7889999987766666788999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999998887432 345899999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 446 ANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.......++..|+|||.+. ...++.++||||||+++|||++|+.|+...... . .............
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~-~~~~~~~~~~~~~-- 235 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R-VLLKIAKSEPPTL-- 235 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------H-HHHHHhcCCCccC--
Confidence 1122356788999999985 345788999999999999999999987532211 0 0011111111000
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++.+||+.+|++||++.++++
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011122235778999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.18 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=207.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC---C--cEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE---G--QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~---g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
+.....++||+|-||.||+|...+ | -.||||..+.. .....+.|..|..+|++++|||||+|+|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 445566899999999999999644 3 35889998774 44557889999999999999999999999986 56799
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|||.++-|.|..||.. +...|+......++.||..+|+|||+.. ++||||.++|||+....-+||+|||+++.+.
T Consensus 468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999964 3445888999999999999999999997 9999999999999999999999999999886
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.+.....+ ...-+..|||||.+.-.+++.++|||.|||.+|||+. |.+||..... .+..-.+
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI~~i 605 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVIGHI 605 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceEEEe
Confidence 55444333 3455779999999999999999999999999999985 8899754321 1122222
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
+..-+-..+...+..|+.|+.+||..+|.+||.+.++...|+.
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 2222233455667788999999999999999999999877754
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.98 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=174.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|+..+.||+|+||.||++.... ++.+|+|.+.... ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 467888999999999999999865 8899999986532 334567888999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999853 345899999999999999999999998 999999999999999999999999998754321
Q ss_pred ccc---------------------------------ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccC
Q 007361 443 QTE---------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 489 (606)
Q Consensus 443 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~ 489 (606)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 01123579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 007361 490 NRGFY 494 (606)
Q Consensus 490 p~~~~ 494 (606)
||...
T Consensus 235 Pf~~~ 239 (360)
T cd05627 235 PFCSE 239 (360)
T ss_pred CCCCC
Confidence 98543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.60 Aligned_cols=198 Identities=26% Similarity=0.370 Sum_probs=167.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-----
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----- 356 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 356 (606)
..++|...+.||+|+||.||++.... |+.+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999999754 889999998654 2334567889999999999999999999986543
Q ss_pred -eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 357 -ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 357 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 47999999975 5555552 23788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
++..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9764322 1223357899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.95 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=192.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-----ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--Cee
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER 358 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 358 (606)
.+|...+.||+|+||.||++.... ++.+++|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468888999999999999999764 8899999886432 12345688999999999999999999998653 567
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999853 234889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 439 FGIDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 439 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
+..... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~-----~ 224 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIAT-----Q 224 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhc-----C
Confidence 543211 11122345788999999999989999999999999999999999997532110 00000000 0
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
......+......+..++ .||..+|++||++++|++
T Consensus 225 ----~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 ----PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001111111122334444 788899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.41 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=198.7
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|++.+.||+|+||.||++... .++.+|+|.+... .......+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999986 5889999988654 233356789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
+++++|..++........+++..+..++.+++.||.|||+. + |+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999886533344689999999999999999999974 5 9999999999999999999999999997653221
Q ss_pred ccccccccccccCccCccccccCC------CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+...... ..... .........
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~-~~~~~~~~~-- 227 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQ-LSAIVDGDP-- 227 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHH-HHHHhhcCC--
Confidence 22345788999999985543 588999999999999999999997532211 11100 000011110
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 -------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1122223456778999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=301.12 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=200.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeCC----cEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEG----QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
++|...++||+|+||.||+|...+. ..+++|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577889999999999999997543 468888886554 3456689999999999999999999998875 557899
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+++++|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999542 235899999999999999999999988 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
..... .....++..|+|||.+....++.++||||||++++||++ |..|+...... .... ........
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~----~~~~~~~~---- 227 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIG----RIENGERL---- 227 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHH----HHHcCCcC----
Confidence 32211 112334568999999988899999999999999999996 99987543221 1111 11111100
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
.... .....+.+++.+|+..+|++||++.++++.|++..
T Consensus 228 -~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -PMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111 12346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.94 Aligned_cols=201 Identities=23% Similarity=0.301 Sum_probs=172.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.+.||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999999765 778999988653 2233456888999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 345889999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccCcccccc-----CCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 443 QTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
... ......||+.|+|||++.+ ..++.++||||||++||||++|+.|+..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 221 1223578999999999875 5688999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.36 Aligned_cols=260 Identities=24% Similarity=0.322 Sum_probs=191.0
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhc---cCCCcceEEEEEee-----CC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKL---QHRNLVKLIGCCTQ-----RD 356 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 356 (606)
+|.+.+.||+|+||.||++...+ ++.+|+|.+..... .....+.+|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47778999999999999999865 78999998865422 2234566777777665 69999999998864 24
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++|+||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 8888875432 344899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc---
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE--- 513 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 513 (606)
+...... ......+|..|+|||++.+..++.++||||||+++|||++|+.|+....... ............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 8764221 1223567899999999999999999999999999999999999875432211 111111000000
Q ss_pred Ccch---hcccccCC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RPVE---LINKSLGG-------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~~~---l~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ........ .........+.+++..|++.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000000 000112245679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=295.69 Aligned_cols=266 Identities=22% Similarity=0.304 Sum_probs=200.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccc--ccccCHHHHHHHHHHHhhccCCCcceEEEEEee-----CCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-----RDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 357 (606)
...|...+.||+|+||.|.++.... |..||+|++.. ......+.-.+|+++|+.++|+||+.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3455557899999999999999765 88999999974 344456778899999999999999999998855 456
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.|+|+|+| +.+|...+. .++.|+......++.||++||.|+|+.+ |+||||||.|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 668888883 3444899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCcccccccccccccCccCccccc-cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH--------HH
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WR 508 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~ 508 (606)
...........+..+.|..|.|||++. ...|+...||||.|||+.||++|+.-|...+.-....++-.. ..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 876542233335578899999999986 467999999999999999999999988765432222111110 00
Q ss_pred HhhhcCcchhccccc-CCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 509 LWIEERPVELINKSL-GGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..........+...- ....+. ......++|..+||..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000111111000 000111 11235678889999999999999999874
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=295.77 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=204.0
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|++.+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+.+++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999975 47789999886543 33567899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965433356899999999999999999999988 99999999999999999999999999987654332
Q ss_pred cc--cccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 445 EA--NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 445 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.. ......++..|+|||.+... .++.++||||||+++|||++|+.|+....... .... .......
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~----- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLML-TLQNDPP----- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHH-HhcCCCC-----
Confidence 21 22345688999999998877 78999999999999999999999975432211 0011 1111111
Q ss_pred ccCCCCC-HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYS-LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+..... ......+.+++..||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0111010 122345678999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.67 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=197.0
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc----------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG----------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD 356 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 356 (606)
+|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+..|+.++..++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999865 488999998753211 11346788999999999999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 46899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCccccccCC--CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
+...............++..|+|||.+.... ++.++||||||+++|||++|..|+..... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc-
Confidence 8654322222233456889999999987654 89999999999999999999999742111 11111110000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ..+...........+.+++..||+.+|++||++.+|++
T Consensus 229 ~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 01111111122356778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=311.36 Aligned_cols=235 Identities=24% Similarity=0.291 Sum_probs=181.4
Q ss_pred ecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc---cCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL---QHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
||+|+||.||+|+... ++.+|+|++.+.. ......+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999765 8899999986532 12233455566666655 699999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999988853 345899999999999999999999998 9999999999999999999999999987643221 12
Q ss_pred ccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
.....||..|+|||++.+. .++.++|||||||++|||++|+.|+...... ........+.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~------~~~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGKV------RFPKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCCC------CCCCc
Confidence 2346799999999998765 4899999999999999999999997532211 11111111110 01100
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
.....+.+++..||+.+|++||++
T Consensus 220 ---~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 220 ---VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred ---cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 112356688999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=305.10 Aligned_cols=261 Identities=26% Similarity=0.358 Sum_probs=197.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|+..++||+|+||.||+|...+ ++.+|+|++..... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 467888999999999999999865 88999998865432 235678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|..+... ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887642 234899999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH---Hhhhc-----C
Q 007361 444 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR---LWIEE-----R 514 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---~~~~~-----~ 514 (606)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+...... ........ .+... .
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHhc
Confidence 1 1223467889999999875 45788999999999999999999887533211 00000000 00000 0
Q ss_pred cchhcccc----cCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKS----LGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~----l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
....++.. ..... .......+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 00000 0112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.81 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=198.7
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEee-CCeeEEEEe
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDERMLIYE 363 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 363 (606)
+|++.+.||+|++|.||++.... ++.+++|++.... ....+.+.+|+.++++++|+|++++++.+.. ....++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47788999999999999999765 6789999986432 3345678999999999999999999998764 446789999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++... ....+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998642 3345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|+..... ...... ...+..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~-~~~~~~-------- 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYR-IIEGKL-------- 219 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-HHhcCC--------
Confidence 2 22335688999999999999999999999999999999999998753211 111111 111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+......+.+++.+|++.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111223346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.24 Aligned_cols=257 Identities=22% Similarity=0.265 Sum_probs=201.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|...+.||+|+||.||++...+ ++.+|+|.+..... ...+.+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888999999999999999875 88999999876432 24567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+.+++|.+++.. .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998853 23456899999999999999999999988 999999999999999999999999998765321
Q ss_pred ccc---------------------------ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCC
Q 007361 443 QTE---------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 495 (606)
Q Consensus 443 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 495 (606)
... .......||..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 11123468889999999999999999999999999999999999975332
Q ss_pred CCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 496 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 496 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
... .+.. ..+....-.........+.+++.+||+.+|++||++...++.|-.
T Consensus 237 ~~~-------~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE-------TFSN--------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH-------HHHH--------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 210 0000 011111000111134578899999999999999994444444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.55 Aligned_cols=201 Identities=23% Similarity=0.307 Sum_probs=171.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.++||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468888999999999999999866 678999988542 2233456888999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999542 345899999999999999999999988 999999999999999999999999999765322
Q ss_pred cccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 443 QTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
.. .......||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 21 1223357999999999986 34688999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.30 Aligned_cols=197 Identities=26% Similarity=0.392 Sum_probs=160.7
Q ss_pred CCeecccCcccEEEEEEeC---CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEee--CCeeEEEEecCC
Q 007361 292 KNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLIYEYLP 366 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 366 (606)
..+||+|+||.||+|+..+ +..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999999754 4689999886542 23467899999999999999999999854 456799999987
Q ss_pred CCCchhhhccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCceEEeecCCc
Q 007361 367 NKSLNDFIFDV------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMA 436 (606)
Q Consensus 367 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~ki~DFGla 436 (606)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 676666321 12235889999999999999999999998 9999999999999 56679999999999
Q ss_pred cccCCCccc-ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 437 RAFGIDQTE-ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 437 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
+.+...... .......+|..|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 222345789999999998764 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.80 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=199.6
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|+..++||+|+||.||++.... |+.+++|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47788999999999999999754 789999998643 233456889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988532 2335789999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||++.+..++.++||||||+++++|++|+.|+..... ..... ....+..
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~-~~~~~~~--------- 218 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVL-KIIRGSY--------- 218 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHH-HHhcCCC---------
Confidence 12234578899999999999999999999999999999999998653211 00000 0011110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+......+.+++.+||+.+|++||++.+|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0011122346788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.07 Aligned_cols=251 Identities=24% Similarity=0.284 Sum_probs=207.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc---CHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 359 (606)
..+.|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678888999999999999999887 999999999776443 3468999999999998 999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC----CCceEEeecCC
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----EMNPKISDFGM 435 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~ki~DFGl 435 (606)
+|||++.||.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999654 2999999999999999999999988 999999999999953 35799999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... ....+..
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence 998754 334556899999999999999999999999999999999999999986543221111 1111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
......-......+-+++..++..||..|+++.++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111111122345678999999999999999999998
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=295.58 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=198.6
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-----ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
+|...+.||+|+||.||+|... +++.+++|.+.... ....+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999987 68899999886543 23456789999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999853 345889999999999999999999998 99999999999999999999999999887543
Q ss_pred CcccccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.|+..... ....+........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~----- 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL----- 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC-----
Confidence 32 223356888999999988776 89999999999999999999999754321 0111110000000
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111112346678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.79 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=200.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|.+.++||.|+||.||++... ++..+|+|.+........+.|..|+.++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467888899999999999999985 4789999998766666667899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999998542 345899999999999999999999998 99999999999999999999999999876532211
Q ss_pred cccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 445 EANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
......++..|+|||.+. +..++.++||||||+++|||++|+.|+...... . ............+.
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~ 229 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------R-VLLKILKSEPPTLD 229 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------H-HHHHHhcCCCCCcC
Confidence 122356888999999975 345788999999999999999999997543211 0 00111111110000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+......+.+++..||+.+|.+||++.+|++
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 230 -------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -------CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 01112235678999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.04 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=195.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------ 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 355 (606)
..++|...+.||+|+||.||++.... ++.+|+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35789999999999999999999754 7899999986542 33456788999999999999999999987543
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
...++||||+++ +|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 6666662 23789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHH-
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHA- 506 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~- 506 (606)
++...... ......+|..|+|||++.+..++.++||||||+++|||++|+.||............ ...
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98653321 223357899999999999999999999999999999999999998643221100000 000
Q ss_pred ------HHHhhhcCcc-------hhccccc---CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 507 ------WRLWIEERPV-------ELINKSL---GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 507 ------~~~~~~~~~~-------~l~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
...+...... .+....+ ...........+.+++.+|++.||++|||+.++++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0000000 000011112367789999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.80 Aligned_cols=201 Identities=25% Similarity=0.323 Sum_probs=172.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999765 889999998652 2234456889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999853 2345889999999999999999999998 999999999999999999999999998765432
Q ss_pred cccccccccccccCccCcccccc-----CCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 443 QTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
... ......||+.|+|||++.. ..++.++||||||+++|||++|+.|+..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 221 1223468999999999863 4578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.15 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=194.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-----ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--Cee
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER 358 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 358 (606)
++|+..++||+|+||.||+|...+ +..|++|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478889999999999999999765 8899999875321 12345788899999999999999999998764 457
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++++||+++++|.+++.. ...+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999853 234788999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 439 FGIDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 439 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~-------- 221 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKI-------- 221 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHH-HHHH--------
Confidence 542211 1122335688899999999988899999999999999999999999753211 000 0000
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.........+......+.+++..|+. +|++||++.+|++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 -ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00000111222333456678888885 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=313.37 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=195.6
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------ 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 355 (606)
..++|...+.||+|+||.||++.... ++.+|+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999998754 8899999986542 23346778899999999999999999988643
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
...++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 347999999975 5666552 23789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccc-hhH-------H--
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN-LLG-------H-- 505 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~-------~-- 505 (606)
++...... ......+|..|+|||++.+..++.++||||||+++|||++|+.||.......... ... .
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98653221 1233578999999999999999999999999999999999999986432110000 000 0
Q ss_pred -----HHHHhhhcCcc-------hhc-ccccC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 506 -----AWRLWIEERPV-------ELI-NKSLG--GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 506 -----~~~~~~~~~~~-------~l~-d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
....+.+.... ... +.... ..........+.+++.+|++.||++|||+.++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00001110000 000 00000 00111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.24 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=192.0
Q ss_pred HHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCC------CcceEEEEEe
Q 007361 281 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR------NLVKLIGCCT 353 (606)
Q Consensus 281 ~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~~~ 353 (606)
++...+++|.+.++||+|+||.||++.+.. ++.||||++.... ....++..|+.++..++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 334456889999999999999999999765 7789999985432 2344567788888777554 5888988887
Q ss_pred eC-CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCC-----
Q 007361 354 QR-DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEM----- 426 (606)
Q Consensus 354 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~----- 426 (606)
.. ...++|+|++ +++|.+++.. ...+++..+..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 54 5688999988 7788888753 34589999999999999999999984 6 99999999999998765
Q ss_pred -----------ceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCC
Q 007361 427 -----------NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 495 (606)
Q Consensus 427 -----------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 495 (606)
.+||+|||.+..... ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998764321 2234679999999999999999999999999999999999999986543
Q ss_pred CCCccchhHHHH----HHhhh----cCcchhcccc--cC------------CCC---CHHHHHHHHHHHhhcccCCCCCC
Q 007361 496 ADHHHNLLGHAW----RLWIE----ERPVELINKS--LG------------GSY---SLSEVLRCIQVGLLCVQQRPEDR 550 (606)
Q Consensus 496 ~~~~~~l~~~~~----~~~~~----~~~~~l~d~~--l~------------~~~---~~~~~~~l~~l~~~Cl~~~P~~R 550 (606)
......++.... ..|.. .....+++.. +. ... .......+++|+..||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 221111110000 00000 0000000000 00 000 00112356799999999999999
Q ss_pred CCHHHHHH
Q 007361 551 PNMSSVVL 558 (606)
Q Consensus 551 Ps~~~vl~ 558 (606)
||+.|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=289.32 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=197.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccc--ccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.+++|++.+.||+|.|+.|++..... |+.+|+|.+.. ......+++.+|+.+-+.|+||||++|.....+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34678888999999999999988654 88888887643 2344778899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCceEEeecCCccc
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARA 438 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~ki~DFGla~~ 438 (606)
+|+|.|++|..=+. .+-.+++..+-..+.||+++|.|+|.++ |||||+||+|++|- ..--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999876553 3355788889999999999999999998 99999999999994 345689999999998
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
++ .........||++|||||++...+|+..+|||+.|||||-|+.|..||-..+. ..+ ......+ -
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rl----ye~I~~g----~ 228 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL----YEQIKAG----A 228 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHH----HHHHhcc----c
Confidence 86 22223347899999999999999999999999999999999999999743111 011 1111111 0
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
.|-.-.... .-.+...+|+.+||..||.+|.|+.|.+
T Consensus 229 yd~~~~~w~--~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 229 YDYPSPEWD--TVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cCCCCcccC--cCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 010000001 1123556889999999999999999877
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=295.84 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=198.7
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|.+.+.||+|+||.||+|... +|+.+++|++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677899999999999999975 48899999987653 33456899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+ +++|.+++.... ..+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999985432 56899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH-----------Hhhh
Q 007361 445 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR-----------LWIE 512 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~~ 512 (606)
.......++..|+|||.+.+. .++.++||||+|++++||++|+.++...... ........ ...+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence 122235688899999998754 4689999999999999999997765432211 11111111 0000
Q ss_pred cCcchhcccccCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 513 ERPVELINKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 513 ~~~~~l~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
......+........ .......+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000000 0112357789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=330.98 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=195.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEee--CCeeE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 359 (606)
..++|.+.++||+|+||.||++.... +..+|+|.+... .......|..|+.++.+++|||||++++++.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 45689999999999999999999866 667888887543 23345678999999999999999999998854 35689
Q ss_pred EEEecCCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeccCCCCCEEEcC----------
Q 007361 360 LIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSR----LRIIHRDLKASNVLLDN---------- 424 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiH~Dlk~~NIll~~---------- 424 (606)
|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986422 23469999999999999999999998542 24999999999999964
Q ss_pred -------CCceEEeecCCccccCCCcccccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCCCCCC
Q 007361 425 -------EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 495 (606)
Q Consensus 425 -------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 495 (606)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3358999999998764322 1233578999999999864 458999999999999999999999975322
Q ss_pred CCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 496 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 496 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
. .. ......... . .+. .......+.+|+..||+.+|.+||++.+++
T Consensus 248 ~-----~~-qli~~lk~~-p------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 248 N-----FS-QLISELKRG-P------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred c-----HH-HHHHHHhcC-C------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 1 10 111111110 0 000 001134678899999999999999999998
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.84 Aligned_cols=244 Identities=26% Similarity=0.414 Sum_probs=200.6
Q ss_pred eecccCcccEEEEEEeCCc-EEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCchh
Q 007361 294 KLGEGGFGPVYKGVLIEGQ-EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND 372 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~~g~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 372 (606)
+||+|.||+||-|++.+++ .+|||-+........+-+.+|+.+-++|+|.|||+++|.+.+++..-+.||.++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999987754 789999988777777889999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCceEEeecCCccccCCCccccccc
Q 007361 373 FIFDVTRSKFL--DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTN 449 (606)
Q Consensus 373 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~ki~DFGla~~~~~~~~~~~~~ 449 (606)
+|... =+++ ++.++-.+..||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+. ....-+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence 99542 2344 77888889999999999999998 99999999999996 47999999999998763 2334455
Q ss_pred ccccccCccCccccccCC--CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 450 RVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 450 ~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
...||..|||||++..++ |..++|||||||.+.||.||++||-....... ..+.-+ . -......
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVG-m-----yKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVG-M-----YKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhc-c-----eecCCCC
Confidence 678999999999997654 89999999999999999999999754322110 000000 0 0112234
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+.+...++..++++|+..+|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 4445567788999999999999999999985
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.32 Aligned_cols=244 Identities=30% Similarity=0.431 Sum_probs=197.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc---CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..|...+.||.|+||.||-++... ...||+|+++....+ .+.++..|+..|.+++|||+|.+-|||......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 356677899999999999999765 678999999876544 3567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|||- ||-.|+|. ...+++.+..+..|..+.+.||+|||+.+ .||||||+.||||++.|.+||+|||.|....
T Consensus 106 EYCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 106 EYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 9994 57777773 34567999999999999999999999998 9999999999999999999999999987653
Q ss_pred cccccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
..+.++||+.|||||++. .+.|+-|+||||+|++..||.-.++|.=. .+.+.... ....+....+
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn------MNAMSALY-HIAQNesPtL- 245 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------MNAMSALY-HIAQNESPTL- 245 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC------chHHHHHH-HHHhcCCCCC-
Confidence 344589999999999985 56799999999999999999988887311 11111111 1111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
...+....+.+++..||+.-|.+|||..+++
T Consensus 246 -------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 246 -------QSNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred -------CCchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 1334456778899999999999999988876
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.51 Aligned_cols=199 Identities=18% Similarity=0.238 Sum_probs=164.8
Q ss_pred cCCeeccc--CcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 291 DKNKLGEG--GFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 291 ~~~~lG~G--~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+.++||+| +|++||++.... |+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 789999998754 8899999986542 233456778999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc-
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT- 444 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~- 444 (606)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985422 234899999999999999999999988 99999999999999999999999987544321111
Q ss_pred ----cccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 445 ----EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 445 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
........++..|+|||++.+ ..++.++||||||+++|||++|+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 011122356778999999976 4689999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.94 Aligned_cols=256 Identities=19% Similarity=0.238 Sum_probs=200.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|...+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+.++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 367888999999999999999865 7889999886543 233567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999854 345899999999999999999999988 999999999999999999999999998742111
Q ss_pred ccc-------------ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 443 QTE-------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 443 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
... .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... .+ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~----~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---EL----FGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHH
Confidence 000 0111245788999999999989999999999999999999999997432111 11 111
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
...... ..+.... .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111100 0000001 123356789999999999999998888888865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.68 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=203.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
+.|+..+.||.|.-|+||++++.+ +..+|+|++.+.. +........|-+||+.++||.+..|++.+......+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456677899999999999999976 5889999997753 344556778999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC-
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI- 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~- 441 (606)
|||+||+|..+++. +..+.+++..+..++..|+-||+|||-.| ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999998854 55667999999999999999999999998 99999999999999999999999998643310
Q ss_pred ---------------------------------Cc--------------------ccccccccccccCccCccccccCCC
Q 007361 442 ---------------------------------DQ--------------------TEANTNRVVGTYGYMPPEYAIDGLF 468 (606)
Q Consensus 442 ---------------------------------~~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 468 (606)
.. .....+..+||-.|+|||++.+..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 0012344679999999999999999
Q ss_pred CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCC
Q 007361 469 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPE 548 (606)
Q Consensus 469 s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~ 548 (606)
+.++|+|+|||+||||+.|..||......+.. ..++...+.-.........+.+||...|..||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999998655433211 111111111111113345678899999999999
Q ss_pred CCCC----HHHHH
Q 007361 549 DRPN----MSSVV 557 (606)
Q Consensus 549 ~RPs----~~~vl 557 (606)
+|.. +.||-
T Consensus 378 kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 378 KRLGSKRGAAEIK 390 (459)
T ss_pred hhhccccchHHhh
Confidence 9998 66665
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=298.04 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=196.8
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc-----CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ-----GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
+|...+.||+|+||.||+|... +++.+++|++...... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999975 4889999998755322 335577899999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985422 36999999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc-------
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE------- 513 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 513 (606)
... ......++..|+|||.+.+ ..++.++||||||++++||++|..++...... .............
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 321 1222356778999998865 46789999999999999999997665432211 1111111000000
Q ss_pred --CcchhcccccCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 514 --RPVELINKSLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 514 --~~~~l~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
..............+ ......+.+++.+||+.+|++||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000001111 1123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.77 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=199.2
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|+..++||+|+||.||+|...+ ++.+++|++... .....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 67888999999999999999875 789999988653 233457889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
++++.|..++. +...+++..+..++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99877776553 2344899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH--------HHHhhhcCc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WRLWIEERP 515 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~ 515 (606)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.|+............... +..+.....
T Consensus 156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 1 22235678899999999888 8899999999999999999999887532211000000000 000000000
Q ss_pred c---hhccccc----CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 V---ELINKSL----GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~---~l~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. +..+... ....+......+.+++..||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000000 00011112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.89 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=198.1
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
.|.....||+|+||.||++... .+..+|+|++........+.+.+|+.++..++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3344467999999999999975 488999999876555566778999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999998832 34899999999999999999999998 99999999999999999999999999876533221
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ..... .+...+...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~----~~~~~-----~~~~~~~~~ 241 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAM----RRIRD-----NLPPRVKDS 241 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHh-----cCCCccccc
Confidence 123356889999999999889999999999999999999999997532211 000 00000 011111111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
. .....+..++..|++.+|++|||+.++++.
T Consensus 242 ~--~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 H--KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 122356678889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.05 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=197.4
Q ss_pred cCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 291 DKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
...+||+|+||.||++... +++.+|+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3467999999999999975 488999999876555566788999999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccccc
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 449 (606)
|..++. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..... ...
T Consensus 105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 999773 245899999999999999999999998 99999999999999999999999999876543221 123
Q ss_pred ccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCH
Q 007361 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL 529 (606)
Q Consensus 450 ~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~ 529 (606)
...++..|+|||++.+..++.++||||||+++|||++|+.|+...... ... .......... .. ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~----~~~~~~~~~~-----~~--~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM----KRLRDSPPPK-----LK--NAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhccCCCC-----cc--ccC
Confidence 356889999999999989999999999999999999999997532211 000 0011100000 00 000
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 530 SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 530 ~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.....+.+++..|++.+|++||++.++++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112356788999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=298.65 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=200.2
Q ss_pred HHHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEe----
Q 007361 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT---- 353 (606)
Q Consensus 280 ~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~---- 353 (606)
..+..+.++|++.+.||+|+||.||++.... ++.+|+|.+.... ....++.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 4455677899999999999999999999765 7889999875432 2346788999999999 6999999999884
Q ss_pred -eCCeeEEEEecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 354 -QRDERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 354 -~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999987532 23456899999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 506 (606)
|||+++....... ......|+..|+|||++. +..++.++||||||+++|||++|+.|+....... .
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~- 237 (286)
T cd06638 167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------A- 237 (286)
T ss_pred cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------H-
Confidence 9999987643221 122346899999999885 3457899999999999999999999975432110 0
Q ss_pred HHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 507 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
...........+..+ . .....+.+++.+||+.+|++||++.+|++-
T Consensus 238 ~~~~~~~~~~~~~~~---~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFKIPRNPPPTLHQP---E----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HhhccccCCCcccCC---C----CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000000000011000 0 112357789999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=292.10 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=199.8
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc--CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|...+.||+|+||.||+|... +++.+++|.+...... ..+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999975 5889999998765443 567899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 345889999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccc--ccccccccCccCccccccCC---CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 445 EAN--TNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 445 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
... .....++..|+|||++.+.. ++.++||||||+++|||++|+.|+...... ......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~----- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GH----- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CC-----
Confidence 211 22356788999999998766 899999999999999999999997543211 000000000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.+... ......+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011111 111345678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=294.45 Aligned_cols=259 Identities=25% Similarity=0.316 Sum_probs=200.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 362 (606)
++|...+.||.|++|.||++.... ++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 357778999999999999999864 78899998865433 3456789999999999999999999998654 4689999
Q ss_pred ecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987532 23455889999999999999999999988 99999999999999999999999999876532
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc-Ccchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE-RPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~l~d 520 (606)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .... ...+... ....+ .
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~--~~~~~~~~~~~~~-~ 229 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIE--LLSYIVNMPNPEL-K 229 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHH--HHHHHhcCCchhh-c
Confidence 211 124568899999999999999999999999999999999999865422111 1111 1111111 11111 1
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ........+.+++.+||+.+|++|||+.+|++
T Consensus 230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111 01122456789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.10 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=193.4
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR----- 355 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 355 (606)
...++|...+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999999754 7899999986542 23345678899999999999999999987543
Q ss_pred -CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 356 -DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 356 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 788888773 345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
+++..... .....||..|+|||++.+ ..++.++||||||+++|||++|+.|+....... ....... ....
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~-~~~~ 234 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIME-VVGT 234 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHH-HhCC
Confidence 99865322 223568999999999877 568999999999999999999999975422110 0000000 0000
Q ss_pred Ccchhccc-----------ccCCCC--CH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RPVELINK-----------SLGGSY--SL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~~~l~d~-----------~l~~~~--~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+.... .+.... .. .....+.+++..|++.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 000000 00 01124678999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=293.61 Aligned_cols=253 Identities=24% Similarity=0.428 Sum_probs=199.6
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
+|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777899999999999999864 488999998864331 134678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCcccc
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF 439 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~ 439 (606)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 345899999999999999999999998 99999999999998775 6999999999876
Q ss_pred CCCccc--ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 440 GIDQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 440 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|+.|+...... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~-------- 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS---NHLALIFKI-------- 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc---chHHHHHHH--------
Confidence 433211 1122356788999999999889999999999999999999999997533211 111111100
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.........+......+.+++.+|++.+|++||++.++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 -ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0001111222233456788999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=295.91 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=198.3
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
-|...++||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++.+++||||+++++++.++...++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999875 47889999876432 334567889999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999884 245899999999999999999999988 99999999999999999999999999876543211
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......++..|+|||.+.+..++.++||||||+++|||++|..|+...... . .......... .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~---------~ 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------K-VLFLIPKNNP---------P 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------H-HHHHHhcCCC---------C
Confidence 122346788999999999888999999999999999999999997532211 0 0000000000 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111223457789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=291.19 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=198.3
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|...+.||+|+||.||++...+ ++.+|+|.+... .......+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 47778999999999999998754 788999988654 233456889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~ki~DFGla~~~~~~~ 443 (606)
+++++|.+++... ....+++..+..++.++++||.|||+.+ ++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999542 2345899999999999999999999988 9999999999999854 568999999998764332
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ..... ........
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~----~~~~~~~~------ 220 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLK----IMSGTFAP------ 220 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHH----HHhcCCCC------
Confidence 1 22356788999999999988999999999999999999999997543211 01100 01110001
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.+++..||+.+|++|||+.++++
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11112346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=291.64 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=205.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|+..+.||+|++|.||+++... ++.+++|++..... .....+.+|+..+.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999875 89999999876544 4567899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
+++++|.+++... ..+++..++.++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999542 568999999999999999999999 87 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+. ........
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~~-------- 220 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGPP-------- 220 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCCC--------
Confidence 22 12356788999999999999999999999999999999999997544321111111 11111101
Q ss_pred CCCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 524 GGSYSLS-EVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 524 ~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
...+.. ....+.+++..|++.+|++||++.++++.
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111 34578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=292.98 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=199.4
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEee--CCeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 362 (606)
+|+..+.||.|+||.||++.... ++.+|+|.+... .....+.+.+|+.++++++|+||+++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 46778999999999999998754 788999988643 23345678899999999999999999998764 45679999
Q ss_pred ecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 363 EYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 363 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
||+++++|.+++... .....+++..++.++.+|+.||.|||..+ ...++|+||+|+||++++++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 22456899999999999999999999332 234999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... .+. .......
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~----- 226 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGK----- 226 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCC-----
Confidence 543221 22346889999999999989999999999999999999999997643211 111 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
....+......+.+++.+|++.+|++||++.+|++.
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111222334577899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=294.74 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=201.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|+..+.||+|+||.||++.... ++.+++|++.... ....+++.+|+.++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 356777899999999999999864 8899999886653 34456789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568999999999999999999999 77 9999999999999999999999999987653221
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ..... ..........
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~------- 222 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFEL-LQYIVNEPPP------- 222 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHH-HHHHhcCCCC-------
Confidence 11 15678899999999999999999999999999999999999754322111 11111 1111111110
Q ss_pred CCCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLS-EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... ....+.+++..||+.+|++||++.+++.
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 --RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 01111 3345778999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=296.78 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=199.3
Q ss_pred CHHHHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEee-
Q 007361 278 DWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ- 354 (606)
Q Consensus 278 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 354 (606)
+..++..+...|+..+.||+|+||.||+|.... ++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 334445567889999999999999999999854 7888988875443 3446788999999998 69999999999853
Q ss_pred -----CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceE
Q 007361 355 -----RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK 429 (606)
Q Consensus 355 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 429 (606)
....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45789999999999999988542 2345888999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCcccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH
Q 007361 430 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 504 (606)
Q Consensus 430 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 504 (606)
|+|||++........ ......|+..|+|||.+. +..++.++||||||+++|||++|+.|+........ .
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~-- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--L-- 235 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--h--
Confidence 999999876532211 223356889999999986 35688899999999999999999999753221100 0
Q ss_pred HHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 505 HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 505 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ...... ... ........+.+++..||+.+|.+||++.++++
T Consensus 236 --~~-~~~~~~-----~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 --FL-IPRNPP-----PKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hh-HhhCCC-----CCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000 000 01112346788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=296.87 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=202.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|...+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888899999999999999865 4789999998665555567889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999843 34789999999999999999999998 99999999999999999999999999876543322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+............ ..... +.
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~------~~-- 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PE-- 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC------CC--
Confidence 122346888999999999888999999999999999999999998543221100000 00000 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
..........+.+++..||+.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111123457789999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.51 Aligned_cols=247 Identities=24% Similarity=0.413 Sum_probs=197.3
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc-cccCHHHHHHHHHHHhhcc---CCCcceEEEEEeeCCeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 362 (606)
.|+..+.||+|+||.||+|... +++.+++|.+... .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999974 4889999988654 3345567889999999996 999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. ..+++...+.++.+++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 36899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.. ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+......... ...... ..+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--------~~~~~~----~~~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--------MLIPKS----KPP 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--------hccccC----CCC
Confidence 32 12234688899999998754 5789999999999999999999997543211100 000000 001
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+... .....+.+++..||+.+|++||++.+++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 12346778999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=300.15 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=197.3
Q ss_pred CCCcCCeecccCcccEEEEEEeC---CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERM 359 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 359 (606)
.|...++||+|+||.||+|.... ++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999999865 7899999997643 44456788999999999999999999999988 7899
Q ss_pred EEEecCCCCCchhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC----CCceEEeec
Q 007361 360 LIYEYLPNKSLNDFIFDVT--RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----EMNPKISDF 433 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~ki~DF 433 (606)
+|+||+++ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666653221 2236899999999999999999999998 999999999999999 999999999
Q ss_pred CCccccCCCcc-cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccch------hHH
Q 007361 434 GMARAFGIDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL------LGH 505 (606)
Q Consensus 434 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l------~~~ 505 (606)
|++........ ........++..|+|||.+.+. .++.++||||||++++||++|+.|+.....+..... +..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1222335678899999988764 589999999999999999999999865443321000 000
Q ss_pred HHHHhh-----------hc-CcchhcccccCCCCC---H--------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 506 AWRLWI-----------EE-RPVELINKSLGGSYS---L--------SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 506 ~~~~~~-----------~~-~~~~l~d~~l~~~~~---~--------~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
....+. +. ......+.......+ . .....+.+++.+|++.+|++|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00 000000000000000 0 12236789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=296.67 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=202.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++.|+..+.||+|+||.||+|.+. +++.+++|.+..... ..+.+.+|+.++++++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999987 488999999865544 56788999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999996432 36999999999999999999999988 9999999999999999999999999987653322
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... . .............
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~----~~~~~~~~~~~~~---- 237 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---A----LFLITTKGIPPLK---- 237 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhcCCCCCc----
Confidence 1 1223457889999999998899999999999999999999999975322110 0 0000011110000
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.+++.+|++.+|.+||++.++++
T Consensus 238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 ---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01112346778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.60 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=192.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHH-HhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLL-IAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|++.+.||+|+||.||+++... |+.||+|++.... .....++..|+.+ ++.++||||+++++++...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468888999999999999999864 8999999986543 2233455566665 566789999999999999999999999
Q ss_pred cCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 364 YLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 364 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|++ ++|.+++... .....+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888877542 2345689999999999999999999986 5 99999999999999999999999999986532
Q ss_pred CcccccccccccccCccCcccccc----CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAID----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... ..... .........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~~ 227 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLK-QVVEEPSPQ 227 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHH-HHHhcCCCC
Confidence 21 1122457889999998865 45789999999999999999999997532111 00000 011111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+. .......+.+++..||+.+|++||++.++++
T Consensus 228 ~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 0112345778999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=297.28 Aligned_cols=262 Identities=26% Similarity=0.344 Sum_probs=201.9
Q ss_pred cCHHHHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEee
Q 007361 277 FDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ 354 (606)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 354 (606)
+....+..++++|...+.||+|+||.||++...+ ++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 3344555678899999999999999999999854 7889999885432 2346778899999999 89999999999875
Q ss_pred C-----CeeEEEEecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 355 R-----DERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 355 ~-----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
. ...++|+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999988532 23456899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccC-----CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 503 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 503 (606)
||+|||++......... .....++..|+|||.+... .++.++||||||+++|||++|+.|+......
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------ 239 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence 99999998865432211 2234678899999998643 3689999999999999999999997532211
Q ss_pred HHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 504 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 504 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... .........+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~-~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 KTLF-KIPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHH-HHhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 011111111110 1122246788999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=286.57 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=204.0
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLIY 362 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 362 (606)
+|...+.||+|++|.||+|... +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677799999999999999987 588999999865542 4567899999999999999999999999988 8899999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++... ..+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998543 26899999999999999999999987 999999999999999999999999999877544
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
..........++..|+|||.+.+..++.++||||||+++++|++|+.|+.... ......+.... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~---------~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGS---------SG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccc---------cC
Confidence 33212334568889999999998889999999999999999999999976543 11111111110 00
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.....+......+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111112222457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=296.92 Aligned_cols=262 Identities=26% Similarity=0.371 Sum_probs=195.1
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|...+.||+|++|.||+|... +++.+|+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999976 478999999865432 2234577899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++ +|.+++... ...+++.....++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 899888542 236899999999999999999999988 99999999999999999999999999876432211
Q ss_pred cccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc-------
Q 007361 445 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV------- 516 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 516 (606)
. .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.|+...... .......+.........
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 112346789999999875 45899999999999999999999987533210 00111111100000000
Q ss_pred --hhcc--------cccCCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 --ELIN--------KSLGGS-YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 --~l~d--------~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ..+... ........+.+++..|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 000000 00111246678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=285.82 Aligned_cols=249 Identities=30% Similarity=0.450 Sum_probs=202.5
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677789999999999999986 588999999977665567889999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985422 46899999999999999999999987 99999999999999999999999999987643322
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... .. ..........+. .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~~~~-----~- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---AL----FKIATNGPPGLR-----N- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HH----HHHHhcCCCCcC-----c-
Confidence 234568889999999998889999999999999999999999975432110 00 000000011110 0
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.......+.+++..||+.+|++|||+.++++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111346788999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.67 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=199.3
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCC-----
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD----- 356 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~----- 356 (606)
.++++|++.+.||+|+||.||+|.... ++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356889999999999999999999864 7789999886543 3457799999999999 7999999999997654
Q ss_pred -eeEEEEecCCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 357 -ERMLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 357 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
..++|+||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886422 2456899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccc-----CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
++....... .......++..|+|||.+.. ..++.++||||||++++||++|+.|+...... ..+ ..
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~-----~~ 229 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RAL-----FK 229 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHH-----HH
Confidence 987653322 12223568889999998753 34788999999999999999999997532111 000 01
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........ + .........+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111100 0 111123346789999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=295.67 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=193.7
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|...+.||+|+||.||+|+... |+.+|+|++.... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 36777899999999999999864 8899999986432 22345678899999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
++ ++|.+++.. ....+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 477777643 2345899999999999999999999998 99999999999999999999999999986643322
Q ss_pred cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC------cch
Q 007361 445 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER------PVE 517 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 517 (606)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ........+...... ..+
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhh
Confidence 1 2234578899999998765 4799999999999999999999885321111 111111000000000 000
Q ss_pred hccc----ccCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINK----SLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~----~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+. ...... .......+.+++..||+.+|.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 000000 0112246678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=294.08 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=198.3
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
.|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3444579999999999999975 578999998865555556778999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999999854 35899999999999999999999998 99999999999999999999999998876533221
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ......... ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~----~~~~~~~~~-----~~~~- 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAM----KRIRDNLPP-----KLKN- 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHH----HHHHhcCCC-----CCcc-
Confidence 122346889999999999989999999999999999999999997432110 011 111111100 0000
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112346789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.16 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=198.3
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+|+..++||.|++|.||+|+... |..+|+|++..... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47788999999999999999864 88899999876533 33567788999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888865444456899999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHHHHHhhhcCcc
Q 007361 446 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLWIEERPV 516 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~~~~ 516 (606)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+............ ...|..+.. ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--Cc
Confidence 11234568899999988664 5789999999999999999999987543221100000 000111100 00
Q ss_pred hhcccccC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 ELINKSLG------GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~l~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........ ..........+.+++..|++.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0001112346778999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=292.32 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=196.0
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++++|...+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.+++.++|+||+++.+++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578889999999999999999875 488999999865433 33456789999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+. ++|.+++.. ....+.+..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 677776643 2245788889999999999999999998 999999999999999999999999999764322
Q ss_pred cccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhh---------
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE--------- 512 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--------- 512 (606)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.|+...... ...+...+..+..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence 21 12234568899999998764 5889999999999999999999998643321 0111111110000
Q ss_pred ----cCcchhcccccCCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 513 ----ERPVELINKSLGGS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 513 ----~~~~~l~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.............. ........+.+++.+|++.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000 00011345678899999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.37 Aligned_cols=247 Identities=29% Similarity=0.410 Sum_probs=193.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.+.|...++||+|+||.||+|+.. +++.||+|++..... ...+++.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999976 488999998864432 2345688999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 567666632 2345899999999999999999999988 99999999999999999999999999876432
Q ss_pred CcccccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+...... ..... ........
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~-~~~~~~~~- 233 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNDSPT- 233 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHH-HhcCCCCC-
Confidence 2 2246788999999874 456889999999999999999999986432110 00000 00000000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
+ ........+.+++..||+.+|++||++.+|+..
T Consensus 234 ----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ----L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 111223467899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.30 Aligned_cols=243 Identities=25% Similarity=0.300 Sum_probs=197.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|+..+.||+|+||.||++.... ++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 367888999999999999999864 7899999886532 234567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999854 346899999999999999999999988 999999999999999999999999999876433
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ........+.. .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------~ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV------R 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc------c
Confidence 23356889999999999888999999999999999999999997533210 11111111110 1
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVV 557 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl 557 (606)
.+......+.+++.+||+.+|.+|| ++.+++
T Consensus 217 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 ----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1111235677899999999999999 556655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=288.76 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=206.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+-|.+..+||+|+||+|||+.+.. |+.+|+|++.. +...+++..|+.++++.+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 446777899999999999999876 89999999854 345788999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
-.||+.+.+. .++++|.++++..++...++||+|||... -||||||+.||||+.+|.+||+|||.|-.+.. +-
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TM 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TM 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hH
Confidence 9999999985 36778999999999999999999999876 89999999999999999999999999987632 33
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
...+.+.||+-|||||++..-.|..++||||+|+...||.-|+.|+...++-..-..+ ....+..+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT~PPPTF------- 249 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PTKPPPTF------- 249 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cCCCCCCC-------
Confidence 4456689999999999999999999999999999999999999997654432111000 00001010
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++..||-.+|++|-|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 112233446788999999999999999888764
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.85 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=196.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 361 (606)
++|+..+.||+|+||.||+|.... ++.+++|++.... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 578888999999999999999864 7889999986543 22334677899999999999999999998877 889999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+++ +|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 898887542 236899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHHHHHhhh
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLWIE 512 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~ 512 (606)
... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.|+............ ...|..+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 12234568899999998765 4689999999999999999999987643221100000 001111100
Q ss_pred c------CcchhcccccCCCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 513 E------RPVELINKSLGGSYSLS-EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 513 ~------~~~~l~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
- .........+....... ....+.+++..||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00000000111111111 2345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.89 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=196.4
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEEEEe
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLIYE 363 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 363 (606)
|++.++||+|+||.||+|+..+ ++.+|+|++.... ......+.+|+.++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5567899999999999999865 7899999997653 33456788999999999999999999999888 88999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++ +|.+++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 888887532 246899999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC---cc---
Q 007361 444 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER---PV--- 516 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~--- 516 (606)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ............. ..
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 21 1222456788999998765 468999999999999999999999875433211 1111100000000 00
Q ss_pred h-----------hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 E-----------LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~-----------l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. .....+...........+.+++..||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000000000011456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.07 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=194.8
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|+..+.||.|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999976 48899999886442 22345788999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 6888887543 2345899999999999999999999988 99999999999999999999999999886643221
Q ss_pred cccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH----------HHHhhh-
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA----------WRLWIE- 512 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~----------~~~~~~- 512 (606)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.|+....... .+.... |..+..
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHH
Confidence 122235678999999887654 6889999999999999999999875432110 010000 000000
Q ss_pred ----cCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 513 ----ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 513 ----~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..........+. .........+.+++.+|++.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000011235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.69 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=193.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCe-----
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDE----- 357 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 357 (606)
++|+..+.||+|+||.||+|.... ++.||+|++.... ......+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468888999999999999999764 8899999876543 223467889999999995 6999999999987665
Q ss_pred eEEEEecCCCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecC
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTR--SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFG 434 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFG 434 (606)
.++||||+++ +|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78888754322 356899999999999999999999998 999999999999998 8999999999
Q ss_pred CccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
+++.+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|..|+....... .+ ..........
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~-~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QL-LHIFKLLGTP 231 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HH-HHHHHHhCCC
Confidence 99865432211 122356788999998865 457999999999999999999998875432110 00 0000000000
Q ss_pred Cc------chhcc----cccCC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RP------VELIN----KSLGG----SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~------~~l~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ....+ +.... .........+.+++..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00000 00000 000112345788999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=288.72 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=198.1
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|+..+.||+|+||.||+|.... |..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 46778999999999999999865 7889999886532 23456788999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~~~~~ 443 (606)
+++++|.+++... ....+++..+..++.++++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999998542 2335799999999999999999999988 99999999999998875 56999999998764322
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.|+..... ...... ..... +..
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~----~~~-- 221 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLK-ICQGY----FAP-- 221 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-Hhccc----CCC--
Confidence 1 12234688899999999988999999999999999999999999743211 111111 01110 000
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.+++.+|++.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11112246778999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=289.97 Aligned_cols=247 Identities=25% Similarity=0.277 Sum_probs=199.7
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
+|...+.||.|+||.||++.... ++.+|+|.+.+.. ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47788999999999999999864 8899999986543 2346789999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998532 46899999999999999999999988 9999999999999999999999999988764332
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ......... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~----------~ 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET----------A 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------c
Confidence 12235678899999999988899999999999999999999999765433211 111110000 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCH--HHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNM--SSVV 557 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~--~~vl 557 (606)
....+......+.+++.+||+.+|.+||++ ++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011111223577889999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=300.04 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=196.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------ 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 355 (606)
..++|...+.||+|+||.||++... .++.+|+|++.+. .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999975 4889999998653 223445678899999999999999999988643
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
...++|+||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 478777632 1889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCc------------cch-
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH------------HNL- 502 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~------------~~l- 502 (606)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ..+
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987543221 2234678899999999999999999999999999999999999854321100 000
Q ss_pred --hHHHHHHhhhcCc-------chhcccccC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 503 --LGHAWRLWIEERP-------VELINKSLG----GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 503 --~~~~~~~~~~~~~-------~~l~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.......+..... .+++...+. ..........+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011111000 001100000 00011234467899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=294.29 Aligned_cols=249 Identities=28% Similarity=0.387 Sum_probs=194.8
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.|...+.||+|+||.||+++.. ++..+|+|++..... .....+.+|+.++++++|||++++++++.+....++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4677789999999999999975 478999999865432 234578899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++ +|.+++.. ....+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9974 77777643 2345899999999999999999999998 99999999999999999999999999875432
Q ss_pred ccccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 444 TEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.....++..|+|||++. .+.++.++||||||+++|||++|+.|+...... .. .........
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~----~~~~~~~~~----- 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SA----LYHIAQNES----- 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HH----HHHHHhccC-----
Confidence 12346788999999974 456899999999999999999999986432110 00 001111100
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...........+.+++.+||+.+|.+||++.+|++.+--.
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0001112234577899999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=290.40 Aligned_cols=260 Identities=19% Similarity=0.218 Sum_probs=183.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCC----cEEEEEEcccccccCH-----------HHHHHHHHHHhhccCCCcceEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEG----QEIAAKRLSKSSGQGM-----------EEFENEVLLIAKLQHRNLVKLIG 350 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g 350 (606)
.++|.+.++||+|+||.||+|...++ ..+++|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36788999999999999999997654 3445554322221111 11223334556678999999999
Q ss_pred EEeeCC----eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 007361 351 CCTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 426 (606)
Q Consensus 351 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~ 426 (606)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 34677787643 55555532 223578889999999999999999998 99999999999999999
Q ss_pred ceEEeecCCccccCCCcc-----cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccc
Q 007361 427 NPKISDFGMARAFGIDQT-----EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN 501 (606)
Q Consensus 427 ~~ki~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 501 (606)
.++|+|||+|+.+..... ........||+.|+|||++.+..++.++||||||++++||++|+.||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 999999999987643211 112233569999999999999999999999999999999999999986542211 1
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
+.......+.. .+....+.- ......+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIK----RLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHH----Hhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111111111 000010000 011356778999999999999999999999874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=290.80 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=194.6
Q ss_pred CCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
|+..++||.|++|.||+|... +|..+|+|++.... ....+.+.+|+.+++.++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999975 58999999986543 233467889999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
+ ++|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68999885432 245899999999999999999999987 999999999999999999999999999765432211
Q ss_pred ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhh---------cCc
Q 007361 446 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE---------ERP 515 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~~~ 515 (606)
.....++..|+|||++.+. .++.++||||||+++|||++|+.|+....... .+.. ..+.... ...
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCChHHhhhhhhc
Confidence 1223568899999988764 57899999999999999999999875432210 0000 0000000 000
Q ss_pred chhcccccCC------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGG------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+........ .........+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 000111246778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=294.95 Aligned_cols=268 Identities=22% Similarity=0.347 Sum_probs=193.6
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe----
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE---- 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 357 (606)
..++|+..++||+|+||.||++.... ++.+|+|++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34578899999999999999999764 8899999886432 2233456789999999999999999999876543
Q ss_pred ----eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeec
Q 007361 358 ----RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433 (606)
Q Consensus 358 ----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DF 433 (606)
.++|+||+.+ +|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4999999964 78777743 2335899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCccc--ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh
Q 007361 434 GMARAFGIDQTE--ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 434 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
|++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999876433221 122234578899999988765 47889999999999999999998875433211111111100000
Q ss_pred h-----hcCcchhcccc-cCCCC---------CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 511 I-----EERPVELINKS-LGGSY---------SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 511 ~-----~~~~~~l~d~~-l~~~~---------~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ........+.. ..... .......+.+++.+||+.+|++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 00000000000 00000 0001235678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.93 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=193.9
Q ss_pred cCCeecccCcccEEEEEEeC-CcEEEEE--Ecccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe--eEEEEe
Q 007361 291 DKNKLGEGGFGPVYKGVLIE-GQEIAAK--RLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE--RMLIYE 363 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~~-g~~vavK--~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~E 363 (606)
...+||+|.|-+||||.+.. |-+||=- ++.+. .....+.|..|+.+|+.|+|||||+++..+.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34789999999999999754 6666532 22221 33345789999999999999999999999977655 788999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCccccCCC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGID 442 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~~~~~ 442 (606)
.|..|+|..|+... +.++...+..++.||++||.|||++. ++|||||||.+||||+. -|.+||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999643 34788899999999999999999987 68999999999999975 589999999999987544
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.. ..+.||+.|||||... ..|...+||||||+.++||+|+..|+..-.. .....+....+....-+.+.
T Consensus 200 ~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 200 HA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred cc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhcc
Confidence 33 2379999999999876 8899999999999999999999999643211 11223333333332222221
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcC
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSG 562 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~ 562 (606)
....+.+++..|+.. .++|||+.|+++ .|..
T Consensus 269 --------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 269 --------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred --------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 123567889999998 899999999984 4443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.31 Aligned_cols=197 Identities=23% Similarity=0.340 Sum_probs=169.6
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhcc-C-----CCcceEEEEEeeCCeeEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-H-----RNLVKLIGCCTQRDERML 360 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 360 (606)
+|.+.+.||+|.||.|.++.... ++.||||+++.. .....+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78899999999999999999765 889999999544 344566788999999997 4 389999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC--CceEEeecCCccc
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARA 438 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~--~~~ki~DFGla~~ 438 (606)
|+|.+. -+|.++|.... -..++...+..|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999994 59999996543 344899999999999999999999988 9999999999999653 4799999999987
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCC
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 495 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 495 (606)
...... ....+.-|.|||++.+.+|+.+.||||||||+.||++|...|....
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 542221 4677889999999999999999999999999999999987766543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.50 Aligned_cols=267 Identities=21% Similarity=0.330 Sum_probs=197.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC--Cee
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR--DER 358 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 358 (606)
..++|+..+.||+|+||.||+|.... ++.+|+|++... .......+..|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45678888999999999999999764 788999988543 233445677899999999 999999999998653 468
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||++ ++|.+++.. ..++|..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888743 26899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc---ccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHH
Q 007361 439 FGIDQTE---ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHA 506 (606)
Q Consensus 439 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~ 506 (606)
+...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 22234568899999998865 45789999999999999999999997543221100000 000
Q ss_pred HHHhhhcCcchhcccccCCC-CCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 507 WRLWIEERPVELINKSLGGS-YSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~l~~~-~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
+..+.......+++...... ... .....+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000111111110000 000 123467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=285.56 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=193.3
Q ss_pred ecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
||.|+||.||+++... ++.+++|.+.+... ...+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999865 88999999865432 3456799999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccc
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 450 (606)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999853 334899999999999999999999988 9999999999999999999999999998764332 2223
Q ss_pred cccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH
Q 007361 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530 (606)
Q Consensus 451 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 530 (606)
..++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+. .. ...... +.......+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~--------~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----ME-IYNDIL--------KGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HH-HHHHHh--------ccCCCCCCCcc
Confidence 467889999999988889999999999999999999999976443211 00 011000 00001111111
Q ss_pred HHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 531 EVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 531 ~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
....+.+++..||+.+|++||+ +.++++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2457789999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.10 Aligned_cols=263 Identities=20% Similarity=0.310 Sum_probs=194.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----Cee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 358 (606)
+++|.+.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999875 48899999986432 33456788999999999999999999987654 357
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+.+ +|.+++. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 7777663 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc-cccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc---
Q 007361 439 FGIDQTEA-NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE--- 513 (606)
Q Consensus 439 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 513 (606)
........ ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 54322211 1223568899999998765 568999999999999999999999875322110 000000000000
Q ss_pred --------Ccchhcccc-cCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 514 --------RPVELINKS-LGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 514 --------~~~~l~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.....+... ....... .....+.+++..||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0000010 113457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=288.20 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=196.4
Q ss_pred ecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
||.|+||.||+++... |+.+++|.+..... ...+.+.+|+.++.+++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999999865433 4566789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc------
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT------ 444 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~------ 444 (606)
.+++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998542 35899999999999999999999988 99999999999999999999999999876533211
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
........++..|+|||.+.+...+.++||||||++++||++|+.|+...... .. ......... .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~-~~~~~~~~~--------~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EI-FQNILNGKI--------E 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHhcCCc--------C
Confidence 11223356788999999999888999999999999999999999997533211 00 000111000 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
..........+.+++..||+.+|++||++.++.+.|+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000001356789999999999999999977777775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.44 Aligned_cols=200 Identities=23% Similarity=0.375 Sum_probs=159.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC--CcEEEEE------------------EcccccccCHHHHHHHHHHHhhccCCC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAK------------------RLSKSSGQGMEEFENEVLLIAKLQHRN 344 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 344 (606)
..++|.+.++||+|+||+||++.+.. +...+.| ++ .........+.+|+.++.+++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~-~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRV-KAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHh-hcchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987643 1111111 11 112223456889999999999999
Q ss_pred cceEEEEEeeCCeeEEEEecCCCCCchhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR--SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 345 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
|+++++++...+..++|+|++. ++|.+++..... ........+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 567776643211 122345667789999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCC
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN 490 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p 490 (606)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999876533221 12235789999999999999999999999999999999998854
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.70 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=202.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEE-EEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~v-avK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+.|.+...||.|+||.||+++.++...+ |.|.+...++...++|.-|+.||+...||+||+|++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3445567899999999999998775544 567777777888899999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
.||-++..+... ...|++.++.-++.+++.||.|||++. |||||||+.|||++-+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 999999988653 446999999999999999999999998 9999999999999999999999999986532 222
Q ss_pred ccccccccccCccCcccc-----ccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 446 ANTNRVVGTYGYMPPEYA-----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.......||+.|||||++ .+.+|+.++||||||+.|.||..+.+|..... .+ ..........+..++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pM-RVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PM-RVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hH-HHHHHHhhcCCCcccC
Confidence 334458899999999987 46789999999999999999999998843211 11 1122222333333332
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
+. .....+.++...||..||..||++++++
T Consensus 258 PS-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 258 PS-------HWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred cc-------hhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 22 2334567888999999999999999987
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=290.45 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=193.2
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|...++||+|+||.||++.... ++.+|+|++.... ......+.+|+.++.++. |+||+++++++......++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45566889999999999999764 7899999986543 234567889999999996 99999999999999999999999
Q ss_pred CCCCCchhhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 365 LPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 365 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+.. +|.++... ......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.+||+|||++..+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55554321 12235689999999999999999999975 5 99999999999999999999999999976543
Q ss_pred CcccccccccccccCccCccccccC---CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
... .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+.... ........ ......
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~-~~~~~~--- 228 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQ-VVKGDP--- 228 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhh-hcCCCC---
Confidence 221 1224578899999999776 68999999999999999999999975432 11111100 011111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
+.+...........+.+++.+||+.+|++||++.+|++.
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111233467899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=284.74 Aligned_cols=248 Identities=26% Similarity=0.345 Sum_probs=201.1
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|++.++||+|+||.||+++.. +++.+++|++.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677899999999999999865 47889999986542 23456788999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999985422 2356899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... .+ .........
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~----~~~~~~~~~-------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DL----RYKVQRGKY-------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHhcCCC--------
Confidence 122245788999999999999999999999999999999999997543211 00 001111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+......+.+++..|++.+|++||++.++++
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1112233456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=291.20 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=204.7
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.-|...+.||+|.|..|-++++. .|..||||++.+.. ......+.+|+.-|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45667789999999999999864 59999999998763 3345678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE-cCCCceEEeecCCccccCCC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll-~~~~~~ki~DFGla~~~~~~ 442 (606)
.=++|+|.+|+.. ....+.+....+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999965 3345899999999999999999999988 9999999999877 56789999999999877543
Q ss_pred cccccccccccccCccCccccccCCCC-ccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
+ ..+..+|...|.|||++.+..|. +++||||||||||-|++|+.||+.....+... -++|.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcc
Confidence 3 34457999999999999999985 68999999999999999999986543322211 12222
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ..+.....++.+|+..||+.+|++|.+.++|+.
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11 123334457889999999999999999999874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=292.01 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=195.0
Q ss_pred CeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCch
Q 007361 293 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLN 371 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 371 (606)
.+||+|+||.||++... +++.+|+|++........+.+.+|+.+++.++|+|++++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 67999999999999885 58899999986555555677999999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccccccc
Q 007361 372 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451 (606)
Q Consensus 372 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 451 (606)
+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 98732 34799999999999999999999998 99999999999999999999999999876543221 12335
Q ss_pred ccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHH
Q 007361 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSE 531 (606)
Q Consensus 452 ~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~ 531 (606)
.++..|+|||.+.+..++.++|+||||+++|||++|..|+....... ... ....... ..+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~----~~~~~~~-----~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDNLP-----PKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhhCC-----cccCC--cccC
Confidence 67899999999988889999999999999999999999975322110 000 0000000 00000 0112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 532 VLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 532 ~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 235678899999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=287.52 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=190.4
Q ss_pred CCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeC--CeeEEEEe
Q 007361 289 FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQR--DERMLIYE 363 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 363 (606)
|+..++||+|+||.||+|... +++.+|+|++.... .........|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999975 48899999986542 222234457888898885 99999999999887 88999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 578777743 2346899999999999999999999998 999999999999999 999999999998764332
Q ss_pred ccccccccccccCccCccccc-cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH-----------Hhh
Q 007361 444 TEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR-----------LWI 511 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~ 511 (606)
.. ....++..|+|||.+. +..++.++||||||+++|||++|..|+...... ........ ...
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhc
Confidence 21 2245788999999765 456789999999999999999999988543221 11111100 000
Q ss_pred hcCcchhcccccCC----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EERPVELINKSLGG----SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~~~~l~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.........+...+ .........+.+++..||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 001122457889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=293.31 Aligned_cols=265 Identities=24% Similarity=0.341 Sum_probs=193.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 360 (606)
.++|+..+.||+|+||.||+|.... |+.||+|++..... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4678899999999999999999864 88999999864322 2234567899999999999999999998765 56899
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+||+.+ +|.+++... ...+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999974 788887532 256899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH--------HHHHHhh
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWRLWI 511 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~ 511 (606)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............. ..|..+.
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 3321 1122345778999999875 458999999999999999999999875432211000000 0000000
Q ss_pred hcCcchhcccccCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EERPVELINKSLGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.......+.......... .....+.+++..|++.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000000000 01335678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=291.07 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=195.4
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC----
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD---- 356 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 356 (606)
...++|++.+.||+|+||.||+|.... ++.+|+|++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 356789999999999999999999865 7899999986543 233456788999999999999999999987655
Q ss_pred ------eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 357 ------ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 357 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
..++|+||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 66666643 2345899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
+|||++..+...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ..+......
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRL 233 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHH
Confidence 999999876433221 1122345778999998865 45789999999999999999999887532211 111111110
Q ss_pred hhhcCc---chh--------ccc------ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 510 WIEERP---VEL--------INK------SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 510 ~~~~~~---~~l--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...... ..+ .+. ....... .....+.+++..||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 000 000 0000000 01346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=282.15 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=203.0
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|...+.||.|+||.||++.... ++.+++|++..... ...+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 46778999999999999999864 88999999865533 4566789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986532 2467999999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+...... . ...........
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~------- 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------E-LALKILKGQYP------- 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------H-HHHHHhcCCCC-------
Confidence 1223356888999999999999999999999999999999999997533211 1 11111111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++.+||+.+|++||++.++++
T Consensus 222 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 --PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111122346778999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.45 Aligned_cols=242 Identities=24% Similarity=0.283 Sum_probs=185.5
Q ss_pred eecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhh---ccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 294 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAK---LQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
.||+|+||.||++...+ ++.+|+|.+.+... .....+.+|..++.. .+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999754 78999998865421 222334455444443 479999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999998853 345999999999999999999999998 9999999999999999999999999987653221
Q ss_pred cccccccccCccCccccc-cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....|+..|+|||.+. +..++.++||||||++++||++|+.|+......... ....... ... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~------~~~----~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL------TVN----V 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhh------cCC----c
Confidence 12246899999999986 456899999999999999999999998643221110 0000000 001 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM 559 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~~ 559 (606)
..+......+.+++..||+.+|++|| +++++++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11122234677899999999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=317.09 Aligned_cols=261 Identities=29% Similarity=0.383 Sum_probs=204.5
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC--------CcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceEEEEEe
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCT 353 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 353 (606)
...++..+.+.||+|.||.|++|.... ...||||.++.... ...+.+..|+++|..+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 344555666799999999999998642 35789999976543 4567899999999998 6999999999999
Q ss_pred eCCeeEEEEecCCCCCchhhhcccC-----C------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 007361 354 QRDERMLIYEYLPNKSLNDFIFDVT-----R------S--KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 420 (606)
Q Consensus 354 ~~~~~~lV~E~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI 420 (606)
..+..++|.||++.|+|.++|...+ . . ..+...+.+.++.|||.||+||++.. ++||||.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence 9999999999999999999997544 0 0 23889999999999999999999987 99999999999
Q ss_pred EEcCCCceEEeecCCccccCCCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCC
Q 007361 421 LLDNEMNPKISDFGMARAFGIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH 498 (606)
Q Consensus 421 ll~~~~~~ki~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~ 498 (606)
|+.++..+||+|||+|+......... ......-+..|||||.+....|+.|+|||||||+||||+| |..|+.....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 99999999999999999754433332 1111113557999999999999999999999999999998 5566543110
Q ss_pred ccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....+....++.. ...+.....+++++++.||+.+|++||++.++++.|+.
T Consensus 528 ----~~~l~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 528 ----TEELLEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred ----HHHHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 0111222222211 11222234577899999999999999999999999987
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.44 Aligned_cols=241 Identities=27% Similarity=0.354 Sum_probs=188.3
Q ss_pred ecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
||+|+||+||++.... |+.+++|.+.... ......+.+|+.++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999998654 8899999886532 22345677899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccc
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 450 (606)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 999864332 35899999999999999999999998 999999999999999999999999998765431 11223
Q ss_pred cccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH
Q 007361 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530 (606)
Q Consensus 451 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 530 (606)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+........... . ..... . .....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~----~~~~~-~-----~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---L----KRRTL-E-----MAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---H----Hhccc-c-----ccccCCcc
Confidence 4578899999999988899999999999999999999999754332111000 0 00000 0 00011111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHH
Q 007361 531 EVLRCIQVGLLCVQQRPEDRPNMSS 555 (606)
Q Consensus 531 ~~~~l~~l~~~Cl~~~P~~RPs~~~ 555 (606)
....+.+++..||+.+|++||+..+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCc
Confidence 2346678999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.12 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=194.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc-----cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--Cee
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER 358 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 358 (606)
.+|.+.+.||+|+||.||+|.... ++.+++|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468889999999999999999754 889999987432 123346788999999999999999999998764 457
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999853 234789999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 439 FGIDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 439 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.|+...... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-------- 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKI-------- 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHH--------
Confidence 532211 11122356889999999999988999999999999999999999997532110 000000
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.........+......+.+++..|++ +|..||+..+++.
T Consensus 222 -~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 -ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00001111222233467789999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.41 Aligned_cols=247 Identities=29% Similarity=0.440 Sum_probs=200.2
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|+..+.||+|++|.||+++... ++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 46778999999999999998764 78999999876543 4567899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998532 56899999999999999999999988 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
. .....++..|+|||...+..++.++||||+|+++++|++|+.|+..... ....+.. ..... .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~~~~-----~--- 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRI-VQDDH-----P--- 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-hccCC-----C---
Confidence 1 2235678899999999888899999999999999999999998753221 0111111 00000 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++.+|++.+|++||++.+++.
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111112346778999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=288.01 Aligned_cols=259 Identities=23% Similarity=0.316 Sum_probs=196.7
Q ss_pred CCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc--CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
|...+.||+|++|.||++... +++.+++|++...... ....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999986 4888999998654332 4567889999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++ +|.+++... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 888877442 246899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc---Ccchhcc-
Q 007361 446 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE---RPVELIN- 520 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~d- 520 (606)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+....... ............ ......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhh
Confidence 112224577899999998876 78999999999999999999998875432211 000000000000 0000000
Q ss_pred -----ccc--CC-----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 -----KSL--GG-----SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 -----~~l--~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... .. .........+.+++..||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00 011122457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=291.15 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=201.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEccc--ccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 362 (606)
...|++.++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 457889999999999999999988888999998754 45667888999999999995 999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||= ..+|..+|... .....+| .+..+..|++.++.++|+++ |||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus 440 E~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 985 56899998542 2333445 67788999999999999998 999999999999865 57999999999999887
Q ss_pred cccccccccccccCccCccccccCC-----------CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGL-----------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
.+.-....-+||..||+||.+.... .+.++||||+|||||+|+.|+.||..+.. .|..
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~aK-- 581 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QIAK-- 581 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HHHH--
Confidence 7776667789999999999985432 56789999999999999999999764321 1111
Q ss_pred hcCcchhcccccCCCC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EERPVELINKSLGGSY-SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+.++.-.-.+ .......+++++..||+.||++||+..++++
T Consensus 582 ---l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 ---LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1223333211111 1111223889999999999999999999975
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.65 Aligned_cols=267 Identities=20% Similarity=0.305 Sum_probs=197.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEee----CCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 358 (606)
.++|++.+.||+|+||.||+|.... ++.+|+|++.... ......+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3678888999999999999999764 8899999987542 2345677889999999999999999988753 3468
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 688888743 345899999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCccc--ccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH--------HHH
Q 007361 439 FGIDQTE--ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAW 507 (606)
Q Consensus 439 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~ 507 (606)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............. ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432221 11123578889999999865 468999999999999999999999985432111000000 000
Q ss_pred HHhhhcCcchhccccc-CCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 508 RLWIEERPVELINKSL-GGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
............+... ..... ......+.+++..||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000011111111000 00111 1124568899999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=287.70 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=193.3
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|+..+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999986 48899999986543 2334678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCccccCCC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGID 442 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~~~~~ 442 (606)
|++ ++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 5777776432 2233688889999999999999999988 999999999999985 567999999999765432
Q ss_pred cccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh---
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL--- 518 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l--- 518 (606)
.. ......++..|+|||.+.+. .++.++||||||+++|+|+||+.|+...... ............ .....
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~-~~~~~~~~ 230 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGT-PNEETWPG 230 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCC-CChhhccc
Confidence 11 11224568899999988764 5789999999999999999999987543211 011100000000 00000
Q ss_pred ----cc-----cccCCC----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 ----IN-----KSLGGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ----~d-----~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+ +..... ........+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000000 00111235778999999999999999999986
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=279.20 Aligned_cols=246 Identities=21% Similarity=0.256 Sum_probs=186.7
Q ss_pred HHHhcCCCcCCee--cccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 283 ANATENFSDKNKL--GEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 283 ~~~~~~~~~~~~l--G~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
....++|.+.+.+ |+|+||.||++.... +..+|+|.+........ |+.....+ +||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3345666766666 999999999999754 67788888754322111 22222222 799999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCcc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMAR 437 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~ 437 (606)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999998532 36899999999999999999999998 99999999999999988 99999999987
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
...... ...++..|+|||++.+..++.++||||||++++||++|+.|+....... ......... . . ...
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~-~-~~~- 227 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-Q-Q-KKL- 227 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-h-c-ccC-
Confidence 654221 2457889999999999999999999999999999999999986322211 111111100 0 0 000
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-MSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~vl~ 558 (606)
.........+.+++..||+.+|.+||+ +.++++
T Consensus 228 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 --------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011123346778999999999999995 688763
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=296.62 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=195.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----Ce
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 357 (606)
.++|.+.+.||+|+||.||+++... ++.||+|++... .......+.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4578889999999999999999754 889999998653 233455678899999999999999999987654 34
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 688887743 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh------
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW------ 510 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------ 510 (606)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+....... .........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence 764322 11223467889999998865 468999999999999999999999975432110 000000000
Q ss_pred -----hhcCcchhcccccC-CCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 511 -----IEERPVELINKSLG-GSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 511 -----~~~~~~~l~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
........+..... ... .......+.+++.+||+.+|++||++.++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000000 000 01123467899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=282.87 Aligned_cols=244 Identities=24% Similarity=0.256 Sum_probs=189.0
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHH-hhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLI-AKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.||+|+||.||+|.... ++.+|+|.+.+... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999754 88999999865432 2223344554444 455899999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999853 345899999999999999999999988 99999999999999999999999999876432
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..+......... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccC------CCCcc
Confidence 22346788999999999888999999999999999999999997532211 111111111100 00001
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.......+.+++..||+.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1112346789999999999999999887777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=286.28 Aligned_cols=244 Identities=26% Similarity=0.343 Sum_probs=198.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.+.|..-++||+||||.||-++..+ |+.+|.|++.+. .+++..-..+|-.+|.+++.+.||.+--.+...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3567888999999999999998765 899999988654 345556678999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+..|.||+|.-+|.+... ..++++.+..++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987655 55899999999999999999999998 99999999999999999999999999998754
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.+.. ...+||.+|||||++.+..|+...|.||+||+||||+.|+.||........ .+-+|.
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvdr 400 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVDR 400 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHHH
Confidence 4332 224899999999999999999999999999999999999999764332211 111111
Q ss_pred ccC---CCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 007361 522 SLG---GSYSLSEVLRCIQVGLLCVQQRPEDRPN 552 (606)
Q Consensus 522 ~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 552 (606)
... ..++..-..++..|....|+.||++|..
T Consensus 401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 111 1122222234456666788999999853
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=296.46 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=204.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc--CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
....|.+..+||+|.|+.|..+++.. +..||+|.+.+.... ....+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45678889999999999999999865 899999999876433 335688999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||..+|.+.++|....+ +.+..+..++.|+..+++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999965333 555888889999999999999999 99999999999999999999999999998752
Q ss_pred CcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.......+|++.|.|||++.+..| .+++|+||+|++||-|++|..||+... ..++-+
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------------lk~Lr~ 265 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------------LKELRP 265 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------------cccccc
Confidence 233445799999999999999876 689999999999999999999986321 222222
Q ss_pred cccCCCCCH--HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSL--SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~--~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+.+.+-+ ....++-+++++++-.+|.+|+++.++.+
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 223222222 12235668899999999999999999874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=285.05 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=198.7
Q ss_pred CCCcCCeecccCcccEEEEEEe----CCcEEEEEEccccc----ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
+|+..+.||+|+||.||+++.. ++..+|+|.+.+.. ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999999853 46789999886432 23346788999999999 599999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998853 345889999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCcccccccccccccCccCccccccCC--CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
+...... ......++..|+|||.+.+.. .+.++||||||+++|||++|..|+........ ... ........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-~~~~~~~~--- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSE-ISRRILKS--- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHH-HHHHHHcc---
Confidence 6433221 122346788999999987765 78899999999999999999999753221110 000 00110000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
... .+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 ---~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ---KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 001 111122456789999999999999999999988865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=288.61 Aligned_cols=260 Identities=19% Similarity=0.224 Sum_probs=190.4
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
.+.+|.|+++.|+++.. +++.+|+|++... .....+.+..|+.+++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455666666666655 6899999998654 34456789999999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc-----
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT----- 444 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~----- 444 (606)
|.+++.... ...+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999986432 234889999999999999999999998 99999999999999999999999998875532111
Q ss_pred cccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH-----------hh
Q 007361 445 EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL-----------WI 511 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~~ 511 (606)
........++..|+|||++.. ..++.++||||||+++|||++|+.|+...... ..+....... ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhh
Confidence 111223456788999999876 35889999999999999999999998643211 1111100000 00
Q ss_pred hcCcch----hccccc----CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EERPVE----LINKSL----GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~~~~----l~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...... ..+... ...........+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 000000 00111122346788999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=278.75 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=212.4
Q ss_pred HHHHHHhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEE
Q 007361 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCC 352 (606)
Q Consensus 280 ~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 352 (606)
.++....+++.....+-+|.||.||+|.+.+ .+.|.+|.++... .-....+..|..++..+.|||++++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3445556778888999999999999997643 4567888886653 33456788999999999999999999998
Q ss_pred eeC-CeeEEEEecCCCCCchhhhc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 007361 353 TQR-DERMLIYEYLPNKSLNDFIF-----DVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 426 (606)
Q Consensus 353 ~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~ 426 (606)
.+. ...+.+|.++.-|+|..||. +......++..+...++.|++.|++|||..+ +||.||.++|.++|+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 664 56899999999999999997 4444556888889999999999999999998 99999999999999999
Q ss_pred ceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHH
Q 007361 427 NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH 505 (606)
Q Consensus 427 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 505 (606)
++||+|=.+++.+-..+..........+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----- 508 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----- 508 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence 999999999998765555544444456789999999999999999999999999999997 77886544332211
Q ss_pred HHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 506 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 506 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....++ .+-..+...+.+|..++.-||...|++||++++++.-|..
T Consensus 509 --~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 --HYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred --HHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111111 1112344456688899999999999999999999998864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=286.83 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=192.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++|+..+.||+|+||.||+|...+ ++.+|+|.+.... .....++..|+.++.+.. |+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999876 8899999986543 233455677777777775 999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
||+. ++|.+++... ...+++..+..++.+|++||+|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 4677666432 23689999999999999999999974 5 99999999999999999999999999976543
Q ss_pred CcccccccccccccCccCccccccCC----CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
.... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+...... ... ...........
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~-~~~~~~~~~~~ 238 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEV-LTKILQEEPPS 238 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHH-HHHHhcCCCCC
Confidence 2221 2235778999999987554 889999999999999999999997532111 000 00111111100
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
... .......+.+++.+||+.+|++||++.++++.
T Consensus 239 -----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00123467889999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=287.87 Aligned_cols=247 Identities=30% Similarity=0.405 Sum_probs=192.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
+.|...+.||+|+||.||+|+... ++.+++|.+... .....+++.+|+.+++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 346667889999999999999764 778999988643 2233457889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+. |+|.+++.. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 577777643 2345899999999999999999999988 999999999999999999999999998765321
Q ss_pred cccccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+....... .. .........
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~----~~~~~~~~~--- 232 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL----YHIAQNESP--- 232 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HH----HHHhhcCCC---
Confidence 2346788999999975 3568889999999999999999999864321110 00 000111000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
..........+.+++.+||+.+|++||++.++++..
T Consensus 233 -----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 001112234577899999999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=284.15 Aligned_cols=263 Identities=25% Similarity=0.298 Sum_probs=194.1
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc-CHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEecC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
|.+.+.||+|+||.||+|+..+ ++.+++|++...... ......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5667899999999999999865 788999998654332 2234567999999999 999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889998885432 346899999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccCccCccccc-cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccc-hhHH----HHHHhhhcC-cchh
Q 007361 446 ANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN-LLGH----AWRLWIEER-PVEL 518 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~----~~~~~~~~~-~~~l 518 (606)
.....++..|+|||.+. ...++.++|+||||++++||++|+.|+.......... .... ....|.+.. ....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22346788999999885 4558999999999999999999998875432211000 0000 000000000 0000
Q ss_pred cccccCCCC-------CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 519 INKSLGGSY-------SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 519 ~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
++..+.... .......+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 00113568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=289.01 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=196.6
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEee-CCee
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDER 358 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 358 (606)
...+++|+..+.||+|+||.||++... +++.+|+|++.+. .....+.+..|+.++..++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999876 5889999988643 22345678899999999999999999999865 5678
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+ +++|.+++. ...+++.....++.|+++||.|||+.+ |+|+||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 568888773 334788889999999999999999998 99999999999999999999999999875
Q ss_pred cCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHHHHH
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRL 509 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~ 509 (606)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............ ......
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 122456889999998866 56899999999999999999999987543211000000 000111
Q ss_pred hhhcCcchhccccc-CCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 510 WIEERPVELINKSL-GGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 510 ~~~~~~~~l~d~~l-~~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
+......+++.... ....+.. ....+.+++..|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111111110 1111111 12467899999999999999999988644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=282.45 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=193.0
Q ss_pred CCCcCCeecccCcccEEEEEEe----CCcEEEEEEccccc----ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
+|++.+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677899999999999999863 58899999986532 22346788999999999 599999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999853 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCccccccC--CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
....... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... .......... ...
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~-~~~--- 227 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRI-LKS--- 227 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHh-hcc---
Confidence 6433221 12235688899999998753 4788999999999999999999997532211 0111111000 000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
. ...+......+.+++..||+.+|++|| ++.+++.
T Consensus 228 ---~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ---E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 011111234567899999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=289.00 Aligned_cols=260 Identities=22% Similarity=0.274 Sum_probs=190.0
Q ss_pred Ceeccc--CcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEG--GFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G--~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
..||+| +||+||++++. .|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999975 58999999986432 23356788999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc-
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA- 446 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~- 446 (606)
++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886532 234899999999999999999999988 9999999999999999999999998654332111100
Q ss_pred ----cccccccccCccCccccccC--CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH--------------
Q 007361 447 ----NTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA-------------- 506 (606)
Q Consensus 447 ----~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-------------- 506 (606)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+....... .+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 01112345679999999764 47899999999999999999999986432110 000000
Q ss_pred --HHHhhhc-------Cc---------chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 507 --WRLWIEE-------RP---------VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 507 --~~~~~~~-------~~---------~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+... .. ....+..+...........+.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000 00 0000111111112234457889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.24 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=192.1
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhc---cCCCcceEEEEEeeCCe-----
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKL---QHRNLVKLIGCCTQRDE----- 357 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 357 (606)
|++.+.||+|+||.||+|+... ++.+|+|++..... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999875 88999999864322 2234566788777666 59999999999988776
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++++||+++ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 7888875432 235899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC---
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER--- 514 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 514 (606)
.+..... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHh
Confidence 7643322 12235788999999999999999999999999999999998886532211 11111100000000
Q ss_pred -c------chhcccccCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 -P------VELINKSLGG---SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 -~------~~l~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. .......... .........+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000000 001122346778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=285.23 Aligned_cols=244 Identities=28% Similarity=0.427 Sum_probs=190.2
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
|...++||+|+||.||+|+... ++.+++|++..... .....+.+|+.+++.++|||++++++++.+....++|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5556789999999999999754 78899999865432 2345688999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 577777643 2345899999999999999999999998 9999999999999999999999999986432
Q ss_pred cccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 445 EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
......++..|+|||++. ...++.++||||||+++|||++|..|+...... ...... ........
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~-~~~~~~~~--- 240 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHI-AQNDSPTL--- 240 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH-HhcCCCCC---
Confidence 122356888999999984 456889999999999999999999986432210 000000 00011010
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
........+.+++.+||+.+|.+||++.+++..
T Consensus 241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112356789999999999999999999843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.14 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=200.2
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 361 (606)
++|...+.||+|+||.||+++.. +++.+++|.+.+. .....+.+.+|+.++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46788899999999999999986 4889999988653 2233467889999999998 99999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999853 336999999999999999999999988 99999999999999999999999999987643
Q ss_pred Cccc------------------ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh
Q 007361 442 DQTE------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 503 (606)
Q Consensus 442 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 503 (606)
.... .......++..|+|||.+.+..++.++||||||+++++|++|+.|+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------ 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence 3221 2223356788999999999888999999999999999999999997643210
Q ss_pred HHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 007361 504 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM----SSVVL 558 (606)
Q Consensus 504 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~----~~vl~ 558 (606)
... ..... .....+......+.+++..||+.+|++||++ .++++
T Consensus 229 ~~~-~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTF-QKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH-HHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000 00000 0011111224567899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=280.69 Aligned_cols=241 Identities=24% Similarity=0.308 Sum_probs=185.1
Q ss_pred eecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHH---HhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 294 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLL---IAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
.||+|+||.||++.... ++.||+|.+.+... .....+..|..+ ++...||||+++++.+.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998765 78999998865422 222234445443 344579999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999998843 346999999999999999999999988 9999999999999999999999999987653221
Q ss_pred cccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.|+.......... ....... ....+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCCCC
Confidence 1234689999999998754 68999999999999999999999976432211100 0000000 0111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
.....+.+++..|++.+|.+|| ++.++++
T Consensus 221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1234677889999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.69 Aligned_cols=202 Identities=29% Similarity=0.437 Sum_probs=174.9
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC------eeEE
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------ERML 360 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 360 (606)
+...+.||+|+||.||+|+... |+.||||.+.+.. ....+....|+++|++++|+|||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999999654 9999999997653 334566788999999999999999999865544 5789
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc----CCCceEEeecCCc
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD----NEMNPKISDFGMA 436 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~----~~~~~ki~DFGla 436 (606)
|||||.+|||...|........|++.+.+.+..++..||.|||+++ |+||||||.||++- ....-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988777788999999999999999999999988 99999999999982 3345799999999
Q ss_pred cccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCC
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA 496 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~ 496 (606)
+.+..+. .....+||..|++||.+.. +.|+..+|.|||||++||.+||..||.....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9876443 4456899999999999984 8899999999999999999999999865433
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.29 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=187.8
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEee------
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ------ 354 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------ 354 (606)
.+-..+|++.+.||+||||.|||++.+ ||+.+||||+.-. +......+.+|+.++++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 455678999999999999999999964 7999999999654 33445668899999999999999999722100
Q ss_pred --------------------------------------------------------------------------------
Q 007361 355 -------------------------------------------------------------------------------- 354 (606)
Q Consensus 355 -------------------------------------------------------------------------------- 354 (606)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeeEEEEecCCCCCchhhhcccCCCCCC-CHHHHHHHHHHHHHHHH
Q 007361 355 -------------------------R--------DERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLL 400 (606)
Q Consensus 355 -------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l-~~~~~~~i~~~ia~gL~ 400 (606)
. ..+|+-||||+..+|.+++... .+. .....++++.+|++||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHH
Confidence 0 1246778999888888877432 222 46778999999999999
Q ss_pred HHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC----------C------CcccccccccccccCccCccccc
Q 007361 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------I------DQTEANTNRVVGTYGYMPPEYAI 464 (606)
Q Consensus 401 yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~----------~------~~~~~~~~~~~gt~~y~aPE~~~ 464 (606)
|+|+++ ||||||||.||+||++..+||+|||+|.... . .......+..+||.-|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999999 9999999999999999999999999998721 0 00111234578999999999997
Q ss_pred cCC---CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhh
Q 007361 465 DGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLL 541 (606)
Q Consensus 465 ~~~---~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~ 541 (606)
+.. |+.|+|+||+||||+||+. ||+... .... ....+..+..... ..+..++...-..++.|
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-----ERa~-iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-----ERAS-ILTNLRKGSIPEP------ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchH-----HHHH-HHHhcccCCCCCC------cccccccchHHHHHHHH
Confidence 655 9999999999999999984 232110 0000 0111111111111 11223344455689999
Q ss_pred cccCCCCCCCCHHHHHH
Q 007361 542 CVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 542 Cl~~~P~~RPs~~~vl~ 558 (606)
+++.||.+|||+.+++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=292.34 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=194.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------ 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 356 (606)
.++|...+.||+|+||.||+|+.. .|+.+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478888999999999999999975 4899999998653 2233456889999999999999999999986543
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 666654 234899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH------
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------ 509 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------ 509 (606)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ......+..
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGP 236 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 764321 123467889999999876 46899999999999999999999998643211 001000000
Q ss_pred -----hhhcCcchhccc---ccCCCCC---HHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCCC
Q 007361 510 -----WIEERPVELINK---SLGGSYS---LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERS 565 (606)
Q Consensus 510 -----~~~~~~~~l~d~---~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~~~~ 565 (606)
+........+.. ....... ......+.+++..||+.+|++||++.+++. .++..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000000 0000000 011235779999999999999999999984 3655544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=291.90 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=199.4
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-----eeE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ERM 359 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 359 (606)
+|.+.+.||+|+||.||+|+... ++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778999999999999999865 8899999987654 344567899999999999999999999988775 789
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+|+||++ ++|.+++.. ...+++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 478888743 336999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHH--------HHHH
Q 007361 440 GIDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AWRL 509 (606)
Q Consensus 440 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~ 509 (606)
..... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.|+.............. .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 1122334678899999999888 899999999999999999999999754332110000000 0000
Q ss_pred hhhcCcchhccccc-CCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 510 WIEERPVELINKSL-GGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 510 ~~~~~~~~l~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.........+.... ....+ ......+.+++..||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000100000 00000 1123467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=289.35 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=193.1
Q ss_pred cCCC-cCCeecccCcccEEEEEEe-CCcEEEEEEcccccccC--------------HHHHHHHHHHHhhccCCCcceEEE
Q 007361 287 ENFS-DKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQG--------------MEEFENEVLLIAKLQHRNLVKLIG 350 (606)
Q Consensus 287 ~~~~-~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 350 (606)
++|. ..+.||+|+||.||+|... .++.+|+|++....... ...+.+|+.++..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3467999999999999976 48899999886542221 125778999999999999999999
Q ss_pred EEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
++...+..++|+||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 688888843 345899999999999999999999988 999999999999999999999
Q ss_pred eecCCccccCCCcc------------cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCC
Q 007361 431 SDFGMARAFGIDQT------------EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 497 (606)
Q Consensus 431 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~ 497 (606)
+|||++.....+.. ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987642111 1111223467889999998764 4789999999999999999999987643321
Q ss_pred CccchhHHHHHHhhhcCcc---hh--------cccccCCC---CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 498 HHHNLLGHAWRLWIEERPV---EL--------INKSLGGS---YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 498 ~~~~l~~~~~~~~~~~~~~---~l--------~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
................ .. ........ ........+.+++..|++.+|++||++.+++.
T Consensus 241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 ---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111110000000 00 00000000 00011345778999999999999999999985
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.06 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=199.0
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.+-++.....||.|.||.||.+...+ |.-.|+|-+.-. .........+|+.++..|+|||+|+.+|+-...+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34466777899999999999999766 777888876533 345567788999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
||||++|+|.+.+. .++..++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999984 3444666667778899999999999999 99999999999999999999999999998765
Q ss_pred Ccc--cccccccccccCccCccccccC---CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 442 DQT--EANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 442 ~~~--~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
+.. ........||+-|||||++.+. ...-++||||+|||++||+||++|+...+.+.. ++-+ +..+..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--IMy~----V~~gh~- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--IMYH----VAAGHK- 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--HHhH----HhccCC-
Confidence 421 1223457899999999999764 366789999999999999999999765543310 0000 000111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.+.+......-.+++..|++.||++|.++.++++-
T Consensus 1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11222222334578889999999999888877654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=284.82 Aligned_cols=264 Identities=24% Similarity=0.309 Sum_probs=192.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCC------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------ 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 356 (606)
.++|++.++||+|+||.||+|.... ++.+|+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999764 78999998865432 22346788999999999999999999875433
Q ss_pred --eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 357 --ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 357 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 66666643 2345999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCccc---------ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH
Q 007361 435 MARAFGIDQTE---------ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 504 (606)
Q Consensus 435 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~ 504 (606)
++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 99865432211 111234678889999988654 58999999999999999999999875332211 111
Q ss_pred HHHHHhhhc---------Ccchhccccc--CCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 505 HAWRLWIEE---------RPVELINKSL--GGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 505 ~~~~~~~~~---------~~~~l~d~~l--~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+...... ......+... ...... .....+.+++.+|++.+|++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111100000 0000000000 000000 11246789999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=289.32 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=192.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeC----------
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR---------- 355 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 355 (606)
.+|...+.||.|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 578888999999999999999765 889999998766666677899999999999999999999776543
Q ss_pred ----CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCceEE
Q 007361 356 ----DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKI 430 (606)
Q Consensus 356 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~ki 430 (606)
...++|+||++ ++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58888773 235889999999999999999999998 99999999999997 4567899
Q ss_pred eecCCccccCCCcccc-cccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccc-hhH---
Q 007361 431 SDFGMARAFGIDQTEA-NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN-LLG--- 504 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~--- 504 (606)
+|||++..+....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... ...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998654322111 1122457889999998754 568899999999999999999999985332110000 000
Q ss_pred ----HHHHHhhhcCcchhcccccCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 505 ----HAWRLWIEERPVELINKSLGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 505 ----~~~~~~~~~~~~~l~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.....+.................+. .....+.+++..||+.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000000000000111 11245778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=287.05 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=194.5
Q ss_pred HHHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC--
Q 007361 282 IANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-- 356 (606)
Q Consensus 282 ~~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 356 (606)
+....++|...+.||+|+||.||++... ++..||+|++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445778999999999999999999865 48899999985432 233456889999999999999999999986553
Q ss_pred ----eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEee
Q 007361 357 ----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD 432 (606)
Q Consensus 357 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~D 432 (606)
..++|+||+ +++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999998 778888773 345899999999999999999999988 99999999999999999999999
Q ss_pred cCCccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCc-cchh-------
Q 007361 433 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH-HNLL------- 503 (606)
Q Consensus 433 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~------- 503 (606)
||++...... .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.|+........ ....
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999865322 122456889999999876 4588999999999999999999999753321100 0000
Q ss_pred HHHHHHhhhcCcchhcccccCC------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 504 GHAWRLWIEERPVELINKSLGG------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 504 ~~~~~~~~~~~~~~l~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
...+..+............... .........+.+++.+|++.+|++|||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000000000000000000 00001123577899999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=278.20 Aligned_cols=249 Identities=26% Similarity=0.346 Sum_probs=192.1
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc-----cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778999999999999998755 344555544321 122344677899999999999999999999999999999
Q ss_pred EecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 362 YEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
+||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23456999999999999999999999988 999999999999975 569999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.... ..... .......
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~-~~~~~~~------ 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVV-LRIVEGP------ 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHH-HHHHcCC------
Confidence 3222 1223467889999999988889999999999999999999999874221 11110 0111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
....+......+.+++.+||+.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11112233456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=279.02 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=196.6
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
|+..+.||+|+||.||+|+... ++.+++|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556889999999999999875 8899999987653 334567889999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999985422 45899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCcc-chh-------HHHHHHhhhcC-c
Q 007361 446 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH-NLL-------GHAWRLWIEER-P 515 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~-------~~~~~~~~~~~-~ 515 (606)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+......... .+. ...|..+.... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223457789999998776 7899999999999999999998887543211000 000 00011000000 0
Q ss_pred chhcccccCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGG---SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.......... .........+.+++..||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 000011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=291.24 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=195.5
Q ss_pred HHHHHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-
Q 007361 280 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR- 355 (606)
Q Consensus 280 ~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~- 355 (606)
..+...+++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 445667899999999999999999999864 58899999986542 22346788899999999999999999988643
Q ss_pred -----CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 356 -----DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 356 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
...+++++++ +++|.+++. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3367788876 789988773 234899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh-H----
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL-G---- 504 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~---- 504 (606)
+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............ .
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998764321 223567889999999876 56889999999999999999999997533221100000 0
Q ss_pred ---HHHHHhhhcCcchhc---ccccCCCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 505 ---HAWRLWIEERPVELI---NKSLGGSY---SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 505 ---~~~~~~~~~~~~~l~---d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.....+........+ ........ .......+.+++..|++.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000000 00000000 00112357799999999999999999988743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.89 Aligned_cols=263 Identities=21% Similarity=0.246 Sum_probs=189.6
Q ss_pred CCCcCCeecccCcccEEEEEEeC---CcEEEEEEccccc--ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC----Ce
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS--GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR----DE 357 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 357 (606)
+|+..+.||+|+||.||++.... +..+|+|++.... ....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999753 6789999986532 22356788899999999 599999999975432 45
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688888886 68888874 3445899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--ccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccch--------hHHH
Q 007361 438 AFGIDQTE--ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL--------LGHA 506 (606)
Q Consensus 438 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l--------~~~~ 506 (606)
.+...... .......||..|+|||.+.+ ..++.++||||||+++|+|++|+.|+........... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76432211 12233578999999998765 5689999999999999999999998754321100000 0000
Q ss_pred HHHhhhcCcchhcccc-cCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 507 WRLWIEERPVELINKS-LGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
+..+........+... ....... .....+.+++.+|++.+|++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000000000 0000000 1124677899999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=268.77 Aligned_cols=204 Identities=26% Similarity=0.383 Sum_probs=171.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-----CcEEEEEEccccccc--CHHHHHHHHHHHhhccCCCcceEEEEEee-CCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 357 (606)
...|+....||+|.||.||+++-.+ +..+|+|+++..... .....-+|+.+++.++||||+.|..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568888999999999999997543 347899999655322 23456789999999999999999999877 778
Q ss_pred eEEEEecCCCCCchhhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC----CceEEe
Q 007361 358 RMLIYEYLPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE----MNPKIS 431 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~ki~ 431 (606)
.+|++||.+. +|...++- ..+.+.++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999976 77777642 334467999999999999999999999998 9999999999999877 999999
Q ss_pred ecCCccccCCCcccc-cccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCC
Q 007361 432 DFGMARAFGIDQTEA-NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 432 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
|||+++.+..+-... ....++-|..|.|||.+.+. .||.+.|||+.|||+.||+|-+.-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999987654332 45567889999999999986 489999999999999999998776643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=268.54 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=197.0
Q ss_pred CeecccCcccEEEEE-EeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 293 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
+.||+|+++.|-.++ +..|.++|||++.+........+.+|++++.+.+ |+||++|+.+|.++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999887 4569999999999888778888999999999996 99999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc---eEEeecCCccccCC--Cc--
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGI--DQ-- 443 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~ki~DFGla~~~~~--~~-- 443 (606)
..++. +++.+++.++.++..+|+.||.|||.++ |.||||||+|||...... +||+||.++..+.. +-
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99985 4566999999999999999999999999 999999999999966543 79999988764422 11
Q ss_pred -ccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCcc----chhHHHHHHhhhc
Q 007361 444 -TEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH----NLLGHAWRLWIEE 513 (606)
Q Consensus 444 -~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~----~l~~~~~~~~~~~ 513 (606)
........+|+..|||||+.. ...|+.++|.||||||||-|++|-.||......... ........
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~----- 312 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN----- 312 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH-----
Confidence 122233467899999999862 345899999999999999999999999764432221 11111111
Q ss_pred CcchhcccccCCCCCHHH------HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RPVELINKSLGGSYSLSE------VLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~------~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+++....+.+..++ .....+++...+..++.+|-++.+++.
T Consensus 313 ---~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 ---KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ---HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 223333333322211 123456777778899999999988875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.88 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=194.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe----
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE---- 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 357 (606)
..++|...+.||+|+||.||+|+... ++.+|+|++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 46789999999999999999999865 788999988653 22234567789999999999999999998766554
Q ss_pred --eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 358 --RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 358 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6699888843 45899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCcc-chh-------HHH
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH-NLL-------GHA 506 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~-------~~~ 506 (606)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......... .+. ...
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9865332 223467889999999865 46789999999999999999999997533211000 000 000
Q ss_pred HHHhhhcCcchhcccccC-CCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 507 WRLWIEERPVELINKSLG-GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~l~-~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+..+........+..... ..... .....+.+++.+|++.+|++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000011110000 00000 11346789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=271.63 Aligned_cols=236 Identities=25% Similarity=0.332 Sum_probs=191.0
Q ss_pred ecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
||+|+||.||++.... ++.+++|.+..... ...+.+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999864 88999998866432 2456889999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccc
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 450 (606)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 999853 235899999999999999999999987 9999999999999999999999999998764322 12334
Q ss_pred cccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH
Q 007361 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530 (606)
Q Consensus 451 ~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 530 (606)
..++..|+|||.+.+...+.++|+||||+++|||++|+.|+..... ..+. ...... . ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~----~~~~~~--------~--~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIY----EKILKD--------P--LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH----HHHhcC--------C--CCCCCC
Confidence 5678899999999988899999999999999999999999753321 0010 100100 0 011111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHH
Q 007361 531 EVLRCIQVGLLCVQQRPEDRPNMSS 555 (606)
Q Consensus 531 ~~~~l~~l~~~Cl~~~P~~RPs~~~ 555 (606)
....+.+++..||+.+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1346678999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=265.73 Aligned_cols=204 Identities=26% Similarity=0.322 Sum_probs=178.1
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc---CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
..++|...++||+|.||.|-.++-+. ++.+|+|++++..-- ....-..|-++|+..+||.+..|--.+...+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34788999999999999999999765 889999999876433 33445568889999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||..||.|.-+|. +.+.+++.....+...|..||.|||+++ ||.||||.+|.|||.+|++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999998884 4556888888889999999999999998 9999999999999999999999999998521
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCC
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA 496 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~ 496 (606)
.....+...+||+.|+|||++.+..|...+|.|.+||++|||++|+.||...+.
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 233445668999999999999999999999999999999999999999764433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=302.50 Aligned_cols=146 Identities=28% Similarity=0.417 Sum_probs=130.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.++||+|+||.||+|.+. .++.||+|++.... ......+..|+.++..++|+||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357888999999999999999986 48899999986542 22346788999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999853 345889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=264.94 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=195.5
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+......||.|+||+|+|-.++. |+.+|||+++.... ...++++.|.....+- +.||||+++|.+...+..++-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34445789999999999998765 99999999976543 5667888888876665 689999999999999999999999
Q ss_pred CCCCCchhhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 365 LPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 365 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|+ .||+.+... ..+...+++...-+|......||.||...- .|||||+||+||||+..|.+||+|||++-.+...
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 577765432 123445888888899999999999998764 5999999999999999999999999998776422
Q ss_pred cccccccccccccCccCccccc--cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAI--DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
- ..+.-.|-..|||||.+. +..|..++||||||++|+|+.||+.|+..+.+. ... ......+++..+..
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feq-l~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQ-LCQVVIGDPPILLF 292 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHH-HHHHHcCCCCeecC
Confidence 1 122346777899999985 345999999999999999999999997655431 111 11222233333221
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.. ........+..++-.|+..|..+||...++.++
T Consensus 293 ~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 122334567888999999999999999998754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=265.07 Aligned_cols=220 Identities=20% Similarity=0.135 Sum_probs=174.7
Q ss_pred cCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCchhhhcc
Q 007361 298 GGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD 376 (606)
Q Consensus 298 G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 376 (606)
|.||.||+++... ++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999864 7899999986543 234455566666799999999999999999999999999999999853
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccC
Q 007361 377 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456 (606)
Q Consensus 377 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 456 (606)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||.+..+.... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 234899999999999999999999988 9999999999999999999999999886653221 12345678
Q ss_pred ccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHH
Q 007361 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCI 536 (606)
Q Consensus 457 y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 536 (606)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... .......+.. .....+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~~~~----~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTLNIPE----WVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccccCCcc----cCCHHHH
Confidence 999999988889999999999999999999997753211100 0000001111 1224577
Q ss_pred HHHhhcccCCCCCCCCHH
Q 007361 537 QVGLLCVQQRPEDRPNMS 554 (606)
Q Consensus 537 ~l~~~Cl~~~P~~RPs~~ 554 (606)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=282.27 Aligned_cols=240 Identities=24% Similarity=0.274 Sum_probs=191.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++.|.....+|.|+|+.|-.+.+.. ++..+||++.+...+ -.+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 36788888899999999999998755 889999999776322 34566555555 7999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE-cCCCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll-~~~~~~ki~DFGla~~~~~ 441 (606)
|.+.++-|.+.+.. .......+.+|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHh----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988877743 22233778889999999999999998 9999999999999 6899999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
. ....+-|..|.|||++....|++++|+||||++||+|++|+.|+..-..+ .++...
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~ 525 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTR 525 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHh
Confidence 3 22345688999999999999999999999999999999999997643332 111112
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+.++........+|+.+|||.+|.+||+|.++..
T Consensus 526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2222222222335668899999999999999999863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=259.25 Aligned_cols=237 Identities=27% Similarity=0.352 Sum_probs=191.9
Q ss_pred CcccEEEEEEeC-CcEEEEEEcccccccC-HHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCchhhhcc
Q 007361 299 GFGPVYKGVLIE-GQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD 376 (606)
Q Consensus 299 ~fG~Vy~g~~~~-g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 376 (606)
+||.||+|+..+ ++.+++|++....... .+.+.+|+..+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8899999997665544 78999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccC
Q 007361 377 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456 (606)
Q Consensus 377 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 456 (606)
.. .+++..++.++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2899999999999999999999997 9999999999999999999999999998765332 2233567889
Q ss_pred ccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH-HHHHH
Q 007361 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS-EVLRC 535 (606)
Q Consensus 457 y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~-~~~~l 535 (606)
|+|||.+.+..++.++||||||+++++|++|..|+..... ...+ ......... . ...... ....+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~----~~~~~~~~~-~-------~~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLEL----FKKIGKPKP-P-------FPPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHH----HHHHhccCC-C-------CccccccCCHHH
Confidence 9999999988899999999999999999999988754211 0001 111110000 0 000000 33578
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 007361 536 IQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 536 ~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=252.74 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=189.4
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-cCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+.+....||.|..|.|++.+... |..+|||.+.+... ...+.+...+.++.+-+ .|.||+.+|+|..+...++-||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 33445779999999999999866 88999999977643 33456667777766664 89999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
|. .-++.+|.. ..+++++..+-++...+.+||.||.++. .|+|||+||+|||+|+.|++|++|||++-.+-....
T Consensus 173 Ms-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 173 MS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 84 345555543 3345888888899999999999998875 599999999999999999999999999977643322
Q ss_pred cccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 445 EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.....|-+.|||||.+. ...|+.++||||||+.|+||.||+.|+.....+- ..+. ....+.+ +
T Consensus 248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~lt----kvln~eP-----P 313 (391)
T KOG0983|consen 248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLT----KVLNEEP-----P 313 (391)
T ss_pred ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHH----HHHhcCC-----C
Confidence 22346778999999985 3468999999999999999999999986543321 1111 1111111 2
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.+..- -...+.+++..||+.|+.+||...++++
T Consensus 314 ~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2222111 1235678888999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=267.38 Aligned_cols=241 Identities=27% Similarity=0.339 Sum_probs=191.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 360 (606)
..+|....+||+|+||.|.++..+. ...+|||++++.. ....+--+.|-++|+.. +-|.++++..++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578888999999999999998765 4568999997753 22334445677777776 56899999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+.||+|--++.+.. .+.+..+..++..||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999988885433 3778888999999999999999999 9999999999999999999999999998521
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.....+...+||+.|+|||++..++|+..+|.|||||+||||+.|+.||+..+.++.. . .+.+
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---~------------aI~e 564 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---Q------------AIME 564 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---H------------HHHH
Confidence 2233456689999999999999999999999999999999999999998765543211 1 1111
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP 551 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 551 (606)
..+ .++.....+...+...-+..+|.+|.
T Consensus 565 hnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 22323334555666777888998884
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=296.58 Aligned_cols=276 Identities=21% Similarity=0.225 Sum_probs=211.1
Q ss_pred HHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccc---ccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC
Q 007361 281 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD 356 (606)
Q Consensus 281 ~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 356 (606)
++.-..++|.+.++||+|+||.|..++++. ++.+|+|++.+ ..+....-|..|-.+|..-+.+-|++|.-.|.+..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 344456899999999999999999999876 77889999977 33455677999999999999999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
++|+|||||+||+|-.++.... .+++..+..++..|..||.-||+.| +|||||||+|||||..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999996533 5899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCcccccccccccccCccCccccc----c-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAI----D-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
-.+..+. .......+|||-|.+||++. + +.|+..+|.||+||++|||+.|..||.... ++...-+-+.
T Consensus 223 lkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~ 295 (1317)
T KOG0612|consen 223 LKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMN 295 (1317)
T ss_pred HhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhc
Confidence 8775443 33455679999999999984 3 569999999999999999999999974321 2211111111
Q ss_pred hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH--h-----cCCCCCCCCCCCCCccc
Q 007361 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN---MSSVVLM--L-----SGERSLPQPKQPGFFTE 577 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~~vl~~--L-----~~~~~~~~p~~p~~~~~ 577 (606)
......+. ...+....+.+|+..-+. +|+.|-. +.++-.= + .++++...|-.|.+.++
T Consensus 296 hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd 363 (1317)
T KOG0612|consen 296 HKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD 363 (1317)
T ss_pred hhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence 11111111 011122345566666654 6778776 6666531 1 34566666666666543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=265.24 Aligned_cols=263 Identities=20% Similarity=0.216 Sum_probs=200.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhcc-C-C----CcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-H-R----NLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~ 357 (606)
.+++|.+..++|+|.||.|-+..+.. +..||+|++ +......+..+-|++++.++. + | -+|++.+++.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIi-k~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKII-KNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHH-HHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36889999999999999999998765 578888888 444555667788999999994 2 3 37888899999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-------------
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------------- 424 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~------------- 424 (606)
.++|+|.+ |-|+.++|.+ ..-.+++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 6699999954 33456889999999999999999999998 999999999999821
Q ss_pred -------CCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCC
Q 007361 425 -------EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 497 (606)
Q Consensus 425 -------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~ 497 (606)
+..+||+|||.|..-...+ ..++.|..|.|||++++-.++..+||||+||||.||.||...|..-..-
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3458999999998743332 4578899999999999999999999999999999999999887654432
Q ss_pred CccchhHHHH--------------HHhhhcCcc-----------hhccccc----CCCCCHHHHHHHHHHHhhcccCCCC
Q 007361 498 HHHNLLGHAW--------------RLWIEERPV-----------ELINKSL----GGSYSLSEVLRCIQVGLLCVQQRPE 548 (606)
Q Consensus 498 ~~~~l~~~~~--------------~~~~~~~~~-----------~l~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~ 548 (606)
++..++.... +.+..+... ...+... .......+..+|++|+..|+..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 2221222111 111111000 0000000 0112335566899999999999999
Q ss_pred CCCCHHHHHH
Q 007361 549 DRPNMSSVVL 558 (606)
Q Consensus 549 ~RPs~~~vl~ 558 (606)
+|+|+.|+++
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=287.48 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=167.1
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-----CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEE------Ee
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC------CT 353 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 353 (606)
..++|...++||+|+||.||+|++.+ +..+|+|++..... .+...+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999999865 58999998854322 1111111 1122222233222211 24
Q ss_pred eCCeeEEEEecCCCCCchhhhcccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 007361 354 QRDERMLIYEYLPNKSLNDFIFDVTR-----------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK 416 (606)
Q Consensus 354 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk 416 (606)
.....++|+||+++++|.+++..... ........+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56679999999999999998854211 011123445679999999999999988 9999999
Q ss_pred CCCEEEcC-CCceEEeecCCccccCCCcccccccccccccCccCccccccC----------------------CCCcccc
Q 007361 417 ASNVLLDN-EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG----------------------LFSVKSD 473 (606)
Q Consensus 417 ~~NIll~~-~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~D 473 (606)
|+|||++. ++.+||+|||+|+.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 689999999999866433222 22346789999999966422 2345679
Q ss_pred chhHHHHHHHHHhccCCCCCCCCCCccch-----hHHHHHHhhhcCcchhcccccCCCCC--HHHHHHHHHHHhhcccCC
Q 007361 474 VFSFGVLVLEIVCGKRNRGFYHADHHHNL-----LGHAWRLWIEERPVELINKSLGGSYS--LSEVLRCIQVGLLCVQQR 546 (606)
Q Consensus 474 V~S~Gvvl~elltG~~p~~~~~~~~~~~l-----~~~~~~~~~~~~~~~l~d~~l~~~~~--~~~~~~l~~l~~~Cl~~~ 546 (606)
||||||+||||+++..+.+.........+ ....|....... ....+..... ........+|+.+||+.|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc----cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999999999997765321100000000 000111110000 0000000000 001123457999999999
Q ss_pred CCCCCCHHHHHH
Q 007361 547 PEDRPNMSSVVL 558 (606)
Q Consensus 547 P~~RPs~~~vl~ 558 (606)
|++|||+.++++
T Consensus 438 P~kR~ta~e~L~ 449 (566)
T PLN03225 438 GRQRISAKAALA 449 (566)
T ss_pred cccCCCHHHHhC
Confidence 999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=270.94 Aligned_cols=194 Identities=29% Similarity=0.424 Sum_probs=168.6
Q ss_pred CCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 292 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
.+.||+|-||+||-|++.. |+.||||.+.+. ......++++|+.+|++++||.||.|--.|...+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 4789999999999999754 999999999764 44556889999999999999999999999999999999999995 4
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEeecCCccccCCCccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~DFGla~~~~~~~~~ 445 (606)
++.+++... ....|++.....++.||+.||.|||.++ |+|+||||+||||.. --++||+|||.|+.++....
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555555432 3345888888889999999999999999 999999999999954 45799999999999875433
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
...++||+.|+|||++.+..|...-|+||.|||+|--++|..||..
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 3348999999999999999999999999999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=277.27 Aligned_cols=262 Identities=19% Similarity=0.276 Sum_probs=179.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEE-----------------eCCcEEEEEEcccccccCHHH--------------HHHH
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVL-----------------IEGQEIAAKRLSKSSGQGMEE--------------FENE 333 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 333 (606)
..++|.+.++||+|+||.||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999974 235679999986543322233 3447
Q ss_pred HHHHhhccCCCc-----ceEEEEEee--------CCeeEEEEecCCCCCchhhhcccC---------------------C
Q 007361 334 VLLIAKLQHRNL-----VKLIGCCTQ--------RDERMLIYEYLPNKSLNDFIFDVT---------------------R 379 (606)
Q Consensus 334 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------~ 379 (606)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 677887753 356899999999999999986421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccC
Q 007361 380 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 459 (606)
Q Consensus 380 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~a 459 (606)
...++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123578889999999999999999988 999999999999999999999999999765332211 1112234789999
Q ss_pred ccccccCC--------------------C--CccccchhHHHHHHHHHhccC-CCCCCCCCCc----cchhHHHHHHhhh
Q 007361 460 PEYAIDGL--------------------F--SVKSDVFSFGVLVLEIVCGKR-NRGFYHADHH----HNLLGHAWRLWIE 512 (606)
Q Consensus 460 PE~~~~~~--------------------~--s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~----~~l~~~~~~~~~~ 512 (606)
||.+.... + ..+.||||+||+++||++|.. |+........ ..-....|+.+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 234799999999999999875 5432111000 0000111222211
Q ss_pred cCcchhcccccCCCCCHHHHHHHHHHHhhcccCCC---CCCCCHHHHHH
Q 007361 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRP---EDRPNMSSVVL 558 (606)
Q Consensus 513 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPs~~~vl~ 558 (606)
... +-.. .........+++..++..+| .+|+|+.++++
T Consensus 459 ~~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111 1000 00112345678888888765 68999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=278.60 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=206.5
Q ss_pred HHHHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEee--
Q 007361 279 WMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ-- 354 (606)
Q Consensus 279 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-- 354 (606)
+..+...++-|++.+.||.|.+|.||+++..+ ++..|+|++.. .....+++..|..+++.+ .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 33444567788899999999999999999765 77777777744 445567888999999988 69999999999854
Q ss_pred ---CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 355 ---RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 355 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
++.++||||||.+||.-|++.+.. ...+.|..+..|+..++.||.+||... ++|||||-.||||+.++.+|+.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 567999999999999999997755 667999999999999999999999987 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccc-----CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 506 (606)
|||.+..+.. +....+...||+.|||||++.- ..|+..+|+||||++..||--|..|+-..++...
T Consensus 166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------- 236 (953)
T KOG0587|consen 166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------- 236 (953)
T ss_pred eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------
Confidence 9999987643 3444556899999999999953 3478899999999999999999999643332110
Q ss_pred HHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 507 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.-....+.+..+ ..+.....++.+++..|+..|-++||++.++++
T Consensus 237 LF~IpRNPPPkL-------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LFLIPRNPPPKL-------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hccCCCCCCccc-------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 000001111111 123344567889999999999999999998873
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=252.20 Aligned_cols=252 Identities=24% Similarity=0.249 Sum_probs=191.8
Q ss_pred HhcCCCcC-CeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEee----CCe
Q 007361 285 ATENFSDK-NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ----RDE 357 (606)
Q Consensus 285 ~~~~~~~~-~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 357 (606)
.+++|.+. ++||-|-.|.|..+..+. ++.+|+|.+... ...++|+++--.. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666544 679999999999998876 778899988543 3457888877666 59999999998753 456
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEeecC
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFG 434 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~DFG 434 (606)
+++|||.|+||.|...+.+. ....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 89999999999999998653 3455899999999999999999999998 999999999999954 5679999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
+|+.... .......+-|+.|.|||++...+|+..+|+||+||++|-|++|-.||-..+......-+ .+....+
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM---k~rI~~g- 282 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KRRIRTG- 282 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH---HhHhhcc-
Confidence 9997542 23334467899999999999999999999999999999999999997543331111000 0000000
Q ss_pred cchhcccccCCCCCHHHH-HHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSYSLSEV-LRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~-~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..++ .+....++ +...++++..|..+|.+|.|+.+++.
T Consensus 283 qy~F------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QYEF------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CccC------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0011 01111222 34567899999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=253.51 Aligned_cols=264 Identities=23% Similarity=0.396 Sum_probs=191.9
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEee--------CC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--------RD 356 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~ 356 (606)
.|....+||+|.||.||+++..+ |+.||+|++.... +.-.....+|+.+|..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556889999999999999766 7788998764432 2233556889999999999999999988743 23
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..+||+.+++. +|.-+|.+. ...++..++.+++.++..||.|+|... |+|||+||.|+|++.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 47999999975 788888543 234888999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccc--ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH-----H
Q 007361 437 RAFGIDQTE--ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-----R 508 (606)
Q Consensus 437 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~ 508 (606)
+.+...... ......+-|..|.+||.+.+. .|+++.|||..|||+.||.|+.+-+..........+++..- .
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 877543332 233345669999999999875 59999999999999999999988765443332222222111 0
Q ss_pred HhhhcCcchh---c--ccccCCCCC--HHHH------HHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 509 LWIEERPVEL---I--NKSLGGSYS--LSEV------LRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 509 ~~~~~~~~~l---~--d~~l~~~~~--~~~~------~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
.|.+-.-..+ + .+...+... .+.. ...++|+..++..||.+||.+.+++
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 1111111111 1 111111110 0111 1567888899999999999988876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=269.55 Aligned_cols=268 Identities=22% Similarity=0.291 Sum_probs=211.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCc-EEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQ-EIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++.....||-||||.|=++..+... .+|+|.+++. .....+.+..|-.+|...+.|.||+|+-.+.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566678999999999999875533 3788877654 4455677889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|-|-||.|...|.+ +..++..+...++..+.+|++|||+++ ||.|||||+|.+|+.+|-+||.|||.|+.++.
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 99999999999954 455888899999999999999999999 99999999999999999999999999998763
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
...+.+.+||+.|.|||++.+..++..+|.||||++++||++|.+||...++...-+++-.....+
T Consensus 573 --g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------ 638 (732)
T KOG0614|consen 573 --GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------ 638 (732)
T ss_pred --CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence 345667999999999999999999999999999999999999999987655433222221111100
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH--h-----cC--CCCCCCCCCCCCcccC
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVLM--L-----SG--ERSLPQPKQPGFFTER 578 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~~--L-----~~--~~~~~~p~~p~~~~~~ 578 (606)
.++..-.....++++.....+|.+|.. +.+|-+- + ++ .+.++.|-.|......
T Consensus 639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~pt 705 (732)
T KOG0614|consen 639 ---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPT 705 (732)
T ss_pred ---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcc
Confidence 112222234567777878899999985 4454421 1 23 2567777777665443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=257.65 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=191.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcc--cccc-----cCHHHHHHHHHHHhhccCCCcceEEEEEe-eCCe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS--KSSG-----QGMEEFENEVLLIAKLQHRNLVKLIGCCT-QRDE 357 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~--~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~ 357 (606)
++|-..++||+|||+.|||+.+.. .+.||||+-. +... ...+...+|..+-+.|.||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 345566789999999999999654 6777887642 2222 12345668999999999999999999985 4566
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCceEEeecC
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFG 434 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~ki~DFG 434 (606)
.+-|+||++|.+|+-||. ..+.+++.++..|+.||+.||.||.+.. ++|||-||||.||||- .-|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999994 4567999999999999999999999875 6899999999999994 45789999999
Q ss_pred CccccCCCccc-----ccccccccccCccCccccccC----CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHH
Q 007361 435 MARAFGIDQTE-----ANTNRVVGTYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 505 (606)
Q Consensus 435 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 505 (606)
+++.+..+... ..+....||..|++||.+.-+ .++.|+||||.|||+|..+.|++||+..... +.++.+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhh
Confidence 99998654433 345567899999999998533 4788999999999999999999998754332 112111
Q ss_pred HHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 506 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 506 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
+.+....+-... ..+....+...++.+||+..-++|....++.
T Consensus 697 -------NTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 -------NTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------hchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 101000000010 0111123456789999999999998765553
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=246.72 Aligned_cols=278 Identities=23% Similarity=0.312 Sum_probs=211.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 360 (606)
.++|...++||+|+|..|..++++. .+.+|+|.+++. ....++-.+.|-.+..+. +||.+|.|..++.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4688999999999999999999876 667888888764 344556677788888776 79999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|.||++||+|--++ ++++.++++.+..+...|..||.|||+.+ ||.||||.+|||+|..|.+||.|+|+.+.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999987665 45566999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCC-ccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH-HHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~l~ 519 (606)
. ....+...+||+.|.|||++.+..|...+|.|++||+++||+.|+.||+....+. ..+-.++.+....+..+
T Consensus 403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi---- 476 (593)
T KOG0695|consen 403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI---- 476 (593)
T ss_pred C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----
Confidence 2 2334566899999999999999999999999999999999999999998654322 22233333332222211
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCC------CHHHHH----------HHhcCCCCCCCCCCCCCcccCCCCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP------NMSSVV----------LMLSGERSLPQPKQPGFFTERNPPE 582 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP------s~~~vl----------~~L~~~~~~~~p~~p~~~~~~~~~~ 582 (606)
. .+.....+...+...-++.||.+|. .++++. ++|+ .+++-.|-+|....+....+
T Consensus 477 ----r--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le-qk~v~ppf~p~i~~d~~l~~ 548 (593)
T KOG0695|consen 477 ----R--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE-QKQVLPPFQPQITDDYGLDN 548 (593)
T ss_pred ----c--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh-hcccCCCCCCccccccCccc
Confidence 0 1111223455677778889998884 223322 2333 34555566777666554433
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=229.69 Aligned_cols=261 Identities=25% Similarity=0.330 Sum_probs=191.4
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+|...++||+|.||+||+|+..+ +..||+|++.-. ++.......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566899999999999999766 678899988644 333345678999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+.. +|..+... -...++.+....++.|+++||.++|+++ +.||||||.|.|++.+|.+|++|||+++.++.+-.
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 67776632 2455899999999999999999999998 99999999999999999999999999999876543
Q ss_pred cccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCC-CCCCCCCCccchhHHHHHH--hhhcCc---ch
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRL--WIEERP---VE 517 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~--~~~~~~---~~ 517 (606)
-. ...+-|..|.+|.++.+.. |+...|+||.||++.||....+| |+..+.+ ..+....|.. ..++.. ..
T Consensus 157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhCCCccccCCcccc
Confidence 22 2245688999999998765 89999999999999999964444 4432222 2222222211 111111 12
Q ss_pred hcccccCCCCCH----H-HHHH----HHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSL----S-EVLR----CIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~----~-~~~~----l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+-|...-..++. . -+.+ =.++....+.-+|.+|.++.+.++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 222222111111 1 1111 245666677779999999887754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=231.95 Aligned_cols=207 Identities=24% Similarity=0.350 Sum_probs=170.1
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc-cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeE
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 359 (606)
....+.......||+|++|.|-+-++. +|+..|+|++... ..+..+....|+.+..+. ..|.+|.++|........+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 334455666788999999999998875 5899999999765 345566778888877665 6899999999999999999
Q ss_pred EEEecCCCCCchhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 360 LIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
+.||.|. .||+.|..+ ..+...+++..+-+|+..|.+||.|||++- .+||||+||+|||++.+|++||+|||++-.
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999994 588887654 245667999999999999999999999975 699999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCcccccc----CCCCccccchhHHHHHHHHHhccCCCCCCC
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAID----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 495 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~ 495 (606)
+...-. .+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++.+.
T Consensus 199 L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 199 LVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 643211 111346678999999843 369999999999999999999999987554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=259.51 Aligned_cols=215 Identities=21% Similarity=0.368 Sum_probs=179.7
Q ss_pred HHHHHHH---hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEE
Q 007361 279 WMAIANA---TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGC 351 (606)
Q Consensus 279 ~~~~~~~---~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~ 351 (606)
|..+.++ ..-|..++.||-|+||.|.++...| ...+|+|.|.+.+ +......+.|-.||+..+.+-||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 3444444 3467788999999999999999777 4568899987753 3455678889999999999999999999
Q ss_pred EeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 352 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
|.+++.+|+||+|++||++-.+|. +...+.+..+..++..+..|+++.|..| +|||||||+|||||.+|++||.
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeee
Confidence 999999999999999999999985 3456888889999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCccc----------------------------------------ccccccccccCccCccccccCCCCcc
Q 007361 432 DFGMARAFGIDQTE----------------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVK 471 (606)
Q Consensus 432 DFGla~~~~~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k 471 (606)
||||+.-+...... ...-..+||..|+|||++....|+.-
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 99998654210000 00123579999999999999999999
Q ss_pred ccchhHHHHHHHHHhccCCCCCCCCCCc
Q 007361 472 SDVFSFGVLVLEIVCGKRNRGFYHADHH 499 (606)
Q Consensus 472 ~DV~S~Gvvl~elltG~~p~~~~~~~~~ 499 (606)
+|.||.|||||||+.|+.||-...+.+.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999999865554443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=273.04 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=186.3
Q ss_pred CCCcCCeecccCccc-EEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecC
Q 007361 288 NFSDKNKLGEGGFGP-VYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
-|...+.+|.|.-|+ ||+|.. +|++||||++-... .+-..+|+..|+.- +||||||+++.-.+....|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 345567789998876 689988 88999999985432 33457899999888 6999999999999999999999999
Q ss_pred CCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCceEEeecCCcccc
Q 007361 366 PNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAF 439 (606)
Q Consensus 366 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~ki~DFGla~~~ 439 (606)
..+|.+++... .......-...+.+..|++.||++||+.+ ||||||||.||||+. ...++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 46999999542 11111111345678899999999999987 999999999999965 357999999999998
Q ss_pred CCCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhc-cCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 440 GIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 440 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
..++.. .......||.+|+|||++....-+..+||||+|||+|+.++| ..||+..-..+...+ .+ ...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl---------~~-~~~ 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL---------TG-NYT 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---------cC-ccc
Confidence 765444 334567899999999999999999999999999999999987 788763211110000 00 001
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
++. + ....+. ...+|+..|+..+|..||++.+|+
T Consensus 732 L~~--L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 732 LVH--L--EPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred eee--e--ccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 100 0 011111 667899999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=229.56 Aligned_cols=211 Identities=36% Similarity=0.573 Sum_probs=183.3
Q ss_pred ecccCcccEEEEEEeC-CcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCchh
Q 007361 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND 372 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 372 (606)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999998655432 35789999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCccccCCCccccccccc
Q 007361 373 FIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGIDQTEANTNRV 451 (606)
Q Consensus 373 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~~~~~~~~~~~~~~ 451 (606)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985421 35899999999999999999999998 999999999999999 89999999999987643321 12234
Q ss_pred ccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHH
Q 007361 452 VGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 530 (606)
Q Consensus 452 ~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 530 (606)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567899999999887 889999999999999998
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 531 EVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 531 ~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4667899999999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-27 Score=227.72 Aligned_cols=198 Identities=33% Similarity=0.459 Sum_probs=172.1
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566899999999999999876 889999999766544 57789999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999854221 1789999999999999999999997 999999999999999999999999999876543211
Q ss_pred cccccccccCccCcccc-ccCCCCccccchhHHHHHHHHHhccCCCC
Q 007361 447 NTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKRNRG 492 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~-~~~~~s~k~DV~S~Gvvl~elltG~~p~~ 492 (606)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22335677899999998 67778889999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=248.45 Aligned_cols=195 Identities=27% Similarity=0.391 Sum_probs=166.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--------cCHHHHHHHHHHHhhcc---CCCcceEEEEEee
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--------QGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQ 354 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 354 (606)
.+|+..+.||+|+||.|+.+.++. ..+|++|.+.+..- ...-.+-.|+.+|+.++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468888999999999999999876 56788887765421 11223556999999997 9999999999999
Q ss_pred CCeeEEEEecC-CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeec
Q 007361 355 RDERMLIYEYL-PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433 (606)
Q Consensus 355 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DF 433 (606)
++..||++|-. ++-+|.+++. ..+.+++.++.-|+.||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999986 4568888883 3455999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCC
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNR 491 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~ 491 (606)
|.|...... .....+||..|.|||++.+.+| ...-|||++|++||.++....|+
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999875332 3445899999999999999887 55689999999999999888774
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=231.33 Aligned_cols=263 Identities=21% Similarity=0.295 Sum_probs=189.9
Q ss_pred CcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----CeeEEE
Q 007361 290 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DERMLI 361 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV 361 (606)
+..+-||-|+||.||.+.++. |+.|+.|++..- .-...+.+.+|+++|...+|.|++..++...-. ++.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 345789999999999999764 899999998543 223456788999999999999999998876433 357888
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+|.|. .+|...+. ....++-..+.-+..||++||.|||+.+ |.||||||.|.|++.|-.+||+|||+++....
T Consensus 136 TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 99884 47777663 3345788888889999999999999998 99999999999999999999999999998765
Q ss_pred CcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHH--------HHHHhhh
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AWRLWIE 512 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~ 512 (606)
++....+. .+-|..|.|||++++. .|+.++||||.|||+.||+..+-.|....+.+..+++-. +.+.--+
T Consensus 209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 55444433 4568899999999976 589999999999999999987776654433222221110 1111111
Q ss_pred cCcchhcccccCC-C--------CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 513 ERPVELINKSLGG-S--------YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 513 ~~~~~l~d~~l~~-~--------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
+....++....+. + .....-...+.+.+.++..+|+.|.+..+.+.-+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111111100 0 0001112345677788999999999988887655
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=219.59 Aligned_cols=257 Identities=19% Similarity=0.315 Sum_probs=189.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCC--eeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRD--ERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~l 360 (606)
..++|++.+++|+|-++.||.|... +++.+++|.++... .+.+.+|+.+|..|. ||||+.|++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 3578889999999999999999954 57788889886543 356889999999997 999999999987654 5789
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCcccc
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAF 439 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~~ 439 (606)
|+||+.+.+...+. ..++...+..++.++++||.|+|+.| |+|||+||.|+++|. ...++|+|+|+|.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998776654 23777888899999999999999999 999999999999986 567999999999987
Q ss_pred CCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH-----------
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW----------- 507 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----------- 507 (606)
...+. .+..+.+..|.-||.+.+- .|+..-|+|||||+|.+|+..+.||=. ..+....++..+.
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh-G~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC-CCCCHHHHHHHHHHhChHHHHHHH
Confidence 64433 2334567788899998764 589999999999999999999999732 1222223332211
Q ss_pred -HHhhh--cCcchhccccc--------CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 508 -RLWIE--ERPVELINKSL--------GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 508 -~~~~~--~~~~~l~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
+.-.. .....++.... ...-..-...+.++++...+..|-++|||++|..
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 00000 00001111100 0000001123567788889999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=233.23 Aligned_cols=131 Identities=28% Similarity=0.379 Sum_probs=110.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeCC-cEEEEEEcccccccCHHHHHHHHHHHhhcc-----C---CCcceEEEEEe----
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEG-QEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-----H---RNLVKLIGCCT---- 353 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~---- 353 (606)
.+|.+.++||-|.|++||++.+..+ +.||+|++ +......+....|+++|++++ | .+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVv-KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVV-KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEE-ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788999999999999999998664 56677766 566666778889999999984 3 36999999985
Q ss_pred eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 354 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
.+.+.+||+|++ |.+|..++... ..+-++...+.+|+.||+.||.|||.++ +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 456899999999 67888887543 3445899999999999999999999987 69999999999997
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=202.20 Aligned_cols=97 Identities=45% Similarity=0.922 Sum_probs=93.0
Q ss_pred CCCCCCCCcceEEEeecCCeEEEEEEecCCCceEEEEEccCCCeEEEEEecCCCCceeeecccCCCCcCCcccccCCCcc
Q 007361 1 MPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYA 80 (606)
Q Consensus 1 ~p~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~l~~~G~~~~~~w~~~~~~w~~~~~~~~~~~~~C~~~~~CG~~g 80 (606)
+|+|..+++|.++|++|++|+||+|.+.+.+.++|++||++|+++++.|+++++.|..+| .+|.|+||+|+.||+||
T Consensus 14 ~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~---~~p~d~Cd~y~~CG~~g 90 (110)
T PF00954_consen 14 IPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFW---SAPKDQCDVYGFCGPNG 90 (110)
T ss_pred cccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEE---EecccCCCCccccCCcc
Confidence 699999999999999999999999999999999999999999999999999999999999 88899999999999999
Q ss_pred cccCCCCCCcccccCCCccCC
Q 007361 81 VCNMNSNSAKCECLEGFVPKS 101 (606)
Q Consensus 81 ~C~~~~~~~~C~C~~gf~~~~ 101 (606)
+|+.+ +.+.|+||+||+|++
T Consensus 91 ~C~~~-~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 91 ICNSN-NSPKCSCLPGFEPKN 110 (110)
T ss_pred EeCCC-CCCceECCCCcCCCc
Confidence 99877 778999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=223.78 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=188.2
Q ss_pred cCCCcCCeecccCcccEEEEEE-eCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------Ce
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------DE 357 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 357 (606)
.+|.....+|.|.- .|-.+.+ ..++.||+|++... .....+...+|..++..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888887 4544443 24889999998653 344567778999999999999999999998643 35
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.|+|||+|. .+|...+. -.++-.++..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 799999995 58888774 23778889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCC----------------ccc
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH----------------HHN 501 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~----------------~~~ 501 (606)
.-+.+ ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|.--|...+.-. ...
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 75433 23344778999999999999999999999999999999999986654321100 001
Q ss_pred hhHHHHHHhhhcCcc-------hh-cccccCCC--CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 502 LLGHAWRLWIEERPV-------EL-INKSLGGS--YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 502 l~~~~~~~~~~~~~~-------~l-~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+...+.. +...... ++ -|...... .+......+.+++.+||..+|++|.++.+++.
T Consensus 244 L~~~~r~-yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRN-YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHH-HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1111111 1111111 11 11111110 11122234567899999999999999999885
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=237.16 Aligned_cols=201 Identities=20% Similarity=0.238 Sum_probs=170.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhcc------CCCcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ------HRNLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~ 357 (606)
....|.+....|+|-|++|.+|.... |+.||||++..+.. -.+.=+.|+++|.+|+ ..|+++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34577778889999999999999765 88999999966532 2344578999999996 3489999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CceEEeecCCc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMA 436 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~ki~DFGla 436 (606)
++||+|-+ .-+|.+.|....+...|....+..++.|+..||..|..-+ |+|.||||.|||+++. ..+||+|||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999988 4589999988777778999999999999999999999888 9999999999999875 56899999999
Q ss_pred cccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
........ ++ +.-+.-|.|||++.|-+|+...|+||.||.||||.||+-.|+..
T Consensus 585 ~~~~enei---tP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 585 SFASENEI---TP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccccc---cH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 87643322 11 33356799999999999999999999999999999999877653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=242.45 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=199.6
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
..++|.....+|.|.+|.|||++... ++..|+|.++-.......-+.+|+-+++..+|||||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34678888999999999999999865 78889999887777777778899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+.+|+|.+.-+ -..++++.++..+....++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 999999999774 3456899999999999999999999998 79999999999999999999999999877642
Q ss_pred ccccccccccccCccCcccc---ccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc--Ccchh
Q 007361 444 TEANTNRVVGTYGYMPPEYA---IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE--RPVEL 518 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~l 518 (606)
.-.......||+.|||||+. ..+.|..++|||+.|+...|+---+.|.-..++. .+..+..+. .+..+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTKSGFQPPTL 237 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhccCCCCCcc
Confidence 22333457899999999987 4567999999999999999987666663211111 111111111 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
-|+. .....+-+++..|+..+|++||++..++
T Consensus 238 kDk~-------kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 238 KDKT-------KWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cCCc-------cchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1111 1223456788899999999999988765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=213.29 Aligned_cols=253 Identities=19% Similarity=0.325 Sum_probs=187.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEE-EeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGC-CTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 362 (606)
.+.|.+.+.||+|.||.+.++.+.. .+.+++|-+.. .....++|.+|..---.| .|.||+.-++. +...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4678889999999999999999876 55677777744 345678899998766666 58999988765 56667788999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE--cCCCceEEeecCCccccC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFG 440 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll--~~~~~~ki~DFGla~~~~ 440 (606)
||++.|+|.+-+-. ..+.+..-..++.|++.||.|||+++ +||||||.+|||+ .+.-++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999987732 34777888899999999999999999 9999999999999 234589999999988654
Q ss_pred CCcccccccccccccCccCccccccC---C--CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDG---L--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
.. ......+..|.|||..... . ..+.+|||.||++++.++||+.|+... ...+-..+.|..|.....
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka---~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA---SIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh---hccCchHHHHHHHhcccC
Confidence 22 1123346689999987433 2 467899999999999999999997632 233344566677766554
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L 560 (606)
..+.+.. ..+ ..++.++..+-+..+|++|-...++.++-
T Consensus 247 ~~~P~~F--~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPKKF--NPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCchhh--ccc----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 4322111 111 23455666788899999995555554443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-26 Score=262.23 Aligned_cols=196 Identities=18% Similarity=0.239 Sum_probs=138.1
Q ss_pred hccC-CCcceEEEEE-------eeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007361 339 KLQH-RNLVKLIGCC-------TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410 (606)
Q Consensus 339 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 410 (606)
.++| .||+++++.+ ......++++|++ +++|.++|.. ....+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 5888888877 3334567788987 5699999953 2345999999999999999999999998 9
Q ss_pred eeccCCCCCEEEcC-------------------CCceEEeecCCccccCCCcc--------------cccccccccccCc
Q 007361 411 IHRDLKASNVLLDN-------------------EMNPKISDFGMARAFGIDQT--------------EANTNRVVGTYGY 457 (606)
Q Consensus 411 iH~Dlk~~NIll~~-------------------~~~~ki~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 457 (606)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666666654211000 0001124578899
Q ss_pred cCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHH
Q 007361 458 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQ 537 (606)
Q Consensus 458 ~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~ 537 (606)
||||++.+..++.++|||||||+||||++|..|+.... ... ...... .+.+ ...........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~----~~~~~~----~~~~-----~~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM----SSLRHR----VLPP-----QILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH----HHHHHh----hcCh-----hhhhcCHHHHH
Confidence 99999999999999999999999999999887743110 000 000000 0000 00112234567
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 007361 538 VGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 538 l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
++.+||+.+|.+||+|.++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=216.54 Aligned_cols=200 Identities=27% Similarity=0.435 Sum_probs=166.3
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEeC----CcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCe
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDE 357 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 357 (606)
....+.|...++||+|.|++||++.+.. ...||+|.+...+. ...+.+|+++|..+. +.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445778889999999999999999754 56899999866543 356889999999995 8999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMA 436 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla 436 (606)
..+|+||++.....+++.. ++...+..++..+++||.++|.+| ||||||||.|+|.+. -+.-.|.|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999998854 678899999999999999999999 999999999999975 467789999999
Q ss_pred cccCCCc-------------cc-----------------------------ccccccccccCccCccccccC-CCCcccc
Q 007361 437 RAFGIDQ-------------TE-----------------------------ANTNRVVGTYGYMPPEYAIDG-LFSVKSD 473 (606)
Q Consensus 437 ~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~D 473 (606)
...+..+ .. ...-...||+||.|||++... ..+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321000 00 000113599999999998764 5789999
Q ss_pred chhHHHHHHHHHhccCCCCC
Q 007361 474 VFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 474 V~S~Gvvl~elltG~~p~~~ 493 (606)
|||.|||++.+++++.||-.
T Consensus 261 iws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred eeeccceeehhhcccccccc
Confidence 99999999999999999743
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=202.09 Aligned_cols=165 Identities=18% Similarity=0.142 Sum_probs=123.0
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|+|.+++.. +...++|..++.++.||++||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688888853 2446999999999999999999999876 999999999999999 99998754321
Q ss_pred ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
..||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .............. ......
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~--------~~~~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD--------DPRDRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC--------Cccccc
Confidence 25789999999999999999999999999999999999997432211 11111111000000 000001
Q ss_pred CHHHH---HHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 528 SLSEV---LRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 528 ~~~~~---~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..... ..+.+++..||+.+|++||++.++++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11111 258899999999999999999999987743
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=213.47 Aligned_cols=177 Identities=17% Similarity=0.178 Sum_probs=134.7
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEe--CCcEEEEEEccccc-----ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR 355 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~--~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 355 (606)
....++|...+.||+|+||+||+|.+. +++.+|||++.... ....+.|.+|++++.+++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999875 46778999875331 1234568999999999999999864332 2
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCEEEcCCCceEEeecC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl-k~~NIll~~~~~~ki~DFG 434 (606)
+..++||||+++++|.... .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 11 1 1467889999999999998 999999 9999999999999999999
Q ss_pred CccccCCCccccc------ccccccccCccCccccccCC------CCccccch
Q 007361 435 MARAFGIDQTEAN------TNRVVGTYGYMPPEYAIDGL------FSVKSDVF 475 (606)
Q Consensus 435 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~s~k~DV~ 475 (606)
+|+.+........ .....++..|+|||.+.... .+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9998754322111 12466788999999985433 23346666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-24 Score=202.66 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=188.3
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
....+|.+...|..|+|+++ |..+++|++... .....++|..|.-.|+...||||+.++|.|.....+.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34467899999999999994 555666766433 333457899999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccccc
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 447 (606)
|||...|++ ..+-..+..++.+++.+||+|++|||+..+ -|.---|.++.|++|++.+++|+-= -+++. ..
T Consensus 272 gslynvlhe-~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarisma-d~kfs------fq 342 (448)
T KOG0195|consen 272 GSLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMA-DTKFS------FQ 342 (448)
T ss_pred hHHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecc-cceee------ee
Confidence 999999976 344557888999999999999999999873 2444568999999999999888631 11110 00
Q ss_pred ccccccccCccCccccccCCC---CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 448 TNRVVGTYGYMPPEYAIDGLF---SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 448 ~~~~~gt~~y~aPE~~~~~~~---s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.......+.||+||.+...+- -..+|+|||+++||||.|..-||....+.+....+. -..+.
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---------------leglr 407 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---------------LEGLR 407 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------------hcccc
Confidence 111234678999999987653 457999999999999999999987655433221110 01122
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
-..++--...+.+|+.-|+..||.+||.+..|+-.|+..
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 223333345677889999999999999999999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-22 Score=205.95 Aligned_cols=259 Identities=22% Similarity=0.253 Sum_probs=190.7
Q ss_pred CCCcCCeecccCcccEEEEEEeCC--cEEEEEEcccccccCHHHHHHHHHHHhhccC----CCcceEEEEE-eeCCeeEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIEG--QEIAAKRLSKSSGQGMEEFENEVLLIAKLQH----RNLVKLIGCC-TQRDERML 360 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 360 (606)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999997664 3677777655433333377889999998873 6889999988 57778899
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-----CceEEeecCC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-----MNPKISDFGM 435 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-----~~~ki~DFGl 435 (606)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|.+||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999775444 566999999999999999999999999 9999999999999754 4699999999
Q ss_pred ccccC--CCcc----cc-c-ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH
Q 007361 436 ARAFG--IDQT----EA-N-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 436 a~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 507 (606)
++.+. .... .. . .....||..|+++..+.+...+.+.|+||++.++.|++.|..|+...........
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~----- 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK----- 248 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH-----
Confidence 99332 2211 11 1 2335699999999999999999999999999999999999999744332111000
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+........... .....+.+ +.++...+-..+..++|....+...|...
T Consensus 249 --~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 249 --FEKDPRKLLTDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred --HHHHhhhhcccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 000000011110 11122233 33444444458889999999999887653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-20 Score=193.70 Aligned_cols=262 Identities=29% Similarity=0.380 Sum_probs=197.3
Q ss_pred CCcCCeecccCcccEEEEEEeCCcEEEEEEccccccc---CHHHHHHHHHHHhhccCC-CcceEEEEEeeCCeeEEEEec
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQHR-NLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 364 (606)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999986 88899988765443 367899999999999988 799999999777778999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~~~~~ 443 (606)
+.+++|.+++........+.......++.+++.++.|+|+.+ ++||||||+||+++..+ .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976643221136889999999999999999999998 99999999999999988 79999999998664433
Q ss_pred ccc----cccccccccCccCcccccc---CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 444 TEA----NTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 444 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+...... ......+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 322 2455789999999999988 67899999999999999999999995443321 0111111111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.................+.+++..++..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001222456678889999999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=181.92 Aligned_cols=203 Identities=22% Similarity=0.315 Sum_probs=172.2
Q ss_pred cCCCcCCeecccCcccEEEEE-EeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
-+|.++++||+|.||.++.|+ +.+++.||+|--...+ ..-++..|....+.|. .+.|...+-+-.++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 478899999999999999998 4578999999754332 3457888999999985 68999999998999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCceEEeecCCcccc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAF 439 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~ki~DFGla~~~ 439 (606)
+ |.||.|++.-. .+.++..++..+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 88999876432 234899999999999999999999998 999999999999954 345899999999998
Q ss_pred CCCccccc-----ccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCC
Q 007361 440 GIDQTEAN-----TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 497 (606)
Q Consensus 440 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~ 497 (606)
..+.+... .....||.+||+-.-..+...+.+.|+-|+|-|++..|-|..||.....+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 76655432 23467999999999999999999999999999999999999998765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-22 Score=217.91 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=185.2
Q ss_pred CcCCeecccCcccEEEEEEeC-CcEEEEEEccc---cc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 290 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK---SS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~---~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.....+|.|.+|.|+...... ....+.|.... .. ......+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 355789999999887776543 33333333221 11 111222566777788899999988887777777666679
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++ +|..++.. ...+...++..++.|+..|+.|||+.+ |.|||||++|++++.++.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99998843 246888899999999999999999999 999999999999999999999999999888666
Q ss_pred ccc--ccccccccccCccCccccccCCCCc-cccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc-chh
Q 007361 443 QTE--ANTNRVVGTYGYMPPEYAIDGLFSV-KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP-VEL 518 (606)
Q Consensus 443 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~l 518 (606)
... ......+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||.......... ..... .+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------~~~~~~~~~ 544 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------KTNNYSDQR 544 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---------hhhcccccc
Confidence 554 4556688999999999999999876 5899999999999999999976543322211 00000 000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
-...-..........+...++..+++.+|.+|.|+.+|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000111223345677899999999999999999985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=175.06 Aligned_cols=203 Identities=23% Similarity=0.303 Sum_probs=169.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccC-CCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH-RNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 363 (606)
..+|...++||.|+||.+|.|... +|..||+|.-+.... ..++.-|..+...|+| ..|..+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 467889999999999999999964 599999998654433 3467789999999986 677788888889999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~DFGla~~~~ 440 (606)
.+ |.||.+++.-.. +.++..+++-++-|++.-++|+|..+ +|||||||+|+|+.- -..+-++|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 889999774332 23788899999999999999999998 999999999999954 4568999999999875
Q ss_pred CCcccc-----cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCC
Q 007361 441 IDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA 496 (606)
Q Consensus 441 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~ 496 (606)
...+.. ......||.+|.+-....+...+...|+-|+|.+|..+--|..|+....+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 443332 22346799999999999999999999999999999999999999875443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-21 Score=211.18 Aligned_cols=251 Identities=18% Similarity=0.222 Sum_probs=184.6
Q ss_pred CCCcCCeecccCcccEEEEEEeCCcEEEEEEccccc-ccCHHHHHHHHHHHh--hccCCCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS-GQGMEEFENEVLLIA--KLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++...+.||.+.|=.|.++++.+|. |+||.+.+.. ....+.|.++++-++ .++|||.+++.-.-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 8888876554 455666666555444 45899999998887777778999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
..+ +|.|.| ..+.++...+..-|+.|++.||.-+|..+ |+|||||.+||||+.-..+.|+||...+....+..
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 865 888887 46778888999999999999999999998 99999999999999999999999988765533322
Q ss_pred cc-cc----cccccccCccCccccccC----------C-CCccccchhHHHHHHHHHhc-cCCCCCCCCCCccchhHHHH
Q 007361 445 EA-NT----NRVVGTYGYMPPEYAIDG----------L-FSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 445 ~~-~~----~~~~gt~~y~aPE~~~~~----------~-~s~k~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~ 507 (606)
.. .. .+...-..|+|||.+... + .+++.||||+||++.||++- +.+|+.. .|..+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhc
Confidence 21 11 122233479999987431 2 67899999999999999985 5555421 1111110
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
-.......++...- ...+..+++.|+|.||++|-++.+.++.-.|
T Consensus 250 --~~~~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 250 --GNADDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred --cCccCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 00111112211111 1156789999999999999999999987554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=176.68 Aligned_cols=140 Identities=17% Similarity=0.146 Sum_probs=109.0
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEccccccc--C-------HHH-----------------HHHHHHHHhhccCCCc
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ--G-------MEE-----------------FENEVLLIAKLQHRNL 345 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 345 (606)
...||+|+||.||+|...+|+.||+|+++..... . ... ...|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999888999999998654211 1 112 2349999999988776
Q ss_pred ceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccCCCCCEEEcC
Q 007361 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL-HQDSRLRIIHRDLKASNVLLDN 424 (606)
Q Consensus 346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~Dlk~~NIll~~ 424 (606)
........ ...++||||+++++|..... ....+++.....++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 23489999999987765432 224588999999999999999999 6777 99999999999998
Q ss_pred CCceEEeecCCccccC
Q 007361 425 EMNPKISDFGMARAFG 440 (606)
Q Consensus 425 ~~~~ki~DFGla~~~~ 440 (606)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=180.66 Aligned_cols=171 Identities=14% Similarity=0.171 Sum_probs=134.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHH---------HHHHHHHHHhhccCCCcceEEEEEeeC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGME---------EFENEVLLIAKLQHRNLVKLIGCCTQR 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~~ 355 (606)
..++|...+.||.|+||.||.... +++.+|+|.+......... .+.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368899999999999999999655 6778999999754332222 268999999999999999999886543
Q ss_pred --------CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc
Q 007361 356 --------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 427 (606)
Q Consensus 356 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 427 (606)
...++||||++|.+|.++.. ++. ....+++.+|..||+.+ ++||||||.||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999988741 222 24568999999999998 99999999999999988
Q ss_pred eEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHH
Q 007361 428 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485 (606)
Q Consensus 428 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ell 485 (606)
++|+|||.......+.... .++....|..++|+||||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999887653221111 1344555778999999999987664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=170.32 Aligned_cols=141 Identities=18% Similarity=0.204 Sum_probs=111.7
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEccccccc---------------------C-----HHHHHHHHHHHhhccCCCc
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ---------------------G-----MEEFENEVLLIAKLQHRNL 345 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni 345 (606)
...||+|+||.||+|.+.+|+.||||.+...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998764211 0 1124578999999999987
Q ss_pred ceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcC
Q 007361 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 424 (606)
Q Consensus 346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIll~~ 424 (606)
.....+... ..+|||||++++++..... ....++......++.+++.+|.+||+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444332 3489999999886544321 22347788899999999999999999 87 99999999999999
Q ss_pred CCceEEeecCCccccCC
Q 007361 425 EMNPKISDFGMARAFGI 441 (606)
Q Consensus 425 ~~~~ki~DFGla~~~~~ 441 (606)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=189.44 Aligned_cols=217 Identities=24% Similarity=0.339 Sum_probs=162.6
Q ss_pred HhhccCCCcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 007361 337 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK 416 (606)
Q Consensus 337 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk 416 (606)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...++.+|++||.|||+.. -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999976 3445899999999999999999999875 13999999
Q ss_pred CCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCC-------CCccccchhHHHHHHHHHhccC
Q 007361 417 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-------FSVKSDVFSFGVLVLEIVCGKR 489 (606)
Q Consensus 417 ~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~k~DV~S~Gvvl~elltG~~ 489 (606)
+.|.++|....+||+|||+.................-...|.|||.+.+.. .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987764211111111123455899999987642 4677999999999999999999
Q ss_pred CCCCCCCCCcc-chhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 490 NRGFYHADHHH-NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 490 p~~~~~~~~~~-~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
|++........ .++.... ......+.+.+.... +....+..++..||..+|.+||++.+|-..++...
T Consensus 157 ~~~~~~~~~~~~eii~~~~-----~~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVK-----KGGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHHHH-----hcCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 98764433322 2222211 111122222221111 22236888999999999999999999998887653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=165.31 Aligned_cols=137 Identities=20% Similarity=0.282 Sum_probs=107.5
Q ss_pred CCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhc-----cCCCcceEEEEEeeCC---e-eE
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-----QHRNLVKLIGCCTQRD---E-RM 359 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 359 (606)
++..+.||+|+||.||. +++....+||++........+.+.+|+.++..+ +||||++++|++.+.. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34458899999999996 544444478988665555667899999999999 5799999999998864 3 33
Q ss_pred EEEec--CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeccCCCCCEEEcC----CCceEEee
Q 007361 360 LIYEY--LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL-LYLHQDSRLRIIHRDLKASNVLLDN----EMNPKISD 432 (606)
Q Consensus 360 lV~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiH~Dlk~~NIll~~----~~~~ki~D 432 (606)
+|+|| +++++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 668999999943 125555 35677888777 9999998 999999999999974 34899999
Q ss_pred cCCc
Q 007361 433 FGMA 436 (606)
Q Consensus 433 FGla 436 (606)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=160.96 Aligned_cols=184 Identities=19% Similarity=0.136 Sum_probs=138.2
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEccccccc----CHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEec
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ----GMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.....|++|+||+||.+.. .+..++.+.+.....- ....|.+|+++|++|+ |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997765 6777777777554331 1225889999999995 5889999886 446999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl-k~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
+.|.+|...+.. ....++.+++++|.++|+.+ |+|||| ||+|||++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654311 11357789999999999998 999999 7999999999999999999998654322
Q ss_pred cc----c-------cccccccccCccCccccccC-CCC-ccccchhHHHHHHHHHhccCCC
Q 007361 444 TE----A-------NTNRVVGTYGYMPPEYAIDG-LFS-VKSDVFSFGVLVLEIVCGKRNR 491 (606)
Q Consensus 444 ~~----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~k~DV~S~Gvvl~elltG~~p~ 491 (606)
.. . ..-....++.|++|+...-. ..+ ...+.++-|..+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 0 01112357788888865322 233 5689999999999999998773
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.1e-19 Score=196.84 Aligned_cols=197 Identities=23% Similarity=0.274 Sum_probs=159.3
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc---CCCcceEEEEEeeCCeeEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 361 (606)
..+.|.+.+.||+|+||+||+|...+|+.||+|.-+.... .+|.-=.+++.+|+ -+.|..+..++.-.+.-+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 4567888999999999999999998899999998765432 22222233444444 23445555555667778999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-------CCCceEEeecC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-------NEMNPKISDFG 434 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-------~~~~~ki~DFG 434 (606)
+||.+.|+|.+++. ..+.++|...+.++.|+++.+..||..+ |||+||||+|.||. ++..++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999994 6677999999999999999999999998 99999999999993 34568999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCC
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN 490 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p 490 (606)
.+-.+..-.........++|-.+--+|...|.+++..+|.|.++.+++-||.|+.-
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 98765433333445567889999999999999999999999999999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-18 Score=168.38 Aligned_cols=232 Identities=22% Similarity=0.297 Sum_probs=148.1
Q ss_pred CCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccC-----------CCcceEEEE--
Q 007361 289 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH-----------RNLVKLIGC-- 351 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-----------~niv~l~g~-- 351 (606)
+...+.||.|+++.||.+++.+ ++++|+|..... .....+++++|...+..+.+ .-++++--.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456889999999999999977 889999987433 33456777777766655432 122222111
Q ss_pred ------EeeC---C-----eeEEEEecCCCCCchhhhc---ccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 007361 352 ------CTQR---D-----ERMLIYEYLPNKSLNDFIF---DVTR-SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 413 (606)
Q Consensus 352 ------~~~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~ 413 (606)
.... . ..+++|+-+ .++|.+++. ...+ ...+....++.+..|+++.+++||+.+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 1111 1 236677777 568877753 2111 123445566778899999999999999 9999
Q ss_pred cCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCcccccc--------CCCCccccchhHHHHHHHHH
Q 007361 414 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID--------GLFSVKSDVFSFGVLVLEIV 485 (606)
Q Consensus 414 Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DV~S~Gvvl~ell 485 (606)
||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999887764432111 233578999997643 24788999999999999999
Q ss_pred hccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCC
Q 007361 486 CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR 550 (606)
Q Consensus 486 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 550 (606)
+|+.|++.......... .-..+. +.++.+..|+..+|+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999875433211110 112233 445567789999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.7e-19 Score=184.33 Aligned_cols=186 Identities=28% Similarity=0.330 Sum_probs=154.8
Q ss_pred eecccCcccEEEEEE----eCCcEEEEEEcccccccC--HHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEecCC
Q 007361 294 KLGEGGFGPVYKGVL----IEGQEIAAKRLSKSSGQG--MEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~----~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
.+|+|.||.|+.+.. ..|..+|+|.+.+..... ......|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998653 346778888876643211 114556778888886 9999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|.|...+.+ ...++......+...++-++.++|+.+ |+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999888743 444677777788889999999999998 99999999999999999999999999987532211
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
.+||..|||||++. .+...+|.||||++.+||+||-.||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 678899999999999999999999754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.3e-17 Score=157.00 Aligned_cols=134 Identities=21% Similarity=0.283 Sum_probs=113.5
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEccccccc--------CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ--------GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7778888876433211 124578899999999999998888777777889999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988431 22 78899999999999999998 99999999999999 78899999999865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-18 Score=177.14 Aligned_cols=124 Identities=27% Similarity=0.442 Sum_probs=109.4
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++.|+++...+|.+||.........++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766666678899999999999999999 55 999999999999999999999999998
Q ss_pred cccCCCc----ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh
Q 007361 437 RAFGIDQ----TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC 486 (606)
Q Consensus 437 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt 486 (606)
....... .......-.||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7764433 2233445689999999999999999999999999999999986
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.1e-17 Score=158.42 Aligned_cols=143 Identities=17% Similarity=0.158 Sum_probs=111.8
Q ss_pred CCCcCCeecccCcccEEEEE--EeCCcEEEEEEccccccc------------------------CHHHHHHHHHHHhhcc
Q 007361 288 NFSDKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQ------------------------GMEEFENEVLLIAKLQ 341 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 341 (606)
.|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 557999999998643210 0123568999999997
Q ss_pred CC--CcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 007361 342 HR--NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419 (606)
Q Consensus 342 H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~N 419 (606)
+. .+.++++. ...++||||+++.+|..++.. ...+.......++.||+.+|.+||+.+ .|+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 63 34445543 235899999999888776522 223566667899999999999999986 49999999999
Q ss_pred EEEcCCCceEEeecCCccccC
Q 007361 420 VLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 420 Ill~~~~~~ki~DFGla~~~~ 440 (606)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=153.36 Aligned_cols=143 Identities=19% Similarity=0.205 Sum_probs=112.1
Q ss_pred HHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEccccccc----------------------CHHHHHHHHHHHhh
Q 007361 282 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ----------------------GMEEFENEVLLIAK 339 (606)
Q Consensus 282 ~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~ 339 (606)
+......|...+.||+|+||.||++...+|+.+|||++...... ....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33334447778999999999999999888999999986543210 11236778999999
Q ss_pred ccCC--CcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 007361 340 LQHR--NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA 417 (606)
Q Consensus 340 l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~ 417 (606)
+.|+ .+...++. ...++||||+++++|...... .....++.+++.++.++|+.+ |+|+||||
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 9887 44555542 456899999999998775420 234578899999999999988 99999999
Q ss_pred CCEEEcCCCceEEeecCCccccC
Q 007361 418 SNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 418 ~NIll~~~~~~ki~DFGla~~~~ 440 (606)
+||++++++.++|+|||++..+.
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.7e-17 Score=178.52 Aligned_cols=146 Identities=18% Similarity=0.335 Sum_probs=116.4
Q ss_pred HHHHHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccc-------cCHHHHHHHHHHHhhccCCCcceEEEE
Q 007361 279 WMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-------QGMEEFENEVLLIAKLQHRNLVKLIGC 351 (606)
Q Consensus 279 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~ 351 (606)
+.........|...++||+|+||.||+|.+.....++.+++.+... ...+.+.+|+.++..++|++++....+
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 3333344455677899999999999999875544333333322111 123568899999999999999988888
Q ss_pred EeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 352 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
+......++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence 888778899999999999999873 35678999999999999998 9999999999999 67899999
Q ss_pred ecCCcccc
Q 007361 432 DFGMARAF 439 (606)
Q Consensus 432 DFGla~~~ 439 (606)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99999763
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=128.82 Aligned_cols=66 Identities=55% Similarity=1.141 Sum_probs=59.5
Q ss_pred cCCCCceeEeccccCCCccccccccccCHHHHHHHhhccCcccccccccccCCCcceeeccccccch
Q 007361 122 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDM 188 (606)
Q Consensus 122 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~gC~~~~~~l~~~ 188 (606)
|+.+|+|+++++|++|++...+++.++++++|+..||+||||+||+|.+++ ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556799999999999999877777779999999999999999999998766 678999999999875
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=152.90 Aligned_cols=130 Identities=23% Similarity=0.346 Sum_probs=106.6
Q ss_pred eecccCcccEEEEEEeCCcEEEEEEcccccc--------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG--------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.||+|+||.||+|.+ ++..+++|....... .....+.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998643221 11356778999999999887665555666677789999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874311 078999999999999998 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.6e-16 Score=152.68 Aligned_cols=197 Identities=20% Similarity=0.270 Sum_probs=132.9
Q ss_pred cCCCcceEEEEEee---------------------------CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHH
Q 007361 341 QHRNLVKLIGCCTQ---------------------------RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 393 (606)
Q Consensus 341 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 393 (606)
+|||||+++++|.+ ...+|+||..++ .+|..++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999987643 234688888775 488888843 2245566677899
Q ss_pred HHHHHHHHHHhCCCCCeeeccCCCCCEEE--cCCC--ceEEeecCCccccCCCcc----cccccccccccCccCcccccc
Q 007361 394 GIARGLLYLHQDSRLRIIHRDLKASNVLL--DNEM--NPKISDFGMARAFGIDQT----EANTNRVVGTYGYMPPEYAID 465 (606)
Q Consensus 394 ~ia~gL~yLH~~~~~~iiH~Dlk~~NIll--~~~~--~~ki~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~ 465 (606)
|+++|+.|||.++ |.|||||++|||+ |+++ .+.|+|||.+-.-..... ....-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4443 578999998754222111 111112346778999999864
Q ss_pred CC------CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHH
Q 007361 466 GL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVG 539 (606)
Q Consensus 466 ~~------~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~ 539 (606)
.+ .-.|+|.|+.|.+.||+++...||-... +...+. +.+.+... +.+ +......+.+|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~-----r~Yqe~qL-----Pal----p~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDT-----RTYQESQL-----PAL----PSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheech-----hhhhhhhC-----CCC----cccCChHHHHHH
Confidence 33 1358999999999999999998874311 100000 00111111 111 222234567889
Q ss_pred hhcccCCCCCCCCHHHHHHHh
Q 007361 540 LLCVQQRPEDRPNMSSVVLML 560 (606)
Q Consensus 540 ~~Cl~~~P~~RPs~~~vl~~L 560 (606)
...++.||.+||+..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876555554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.5e-15 Score=134.39 Aligned_cols=135 Identities=21% Similarity=0.216 Sum_probs=115.8
Q ss_pred cCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccC--CCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 291 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..++| .++.+++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899998865443 5678999999999976 58999999988888899999999988
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
.+..+ +......++.+++++|++||......++|+||+|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 5567778899999999999987545699999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-16 Score=172.33 Aligned_cols=215 Identities=20% Similarity=0.272 Sum_probs=140.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..+|..++.|..|++|.||..++.. .+.+|+ ++.+..-- +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hhc---cccccCCccee------------------
Confidence 4678888999999999999999876 456676 44332210 000 22222233332
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc-
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ- 443 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~- 443 (606)
|+-...+... +.++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 ---gDc~tllk~~---g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNI---GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccC---CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 3333333221 223322 278899999998 9999999999999999999999999987642110
Q ss_pred ------------ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 444 ------------TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 444 ------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
.......++||+.|.|||++....|...+|+|++|+|+||.+-|..||....+++ |......
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~vis--- 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVIS--- 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhh---
Confidence 0112344789999999999999999999999999999999999999976543321 1111111
Q ss_pred hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
... ...+-+.....++.+++...|+.+|..|--....+
T Consensus 273 -d~i-------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 273 -DDI-------EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred -hhc-------cccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 000 00011222234556777788899999997444333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=6e-15 Score=140.17 Aligned_cols=137 Identities=20% Similarity=0.240 Sum_probs=99.0
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEccccccc--CHHH----------------------HHHHHHHHhhccCC--Cc
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ--GMEE----------------------FENEVLLIAKLQHR--NL 345 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~--ni 345 (606)
.+.||+|+||.||++...+++.||||.+...... .... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987653211 1111 13566666666443 34
Q ss_pred ceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcC
Q 007361 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 424 (606)
Q Consensus 346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIll~~ 424 (606)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|+ .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 455543 246899999999654322111000 11 5677899999999999999 76 99999999999999
Q ss_pred CCceEEeecCCccccC
Q 007361 425 EMNPKISDFGMARAFG 440 (606)
Q Consensus 425 ~~~~ki~DFGla~~~~ 440 (606)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.4e-14 Score=140.06 Aligned_cols=135 Identities=20% Similarity=0.244 Sum_probs=105.2
Q ss_pred CCeec-ccCcccEEEEEEeCCcEEEEEEccccc-------------ccCHHHHHHHHHHHhhccCCCc--ceEEEEEeeC
Q 007361 292 KNKLG-EGGFGPVYKGVLIEGQEIAAKRLSKSS-------------GQGMEEFENEVLLIAKLQHRNL--VKLIGCCTQR 355 (606)
Q Consensus 292 ~~~lG-~G~fG~Vy~g~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 355 (606)
...|| .||.|+||++.. .+..+++|+..... ......+.+|+.++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 36788 899999999988 47788888774311 1223567889999999998775 7777765433
Q ss_pred Ce----eEEEEecCCC-CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 356 DE----RMLIYEYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 356 ~~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
.. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+|+||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 3599999997 689888743 234443 3568999999999998 999999999999999899999
Q ss_pred eecCCccc
Q 007361 431 SDFGMARA 438 (606)
Q Consensus 431 ~DFGla~~ 438 (606)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-15 Score=168.23 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=185.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC--CcEEEEEEccccc--ccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 361 (606)
..|...+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667789999999998887644 3456666665443 333344455777777776 99999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCcccc
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH-QDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF 439 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~ 439 (606)
.+|..++++.+-+.. ......+....-.+..|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999988741 12223555666778999999999999 777 99999999999999999 9999999999988
Q ss_pred CC-Cccccccccccc-ccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 440 GI-DQTEANTNRVVG-TYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 440 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++......... ..|.+..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~-- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNK-- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------eeecccc--
Confidence 66 444445555678 9999999999884 45778999999999999999999976543322110 0111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
........... .....++...++..+|..|.+.+++.
T Consensus 248 ~~~~~~~~~~~----~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 GRFTQLPWNSI----SDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccCccccC----ChhhhhcccccccCCchhcccccccc
Confidence 00000111111 12345666778888999999877764
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-14 Score=115.66 Aligned_cols=71 Identities=24% Similarity=0.430 Sum_probs=62.4
Q ss_pred cCCCCceeEeccccCCCccccccccccCHHHHHHHhhc---cCcccccccccccCCCcceeeccccc-cchhhccccccc
Q 007361 122 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSK---NCSCTAYANADVRGGGSGCLLWFHDL-IDMKELSESGQD 197 (606)
Q Consensus 122 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~~~gC~~~~~~l-~~~~~~~~~~~~ 197 (606)
|...++|+++.++++|++.. +++++|++.|++ ||||.||+|.++ +.||.+|+++| ++++.....|.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44567899999999999874 689999999999 999999999763 45899999999 999988777899
Q ss_pred eeee
Q 007361 198 LFVR 201 (606)
Q Consensus 198 ~ylr 201 (606)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9998
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.8e-13 Score=111.97 Aligned_cols=80 Identities=50% Similarity=0.941 Sum_probs=65.9
Q ss_pred ccccCCC---CceeEeccccCCCccccccccccCHHHHHHHhhccCcccccccccccCCCcceeeccccccchhhccccc
Q 007361 119 QLDCEHG---DGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESG 195 (606)
Q Consensus 119 ~~~C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~gC~~~~~~l~~~~~~~~~~ 195 (606)
+++|... ++|..++++++|++.+.. ..+++++|++.||+||+|.||+|.+ ++++|++|.+++.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4578554 689999999999887543 6789999999999999999999975 4679999999998877654445
Q ss_pred cceeeecc
Q 007361 196 QDLFVRMA 203 (606)
Q Consensus 196 ~~~ylr~~ 203 (606)
..+|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 77999874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.1e-13 Score=141.93 Aligned_cols=141 Identities=21% Similarity=0.276 Sum_probs=101.0
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccccccCH----------------------------------------HHHH
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGM----------------------------------------EEFE 331 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 331 (606)
.+.||.|++|.||+|++.+|+.||||+......... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421110 0244
Q ss_pred HHHHHHhhcc----CCCcceEEEEEe-eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 007361 332 NEVLLIAKLQ----HRNLVKLIGCCT-QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR-GLLYLHQD 405 (606)
Q Consensus 332 ~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 405 (606)
+|+..+.++. |.+-+.+-..+. .....+|||||++|++|.++...... .. .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5665555552 333333333332 23457999999999999987642111 12 23456666666 47888988
Q ss_pred CCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 406 ~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
+ ++|+|+||.||++++++.+++.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.7e-13 Score=131.28 Aligned_cols=204 Identities=22% Similarity=0.230 Sum_probs=139.5
Q ss_pred HHHHHhhccCCCcceEEEEEeeC-----CeeEEEEecCCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 007361 333 EVLLIAKLQHRNLVKLIGCCTQR-----DERMLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDS 406 (606)
Q Consensus 333 E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 406 (606)
-..-|-++.|.|||++..++.+. ....++.|||+.|+|..+|.+.. ..+.+......+++-||..||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34445566799999999988654 34789999999999999997633 3455777788899999999999999975
Q ss_pred CCCeeeccCCCCCEEEcCCCceEEeecCCccccCC---CcccccccccccccCccCccccccCCCCccccchhHHHHHHH
Q 007361 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI---DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 483 (606)
Q Consensus 407 ~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~e 483 (606)
++|+|+++..+-|++..++-+||.--- ...+.. ...........+.++|.|||.=.....+-.+|||+||+..+|
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 689999999999999999988885311 111110 001112223456789999998877788889999999999999
Q ss_pred HHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 484 IVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 484 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
|.-|.-......+. .. ..+.+...+.+..+. .=..++..|++..|..||+|++++
T Consensus 275 mailEiq~tnseS~---~~------------~ee~ia~~i~~len~----lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 275 MAILEIQSTNSESK---VE------------VEENIANVIIGLENG----LQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHheeccCCCcce---ee------------hhhhhhhheeeccCc----cccCcCcccccCCCCCCcchhhhh
Confidence 98876431111000 00 000000000000000 112456689999999999999876
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-11 Score=114.26 Aligned_cols=130 Identities=21% Similarity=0.157 Sum_probs=97.8
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcc-eEEEEEeeCCeeEEEEecCCCCCch
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV-KLIGCCTQRDERMLIYEYLPNKSLN 371 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~ 371 (606)
+.|+.|.++.||++.. .++.+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 5789999999999987 478899998754432 233568899999998765554 455443 33468999999998876
Q ss_pred hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 372 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 372 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
... . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 531 0 11245678999999999986 23469999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-11 Score=130.88 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=174.9
Q ss_pred cCCCcCCeecc--cCcccEEEEEE--e-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 287 ENFSDKNKLGE--GGFGPVYKGVL--I-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 287 ~~~~~~~~lG~--G~fG~Vy~g~~--~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
..|.....+|. |.+|.||.+.. . ++..+|+|+-+... ......=.+|+...+++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45566788999 99999999987 3 37788888843322 22223335677777777 499999998999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeccCCCCCEEEcCC-CceEEeec
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDF 433 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~ki~DF 433 (606)
++-+|++. .+|..+... ....++....+.+..+... ||..+|+.. ++|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999985 677777643 3445677777778888888 999999998 9999999999999998 89999999
Q ss_pred CCccccCCCcccccc---cccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCC-CCCCccchhHHHHHH
Q 007361 434 GMARAFGIDQTEANT---NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY-HADHHHNLLGHAWRL 509 (606)
Q Consensus 434 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~-~~~~~~~l~~~~~~~ 509 (606)
|+...++........ ....|...|++||.. .+.++...|+|++|.++.|-.++....... .. .|..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---------~W~~ 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS---------SWSQ 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC---------Cccc
Confidence 999887654322211 223577899999965 566789999999999999999887553211 11 1111
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
..... +-+....+ -..++..++..+++.+|-.|++.+.+.
T Consensus 338 ~r~~~---ip~e~~~~-----~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 338 LRQGY---IPLEFCEG-----GSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccccc---CchhhhcC-----cchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11110 10111100 112334477889999999999876655
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=6e-11 Score=128.68 Aligned_cols=143 Identities=15% Similarity=0.214 Sum_probs=95.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccC----------------------------------HH---
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG----------------------------------ME--- 328 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~----------------------------------~~--- 328 (606)
..|+. +.||+|++|.||+|++.+ |+.||||++.+..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999988 9999999997542110 01
Q ss_pred ---HHHHHHHHHhhcc----CCCcceEEEEEee-CCeeEEEEecCCCCCchhhhcccCCC---CCCCHHHHHHHHHHHHH
Q 007361 329 ---EFENEVLLIAKLQ----HRNLVKLIGCCTQ-RDERMLIYEYLPNKSLNDFIFDVTRS---KFLDWSKRCQIIGGIAR 397 (606)
Q Consensus 329 ---~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~ 397 (606)
+|.+|+.-+.++. +.+.+.+-.++.+ ....+|||||++|+.|.++-.-.... +.+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2344554444442 4444444444433 45678999999999998753111111 11222222223333
Q ss_pred HHHHHHhCCCCCeeeccCCCCCEEEcCCC----ceEEeecCCccccC
Q 007361 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFGMARAFG 440 (606)
Q Consensus 398 gL~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~ki~DFGla~~~~ 440 (606)
++..+ ++|+|+||.||+++.++ .+++.|||+...+.
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 33455 99999999999999888 99999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-10 Score=121.92 Aligned_cols=167 Identities=16% Similarity=0.231 Sum_probs=124.4
Q ss_pred eCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHH
Q 007361 309 IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 388 (606)
Q Consensus 309 ~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~ 388 (606)
.++.++.|...+.......+...+-++.|+.++||||++++......+..|+|+|-+. -|..++.+ +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 3578888887766655445567888999999999999999999999999999999873 45555533 234556
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCC
Q 007361 389 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468 (606)
Q Consensus 389 ~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 468 (606)
.-.+.||+.||.|||+.+ .++|++|....|+++..|..||++|.++.....-.. ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 667889999999999877 599999999999999999999999988754321111 111111222456666442211
Q ss_pred CccccchhHHHHHHHHHhccC
Q 007361 469 SVKSDVFSFGVLVLEIVCGKR 489 (606)
Q Consensus 469 s~k~DV~S~Gvvl~elltG~~ 489 (606)
-..|.|.||++++|++.|..
T Consensus 182 -~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -cchhhhhHHHHHHHHhCccc
Confidence 34699999999999999943
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.2e-10 Score=108.95 Aligned_cols=142 Identities=18% Similarity=0.253 Sum_probs=112.4
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccc-cCHHHHHHHHHHHhhccC--CCcceEEEEEeeCC---eeEEEEecCC
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRD---ERMLIYEYLP 366 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~ 366 (606)
+.|+.|..+.||++...+|+.+++|....... .....+..|+.++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998755432 245678999999999975 45677888776543 5689999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS---------------------------------------- 406 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 406 (606)
+.+|.+.+.. ..++......++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988876521 34677888888999999999998531
Q ss_pred -------------CCCeeeccCCCCCEEEcC--CCceEEeecCCccc
Q 007361 407 -------------RLRIIHRDLKASNVLLDN--EMNPKISDFGMARA 438 (606)
Q Consensus 407 -------------~~~iiH~Dlk~~NIll~~--~~~~ki~DFGla~~ 438 (606)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-10 Score=123.63 Aligned_cols=248 Identities=21% Similarity=0.182 Sum_probs=173.9
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEe--CCcEEEEEEcccccccCHHH--HHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSSGQGMEE--FENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~--~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
....+|.....||.|.|+.|++.... ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34568889999999999999998754 36788888886654333322 23466666666 589999988888777788
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CceEEeecCCcc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 437 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~ki~DFGla~ 437 (606)
++--||++++++...+ .....++...++++..+++.++.++|+.. ++|+|+||+||++.++ +..+++|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999988766 23344788889999999999999999887 9999999999999886 888999999986
Q ss_pred ccCCCcccccccccccccCcc--CccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 438 AFGIDQTEANTNRVVGTYGYM--PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
.+..... ...+..++. +++......+-.+.|++|||.-+.|.+++..-..... ..
T Consensus 416 ~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------------~~ 472 (524)
T KOG0601|consen 416 RLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------------QS 472 (524)
T ss_pred ccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccc------------------cc
Confidence 4321111 112223334 5666667788999999999999999998875321100 00
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+...... ..+.. ...+..+...++..++..||.+.++....+-
T Consensus 473 ~~i~~~~~p-~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 473 LTIRSGDTP-NLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eeeeccccc-CCCch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000000000 00111 1344456667888999999998887765543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.2e-09 Score=99.59 Aligned_cols=136 Identities=12% Similarity=0.079 Sum_probs=98.9
Q ss_pred CeecccCcccEEEEEEeC-------CcEEEEEEcccccc----------------------cCHHHHH----HHHHHHhh
Q 007361 293 NKLGEGGFGPVYKGVLIE-------GQEIAAKRLSKSSG----------------------QGMEEFE----NEVLLIAK 339 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~~----------------------~~~~~~~----~E~~~l~~ 339 (606)
..||.|--+.||.|...+ +..+|||..+.... .....+. .|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998653 47899997643210 0022233 79999999
Q ss_pred ccC--CCcceEEEEEeeCCeeEEEEecCCCCCchh-hhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccC
Q 007361 340 LQH--RNLVKLIGCCTQRDERMLIYEYLPNKSLND-FIFDVTRSKFLDWSKRCQIIGGIARGLLYL-HQDSRLRIIHRDL 415 (606)
Q Consensus 340 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~Dl 415 (606)
+.. -++.+++++ ...++||||+.+..+.. .+. ...++......+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 566777765 56789999998754432 221 12245556677889999999999 7777 999999
Q ss_pred CCCCEEEcCCCceEEeecCCccccC
Q 007361 416 KASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 416 k~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
++.||+++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.9e-09 Score=96.54 Aligned_cols=131 Identities=22% Similarity=0.329 Sum_probs=99.8
Q ss_pred CeecccCcccEEEEEEeCCcEEEEE-Eccccccc-------CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAK-RLSKSSGQ-------GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK-~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..+++|+-..+|.+.+.+.. +++| ++.+.-.. ..+.-.+|+.++.+++--.|.-.+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999774434 4444 34333211 123456799999998765555555566677888999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|..|.+++... ...++..|-.-+.-||..+ |+|+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 3567778888889999998 99999999999998876 99999999975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-08 Score=105.74 Aligned_cols=170 Identities=22% Similarity=0.292 Sum_probs=132.2
Q ss_pred CcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEe----eCCeeEEEEecCCC-CCchh
Q 007361 299 GFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT----QRDERMLIYEYLPN-KSLND 372 (606)
Q Consensus 299 ~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~ 372 (606)
.-.+.||+... +|..+++|++.....+.......-+++++++.|+|+|++..++. .+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44678898854 69999999996554444444556788999999999999998876 24468999999985 57777
Q ss_pred hhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 373 FIFDVT------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 373 ~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
+-+... ....+++..+|.++.|++.||.++|+.| +.-+-|.+++|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 665321 2234778999999999999999999999 8889999999999999999999998887765
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCC
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN 490 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p 490 (606)
.+.... +. --.+-|.=.||.+++-|.||...
T Consensus 445 ~d~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 443111 11 12356888999999999999765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-08 Score=91.95 Aligned_cols=143 Identities=22% Similarity=0.316 Sum_probs=103.7
Q ss_pred cCCeecccCcccEEEEEEeCCcEEEEE-Ecccccc-------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 291 DKNKLGEGGFGPVYKGVLIEGQEIAAK-RLSKSSG-------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~~g~~vavK-~l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
....|-+|+-+.|+++.+ .|+...|| +..+.-+ -......+|++++.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 55655554 3433321 12345678999999987555554445566677778999
Q ss_pred ecCCC-CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---ceEEeecCCccc
Q 007361 363 EYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARA 438 (606)
Q Consensus 363 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~ki~DFGla~~ 438 (606)
||+++ .++.+++...-... ........++..|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 57888875433222 222233678888999999999998 99999999999996543 458999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.5e-10 Score=124.96 Aligned_cols=205 Identities=20% Similarity=0.241 Sum_probs=143.5
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccc---ccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
...+.+.+.+-+-+|.++.++...-.. |...+.|.... -.....+....+-.++-..+||-+++...-+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345677788888899999998866322 32222222211 11111222222222222234566665555555677889
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
|+++|+.+++|...|+... ..+.......+..+.++++|||+.. +.|+|++|.|++...++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999886533 4556666677788999999999976 899999999999999999999999843322
Q ss_pred CC-------------------------Cccc----ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCC
Q 007361 440 GI-------------------------DQTE----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN 490 (606)
Q Consensus 440 ~~-------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p 490 (606)
+. ++.. .......+|+.|.+||...+......+|.|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0000 112235689999999999999999999999999999999999999
Q ss_pred CCCC
Q 007361 491 RGFY 494 (606)
Q Consensus 491 ~~~~ 494 (606)
+...
T Consensus 1035 ~na~ 1038 (1205)
T KOG0606|consen 1035 FNAE 1038 (1205)
T ss_pred CCCc
Confidence 7543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.8e-08 Score=95.69 Aligned_cols=141 Identities=18% Similarity=0.138 Sum_probs=101.5
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccc-----------cCHHHHHHHHHHHhhccC--CCcceEEEEEee-----
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-----------QGMEEFENEVLLIAKLQH--RNLVKLIGCCTQ----- 354 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~----- 354 (606)
+.+-.-....|++..+ +|+.+.||+...... .....+.+|...+.++.. -....++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777765 788999997643221 111247889999988853 344555666543
Q ss_pred CCeeEEEEecCCCC-CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-------CC
Q 007361 355 RDERMLIYEYLPNK-SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------EM 426 (606)
Q Consensus 355 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-------~~ 426 (606)
....++|+|++++. +|.+++.+.. ....+......++.+++..+.-||..+ |+|+|+++.|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999986 8988874321 233556677889999999999999999 999999999999975 56
Q ss_pred ceEEeecCCccc
Q 007361 427 NPKISDFGMARA 438 (606)
Q Consensus 427 ~~ki~DFGla~~ 438 (606)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=9.8e-08 Score=89.94 Aligned_cols=126 Identities=25% Similarity=0.332 Sum_probs=82.3
Q ss_pred cEEEEEEeCCcEEEEEEccccc--------------c------------cCHHHHHHHHHHHhhccCC--CcceEEEEEe
Q 007361 302 PVYKGVLIEGQEIAAKRLSKSS--------------G------------QGMEEFENEVLLIAKLQHR--NLVKLIGCCT 353 (606)
Q Consensus 302 ~Vy~g~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 353 (606)
.||.|...+|..+|+|.-.... + .......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999764321 0 0123466799999999765 566666552
Q ss_pred eCCeeEEEEecCC--CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 354 QRDERMLIYEYLP--NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY-LHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 354 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
...+||||++ +..+..+. +.. ++......++.+++..+.. +|..+ |+|+||.+.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 55554433 211 1123445677778776555 46777 9999999999999988 9999
Q ss_pred eecCCccccC
Q 007361 431 SDFGMARAFG 440 (606)
Q Consensus 431 ~DFGla~~~~ 440 (606)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-06 Score=89.57 Aligned_cols=262 Identities=15% Similarity=0.119 Sum_probs=151.9
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEE------eeC-CeeEEE
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCC------TQR-DERMLI 361 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~------~~~-~~~~lV 361 (606)
...+.||+|+-+.+|-.-- -..-+.|+..........+ .+..|... .||-+..-+.+= -+. ...-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4567899999999997432 1223445554443322222 23334443 566443312211 112 225567
Q ss_pred EecCCCCC-chhhhcc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 362 YEYLPNKS-LNDFIFD---VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 362 ~E~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
|..+++.. ...++.. ...-...+|.-.++.+..+|.+.+-||..| .+-+|+.++|+|+++++.+.|.|=....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776542 2222221 122345889999999999999999999999 8999999999999999999999854333
Q ss_pred ccCCCcccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhc-cCCCCCCCC--CCccchh-HHHHH
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHA--DHHHNLL-GHAWR 508 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG-~~p~~~~~~--~~~~~l~-~~~~~ 508 (606)
.- .........+|...|.+||.-. +..-+...|-|.+|+++++|+.| +.|+..... +....+. +.+..
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 21 1222223357888999999754 34457789999999999999987 888864321 1111111 11111
Q ss_pred HhhhcCcchhcccccCCCCCHHH-HHHHHHHHhhcccC--CCCCCCCHHHHHHHhcC
Q 007361 509 LWIEERPVELINKSLGGSYSLSE-VLRCIQVGLLCVQQ--RPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~~~~~~-~~~l~~l~~~Cl~~--~P~~RPs~~~vl~~L~~ 562 (606)
.+........--..-..+.+... ...+..+...|+.. ++.-|||++..+..|..
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 11110000000000011122211 12333445567654 35689999999887754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=2e-06 Score=81.70 Aligned_cols=139 Identities=16% Similarity=0.151 Sum_probs=103.9
Q ss_pred ecccCcccEEEEEEeCCcEEEEEEccccc------ccCHHHHHHHHHHHhhccC--CCcceEEEEEeeC----CeeEEEE
Q 007361 295 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS------GQGMEEFENEVLLIAKLQH--RNLVKLIGCCTQR----DERMLIY 362 (606)
Q Consensus 295 lG~G~fG~Vy~g~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~----~~~~lV~ 362 (606)
-|+||-+.|++-.+ +|+.+.+|+-.... ..+...|.+|+..|.++.. -.+.+.+.+.... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46789999999776 55679999875221 3356789999999999953 3355555222221 2368999
Q ss_pred ecCCC-CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc--eEEeecCCccc
Q 007361 363 EYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMARA 438 (606)
Q Consensus 363 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~ki~DFGla~~ 438 (606)
|-+++ -+|.+++.+.. ....+...+..++.++++.+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 58888874422 234677778899999999999999999 999999999999986667 99999987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=7e-07 Score=86.71 Aligned_cols=134 Identities=21% Similarity=0.255 Sum_probs=94.2
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccc----------cc------------cCHHHHHHHHHHHhhccCC--Cc
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS----------SG------------QGMEEFENEVLLIAKLQHR--NL 345 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~----------~~------------~~~~~~~~E~~~l~~l~H~--ni 345 (606)
.++.+||.|--+.||.|..++|.++|||.=... .. ......++|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 456899999999999999999999999843211 00 1123466899999998644 66
Q ss_pred ceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC
Q 007361 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 425 (606)
Q Consensus 346 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~ 425 (606)
.+.+++ +...+||||+++-.|...- ++....-.++..|++-+.-+-..| |||+|+.+-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 666554 5568999999987665532 122223333444444444444555 9999999999999999
Q ss_pred CceEEeecCCccc
Q 007361 426 MNPKISDFGMARA 438 (606)
Q Consensus 426 ~~~ki~DFGla~~ 438 (606)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.2e-07 Score=85.63 Aligned_cols=106 Identities=26% Similarity=0.333 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHhhcc--CCCcceEEEEEeeCC----eeEEEEecCCCC-CchhhhcccCCCCCCCHHHHHHHHHHHHHHH
Q 007361 327 MEEFENEVLLIAKLQ--HRNLVKLIGCCTQRD----ERMLIYEYLPNK-SLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 399 (606)
Q Consensus 327 ~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 399 (606)
.....+|...+..+. .-...+.+++..... ..++|+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 346778888888885 344566777765533 358999999984 79998854222 56677889999999999
Q ss_pred HHHHhCCCCCeeeccCCCCCEEEcCCC---ceEEeecCCccc
Q 007361 400 LYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARA 438 (606)
Q Consensus 400 ~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~ki~DFGla~~ 438 (606)
.-||+.+ |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999998887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.45 E-value=3e-07 Score=73.53 Aligned_cols=72 Identities=35% Similarity=0.687 Sum_probs=54.9
Q ss_pred CceeEeccccCCCccccccccccCHHHHHHHhhc-cCcccccccccccCCCcceeecc-ccccchhhccccccceeee
Q 007361 126 DGFLKRESVKLPDTRFSLVDNKISLLECKELCSK-NCSCTAYANADVRGGGSGCLLWF-HDLIDMKELSESGQDLFVR 201 (606)
Q Consensus 126 ~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~~~gC~~~~-~~l~~~~~~~~~~~~~ylr 201 (606)
..|..++++++++..... ....++++|++.|++ +|+|.||.|.+ ++.+|.+|. +.+.+.......+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 569999999999765433 356799999999999 99999999975 456999999 7776665333344455554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.8e-08 Score=104.12 Aligned_cols=152 Identities=20% Similarity=0.319 Sum_probs=99.2
Q ss_pred HHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc-------ccccccccccCccCccccc
Q 007361 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-------ANTNRVVGTYGYMPPEYAI 464 (606)
Q Consensus 392 ~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~ 464 (606)
+.+++.||.|+|... ++||++|.|++|.++.++..||+.|+.+.....+... ...........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445669999999875 6999999999999999999999999987654321111 1111123456899999999
Q ss_pred cCCCCccccchhHHHHHHHHHhccCC-CCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcc
Q 007361 465 DGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCV 543 (606)
Q Consensus 465 ~~~~s~k~DV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl 543 (606)
+...+.++|+||+|++++-+..|.++ +..... +..+.... ...+.. ...++..-+.++.+=+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-----~~~~~~~~-------~~~~~~-~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-----LLSYSFSR-------NLLNAG-AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC-----cchhhhhh-------cccccc-cccccccCcHHHHHHHHHHh
Confidence 98899999999999999999955544 221111 00010000 000000 01112223345556667788
Q ss_pred cCCCCCCCCHHHHHH
Q 007361 544 QQRPEDRPNMSSVVL 558 (606)
Q Consensus 544 ~~~P~~RPs~~~vl~ 558 (606)
..++.-||++..+..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997766543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.5e-06 Score=91.21 Aligned_cols=146 Identities=17% Similarity=0.264 Sum_probs=95.6
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccC------------------------------HH--------
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG------------------------------ME-------- 328 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~------------------------------~~-------- 328 (606)
..|+. +-|+.++-|.||+|++.+|+.||||+.++..... .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 6799999999999999999999999986643211 01
Q ss_pred --HHHHHHHHHhhc----cCCCcceEEEEEe-eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHH
Q 007361 329 --EFENEVLLIAKL----QHRNLVKLIGCCT-QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401 (606)
Q Consensus 329 --~~~~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 401 (606)
++..|..-+.++ ++..-+++=.++. -.....|+|||++|-.+.+...... ..++...+.....++. +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHH
Confidence 133444444444 2222233333443 2456799999999999998853222 2245333333222222 222
Q ss_pred HHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 402 LH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
+-..+ ++|.|.+|.||+++.++++.+.|||+...+.
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 22244 9999999999999999999999999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.1e-05 Score=78.96 Aligned_cols=132 Identities=18% Similarity=0.162 Sum_probs=85.9
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCC--cceEEEEEeeCCeeEEEEecCCCCC-
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN--LVKLIGCCTQRDERMLIYEYLPNKS- 369 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs- 369 (606)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67999999999984 35567777765432 3456789999999986433 4677888877777889999999963
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhC-CCCC
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARG---------------------------------------LLYLHQD-SRLR 409 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~g---------------------------------------L~yLH~~-~~~~ 409 (606)
+...+. .+......++..+++. ..+|... ....
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 221110 0001111111111111 1222211 2335
Q ss_pred eeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 410 IIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 410 iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
++|+|+.|.||++++++ +.|.||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.1e-06 Score=60.74 Aligned_cols=44 Identities=59% Similarity=0.927 Sum_probs=39.1
Q ss_pred CCCCCCCCCCCCcccCCCCCCCCCCccc--CccCccceeeEeeecC
Q 007361 563 ERSLPQPKQPGFFTERNPPESGSSSSKR--SLLSTNEITISLIEGR 606 (606)
Q Consensus 563 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 606 (606)
...||.|++|+|+..+......++++.. ..+|+|++|+|+++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4689999999999999887777777766 8999999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.2e-05 Score=76.10 Aligned_cols=104 Identities=23% Similarity=0.276 Sum_probs=83.4
Q ss_pred HHHHHHHhhccC-CCcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007361 331 ENEVLLIAKLQH-RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409 (606)
Q Consensus 331 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 409 (606)
.+|..++..+++ +++.+++|.|- .++|.||...+++...-....+--..+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 69999999994 3789999987766432101111123689999999999999999999875556
Q ss_pred eeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 410 IIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 410 iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
+.-.|++++|+-+++++++|+.|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=6.1e-07 Score=95.80 Aligned_cols=183 Identities=17% Similarity=0.126 Sum_probs=133.0
Q ss_pred cCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCC-cceEEEEEeeCCeeEEEEecCCCC-
Q 007361 291 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN-LVKLIGCCTQRDERMLIYEYLPNK- 368 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g- 368 (606)
..+.+++|.+++++|.+-...+.+.++.+... ....-++++|.+++||| .++.++-+..+....++++++..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34568899999999987655566666655433 44567889999999999 777777777788889999999877
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 448 (606)
+-..-.. ...-.+...+...+...-++++++||+.. =+|+| ||+..+ +..|..||+.+..+.... ..
T Consensus 321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred cccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 2221110 00011333334455566778999999864 48888 777766 678999999987764332 33
Q ss_pred cccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCC
Q 007361 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR 491 (606)
Q Consensus 449 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~ 491 (606)
+...+|+.++|||+.....+..+.|+|+.|+-.-++--|-.|.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4467899999999999999999999999998777777666654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.2e-05 Score=75.81 Aligned_cols=140 Identities=16% Similarity=0.130 Sum_probs=85.8
Q ss_pred eecccCc-ccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEecCCCCCch
Q 007361 294 KLGEGGF-GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSLN 371 (606)
Q Consensus 294 ~lG~G~f-G~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 371 (606)
.|-.|.. ..||+.... +..+++|+..... ..++..|+.++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 788998764 4677888775432 345678999988884 445667788777666789999999998876
Q ss_pred hhhc-------------------ccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 007361 372 DFIF-------------------DVTR-SKFLD--WSKRCQIIG--------------------GIARGLLYLHQ----D 405 (606)
Q Consensus 372 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 405 (606)
.... .... ...+. ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 1000 00111 000000000 01111122211 1
Q ss_pred CCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 406 ~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23459999999999999998888999998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.03 E-value=4e-05 Score=73.15 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=91.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHH---------HHHHHHHhhccC---CCcceEEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEF---------ENEVLLIAKLQH---RNLVKLIGCC 352 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~g~~ 352 (606)
...+|...+.+-......|.+-.. +|+.+++|..........+.| .+++..+.+++. ...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356777777787777777777665 678888887755433222222 233444444432 2233333222
Q ss_pred e-----eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc
Q 007361 353 T-----QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 427 (606)
Q Consensus 353 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 427 (606)
. -....+|||||++|..|.++.. ++. .++..+.+++.-||+.| +.|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2234578999999988877541 222 35566788899999999 99999999999999655
Q ss_pred eEEeecCCccc
Q 007361 428 PKISDFGMARA 438 (606)
Q Consensus 428 ~ki~DFGla~~ 438 (606)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.01 E-value=5e-05 Score=74.25 Aligned_cols=142 Identities=20% Similarity=0.230 Sum_probs=85.3
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCC--CcceEEEEEeeC---CeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR--NLVKLIGCCTQR---DERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~E~~~~ 367 (606)
+.|+.|..+.||+....+ +.+++|..... .....+..|+.++..+... .+.+++...... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999866 68889986544 4556788999999888533 356677654332 346899999999
Q ss_pred CCchh----------------hhc---cc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh-
Q 007361 368 KSLND----------------FIF---DV-TRSKFLDWSKR---------CQI------------IGGIAR-GLLYLHQ- 404 (606)
Q Consensus 368 gsL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~- 404 (606)
..+.. .+. .. .......+... ... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 98877 111 11 11111111110 000 111222 2333332
Q ss_pred ---CCCCCeeeccCCCCCEEEc-CCCceEEeecCCcc
Q 007361 405 ---DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMAR 437 (606)
Q Consensus 405 ---~~~~~iiH~Dlk~~NIll~-~~~~~ki~DFGla~ 437 (606)
.....++|+|+.|.||+++ +++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 56666899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00016 Score=68.82 Aligned_cols=133 Identities=17% Similarity=0.250 Sum_probs=93.0
Q ss_pred cCCeecccCcccEEEEEEeCCcEEEEEEccccc----------------ccCHHHHHHHHHHHhhcc------CCCcceE
Q 007361 291 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS----------------GQGMEEFENEVLLIAKLQ------HRNLVKL 348 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 348 (606)
....||+|+.-.||. +++.....||.+.... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457899999999998 5567777888876554 233566777777666665 8899999
Q ss_pred EEEEeeCCeeEEEEecCCC------CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 349 IGCCTQRDERMLIYEYLPN------KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 349 ~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
+|+..+....-+|+|.+.+ .+|.+++. ...++. ...+.+ -+-..||-+.. |+.+||+|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHH---HHHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998743 24666662 233444 333333 34445666555 9999999999999
Q ss_pred cCC---C-ceEEee-cCCc
Q 007361 423 DNE---M-NPKISD-FGMA 436 (606)
Q Consensus 423 ~~~---~-~~ki~D-FGla 436 (606)
..+ . .+.|+| ||-.
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 432 2 577777 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00023 Score=83.02 Aligned_cols=80 Identities=20% Similarity=0.333 Sum_probs=59.2
Q ss_pred CCeecccCcccEEEEEEeCC---cEEEEEEccccc-ccCHHHHHHHHHHHhhcc-CCCc--ceEEEEEeeC---CeeEEE
Q 007361 292 KNKLGEGGFGPVYKGVLIEG---QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQ-HRNL--VKLIGCCTQR---DERMLI 361 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 361 (606)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47789999999999887554 367777764332 223457889999999995 6654 8888888764 457899
Q ss_pred EecCCCCCch
Q 007361 362 YEYLPNKSLN 371 (606)
Q Consensus 362 ~E~~~~gsL~ 371 (606)
|||+++..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999987543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00012 Score=79.26 Aligned_cols=141 Identities=15% Similarity=0.178 Sum_probs=91.7
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccccC-------------------------------------HHHHHHHHH
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG-------------------------------------MEEFENEVL 335 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~ 335 (606)
+.||.-+.|.||++++++|+.||||.-++.-+.. .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999876542211 012344444
Q ss_pred HHhh----ccCCCc---ceEEEEEee-CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007361 336 LIAK----LQHRNL---VKLIGCCTQ-RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407 (606)
Q Consensus 336 ~l~~----l~H~ni---v~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 407 (606)
-..+ +.|-++ |.+-.++.+ ...+.|+||||+|..+.+.-.-. ...++...+..-+.++..-+-+-| |
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~qIf~~--G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQIFKT--G- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHHHHhc--C-
Confidence 3333 345551 222233322 34689999999999988875321 222454544433333332222322 3
Q ss_pred CCeeeccCCCCCEEEc----CCCceEEeecCCccccC
Q 007361 408 LRIIHRDLKASNVLLD----NEMNPKISDFGMARAFG 440 (606)
Q Consensus 408 ~~iiH~Dlk~~NIll~----~~~~~ki~DFGla~~~~ 440 (606)
++|+|=+|.||+++ .++.+.+-|||+...+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 99999999999998 36789999999987653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00023 Score=68.85 Aligned_cols=151 Identities=16% Similarity=0.177 Sum_probs=97.7
Q ss_pred HHHHHHHhcCCCcCC---eecccCcccEEEEEEeCCcEEEEEEccccccc-------------------CHH-----HHH
Q 007361 279 WMAIANATENFSDKN---KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ-------------------GME-----EFE 331 (606)
Q Consensus 279 ~~~~~~~~~~~~~~~---~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-------------------~~~-----~~~ 331 (606)
++.+........+.. .|..|--..||+|...++..+|||+....... ..+ -..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 444444444444444 45567778899999888999999988543211 111 123
Q ss_pred HHHHHHhhcc--CCCcceEEEEEeeCCeeEEEEecCCCCCc-hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 007361 332 NEVLLIAKLQ--HRNLVKLIGCCTQRDERMLIYEYLPNKSL-NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408 (606)
Q Consensus 332 ~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 408 (606)
.|+.-|.++. +-.+.+.+++.. -.|||||+....+ .-.|.+ ..+.......+..++++.+.-|-...
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 4666666663 445555555543 4799999965421 111211 11223356667778888888887733
Q ss_pred CeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 409 ~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
.+||+||..-|||+. ++.+.|+|||-|....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999887654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00018 Score=70.83 Aligned_cols=74 Identities=12% Similarity=0.220 Sum_probs=47.0
Q ss_pred CeecccCccc-EEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCC---CcceEEEEEeeC---CeeEEEEecC
Q 007361 293 NKLGEGGFGP-VYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR---NLVKLIGCCTQR---DERMLIYEYL 365 (606)
Q Consensus 293 ~~lG~G~fG~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~~ 365 (606)
+.|+.|+... ||+. +..+++|.... ......+..|.+++..+... .+.+.++..... ...++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 5677777764 8875 34566665433 22355789999999888532 344445444332 2348899999
Q ss_pred CCCCchh
Q 007361 366 PNKSLND 372 (606)
Q Consensus 366 ~~gsL~~ 372 (606)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9988753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00049 Score=70.30 Aligned_cols=78 Identities=15% Similarity=0.134 Sum_probs=57.5
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccC---CCcceEEEEEeeC---CeeEEEEe
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH---RNLVKLIGCCTQR---DERMLIYE 363 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E 363 (606)
...+.||.|..+.||+....+++ +++|.. +. ......|..|...++.+.. ..+.++++.+... +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~-~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMA-RS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEe-cc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34578999999999998765554 555553 22 1133578999999999853 4688889887543 56899999
Q ss_pred cCCCCCc
Q 007361 364 YLPNKSL 370 (606)
Q Consensus 364 ~~~~gsL 370 (606)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998766
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00029 Score=64.43 Aligned_cols=131 Identities=21% Similarity=0.239 Sum_probs=87.3
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
...+.|++|.+|.||+|.+ .|..+|+|.-... .....+..|++++..++-.++-+=+-.+. .-++.|||+.|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcc
Confidence 3457899999999999998 5568888875433 34567899999999998777655433332 2345599999988
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC-CCEEEcCCCceEEeecCCcccc
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA-SNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~-~NIll~~~~~~ki~DFGla~~~ 439 (606)
|.+.-... +-++ +..+++.---|-..+ |-|+.|.- ..++|-++..+-|+||..|..-
T Consensus 99 L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 87754211 2222 333444433444445 88888864 4444444449999999998753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00066 Score=67.77 Aligned_cols=139 Identities=17% Similarity=0.105 Sum_probs=80.5
Q ss_pred eecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCc-ceEEEEEeeCCeeEEEEecCCCCCchh
Q 007361 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYLPNKSLND 372 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~ 372 (606)
.+..|-...+|+.. .+++.+++|..........-+..+|..+++.+....+ .++++... ..+|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 35678888999887 3567788887544332221245789999998864433 33444432 368999999877653
Q ss_pred h-----------------hcccCC-CCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeeeccCCCCC
Q 007361 373 F-----------------IFDVTR-SKFLDWSKR-CQIIGG---------IARGLLYLHQD-----SRLRIIHRDLKASN 419 (606)
Q Consensus 373 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiH~Dlk~~N 419 (606)
- |+.... ...++.... .....+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 111111 111222211 111111 11112222111 13458999999999
Q ss_pred EEEcCCCceEEeecCCccc
Q 007361 420 VLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 420 Ill~~~~~~ki~DFGla~~ 438 (606)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00071 Score=66.50 Aligned_cols=140 Identities=19% Similarity=0.248 Sum_probs=81.8
Q ss_pred CeecccCcccEEEEEEeC--CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCc-ceEEEEEeeCCeeEEEEecCCCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
+.|..|-...+|+....+ ++.+++|........ ..+..+|+.++..+....+ .++++... ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888889999988764 567888876543222 2233578888888854333 44444332 248999999987
Q ss_pred chhh-------h----------cccCCC--------CCC-CHHHHHHHHH----------------------HHH---HH
Q 007361 370 LNDF-------I----------FDVTRS--------KFL-DWSKRCQIIG----------------------GIA---RG 398 (606)
Q Consensus 370 L~~~-------l----------~~~~~~--------~~l-~~~~~~~i~~----------------------~ia---~g 398 (606)
+... + +..... ... -|..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6422 0 111111 011 1222212111 111 11
Q ss_pred H-HHHHhC-CCCCeeeccCCCCCEEEcC-CCceEEeecCCcc
Q 007361 399 L-LYLHQD-SRLRIIHRDLKASNVLLDN-EMNPKISDFGMAR 437 (606)
Q Consensus 399 L-~yLH~~-~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~ 437 (606)
| ..+... ....++|+|+.+.|||+++ ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 112211 2346999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00061 Score=78.24 Aligned_cols=198 Identities=20% Similarity=0.181 Sum_probs=136.4
Q ss_pred HHHHHHHHHhhccCCCcceEEEEEeeCCee----EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007361 329 EFENEVLLIAKLQHRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404 (606)
Q Consensus 329 ~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 404 (606)
...-|...+.++.|+|+++++.+-.+.... .+..|+++.-++...+.. -..++....+.+..++.+||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344577788889999999999998765443 344677888788777743 3457888888999999999999999
Q ss_pred CCCCCeeeccCCCC---CEEEcCCCceEEe--ecCCccccCCCcccccccccccccCccCccccccCCCCc--cccchhH
Q 007361 405 DSRLRIIHRDLKAS---NVLLDNEMNPKIS--DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV--KSDVFSF 477 (606)
Q Consensus 405 ~~~~~iiH~Dlk~~---NIll~~~~~~ki~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--k~DV~S~ 477 (606)
.. ..|.-|..+ +.-.+..+...++ ||+.++.+....... ....+..+.|||......+.. ..|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 85 666555555 4555667777777 898887764332221 123355678888776665544 4799999
Q ss_pred HHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 478 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 478 Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
|..+..+..|..+..... .+..+++.. .. . .+.+....|+..++++|++..+++
T Consensus 379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~~----~~-~---~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA------------------VPVSLLDVL----ST-S---ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc------------------chhhhhccc----cc-h---hhhhhhhhhcchhhhhccchhhhh
Confidence 999999998876622110 011111111 11 0 345666789999999999999998
Q ss_pred HHhc
Q 007361 558 LMLS 561 (606)
Q Consensus 558 ~~L~ 561 (606)
...-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 7653
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0018 Score=68.30 Aligned_cols=75 Identities=13% Similarity=0.181 Sum_probs=54.7
Q ss_pred CeecccCcccEEEEEEeCC-cEEEEEEccccc-------ccCHHHHHHHHHHHhhcc---CCCcceEEEEEeeCCeeEEE
Q 007361 293 NKLGEGGFGPVYKGVLIEG-QEIAAKRLSKSS-------GQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 361 (606)
+.||.|.+..||++...+| +.++||.-.... ....+.+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999999877 489999854221 224566778888888763 2456667766 44567899
Q ss_pred EecCCCCC
Q 007361 362 YEYLPNKS 369 (606)
Q Consensus 362 ~E~~~~gs 369 (606)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0019 Score=61.08 Aligned_cols=125 Identities=25% Similarity=0.375 Sum_probs=89.7
Q ss_pred cCCCcCCeecccCc-ccEEEEEEeCCcEEEEEEccc---cc--------c----------cCHHHHHHHHHHHhhcc---
Q 007361 287 ENFSDKNKLGEGGF-GPVYKGVLIEGQEIAAKRLSK---SS--------G----------QGMEEFENEVLLIAKLQ--- 341 (606)
Q Consensus 287 ~~~~~~~~lG~G~f-G~Vy~g~~~~g~~vavK~l~~---~~--------~----------~~~~~~~~E~~~l~~l~--- 341 (606)
.+++..+.||.|.- |.||+++. +|+.+|+|.... .. . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 99999998 788999999321 00 0 12345888999999885
Q ss_pred CCCc--ceEEEEEeeCC------------------eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHH
Q 007361 342 HRNL--VKLIGCCTQRD------------------ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401 (606)
Q Consensus 342 H~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 401 (606)
+.++ |+.+|+..-.. ...+|.||.+... .....-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 3455 89999873221 1355666665432 1122345677888889
Q ss_pred HHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 402 LH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999986 3488999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0026 Score=64.96 Aligned_cols=142 Identities=20% Similarity=0.161 Sum_probs=87.2
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCC--CcceEEEE------EeeCCeeEEEEe
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR--NLVKLIGC------CTQRDERMLIYE 363 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E 363 (606)
.+.|..|....+|+.... +..+++|+... ...+....|+.++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456778888899998764 45678887654 2345677788888888533 34455432 123445689999
Q ss_pred cCCCCCchhh----h----------cccC--------CCCCCCHHHHHH----------HHHHHHHHHHHHHh----CCC
Q 007361 364 YLPNKSLNDF----I----------FDVT--------RSKFLDWSKRCQ----------IIGGIARGLLYLHQ----DSR 407 (606)
Q Consensus 364 ~~~~gsL~~~----l----------~~~~--------~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~ 407 (606)
+++|..+... . +... ......|..... ....+...+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876431 0 1100 001123322210 11123344555543 123
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 408 LRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 408 ~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
..++|+|+.|.||+++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998778999998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0026 Score=65.15 Aligned_cols=141 Identities=26% Similarity=0.347 Sum_probs=84.3
Q ss_pred CeecccCcccEEEEEEeC-------CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCc-ceEEEEEeeCCeeEEEEec
Q 007361 293 NKLGEGGFGPVYKGVLIE-------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 364 (606)
+.|..|-...+|+....+ ++.+++|...... ....+..+|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456677777899988755 4778888864433 233456788888888854333 345555532 368999
Q ss_pred CCCCCchhhh-----------------cccCCCC------C--CCHHHHHH--------------------------HHH
Q 007361 365 LPNKSLNDFI-----------------FDVTRSK------F--LDWSKRCQ--------------------------IIG 393 (606)
Q Consensus 365 ~~~gsL~~~l-----------------~~~~~~~------~--l~~~~~~~--------------------------i~~ 393 (606)
++|..+.... +...... . .-|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9988775321 1111110 0 00111111 111
Q ss_pred HHHHHHHHHHh------CCCCCeeeccCCCCCEEEcCC----CceEEeecCCccc
Q 007361 394 GIARGLLYLHQ------DSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA 438 (606)
Q Consensus 394 ~ia~gL~yLH~------~~~~~iiH~Dlk~~NIll~~~----~~~ki~DFGla~~ 438 (606)
.+..-+..|.. .....++|+|+.+.||+++++ +.+.++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 244579999999999999985 8899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00044 Score=54.49 Aligned_cols=53 Identities=21% Similarity=0.401 Sum_probs=39.4
Q ss_pred eeEeccccCCCccccccccccCHHHHHHHhhccCcccccccccccCCCcceeecccc
Q 007361 128 FLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHD 184 (606)
Q Consensus 128 f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~gC~~~~~~ 184 (606)
|..++++.++..+...+ ...+.++|++.|+.+|+|.||.|.. +...|+++...
T Consensus 6 ~~~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 6 FRQGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred ccccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 33445677776655444 3568999999999999999999974 45679887764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.023 Score=58.65 Aligned_cols=141 Identities=18% Similarity=0.195 Sum_probs=78.5
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccC--CCcceEEE------EEeeCCeeEEEEec
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLIG------CCTQRDERMLIYEY 364 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g------~~~~~~~~~lV~E~ 364 (606)
+.|+.|....+|+....+| .+++|+... ...+....|+.++..|.. -.+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5567787789999886555 678887642 223444556666666532 22334332 11234567899999
Q ss_pred CCCCCchh-----------hh---cccCC--------CCCCCH-HHHHHH------------HHH-HHHHHHHHHhC---
Q 007361 365 LPNKSLND-----------FI---FDVTR--------SKFLDW-SKRCQI------------IGG-IARGLLYLHQD--- 405 (606)
Q Consensus 365 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~i------------~~~-ia~gL~yLH~~--- 405 (606)
++|..+.. .| +.... ...+.| .....- +.+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99976532 11 11100 011112 221111 111 11222333211
Q ss_pred -CCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 406 -SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 406 -~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
-+..++|+|+.+.||+++++...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23459999999999999977666899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.026 Score=57.94 Aligned_cols=143 Identities=21% Similarity=0.207 Sum_probs=83.6
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccC--CCcceEEEEE------eeCCeeEEEEe
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLIGCC------TQRDERMLIYE 363 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~------~~~~~~~lV~E 363 (606)
.+.++.|....+|+....+| .+++|+..... ..++...|+.++..|.. -.+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876444 56777764421 23455667777777742 2244544421 22355789999
Q ss_pred cCCCCCchhh--------------hcccCCC---------CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 007361 364 YLPNKSLNDF--------------IFDVTRS---------KFLDWSKRCQ------------IIGGIARGLLYLHQ---- 404 (606)
Q Consensus 364 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~~------------i~~~ia~gL~yLH~---- 404 (606)
|++|..+... ++..... ..-.|..... ....+.+.+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998665311 1110000 0112221111 01123344555543
Q ss_pred CCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 405 ~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
..+..++|+|+.+.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223469999999999999998877899998774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.013 Score=61.15 Aligned_cols=141 Identities=14% Similarity=0.230 Sum_probs=83.4
Q ss_pred CeecccCcccEEEEEEeC-----CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcc-eEEEEEeeCCeeEEEEecCC
Q 007361 293 NKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV-KLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~ 366 (606)
..|-.|-.-.+|+....+ ++.+++|..........+ -.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456567788899987543 357888877554433333 37799999888654443 456655332 5899998
Q ss_pred CCCchhh-----------------hcccC--C-CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 007361 367 NKSLNDF-----------------IFDVT--R-SKFLDWSKRCQIIGGI-----------------ARGLLYL----HQ- 404 (606)
Q Consensus 367 ~gsL~~~-----------------l~~~~--~-~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~- 404 (606)
+.+|..- ++... . ..+..|.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776522 11111 0 1112233333332111 1112122 22
Q ss_pred CCCCCeeeccCCCCCEEEcC-CCceEEeecCCccc
Q 007361 405 DSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA 438 (606)
Q Consensus 405 ~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~ 438 (606)
.....++|+|+++.||++++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 47899999988753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.024 Score=57.86 Aligned_cols=144 Identities=13% Similarity=0.222 Sum_probs=82.0
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEccc--ccccCHHHHHHHHHHHhhccC--CCcceEEEEEeeCC--eeEEEEecCC
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRD--ERMLIYEYLP 366 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~ 366 (606)
+.+..|..-.+|..... ++.+++. ... ..........+|..+|+.+.- .-+.+.++.|.++. ..+.||+|.+
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 33333333344444332 6677777 321 222334556778888888743 34555677777766 6799999999
Q ss_pred CCCchhhhcccCCC-----------------------------------CCCCHHHHHHHHH--------HHHHHHHHHH
Q 007361 367 NKSLNDFIFDVTRS-----------------------------------KFLDWSKRCQIIG--------GIARGLLYLH 403 (606)
Q Consensus 367 ~gsL~~~l~~~~~~-----------------------------------~~l~~~~~~~i~~--------~ia~gL~yLH 403 (606)
|..+.+.+...... +.-.|...+..+. ....-..+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 85444433211100 0111111111000 1122233443
Q ss_pred hC-----CCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 404 QD-----SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 404 ~~-----~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
+. ++..++|+|+.+.||+++.+.-+-|.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 33 234699999999999999988899999999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.013 Score=59.23 Aligned_cols=75 Identities=21% Similarity=0.275 Sum_probs=49.5
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc---CCCcceEEEEEeeCCeeEEEEecCC
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
+..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445678999999999987 578889999875 333456888988888883 4457788998887778899999998
Q ss_pred CC
Q 007361 367 NK 368 (606)
Q Consensus 367 ~g 368 (606)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.029 Score=56.58 Aligned_cols=31 Identities=23% Similarity=0.506 Sum_probs=25.7
Q ss_pred CCeeeccCCCCCEEEcCCCc-eEEeecCCccc
Q 007361 408 LRIIHRDLKASNVLLDNEMN-PKISDFGMARA 438 (606)
Q Consensus 408 ~~iiH~Dlk~~NIll~~~~~-~ki~DFGla~~ 438 (606)
..++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.0086 Score=60.15 Aligned_cols=146 Identities=16% Similarity=0.206 Sum_probs=96.6
Q ss_pred cCHHHHHHHhc---CCCcCCeecccCcccEEEEEEeCCcEEEEEEccc---------ccc-------c------CHHHHH
Q 007361 277 FDWMAIANATE---NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK---------SSG-------Q------GMEEFE 331 (606)
Q Consensus 277 ~~~~~~~~~~~---~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~---------~~~-------~------~~~~~~ 331 (606)
+++..+..... -++.+++||-|--+.||.+...+|++.++|.-.- ..+ . +.-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 55555554433 4578899999999999999998899988873210 000 0 112345
Q ss_pred HHHHHHhhcc-C-CCcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007361 332 NEVLLIAKLQ-H-RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409 (606)
Q Consensus 332 ~E~~~l~~l~-H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 409 (606)
.|+..|+.|. | --+.+.+++ +..++|||++.+-.|...- ...+..++.. .+..-+.-|-..|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~---~lm~~Iv~la~~G--- 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYD---DLMGLIVRLANHG--- 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHH---HHHHHHHHHHHcC---
Confidence 6888888884 3 234444443 4568899999887766532 1123333333 3333344555666
Q ss_pred eeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 410 IIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 410 iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
+||+|..--||+++++..++++||--.-.
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999999999999999999965443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.074 Score=55.18 Aligned_cols=141 Identities=16% Similarity=0.229 Sum_probs=81.2
Q ss_pred CeecccCcccEEEEEEeC----CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcc-eEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV-KLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~ 367 (606)
+.|..|-.-.+|+....+ +..++++........ .-+-.+|..++..+...++. ++++++.. + +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 456567777889887543 237778876554433 22346789999988765553 55665532 2 58999987
Q ss_pred CCchhh-------h----------cccC--C-CCCCCHHHHHHHHHHH----------------------HHHHH----H
Q 007361 368 KSLNDF-------I----------FDVT--R-SKFLDWSKRCQIIGGI----------------------ARGLL----Y 401 (606)
Q Consensus 368 gsL~~~-------l----------~~~~--~-~~~l~~~~~~~i~~~i----------------------a~gL~----y 401 (606)
..|..- + +... . ..+.-|..+.++..++ .+-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 1 1111 0 1111233332222221 11111 1
Q ss_pred HHh-CCCCCeeeccCCCCCEEEcC-CCceEEeecCCccc
Q 007361 402 LHQ-DSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA 438 (606)
Q Consensus 402 LH~-~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~ 438 (606)
+.+ ..+..++|+|+.+.||++++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 12335899999999999975 57899999988754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.16 Score=52.12 Aligned_cols=32 Identities=25% Similarity=0.312 Sum_probs=28.1
Q ss_pred CCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 407 ~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
+..++|+|+.++||++++++.+-|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44699999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.13 Score=53.51 Aligned_cols=79 Identities=11% Similarity=0.128 Sum_probs=49.9
Q ss_pred eecccCcccEEEEEEeCC-cEEEEEEcccc-------cccCHHHHHHHHHHHhhcc--CCC-cceEEEEEeeCCeeEEEE
Q 007361 294 KLGEGGFGPVYKGVLIEG-QEIAAKRLSKS-------SGQGMEEFENEVLLIAKLQ--HRN-LVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~~g-~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lV~ 362 (606)
.||.|....||++...+| +.++||.-... .....+...-|...|.... -|. +.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 589999999999998654 68999875321 1333455566777776653 343 333433 3445567999
Q ss_pred ecCCCC-Cchhhh
Q 007361 363 EYLPNK-SLNDFI 374 (606)
Q Consensus 363 E~~~~g-sL~~~l 374 (606)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 343433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.17 Score=53.52 Aligned_cols=80 Identities=14% Similarity=0.078 Sum_probs=52.7
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccccc-------cCHHHHHHHHHHHhhcc---CCCcceEEEEEeeCCeeEEE
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-------QGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 361 (606)
.+.||.|....||+... +++.++||+-..... ...+.-..|...|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46799999999999886 456788887652211 12333344566666553 347778888877 446788
Q ss_pred EecCCC--CCchhhh
Q 007361 362 YEYLPN--KSLNDFI 374 (606)
Q Consensus 362 ~E~~~~--gsL~~~l 374 (606)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999977 3444433
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.29 Score=50.18 Aligned_cols=65 Identities=15% Similarity=0.207 Sum_probs=40.3
Q ss_pred cEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCC--CcceEEEE------EeeCCeeEEEEecCCCCCch
Q 007361 302 PVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR--NLVKLIGC------CTQRDERMLIYEYLPNKSLN 371 (606)
Q Consensus 302 ~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E~~~~gsL~ 371 (606)
.||+....+| .+++|+.... .+.+..|+..+..|... .+.+++.. ...++..+.|+||++|.++.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4888876444 6788887422 23455567767666322 34444432 22355689999999987654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.0013 Score=77.28 Aligned_cols=160 Identities=13% Similarity=-0.043 Sum_probs=114.6
Q ss_pred HHHHHHHHhhccCCCcceEEEEEe--eCCeeEEEEecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 007361 330 FENEVLLIAKLQHRNLVKLIGCCT--QRDERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDS 406 (606)
Q Consensus 330 ~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 406 (606)
...|...++...|+++.....-.. +..+.+.+++|+..|.+.+.+... .+...++.......-.+...+..-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 334555566678988877655443 234568899999999999988643 33444555544444444355555555442
Q ss_pred --CCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHH
Q 007361 407 --RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484 (606)
Q Consensus 407 --~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~el 484 (606)
..-.+|++||+-|.+|..+..+|++++|+.+.... .........+++.|++|++...-.++.++|+|..|..+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 34579999999999999999999999999984322 22223345678899999999999999999999999999999
Q ss_pred HhccCCC
Q 007361 485 VCGKRNR 491 (606)
Q Consensus 485 ltG~~p~ 491 (606)
-.|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8777663
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.036 Score=53.46 Aligned_cols=123 Identities=20% Similarity=0.254 Sum_probs=60.1
Q ss_pred CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCc-ceEEEEEeeCCeeEEEEecCCCCCchhh-h--------------
Q 007361 311 GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYLPNKSLNDF-I-------------- 374 (606)
Q Consensus 311 g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l-------------- 374 (606)
++.|+++..... ....-.-..|..+++.+...++ .++++.+.+ ..|+||+++..|..- +
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 345666666444 3444566789999998865444 556665533 267799977665331 1
Q ss_pred --cc--c--CCCCCCCHHHHHHH----------------------HHHHHHHHHHHH----hC-CCCCeeeccCCCCCEE
Q 007361 375 --FD--V--TRSKFLDWSKRCQI----------------------IGGIARGLLYLH----QD-SRLRIIHRDLKASNVL 421 (606)
Q Consensus 375 --~~--~--~~~~~l~~~~~~~i----------------------~~~ia~gL~yLH----~~-~~~~iiH~Dlk~~NIl 421 (606)
+. . ......-|.....+ ...+.+-+..+. .. ....+.|+||.+.||+
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0 01111112222222 011111122221 11 1235899999999999
Q ss_pred E-cCCCceEEeecCCccc
Q 007361 422 L-DNEMNPKISDFGMARA 438 (606)
Q Consensus 422 l-~~~~~~ki~DFGla~~ 438 (606)
+ +.++.++++||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.55 Score=48.50 Aligned_cols=140 Identities=23% Similarity=0.280 Sum_probs=82.2
Q ss_pred eecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc---CCCcce---EEE----EEeeCCeeEEEEe
Q 007361 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRNLVK---LIG----CCTQRDERMLIYE 363 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~---l~g----~~~~~~~~~lV~E 363 (606)
.|.+ .-..+|+....+|+. ++|..... ....++..|...+.-|. .+=.++ +=| ........+-|++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789998877777 66666544 44566677777777763 222222 111 1122236788999
Q ss_pred cCCCCCchh-hh--------------c----ccC--C---CCCCCHHH---H----------HHHHHHHHHHHHHHHhC-
Q 007361 364 YLPNKSLND-FI--------------F----DVT--R---SKFLDWSK---R----------CQIIGGIARGLLYLHQD- 405 (606)
Q Consensus 364 ~~~~gsL~~-~l--------------~----~~~--~---~~~l~~~~---~----------~~i~~~ia~gL~yLH~~- 405 (606)
|++|..+.. .. + +.. + .....|.. . .....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999998883 11 1 000 1 11234431 0 01223344444444433
Q ss_pred ---CC---CCeeeccCCCCCEEEcCCCc-eEEeecCCcc
Q 007361 406 ---SR---LRIIHRDLKASNVLLDNEMN-PKISDFGMAR 437 (606)
Q Consensus 406 ---~~---~~iiH~Dlk~~NIll~~~~~-~ki~DFGla~ 437 (606)
-+ ..+||+|+.|.||+++.+.. ..+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 23999999999999999885 8999999775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.72 E-value=1.3 Score=45.75 Aligned_cols=94 Identities=14% Similarity=0.062 Sum_probs=54.6
Q ss_pred ccCHHHHHHHhcCCCcC---C-eecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccC--CCcceEE
Q 007361 276 IFDWMAIANATENFSDK---N-KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLI 349 (606)
Q Consensus 276 ~~~~~~~~~~~~~~~~~---~-~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~ 349 (606)
.++...+..+.+.+... + ..-.+.-..||+....++..+++|.... ......++..|+..+..|.. -.++..+
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 34445555554444221 1 2223455779999887788888887642 22345667788888877732 1223222
Q ss_pred ---E--EEeeCCeeEEEEecCCCCCc
Q 007361 350 ---G--CCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 350 ---g--~~~~~~~~~lV~E~~~~gsL 370 (606)
| ....++..+.|+++++|...
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 1 12224567889999988754
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.51 Score=56.50 Aligned_cols=142 Identities=18% Similarity=0.246 Sum_probs=78.2
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc--CCC--cceEEE--------EEee-CC--e
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--HRN--LVKLIG--------CCTQ-RD--E 357 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~n--iv~l~g--------~~~~-~~--~ 357 (606)
+.|+ |..-.+|+....+|+.+++|...... .......|...+..|. ++. +.+++- .... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 45688899888788889999986542 2334444555555442 122 223221 1111 12 4
Q ss_pred eEEEEecCCCCCchhhh-----------------c----ccC---CCCCCCHHH-----------------HHHHHHHHH
Q 007361 358 RMLIYEYLPNKSLNDFI-----------------F----DVT---RSKFLDWSK-----------------RCQIIGGIA 396 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l-----------------~----~~~---~~~~l~~~~-----------------~~~i~~~ia 396 (606)
.+-+++|++|..|.+.. + +.. ....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999998776511 0 000 011233321 112222333
Q ss_pred HHHH-----HHHhCCCCCeeeccCCCCCEEEcCCC--ceE-EeecCCccc
Q 007361 397 RGLL-----YLHQDSRLRIIHRDLKASNVLLDNEM--NPK-ISDFGMARA 438 (606)
Q Consensus 397 ~gL~-----yLH~~~~~~iiH~Dlk~~NIll~~~~--~~k-i~DFGla~~ 438 (606)
+.+. .|. .-+..+||+|+.+.|||++.+. .+. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 121 2234599999999999998875 454 999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.17 Score=53.15 Aligned_cols=74 Identities=11% Similarity=0.095 Sum_probs=49.6
Q ss_pred CCeecccCcccEEEEEEeC-CcEEEEEEcccc------cccCHHHHHHHHHHHhhcc--CCC-cceEEEEEeeCCeeEEE
Q 007361 292 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------SGQGMEEFENEVLLIAKLQ--HRN-LVKLIGCCTQRDERMLI 361 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lV 361 (606)
.+.||.|.-..||++.+.. ++.|+||.-... ..-..+...-|.+.|+... -|. +.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3679999999999999853 678999865321 2334566677777777663 343 4445433 44556788
Q ss_pred EecCCC
Q 007361 362 YEYLPN 367 (606)
Q Consensus 362 ~E~~~~ 367 (606)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 606 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-18 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-144
Identities = 103/313 (32%), Positives = 166/313 (53%), Gaps = 19/313 (6%)
Query: 264 DRGNREEEMELPIFDWMAIANATENFSDK------NKLGEGGFGPVYKGVLIEGQEIAAK 317
++ + F + + N T NF ++ NK+GEGGFG VYKG + +A K
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 318 RLSK----SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF 373
+L+ ++ + ++F+ E+ ++AK QH NLV+L+G + D+ L+Y Y+PN SL D
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 374 IFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433
+ + + L W RC+I G A G+ +LH++ IHRD+K++N+LLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493
G+ARA T+R+VGT YM PE + G + KSD++SFGV++LEI+ G
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 494 YHADHHHNLLGHAWRLWIEERPVE-LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 552
+ LL + EE+ +E I+K + + V V C+ ++ RP+
Sbjct: 237 HREP--QLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 553 MSSVVLMLSGERS 565
+ V +L +
Sbjct: 294 IKKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 408 bits (1052), Expect = e-140
Identities = 124/292 (42%), Positives = 169/292 (57%), Gaps = 5/292 (1%)
Query: 276 IFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGME-EFENEV 334
F + A++NFS+KN LG GGFG VYKG L +G +A KRL + QG E +F+ EV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 335 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIG 393
+I+ HRNL++L G C ER+L+Y Y+ N S+ + + S+ LDW KR +I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
G ARGL YLH +IIHRD+KA+N+LLD E + DFG+A+ T T V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197
Query: 454 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN--RGFYHADHHHNLLGHAWRLWI 511
T G++ PEY G S K+DVF +GV++LE++ G+R D LL L
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563
E++ L++ L G+Y EV + IQV LLC Q P +RP MS VV ML G+
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-121
Identities = 107/319 (33%), Positives = 168/319 (52%), Gaps = 6/319 (1%)
Query: 253 KTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQ 312
+ ++ ++ + E + + AT NF K +G G FG VYKGVL +G
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64
Query: 313 EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND 372
++A KR + S QG+EEFE E+ ++ +H +LV LIG C +R+E +LIY+Y+ N +L
Sbjct: 65 KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124
Query: 373 FIFDVTRSKF-LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431
++ + W +R +I G ARGL YLH + IIHRD+K+ N+LLD PKI+
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181
Query: 432 DFGMARAF-GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN 490
DFG+++ +DQT +T V GT GY+ PEY I G + KSDV+SFGV++ E++C +
Sbjct: 182 DFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 491 RGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR 550
NL A + ++++ +L + + + C+ EDR
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 551 PNMSSVVLMLSGERSLPQP 569
P+M V+ L L +
Sbjct: 301 PSMGDVLWKLEYALRLQES 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 8e-93
Identities = 66/302 (21%), Positives = 123/302 (40%), Gaps = 28/302 (9%)
Query: 282 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 341
+ + G FG V+K + + +A K Q + E EV + ++
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMK 76
Query: 342 HRNLVKLIGCCTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 397
H N+++ IG + + LI + SL+DF+ ++ + W++ C I +AR
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMAR 132
Query: 398 GLLYLHQD-------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
GL YLH+D + I HRD+K+ NVLL N + I+DFG+A F ++ +T+
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 451 VVGTYGYMPPEYAIDGL-----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 505
VGT YM PE + ++ D+++ G+++ E+ ++
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 506 AWRLWIEERPVELINK-----SLGGSYSLSEVLRCI-QVGLLCVQQRPEDRPNMSSVVLM 559
+ E E++ L + + + + C E R + V
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312
Query: 560 LS 561
++
Sbjct: 313 IT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 5e-74
Identities = 71/339 (20%), Positives = 128/339 (37%), Gaps = 51/339 (15%)
Query: 272 MELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE 331
ME + +N +G G +G VYKG L + + +A K S ++ Q E
Sbjct: 1 MEAAASEPSL---DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-E 55
Query: 332 NEVLLIAKLQHRNLVKLIGCCT-----QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 386
+ + ++H N+ + I R E +L+ EY PN SL ++ DW
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWV 111
Query: 387 KRCQIIGGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF- 439
C++ + RGL YLH + + I HRDL + NVL+ N+ ISDFG++
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 440 -----GIDQTEANTNRVVGTYGYMPPEYAIDGLFSV--------KSDVFSFGVLVLEIVC 486
+ + VGT YM PE ++G ++ + D+++ G++ EI
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 487 GKRNRGFYHADHHHNLLGHAWRLWIEERP-VELINK---------SLGGSYSLSEVLRCI 536
+ + + + A++ + P E + ++ + +
Sbjct: 231 RCTDLFPGESVPEYQM---AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 537 QVGLL--CVQQRPEDRPNMSSVVLMLSG-ERSLPQPKQP 572
+ C Q E R ++ + K
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-60
Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 9/206 (4%)
Query: 288 NFSD---KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQH 342
+ D K K+G G FG V++ G ++A K L + + + EF EV ++ +L+H
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N+V +G TQ ++ EYL SL + + LD +R + +A+G+ YL
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H I+HR+LK+ N+L+D + K+ DFG++R T ++ GT +M PE
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEV 210
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
D + KSDV+SFGV++ E+ +
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-59
Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 46/298 (15%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
+ + +G G FG V K +++A K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
KL G C L+ EY SL + + + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 407 RLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
+IHRDLK N+LL KI DFG A D TN G+ +M PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEG 177
Query: 466 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP---------- 515
+S K DVFS+G+++ E++ ++ + + W + RP
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML-SGERSLPQPKQP 572
L+ + C + P RP+M +V ++ R P +P
Sbjct: 234 ESLMTR--------------------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-59
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLVK 347
+ +G GGFG VY+ G E+A K Q +E E L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
L G C + L+ E+ LN + K + IARG+ YLH ++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 408 LRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGIDQTEANTNRVVGTYGYMP 459
+ IIHRDLK+SN+L+ ++ KI+DFG+AR +T + G Y +M
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSA--AGAYAWMA 182
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE +FS SDV+S+GVL+ E++ G+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-57
Identities = 81/319 (25%), Positives = 119/319 (37%), Gaps = 50/319 (15%)
Query: 292 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 350
LG+G FG K E G+ + K L + + F EV ++ L+H N++K IG
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
+ I EY+ +L I WS+R IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR------------VVGTYGYM 458
IHRDL + N L+ N ++DFG+AR ++T+ R VVG +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR---NRGFYHADHHHNLLGHAWRLWI-EER 514
PE + K DVFSFG+++ EI+ + D N+ G +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-DRYCPPNC 248
Query: 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML-----SGERSLPQP 569
P + + C PE RP+ + L LP
Sbjct: 249 PPSF-----------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
Query: 570 KQ-----PGFFTERNPPES 583
Q GF+ ES
Sbjct: 292 PQLEQLDRGFWETYRRGES 310
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-57
Identities = 67/296 (22%), Positives = 131/296 (44%), Gaps = 52/296 (17%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG-------MEEFENEVLLIA 338
+ ++G+GGFG V+KG L++ +A K L +G +EF+ EV +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 398
L H N+VKL G ++ E++P L + D ++ + WS + +++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAFGIDQTEANTNRVVG 453
+ Y+ I+HRDL++ N+ L + + K++DFG+++ Q+ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 454 TYGYMPPE--YAIDGLFSVKSDVFSFGVLVLEIVCGK---RNRGFYHADHHHNLLGHAWR 508
+ +M PE A + ++ K+D +SF +++ I+ G+ + + + R
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 509 L----WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
R +I C P+ RP+ S +V L
Sbjct: 249 PTIPEDCPPRLRNVIEL--------------------CWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 1e-55
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 288 NFSD---KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQH 342
+F KL E G ++KG +G +I K L S + +F E + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 343 RNLVKLIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
N++ ++G C LI ++P SL + + + T +D S+ + +ARG+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMA 125
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
+LH L I L + +V++D +M +IS + +F + + ++ P
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAP 177
Query: 461 EYAIDG----LFSVKSDVFSFGVLVLEIVCGK 488
E A+ +D++SF VL+ E+V +
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-55
Identities = 64/279 (22%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 344
+ ++G G FG VYKG ++A K L+ + + Q ++ F+NEV ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
++ +G T + ++ ++ SL + + K I ARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA 138
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--- 461
IIHRDLK++N+ L + KI DFG+A ++ G+ +M PE
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521
+S +SDV++FG+++ E++ G+ Y + +N + +L
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP---Y--SNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+ ++ C++++ ++RP+ ++ +
Sbjct: 251 RSNCPKRMKRLMA------ECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 44/303 (14%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLI 349
+G+G FG VY G E+A + + + ++ F+ EV+ + +H N+V +
Sbjct: 38 GELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409
G C +I ++L + D LD +K QI I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMPPE----- 461
I+H+DLK+ NV DN I+DFG+ G+ Q ++ G ++ PE
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 462 ----YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517
FS SDVF+ G + E+ + + W++ +P
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---F---KTQPAEAIIWQMGTGMKP-N 262
Query: 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ----PKQPG 573
L + +S++L C E+RP + ++ ML LP+ PG
Sbjct: 263 LSQIGM--GKEISDILL------FCWAFEQEERPTFTKLMDML---EKLPKRNRRLSHPG 311
Query: 574 FFT 576
F
Sbjct: 312 HFW 314
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 5e-52
Identities = 68/316 (21%), Positives = 121/316 (38%), Gaps = 43/316 (13%)
Query: 274 LPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENE 333
LP+ IA + ++G+G +G V+ G G+++A K + E E
Sbjct: 27 LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-SWFRETE 81
Query: 334 VLLIAKLQHRNLVKLIGCCTQ----RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 389
+ ++H N++ I + + LI +Y N SL D++ +S LD
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSML 137
Query: 390 QIIGGIARGLLYLHQDSRLR-----IIHRDLKASNVLLDNEMNPKISDFGMARAF--GID 442
++ GL +LH + I HRDLK+ N+L+ I+D G+A F +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 443 QTEANTNRVVGTYGYMPPEYAIDGLFSV-------KSDVFSFGVLVLEIVCGKRNRG--- 492
+ + N VGT YMPPE +D + +D++SFG+++ E+ + G
Sbjct: 198 EVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 493 -----FYHADHHHNLLGHAWRLWIEE--RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQ 545
++ + + RP L ++ + + C
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPS--FPNRWSSDECLRQMGKLMTE---CWAH 311
Query: 546 RPEDRPNMSSVVLMLS 561
P R V L+
Sbjct: 312 NPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-52
Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 38/296 (12%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
+G+G +G V++G +G+ +A K S + E E+ L+H N++ I
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK-SWFRETELYNTVMLRHENILGFIASD 71
Query: 353 T----QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
+ LI Y SL D++ + LD +I+ IA GL +LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 409 R-----IIHRDLKASNVLLDNEMNPKISDFGMAR--AFGIDQTEANTNRVVGTYGYMPPE 461
I HRDLK+ N+L+ I+D G+A + +Q + N VGT YM PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 462 ------YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG--------FYHADHHHNLLGHAW 507
+ D+++FG+++ E+ + G FY +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 508 RLWIEE--RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
++ + RP I +L+ + + ++ C Q P R + L+
Sbjct: 248 KVVCVDQQRPN--IPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 9e-51
Identities = 68/316 (21%), Positives = 122/316 (38%), Gaps = 43/316 (13%)
Query: 274 LPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENE 333
LP+ IA + +G+G FG V++G G+E+A K S + E E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAE 86
Query: 334 VLLIAKLQHRNLVKLIGCCTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 389
+ L+H N++ I + + + L+ +Y + SL D++ +
Sbjct: 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMI 142
Query: 390 QIIGGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GID 442
++ A GL +LH + + I HRDLK+ N+L+ I+D G+A D
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 443 QTEANTNRVVGTYGYMPPEYAIDGLFSV-------KSDVFSFGVLVLEIVCGKRNRG--- 492
+ N VGT YM PE +D ++ ++D+++ G++ EI G
Sbjct: 203 TIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 493 -----FYHADHHHNLLGHAWRLWIEE--RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQ 545
+Y + ++ E+ RP I +L + + ++ C
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN--IPNRWQSCEALRVMAKIMR---ECWYA 316
Query: 546 RPEDRPNMSSVVLMLS 561
R + LS
Sbjct: 317 NGAARLTALRIKKTLS 332
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-47
Identities = 81/332 (24%), Positives = 132/332 (39%), Gaps = 70/332 (21%)
Query: 292 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
++LG+G FG V G +A K+L S +F+ E+ ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 347 KLIGCCTQRDER--MLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLL 400
K G + L+ EYLP+ L DF+ + S+ L +S I +G+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGME 141
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP- 459
YL R +HRDL A N+L+++E + KI+DFG+A+ +D+ VV G P
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPI 194
Query: 460 ----PEYAIDGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWIEER 514
PE D +FS +SDV+SFGV++ E+ ++
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSA 235
Query: 515 PVELINKSLGGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVV 557
+ +LS +L ++ G LC P+DRP+ S++
Sbjct: 236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295
Query: 558 L----MLSGERSLPQPKQPGFFTERNPPESGS 585
+ SG R ++ S S
Sbjct: 296 PQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-47
Identities = 75/311 (24%), Positives = 114/311 (36%), Gaps = 59/311 (18%)
Query: 292 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNL 345
LGEG FG V G+ +A K L +G Q ++ E+ ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 346 VKLIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
+K GCC L+ EY+P SL D++ + ++ I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP---- 459
IHRDL A NVLLDN+ KI DFG+A+A V G P
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204
Query: 460 -PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
PE + F SDV+SFGV + E+ H D + L +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYEL--------LTHCDSSQSPPTKFLELIGIAQG--- 253
Query: 519 INKSLGGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
++ + ++ G C + RP +++ +L
Sbjct: 254 -------QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
Query: 562 GERSLPQPKQP 572
Q + P
Sbjct: 307 TVHEKYQGQAP 317
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-47
Identities = 75/303 (24%), Positives = 117/303 (38%), Gaps = 63/303 (20%)
Query: 292 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
+LG+G FG V G+ +A K+L S+ + + +FE E+ ++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 347 KLIGCCTQRDER--MLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLL 400
K G C R LI EYLP SL D++ + K L ++ I +G+
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGME 159
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG---- 456
YL R IHRDL N+L++NE KI DFG+ + D+ V G
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPI 212
Query: 457 -YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515
+ PE + FSV SDV+SFGV++ E+ A+ +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-------- 264
Query: 516 VELINKSLGGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVL 558
G + ++ ++ C RP+ + L
Sbjct: 265 ---------GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
Query: 559 MLS 561
+
Sbjct: 316 RVD 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 63/303 (20%)
Query: 292 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
+LG+G FG V G+ +A K+L S+ + + +FE E+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 347 KLIGCCTQRDER--MLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLL 400
K G C R LI EYLP SL D++ + K L ++ I +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGME 128
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP- 459
YL R IHRDL N+L++NE KI DFG+ + D+ V G P
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPI 181
Query: 460 ----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515
PE + FSV SDV+SFGV++ E+ F + + + R+ ++
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 516 VELINKSLGGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVL 558
++I ++ ++ C RP+ + L
Sbjct: 234 GQMIV---------FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284
Query: 559 MLS 561
+
Sbjct: 285 RVD 287
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 80/314 (25%), Positives = 122/314 (38%), Gaps = 89/314 (28%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
K +LGEG FG V+ + +A K L + ++F+ E L+ LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDF-------------IFDVTRSKFLDWSKRCQII 392
VK G C D ++++EY+ + LN F L S+ I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
IA G++YL + +HRDL N L+ + KI DFGM+R D + R V
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-V 191
Query: 453 GTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507
G + +MPPE + F+ +SDV+SFGV++ EI
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF---------------------- 229
Query: 508 RLWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQR 546
+ G S +EV+ CI G L C Q+
Sbjct: 230 --------------TYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQRE 275
Query: 547 PEDRPNMSSVVLML 560
P+ R N+ + +L
Sbjct: 276 PQQRLNIKEIYKIL 289
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 73/305 (23%), Positives = 110/305 (36%), Gaps = 64/305 (20%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRN 344
E+ ++G G FG V+ G L + +A K +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+V+LIG CTQ+ ++ E + F+ T L Q++G A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
IHRDL A N L+ + KISDFGM+R A+ + PE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
G +S +SDV+SFG+L+ E SLG
Sbjct: 289 YGRYSSESDVWSFGILLWETF------------------------------------SLG 312
Query: 525 GS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLSGE 563
S S + ++ G C P RP+ S++ L
Sbjct: 313 ASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
Query: 564 RSLPQ 568
R +
Sbjct: 373 RKRHR 377
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-44
Identities = 70/308 (22%), Positives = 127/308 (41%), Gaps = 73/308 (23%)
Query: 292 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNL 345
LGEG FG V G+++A K L +S G + + + E+ ++ L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 346 VKLIGCCTQRDER--MLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGL 399
VK G CT+ LI E+LP+ SL +++ + + L ++ I +G+
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------QICKGM 139
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG--- 456
YL + +HRDL A NVL+++E KI DFG+ +A D+ V
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSP 192
Query: 457 --YMPPEYAIDGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWIEE 513
+ PE + F + SDV+SFGV + E++ +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS--------------------- 231
Query: 514 RPVELINKSLGGSY---SLSEVLRCIQVG-----------------LLCVQQRPEDRPNM 553
P+ L K +G ++ +++ ++ ++ G C + +P +R +
Sbjct: 232 -PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF 290
Query: 554 SSVVLMLS 561
+++
Sbjct: 291 QNLIEGFE 298
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 76/313 (24%), Positives = 123/313 (39%), Gaps = 88/313 (28%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
K +LGEG FG V+ + +A K L ++S ++F+ E L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDF------------IFDVTRSKFLDWSKRCQIIG 393
V+ G CT+ ++++EY+ + LN F + L + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
+A G++YL + L +HRDL N L+ + KI DFGM+R D + R VG
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217
Query: 454 TYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 508
+MPPE + F+ +SDV+SFGV++ EI
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF----------------------- 254
Query: 509 LWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRP 547
+ G S +E + CI G C Q+ P
Sbjct: 255 -------------TYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREP 301
Query: 548 EDRPNMSSVVLML 560
+ R ++ V L
Sbjct: 302 QQRHSIKDVHARL 314
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 78/315 (24%), Positives = 123/315 (39%), Gaps = 90/315 (28%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRN 344
+LGE FG VYKG L + Q +A K L + G EEF +E +L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDF-------------IFDVTRSKFLDWSKRCQI 391
+V L+G T+ +I+ Y + L++F D T L+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451
+ IA G+ YL S ++H+DL NVL+ +++N KISD G+ R + +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR--EVYAADYYK--- 185
Query: 452 VGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506
+ +M PE + G FS+ SD++S+GV++ E+
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF--------------------- 224
Query: 507 WRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQ 545
S G YS +V+ I+ + C +
Sbjct: 225 ---------------SYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNE 269
Query: 546 RPEDRPNMSSVVLML 560
P RP + L
Sbjct: 270 FPSRRPRFKDIHSRL 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 79/330 (23%), Positives = 129/330 (39%), Gaps = 84/330 (25%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRN 344
+LG+G FG VY+GV +A K +++ +S + EF NE ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDF-------IFDVTRSKFLDWSKRCQIIGGIAR 397
+V+L+G +Q ++I E + L + + + SK Q+ G IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
G+ YL + + +HRDL A N ++ + KI DFGM R D E + R G G
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGL 201
Query: 458 -----MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512
M PE DG+F+ SDV+SFGV++ EI
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--------------------------- 234
Query: 513 ERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRP 551
+L S +VLR + G +C Q P+ RP
Sbjct: 235 ---------TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 285
Query: 552 NMSSVVLMLSGERSLPQPKQPGFFTERNPP 581
+ ++ + E + +++E N
Sbjct: 286 SFLEIISSIKEEMEPGFREVSFYYSEENKL 315
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 30/208 (14%)
Query: 293 NKLGEGGFGPVYKGVLIEGQE-----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLV 346
LG G FG VYKG+ I E +A K L + +S + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYL 402
+L+G C LI + +P L D++ + + L+W IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP--- 459
R++HRDL A NVL+ + KI+DFG+A+ G ++ E + G +P
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185
Query: 460 --PEYAIDGLFSVKSDVFSFGVLVLEIV 485
E + +++ +SDV+S+GV V E++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 88/332 (26%), Positives = 121/332 (36%), Gaps = 84/332 (25%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRN 344
LG G FG VY+G + ++A K L + S Q +F E L+I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLL 400
+V+ IG Q R ++ E + L F+ ++ L + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
YL IHRD+ A N LL KI DFGMAR D A+ R G
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAM 206
Query: 458 -----MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512
MPPE ++G+F+ K+D +SFGVL+ EI
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------------------- 239
Query: 513 ERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRP 551
SLG S EVL + G C Q +PEDRP
Sbjct: 240 ---------SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 290
Query: 552 NMSSVVLMLSGERSLPQPKQPGFFTERNPPES 583
N + ++ + P E P
Sbjct: 291 NFAIILERIEYCTQDPDVINTALPIEYGPLVE 322
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 88/332 (26%), Positives = 120/332 (36%), Gaps = 84/332 (25%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRN 344
LG G FG VY+G + ++A K L + S Q +F E L+I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLL 400
+V+ IG Q R ++ E + L F+ ++ L + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
YL IHRD+ A N LL KI DFGMAR D A R G
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAM 247
Query: 458 -----MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512
MPPE ++G+F+ K+D +SFGVL+ EI
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------------------- 280
Query: 513 ERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRP 551
SLG S EVL + G C Q +PEDRP
Sbjct: 281 ---------SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 331
Query: 552 NMSSVVLMLSGERSLPQPKQPGFFTERNPPES 583
N + ++ + P E P
Sbjct: 332 NFAIILERIEYCTQDPDVINTALPIEYGPLVE 363
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 79/346 (22%), Positives = 132/346 (38%), Gaps = 97/346 (28%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRL-SKSSGQGMEEFENEVLLI 337
+ + LGEG FG V + E +A K L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 338 AKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-- 394
+ +H+N++ L+G CTQ +I EY +L +++ R +++S +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQ 153
Query: 395 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442
+ARG+ YL + + IHRDL A NVL+ KI+DFG+AR D
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----D 206
Query: 443 QTEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 497
+ + T G +M PE D +++ +SDV+SFGVL+ EI
Sbjct: 207 INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF------------ 253
Query: 498 HHHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG-------------- 539
+LGGS + E+ + ++ G
Sbjct: 254 ------------------------TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY 289
Query: 540 ---LLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPE 582
C P RP +V L +R L + P E
Sbjct: 290 MMMRDCWHAVPSQRPTFKQLVEDL--DRILTLTTNEEYLDLSQPLE 333
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 3e-42
Identities = 77/298 (25%), Positives = 116/298 (38%), Gaps = 78/298 (26%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
++G G FG V+ G + ++A K + + E+F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
C ++ L+ E++ + L+D++ L + G+ YL
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL------DVCEGMAYL---EE 122
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAI 464
+IHRDL A N L+ K+SDFGM R DQ ++T GT + PE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 178
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
+S KSDV+SFGVL+ E+ S G
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVF------------------------------------SEG 202
Query: 525 GS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
S SEV+ I G C ++RPEDRP S ++ L+
Sbjct: 203 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 79/344 (22%), Positives = 133/344 (38%), Gaps = 96/344 (27%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKL-QHRNLV 346
++ +GEG FG V K + + A KR+ +S +F E+ ++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDF-------------IFDVTRSKFLDWSKRCQIIG 393
L+G C R L EY P+ +L DF + + L +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN---- 449
+ARG+ YL S+ + IHRDL A N+L+ KI+DFG++R G + T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204
Query: 450 -RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 508
R +M E +++ SDV+S+GVL+ EIV
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIV----------------------- 235
Query: 509 LWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRP 547
SLGG+ + +E+ + G C +++P
Sbjct: 236 -------------SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKP 282
Query: 548 EDRPNMSSVVLMLSGERSLPQPKQ---PGFFTERNPPESGSSSS 588
+RP+ + +++ L R L + K + + S+
Sbjct: 283 YERPSFAQILVSL--NRMLEERKTYVNTTLYEKFTYAGIDCSAE 324
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-42
Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 78/302 (25%)
Query: 293 NKLGEGGFGPVYKGVLIEG----QEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 347
+G G FG VY G L++ A K L++ + + +F E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 348 LIGCCTQRDE-RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
L+G C + + +++ Y+ + L +FI + + +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------YMPP 460
+ +HRDL A N +LD + K++DFG+AR D + V G +M
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
E F+ KSDV+SFGVL+ E++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELM----------------------------------- 226
Query: 521 KSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLM 559
+ G + ++ + G L C + E RP+ S +V
Sbjct: 227 -TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
Query: 560 LS 561
+S
Sbjct: 286 IS 287
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-42
Identities = 71/323 (21%), Positives = 118/323 (36%), Gaps = 98/323 (30%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRN 344
+GEG FG V++ +A K L ++S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDF---------------------IFDVTRSKFL 383
+VKL+G C L++EY+ LN+F L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 384 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443
+++ I +A G+ YL S + +HRDL N L+ M KI+DFG++R +
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224
Query: 444 TEANTNRVVGTYGY-----MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
A+ + MPPE ++ +SDV+++GV++ EI
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF------------- 270
Query: 499 HHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG--------------- 539
S G + EV+ ++ G
Sbjct: 271 -----------------------SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYN 307
Query: 540 --LLCVQQRPEDRPNMSSVVLML 560
LC + P DRP+ S+ +L
Sbjct: 308 LMRLCWSKLPADRPSFCSIHRIL 330
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 75/299 (25%), Positives = 119/299 (39%), Gaps = 70/299 (23%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
E + +LG G FG V G ++A K + K +EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
K G C++ ++ EY+ N L +++ + K L+ S+ ++ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYA 463
+ IHRDL A N L+D ++ K+SDFGM R DQ ++ GT + PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVF 177
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+S KSDV++FG+L+ E+ SL
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVF------------------------------------SL 201
Query: 524 GGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
G Y+ SEV+ + G C + PE RP ++ +
Sbjct: 202 GKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 76/328 (23%), Positives = 126/328 (38%), Gaps = 98/328 (29%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVL--IEGQE----IAAKRL-SKSSGQGMEEFENEVLLIAK 339
+N LGEG FG V K ++G+ +A K L +S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF---------------------IFDVT 378
+ H +++KL G C+Q +LI EY SL F D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 379 RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438
+ L I++G+ YL + ++++HRDL A N+L+ KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 439 FGIDQTEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493
D E ++ + G +M E D +++ +SDV+SFGVL+ EIV
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV-------- 246
Query: 494 YHADHHHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG---------- 539
+LGG+ + ++ G
Sbjct: 247 ----------------------------TLGGNPYPGIPPERLFNLLKTGHRMERPDNCS 278
Query: 540 -------LLCVQQRPEDRPNMSSVVLML 560
L C +Q P+ RP + + L
Sbjct: 279 EEMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 270 EEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE----IAAKRLSK-SSG 324
+++ +P + + +G+G FG VY G I+ + A K LS+ +
Sbjct: 12 KDVLIP-HERVVT-------HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63
Query: 325 QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFL 383
Q +E F E LL+ L H N++ LIG + ++ Y+ + L FI +
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNP 121
Query: 384 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443
+ARG+ YL + + +HRDL A N +LD K++DFG+AR I
Sbjct: 122 TVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR--DILD 176
Query: 444 TEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
E + + + + E F+ KSDV+SFGVL+ E++
Sbjct: 177 REYYSVQ-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 292 KNKLGEGGFGPVYKGVLI---EGQEI--AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNL 345
LG G FG V+KGV I E +I K + SG Q + + +L I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLY 401
V+L+G C L+ +YLP SL D + + L+W IA+G+ Y
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYY 130
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-- 459
L ++HR+L A NVLL + +++DFG+A D + + P
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182
Query: 460 ---PEYAIDGLFSVKSDVFSFGVLVLEIV 485
E G ++ +SDV+S+GV V E++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-41
Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 70/298 (23%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
++ + +LG G FG V G ++A K + K +EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L G CT++ +I EY+ N L +++ + ++ + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYA 463
+ +HRDL A N L++++ K+SDFG++R D+ ++ G+ + PPE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVL 193
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+ FS KSD+++FGVL+ EI SL
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIY------------------------------------SL 217
Query: 524 GGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLML 560
G ++ SE I G C ++ ++RP ++ +
Sbjct: 218 GKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 292 KNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 350
K+KLG G +G VY+GV +A K L K +EEF E ++ +++H NLV+L+G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
CT+ +I E++ +L D++ + + + + I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-----RVVGTYGYMPPEYAID 465
IHRDL A N L+ K++DFG++R D A+ + + PE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186
Query: 466 GLFSVKSDVFSFGVLVLEIV 485
FS+KSDV++FGVL+ EI
Sbjct: 187 NKFSIKSDVWAFGVLLWEIA 206
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 80/335 (23%), Positives = 133/335 (39%), Gaps = 97/335 (28%)
Query: 292 KNKLGEGGFGPVYKGVLI--------EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 341
LGEG FG V I ++A K L S ++ + + + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------- 394
H+N++ L+G CTQ +I EY +L +++ R L++S
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 395 -------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEA 446
+ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR ID +
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 447 NTN-----RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN 501
TN + +M PE D +++ +SDV+SFGVL+ EI
Sbjct: 250 TTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIF---------------- 287
Query: 502 LLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------L 540
+LGGS + E+ + ++ G
Sbjct: 288 --------------------TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 327
Query: 541 LCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF 575
C P RP +V L +L ++ G++
Sbjct: 328 DCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 67/311 (21%), Positives = 116/311 (37%), Gaps = 86/311 (27%)
Query: 292 KNKLGEGGFGPVYKGVLI----EGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNL 345
LGEG FG V +G L ++A K + SS + +EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 346 VKLIGCCTQRD-----ERMLIYEYLPNKSLNDFI---FDVTRSKFLDWSKRCQIIGGIAR 397
++L+G C + + M+I ++ L+ ++ T K + + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGIDQTEANTN-----RV 451
G+ YL S +HRDL A N +L ++M ++DFG+++ + D +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214
Query: 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511
++ E D +++ KSDV++FGV + EI
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIA-------------------------- 243
Query: 512 EERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDR 550
+ G + E+ + G C + P DR
Sbjct: 244 ----------TRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293
Query: 551 PNMSSVVLMLS 561
P S + L L
Sbjct: 294 PTFSVLRLQLE 304
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 73/323 (22%), Positives = 123/323 (38%), Gaps = 93/323 (28%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRL-SKSSGQGMEEFENEVLLI 337
+ + LGEG FG V + E +A K L ++ + + + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 338 AKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-------------IFDVTRSKFL 383
+ +H+N++ L+G CTQ +I EY +L ++ + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 384 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443
+ +ARG+ YL + + IHRDL A NVL+ KI+DFG+AR D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253
Query: 444 TEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
+ + T G +M PE D +++ +SDV+SFGVL+ EI
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF------------- 299
Query: 499 HHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG--------------- 539
+LGGS + E+ + ++ G
Sbjct: 300 -----------------------TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM 336
Query: 540 --LLCVQQRPEDRPNMSSVVLML 560
C P RP +V L
Sbjct: 337 MMRDCWHAVPSQRPTFKQLVEDL 359
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 30/208 (14%)
Query: 293 NKLGEGGFGPVYKGVLIEGQE-----IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLV 346
LG G FG VYKG+ I E +A K L +S + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYL 402
+L+G C LI + +P L D++ + + L+W IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP--- 459
R++HRDL A NVL+ + KI+DFG+A+ G ++ E + G +P
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185
Query: 460 --PEYAIDGLFSVKSDVFSFGVLVLEIV 485
E + +++ +SDV+S+GV V E++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 72/302 (23%), Positives = 120/302 (39%), Gaps = 78/302 (25%)
Query: 292 KNKLGEGGFGPVYKGVLI----EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLV 346
+ +G G G V G L +A K L + + + +F +E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L G T+ M++ EY+ N SL+ F+ T + ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------YMPP 460
L +HRDL A NVL+D+ + K+SDFG++R D A T T G + P
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP 223
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
E FS SDV+SFGV++ E++
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVL----------------------------------- 248
Query: 521 KSLG----GSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLM 559
+ G + + +V+ ++ G L C + RP S +V +
Sbjct: 249 -AYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307
Query: 560 LS 561
L
Sbjct: 308 LD 309
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-40
Identities = 76/293 (25%), Positives = 119/293 (40%), Gaps = 70/293 (23%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
KLG G FG V+ + ++A K + K +E F E ++ LQH LVKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
T+ + +I E++ SL DF+ K IA G+ ++ + IH
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLFS 469
RDL+A+N+L+ + KI+DFG+AR ++ A G + PE G F+
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFT 363
Query: 470 VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS--- 526
+KSDV+SFG+L++EIV + G
Sbjct: 364 IKSDVWSFGILLMEIV------------------------------------TYGRIPYP 387
Query: 527 -YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
S EV+R ++ G + C + RPE+RP + +L
Sbjct: 388 GMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 60/321 (18%), Positives = 110/321 (34%), Gaps = 103/321 (32%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVL--------IEGQEIAAKRLSKSSGQGMEEFENEVLLIA 338
E+ LG+G F ++KGV + E+ K L K+ E F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGG 394
KL H++LV G C DE +L+ E++ SL+ ++ + L+ +K
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK------Q 121
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGIDQTEA 446
+A + +L +IH ++ A N+LL E + K+SD G++
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------- 170
Query: 447 NTNRVVGTYGY------MPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 499
V+ +PPE + ++ +D +SFG + EI
Sbjct: 171 ----VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC-------------- 212
Query: 500 HNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG---------------L 540
S G L+ +
Sbjct: 213 ----------------------SGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLIN 250
Query: 541 LCVQQRPEDRPNMSSVVLMLS 561
C+ P+ RP+ +++ L+
Sbjct: 251 NCMDYEPDHRPSFRAIIRDLN 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 82/373 (21%), Positives = 133/373 (35%), Gaps = 103/373 (27%)
Query: 239 GFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFD-WMAIANATE----NFSDKN 293
G Y +K++ + Q + + N + +LP + W E N
Sbjct: 1 GVDYKYKQKPKYQVRWKIIESYEGNSYTF-IDPTQLPYNEKW-------EFPRNNLQFGK 52
Query: 294 KLGEGGFGPVYKGVL--IEGQE----IAAKRL-SKSSGQGMEEFENEVLLIAKL-QHRNL 345
LG G FG V + + ++ +A K L S + E +E+ +++ L QH N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDF-----------IFDVTRSKFLDWSKRCQIIGG 394
V L+G CT ++I EY L +F +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A+G+ +L + IHRD+ A NVLL N KI DFG+AR ++N +V
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKG 224
Query: 455 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509
+M PE D +++V+SDV+S+G+L+ EI
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------------------ 260
Query: 510 WIEERPVELINKSLGGS-Y----SLSEVLRCIQVG-----------------LLCVQQRP 547
SLG + Y S+ + ++ G C P
Sbjct: 261 ------------SLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 308
Query: 548 EDRPNMSSVVLML 560
RP + L
Sbjct: 309 THRPTFQQICSFL 321
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 25/201 (12%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
+G+G FG V G G ++A K + + + F E ++ +L+H NLV+L+G
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 352 CTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
+ ++ EY+ SL D++ L + + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------YMPPEYAI 464
+HRDL A NVL+ + K+SDFG+ + + + + PE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAPEALR 187
Query: 465 DGLFSVKSDVFSFGVLVLEIV 485
+ FS KSDV+SFG+L+ EI
Sbjct: 188 EKKFSTKSDVWSFGILLWEIY 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 80/322 (24%), Positives = 130/322 (40%), Gaps = 64/322 (19%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQE-----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNL 345
+ +G G FG VYKG+L +A K L + + +F E ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
++L G ++ M+I EY+ N +L+ F+ + + ++ GIA G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY--MPPEYA 463
+ + +HRDL A N+L+++ + K+SDFG++R D EA G PE
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAI 222
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
F+ SDV+SFG+++ E++ G ERP
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT----------------YG--------ERPYW------ 252
Query: 524 GGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLSGERSL 566
S EV++ I G + C QQ RP + +V +L
Sbjct: 253 --ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
Query: 567 PQP-KQPGFFTERNPPESGSSS 587
P K F R S+S
Sbjct: 311 PDSLKTLADFDPRVSIRLPSTS 332
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 294 KLGEGGFGPVYKGVL-IEGQEI--AAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLVKL 348
+LG G FG V KG ++ A K L + +E E ++ +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
IG C + ML+ E LN + + +++ + +++ ++ G+ YL
Sbjct: 84 IGICEA-ESWMLVMEMAELGPLNKY---LQQNRHVKDKNIIELVHQVSMGMKYL---EES 136
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEYA 463
+HRDL A NVLL + KISDFG+++A D+ T+G P PE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 192
Query: 464 IDGLFSVKSDVFSFGVLVLEIV 485
FS KSDV+SFGVL+ E
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAF 214
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 64/311 (20%), Positives = 111/311 (35%), Gaps = 85/311 (27%)
Query: 292 KNKLGEGGFGPVYKGVLI----EGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNL 345
LG+G FG V + L ++A K L + +EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 346 VKLIGCCTQRDER------MLIYEYLPNKSLNDFIFD---VTRSKFLDWSKRCQIIGGIA 396
KL+G + + M+I ++ + L+ F+ L + + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
G+ YL S IHRDL A N +L +M ++DFG++R + R G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR-QGCAS 199
Query: 457 -----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511
++ E D L++V SDV++FGV + EI+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM-------------------------- 233
Query: 512 EERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDR 550
+ G + +E+ + G C P+ R
Sbjct: 234 ----------TRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283
Query: 551 PNMSSVVLMLS 561
P+ + + + L
Sbjct: 284 PSFTCLRMELE 294
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-40
Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 64/291 (21%)
Query: 293 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
+KLG G +G VY+GV +A K L K +EEF E ++ +++H NLV+L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
CT+ +I E++ +L D++ + R + + + I+ + YL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 412 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 471
HR+L A N L+ K++DFG++R D A+ + PE FS+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399
Query: 472 SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS----Y 527
SDV++FGVL+ EI + G S
Sbjct: 400 SDVWAFGVLLWEIA------------------------------------TYGMSPYPGI 423
Query: 528 SLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
LS+V ++ C Q P DRP+ + +
Sbjct: 424 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 78/302 (25%)
Query: 293 NKLGEGGFGPVYKGVLIEG----QEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 347
+G G FG VY G L++ A K L++ + + +F E +++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 348 LIGCCTQRDE-RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
L+G C + + +++ Y+ + L +FI + + +A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------YMPP 460
+ +HRDL A N +LD + K++DFG+AR D + + V G +M
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
E F+ KSDV+SFGVL+ E++
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELM----------------------------------- 290
Query: 521 KSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLM 559
+ G + ++ + G L C + E RP+ S +V
Sbjct: 291 -TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349
Query: 560 LS 561
+S
Sbjct: 350 IS 351
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQE---IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 347
+LG G FG V +GV ++ +A K L + + EE E ++ +L + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
LIG C + ML+ E L+ F+ V + + + S +++ ++ G+ YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEY 462
+HRDL A NVLL N KISDFG+++A G D + + G P PE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPEC 184
Query: 463 AIDGLFSVKSDVFSFGVLVLEIV 485
FS +SDV+S+GV + E +
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEAL 207
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQE----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLV 346
+G G FG V G L + +A K L + + +F E ++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L G T+ M++ EY+ N SL+ F+ + ++ GIA G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYA 463
+ +HRDL A N+L+++ + K+SDFG+ R D A T R G + PE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAI 222
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
F+ SDV+S+G+++ E++ G ERP
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS----------------YG--------ERPYW------ 252
Query: 524 GGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
S +V++ + G L C Q+ +RP +V +L
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 67/197 (34%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
+LG G FG V+ G ++A K L K + F E L+ +LQH+ LV+L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
TQ + +I EY+ N SL DF+ L +K + IA G+ ++ I
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 412 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLF 468
HRDL+A+N+L+ + ++ KI+DFG+AR ++ A G + PE G F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187
Query: 469 SVKSDVFSFGVLVLEIV 485
++KSDV+SFG+L+ EIV
Sbjct: 188 TIKSDVWSFGILLTEIV 204
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 60/206 (29%), Positives = 85/206 (41%), Gaps = 26/206 (12%)
Query: 294 KLGEGGFGPVYKGVL--IEGQEI--AAKRL---SKSSGQGMEEFENEVLLIAKLQHRNLV 346
KLG+G FG V +G G+ + A K L S + M++F EV + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLLYL 402
+L G ++ E P SL D + ++ +A G+ YL
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYL 137
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMP 459
R IHRDL A N+LL KI DFG+ RA + + +
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIV 485
PE FS SD + FGV + E+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 66/294 (22%), Positives = 106/294 (36%), Gaps = 74/294 (25%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
+G+G FG V G G ++A K + + + F E ++ +L+H NLV+L+G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 352 CTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
+ ++ EY+ SL D++ R L + + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY--MPPEYAIDGLF 468
+HRDL A NVL+ + K+SDFG+ + EA++ + G PE + F
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 469 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS-- 526
S KSDV+SFG+L+ EI S G
Sbjct: 364 STKSDVWSFGILLWEIY------------------------------------SFGRVPY 387
Query: 527 --YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
L +V+ ++ G C RP + L
Sbjct: 388 PRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 73/318 (22%), Positives = 113/318 (35%), Gaps = 93/318 (29%)
Query: 292 KNKLGEGGFGPVYKGVLI------EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKL-QHR 343
LG G FG V + + +A K L ++ +E+ ++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 344 NLVKLIGCCTQRDE-RMLIYEYLPNKSLNDF-------------IFDVTRSKFLDWSKRC 389
N+V L+G CT+ M+I E+ +L+ + + FL
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 390 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449
+A+G+ +L + + IHRDL A N+LL + KI DFG+AR D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDY 204
Query: 450 RVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 504
+M PE D +++++SDV+SFGVL+ EI
Sbjct: 205 V-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------------------- 244
Query: 505 HAWRLWIEERPVELINKSLGGS-Y----SLSEVLRCIQVG-----------------LLC 542
SLG S Y E R ++ G L C
Sbjct: 245 -----------------SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 543 VQQRPEDRPNMSSVVLML 560
P RP S +V L
Sbjct: 288 WHGEPSQRPTFSELVEHL 305
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 64/290 (22%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
KLG+G FG V+ G +A K L K E F E ++ KL+H LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
++ + ++ EY+ SL DF+ K+L + + IA G+ Y+ R+ +H
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 472
RDL+A+N+L+ + K++DFG+AR ++ A + PE A+ G F++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362
Query: 473 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS----YS 528
DV+SFG+L+ E+ + G
Sbjct: 363 DVWSFGILLTELT------------------------------------TKGRVPYPGMV 386
Query: 529 LSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
EVL ++ G C ++ PE+RP + L
Sbjct: 387 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 4e-39
Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 64/290 (22%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
KLG+G FG V+ G +A K L K E F E ++ KL+H LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
++ + ++ EY+ SL DF+ K+L + + IA G+ Y+ R+ +H
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 472
RDL+A+N+L+ + K++DFG+AR ++ A + PE A+ G F++KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445
Query: 473 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS----YS 528
DV+SFG+L+ E+ + G
Sbjct: 446 DVWSFGILLTELT------------------------------------TKGRVPYPGMV 469
Query: 529 LSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 561
EVL ++ G C ++ PE+RP + L
Sbjct: 470 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 66/306 (21%), Positives = 110/306 (35%), Gaps = 89/306 (29%)
Query: 292 KNKLGEGGFGPVYKGVLI--EGQEI--AAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLV 346
LGEG FG VY+GV +G++I A K K + E+F +E +++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLLYL 402
KLIG + + +I E P L ++ + + +S I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMAYL 129
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------ 456
+ +HRD+ N+L+ + K+ DFG++R + +
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-------VTRLPIK 179
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516
+M PE F+ SDV+ F V + EI+
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEIL------------------------------- 208
Query: 517 ELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSS 555
S G +V+ ++ G C P DRP +
Sbjct: 209 -----SFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTE 263
Query: 556 VVLMLS 561
+V LS
Sbjct: 264 LVCSLS 269
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 69/325 (21%), Positives = 110/325 (33%), Gaps = 96/325 (29%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAK 339
S LG G FG V + +A K L S E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 340 L-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG---- 394
L H N+V L+G CT ++I EY L +F+ S + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 395 -----------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGID 442
+A+G+ +L + IHRDL A N+LL + KI DFG+AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 443 QTEANTN-----RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 497
N + +M PE + +++ +SDV+S+G+ + E+
Sbjct: 200 NYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELF------------ 241
Query: 498 HHHNLLGHAWRLWIEERPVELINKSLGGS-Y----SLSEVLRCIQVG------------- 539
SLG S Y S+ + I+ G
Sbjct: 242 ------------------------SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEM 277
Query: 540 ----LLCVQQRPEDRPNMSSVVLML 560
C P RP +V ++
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 74/375 (19%), Positives = 123/375 (32%), Gaps = 104/375 (27%)
Query: 242 YLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFG 301
Y + R+ Q + ++ + E EN LG G FG
Sbjct: 3 YKKQFRYESQLQM-VQVTGSSDNEYFYVDFREYEYDLKWEFPR--ENLEFGKVLGSGAFG 59
Query: 302 PVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT 353
V ++A K L + E +E+ ++ +L H N+V L+G CT
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 354 QRDERMLIYEYLPNKSLNDF------IFDVTRSKFLDWSKRCQIIGG------------- 394
LI+EY L ++ F ++ + + +
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 395 -IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTN--- 449
+A+G+ +L +HRDL A NVL+ + KI DFG+AR N
Sbjct: 180 QVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 450 --RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507
+ +M PE +G++++KSDV+S+G+L+ EI
Sbjct: 237 PVK------WMAPESLFEGIYTIKSDVWSYGILLWEIF---------------------- 268
Query: 508 RLWIEERPVELINKSLGGS-Y----SLSEVLRCIQVG-----------------LLCVQQ 545
SLG + Y + + IQ G C
Sbjct: 269 --------------SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 314
Query: 546 RPEDRPNMSSVVLML 560
RP+ ++ L
Sbjct: 315 DSRKRPSFPNLTSFL 329
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 64/312 (20%), Positives = 110/312 (35%), Gaps = 87/312 (27%)
Query: 294 KLGEGGFGPVYKGVLI--EGQEI--AAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVKL 348
+GEG FG V++G+ + E + A K +S E+F E L + + H ++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
IG T+ + +I E L F+ + + + + ++ ++ L YL
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY------QLSTALAYL-- 132
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-----RVVGTYGYMP 459
R +HRD+ A NVL+ + K+ DFG++R + + +M
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMA 185
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519
PE F+ SDV+ FGV + EI+
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEIL---------------------------------- 211
Query: 520 NKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVL 558
G ++V+ I+ G C P RP + +
Sbjct: 212 --MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269
Query: 559 MLSGERSLPQPK 570
LS + +
Sbjct: 270 QLSTILEEEKAQ 281
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVK 347
+LG G FG V +GV ++ +A K L + EE E ++ +L + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 348 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 407
LIG C + ML+ E L+ F+ V + + + S +++ ++ G+ YL
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEY 462
+HR+L A NVLL N KISDFG+++A G D + + G P PE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPEC 510
Query: 463 AIDGLFSVKSDVFSFGVLVLEIV 485
FS +SDV+S+GV + E +
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEAL 533
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 68/289 (23%), Positives = 120/289 (41%), Gaps = 53/289 (18%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
+F + +G GGFG V+K I+G+ KR+ ++ E+ E EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 346 VKLIGCCTQRDERM----------------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 389
V GC D + E+ +L +I + R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 390 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 449
++ I +G+ Y+H ++I+RDLK SN+ L + KI DFG+ + + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509
R GT YM PE + + D+++ G+++ E++ A
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFF------ 228
Query: 510 WIEERPVELINKSLGGSYS--LSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
+L + + + +L+ + ++PEDRPN S +
Sbjct: 229 ------TDLRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 61/273 (22%), Positives = 115/273 (42%), Gaps = 25/273 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHR 343
E + K+GEG FG +G++ K +S+ S + EE EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
N+V+ + ++ +Y L I + + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVH 142
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
+I+HRD+K+ N+ L + ++ DFG+AR A +GT Y+ PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+ ++ KSD+++ G ++ E+ K + A NL+ I ++
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLVLK-----IISGSFPPVSLHY 249
Query: 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
SY L ++ ++ P DRP+++S+
Sbjct: 250 --SYDLRSLVS------QLFKRNPRDRPSVNSI 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 74/352 (21%), Positives = 124/352 (35%), Gaps = 71/352 (20%)
Query: 245 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVY 304
+++ + S DY + + E+ +P I E +GEG FG V+
Sbjct: 350 EKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR--ERIELGRCIGEGQFGDVH 407
Query: 305 KGVLI--EGQEI--AAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359
+G+ + E + A K + +S E+F E L + + H ++VKLIG T+ +
Sbjct: 408 QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466
Query: 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419
+I E L F+ R LD + ++ L YL R +HRD+ A N
Sbjct: 467 IIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARN 521
Query: 420 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 479
VL+ + K+ DFG++R + + +M PE F+ SDV+ FGV
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGV 580
Query: 480 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRC 535
+ EI+ G ++V+
Sbjct: 581 CMWEIL------------------------------------MHGVKPFQGVKNNDVIGR 604
Query: 536 IQVG-----------------LLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 570
I+ G C P RP + + LS + +
Sbjct: 605 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 344
+S ++G GG V++ + + Q A K ++ Q ++ + NE+ + KLQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 345 L--VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
++L ++ E N LN ++ + K +D +R + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE- 461
HQ I+H DLK +N L+ + K+ DFG+A D T + VGT YMPPE
Sbjct: 144 HQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 462 ----------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
S KSDV+S G ++ + GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-37
Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 38/245 (15%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 344
+F + LG+G FG V K ++ + A K++ + + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 345 LVKLIGC----------CTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQI 391
+V+ T ++ ++ EY N +L D I + + + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF------------ 439
I L Y+H IIHRDLK N+ +D N KI DFG+A+
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 440 GIDQTEANTNRVVGTYGYMPPE-YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
+ + N +GT Y+ E G ++ K D++S G++ E++ F
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFSTGME 233
Query: 499 HHNLL 503
N+L
Sbjct: 234 RVNIL 238
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 63/327 (19%), Positives = 114/327 (34%), Gaps = 58/327 (17%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRN 344
+F LG GGFG V++ ++ A KR+ E+ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 345 LVKLIGC---------CTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQII 392
+V+ ++ +Y + ++L D++ + + S I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV- 451
IA + +LH ++HRDLK SN+ + K+ DFG+ A D+ E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 452 ---------VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 502
VGT YM PE +S K D+FS G+++ E++ F
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PFSTQMERVRT 236
Query: 503 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562
L + + +++ + P +RP +++
Sbjct: 237 LTD-----VRNLKFPPLFTQK--YPCEYVMVQ------DMLSPSPMERPEAINII----- 278
Query: 563 ERSLPQPKQPGFFTERNPPESGSSSSK 589
+ F + + P +
Sbjct: 279 -------ENA-VFEDLDFPGKTVLRQR 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNL--VKL 348
++G GG V++ + + Q A K ++ Q ++ + NE+ + KLQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
++ E N LN ++ + K +D +R + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------- 461
I+H DLK +N L+ + K+ DFG+A D T + VGT YMPPE
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 462 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
S KSDV+S G ++ + GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 350
++G G F VYKG+ E+A + K + + F+ E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 351 CC--TQRDERML--IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
T + ++ + + E + + +L ++ R K + I +GL +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 407 RLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
IIHRDLK N+ + + KI D G+A + + V+GT +M PE +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YE 203
Query: 466 GLFSVKSDVFSFGVLVLEIVCGK 488
+ DV++FG+ +LE+ +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE 226
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 36/283 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 343
E++ +G G +G K +G+ + K L + + +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 344 NLVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLL 400
N+V+ R L + EY L I T+ + +LD +++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 401 YLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
H+ D ++HRDLK +NV LD + N K+ DFG+AR D + A T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
PE ++ KSD++S G L+ E+ F EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTAFSQK-----------------EL 224
Query: 519 INKSLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
K G + S+ L I +L ++ RP++ +
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLK--DYHRPSVEEI 265
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 29/235 (12%)
Query: 264 DRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS 322
D + E + + D+ LG+G +G VY G + IA K + +
Sbjct: 9 DCESDLLEYDYEYDENG----------DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER 58
Query: 323 SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF 382
+ + E+ L L+H+N+V+ +G ++ + E +P SL+ + RSK+
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL----RSKW 114
Query: 383 LDWSKRCQIIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMAR 437
Q IG + GL YLH + +I+HRD+K NVL++ KISDFG ++
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171
Query: 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKR 489
+ T GT YM PE ID + +D++S G ++E+ GK
Sbjct: 172 R--LAGINPCTETFTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRL---SKSSGQGMEEFENEVLLIAKLQH 342
NF + K+G G F VY+ L++G +A K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGLLY 401
N++K + +E ++ E L+ I + + + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
+H R++HRD+K +NV + K+ D G+ R F T A++ +VGT YM PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521
+ ++ KSD++S G L+ E+ + ++ D + L K
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN--------------LYSLCKK 249
Query: 522 SLGGSYS------LSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
Y SE LR Q+ +C+ PE RP+++ V
Sbjct: 250 IEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYV 288
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNL--VKL 348
++G GG V++ + + Q A K ++ Q ++ + NE+ + KLQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
++ E N LN ++ + K +D +R + + +HQ
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------- 461
I+H DLK +N L+ + K+ DFG+A D T + VG YMPPE
Sbjct: 175 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 462 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
S KSDV+S G ++ + GK
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 66/309 (21%), Positives = 115/309 (37%), Gaps = 48/309 (15%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
+++ KLGEGGF V L +G A KR+ Q EE + E + H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 346 VKLIGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLL 400
++L+ C + L+ + +L + I + FL + ++ GI RGL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV-------G 453
+H HRDLK +N+LL +E P + D G I + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 454 TYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509
T Y PE + ++DV+S G ++ ++ G+ G
Sbjct: 206 TISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKG----- 253
Query: 510 WIEERPVELINKSLGGSYSL------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563
+ + ++ S+ S L + ++ V P RP++ ++ L
Sbjct: 254 -------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVD--PHQRPHIPLLLSQLEAL 304
Query: 564 RSLPQPKQP 572
+ P P Q
Sbjct: 305 QP-PAPGQH 312
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEE-FENEVLLIAKLQHRNLVKLIG 350
LG+GGF ++ + + A K + KS E E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYLHQDSR 407
D ++ E +SL + R + R QI+ G YLH+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLG----CQYLHR--- 159
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 467
R+IHRDLK N+ L+ ++ KI DFG+A D + GT Y+ PE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217
Query: 468 FSVKSDVFSFGVLVLEIVCGK 488
S + DV+S G ++ ++ GK
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEE-FENEVLLIAKLQHRNLVKLIG 350
LG+GGF ++ + + A K + KS E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYLHQDSR 407
D ++ E +SL + R + R QI+ G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLG----CQYLH---R 133
Query: 408 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 467
R+IHRDLK N+ L+ ++ KI DFG+A D + GT Y+ PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191
Query: 468 FSVKSDVFSFGVLVLEIVCGK 488
S + DV+S G ++ ++ GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 55/251 (21%), Positives = 101/251 (40%), Gaps = 27/251 (10%)
Query: 245 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVY 304
+ R +T+ + + ++ + W + + ++G G FG V+
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHW---------MTHQPRVGRGSFGEVH 75
Query: 305 KGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363
+ + G + A K++ + E++ A L +V L G + + E
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423
L SL I + L + +G GL YLH RI+H D+KA NVLL
Sbjct: 131 LLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLS 184
Query: 424 NEMNP-KISDFGMAR---AFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFG 478
++ + + DFG A G+ ++ + + GT +M PE + G K D++S
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSC 243
Query: 479 VLVLEIVCGKR 489
++L ++ G
Sbjct: 244 CMMLHMLNGCH 254
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 61/272 (22%), Positives = 101/272 (37%), Gaps = 38/272 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE--NEVLLIAKL-QH 342
++F ++LG G +G V+K +G+ A KR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 343 RNLVKLIGCCTQRDERMLIY-EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
V+L + + + E SL L ++ + L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAH 172
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH ++H D+K +N+ L K+ DFG+ G G YM PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEV--QEGDPRYMAPE 226
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521
+ G + +DVFS G+ +LE+ C H G W+ +L
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME--------LPHG--GEGWQ--------QLRQG 267
Query: 522 SLGGSYS--LSEVLRCIQVGLLCVQQRPEDRP 551
L ++ LS LR V ++ ++ P+ R
Sbjct: 268 YLPPEFTAGLSSELR--SVLVMMLEPDPKLRA 297
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 60/244 (24%), Positives = 109/244 (44%), Gaps = 11/244 (4%)
Query: 247 RHRKQGKTDGSSKLDYNDRGN-REEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYK 305
H D ++ Y G E+ + + + + K+GEG G V
Sbjct: 4 HHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCL 63
Query: 306 GVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364
G+++A K + Q E NEV+++ QH N+V++ +E ++ E+
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 424
L +L D + L+ + + + + L YLH +IHRD+K+ ++LL
Sbjct: 124 LQGGALTD----IVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176
Query: 425 EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+ K+SDFG I + +VGT +M PE L++ + D++S G++V+E+
Sbjct: 177 DGRVKLSDFGFCAQ--ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 485 VCGK 488
V G+
Sbjct: 235 VDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 54/204 (26%), Positives = 105/204 (51%), Gaps = 10/204 (4%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 344
+ ++ K+G+G G VY + + GQE+A ++++ E NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+V + DE ++ EYL SL D V +D + + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ ++IHRD+K+ N+LL + + K++DFG I ++ + +VGT +M PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGK 488
+ K D++S G++ +E++ G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 22/221 (9%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQ 341
+ + + LG+G V++G + G A K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 342 HRNLVKLIGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 399
H+N+VKL + R LI E+ P SL + + + + L S+ ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 400 LYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
+L + I+HR++K N++ D + K++DFG AR D + + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 456 GYMPPE--------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y+ P+ + D++S GV G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 71/331 (21%), Positives = 116/331 (35%), Gaps = 64/331 (19%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGC 351
L EGGF VY+ + G+E A KRL + + EV + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 352 CTQRDERM-------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+ E L+ L L +F+ + L +I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR----------VVGT 454
+ IIHRDLK N+LL N+ K+ DFG A + + + T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 455 YGYMPPEYAIDGLFSV--------KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506
Y PE + + K D+++ G ++ + + H L
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HPFEDGAKL--- 259
Query: 507 WRLWIEERPVELINKSLGGSYSL------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+ + G YS+ V + +L V PE+R +++ VV L
Sbjct: 260 --------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVHQL 303
Query: 561 SGERSLPQPKQPGFFTERNPPESGSSSSKRS 591
+ TE G S+ S
Sbjct: 304 QEIAAARNVNPKSPITELLEQNGGYGSATLS 334
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEE-FENEVLLIAKLQHRNLVKLIG 350
LG+G F VY+ I G E+A K + K + GM + +NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
+ L+ E N +N ++ R K ++ + I G+LYLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLH---SHGI 133
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMPPEYAIDGL 467
+HRDL SN+LL MN KI+DFG+A Q + + + GT Y+ PE A
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 468 FSVKSDVFSFGVLVLEIVCGK 488
++SDV+S G + ++ G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEV-LLIAKLQHRNLV 346
+F K+ LG G G + + + +++A KR+ + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+ R + + E +L +++ + + ++ GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 407 RLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAFGIDQTE-ANTNRVVGTYGYMPP 460
L I+HRDLK N+L+ ++ ISDFG+ + + + + + V GT G++ P
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 461 EY---AIDGLFSVKSDVFSFGVLVLEIVCG 487
E + D+FS G + ++
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 344
E + +LG+G FG VYK E G AAK + S + +E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+VKL+G + ++ E+ P +++ + + + L + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--- 461
RIIHRDLKA NVL+ E + +++DFG++ +T + +GT +M PE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 462 --YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
D + K+D++S G+ ++E+ +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 22/221 (9%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQ 341
+ + + LG+G V++G + G A K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 342 HRNLVKLIGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 399
H+N+VKL + R LI E+ P SL + + + + L S+ ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 400 LYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
+L + I+HR++K N++ D + K++DFG AR D + + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 456 GYMPPE--------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y+ P+ + D++S GV G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 57/294 (19%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKR--LSKSSGQGMEEFENEVLLIAKL-Q 341
T F + K+G G FG V+K V ++G A KR + + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 342 HRNLVKLIGCCTQRDERMLIY-EYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGL 399
H ++V+ + D MLI EY SL D I + R + ++ ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMARAFG 440
Y+H ++H D+K SN+ + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFS--VKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
Q E G ++ E + ++ K+D+F+ + V+ +
Sbjct: 186 SPQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE---------- 228
Query: 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 552
G W + R + S +E+L+ + + PE RP+
Sbjct: 229 PLPRNGDQWHEIRQGRLPRIPQVL---SQEFTELLK------VMIHPDPERRPS 273
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 10/204 (4%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 344
E F KLGEG +G VYK + E GQ +A K++ ++E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+VK G + + ++ EY S++D I R+K L + I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
R IHRD+KA N+LL+ E + K++DFG+A + T A N V+GT +M PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGK 488
+ ++ +D++S G+ +E+ GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 283 ANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS-KSSGQGMEEFENEVLLIAKL 340
A+ E F+ K+G+G FG V+KG+ + +A K + + + +E+ + E+ ++++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
+ K G + + +I EYL S D + LD ++ I+ I +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD----LLEPGPLDETQIATILREILKGLD 133
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
YLH + + IHRD+KA+NVLL K++DFG+A + T+ N VGT +M P
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAP 188
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
E + K+D++S G+ +E+ G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE----FENEVLLIAKLQHRNLVKL 348
KLG GG VY I ++A K + + EE FE EV ++L H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
I + D L+ EY+ +L+++I L I G+ + H +
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 409 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 468
RI+HRD+K N+L+D+ KI DFG+A+A + + TN V+GT Y PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 469 SVKSDVFSFGVLVLEIVCGKR 489
+D++S G+++ E++ G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNL 345
+ K +LG GGFG V + + + G+++A K+ + E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 346 VKLI------GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 399
V D +L EY L ++ L ++ I+ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 400 LYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
YLH+ RIIHRDLK N++L + KI D G A+ VGT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQ 188
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 489
Y+ PE ++V D +SFG L E + G R
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 18/234 (7%)
Query: 267 NREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG 326
+ L D A+ + F +G G +G VYKG ++ ++AA ++ +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 327 MEEFENEVLLIAKL-QHRNLVKLIGC------CTQRDERMLIYEYLPNKSLNDFIFDVTR 379
EE + E+ ++ K HRN+ G D+ L+ E+ S+ D + T+
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTK 122
Query: 380 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439
L I I RGL +LHQ ++IHRD+K NVLL K+ DFG++
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-- 177
Query: 440 GIDQTEANTNRVVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+D+T N +GT +M PE D + KSD++S G+ +E+ G
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 57/291 (19%), Positives = 101/291 (34%), Gaps = 51/291 (17%)
Query: 294 KLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLVKL-- 348
+ GG G +Y + + G+ + K L S + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 349 IGCCTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
T R + Y EY+ +SL L ++ + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
+ +++ DLK N++L E K+ D G I+ + GT G+ PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSF----GYLYGTPGFQAPEIV-R 250
Query: 466 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525
+V +D+++ G + + + + L E+ PV S
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLP---TRNGRYVDGL--------PEDDPVLKTYDSY-- 297
Query: 526 SYSLSEVLRCIQVGLLCVQQRPEDRPN----MSSVVLMLSGERSLPQPKQP 572
L + R I P R MS+ + + E P
Sbjct: 298 -GRL--LRRAI-------DPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 55/237 (23%), Positives = 86/237 (36%), Gaps = 38/237 (16%)
Query: 282 IANATENFSD----KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEV-LL 336
I N ++ + + LG G G V +G+ +A KR+ + E+ LL
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLL 62
Query: 337 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQII 392
H N+++ T + E N +L D + K ++
Sbjct: 63 TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-------------KISDFGMARAF 439
IA G+ +LH L+IIHRDLK N+L+ ISDFG+ +
Sbjct: 122 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 440 GIDQT--EANTNRVVGTYGYMPPEYAIDGLFSV-------KSDVFSFGVLVLEIVCG 487
Q+ N N GT G+ PE + D+FS G + I+
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 34/222 (15%), Positives = 67/222 (30%), Gaps = 22/222 (9%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK 339
++ + LGEG F VY+ Q+ K ++ + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIAR 397
+K ++ +L+ E +L + I + T K + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-----------KISDFGMARAFGIDQTEA 446
+ +H IIH D+K N +L N + D G + +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
T G+ E + ++ + D F V ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-29
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 280 MAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFEN 332
M I + + S+ KLG G +G V E A K + K+ S +
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 333 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQ 390
EV ++ L H N++KL + L+ E L D I + R KF ++
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKF---NEVDAAV 140
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEAN 447
II + G+ YLH+ I+HRDLK N+LL++ + KI DFG++ F +
Sbjct: 141 IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--- 194
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 489
+GT Y+ PE + + K DV+S GV++ ++ G
Sbjct: 195 MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE----FENEVLLIAKLQHRNLVKL 348
LG GG V+ L + +++A K L ++ F E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 349 --IGCCTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
G + L Y EY+ +L D + + + ++I + L + H
Sbjct: 78 YDTGE-AETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID-QTEANTNRVVGTYGYMPPEY 462
+ IIHRD+K +N+++ K+ DFG+ARA + T V+GT Y+ PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKR 489
A +SDV+S G ++ E++ G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 61/323 (18%), Positives = 128/323 (39%), Gaps = 39/323 (12%)
Query: 259 KLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKR 318
+L+ +++ + E L + ++F ++LG G G V+K + A++
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 319 L--SKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD 376
L + + E+ ++ + +V G E + E++ SL+ +
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-- 122
Query: 377 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436
++ + ++ + +GL YL + +I+HRD+K SN+L+++ K+ DFG++
Sbjct: 123 -KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-------- 488
+ + AN+ VGT YM PE +SV+SD++S G+ ++E+ G+
Sbjct: 180 G--QLIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 489 -RNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGL------- 540
+ + R RP+ ++ E+L I
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
Query: 541 -----------LCVQQRPEDRPN 552
C+ + P +R +
Sbjct: 296 VFSLEFQDFVNKCLIKNPAERAD 318
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEE-FENEVLLIAKLQH 342
E+F LG+G FG VY + +A K L K+ G+E EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N+++L G LI EY P ++ + SKF + I +A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSYC 125
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMP 459
H R+IHRD+K N+LL + KI+DFG + A ++R + GT Y+P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLP 175
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE + K D++S GVL E + GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 28/186 (15%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--------EVLLIA 338
E + K+GEG +G VYK +G+ +A KR+ ++ + E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGI 395
+L H N+V LI L++E++ K L + D ++ D + Q++
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLYQLL--- 129
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
RG+ + HQ RI+HRDLK N+L++++ K++DFG+ARAFGI + T+ VV T
Sbjct: 130 -RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TL 183
Query: 456 GYMPPE 461
Y P+
Sbjct: 184 WYRAPD 189
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 25/221 (11%)
Query: 280 MAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFE 331
M + ++T FSD+ LG+G FG V GQE A K +SK E
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 332 NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--C 389
EV L+ +L H N++KL + L+ E L D I ++R +F S+
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRF---SEVDAA 129
Query: 390 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEA 446
+II + G+ Y+H+ +I+HRDLK N+LL++ + N +I DFG++ F +
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-- 184
Query: 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
+GT Y+ PE + G + K DV+S GV++ ++ G
Sbjct: 185 -MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 52/188 (27%), Positives = 91/188 (48%), Gaps = 21/188 (11%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-------EVL 335
+++ F KLG G + VYKG+ G +A K + ++ E E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK------LDSEEGTPSTAIREIS 55
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRCQIIG 393
L+ +L+H N+V+L ++ L++E++ N K D + L+ +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
+ +GL + H++ +I+HRDLK N+L++ K+ DFG+ARAFGI ++ VV
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV- 170
Query: 454 TYGYMPPE 461
T Y P+
Sbjct: 171 TLWYRAPD 178
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 22/184 (11%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN--------EVLLI 337
ENF K+GEG +G VYK G+ +A K++ ++ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 338 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 397
+L H N+VKL+ ++ L++E+L + L F+ D + + + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQ 114
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
GL + H R++HRDLK N+L++ E K++DFG+ARAFG+ T+ VV T Y
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWY 169
Query: 458 MPPE 461
PE
Sbjct: 170 RAPE 173
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 54/243 (22%), Positives = 100/243 (41%), Gaps = 11/243 (4%)
Query: 248 HRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV 307
+ +GK DG DY+ + +P + + + + +LG G FG V++ V
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 308 LIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366
G+ AK ++ +NE+ ++ +L H L+ L + E +LI E+L
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 426
L D I + ++ + GL ++H+ I+H D+K N++ + +
Sbjct: 132 GGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKK 186
Query: 427 NP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
KI DFG+A D+ T + PE +D+++ GVL +
Sbjct: 187 ASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 243
Query: 485 VCG 487
+ G
Sbjct: 244 LSG 246
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 20/232 (8%)
Query: 265 RGNREEEMELP-IFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS-- 320
G R ++ P + + + + FSD ++G G FG VY + + +A K++S
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90
Query: 321 -KSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR 379
K S + ++ EV + KL+H N ++ GC + L+ EY S +D +
Sbjct: 91 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVH 147
Query: 380 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439
K L + + G +GL YLH +IHRD+KA N+LL K+ DFG A
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204
Query: 440 GIDQTEANTNRVVGTYGYMPPE---YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
AN+ VGT +M PE +G + K DV+S G+ +E+ K
Sbjct: 205 ----APANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-28
Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
+ + N +G G +G V V AAK++ K + ++ F+ E+ ++ L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARG 398
H N+++L + L+ E L + + V + F + +I+ +
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVF---RESDAARIMKDVLSA 118
Query: 399 LLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
+ Y H+ L + HRDLK N L + K+ DFG+A F + VGT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTP 172
Query: 456 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
Y+ P+ ++GL+ + D +S GV++ ++CG
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 26/230 (11%), Positives = 53/230 (23%), Gaps = 45/230 (19%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIG 350
L G V+ +E ++ A K + S +E A+L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 351 CC--------------------------TQRDERMLIYEYLPNKSLNDFI----FDVTRS 380
+L+ + L F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFR 188
Query: 381 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440
+ + R L ++H N+ + + + D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 441 IDQTEANTNRVVGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y P E+ A F+ + + G+ + + C
Sbjct: 246 -----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 28/186 (15%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--------EVLLIA 338
E + K+GEG +G VYK G+ A K++ +E+ + E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGI 395
+L+H N+VKL + +L++E+L + L + DV + + Q++
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL-DVCEGGLESVTAKSFLLQLL--- 110
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
G+ Y H R++HRDLK N+L++ E KI+DFG+ARAFGI T+ +V T
Sbjct: 111 -NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TL 164
Query: 456 GYMPPE 461
Y P+
Sbjct: 165 WYRAPD 170
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 45/333 (13%), Positives = 89/333 (26%), Gaps = 68/333 (20%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH-------- 342
LG+ + G+ + +++ + EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 343 --------RNLVKLIGCCT-----QRDERMLIYEY-----LPNKSLNDFIF----DVTRS 380
+LVK + M + +L F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 381 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440
K L R Q+ + R L LH ++H L+ +++LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 441 IDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 495
+ R L + D ++ G+ + I C
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-------- 313
Query: 496 ADHHHNLLGHAWRL-WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMS 554
L ++ + ++ + +R + G L + EDR
Sbjct: 314 ------------DLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPL 359
Query: 555 SVVL--MLSGERSLPQPKQPGFFTERNPPESGS 585
+ R+ P + T+ P G
Sbjct: 360 QAMETPEYEQLRTELSAALPLYQTDGEPTREGG 392
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 51/189 (26%), Positives = 88/189 (46%), Gaps = 33/189 (17%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN--------EVLLI 337
+ + K+GEG +G V+K E EI A KR+ +++ + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 338 AKLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRC---QII 392
+L+H+N+V+L + L++E+ K FD + Q++
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY----FDSCNGDLDPEIVKSFLFQLL 111
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
+GL + H ++HRDLK N+L++ K+++FG+ARAFGI + VV
Sbjct: 112 ----KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV 163
Query: 453 GTYGYMPPE 461
T Y PP+
Sbjct: 164 -TLWYRPPD 171
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 44/203 (21%), Positives = 82/203 (40%), Gaps = 17/203 (8%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNLVKL- 348
+G GG G VY+ + + +A K +S++ + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 349 -IGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
G + D ++ + + L + R L + I+ I L H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
HRD+K N+L+ + + DFG+A A D+ VGT YM PE +
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 467 LFSVKSDVFSFGVLVLEIVCGKR 489
+ ++D+++ ++ E + G
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 35/221 (15%)
Query: 294 KLGEGGFGPVY---------------KGVLIEGQEIAAKRLSKSSGQGMEE-FENEVLLI 337
L +G F + K +L + ++ K S + + F+NE+ +I
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 338 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQII 392
+++ + G T DE +IYEY+ N S+ F D + F+ II
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
+ Y+H + I HRD+K SN+L+D K+SDFG + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----VDKKIKGSR 211
Query: 453 GTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
GTY +MPPE + +G K D++S G+ + +
Sbjct: 212 GTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIA 338
F+++ LG+G FG V K QE A K ++K+ + EV L+
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 396
KL H N++KL ++ E L D I + R +F S+ +II +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRF---SEHDAARIIKQVF 131
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVG 453
G+ Y+H+ I+HRDLK N+LL++ + + KI DFG++ F + +G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIG 185
Query: 454 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
T Y+ PE + G + K DV+S GV++ ++ G
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVL-----LIAKL 340
E+ D ++G G +G V K V GQ +A KR+ + E+ + ++L ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR--- 397
+V+ G + + + E + + S + F V LD +I+G I
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSV--LDDVIPEEILGKITLATV 135
Query: 398 -GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
L +L L+IIHRD+K SN+LLD N K+ DFG++ + + A T G
Sbjct: 136 KALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTR-DAGCRP 190
Query: 457 YMPPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
YM PE A + V+SDV+S G+ + E+ G+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 50/244 (20%), Positives = 99/244 (40%), Gaps = 11/244 (4%)
Query: 247 RHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKG 306
K + G+ +Y++ + P + + +++ +LG G FG V++
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176
Query: 307 VLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365
G AAK + E E+ ++ L+H LV L +E ++IYE++
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 425
L + + + + + + + +GL ++H+ +H DLK N++ +
Sbjct: 237 SGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTK 291
Query: 426 MNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 483
+ K+ DFG+ Q + GT + PE A +D++S GVL
Sbjct: 292 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 484 IVCG 487
++ G
Sbjct: 349 LLSG 352
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 56/185 (30%), Positives = 83/185 (44%), Gaps = 26/185 (14%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-------EVLLIA 338
E + +KLGEG + VYKG +A K + +E E EV L+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLK 55
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRCQIIGGIA 396
L+H N+V L L++EYL K D ++ + +
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-----DCGNIINMHNVKLFLFQLL 110
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
RGL Y H+ +++HRDLK N+L++ K++DFG+ARA I T+ N VV T
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLW 165
Query: 457 YMPPE 461
Y PP+
Sbjct: 166 YRPPD 170
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIA 338
F+++ LG+G FG V K QE A K ++K+ + EV L+
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 396
KL H N++KL ++ E L D I + R +F S+ +II +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRF---SEHDAARIIKQVF 131
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
G+ Y+H+ I+HRDLK N+LL + + + KI DFG++ F + +G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIG 185
Query: 454 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
T Y+ PE + G + K DV+S GV++ ++ G
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVL-----LIAKL 340
++ +LG G +G V K + GQ +A KR+ + + + +L + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTV 63
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC--QIIGGIAR- 397
V G + + + E + + SL+ F V + I+G IA
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKG-----QTIPEDILGKIAVS 117
Query: 398 ---GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
L +LH S+L +IHRD+K SNVL++ K+ DFG++ +D + + G
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGC 172
Query: 455 YGYMPPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
YM PE +SVKSD++S G+ ++E+ +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 17/212 (8%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAK 339
D KLG G FG V+ G E K ++K Q E E E+ ++
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARG 398
L H N++K+ ++ E L + I R K L +++ +
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
L Y H ++H+DLK N+L + KI DFG+A F D+ + GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190
Query: 456 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
YM PE + K D++S GV++ ++ G
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 50/196 (25%), Positives = 88/196 (44%), Gaps = 30/196 (15%)
Query: 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN------ 332
+ + + + + + LGEG F VYK Q +A K++ E ++
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTA 59
Query: 333 --EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKR 388
E+ L+ +L H N++ L+ + L+++++ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTPSHIK 115
Query: 389 C---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445
+ +GL YLHQ I+HRDLK +N+LLD K++DFG+A++FG
Sbjct: 116 AYMLMTL----QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNR 167
Query: 446 ANTNRVVGTYGYMPPE 461
A T++VV T Y PE
Sbjct: 168 AYTHQVV-TRWYRAPE 182
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQ 341
+++ + +G G V +++A KR++ + M+E E+ +++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK-RCQIIGGIAR--- 397
H N+V +DE L+ + L S+ D I + I I R
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 398 -GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA---RAFGIDQTEANTNRVVG 453
GL YLH++ IHRD+KA N+LL + + +I+DFG++ G VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 454 TYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
T +M PE Y K+D++SFG+ +E+ G
Sbjct: 189 TPCWMAPEVMEQVRGY------DFKADIWSFGITAIELATGA 224
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 43/200 (21%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN--------EVLLI 337
+ K+G+G FG V+K + + A K++ ME + E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 338 AKLQHRNLVKLIGCCTQRDERM--------LIYEYLPN--KSLNDFIFDVTRSKFLDWSK 387
L+H N+V LI C + L++++ + L KF
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTLSEI 126
Query: 388 RC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444
+ ++ GL Y+H++ +I+HRD+KA+NVL+ + K++DFG+ARAF + +
Sbjct: 127 KRVMQMLL----NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 445 EAN---TNRVVGTYGYMPPE 461
TNRVV T Y PPE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 43/311 (13%), Positives = 90/311 (28%), Gaps = 81/311 (26%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQ--------- 341
LG+ + E G+ + +++ + EVL + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 342 ----------------HRNLVKLIGCCTQRDERMLIY---EYLPNKSLNDF---IFDVTR 379
+ ++++ +RD +L +L F + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 380 -SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438
K L R Q+ + R L LH ++H L+ +++LD ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 439 FGIDQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLEIVCG 487
G + G+ PPE L + D ++ G+++ I C
Sbjct: 256 DGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 488 KRNRGFYHADHHHNLLGHAWRL-WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQR 546
L ++ + ++ + +R + G L
Sbjct: 310 --------------------DLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--P 347
Query: 547 PEDRPNMSSVV 557
EDR +
Sbjct: 348 KEDRLLPLQAM 358
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIA 338
+ FSD +LG+G F V + V G E AAK ++ S + ++ E E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 396
KLQH N+V+L + L+++ + L + I V R + S+ I I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFY---SEADASHCIQQIL 115
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVG 453
+ Y H I+HR+LK N+LL ++ K++DFG+A + + G
Sbjct: 116 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 454 TYGYMPPEYAIDGLFSVKSDVFSFGV 479
T GY+ PE +S D+++ GV
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 275 PIFDWMAIANATENFSD------KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM 327
FD + + LG G FG V+K G ++AAK + +
Sbjct: 71 APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130
Query: 328 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 387
EE +NE+ ++ +L H NL++L +++ +L+ EY+ L D I + S L
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELD 188
Query: 388 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTE 445
+ I G+ ++HQ + I+H DLK N+L N KI DFG+AR + +
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-- 243
Query: 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
GT ++ PE S +D++S GV+
Sbjct: 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 280 MAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------------ 322
M + + KLG G +G V E A K + KS
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 323 -SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK 381
+ EE NE+ L+ L H N++KL + L+ E+ L + I + R K
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHK 142
Query: 382 FLDWSKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMA 436
F + I+ I G+ YLH+ I+HRD+K N+LL+N +N KI DFG++
Sbjct: 143 F---DECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 489
F D +GT Y+ PE + ++ K DV+S GV++ ++CG
Sbjct: 197 SFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-26
Identities = 36/215 (16%), Positives = 73/215 (33%), Gaps = 16/215 (7%)
Query: 286 TENFSDKNKLGEG--GFGPVYKGVLIEGQEIAA-KR--LSKSSGQGMEEFENEVLLIAKL 340
+ +G+G V E +R L S + + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
H N+V +E ++ ++ S D + ++ I+ G+ + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALD 142
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT-----NRVVGTY 455
Y+H +HR +KAS++L+ + +S + V
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 456 GYMPPE--YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
++ PE + KSD++S G+ E+ G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
T N LG G F V+ G+ A K + KS ENE+ ++ K+
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARG 398
+H N+V L L+ + + L D I + R + +++ +I +
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI--LERGVY---TEKDASLVIQQVLSA 118
Query: 399 LLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
+ YLH+ I+HRDLK N+L + I+DFG+++ + GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTP 171
Query: 456 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
GY+ PE +S D +S GV+ ++CG
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 43/185 (23%), Positives = 80/185 (43%), Gaps = 25/185 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVLL 336
E + K+GEG +G V+K + GQ +A K+ +E ++ E+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRM 55
Query: 337 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 396
+ +L+H NLV L+ ++ L++EY + ++ + + + I
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDR--YQRGVPEHLVKSITWQTL 112
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
+ + + H+ IHRD+K N+L+ K+ DFG AR ++ + V T
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRW 167
Query: 457 YMPPE 461
Y PE
Sbjct: 168 YRSPE 172
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVLL 336
E + + +GEG +G V K + G+ +A K+ +E ++ E+ L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77
Query: 337 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 396
+ +L+H NLV L+ C ++ L++E++ + ++ D + LD+ + + I
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLEL--FPNGLDYQVVQKYLFQII 134
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
G+ + H IIHRD+K N+L+ K+ DFG AR E + V T
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRW 189
Query: 457 YMPPE 461
Y PE
Sbjct: 190 YRAPE 194
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEE-FENEVLLIAKLQHRNLVKLIG 350
LG+G FG VY + +A K L KS +G+E E+ + + L+H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
R L+ E+ P L + +F + + +A L Y H ++
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSA-TFMEELADALHYCH---ERKV 135
Query: 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMPPEYAIDGL 467
IHRD+K N+L+ + KI+DFG + A + R + GT Y+PPE
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYLPPEMIEGKT 188
Query: 468 FSVKSDVFSFGVLVLEIVCGK 488
K D++ GVL E + G
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGM 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 23/218 (10%)
Query: 279 WMAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAK-----RLSKSSGQGME 328
+ +A+ F D +G+G F V + + E GQ+ A K + + S G E
Sbjct: 12 ILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE 71
Query: 329 EFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW--- 385
+ + E + L+H ++V+L+ + +++E++ L I V R+
Sbjct: 72 DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSE 129
Query: 386 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGID 442
+ + I L Y H IIHRD+K VLL ++ N K+ FG+A G
Sbjct: 130 AVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
A VGT +M PE + DV+ GV+
Sbjct: 187 GLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 286 TENFSD----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS------GQGMEEFENEV 334
+ D +LG G F V K G E AAK + K G EE E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 335 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQII 392
++ ++ H N++ L R + +LI E + L DF+ + S+ I
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESL---SEEEATSFI 121
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANT 448
I G+ YLH +I H DLK N++L ++ P K+ DFG+A
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175
Query: 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
+ GT ++ PE +++D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 58/191 (30%), Positives = 85/191 (44%), Gaps = 33/191 (17%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN--------EVLLI 337
+ + KLGEG +G VYK + + +A KR+ +E E EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 338 AKLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRCQIIGGI 395
+LQHRN+++L LI+EY N K D ++ + + +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD------KNPDVSMRVIKSFLYQL 141
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGIDQTEANTNR 450
G+ + H R +HRDLK N+LL KI DFG+ARAFGI T+
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHE 197
Query: 451 VVGTYGYMPPE 461
++ T Y PPE
Sbjct: 198 II-TLWYRPPE 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 24/210 (11%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------SGQGMEEFENEV 334
+ D +LG G F V K G E AAK + K G EE E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 335 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG 394
++ ++ H N++ L R + +LI E + L DF+ + + L + I
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ 123
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNR 450
I G+ YLH +I H DLK N++L ++ P K+ DFG+A
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKN 177
Query: 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
+ GT ++ PE +++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 13/178 (7%)
Query: 320 SKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR 379
SS M+ ++ + +N V + + + + + ++L D++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 380 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439
+ + I IA + +LH ++HRDLK SN+ + K+ DFG+ A
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 440 GIDQTEANTN----------RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
D+ E VGT YM PE +S K D+FS G+++ E++
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 43/201 (21%), Positives = 81/201 (40%), Gaps = 16/201 (7%)
Query: 287 ENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 341
+ +K LG G FG V++ V + AK + G + E+ ++ +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIAR 59
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
HRN++ L +E ++I+E++ + + I T + L+ + + + L +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQF 117
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMP 459
LH I H D++ N++ + KI +FG AR + Y
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA 171
Query: 460 PEYAIDGLFSVKSDVFSFGVL 480
PE + S +D++S G L
Sbjct: 172 PEVHQHDVVSTATDMWSLGTL 192
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 282 IANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEV 334
+ NA+ FSD +LG+G F V + V G E AAK ++ S + ++ E E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 335 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQII 392
+ KLQH N+V+L + L+++ + L + I V R + S+ I
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFY---SEADASHCI 134
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTN 449
I + Y H I+HR+LK N+LL ++ K++DFG+A + +
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WH 188
Query: 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 479
GT GY+ PE +S D+++ GV
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 278 DWMAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM----- 327
+ +++T F + LG G V + + +E A K + + G
Sbjct: 4 AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 328 ----EEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF 382
E EV ++ K+ H N+++L L+++ + L D++ +
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTL 121
Query: 383 LDWSKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440
S++ +I+ + + LH+ L I+HRDLK N+LLD++MN K++DFG +
Sbjct: 122 ---SEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 441 IDQTEANTNRVVGTYGYMPPE------YAIDGLFSVKSDVFSFGVLVLEIVCG 487
+ V GT Y+ PE + + D++S GV++ ++ G
Sbjct: 176 PGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 283 ANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------SGQGMEEFENEVL 335
+ +++ +LG G F V K G+E AAK + K G EE E EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIG 393
++ +++H N++ L + + +LI E + L DF+ + ++ Q +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESL---TEDEATQFLK 115
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTN 449
I G+ YLH RI H DLK N++L ++ P K+ DFG+A
Sbjct: 116 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FK 169
Query: 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
+ GT ++ PE +++D++S GV+
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/275 (18%), Positives = 90/275 (32%), Gaps = 52/275 (18%)
Query: 263 NDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAK---- 317
+ + E F ++ + + K +G+G +G V + + A K
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61
Query: 318 -RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD 376
++ + + + +E + EV L+ KL H N+ +L L+ E L D +
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 377 VTRSKFLDWSKRC-------------------------------------QIIGGIARGL 399
+ I+ I L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 400 LYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFGIDQTEANT--NRVVGTY 455
YLH I HRD+K N L + K+ DFG+++ F GT
Sbjct: 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 456 GYMPPE--YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
++ PE + + K D +S GVL+ ++ G
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 32/193 (16%)
Query: 287 ENFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSGQGMEEFEN--------EVLL 336
+ + ++GEG +G V+K + G+ +A KR+ ++ E EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 337 IAKLQ---HRNLVKLIGCCTQRDER-----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 388
+ L+ H N+V+L CT L++E++ ++ L ++ D +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 389 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448
++ + RGL +LH R++HRDLK N+L+ + K++DFG+AR + T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 449 NRVVGTYGYMPPE 461
+ VV T Y PE
Sbjct: 178 SVVV-TLWYRAPE 189
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLVKLIGCC 352
LGEG +G V V + + +A K + E + E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR---CQIIGGIARGLLYLHQDSRLR 409
+ + + L EY L D I + + Q++ G+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV----YLH---GIG 125
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------YA 463
I HRD+K N+LLD N KISDFG+A F + E N++ GT Y+ PE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF- 184
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCG 487
DV+S G+++ ++ G
Sbjct: 185 -HAE---PVDVWSCGIVLTAMLAG 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------SGQGMEEFENEV 334
EN D +LG G F V K G + AAK + K G E+ E EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 335 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQII 392
++ ++QH N++ L + + +LI E + L DF+ + ++ + +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESL---TEEEATEFL 120
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANT 448
I G+ YLH L+I H DLK N++L + P KI DFG+A
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174
Query: 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
+ GT ++ PE +++D++S GV+
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 22/191 (11%)
Query: 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS-KSSGQGMEEFEN----EVLLIA 338
AT + ++G G +G VYK G +A K + + G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 339 KLQ---HRNLVKLIGCCTQRDER-----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 390
+L+ H N+V+L+ C L++E++ ++ L ++ D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
++ RGL +LH + I+HRDLK N+L+ + K++DFG+AR + T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 451 VVGTYGYMPPE 461
VV T Y PE
Sbjct: 180 VV-TLWYRAPE 189
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLVKLIGCC 352
LGEG +G V V + + +A K + E + E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYLHQDSRLR 409
+ + + L EY L D I + + Q++ G+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV----YLH---GIG 125
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------YA 463
I HRD+K N+LLD N KISDFG+A F + E N++ GT Y+ PE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF- 184
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCG 487
DV+S G+++ ++ G
Sbjct: 185 -HAE---PVDVWSCGIVLTAMLAG 204
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 43/212 (20%), Positives = 84/212 (39%), Gaps = 20/212 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVL-----LIAKLQ 341
+ + ++G G G V+K + + A + + SG +E +L ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHD 82
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
+V+ G + + E + + ++ I + L Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYY 139
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
L + +IHRD+K SN+LLD K+ DFG++ + +A G YM PE
Sbjct: 140 LK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDR-SAGCAAYMAPE 194
Query: 462 -----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ +++DV+S G+ ++E+ G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 37/210 (17%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
+G+G F V ++ G+E+A K + K+ + +++ EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 352 CTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
LI EY + D++ RSKF QI+ + Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF------RQIVSAVQ----YCH- 131
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--- 461
+ RI+HRDLKA N+LLD +MN KI+DFG + F + + G Y PE
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQ 186
Query: 462 ---YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y DG + DV+S GV++ +V G
Sbjct: 187 GKKY--DGP---EVDVWSLGVILYTLVSGS 211
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 50/253 (19%), Positives = 99/253 (39%), Gaps = 29/253 (11%)
Query: 245 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVY 304
+ K + + + + E + DW A + + K+ +G G V
Sbjct: 52 ANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVR 111
Query: 305 KGVLIE-GQEIAAKRLSKSSGQG--------MEEFENEVLLIAKL-QHRNLVKLIGCCTQ 354
+ V G E A K + ++ + E E ++ ++ H +++ LI
Sbjct: 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171
Query: 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYLHQDSRLRIIH 412
L+++ + L D++ + S++ I+ + + +LH I+H
Sbjct: 172 SSFMFLVFDLMRKGELFDYL--TEKVAL---SEKETRSIMRSLLEAVSFLHA---NNIVH 223
Query: 413 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------YAIDG 466
RDLK N+LLD+ M ++SDFG + + + GT GY+ PE
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHP 280
Query: 467 LFSVKSDVFSFGV 479
+ + D+++ GV
Sbjct: 281 GYGKEVDLWACGV 293
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 30/217 (13%)
Query: 286 TENFSD-----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAK 339
+ F D ++ LGEG V + + QE A K + K G EV ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 340 LQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 396
Q HRN+++LI + D L++E + S+ I R F ++ ++ +A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHF---NELEASVVVQDVA 121
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAF--GIDQTEANTNR- 450
L +LH I HRDLK N+L ++ KI DF + D + +T
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 451 --VVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVL 480
G+ YM PE ++ + D++S GV+
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKL- 348
LGEG +G V + + A K L K G + E+ L+ +L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 349 --IGCCTQRDERMLIY---EYLPNKSLNDFIFD-VTRSKFLDWSKR---CQIIGGIARGL 399
+ ++ +Y EY + D V +F CQ+I G+
Sbjct: 73 DVLYNEEKQK----MYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE--- 123
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 459
YLH I+H+D+K N+LL KIS G+A A + G+ + P
Sbjct: 124 -YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 460 PE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE + G K D++S GV + I G
Sbjct: 180 PEIANGLDTF--SGF---KVDIWSAGVTLYNITTGL 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 53/225 (23%), Positives = 99/225 (44%), Gaps = 46/225 (20%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRN 344
+++ +G G FG V++ L+E E+A K++ + + F+N E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 345 LVKLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG---- 394
+V L ++ L+ EY+P +++ + K Q +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLK--------QTMPMLLIK 144
Query: 395 -----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANT 448
+ R L Y+H + I HRD+K N+LLD K+ DFG A+ E N
Sbjct: 145 LYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199
Query: 449 NRVVGTYGYMPPEYAIDGLF-----SVKSDVFSFGVLVLEIVCGK 488
+ + Y Y PE +F + D++S G ++ E++ G+
Sbjct: 200 SYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 42/194 (21%)
Query: 294 KLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEEFEN-------EVLLIAKLQHR 343
K+G G +G VYK + ++ A K++ E E+ L+ +L+H
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI---------EGTGISMSACREIALLRELKHP 78
Query: 344 NLVKLIGCCTQRDER--MLIYEYLPN------KSLNDFIFDVTRSKFLDWSKRC---QII 392
N++ L +R L+++Y + K + + + QI+
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGI-DQTEAN 447
G+ YLH + ++HRDLK +N+L+ E KI+D G AR F + A+
Sbjct: 139 ----DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 448 TNRVVGTYGYMPPE 461
+ VV T+ Y PE
Sbjct: 192 LDPVVVTFWYRAPE 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--FENEVLLIA 338
F+++ +LG+G F V + V + GQE AA ++ + E E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 339 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 396
L+H N+V+L ++ LI++ + L + I V R + S+ I I
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI--VAREYY---SEADASHCIQQIL 120
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVG 453
+L+ HQ + ++HR+LK N+LL +++ K++DFG+A +Q G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175
Query: 454 TYGYMPPEYAIDGLFSVKSDVFSFGV 479
T GY+ PE + D+++ GV
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 36/219 (16%)
Query: 286 TENFSD----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
+ F+D K +G G + + + E A K + KS EE E +L+
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYG 73
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARG 398
QH N++ L ++ E + L D I + + F S+R ++ I +
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFF---SEREASAVLFTITKT 128
Query: 399 LLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+ YLH ++HRDLK SN+L N + +I DFG A+ + T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
Query: 455 YGYMPPE------YAIDGLFSVKSDVFSFGVLVLEIVCG 487
++ PE Y D++S GVL+ ++ G
Sbjct: 184 ANFVAPEVLERQGY------DAACDIWSLGVLLYTMLTG 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 29/221 (13%)
Query: 286 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--------FEN 332
+ D+ LG G G V + +++A + +SK E
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 333 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQII 392
E+ ++ KL H ++K+ D ++ E + L D + +K L +
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV---VGNKRLKEATCKLYF 245
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTN 449
+ + YLH+ IIHRDLK NVLL ++ KI+DFG ++ G + + T
Sbjct: 246 YQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT- 300
Query: 450 RVVGTYGYMPPE---YAIDGLFSVKSDVFSFGVLVLEIVCG 487
+ GT Y+ PE ++ D +S GV++ + G
Sbjct: 301 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 46/218 (21%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQHR--NL 345
LG GGFG VY G+ + + +A K + K E N EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 346 VKLIGCCTQRDERMLIYEY-LPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIAR 397
++L+ + D +LI E P + L DFI ++ RS F Q++ +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF------WQVLEAVR- 163
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
+ H ++HRD+K N+L+D N K+ DFG + GT
Sbjct: 164 ---HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 213
Query: 457 YMPPE------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y PPE Y G + V+S G+L+ ++VCG
Sbjct: 214 YSPPEWIRYHRY--HGR---SAAVWSLGILLYDMVCGD 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 55/245 (22%), Positives = 96/245 (39%), Gaps = 23/245 (9%)
Query: 245 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDK----NKLGEGGF 300
G + + + + + D+ + + SD ++LG G
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66
Query: 301 GPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359
VY+ + A K L K+ + + E+ ++ +L H N++KL E
Sbjct: 67 SIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKA 417
L+ E + L D I V + + S+R + I + YLH+ I+HRDLK
Sbjct: 125 LVLELVTGGELFDRI--VEKGYY---SERDAADAVKQILEAVAYLHE---NGIVHRDLKP 176
Query: 418 SNVLL---DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDV 474
N+L + KI+DFG+++ V GT GY PE + + D+
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDM 233
Query: 475 FSFGV 479
+S G+
Sbjct: 234 WSVGI 238
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 286 TENFSDK-----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLI 337
ENF++ +LG G F V + + GQE AAK L K E +E+ ++
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 338 AKLQHR-NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGG 394
+ ++ L E +LI EY + S+ ++I
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVIRLIKQ 139
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 451
I G+ YLHQ I+H DLK N+LL + + KI DFGM+R G +
Sbjct: 140 ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREI 193
Query: 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVL 480
+GT Y+ PE + +D+++ G++
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 35/220 (15%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHR 343
+++D +G G FG VY+ L + G+ +A K++ + + F+N E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 344 NLVKLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIA 396
N+V+L E+ L+ +Y+P +++ +R+K L + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGTY 455
R L Y+H I HRD+K N+LLD + K+ DFG A+ + E N + + Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY 221
Query: 456 GYMPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y PE Y + DV+S G ++ E++ G+
Sbjct: 222 -YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN------EV----LLIAKLQHR 343
LG+GGFG V+ G L + ++A K + ++ G + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 344 NLVKLIGCCTQRDERMLIYEY-LPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGI 395
+++L+ ++ ML+ E LP + L D+I +R F Q++ I
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF------GQVVAAI 152
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGT 454
+ H ++HRD+K N+L+D K+ DFG A + GT
Sbjct: 153 Q----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-AL-LHDEPYTD--FDGT 201
Query: 455 YGYMPPEYAIDGLFS-VKSDVFSFGVLVLEIVCG 487
Y PPE+ + + + V+S G+L+ ++VCG
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 39/230 (16%)
Query: 282 IANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE------- 329
++ + D+ LG G G V + +++A K +SK
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 330 -FENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDW 385
E E+ ++ KL H ++K+ D Y E + L D + V +
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELMEGGELFDKV--VGNKRL--- 111
Query: 386 SKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 440
+ + + YLH IIHRDLK NVLL + + KI+DFG ++ G
Sbjct: 112 KEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 441 IDQTEANTNRVVGTYGYMPPE---YAIDGLFSVKSDVFSFGVLVLEIVCG 487
+ + T + GT Y+ PE ++ D +S GV++ + G
Sbjct: 169 -ETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
LGEG F V + A K L K + E +V+ ++L H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRLDHPFFVKL 95
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
Q DE++ Y N L FD T ++F I L YL
Sbjct: 96 YFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIVSALEYL 146
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H IIHRDLK N+LL+ +M+ +I+DFG A+ + +A N VGT Y+ PE
Sbjct: 147 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ SD+++ G ++ ++V G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 54/216 (25%), Positives = 84/216 (38%), Gaps = 27/216 (12%)
Query: 286 TENFSD-------KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLI 337
F LGEG F K V + Q A K +SK + E+ +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITAL 59
Query: 338 AKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGG 394
+ H N+VKL + L+ E L L + I + F S+ I+
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHF---SETEASYIMRK 114
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRV 451
+ + ++H + ++HRDLK N+L +E + KI DFG AR D T
Sbjct: 115 LVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--P 169
Query: 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
T Y PE + D++S GV++ ++ G
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 53/232 (22%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS-------------------------SGQGME 328
+G+G +G V + A K LSK +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 329 EF-ENEVLLIAKLQHRNLVKL---IGCCTQRDERMLIYEYLPNKSLNDFIFD-VTRSKFL 383
E E+ ++ KL H N+VKL + D +++E + + + T
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 384 DWSKRC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440
+ R +I GI YLH +IIHRD+K SN+L+ + + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSV----KSDVFSFGVLVLEIVCGK 488
+ VGT +M PE ++ + DV++ GV + V G+
Sbjct: 189 GSDALLSN--TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKS-----SGQGMEEFENEVLLIAKL 340
+ F D LG GGFG V+ + ++ A K+L+K G E ++L AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL--AKV 242
Query: 341 QHRNLVKLIGCCTQRDERM-LIYEY---------LPNKSLNDFIFDVTRSKFLDWSKRCQ 390
R +V L + + L+ + N ++ F R+ F
Sbjct: 243 HSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------- 294
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
I GL +LHQ II+RDLK NVLLD++ N +ISD G+A QT+
Sbjct: 295 -TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-- 348
Query: 451 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
GT G+M PE + + D F+ GV + E++ +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 52/232 (22%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFEN------EVLLIAKLQHRNL 345
LG G FG V+ V + +E+ K + K E E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 346 VKLIGCCTQRDERMLIYE-YLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIAR 397
+K++ + L+ E + L FI + F Q++ +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF------RQLVSAVG- 144
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
YL IIHRD+K N+++ + K+ DFG A + GT Y
Sbjct: 145 ---YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEY 195
Query: 458 MPPE------YAIDGLFSVKSDVFSFGVLVLEIVCG--------KRNRGFYH 495
PE Y G + +++S GV + +V + H
Sbjct: 196 CAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIH 242
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 5e-21
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSS-----GQGMEEFENEVL-LIAK 339
+FS +G GGFG VY + ++ A K L K G+ + E +L L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 340 LQHRNLVKLIGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIG 393
+V + +++ I + + L +F +F
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--------AA 299
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
I GL ++H +++RDLK +N+LLD + +ISD G+A F ++ + VG
Sbjct: 300 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVG 352
Query: 454 TYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGK 488
T+GYM PE G+ S D FS G ++ +++ G
Sbjct: 353 THGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKS-----SGQGMEEFENEVLLIAKL 340
F LG+GGFG V + ++ A K+L K G+ M E ++L K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL--EKV 241
Query: 341 QHRNLVKLIGCCTQRDERM-LIYEYLPNKSL-------NDFIFDVTRSKFLDWSKRCQII 392
R +V L + + + L+ + L F R+ F
Sbjct: 242 NSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------A 292
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
I GL LH R RI++RDLK N+LLD+ + +ISD G+A QT V
Sbjct: 293 AEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRV 346
Query: 453 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
GT GYM PE + ++ D ++ G L+ E++ G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 38/211 (18%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIG 350
LG G FG V G + G ++A K L++ S + + + E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLH 403
+ + ++ EY+ L D+I R F QI+ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF------QQILSAVD----YCH 128
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-- 461
R ++HRDLK NVLLD MN KI+DFG++ D T G+ Y PE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRT--SCGSPNYAAPEVI 182
Query: 462 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y G + D++S GV++ ++CG
Sbjct: 183 SGRLY--AGP---EVDIWSCGVILYALLCGT 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 38/211 (18%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIG 350
LG G FG V G + G ++A K L++ S + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLH 403
+ + ++ EY+ L D+I +R F QI+ G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF------QQILSGVD----YCH 133
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-- 461
R ++HRDLK NVLLD MN KI+DFG++ + T+ G+ Y PE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVI 187
Query: 462 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y G + D++S GV++ ++CG
Sbjct: 188 SGRLY--AGP---EVDIWSSGVILYALLCGT 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 49/218 (22%), Positives = 82/218 (37%), Gaps = 31/218 (14%)
Query: 286 TENFSD-----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEV-LLIA 338
+D K LG G G V + GQ+ A K L S + EV
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77
Query: 339 KLQHRNLVKLIGCC-TQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKR--CQII 392
++V ++ + + E + L I + F ++R +I+
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF---TEREAAEIM 134
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGIDQTEANTN 449
I + +LH I HRD+K N+L + + K++DFG A+ Q T
Sbjct: 135 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT- 188
Query: 450 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
T Y+ PE + D++S GV++ ++CG
Sbjct: 189 -PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 47/231 (20%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------E 333
+ F + G+G FG V G G +A K++ ++
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQI 69
Query: 334 VLLIAKLQHRNLVKLIGCCTQRDER-------MLIYEYLPNKSLNDFIFDVTRSK-FLDW 385
+ +A L H N+V+L ER ++ EY+P +L+ + R +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPP 128
Query: 386 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQT 444
+ + R + LH S + + HRD+K NVL++ K+ DFG A+ +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185
Query: 445 EANTNRVVGTYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
E N + Y Y PE Y + D++S G + E++ G+
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 39/211 (18%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIG 350
LGEG FG V Q++A K +S+ E E+ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 351 CCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLH 403
T + +++ EY L D+I D R F QII I Y H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFF------QQIICAIE----YCH 125
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-- 461
R +I+HRDLK N+LLD+ +N KI+DFG++ T+ G+ Y PE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPEVI 179
Query: 462 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y G + DV+S G+++ ++ G+
Sbjct: 180 NGKLY--AGP---EVDVWSCGIVLYVMLVGR 205
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 40/210 (19%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLVKLIGCC 352
+G G FG + + +A K + + G ++E + E++ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 353 TQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
+I EY L + I D R F Q++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ------QLLSGVS----YCH-- 133
Query: 406 SRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-- 461
++I HRDLK N LLD KI DFG +++ + + VGT Y+ PE
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS--TVGTPAYIAPEVL 189
Query: 462 ----YAIDGLFSVKSDVFSFGVLVLEIVCG 487
Y DG +DV+S GV + ++ G
Sbjct: 190 LRQEY--DGK---IADVWSCGVTLYVMLVG 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFEN---EVLLIAKLQHRNLVKLIG 350
+G+G FG V + +++ A K ++K E N E+ ++ L+H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 351 CCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
Q +E M ++ + L L + F K I + L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELVMALDYLQN 133
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--Y 462
RIIHRD+K N+LLD + I+DF +A +T+ T + GT YM PE
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAPEMFS 187
Query: 463 AIDGL---FSVKSDVFSFGVLVLEIVCGKR 489
+ G F+V D +S GV E++ G+R
Sbjct: 188 SRKGAGYSFAV--DWWSLGVTAYELLRGRR 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 27/209 (12%)
Query: 291 DKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEV-LLIAKLQHRNLVKL 348
LG G G V + ++ A K L + EV L Q ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 349 IGCC-TQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYL 402
+ R + E L L I D F ++R +I+ I + YL
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGEAIQYL 177
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVVGTYGYM 458
H + I HRD+K N+L ++ P K++DFG A+ + T Y+
Sbjct: 178 HS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYV 230
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCG 487
PE + D++S GV++ ++CG
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+A+G+ +L + + IHRDL A N+LL + KI DFG+AR D + G
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGD 254
Query: 455 ----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 485
+M PE D +++++SDV+SFGVL+ EI
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 31/160 (19%), Positives = 60/160 (37%), Gaps = 19/160 (11%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQG-MEEFENEVLLIAK 339
+ LG G FG V + + +A K L + + +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 340 L-QHRNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 397
+ H N+V L+G CT+ M+I E+ +L+ ++ SKR + + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437
G + + I DLK + + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 52/285 (18%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKL 340
E+F +G G FG V L ++ A K L+K E E +VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNG 131
Query: 341 QHRNLVKLIGCCTQRDERM-LIYEYLPNKSL------NDFIFDVTRSKFLDWSKRCQIIG 393
+ + L Q D + L+ +Y L + ++F +
Sbjct: 132 DSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--------LA 182
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
+ + +HQ L +HRD+K N+L+D + +++DFG ++ ++ VG
Sbjct: 183 EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVG 238
Query: 454 TYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH---HNLLGH 505
T Y+ PE G + + D +S GV + E++ G+ FY ++ H
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FYAESLVETYGKIMNH 296
Query: 506 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR 550
R + P ++ + +SE + + L+C E R
Sbjct: 297 KERF---QFPTQVTD--------VSENAKDLIRRLIC---SREHR 327
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 35/221 (15%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKL 340
++F +G G F V + + ++ A K ++K E E +VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL--VNG 118
Query: 341 QHRNLVKLIGCCTQRDERM-LIYEYLPNKSL------NDFIFDVTRSKFLDWSKRCQIIG 393
R + +L Q + + L+ EY L ++F +
Sbjct: 119 DRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--------LA 169
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
I + +H+ L +HRD+K N+LLD + +++DFG D T + VG
Sbjct: 170 EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVG 225
Query: 454 TYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCG 487
T Y+ PE G + + D ++ GV E+ G
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
LG+G FG V A K L K +E EN VL +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL--QNSRHPFLTAL 213
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
Q +R+ + EY L + +F R++F I L YL
Sbjct: 214 K-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIVSALDYL 264
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H S +++RDLK N++LD + + KI+DFG+ + D T GT Y+ PE
Sbjct: 265 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEV 320
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
D + D + GV++ E++CG+ FY+ DH
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 354
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 51/229 (22%), Positives = 99/229 (43%), Gaps = 29/229 (12%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ- 341
+++ KLG G + V++ + I +++ K L ++ + E+ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89
Query: 342 HRNLVKLIGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIA 396
N++ L R L++E++ N D+ R +I+
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---- 140
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEANTNRVVGTY 455
+ L Y H S I+HRD+K NV++D+E ++ D+G+A F E RV Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQE-YNVRVASRY 195
Query: 456 GYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 503
+ PE +D S D++S G ++ ++ K F+H +++ L
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFHGHDNYDQL 241
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 50/253 (19%), Positives = 99/253 (39%), Gaps = 65/253 (25%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQ 341
+++ +S LG G FG V + IE G+ A K++ + ++N E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58
Query: 342 HRNLVKLIGC--------------------CTQRDERMLIYEYLPNKSLNDFIF------ 375
H N++KL+ ++ + + + + +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 376 --DVTRSKFLD-WSKRCQIIGG---------IARGLLYLHQDSRLRIIHRDLKASNVLLD 423
T K L + + + I + R + ++H L I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 424 NEMNP-KISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-------YAIDGLFSVKSDVF 475
++ N K+ DFG A+ +E + + + Y PE Y + D++
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDLW 226
Query: 476 SFGVLVLEIVCGK 488
S G + E++ GK
Sbjct: 227 SIGCVFGELILGK 239
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 36/211 (17%)
Query: 295 LGEGGFGPVY---KGVLIEGQEI-AAKRLSKSSGQGMEEF----ENEVLLIAKLQHRNLV 346
LG+G FG V+ K + +++ A K L K++ + + E ++L+ H +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIV 89
Query: 347 KLIGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
KL Q + ++ LI ++L L + +F KF + +A L
Sbjct: 90 KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALD 140
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
+LH L II+RDLK N+LLD E + K++DFG+++ + +A + GT YM P
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAP 195
Query: 461 EYAIDGL---FSVKSDVFSFGVLVLEIVCGK 488
E ++ S D +SFGVL+ E++ G
Sbjct: 196 E-VVNRRGHTQSA--DWWSFGVLMFEMLTGT 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 28/206 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
LG+G FG V A K L K +E E+ VL +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL--QNTRHPFLTAL 70
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
Q +R+ + EY L + +F R++F I L YL
Sbjct: 71 K-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSALEYL 121
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H +++RD+K N++LD + + KI+DFG+ + D T GT Y+ PE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
D + D + GV++ E++CG+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 36/207 (17%), Positives = 79/207 (38%), Gaps = 57/207 (27%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+ + ++ +G G +G V + +E + +A K++ + FE+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 336 LIAKLQHRNLVKLIGCCTQRDERM-----LIYEYLP---------NKSLND-----FIFD 376
++ +L H ++VK++ +D ++ E L + ++
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163
Query: 377 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436
++ G+ Y+H S I+HRDLK +N L++ + + K+ DFG+A
Sbjct: 164 -------------NLL----VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 437 RAFGIDQTEANTNRVVGTYGYMPPEYA 463
R + + + M
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTF 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEE---FENEVLLIAKLQH 342
E++ +G G FG V +++ A K LSK + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 343 RNLVKLIGCCTQRDERM-LIYEYLPN----KSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 397
+V+L Q D + ++ EY+P ++++ ++F +
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY--------TAEVVL 179
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
L +H + IHRD+K N+LLD + K++DFG + + VGT Y
Sbjct: 180 ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDY 235
Query: 458 MPPE----YAIDGLFSVKSDVFSFGVLVLEIVCG 487
+ PE DG + + D +S GV + E++ G
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 30/254 (11%)
Query: 256 GSSKLDYNDRGNREEEMELPIFDWMAIANAT-ENFSDKNKLGEGGFGPVYKGVLIEGQEI 314
GS + + + +E L ++ + A + F LG G FG V E
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 315 -AAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLIGCCTQRDERM-LIYEYLPNKS 369
A K L K +++ E NE ++ + LVKL + + + ++ EY+
Sbjct: 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVAGGE 127
Query: 370 L-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 424
+ F ++F I YLH L +I+RDLK N+L+D
Sbjct: 128 MFSHLRRIGRFSEPHARF--------YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176
Query: 425 EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 484
+ +++DFG A+ + + T + GT + PE + ++ D ++ GVL+ E+
Sbjct: 177 QGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 485 VCGKRNRGFYHADH 498
G F+
Sbjct: 232 AAGYPP--FFADQP 243
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
+G G + V L + I A K + K E+ E V A H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
C Q + R+ + EY+ L ++F I+ L YL
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 126
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H+ II+RDLK NVLLD+E + K++D+GM + +T GT Y+ PE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 181
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ D ++ GVL+ E++ G+
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
LG+G FG V E+ A K L K ++ E VL + + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
C Q +R+ + EY+ L F + F IA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIGLFFL 137
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
II+RDLK NV+LD+E + KI+DFGM + D T GT Y+ PE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 192
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ D ++FGVL+ E++ G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
+G G + V L + I A + + K E+ E V A H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 118
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
C Q + R+ + EY+ L ++F I+ L YL
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 169
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H+ II+RDLK NVLLD+E + K++D+GM + +T GT Y+ PE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 224
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ D ++ GVL+ E++ G+
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
LG+G FG V + E ++ A K L K ++ E +L +A+ H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 89
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
CC Q +R+ + E++ L FD R++F I L++L
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--------YAAEIISALMFL 140
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H II+RDLK NVLLD+E + K++DFGM + + T GT Y+ PE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEI 195
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ L+ D ++ GVL+ E++CG
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 51/227 (22%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+ + + +G G G V I + +A K+LS+ F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-----IFD--------VTRSKF 382
L+ + H+N++ L+ + P KSL +F + + V + +
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 383 LDWSKRCQ-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441
+R ++ + G+ +LH IIHRDLK SN+++ ++ KI DFG+AR
Sbjct: 125 DH--ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177
Query: 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ T VV T Y PE + + D++S G ++ E++ G
Sbjct: 178 GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 38/226 (16%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE--FEN---------EV 334
++ + + G +G V GV EG +A KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 335 LLIAKLQHRNLVKLIGCCTQRDERM-----LIYEYLPNKSLNDFIFDVTRSKFLDWSK-R 388
L+ H N++ L +E L+ E + L I + + S
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI----HDQRIVISPQH 135
Query: 389 CQ-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 447
Q + I GL LH+ ++HRDL N+LL + + I DF +AR
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTADANK 190
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 488
T+ V Y PE + K D++S G ++ E+ K
Sbjct: 191 THYVT-HRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
LG+G FG V+ + + A K L K ++ E VL +A +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
C Q E + + EYL L + FD++R+ F I GL +L
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--------YAAEIILGLQFL 134
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H I++RDLK N+LLD + + KI+DFGM + + + NT GT Y+ PE
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 189
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCG 487
+ ++ D +SFGVL+ E++ G
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 295 LGEGGFGPVY---KGVLIEGQEI-AAKRLSKSS-GQGMEEF-----ENEVLLIAKLQHRN 344
LG+GG+G V+ K +I A K L K+ + ++ E +L +++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL--EEVKHPF 82
Query: 345 LVKLIGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARG 398
+V LI Q ++ LI EYL L + IF + F + I+
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMA 133
Query: 399 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
L +LHQ II+RDLK N++L+++ + K++DFG+ + D T +T GT YM
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYM 188
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE + + D +S G L+ +++ G
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+ + +G G +G V + G+++A K+LS+ F++ E+L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 336 LIAKLQHRNLVKL--IGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 389
L+ +QH N++ L + L+ ++ L + KF + ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSE--EKI 128
Query: 390 Q-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448
Q ++ + +GL Y+H ++HRDLK N+ ++ + KI DFG+AR + T
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--- 182
Query: 449 NRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 488
V T Y PE + ++ D++S G ++ E++ GK
Sbjct: 183 --YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 32/294 (10%), Positives = 85/294 (28%), Gaps = 52/294 (17%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLI 349
G ++ + +++A + ++E + L ++++ + +++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 350 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 409
R +++ E++ SL + + + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 410 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 469
+ S V +S G V+ MP +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180
Query: 470 VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL 529
+ D+ G + ++ + + L A R +P+E + + +
Sbjct: 181 PQDDIRGIGASLYALLVNRWP---LPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQI 236
Query: 530 SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPES 583
S V VQ R S+++ ++ ++ + + P +
Sbjct: 237 SAVA------ARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVSA 283
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 43/271 (15%)
Query: 245 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANAT-------ENFSDKNKLGE 297
H ++G + G + D G+ E++ + ENF LG
Sbjct: 5 HHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGT 64
Query: 298 GGFGPVY---KGVLIEGQEI-AAKRLSKSS-GQGMEEF-----ENEVLLIAKLQHRNLVK 347
G +G V+ K + ++ A K L K++ Q + E +VL + Q LV
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVT 123
Query: 348 LIGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
L Q + ++ LI +Y+ L F + +G I L +
Sbjct: 124 LH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--------YVGEIVLALEH 174
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH+ L II+RD+K N+LLD+ + ++DFG+++ + GT YM P+
Sbjct: 175 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPD 230
Query: 462 YAIDGL----FSVKSDVFSFGVLVLEIVCGK 488
G +V D +S GVL+ E++ G
Sbjct: 231 IVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
+G+G FG V + A K L K + +E E VLL ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGL 104
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
Q +++ + +Y+ L + F R++F IA L YL
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--------AAEIASALGYL 155
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H L I++RDLK N+LLD++ + ++DFG+ + I+ + T+ GT Y+ PE
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEH-NSTTSTFCGTPEYLAPEV 210
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ D + G ++ E++ G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 34/193 (17%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+++ + +GEG +G V + +A K++S FE+ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 336 LIAKLQHRNLVKLIGCCTQRDERM-----LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 390
++ + +H N++ + ++ + + L + +++ L C
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY 132
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN--T 448
+ I RGL Y+H S ++HRDLK SN+LL+ + KI DFG+AR D T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 449 NRVVGTYGYMPPE 461
V T Y PE
Sbjct: 190 EYVA-TRWYRAPE 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 59/231 (25%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+ D +G G +G V V G ++A K+L + F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-----IFD--------VTRSKF 382
L+ ++H N++ L+ + P+++L+DF + + + +
Sbjct: 77 LLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 383 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442
L + ++ + +GL Y+H IIHRDLK N+ ++ + KI DFG+AR +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 488
T V T Y PE + + D++S G ++ E++ GK
Sbjct: 182 MTGY-----VVTRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 55/229 (24%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+ + + +G G G V + + +A K+LS+ F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-----IFD--------VTRSKF 382
L+ + H+N++ L+ + P K+L +F + + V + +
Sbjct: 114 LMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 383 LDWSKR---CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439
Q++ G+ +LH IIHRDLK SN+++ ++ KI DFG+AR
Sbjct: 162 DHERMSYLLYQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 212
Query: 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ T VV T Y PE + + D++S G ++ E+V K
Sbjct: 213 TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 348
LG+G FG V E+ A K L K ++ E VL + + L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPFLTQL 407
Query: 349 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
C Q +R+ + EY+ L F + F IA GL +L
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--------AAEIAIGLFFL 458
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
II+RDLK NV+LD+E + KI+DFGM + D T GT Y+ PE
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 513
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGK 488
+ D ++FGVL+ E++ G+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 38/156 (24%), Positives = 60/156 (38%), Gaps = 22/156 (14%)
Query: 292 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEV-LLIAKLQHRNLVKLI 349
LG G G V + ++ A K L + EV L Q ++V+++
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 77
Query: 350 GCC-TQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYLH 403
R + E L L I D F ++R +I+ I + YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGEAIQYLH 134
Query: 404 QDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMA 436
+ I HRD+K N+L ++ K++DFG A
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 33/206 (16%)
Query: 295 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLIG 350
LG G FG V+ A K L K +++ E +E L+++ + H ++++ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 351 CCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
Q +++ +I +Y+ L F +KF + L YLH
Sbjct: 74 TF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--------AAEVCLALEYLHS 124
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
II+RDLK N+LLD + KI+DFG A+ T + GT Y+ PE +
Sbjct: 125 ---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE-VV 175
Query: 465 DGL---FSVKSDVFSFGVLVLEIVCG 487
S+ D +SFG+L+ E++ G
Sbjct: 176 STKPYNKSI--DWWSFGILIYEMLAG 199
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 46/231 (19%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+ D LG GG G V+ V + +A K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND--FIFD--------VTRSKFLDW 385
+I +L H N+VK+ L + LN + + V L
Sbjct: 61 IIRRLDHDNIVKVFEILGP-SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119
Query: 386 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQT 444
+ + RGL Y+H + ++HRDLK +N+ ++ E + KI DFG+AR +
Sbjct: 120 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 445 EAN--TNRVVGTYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 488
+ +V T Y P L S + D+++ G + E++ GK
Sbjct: 177 HKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 41/230 (17%), Positives = 84/230 (36%), Gaps = 51/230 (22%)
Query: 261 DYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRL 319
++ RE I + + +N+ K+ +G G +G VY + +A K++
Sbjct: 4 HHHHSSGRENLYFQGIKNV----HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV 59
Query: 320 SKSSGQGMEEFEN---------EVLLIAKLQHRNLVKLIGCCTQRDERM-----LIYEYL 365
++ FE+ E+ ++ +L+ +++L D ++ E
Sbjct: 60 NRM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA 112
Query: 366 P---------NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK 416
L + K + + ++ G ++H IIHRDLK
Sbjct: 113 DSDLKKLFKTPIFLTEE-----HIKTILY----NLL----LGENFIH--ES-GIIHRDLK 156
Query: 417 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
+N LL+ + + K+ DFG+AR ++ N + P +
Sbjct: 157 PANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 51/227 (22%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVL 335
E + + + +G G +G V + G +A K+LS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-----IFD--------VTRSKF 382
L+ ++H N++ L+ + P +SL +F + + + +
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 383 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442
L +I I RGL Y+H IIHRDLK SN+ ++ + KI DFG+AR +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 443 QTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 488
T V T Y PE ++ ++ D++S G ++ E++ G+
Sbjct: 186 MTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 7e-13
Identities = 38/200 (19%), Positives = 63/200 (31%), Gaps = 46/200 (23%)
Query: 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--------SKSSGQGMEEFENEVLL 336
TE K+GEG FG V++ + + +A K + + S + EE E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 337 IAKLQ---------HRNLVKLIG--CCTQRDERMLIYEYL----PNKSLNDFI------- 374
+L + L C +L+ + S ND
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 375 -------------FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 421
+ R+K + I+ + L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 422 LDNEMNPKISDFGMARAFGI 441
L K+ ++ I
Sbjct: 195 LKKTSLKKLHYTLNGKSSTI 214
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 34/192 (17%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+ +F K+ LGEG +G V G+ +A K++ F+ E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 336 LIAKLQHRNLVKLIGCCTQRDERM-----LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 390
++ +H N++ + +I E + L+ I ++ L
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY 116
Query: 391 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 450
I R + LH + +IHRDLK SN+L+++ + K+ DFG+AR ID++ A+ +
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSE 171
Query: 451 VVGTYGYMPPEY 462
G M E+
Sbjct: 172 PTGQQSGM-VEF 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 46/196 (23%), Positives = 91/196 (46%), Gaps = 30/196 (15%)
Query: 286 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 335
+ KLG+G +G V+K + G+ +A K++ + F+N E++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 336 LIAKLQ-HRNLVKLIGCCT--QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ-I 391
++ +L H N+V L+ + L+++Y+ L+ I R+ L+ Q +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILE-PVHKQYV 114
Query: 392 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 451
+ + + + YLH S ++HRD+K SN+LL+ E + K++DFG++R+F + N +
Sbjct: 115 VYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 452 VGTYGYMPPEYAIDGL 467
+ L
Sbjct: 172 SINENTENFDDDQPIL 187
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 38/151 (25%), Positives = 66/151 (43%), Gaps = 13/151 (8%)
Query: 294 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH-RNLVKLIGC 351
K+G G FG +Y G I G+E+A K + E+++ + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKM--MQGGVGIPTIRWC 73
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411
+ D +++ E L SL D +F+ KF + + + Y+H + I
Sbjct: 74 GAEGDYNVMVMELL-GPSLED-LFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 412 HRDLKASNVLLDNEMNPK---ISDFGMARAF 439
HRD+K N L+ I DFG+A+ +
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 35/158 (22%), Positives = 58/158 (36%), Gaps = 25/158 (15%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
K+G G FG + G L + +A K S E + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFG 74
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYLHQDS 406
++ E L SL D +FD+ F S + Q+I + Y+H +
Sbjct: 75 PCGKYNAMVLELL-GPSLED-LFDLCDRTF---SLKTVLMIAIQLISRME----YVHSKN 125
Query: 407 RLRIIHRDLKASNVLLDNEMNPK-----ISDFGMARAF 439
+I+RD+K N L+ N I DF +A+ +
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 42/186 (22%), Positives = 77/186 (41%), Gaps = 38/186 (20%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV-KLIGC 351
K+G G FG +Y G + +E+A K + + +E+++ I LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRI--LQGGTGIPNVRWF 71
Query: 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYLHQD 405
+ D +L+ + L SL D +F+ K S + Q+I + ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLED-LFNFCSRKL---SLKTVLMLADQMINRVE----FVHSK 122
Query: 406 SRLRIIHRDLKASNVLLDNEMNPK---ISDFGMARAFGIDQTEANTNR---------VVG 453
S +HRD+K N L+ I DFG+A+ + + +T++ + G
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKNLTG 175
Query: 454 TYGYMP 459
T Y
Sbjct: 176 TARYAS 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 33/158 (20%), Positives = 66/158 (41%), Gaps = 25/158 (15%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
++GEG FG +++G L+ Q++A K + S E + + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGIPNVYYFG 75
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYLHQDS 406
+ +L+ + L SL D + D+ KF S + Q++ + +H+ S
Sbjct: 76 QEGLHNVLVIDLLG-PSLED-LLDLCGRKF---SVKTVAMAAKQMLARVQ----SIHEKS 126
Query: 407 RLRIIHRDLKASNVLLDNEMNPK-----ISDFGMARAF 439
+++RD+K N L+ + + DFGM + +
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 45/238 (18%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ----------- 341
KLG G F V+ ++ +A K + + E E+E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 342 HRNLVKLIGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSKF----LDWSKRCQIIG 393
+++KL+ + +++E L ++L I + + L + K+ I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI---KKYEHRGIPLIYVKQ--ISK 138
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP------KISDFGMARAFGIDQTEAN 447
+ GL Y+H R IIH D+K NVL++ +P KI+D G A + +
Sbjct: 139 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WYDEH 191
Query: 448 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-----RNRGFYHADHHH 500
+ T Y PE + + +D++S L+ E++ G Y D H
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 31/200 (15%), Positives = 70/200 (35%), Gaps = 46/200 (23%)
Query: 293 NKLGEGGFGPVYKGV---------LIEGQEIAAKRLSKSSGQGMEEF--------ENEVL 335
+ G +Y+ + Q+ + K L G+ E +V
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 336 LIAKLQHRNLV---KLIGCCTQRDE-RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC-- 389
KL L+ +G +D+ R L+ L +SL + + S+R
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL---SERSVL 162
Query: 390 ----QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAF---- 439
+++ + +LH++ +H ++ A N+ +D E ++ + +G A +
Sbjct: 163 QVACRLLDALE----FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 440 -GIDQTEANTNRVVGTYGYM 458
+ E + + G ++
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 33/175 (18%), Positives = 67/175 (38%), Gaps = 41/175 (23%)
Query: 294 KLGEGGFGPVYKGVLIEGQEI------AAKRLSKSSGQGMEEFE-----NEVLLIAKLQH 342
+G+GGFG +Y + + + K +G E + + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 343 RNLVKLIG----------CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC--- 389
+K +G + R +I + L I++ +F S++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRF---SRKTVLQ 156
Query: 390 ---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAF 439
+I+ + Y+H+ +H D+KASN+LL+ + ++ D+G+A +
Sbjct: 157 LSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 1e-07
Identities = 56/477 (11%), Positives = 132/477 (27%), Gaps = 133/477 (27%)
Query: 182 FHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFV 241
F D D K++ + + + + E+D I + LL ++ FV
Sbjct: 29 FVDNFDCKDVQDMPKSIL---SKEEIDHI-IMSKDAVSGTLRLFW-TLLSKQEEMVQKFV 83
Query: 242 ---------YLWKRRHRKQGKTDGSSKL--DYNDRG------------NREEEMELPIFD 278
+L +Q + +++ + DR +R +
Sbjct: 84 EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL----- 138
Query: 279 WMAIANATENFSDKNKL---GEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVL 335
+ A + G G G K + A Q + + ++
Sbjct: 139 --KLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCLSYKVQ--CKMDFKIF 185
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 395
+ + C + + + L ++ + +W+ R I
Sbjct: 186 WLN----------LKNCNSPETVLEM--------LQKLLYQIDP----NWTSRSDHSSNI 223
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID-QT------EANT 448
+ + + R + + + ++L N N K AF + + + T
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA-----WNAFNLSCKILLTTRFKQVT 278
Query: 449 NRVVG-TYGYMPPEYAIDGLFSVKS-DVFS--FGV--------------LVLEIVCGKRN 490
+ + T ++ ++ L + + L I+ +
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII-AESI 337
Query: 491 RGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS--EVLRC-IQVGLLCVQQRP 547
R N W+ ++ +I SL L E + ++ + P
Sbjct: 338 RD--GLATWDN-----WKHVNCDKLTTIIESSLN---VLEPAEYRKMFDRLSVF-----P 382
Query: 548 EDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLL--STNEITISL 602
+ ++ ++ + + + + K SL+ E TIS+
Sbjct: 383 PSAHIPTILLSLIWFDV-----------IKSDVMVVVNKLHKYSLVEKQPKESTISI 428
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 5e-06
Identities = 63/395 (15%), Positives = 125/395 (31%), Gaps = 103/395 (26%)
Query: 248 HRKQGKTD-GSSKLDYNDRGNREEEMELPIFDWMAIANATEN-FSDKNKLGEGGFGPVYK 305
H + G + Y D + E+ + FD + + ++ S +
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKE----------EID 52
Query: 306 GVLIEGQEIAAKR-----LSKSSGQGMEEFENEVL------LIAKLQHRNLVKLIGCCTQ 354
+++ ++ L + +++F EVL L++ ++ Q
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE--------QRQ 104
Query: 355 RDERMLIYEYLPNKSLND---FI-FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410
+Y ++ ND F ++V+R + + + LL L + +
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL---------KLRQALLELRPAKNV-L 154
Query: 411 IHRDL---K---ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--- 461
I L K A +V L ++ K+ DF + F ++ N+ V +
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKM-DFKI---FWLNLKNCNSPETV-----LEMLQKL 205
Query: 462 -YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL--LGHAWRLWIEERPVEL 518
Y ID ++ +SD S L + + + R + + L L +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA----WNA 261
Query: 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTER 578
N L C ++ L + R + + + SL
Sbjct: 262 FN------------LSC-KI-L--LTTR--FKQVTDFLSAATTTHISL-DHHSMTL---- 298
Query: 579 NPPESGSSSSK----------RSLLSTNEITISLI 603
P E S K R +L+TN +S+I
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 33/173 (19%), Positives = 62/173 (35%), Gaps = 40/173 (23%)
Query: 294 KLGEGGFGPVYKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIA------------- 338
K+G GGFG +Y E A+ + K G E +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 339 KLQHRNLVKLIGC----CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC----- 389
+L + + G R R ++ E L L I F K
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNG-TF---KKSTVLQLG 157
Query: 390 -QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAF 439
+++ + Y+H++ +H D+KA+N+LL + ++ +D+G++ +
Sbjct: 158 IRMLDVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 38/215 (17%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAA----KRLSKSSGQGMEEFENEVLLIAKLQHR----- 343
+ +G+G FG V K QE A K Q EV L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 344 -NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS-KRCQIIGG-IARGLL 400
+V L R+ L++E L + +L D + + F S + + LL
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL---RNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTY--- 455
+L L IIH DLK N+LL N KI DFG + + + Y
Sbjct: 172 FLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------CQLGQRIYQYIQS 221
Query: 456 -GYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 488
Y PE + G+ + + D++S G +++E+ G+
Sbjct: 222 RFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 44/243 (18%), Positives = 70/243 (28%), Gaps = 89/243 (36%)
Query: 390 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE------------------------ 425
+II + +GL YLH ++ RIIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 426 -------------------------MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
+ KI+D G A TE + T Y
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSL 262
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKR------NRGFYHADHH----HNLLG----HA 506
E I ++ +D++S + E+ G + + H LLG
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 507 WRLWIEERPV------ELINKSLGGSYSLSEVLR------------CIQVGLLCVQQRPE 548
+ +L + + + L EVL L ++ PE
Sbjct: 323 IVAG-KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE 381
Query: 549 DRP 551
R
Sbjct: 382 KRA 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 38/212 (17%)
Query: 295 LGEGGFGPVYKGV-LIEGQEIAAKRL---SKSSGQGMEEFENEVLLIAKLQHR------N 344
+G+G FG V K Q +A K + + Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS-KRCQIIGG-IARGLLYL 402
++ ++ T R+ + +E L + +L + I ++KF +S + I + L L
Sbjct: 161 VIHMLENFTFRNHICMTFELL-SMNLYELI---KKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTY----G 456
H + RIIH DLK N+LL + K+ DFG + ++ V TY
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEHQRVYTYIQSRF 264
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
Y PE + + + D++S G ++ E++ G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.91 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.13 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.12 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.06 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.99 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.38 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.56 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.42 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 88.36 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 84.36 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 83.74 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.17 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.96 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 82.79 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=443.03 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=211.4
Q ss_pred CCCcCCeecccCcccEEEEEEe------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++...++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455689999999999999973 46789999997543 3456789999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc
Q 007361 361 IYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 427 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 427 (606)
||||+++|+|.++|..... ...++|..+++|+.|||+||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999964321 245999999999999999999999998 999999999999999999
Q ss_pred eEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHH
Q 007361 428 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA 506 (606)
Q Consensus 428 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 506 (606)
+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~--- 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVV--- 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHH---
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHH---
Confidence 99999999997755444444555789999999999999999999999999999999998 88997543211 111
Q ss_pred HHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 507 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
.....+... ..+...+..+.+|+.+||+.||++||||.+|++.|+....
T Consensus 258 -~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 258 -EMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -HHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 111111111 1122233567899999999999999999999999986543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-55 Score=448.00 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=206.5
Q ss_pred cCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|...++||+|+||.||+|++. +++.||||++........++|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999874 378899999987777777899999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 361 IYEYLPNKSLNDFIFDVT------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
||||+++|+|.++|.... ....++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996532 2346999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~---- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI---- 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH----
Confidence 9999999997755444444455789999999999999999999999999999999999 89997543211 111
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
.....+... ..+......+.+|+.+||+.||++||||.+|++.|+.+.+
T Consensus 271 ~~i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 111111111 1111223467889999999999999999999999988654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-55 Score=443.65 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=213.2
Q ss_pred cCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|.+.++||+|+||+||+|++. ++..||||+++.......++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999874 367899999987777777899999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 361 IYEYLPNKSLNDFIFDV----------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
||||+++|+|.++|... .....++|..++.|+.|||+||.|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999642 23456999999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHH
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+. ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~----~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVI----EC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH----HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HH
Confidence 99999987655444444445679999999999999999999999999999999999 89997643211 111 11
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+... ..+......+.+|+.+||+.||++||||.+|++.|+.+
T Consensus 243 i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1122111 11112234678999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=431.66 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=200.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.+++.+.++||+|+||+||+|++. ..||||+++.. .....+.|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 356778899999999999999874 36899998643 33446789999999999999999999999865 56899999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.++|.. ....++|..++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999964 2345999999999999999999999988 9999999999999999999999999998765444
Q ss_pred ccccccccccccCccCcccccc---CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 444 TEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
........+||+.|||||++.+ .+|+.++|||||||+||||+||+.||...... .........+.. .
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~----~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYA----S 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCC----C
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----C
Confidence 4444455789999999999964 46999999999999999999999998643221 011111111110 1
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+.+. .........+.+|+.+||+.+|++||||.+|++.|+.+
T Consensus 257 p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 257 PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1110 11112234677899999999999999999999999765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=429.79 Aligned_cols=269 Identities=26% Similarity=0.373 Sum_probs=217.0
Q ss_pred cCHHHHHHHhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEcccccc-cCHHHHHHHHHHHhhccC-CCcceE
Q 007361 277 FDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQH-RNLVKL 348 (606)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l 348 (606)
++....+...++|.+.++||+|+||.||+|.+.. ++.||||++..... ...++|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444455567889999999999999999999754 35899999976543 345679999999999965 899999
Q ss_pred EEEEeeC-CeeEEEEecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecc
Q 007361 349 IGCCTQR-DERMLIYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 414 (606)
Q Consensus 349 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~D 414 (606)
+|+|.+. +..++|||||++|+|.++|.... ....++|..++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 56899999999999999996422 2356999999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCC
Q 007361 415 LKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGF 493 (606)
Q Consensus 415 lk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~ 493 (606)
|||+||||++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765555445556789999999999999999999999999999999998 8999864
Q ss_pred CCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 494 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 494 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..... ........+... . .+......+.+++..||+.||++|||+.+|++.|+.+
T Consensus 291 ~~~~~------~~~~~i~~g~~~-----~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGTRM-----R----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSH------HHHHHHHHTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcCCCC-----C----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 33211 111112221111 1 1111234677899999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=420.00 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=200.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC----eeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----ERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 362 (606)
++|.+.++||+|+||+||+|++ .|+.||||++..... ....+..|+..+.+++|||||+++|+|.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3466778999999999999998 689999999965432 2223445666677899999999999998754 579999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
||+++|+|.++|.. ..++|..+++++.|+++||+|||++ ..++|+||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999954 3489999999999999999999987 23459999999999999999999999999998
Q ss_pred ccCCCccc--ccccccccccCccCccccccC------CCCccccchhHHHHHHHHHhccCCCCCCCCCCcc--c------
Q 007361 438 AFGIDQTE--ANTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH--N------ 501 (606)
Q Consensus 438 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~--~------ 501 (606)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||+.|+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76443322 223346899999999999764 4788999999999999999999876543221110 0
Q ss_pred hhHHHHHHhhhcCcchhcccccCCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGS-YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
............ .+++.+... .+.+....+.+|+.+||+.||++||||.+|++.|+.+
T Consensus 237 ~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 011111111111 111222111 1234556788999999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=420.09 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=207.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+.|+..++||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 568888999999999999999864 8999999997766666778999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999853 34899999999999999999999998 99999999999999999999999999998754322
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ... ..........+ .
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~----~~i~~~~~~~~-----~- 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM----KMIRDNLPPRL-----K- 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHSSCCCC-----S-
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH----HHHHcCCCCCC-----C-
Confidence 234578999999999999999999999999999999999999998543211 111 11111111110 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.+|+.+||+.||++|||+.|+++
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111245678999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=422.75 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=200.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|.+.++||+|+||.||+|+... |+.||||++.+. .....+.|.+|+.++++++|||||++++++.+.+..++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999999754 899999999654 23345789999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.++|.. .+...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999954 23455899999999999999999999998 9999999999999999999999999998764321
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
......+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ..+. . ....+... .+
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~---~-~i~~~~~~-----~~ 245 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLV---L-KIISGSFP-----PV 245 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---H-HHHHTCCC-----CC
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHH---H-HHHcCCCC-----CC
Confidence 223346899999999999999999999999999999999999999864321 1111 1 11111111 11
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ...+.+|+.+||+.||++|||+.++++
T Consensus 246 ~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122 245778999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=416.80 Aligned_cols=263 Identities=23% Similarity=0.277 Sum_probs=207.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+.|...++||+|+||.||+|++.. |+.||||++..... ..+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 457778899999999999999865 89999999965432 246999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCccccCCCcc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQT 444 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~~~~~~ 444 (606)
++|+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999964 345999999999999999999999998 99999999999999987 699999999998754322
Q ss_pred c---ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 445 E---ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 445 ~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||....... +..... .... .+ .
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~----~~~~-~~--~ 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIA----SEPP-PI--R 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHH----HSCC-GG--G
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH----cCCC-Cc--h
Confidence 2 12334689999999999999999999999999999999999999986543321 111111 1111 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC----CCCCCCCCCCCC
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG----ERSLPQPKQPGF 574 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~----~~~~~~p~~p~~ 574 (606)
.+.... ...+.+++.+||+.||++|||+.|+++.|.. ...+.-|....+
T Consensus 277 ~~~~~~----s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 277 EIPPSC----APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp GSCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred hcCccC----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 111222 2456789999999999999999999877643 445666655444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=413.04 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=208.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.++||+|+||+||+++... |+.||+|++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999764 889999999753 3445678999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999954 345999999999999999999999998 999999999999999999999999999987655
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.........+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ..+.. ....... .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~----~i~~~~~------~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFA----KIIKLEY------D 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTCC------C
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHH----HHHcCCC------C
Confidence 444555668999999999999999999999999999999999999999854221 11111 1111111 1
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
+....+ ..+.+|+.+||+.||++|||+.|++
T Consensus 253 ~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 112222 3567899999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=401.15 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=195.2
Q ss_pred CcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEee----CCeeEEEE
Q 007361 290 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERMLIY 362 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 362 (606)
...++||+|+||.||+|.+.. +..||+|++... .....+.|.+|+.++++++|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 455789999999999999865 889999998654 23345679999999999999999999999865 34579999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~~~~ 441 (606)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999954 345999999999999999999999975 35999999999999984 79999999999986432
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... .........+.....++
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD- 252 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG-
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCCC-
Confidence 2 2345789999999998865 6999999999999999999999998532211 11111111111111111
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+ ..+.+|+.+||+.||++|||+.++++
T Consensus 253 ---~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ---KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 35678999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=420.90 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=208.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.+.|+..++||+|+||.||+|+... |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3568999999999999999999865 899999999877666677899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
|++|+|.+++.. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999853 34899999999999999999999998 99999999999999999999999999998754322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+. ..........+- ..
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~----~~i~~~~~~~~~---~~ 370 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM----KMIRDNLPPRLK---NL 370 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHSCCCCCS---CT
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH----HHHHcCCCCCCc---cc
Confidence 234578999999999999999999999999999999999999998532211 111 111111111100 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ...+.+|+.+||+.||++|||+.|+++
T Consensus 371 ~~~----s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKV----SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 235678999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=393.81 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=189.3
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.+.||+|+||+||+|+.. +|+.||+|++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 4899999999654 2344567999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899998854 345999999999999999999999998 999999999999999999999999999875432
Q ss_pred cccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ..+. ........
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~----~~i~~~~~------ 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLF----KNISNGVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCC------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHH----HHHHcCCC------
Confidence 2 2234689999999999998886 5799999999999999999999854221 1111 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+....+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111222 35678999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=403.58 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=191.5
Q ss_pred cCCCcCCeecccCcccEEEEEEe----CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|++.+.||+|+||+||+++.. .++.||+|.+.+.. ......+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999863 36789999996542 2234468899999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 345999999999999999999999998 9999999999999999999999999998754
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
... ......+||+.|||||++.+..|+.++||||+||+||||+||+.||...... .+... ......
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~----i~~~~~----- 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTM----ILKAKL----- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHCCC-----
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHH----HHcCCC-----
Confidence 322 2233478999999999999999999999999999999999999998643211 11111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
...... ...+.+|+.+||+.||++|||+
T Consensus 244 -~~p~~~----s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -GMPQFL----SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCCCcC----CHHHHHHHHHHcccCHHHCCCC
Confidence 111122 2356789999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=395.60 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=188.8
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCC--------
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-------- 356 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 356 (606)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46888999999999999999975 489999999965433 34567999999999999999999999987654
Q ss_pred ----eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEee
Q 007361 357 ----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD 432 (606)
Q Consensus 357 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~D 432 (606)
..++||||+++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976544455778889999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCcccc----------cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccch
Q 007361 433 FGMARAFGIDQTEA----------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 502 (606)
Q Consensus 433 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 502 (606)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence 99999875432211 1234579999999999999999999999999999999996 543110 00
Q ss_pred hHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 503 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 503 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ............. .......+.+|+.+||+.||++|||+.++++
T Consensus 234 ~~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0111111111000 0112234568999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=385.19 Aligned_cols=284 Identities=36% Similarity=0.600 Sum_probs=244.4
Q ss_pred HHHHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 280 ~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
.++...+++|...+.||+|+||.||+|++.+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34455778999999999999999999998889999999998777677788999999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
+||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999965332 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
..............||+.|+|||++.+..++.++||||||+++|||++|+.|+.............+.............
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 54433333334467899999999999999999999999999999999999998766555555555555555555556667
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 566 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~ 566 (606)
+++.+...........+.+++.+||+.||++|||+.+|++.|+....+
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 777777777888888999999999999999999999999999876443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=376.98 Aligned_cols=289 Identities=42% Similarity=0.684 Sum_probs=242.3
Q ss_pred cCccCHHHHHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEE
Q 007361 274 LPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCC 352 (606)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 352 (606)
...++..++....++|...+.||+|+||.||+|...+++.||+|++..... .....+.+|+.++.+++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788899999999999999999999999999988899999999976532 2334789999999999999999999999
Q ss_pred eeCCeeEEEEecCCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 353 TQRDERMLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 353 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997543 34459999999999999999999999922239999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCC--CCCccchhHHHHHH
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH--ADHHHNLLGHAWRL 509 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~--~~~~~~l~~~~~~~ 509 (606)
|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.|++... ......+..+....
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999876543322 2333569999999999999999999999999999999999999986322 22223334444444
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
........+++..+...........+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 445555667777777788888899999999999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=384.95 Aligned_cols=262 Identities=19% Similarity=0.264 Sum_probs=198.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEee------CCe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ------RDE 357 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 357 (606)
++|.+.++||+|+||.||+|++.. |+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 578999999999999999999854 8999999996543 2334678899999999999999999999764 357
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.+|||||++ |+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 679998843 456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCc--ccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 438 AFGIDQ--TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 438 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...... ..+...........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCC
Confidence 764332 22234457899999999998875 4699999999999999999999998643221 11111111000000
Q ss_pred -----------cchhccccc-CCCCCHHH-----HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 -----------PVELINKSL-GGSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 -----------~~~l~d~~l-~~~~~~~~-----~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
....+.... ....+... ...+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000 00011111 235678999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=374.00 Aligned_cols=199 Identities=25% Similarity=0.357 Sum_probs=171.3
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEe----CCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
...+.|.+.++||+|+||+||+|+.. .++.||+|++.+.. ....+.+|++++..+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 35678999999999999999999864 36789999986543 346788999999998 699999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CceEEeecCCcc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 437 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~ki~DFGla~ 437 (606)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999983 3899999999999999999999998 9999999999999876 799999999998
Q ss_pred ccCCCccc--------------------------ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCC
Q 007361 438 AFGIDQTE--------------------------ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRN 490 (606)
Q Consensus 438 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p 490 (606)
........ ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432211 112335799999999999876 489999999999999999999999
Q ss_pred CCC
Q 007361 491 RGF 493 (606)
Q Consensus 491 ~~~ 493 (606)
|..
T Consensus 247 f~~ 249 (361)
T 4f9c_A 247 FYK 249 (361)
T ss_dssp SSC
T ss_pred CCC
Confidence 843
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=357.07 Aligned_cols=284 Identities=35% Similarity=0.584 Sum_probs=231.5
Q ss_pred cccCccCHHHHHHHhcCCCcC------CeecccCcccEEEEEEeCCcEEEEEEccccc----ccCHHHHHHHHHHHhhcc
Q 007361 272 MELPIFDWMAIANATENFSDK------NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQ 341 (606)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~------~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~ 341 (606)
.+.+.|++.++..++++|... ++||+|+||.||+|.. +++.+|+|++.... ....+.+.+|+.++++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 445678999999999999887 8999999999999987 68899999986532 334578999999999999
Q ss_pred CCCcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 007361 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 421 (606)
Q Consensus 342 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIl 421 (606)
||||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999975555567999999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccc
Q 007361 422 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN 501 (606)
Q Consensus 422 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 501 (606)
++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.|+........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 99999999999999987654433333445678999999998765 589999999999999999999999865433221
Q ss_pred hhHHHHHHhh--hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 502 LLGHAWRLWI--EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 502 l~~~~~~~~~--~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
+... ..... .......++..+ ..........+.+++..||+.+|.+||++.+|++.|+.+.
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDI-KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHH-HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHH-HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111 11111 111223333333 2345667778999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=396.17 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=206.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|.+.+.||+|+||.||+++... |+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3689999999999999999999865 899999999776666677899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC--CceEEeecCCccccCCC
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARAFGID 442 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~--~~~ki~DFGla~~~~~~ 442 (606)
+++|+|.++|.. +...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999853 3346999999999999999999999998 9999999999999854 89999999999987533
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .... ....... .+ ...
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~----~i~~~~~-~~-~~~ 378 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLR----NVKSCDW-NM-DDS 378 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHTTCC-CC-CSG
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH----HHHhCCC-CC-Ccc
Confidence 2 233468999999999999999999999999999999999999998643221 1111 1111100 00 000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.....+ ..+.+|+..||+.||++|||+.|+++
T Consensus 379 ~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122 35678999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=391.89 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=198.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHH---HHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENE---VLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.++|.+.++||+|+||.||+++... |+.||+|++.+. .......+.+| +.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4689999999999999999999865 899999999653 12333334444 5666778999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||++||+|.++|.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999964 345999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
+.... ....+||+.|||||++.+ ..|+.++||||+||+||||++|+.||..........+.. ......
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~----~i~~~~--- 410 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTMA--- 410 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH----HHHHCC---
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hhcCCC---
Confidence 65332 334789999999999974 579999999999999999999999986433221111111 111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVV 557 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl 557 (606)
.......+ ..+.+|+..||+.||.+|++ +.+|+
T Consensus 411 ---~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 ---VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp ---CCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred ---CCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 01112222 35678999999999999998 56765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=358.64 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=211.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|...++||+|+||.||++.+.. ++.+|+|++........+.|.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3578888999999999999999864 889999998777667778899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999642 345899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cc------------cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhh
Q 007361 445 EA------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512 (606)
Q Consensus 445 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 512 (606)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------- 235 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence 11 1114579999999999999999999999999999999999999876543322111100
Q ss_pred cCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 513 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
.....+....... ...+.+++..||+.||++|||+.++++.|+.++
T Consensus 236 --~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 236 --VRGFLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp --HHHHHHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hhccccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0011111111111 235678999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=362.06 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=202.8
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..++|.+.++||+|+||.||+|+. .|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356788899999999999999987 68899999986543 234567899999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999965433345999999999999999999999975 34999999999999999999999999999865332
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ........
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~---~~~~~~~~-------- 256 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VV---AAVGFKCK-------- 256 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH---HHHHHSCC--------
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhcCC--------
Confidence 2 12234678999999999999999999999999999999999999986432110 00 00000000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
....+......+.+++.+||+.+|++|||+.++++.|+....
T Consensus 257 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 257 -RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001111222457789999999999999999999999987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.85 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=210.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe--------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR 355 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 355 (606)
.++|.+.+.||+|+||.||+|++. .+..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999864 24579999997653 33456799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999965321 235899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 501 (606)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999987654443334444567889999999999999999999999999999999 99987643221 1
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+. ........ ...+......+.+++..||+.+|++||++.++++.|+.+
T Consensus 314 ~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 LF----KLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HH----HHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11111110 111112234678899999999999999999999999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=362.80 Aligned_cols=265 Identities=24% Similarity=0.362 Sum_probs=207.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC----eeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----ERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 361 (606)
.++|.+.++||+|+||.||+|++. ++.||||++.... .....+..|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467889999999999999999874 8999999996543 33445677999999999999999999998754 36999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD----------SRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
|||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999954 3489999999999999999999998 6 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccc-----CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHH-
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH- 505 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~- 505 (606)
|||+++.+.............||+.|+|||++.+ ..++.++||||||+++|||++|+.|+..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999988765544444445689999999999987 3567789999999999999999999865433222111110
Q ss_pred --------HHHHhhhcCcchhcccccCCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 506 --------AWRLWIEERPVELINKSLGGS-YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 506 --------~~~~~~~~~~~~l~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.......... .+.+... ........+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000000000 0111100 1123455688999999999999999999999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=351.71 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=207.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
..++|...++||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3468999999999999999999964 488999999977766677889999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999854 24899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ .+
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~~----- 236 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL----- 236 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC-----
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-CC-----
Confidence 2 233467999999999999999999999999999999999999997543211 111111111110 00
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+++..||+.||++|||+.++++
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011112345778999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=351.88 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=213.2
Q ss_pred CccCHHHHHHHhcC----------CCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCC
Q 007361 275 PIFDWMAIANATEN----------FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 343 (606)
Q Consensus 275 ~~~~~~~~~~~~~~----------~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ 343 (606)
+.++..++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777777777654 566779999999999999987 5999999999877777788899999999999999
Q ss_pred CcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 007361 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423 (606)
Q Consensus 344 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~ 423 (606)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999999842 35899999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh
Q 007361 424 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 503 (606)
Q Consensus 424 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~ 503 (606)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------ 247 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------ 247 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 999999999999987654322 223467999999999999999999999999999999999999997533211
Q ss_pred HHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 504 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 504 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.............+ . ........+.+++.+||+.||++|||+.++++
T Consensus 248 -~~~~~~~~~~~~~~-----~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 248 -QAMKRLRDSPPPKL-----K--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHHHHHHHSSCCCC-----T--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHhcCCCCCc-----C--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111111111110 0 00111245778999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.94 Aligned_cols=259 Identities=26% Similarity=0.375 Sum_probs=206.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEe----CCcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.++|.+.+.||+|+||.||+|.+. .+..||||++... .....+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356788899999999999999985 3456999999764 33445679999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999954 2345999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 441 IDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 441 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |+.|+...... .+ .......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~----~~~~~~~----- 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV----ISSVEEG----- 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH----HHHHHTT-----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcC-----
Confidence 432221 2223456788999999999999999999999999999999 99997533211 11 1111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
.....+......+.+|+..||+.+|++||++.+|+++|+.+..
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111111223467889999999999999999999999987643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.08 Aligned_cols=269 Identities=26% Similarity=0.379 Sum_probs=213.9
Q ss_pred cCHHHHHHHhcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceE
Q 007361 277 FDWMAIANATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKL 348 (606)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 348 (606)
++........++|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445555567789999999999999999999853 257899999976432 3456799999999999 79999999
Q ss_pred EEEEeeCCe-eEEEEecCCCCCchhhhcccCC------------------------------------------------
Q 007361 349 IGCCTQRDE-RMLIYEYLPNKSLNDFIFDVTR------------------------------------------------ 379 (606)
Q Consensus 349 ~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 379 (606)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999965332
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 380 ---------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 380 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 223899999999999999999999998 99999999999999999999999999987654444
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
........||+.|+|||++.+..++.++||||||+++|||++ |+.|+....... ............
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~------- 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM------- 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCC-------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCC-------
Confidence 344445678999999999999999999999999999999998 999975433221 111111111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+......+.+++..||+.+|++|||+.+|++.|+.+
T Consensus 316 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 --RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11111224577899999999999999999999999764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=364.69 Aligned_cols=271 Identities=26% Similarity=0.390 Sum_probs=215.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC--------CcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR 355 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 355 (606)
.++|.+.++||+|+||.||+|+... +..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4678888999999999999999632 3579999986643 33457789999999999 999999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999965331 245999999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 501 (606)
+.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999987755444344445677899999999999999999999999999999999 99887533211
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCc
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF 575 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~~~~p~~p~~~ 575 (606)
........... ...+......+.+++..||+.+|++|||+.+|++.|+.+.........+..
T Consensus 301 ---~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 301 ---ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp ---HHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred ---HHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 11111111111 111112234678899999999999999999999999987655544444443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=344.61 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=208.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|...+.||+|+||.||+|...+++.||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5688889999999999999999889999999996543 345789999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 9999999954 3346899999999999999999999998 999999999999999999999999999876433221
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ....... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~----~~~~~~~---------~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EV----VEDISTG---------FRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTT---------CCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HH----HHHHhcC---------ccC
Confidence 2233456788999999999999999999999999999999 88887543211 11 1111111 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+......+.+++..||+.+|++||++.++++.|+.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11111234577899999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=367.99 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=207.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|...++||+|+||.||+|++. +++.||+|.+..... ...+.|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888899999999999999986 588999999875432 234568899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999964 2335899999999999999999999998 9999999999999999999999999998754332
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ........+.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~-------- 332 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGG-------- 332 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTC--------
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC--------
Confidence 2222222345778999999999999999999999999999998 88887543211 0111111110
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....+......+.+|+..||+.+|++|||+.+|++.|+.+
T Consensus 333 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 -RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0011111234677899999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=363.33 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=196.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEe----CCcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.++|.+.+.||+|+||.||+|++. .+..||+|++... .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999975 4678999999754 33445689999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999964 3345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 441 IDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 441 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |+.|+...... .+. .....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~----~~i~~------ 265 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVI----KAVDE------ 265 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHH----HHHHT------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHc------
Confidence 432221 1222345778999999999999999999999999999998 99997533211 111 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
......+......+.+++..||+.+|++||++.+|+++|+.+
T Consensus 266 ---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 266 ---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111111222335678999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=354.90 Aligned_cols=264 Identities=28% Similarity=0.399 Sum_probs=204.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-----CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--Cee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 358 (606)
.++|++.++||+|+||.||++++. .++.||+|++........+.+.+|+.++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 367888899999999999999842 4889999999877666678899999999999999999999998653 558
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999642 334899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCC--------Cccch-hHHHHH
Q 007361 439 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD--------HHHNL-LGHAWR 508 (606)
Q Consensus 439 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~--------~~~~l-~~~~~~ 508 (606)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+...... ..... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543222 2223345777899999999999999999999999999999999886532110 00000 000011
Q ss_pred HhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 509 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.+........+......+.+++..||+.+|++|||+.++++.|+.+
T Consensus 244 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 ---------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp ---------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111111111222335678899999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=343.43 Aligned_cols=257 Identities=28% Similarity=0.383 Sum_probs=209.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|.+.+.||+|+||.||++...++..||+|++.... ...+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46788889999999999999999888899999996543 34578999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999542 345899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
. .....+|..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .......... .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--~------ 224 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHR--L------ 224 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCC--C------
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCC--C------
Confidence 2 223456778999999999999999999999999999999 999975432210 0111111100 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
..+......+.+++..||+.+|++|||+.++++.|+.+..
T Consensus 225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 -YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0011112357789999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=355.18 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=200.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-Cc----EEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|...++||+|+||.||+|++.. ++ .||+|.+... .....++|.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 568888999999999999999754 43 3688887543 3456678999999999999999999999998754 789
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999652 345899999999999999999999998 9999999999999999999999999998876
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
............+|..|+|||++.+..++.++||||||+++|||++ |+.|+....... +.. .+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~-------------~~ 232 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS-------------IL 232 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH-------------HH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH-------------HH
Confidence 5544444444567889999999999999999999999999999999 999976433221 111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
........+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111111222334678899999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=372.22 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=210.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|.+.++||+|+||.||+|++.. +..||||.+.... ...++|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568888999999999999999876 8899999996543 4578899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999653 2345899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......+|..|+|||++.+..++.++||||||++||||++ |+.|+...... .+. ..... ..
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~---------~~ 436 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY----ELLEK---------DY 436 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH----HHHHT---------TC
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHc---------CC
Confidence 2 2223456789999999999999999999999999999999 88887543221 111 11111 11
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
....+......+.+|+.+||+.+|++|||+.+|++.|+...
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11112222356788999999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.58 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=203.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468899999999999999999986 58899999986443 2334678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999843 345999999999999999999999998 9999999999999999999999999998765444
Q ss_pred ccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+...... ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~--~~-- 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--LN-- 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------HHHHHHTTCTT--ST--
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHhccccc--CC--
Confidence 3334445789999999999988775 7899999999999999999999864332211 01111111100 00
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
........+.+|+..||+.||++|||+.++++-
T Consensus 230 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001112456789999999999999999999753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=370.31 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=209.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..++|...++||+|+||.||+|.+.++..||||++.... ...+.|.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456788889999999999999999889999999997543 45789999999999999999999999986 5678999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999542 1234889999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......+|..|+|||++....++.++||||||++||||++ |+.|+...... .+. .....+.
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~----~~i~~~~--------- 402 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALERGY--------- 402 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHHHHTC---------
T ss_pred e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCC---------
Confidence 1 1223456789999999999999999999999999999999 99997543211 111 1111110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
....+......+.+|+..||+.||++|||+.+|+++|+....
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 001111223467889999999999999999999999998643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.01 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=211.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3467888999999999999999873 34789999997543 3445778999999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTR---------------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK 416 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk 416 (606)
.++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999965332 234899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCC
Q 007361 417 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYH 495 (606)
Q Consensus 417 ~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~ 495 (606)
|+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755444333444567889999999999999999999999999999999 999975433
Q ss_pred CCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 496 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 496 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
... + ......... ...+......+.+++..||+.||++||++.++++.|+.+
T Consensus 258 ~~~---~----~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PER---L----FNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGG---H----HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---H----HHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 211 1 111111110 111112234678899999999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.52 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=203.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++|.+.+.||+|+||.||+|++. .|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467899999999999999999984 5899999998654 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998543 34899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccccccccccccCccCccccccCCCC-ccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
. ......||+.|+|||++.+..+. .++||||||+++|||++|+.||...... .+ ......+..
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~----~~~i~~~~~------ 231 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---EL----RERVLRGKY------ 231 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCC------
Confidence 2 23446799999999999988875 8999999999999999999998643211 11 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. .+......+.+++..||+.||.+|||+.++++
T Consensus 232 ~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 R----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp C----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred C----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 11112245678999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.10 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=209.0
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccc-cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD 356 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 356 (606)
..++|...+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578889999999999999999973 3568999999754 334567899999999999 8999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRS--------------------KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK 416 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk 416 (606)
..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999653321 34899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCC
Q 007361 417 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYH 495 (606)
Q Consensus 417 ~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~ 495 (606)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.|+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654443333444667889999999999999999999999999999998 999976443
Q ss_pred CCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 496 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 496 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
... ......... .....+......+.+|+..||+.||.+||++.+|++.|+..
T Consensus 280 ~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 280 VDA------NFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp CSH------HHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHH------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 221 111111111 11111112234678899999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=354.73 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=212.0
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD 356 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 356 (606)
...++|.+.+.||+|+||.||+|+... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 346789999999999999999999853 4789999997653 334567999999999999999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTR---------------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL 415 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl 415 (606)
..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999965321 256999999999999999999999998 999999
Q ss_pred CCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCC
Q 007361 416 KASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFY 494 (606)
Q Consensus 416 k~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~ 494 (606)
||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987654433333344568899999999999999999999999999999999 99887532
Q ss_pred CCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 495 HADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 495 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
... ........+.... .+......+.+++..||+.+|++||++.+|++.|+.+..
T Consensus 281 ~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 281 AHE-------EVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CHH-------HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ChH-------HHHHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 211 1111111111110 111223467889999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=360.92 Aligned_cols=259 Identities=29% Similarity=0.416 Sum_probs=207.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.++|.+.++||+|+||.||+|++. .++.||||++... .......+.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888899999999999999953 3668999999654 334456789999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---ceEEe
Q 007361 359 MLIYEYLPNKSLNDFIFDVT----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKIS 431 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~ki~ 431 (606)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996532 2245899999999999999999999998 99999999999999554 59999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHh
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |..|+...... .+ ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~----~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EV----LEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH----HHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHH
Confidence 9999986543333333344678899999999999999999999999999999998 88887543211 11 1111
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..... ...+......+.+|+..||+.+|++||++.+|++.|+..
T Consensus 300 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11110 111112234577899999999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.81 Aligned_cols=253 Identities=29% Similarity=0.449 Sum_probs=195.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEccccc----ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|...+.||+|+||.||+|.+ .++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788889999999999999997 58999999986543 23457899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--------CCceEEeec
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------EMNPKISDF 433 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~--------~~~~ki~DF 433 (606)
|||+++++|.+++. ...+++..++.++.|++.||.|||+.+..+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 346899999999999999999999988666999999999999986 778999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
|++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .........
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~- 229 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMN- 229 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTS-
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcC-
Confidence 99986543222 2357899999999999999999999999999999999999997543211 111111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
......+......+.+++..||+.+|++|||+.++++.|+.
T Consensus 230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 --------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 01111112223467889999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.80 Aligned_cols=269 Identities=21% Similarity=0.278 Sum_probs=214.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC--eeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--ERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 361 (606)
.++|.+.++||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3578889999999999999999875 8899999997543 345678899999999999999999999998765 67999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCceEEeecCCcc
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMAR 437 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~ki~DFGla~ 437 (606)
|||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 788899999999998
Q ss_pred ccCCCcccccccccccccCccCccccc--------cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCcc-chhHHHHH
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAI--------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH-NLLGHAWR 508 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~ 508 (606)
....... .....||..|+|||++. +..++.++||||||+++|||++|+.||......... .....
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--- 238 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK--- 238 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH---
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH---
Confidence 7654322 23357899999999986 578999999999999999999999998643322111 11111
Q ss_pred HhhhcCcchhcc---------------cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 509 LWIEERPVELIN---------------KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 509 ~~~~~~~~~l~d---------------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
...+.+..... ..............+.+++..||+.||++|||+.++++-.++..
T Consensus 239 -~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 -IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp -HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred -HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111111000 01112344566667889999999999999999999999887643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=348.70 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=199.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------- 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 356 (606)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467888999999999999999986 58999999986543 334578999999999999999999999986654
Q ss_pred --------------------------------------------------eeEEEEecCCCCCchhhhcccCCCCCCCHH
Q 007361 357 --------------------------------------------------ERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 386 (606)
Q Consensus 357 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 386 (606)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999766555667888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc----------ccccccccccC
Q 007361 387 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE----------ANTNRVVGTYG 456 (606)
Q Consensus 387 ~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~----------~~~~~~~gt~~ 456 (606)
.++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999887543221 12233579999
Q ss_pred ccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHH
Q 007361 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCI 536 (606)
Q Consensus 457 y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~ 536 (606)
|+|||++.+..++.++||||||+++|||++|..|+.. . .............. ........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~-~~~~~~~~~~~~~~---------~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------R-VRIITDVRNLKFPL---------LFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------H-HHHHHHHHTTCCCH---------HHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------H-HHHHHHhhccCCCc---------ccccCChhHH
Confidence 9999999999999999999999999999998765210 0 00001011110000 0112234667
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 007361 537 QVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 537 ~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+++..||+.||++|||+.++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=341.83 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=199.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhh--ccCCCcceEEEEEeeC----CeeE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQR----DERM 359 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 359 (606)
.++|.+.++||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46789999999999999999988 7899999998643 33556667776666 7999999999997543 4589
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
+||||+++|+|.+++. ...+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 345999999999999999999999 666 9999999999999999999999
Q ss_pred ecCCccccCCCccc--ccccccccccCccCccccccC------CCCccccchhHHHHHHHHHhc----------cCCCCC
Q 007361 432 DFGMARAFGIDQTE--ANTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLEIVCG----------KRNRGF 493 (606)
Q Consensus 432 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~S~Gvvl~elltG----------~~p~~~ 493 (606)
|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.|+..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999875433222 122335799999999999877 566899999999999999999 666543
Q ss_pred CCCCCccchhHHHHHHhhhcCcchhcccccCC-CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 494 YHADHHHNLLGHAWRLWIEERPVELINKSLGG-SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 494 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
....... ............. .+.+.. .........+.+|+..||+.||++|||+.+|++.|+.
T Consensus 236 ~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPS--FEDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCC--HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcc--hhhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 2221111 1111111111000 001100 1122456678999999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.79 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=210.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 357 (606)
.++|...+.||+|+||.||+|++. .++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 467888999999999999999852 367899999975533 3457799999999999 99999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTR---------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999965332 225899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 501 (606)
+.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence 9999999999999988765544333444567889999999999999999999999999999999 998875433211
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
......... .....+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 256 ---~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 256 ---KFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ---HHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111111111 00011111234678899999999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=345.21 Aligned_cols=263 Identities=24% Similarity=0.393 Sum_probs=200.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|.+.+.||+|+||.||+++. .++.||+|++... ...+.|.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 5678889999999999999987 5789999998643 345789999999999999999999998873 4899999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc-eEEeecCCccccCCCccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGIDQTE 445 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~-~ki~DFGla~~~~~~~~~ 445 (606)
+++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976544456899999999999999999999943234999999999999988886 799999999765322
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+...... .....+... ...... ...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~-----~~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVH-NGTRPP-----LIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHH-TTCCCC-----CBT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHh-cCCCCC-----ccc
Confidence 12346899999999999999999999999999999999999998643221 111111111 111111 111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC-CCCCCCCCCC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE-RSLPQPKQPG 573 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~-~~~~~p~~p~ 573 (606)
.. ...+.+++.+||+.+|++|||+.++++.|+.+ ..++.+..|.
T Consensus 228 ~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 228 NL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred cc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 12 24577899999999999999999999999875 3344333333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.00 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=203.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..++|...++||+|+||.||+|.+.++..||||++.... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346788889999999999999999888899999997543 446789999999999999999999999876 678999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999532 2245899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ......+ .
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~----~~~i~~~---------~ 398 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERG---------Y 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTT---------C
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcC---------C
Confidence 1 1223456789999999999999999999999999999999 88887532211 11 1111111 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
....+......+.+|+..||+.+|++|||+.+|++.|+....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 011112223467889999999999999999999999998643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.23 Aligned_cols=259 Identities=18% Similarity=0.206 Sum_probs=207.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 367888999999999999999974 588999999865432 34688999999999 99999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc-----eEEeecCCccc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISDFGMARA 438 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~ki~DFGla~~ 438 (606)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998643 346999999999999999999999998 999999999999999887 99999999987
Q ss_pred cCCCcccc-----cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 439 FGIDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 439 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..................-...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 64433221 1245689999999999999999999999999999999999999987654332221111111100000
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+ .+.... . .+.+++..||+.+|.+||++.+|++.|+.
T Consensus 240 -~~~----~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 240 -PIE----VLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp -CHH----HHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred -CHH----HHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000 001111 1 77889999999999999999999999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=352.86 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=202.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcE----EEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQE----IAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|...++||+|+||.||+|++.. ++. ||+|.+.... ....+.+.+|+.++.+++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 568888999999999999999754 443 7888775432 344566789999999999999999999986 466899
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999954 2346899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
............+|..|+|||.+.+..++.++||||||+++|||++ |+.|+....... +. .........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~--- 236 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VP----DLLEKGERL--- 236 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HH----HHHHTTCBC---
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCCCC---
Confidence 5544444455678889999999999999999999999999999999 999986433221 11 111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
..+......+.+++..||+.+|++||++.++++.|+...
T Consensus 237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 ------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001111224668999999999999999999999997653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=349.54 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=203.6
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc------CHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ------GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
..+.|.+.+.||+|+||.||+++... |+.+|+|.+.+.... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34678899999999999999999864 889999998764322 35789999999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----ceEEeec
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDF 433 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~ki~DF 433 (606)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999943 456999999999999999999999998 99999999999998876 7999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..||...... .+. ......
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~----~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANITAV 233 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHTT
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhc
Confidence 9998764322 223467999999999999999999999999999999999999997542211 111 111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. . ++....... ...+.+++..||+.||++|||+.++++
T Consensus 234 ~~-~-~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY-D-FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC-C-CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC-C-CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 000000011 235678999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.77 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=205.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|...+.||+|+||.||++.+.++..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46788889999999999999999888899999996543 34578999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999642 345899999999999999999999998 999999999999999999999999999876433221
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ........ ..
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~---------~~ 239 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQG---------LR 239 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTT---------CC
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhcc---------cC
Confidence 2223456788999999999999999999999999999998 999975432210 01111111 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011111124677899999999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.27 Aligned_cols=260 Identities=23% Similarity=0.386 Sum_probs=192.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCc----EEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQ----EIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
..++|.+.+.||+|+||.||+|++.... .||+|.+... .....+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3568999999999999999999976533 7999998654 344567899999999999999999999999877665
Q ss_pred ------EEEEecCCCCCchhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceE
Q 007361 359 ------MLIYEYLPNKSLNDFIFDVT---RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK 429 (606)
Q Consensus 359 ------~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 429 (606)
++|+||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999986422 2235899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHH
Q 007361 430 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWR 508 (606)
Q Consensus 430 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 508 (606)
|+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. .
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~----~ 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIY----N 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH----H
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHH----H
Confidence 999999987654433333334567889999999999999999999999999999999 88887543221 111 1
Q ss_pred HhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 509 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....... ...+......+.+++..||+.||++|||+.++++.|+.+
T Consensus 251 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 251 YLIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111 011112234678999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=348.04 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=203.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|...+.||+|+||.||+++... |+.||+|.+.+. .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3578889999999999999999864 889999999654 344567889999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .+ .........
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~~------ 222 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL----FELILMEEI------ 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC------
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC------
Confidence 22 2234468999999999999999999999999999999999999997532211 11 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
...... ...+.+++..||+.||++|| ++.++++
T Consensus 223 ~~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 RFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111112 24567899999999999999 8888874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=362.08 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=204.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC-eeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-ERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~ 364 (606)
.++|...++||+|+||.||+|.+ .++.||||++.... ..+.|.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46788889999999999999988 47899999997543 5678999999999999999999999987765 78999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999653 2344799999999999999999999998 999999999999999999999999999864322
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ....+.
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~--------- 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGY--------- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTTC---------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCC---------
Confidence 112356889999999999999999999999999999998 999976443221 111 111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....+......+.+|+..||+.+|++|||+.++++.|+.+
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0111122235678899999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=341.29 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=204.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||+++.. .++.+|+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367889999999999999999975 48899999985543 23356789999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999542 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... ...... ..
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~-~~~~~~-~~ 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQ-DSVPNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHS-SCCCCH-HH
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhh-ccCCCc-ch
Confidence 322 223346799999999999999999999999999999999999999754321 111111111 111111 01
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhcCCCC
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGERS 565 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~vl~~L~~~~~ 565 (606)
...... ...+.+++.+|++.+|++|| ++.++.+.|+....
T Consensus 235 ~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 DVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 111112 24677899999999999999 99999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=341.12 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=194.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--------------------------cCHHHHHHHHHHHh
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--------------------------QGMEEFENEVLLIA 338 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 338 (606)
.++|.+.+.||+|+||.||+|+... ++.||+|++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3678899999999999999999754 78999999865421 12356899999999
Q ss_pred hccCCCcceEEEEEee--CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 007361 339 KLQHRNLVKLIGCCTQ--RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK 416 (606)
Q Consensus 339 ~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk 416 (606)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999999876 3346999999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCC---CCccccchhHHHHHHHHHhccCCCCC
Q 007361 417 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 417 ~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987653322 223357999999999998765 47889999999999999999999753
Q ss_pred CCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 494 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 494 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ... ......... .. ...... ...+.+++.+||+.||++||++.++++
T Consensus 243 ~~~------~~~-~~~~~~~~~-~~---~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI------MCL-HSKIKSQAL-EF---PDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH------HHH-HHHHHHCCC-CC---CSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH------HHH-HHHHhcccC-CC---CCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 110 111111100 00 001111 245778999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=343.49 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=200.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.++||+|+||.||+++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467889999999999999999998899999999865432 234678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 78777754 3345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh----
Q 007361 444 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL---- 518 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l---- 518 (606)
. ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ................
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGT
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhh
Confidence 2 2233578999999999876 5689999999999999999999999865433221 1111111100000000
Q ss_pred -----ccc--ccCCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 -----INK--SLGGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 -----~d~--~l~~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+. ......... ....+.+|+..||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 000001111 1236778999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=344.72 Aligned_cols=251 Identities=19% Similarity=0.268 Sum_probs=202.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|.+.+.||+|+||.||++.... ++.+|+|.+... ....+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4678899999999999999999865 788999988643 33456788999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCceEEeecCCccccCCC
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGID 442 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~ki~DFGla~~~~~~ 442 (606)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999853 2345899999999999999999999998 999999999999987 789999999999876433
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ......... . ...
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~-~-~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII----ENIMNAEYT-F-DEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHHTCCC-C-CHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHH----HHHHcCCCC-C-Chh
Confidence 2 223467899999999999999999999999999999999999997543211 111 111111100 0 000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ....+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001 1246778999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=334.62 Aligned_cols=255 Identities=27% Similarity=0.496 Sum_probs=201.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccC-------HHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQG-------MEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
.++|...+.||+|+||.||+|++. +++.||+|++....... .+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888999999999999999985 58899999986543221 267899999999999999999999987655
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc-----eEEee
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISD 432 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~ki~D 432 (606)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999999999998854 3456999999999999999999999975 34999999999999988776 99999
Q ss_pred cCCccccCCCcccccccccccccCccCcccc--ccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh
Q 007361 433 FGMARAFGIDQTEANTNRVVGTYGYMPPEYA--IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 433 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.|+......... . ....
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~-~~~~ 242 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----F-INMI 242 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----H-HHHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----H-HHHH
Confidence 999985432 22336789999999998 4556889999999999999999999998644322110 0 0111
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.... .....+......+.+++..||+.||++|||+.++++.|+.+
T Consensus 243 ~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEG--------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSC--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccC--------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 11111122234678999999999999999999999999753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=346.40 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=209.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe--------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEee
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ 354 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 354 (606)
..++|.+.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478889999999999999999873 46789999997543 33456789999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEE
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 421 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIl 421 (606)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965332 234899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCcc
Q 007361 422 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHH 500 (606)
Q Consensus 422 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 500 (606)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 99999999999999987755443333444567889999999999999999999999999999999 99887543211
Q ss_pred chhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 501 NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 501 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
........... ...+......+.+++..||+.+|.+||++.++++.|+.+.
T Consensus 267 ----~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 ----ELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp ----HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111111 0111122346778999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=334.18 Aligned_cols=261 Identities=16% Similarity=0.197 Sum_probs=208.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 457889999999999999999974 58899999885443 234578899999999 79999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc-----eEEeecCCccc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISDFGMARA 438 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~-----~ki~DFGla~~ 438 (606)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999642 345899999999999999999999998 999999999999987776 99999999987
Q ss_pred cCCCccc-----ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 439 FGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 439 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7543322 12344679999999999999999999999999999999999999987644332222221111111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.... +.... ...+.+++..||+.+|++||++.+|++.|+.+
T Consensus 241 ~~~~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHH-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111 11112 24677899999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.34 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=209.3
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR 355 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 355 (606)
...++|...+.||+|+||.||+|.... ...||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345788999999999999999999753 24799999865532 3456799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVT-----------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 424 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~ 424 (606)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 99999999999999999986421 1345899999999999999999999998 999999999999999
Q ss_pred CCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchh
Q 007361 425 EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLL 503 (606)
Q Consensus 425 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 503 (606)
++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----- 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-----
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-----
Confidence 99999999999987654433333344567889999999999999999999999999999998 888875432211
Q ss_pred HHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 504 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 504 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
......... .....+......+.+++..||+.+|.+|||+.+|++.|+..
T Consensus 275 -~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 -KFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111111111 00011111234677899999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.78 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=202.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.+.|.+.+.||+|+||.||++.... |+.+|+|.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4568889999999999999999864 88999999865432 2467899999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----ceEEeecC
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG 434 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~ki~DFG 434 (606)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999943 456999999999999999999999998 99999999999999887 89999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .... ......
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA----NVSAVN 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHHTC
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHH----HHHhcC
Confidence 998764322 223467999999999999999999999999999999999999997532211 1111 011000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ..... .... ....+.+++..||+.||++|||+.++++
T Consensus 234 ~-~~~~~-~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 Y-EFEDE-YFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-CCCHH-HHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-CcCcc-cccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000 0001 1235678999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.22 Aligned_cols=249 Identities=26% Similarity=0.373 Sum_probs=198.6
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 359 (606)
..++|.+.++||+|+||.||+++... ++.||+|++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34789999999999999999999865 889999999754 334567788999999988 7999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998543 45899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
... .......+||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+ .........
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~~~---- 241 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DL----FEAILNDEV---- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC----
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCC----
Confidence 322 12234468999999999999999999999999999999999999998543211 11 111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCH------HHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM------SSVVL 558 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~~vl~ 558 (606)
. .+......+.+++..||+.||++||++ .++++
T Consensus 242 --~----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --V----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --C----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --C----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 111122456789999999999999998 66663
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.36 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=198.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 360 (606)
.++|.+.++||+|+||.||+++... ++.+|+|++.+.. ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4678899999999999999999875 7789999987642 23345688999999887 89999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999854 345899999999999999999999998 9999999999999999999999999998632
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCc--cchhHHHHHHhhhcCcchh
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH--HNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~l 518 (606)
.. .......+||+.|+|||++.+..++.++||||||+++|||++|+.||........ ................
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 22 1223457899999999999999999999999999999999999999864322111 1111111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
.+... ....+.+|+..||+.||++||++
T Consensus 280 ---~~p~~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---RIPRS----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---CCCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 11111 22457789999999999999996
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=348.54 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=202.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc-----cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
.+.|.+.+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3578889999999999999999764 899999998542 2234678999999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc---eEEeecCC
Q 007361 360 LIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGM 435 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~ki~DFGl 435 (606)
+||||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887543 23345899999999999999999999998 999999999999986654 99999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ...........
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCC
Confidence 987654322 22345799999999999999999999999999999999999999754211 11111111110
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ..+...... ...+.+|+.+||+.||++|||+.++++
T Consensus 250 ~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000000011 246778999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=334.72 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=207.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|...+.||+|+||.||++...+++.+|+|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5678889999999999999999888999999996543 345789999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 9999999954 2345899999999999999999999998 99999999999999999999999999987643221 1
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ........... .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~i~~~~~---------~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFR---------L 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCC---------C
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-------HHHHHHhcCCc---------C
Confidence 2223456789999999999999999999999999999999 88887542211 01111111100 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111234677899999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.71 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=203.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3578889999999999999999865 788999998653 244567889999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999953 345999999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCcccccc---CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..........+... .....
T Consensus 168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~~~---- 236 (384)
T 4fr4_A 168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----FETTV---- 236 (384)
T ss_dssp T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----HHHCC----
T ss_pred C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhhcc----
Confidence 2 22344689999999999974 4589999999999999999999999865433222111111 11110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-MSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~vl~ 558 (606)
...+......+.+|+..||+.+|++||+ +.+|++
T Consensus 237 ------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111112246778999999999999998 666653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.77 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=210.1
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
..++|.+.+.||+|+||.||+|.+.. +..+|+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678888999999999999999876 788999998653 3456789999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999653 3455899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. .......+|..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... .... .
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~---------~ 228 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEK---------D 228 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHT---------T
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhc---------c
Confidence 2 22233567889999999999999999999999999999999 888875432211 111 1111 1
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.....+......+.+++..||+.+|++|||+.++++.|+..
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11111112234678899999999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.85 Aligned_cols=264 Identities=26% Similarity=0.418 Sum_probs=211.8
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeC
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR 355 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 355 (606)
....++|.+.+.||+|+||.||+|++. .++.||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999875 367899999975432 3445789999999999999999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVT-------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999986421 1245799999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~ 250 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVL 250 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------HHH
Confidence 9999999987654433333344567889999999999999999999999999999999 78886532211 111
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
......... ..+......+.+++..||+.+|++|||+.++++.|+....
T Consensus 251 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 RFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111110 0111223457789999999999999999999999987644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=347.64 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=194.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccC--CCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 361 (606)
.+.|.+.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++.+++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999988999999998654 33345789999999999986 9999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999964 345899999999999999999999998 99999999999997 57899999999988755
Q ss_pred CcccccccccccccCccCcccccc-----------CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
...........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... .....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~--- 231 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLH--- 231 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH---
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHH---
Confidence 444333445689999999999865 67899999999999999999999998532211 11110
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..++.......+......+.+|+..||+.||++|||+.++++
T Consensus 232 ------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 232 ------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 111111111111111245778999999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=343.41 Aligned_cols=269 Identities=26% Similarity=0.383 Sum_probs=213.4
Q ss_pred cCHHHHHHHhcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceE
Q 007361 277 FDWMAIANATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKL 348 (606)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 348 (606)
+.........++|.+.+.||+|+||.||+|++. .++.||+|++..... ...+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344445556788999999999999999999853 357899999876433 3456789999999999 79999999
Q ss_pred EEEEeeCC-eeEEEEecCCCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecc
Q 007361 349 IGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 414 (606)
Q Consensus 349 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~D 414 (606)
++++...+ ..++|+||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99997755 48999999999999999965332 223899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCC
Q 007361 415 LKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGF 493 (606)
Q Consensus 415 lk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~ 493 (606)
|||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654444333444678899999999999999999999999999999998 9998754
Q ss_pred CCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 494 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 494 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..... ............ .... .....+.+++..||+.+|.+|||+.+|++.|+.+
T Consensus 254 ~~~~~------~~~~~~~~~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDE------EFCRRLKEGTRM-----RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSH------HHHHHHHHTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhH------HHHHHhccCccC-----CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 33211 111111111110 0111 1224677899999999999999999999999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.08 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=198.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-Cc----EEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
.++|.+.++||+|+||.||+|.+.. ++ .|++|.+... .....+.+.+|+.++.+++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3678889999999999999999754 44 3577777543 3456788999999999999999999999998755 78
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999652 345899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.|+....... +... ....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~~~~----- 235 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKG----- 235 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTT-----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcC-----
Confidence 54444333444567889999999999999999999999999999999 999976433221 1110 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
.....+......+.+++..||+.+|++||++.++++.|+...
T Consensus 236 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 236 ----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111111122346788999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.30 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=193.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.++|.+.+.||+|+||.||+|.+.. +..+|+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4578888999999999999999754 4579999986543 334567999999999999999999999984 467899
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999642 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+...... ..... .......
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~----i~~~~~~--- 236 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERL--- 236 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCC---
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH----HHcCCCC---
Confidence 33221 1223456789999999999999999999999999999997 88887643221 11111 1111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+......+.+++..||+.+|++||++.++++.|+.+
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11112234677899999999999999999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.88 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=198.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|...++||+|+||+||+|+... ++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 468888999999999999999865 88999999865432 334778899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 55554432 2345999999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc---h--
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV---E-- 517 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~-- 517 (606)
. ......||+.|+|||++.+.. ++.++||||||+++|||++|..|+-... ................... .
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhc
Confidence 2 223357899999999998766 8999999999999999999998852211 1111111111111100000 0
Q ss_pred -hcccc---------cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 -LINKS---------LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 -l~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+.. ............+.+++..||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 000011122346678999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.21 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=202.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
..++|.+.+.||+|+||.||++.... ++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35679999999999999999999864 8899999986542 23456789999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CceEEeecCCccc
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARA 438 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~ki~DFGla~~ 438 (606)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998843 456899999999999999999999998 9999999999999765 4599999999987
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+ ......+.. ..
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~----~~~i~~~~~-~~ 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL----YAQIKAGAY-DY 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCC-CC
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHhCCC-CC
Confidence 65322 22346799999999999999999999999999999999999999753221 111 111111111 00
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+. .......+.+++..||+.||++||++.++++
T Consensus 250 ~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Cccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 0011245778999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.58 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=202.4
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
...++|.+.++||+|+||.||++... .|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999875 48899999986543 2345678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCceEEeecCCcc
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMAR 437 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~ki~DFGla~ 437 (606)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999998864 345999999999999999999999998 99999999999998 56789999999998
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
....... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||..... ..+ ......+.. .
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~----~~~i~~~~~-~ 231 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRL----YQQIKAGAY-D 231 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH----HHHHHHTCC-C
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHH----HHHHHhCCC-C
Confidence 7653322 22346799999999999999999999999999999999999999753221 111 111111111 0
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+. .. .....+.+|+..||+.||++|||+.++++
T Consensus 232 ~~~~~-~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSPE-WD----TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTTT-TT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCccc-cc----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 01 11245778999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=355.14 Aligned_cols=262 Identities=18% Similarity=0.183 Sum_probs=205.7
Q ss_pred HHHHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEee
Q 007361 279 WMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 354 (606)
Q Consensus 279 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 354 (606)
..++....++|.+.++||+|+||.||+|++.. ++.+|+|++.+. .....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34444567899999999999999999999876 788999998653 22233458899999999999999999999999
Q ss_pred CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
.+..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999964 2345999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
+++........ .....+||+.|+|||++. ...++.++||||||+++|||++|+.||...... .........
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~ 296 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNH 296 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhc
Confidence 99876433222 223468999999999997 567999999999999999999999998643211 111111000
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVL 558 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~vl~ 558 (606)
...... +...... ...+.+|+..||+.+|++ ||++.++++
T Consensus 297 ~~~~~~-----p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 KERFQF-----PTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHCCC-----CSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccccC-----CcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000000 0000111 235678888999888888 999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=340.45 Aligned_cols=266 Identities=19% Similarity=0.218 Sum_probs=200.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe----CCcEEEEEEccccccc-----------CHHHHHHHHHHHhhccCCCcceEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSGQ-----------GMEEFENEVLLIAKLQHRNLVKLIG 350 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 350 (606)
.++|.+.+.||+|+||.||+|... .+..+|+|++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999999999999986 4678999998655321 2234677888999999999999999
Q ss_pred EEee----CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC
Q 007361 351 CCTQ----RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 426 (606)
Q Consensus 351 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~ 426 (606)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 99999998543 26999999999999999999999998 99999999999998877
Q ss_pred --ceEEeecCCccccCCCccc-----ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCc
Q 007361 427 --NPKISDFGMARAFGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 499 (606)
Q Consensus 427 --~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~ 499 (606)
.+||+|||+++.+...... .......||..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876433211 112345799999999999999999999999999999999999999853222111
Q ss_pred cchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 500 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 500 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
............ ....+....... .....+.+++..||+.+|++||++.+|++.|+...
T Consensus 269 --~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 269 --AVQTAKTNLLDE-LPQSVLKWAPSG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp --HHHHHHHHHHHT-TTHHHHHHSCTT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred --HHHHHHHhhccc-ccHHHHhhcccc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111111111 111111111100 12246778999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=339.75 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=202.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-C-------cEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-G-------QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
.++|...+.||+|+||.||+|+... + ..||+|.+........+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578888999999999999999765 3 4799999977777777889999999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc--------eE
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--------PK 429 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~--------~k 429 (606)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999964 2334899999999999999999999998 999999999999988887 99
Q ss_pred EeecCCccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH
Q 007361 430 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 508 (606)
Q Consensus 430 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 508 (606)
|+|||++...... ....+|..|+|||.+.+ ..++.++||||||+++|||++|..|+..... ... ...
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~-~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQR-KLQ 229 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHH-HHH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHH-HHH
Confidence 9999998764321 23457889999999987 7799999999999999999997655321111 000 000
Q ss_pred HhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 509 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
.... . ..+... ....+.+++..||+.||++|||+.++++.|+.+..
T Consensus 230 ~~~~-~------~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYED-R------HQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHT-T------CCCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred Hhhc-c------CCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0000 0 000011 12356789999999999999999999999987544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=345.72 Aligned_cols=267 Identities=18% Similarity=0.186 Sum_probs=205.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccccc-----------CHHHHHHHHHHHhhccCCCcce
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-----------GMEEFENEVLLIAKLQHRNLVK 347 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~ 347 (606)
..++|.+.++||+|+||.||+|.+.. ++.||+|.+...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999865 378999998654321 1123445666777888999999
Q ss_pred EEEEEeeC----CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 007361 348 LIGCCTQR----DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423 (606)
Q Consensus 348 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~ 423 (606)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 4589999999 9999999964 3356999999999999999999999998 99999999999999
Q ss_pred --CCCceEEeecCCccccCCCcccc-----cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCC
Q 007361 424 --NEMNPKISDFGMARAFGIDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA 496 (606)
Q Consensus 424 --~~~~~ki~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~ 496 (606)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765332211 12335699999999999999999999999999999999999999864322
Q ss_pred CCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 497 DHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 497 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+. ....... .........+++..+..... ...+.+++..||+.+|++||++.+|+++|+..
T Consensus 267 ~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 DP--KYVRDSK-IRYRENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp CH--HHHHHHH-HHHHHCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CH--HHHHHHH-HHhhhhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 21 1111111 11122334444444422211 24567889999999999999999999999764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.58 Aligned_cols=264 Identities=28% Similarity=0.389 Sum_probs=209.8
Q ss_pred cCCCcCCeecccCcccEEEEEE-----eCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEe--eCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVL-----IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT--QRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 359 (606)
++|...+.||+|+||.||++++ ..++.||+|++........+.+.+|+.++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999984 347899999998776666778999999999999999999999986 456689
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999542 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCC--------ccchhHHHHHHh
Q 007361 440 GIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH--------HHNLLGHAWRLW 510 (606)
Q Consensus 440 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~--------~~~l~~~~~~~~ 510 (606)
...... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.....+. ........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 253 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL---- 253 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH----
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH----
Confidence 543322 22333567888999999999999999999999999999999999864321100 00000000
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
...+........+......+.+|+..||+.||++|||+.++++.|+.+.
T Consensus 254 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 254 -----LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred -----HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111111111222233456789999999999999999999999998763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.36 Aligned_cols=245 Identities=22% Similarity=0.266 Sum_probs=192.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc--cCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|...++||+|+||+||+|++. +++.||||++..... .....+..|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367899999999999999999987 589999999865432 2334455666666555 899999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+ +++|.+++... ...++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67998888643 345999999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..++... ..+...........
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~~--- 272 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPPE--- 272 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCHH---
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCcc---
Confidence 32 2233568999999998876 7999999999999999999997664221 11111111111110
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ....+.+++.+||+.||++|||+.++++
T Consensus 273 -~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 -FTAG----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cccC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0011 1246788999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=369.78 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=208.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..++|.+.++||+|+||.||+|.+.++..||||++.... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346788889999999999999999888899999996543 456789999999999999999999999876 678999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++|+|.++|... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999532 2245899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.......++..|+|||.+.+..++.++||||||++||||++ |+.|+...... .+ ......+.
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~----~~~i~~~~--------- 481 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGY--------- 481 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HH----HHHHHTTC---------
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCC---------
Confidence 11223456789999999999999999999999999999999 88887532211 11 11111110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
....+......+.+|+..||+.+|++|||+.+|+++|+....
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 011111223467889999999999999999999999997643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.47 Aligned_cols=257 Identities=19% Similarity=0.217 Sum_probs=204.1
Q ss_pred HHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC
Q 007361 281 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD 356 (606)
Q Consensus 281 ~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 356 (606)
.+....++|.+.++||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.++..++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 334456889999999999999999999875 789999998653 2233456889999999999999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999854 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCccccccCC----CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhh
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 512 (606)
+....... ......+||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ...... ..
T Consensus 216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i----~~ 287 (410)
T 3v8s_A 216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKI----MN 287 (410)
T ss_dssp EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH----HT
T ss_pred EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHH----Hh
Confidence 87643322 2233468999999999998765 889999999999999999999998543211 111111 00
Q ss_pred cCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 007361 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVL 558 (606)
Q Consensus 513 ~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~vl~ 558 (606)
.. ..+ ........ ...+.+|+..||+.+|.+ ||++.+|++
T Consensus 288 ~~-~~~-~~p~~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 288 HK-NSL-TFPDDNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HH-HHC-CCCTTCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cc-ccc-cCCCcccc----cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00 000 00000111 235678899999999988 999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=338.94 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=202.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||+++.. +|+.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357888999999999999999986 4889999998654 234567788999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999954 345899999999999999999999998 99999999999999999999999999987542
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ..........
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~-~~~~i~~~~~------ 220 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MK-TYEKILNAEL------ 220 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HH-HHHHHHHCCC------
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HH-HHHHHHhCCC------
Confidence 2 2346799999999999999999999999999999999999999753221 11 1111111110
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVV 557 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl 557 (606)
...... ...+.+++..||+.+|++|| ++.+++
T Consensus 221 ~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 221 RFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 111112 24567899999999999999 888887
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.65 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=200.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||+|.+. .++.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367889999999999999999974 4889999998653 233456789999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78898888543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ..+.
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~ 221 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVN 221 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCC
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHH
Confidence 32 2234579999999999998876 78999999999999999999998643221110 0000
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ...+......+.+++..||+.||.+|||+.++++
T Consensus 222 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000 0011112245678999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=333.04 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=198.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|...++||+|+||.||+|+...|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999999779999999986543 33457889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 985 88888854 2345899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc---c----
Q 007361 445 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP---V---- 516 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~---- 516 (606)
......+|+.|+|||++.+. .++.++||||||+++|||++|+.|+...... ............... .
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence 12235689999999999764 5899999999999999999999998643211 111111111100000 0
Q ss_pred -hhcccccCC-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 -ELINKSLGG-------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 -~l~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...++.... .........+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 000111245678999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=348.18 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=204.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.+.|.+.+.||+|+||.||+|.... ++.+|+|.+..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4678999999999999999999864 889999998766555566899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCceEEeecCCccccCCC
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGID 442 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~ki~DFGla~~~~~~ 442 (606)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999853 2345899999999999999999999998 999999999999974 578999999999876433
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ..... ...... . .+..
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~----i~~~~~-~-~~~~ 272 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQN----VKRCDW-E-FDED 272 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH----HHHCCC-C-CCSS
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCC-C-CCcc
Confidence 22 22357899999999999999999999999999999999999997543211 11111 111100 0 0011
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... .....+.+++..||+.||++|||+.++++
T Consensus 273 ~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 273 AFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111 12246778999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.30 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=205.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|.+.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 36788889999999999999998888899999986543 456789999999999999999999999864 5689999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998532 1225899999999999999999999998 999999999999999999999999999876543222
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. ....... ...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~~-----~~~-- 230 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI----QNLERGY-----RMV-- 230 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTC-----CCC--
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH----HHHhccc-----CCC--
Confidence 2223456789999999999999999999999999999999 88887532211 111 1111110 001
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.+......+.+++..||+.+|++|||+.++++.|+..
T Consensus 231 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 231 --RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1111234677899999999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.60 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=203.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 361 (606)
.++|...+.||+|+||.||+|++ .++.+|+|++.... ....+.|.+|+.++.+++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35788889999999999999998 58899999987543 33456799999999999999999999999887 778999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ ..|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999642 2335899999999999999999999875 3599999999999999999999999988765321
Q ss_pred CcccccccccccccCccCccccccCCCCc---cccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSV---KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.|+...... ..........
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~----- 227 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEG----- 227 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSC-----
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcC-----
Confidence 2246799999999998766554 899999999999999999997543211 1111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
.....+......+.+++..||+.+|++|||+.++++.|+.+.
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 ----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111122346788999999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=340.92 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=196.3
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
...++|.+.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345788899999999999999998753 4479999986542 3345679999999999999999999999987653
Q ss_pred -----eEEEEecCCCCCchhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceE
Q 007361 358 -----RMLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK 429 (606)
Q Consensus 358 -----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~k 429 (606)
.++|+||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 49999999999999998532 23456999999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHH
Q 007361 430 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWR 508 (606)
Q Consensus 430 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 508 (606)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...... .+..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---- 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD---- 260 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH----
Confidence 999999987654433333334567889999999999999999999999999999999 88887543221 1111
Q ss_pred HhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 509 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
........ ..+......+.+++..||+.+|++||++.++++.|+.+
T Consensus 261 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 261 YLLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111110 11112224678899999999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.00 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=195.4
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhcc--CCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 362 (606)
+.|.+.+.||+|+||.||++....++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 468899999999999999999888999999998654 3344578999999999996 599999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 578899999864 235899999999999999999999998 99999999999995 588999999999887544
Q ss_pred cccccccccccccCccCcccccc-----------CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 443 QTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .... .
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~-~--- 278 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL-H--- 278 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHH-H---
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHH-H---
Confidence 43333445689999999999865 46899999999999999999999998532211 1111 1
Q ss_pred hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+++.......+......+.+|+..||+.||++||++.++++
T Consensus 279 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 279 -----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111111111111245778999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=347.02 Aligned_cols=267 Identities=27% Similarity=0.362 Sum_probs=204.8
Q ss_pred CCcCCeecccCcccEEEEEEe-----CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--CeeEE
Q 007361 289 FSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERML 360 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 360 (606)
|.+.++||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 47899999997653 23456799999999999999999999999874 67899
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999954 23899999999999999999999998 9999999999999999999999999998775
Q ss_pred CCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+........ ................+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 43222 223335678889999999999999999999999999999999998643211000 0000000000000011112
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
........+......+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22111222223345788999999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=340.20 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=198.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 361 (606)
++|...+.||+|+||.||+++... ++.+|+|++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 578888999999999999999865 7899999997643 23345688999999988 899999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998542 35899999999999999999999998 99999999999999999999999999986432
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCc--cchhHHHHHHhhhcCcchhc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH--HNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~l~ 519 (606)
.. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||........ ................
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 21 223446899999999999999999999999999999999999999864322111 0111111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
.+... ....+.+++..||+.||++||++
T Consensus 237 --~~p~~----~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RIPRS----LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCCTT----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCCCC----CCHHHHHHHHHHhcCCHhHCCCC
Confidence 11111 22457789999999999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.28 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=197.6
Q ss_pred cCCCcC-CeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDK-NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~-~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 363 (606)
+.|.+. +.||+|+||.||++... +++.||+|++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 466664 78999999999999965 5899999999777666778899999999985 79999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc---eEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~ki~DFGla~~~~ 440 (606)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999643 45899999999999999999999998 999999999999988776 9999999998654
Q ss_pred CCcc-----cccccccccccCccCcccccc-----CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccch--------
Q 007361 441 IDQT-----EANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-------- 502 (606)
Q Consensus 441 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l-------- 502 (606)
.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223568999999999875 5689999999999999999999999865432211100
Q ss_pred hHHHHHHhhhcCcchhcccccCCCCCHH----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 503 LGHAWRLWIEERPVELINKSLGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 503 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
............. ..+.. ....+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0001111111100 11111 1246789999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.66 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=193.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.++||+|+||.||+|+.. ..+|+|++.... ....+.|.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467899999999999999999863 469999986543 33457799999999999999999999965 4566899999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999853 3455899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 444 TEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.........||+.|+|||.+. +..++.++||||||+++|||++|+.|+...... . ..............+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~----~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--D----QIIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--H----HHHHHHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--H----HHHHHhcccccCcchh
Confidence 333344567999999999986 667899999999999999999999998543221 1 1111111111111000
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
. ........+.+++..||+.+|++|||+.+++++|+.+.
T Consensus 249 -~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -K----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -S----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -h----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 11122356789999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=367.41 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=197.3
Q ss_pred eecccCcccEEEEEEe---CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 294 KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
+||+|+||.||+|.+. ++..||||++.... ....++|.+|+.++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 35679999997653 3457889999999999999999999999976 56899999999999
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc-ccc
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-ANT 448 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~-~~~ 448 (606)
|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...... ...
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999954 3456999999999999999999999998 999999999999999999999999999876533221 112
Q ss_pred cccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCC
Q 007361 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY 527 (606)
Q Consensus 449 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~ 527 (606)
....+|+.|+|||++.+..++.++||||||++||||++ |+.|+....... +. .....+. ....
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~---------~~~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGK---------RMEC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTTC---------CCCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCC---------CCCC
Confidence 22345789999999999999999999999999999998 999976433211 11 1111111 1111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 528 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 528 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+......+.+|+..||+.+|++||++.+|++.|+..
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222335678999999999999999999999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.32 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=202.6
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCee
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 358 (606)
...++|.+.+.||+|+||.||+++... |+.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 345789999999999999999999865 8899999997642 34567788999999887 899999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999542 35899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
..... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+ ........
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~---- 234 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL----FHSIRMDN---- 234 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCC----
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHhCC----
Confidence 43222 2234578999999999999999999999999999999999999997543211 11 11111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMS-SVV 557 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~vl 557 (606)
....... ...+.+++..||+.||++||++. +++
T Consensus 235 --~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 --PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111112 24577899999999999999997 654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=337.61 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=188.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|...++||+|+||.||+|.... |+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678899999999999999999764 8899999986543 3345788999999999999999999999999999999999
Q ss_pred cCCCCCchhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999988542 12245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC-----
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER----- 514 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 514 (606)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .............
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhh
Confidence 3322 22335789999999999764 68999999999999999999999986433211 1111111000000
Q ss_pred -------------------cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 -------------------PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 -------------------~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+.+.+...... ...+.+++..||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000011111111 236789999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.27 Aligned_cols=270 Identities=23% Similarity=0.313 Sum_probs=198.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe----
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE---- 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 357 (606)
.++|.+.+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467889999999999999999974 588999999976532 234578899999999999999999999876554
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999999642 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 438 AFGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 438 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence 76443222 2233467899999999999999999999999999999999999997543211 1111111111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH-HHhcCCCCCCCCCCCCC
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV-LMLSGERSLPQPKQPGF 574 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl-~~L~~~~~~~~p~~p~~ 574 (606)
. ...... ....+.+++.+||+.||++||++.+++ ..|........|..|..
T Consensus 239 ~---~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 290 (311)
T 3ork_A 239 P---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290 (311)
T ss_dssp H---HHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred c---ccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 0 000011 124577899999999999999665544 55544333333433433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=340.53 Aligned_cols=268 Identities=23% Similarity=0.317 Sum_probs=198.8
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhc--cCCCcceEEEEEeeC----C
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL--QHRNLVKLIGCCTQR----D 356 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~ 356 (606)
....++|.+.++||+|+||.||+|+. .++.||+|++.... ...+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34557899999999999999999987 48999999985432 33445555665554 899999999999887 7
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCCCCEEEcCCCceEEe
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. +.+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 88999999999999999953 34899999999999999999999981 1129999999999999999999999
Q ss_pred ecCCccccCCCcccc--cccccccccCccCccccccCCCCcc------ccchhHHHHHHHHHhccC----------CCCC
Q 007361 432 DFGMARAFGIDQTEA--NTNRVVGTYGYMPPEYAIDGLFSVK------SDVFSFGVLVLEIVCGKR----------NRGF 493 (606)
Q Consensus 432 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------~DV~S~Gvvl~elltG~~----------p~~~ 493 (606)
|||+++.+....... ......||+.|+|||++.+...+.+ +||||||+++|||++|.. |+..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998764332221 1234579999999999988776665 999999999999999954 4332
Q ss_pred CCCCCccchhHHHHHHhhhcCcchhcccccCCCC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 494 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSY-SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 494 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
...... ............ ...+...... .......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 265 ~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 265 LVPSDP--SYEDMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TSCSSC--CHHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC--chhhhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 211111 001111100000 0011111111 1245567899999999999999999999999998653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.32 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=204.5
Q ss_pred cCCCcCCeecccCcccEEEEEE-----eCCcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC--Cee
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVL-----IEGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER 358 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 358 (606)
+.|...++||+|+||.||++++ ..++.||+|++... .....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 35889999999754 334567899999999999999999999999876 668
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999999542 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCC--------CCCccchhHHHHHH
Q 007361 439 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH--------ADHHHNLLGHAWRL 509 (606)
Q Consensus 439 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~--------~~~~~~l~~~~~~~ 509 (606)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+.... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7544322 22334568888999999999999999999999999999999998743210 00000000001111
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
. ........+......+.+++..||+.||++|||+.++++.|+.+
T Consensus 256 ~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 L---------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp H---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1 11111111222335678999999999999999999999999753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=338.65 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=205.4
Q ss_pred hcCCCcCCeecccCcccEEEEEE-eCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEee----CCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 360 (606)
.++|.+.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46789999999999999999997 4589999999877666667889999999999999999999999863 347899
Q ss_pred EEecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 361 IYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
|+||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998642 23456999999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccc-------cccccccccCccCccccccCC---CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 440 GIDQTEA-------NTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 440 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+........ .+. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~-~~--- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA-LA--- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH-HH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh-HH---
Confidence 3221110 112345799999999987654 78999999999999999999999753211100 000 00
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
... .............+.+++..||+.||.+||++.++++.|+.+..
T Consensus 260 -~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 -VQN--------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -HHC--------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -hhc--------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 00001111123467889999999999999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=328.49 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=205.0
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467888999999999999999986 48899999986543 334578999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+...
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999999876443
Q ss_pred cccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
..........||..|+|||.+.+..+ +.++||||||+++|||++|+.|+........ ....+...... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~--~~- 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--LN- 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTTCTT--ST-
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhcccc--cC-
Confidence 33333445678999999999988775 7899999999999999999999864332110 11111111100 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.+++..||+.||++|||+.++++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00111235678999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.41 Aligned_cols=213 Identities=27% Similarity=0.317 Sum_probs=182.6
Q ss_pred ccccCccCHHHHHHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhcc-----CCC
Q 007361 271 EMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-----HRN 344 (606)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~n 344 (606)
+.+...+++.......++|.+.++||+|+||.||+|+.. +++.||+|++... ....+.+..|+.++..++ |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 344445566666667789999999999999999999985 4889999998642 334567788999999996 999
Q ss_pred cceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC
Q 007361 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 424 (606)
Q Consensus 345 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~ 424 (606)
|+++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDD 172 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcc
Confidence 999999999999999999999 99999999653 2335899999999999999999999998 999999999999975
Q ss_pred -------------------------CCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHH
Q 007361 425 -------------------------EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 479 (606)
Q Consensus 425 -------------------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gv 479 (606)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 789999999999864322 23467899999999999999999999999999
Q ss_pred HHHHHHhccCCCCCC
Q 007361 480 LVLEIVCGKRNRGFY 494 (606)
Q Consensus 480 vl~elltG~~p~~~~ 494 (606)
++|||++|+.||...
T Consensus 248 il~ell~g~~pf~~~ 262 (360)
T 3llt_A 248 VLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHSSCSCCCS
T ss_pred HHHHHHHCCCCCCCC
Confidence 999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=346.14 Aligned_cols=248 Identities=25% Similarity=0.308 Sum_probs=195.7
Q ss_pred CcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCCC
Q 007361 290 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK 368 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 368 (606)
...+.||+|+||.||+|.... |+.||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 335789999999999999754 8899999997766566778999999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE--cCCCceEEeecCCccccCCCcccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll--~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99998854 2345899999999999999999999998 9999999999999 6678999999999987643322
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .... ....... .+.... ...
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~----~i~~~~~-~~~~~~-~~~ 314 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLN----NILACRW-DLEDEE-FQD 314 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHHTCC-CSCSGG-GTT
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhccC-CCChhh-hcc
Confidence 23356999999999999999999999999999999999999997543211 1111 1111100 000000 011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ...+.+|+.+||+.+|++||++.++++
T Consensus 315 ~----~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 I----SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 246778999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=326.72 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=203.3
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEE-eeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC-TQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 362 (606)
..++|.+.+.||+|+||.||+|+.. .++.||+|++..... .+.+.+|+.++..++|++++..++.+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999974 588999998654332 23578899999999988877777665 6677889999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCceEEeecCCcccc
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAF 439 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~ki~DFGla~~~ 439 (606)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 345899999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCccc-----ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 440 GIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 440 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 122346789999999999999999999999999999999999999876544333333222211111111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
. . .+.... ...+.+++..||+.+|++||++.+|++.|+..
T Consensus 239 ~-~----~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 I-E----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-H----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-h----hhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0 0 011111 24678899999999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=332.45 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=204.4
Q ss_pred cCCCcCC-eecccCcccEEEEEEe---CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKN-KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~-~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
++|.+.+ .||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999864 47789999997643 34567899999999999999999999999 55678999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 3455999999999999999999999998 99999999999999999999999999987754
Q ss_pred Cccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 442 DQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 442 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. ........
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----~~i~~~~~---- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKR---- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCC----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHhcCCc----
Confidence 3322 22233456889999999998999999999999999999998 99997543221 111 11111110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+......+.+++..||+.+|++||++.++++.|+..
T Consensus 232 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111122235678899999999999999999999999764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=344.80 Aligned_cols=265 Identities=28% Similarity=0.405 Sum_probs=207.0
Q ss_pred hcCCCcCCeecccCcccEEEEEE-----eCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC--ee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVL-----IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--ER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 358 (606)
.++|.+.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688889999999999999984 358899999998776666788999999999999999999999987654 68
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999643 345899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCC--------CCccchhHHHHHH
Q 007361 439 FGIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA--------DHHHNLLGHAWRL 509 (606)
Q Consensus 439 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~--------~~~~~l~~~~~~~ 509 (606)
........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+..... ..........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 271 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH--- 271 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH---
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH---
Confidence 75443221 12234567789999999999999999999999999999999988542110 0000000000
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+.+........+......+.+++..||+.+|++||++.+|++.|+.+
T Consensus 272 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 -----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp -----HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011111111111122235678899999999999999999999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=341.87 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=188.0
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
..+.|.+.+.||+|+||.||+|+... ++.||+|++.... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 35678899999999999999999875 7889999986543 34678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~DFGla~~~~ 440 (606)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999853 455899999999999999999999998 999999999999975 8899999999998754
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ........... ....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-~~~~ 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-CCCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-ccCC
Confidence 321 2234678999999999999999999999999999999999999975332210 01111111111 0000
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.........+.+++.+||+.||++|||+.++++
T Consensus 273 -----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112346778999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=337.60 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=178.3
Q ss_pred CCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 292 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
.+.||+|+||.||++.... ++.||+|++.+. ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 4789999999999999864 889999998643 3467889999999997 9999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---ceEEeecCCccccCCCcccc
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~---~~ki~DFGla~~~~~~~~~~ 446 (606)
|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 9999964 345999999999999999999999998 99999999999997665 899999999986543222
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....................+... ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence 2233578999999999999999999999999999999999999986543221111111111111111100 0000
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.+|+..||+.||++|||+.++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00011346788999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=337.06 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=197.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|...++||+|+||.||+|+... |+.||+|++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578889999999999999999865 88999999865432 235678899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999998743 345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH--------HHHhhhcC
Q 007361 444 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WRLWIEER 514 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 514 (606)
. ......||..|+|||++.+ ..++.++||||||+++|||++|+.|+............... ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 2233578999999999976 66899999999999999999999998654322111111000 00000000
Q ss_pred cchhcc-cccCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELIN-KSLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d-~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...-.. +....... ......+.+++..||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00000000 011235778999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=332.57 Aligned_cols=256 Identities=27% Similarity=0.318 Sum_probs=201.6
Q ss_pred CCCcCCeecccCcccEEEEEEeC-C---cEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee-EEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER-MLI 361 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 361 (606)
.|...++||+|+||.||+|.+.+ + ..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999999754 2 2699999875433 3457889999999999999999999999876665 999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999954 3456899999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccc--cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 442 DQT--EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 442 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
... ........+|..|+|||.+.+..++.++||||||+++|||++|..|+..... ...+... .....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~----~~~~~----- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHF----LAQGR----- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHH----HHTTC-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHH----hhcCC-----
Confidence 321 2223345678999999999999999999999999999999997766322111 1111111 11110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....+......+.+++..||+.+|.+|||+.++++.|+.+
T Consensus 246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011111224677899999999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.83 Aligned_cols=206 Identities=17% Similarity=0.237 Sum_probs=177.5
Q ss_pred HhcCCCcCCeeccc--CcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 285 ATENFSDKNKLGEG--GFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G--~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
..++|.+.++||+| +||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34678899999999 99999999987 48999999996543 334567889999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998653 2345899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCcc-----cccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 440 GIDQT-----EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 440 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
..... ........||..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 22111 112233478999999999987 67999999999999999999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=341.00 Aligned_cols=244 Identities=21% Similarity=0.246 Sum_probs=202.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|...+.||+|+||.||+++... |+.||+|.+.+. .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 578889999999999999999864 889999998654 2345678899999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999643 34899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . .......... .
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~----~~~~i~~~~~------~ 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---Q----IYEKIVSGKV------R 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCC------C
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---H----HHHHHHcCCC------C
Confidence 23467999999999999999999999999999999999999997532211 1 1111111111 1
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
+.... ...+.+++..||+.||++||+ +.+|++
T Consensus 257 ~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11112 245778999999999999998 788874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.40 Aligned_cols=257 Identities=23% Similarity=0.273 Sum_probs=189.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEe--------eC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCT--------QR 355 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~~ 355 (606)
..+|.+.++||+|+||.||+++.. +++.||+|++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457888999999999999999975 48899999997666666778999999999996 999999999994 33
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
...++|+||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45799999996 799998865445567999999999999999999999875 3499999999999999999999999999
Q ss_pred ccccCCCcccc----------cccccccccCccCcccc---ccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccch
Q 007361 436 ARAFGIDQTEA----------NTNRVVGTYGYMPPEYA---IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 502 (606)
Q Consensus 436 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 502 (606)
++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----- 259 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----- 259 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence 98765332211 11235689999999998 5677899999999999999999999997532211
Q ss_pred hHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 503 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 503 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+...............+.+|+..||+.+|++||++.++++.|+..
T Consensus 260 --------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 260 --------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000000000111112467899999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.38 Aligned_cols=261 Identities=20% Similarity=0.227 Sum_probs=200.5
Q ss_pred HHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc-----cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC
Q 007361 282 IANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR 355 (606)
Q Consensus 282 ~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 355 (606)
+....++|.+.+.||+|+||.||+|.... ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 45677889999999999999999999854 788999988653 334567899999999999999999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVT-------------------------------------RSKFLDWSKRCQIIGGIARG 398 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g 398 (606)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01224677888999999999
Q ss_pred HHHHHhCCCCCeeeccCCCCCEEEcCCC--ceEEeecCCccccCCCccc--ccccccccccCccCcccccc--CCCCccc
Q 007361 399 LLYLHQDSRLRIIHRDLKASNVLLDNEM--NPKISDFGMARAFGIDQTE--ANTNRVVGTYGYMPPEYAID--GLFSVKS 472 (606)
Q Consensus 399 L~yLH~~~~~~iiH~Dlk~~NIll~~~~--~~ki~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~k~ 472 (606)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 8999999999876432221 12334678999999999975 6789999
Q ss_pred cchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 007361 473 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 552 (606)
Q Consensus 473 DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 552 (606)
||||||+++|||++|+.|+...... ..... ...... ....+. .......+.+++..||+.+|++||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~-~~~~~~-~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQ-VLNKKL-CFENPN-----YNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCC-CTTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH------HHHHH-HHhccc-ccCCcc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999997543211 11111 111110 000000 0011246778999999999999999
Q ss_pred HHHHHH
Q 007361 553 MSSVVL 558 (606)
Q Consensus 553 ~~~vl~ 558 (606)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=328.93 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=203.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
..++|.+.++||+|+||.||+|.... +..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34678899999999999999999866 67899999987766778899999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCceEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~ki~DFGla~~~~ 440 (606)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998854 344899999999999999999999998 9999999999999 788999999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.|+...... . ........... ...
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~-~~~ 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---E----VMLKIREGTFT-FPE 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCCC-CCH
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHhCCCC-CCc
Confidence 332 22335789999999988654 999999999999999999999997542211 0 11111111100 000
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... . .....+.+++..||+.+|++||++.++++
T Consensus 229 ~~~-~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW-L----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh-h----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 11246778999999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.19 Aligned_cols=268 Identities=21% Similarity=0.277 Sum_probs=212.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC--eeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--ERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 361 (606)
.++|.+.++||+|+||.||+|++.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3578889999999999999999865 8999999997543 345678889999999999999999999998765 67999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCceEEeecCCcc
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMAR 437 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~ki~DFGla~ 437 (606)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976544455999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCcccccccccccccCccCcccccc--------CCCCccccchhHHHHHHHHHhccCCCCCCCCCCc-cchhHHHHH
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAID--------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH-HNLLGHAWR 508 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~ 508 (606)
...... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||........ .....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~---- 237 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY---- 237 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH----
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH----
Confidence 764332 2233579999999999865 5688899999999999999999999864432211 11111
Q ss_pred HhhhcCcchhcc---------------cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 509 LWIEERPVELIN---------------KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 509 ~~~~~~~~~l~d---------------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....+.+...+. ..............+.+++..||+.||++||++.++++.|+.+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 111122111110 0111223456667788999999999999999999999888664
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=343.06 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=192.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|.+.++||+|+||.||+++.. .++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999986 48899999996543 3346789999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc--eEEeecCCccccCCC
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMARAFGID 442 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~ki~DFGla~~~~~~ 442 (606)
+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999998542 34899999999999999999999998 999999999999987765 999999999753222
Q ss_pred cccccccccccccCccCccccccCCCCcc-ccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.......||+.|+|||++.+..++.+ +||||||+++|||++|+.||........ .... .........
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~-~~~~~~~~~------ 239 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKT-IQRILSVKY------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHH-HHHHHTTCC------
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHH-HHHHhcCCC------
Confidence 12233579999999999988887655 8999999999999999999864332111 1111 111111000
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... .......+.+|+.+||+.+|++|||+.++++
T Consensus 240 ~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 SIPD--DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0000 0011245678999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=340.34 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=198.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeCC-----cEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEG-----QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|...+.||+|+||.||+|.+... ..||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 4667779999999999999997642 359999987543 3345678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999964 2345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 441 IDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 441 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+ ........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~----~~~~~~~~---- 267 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EV----MKAINDGF---- 267 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTTC----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHCCC----
Confidence 332211 2222456788999999999999999999999999999999 99997532211 11 11111110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011112234678899999999999999999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=325.15 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=206.3
Q ss_pred hcCCCcCCeecccCcccEEEEEE-eCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEE-eeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC-TQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 363 (606)
.++|.+.+.||+|+||.||+|+. .+++.||+|++..... .+.+.+|+.++..++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46889999999999999999997 4588999998865432 34689999999999998877766665 66777899999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCceEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~ki~DFGla~~~~ 440 (606)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999953 2345999999999999999999999998 9999999999999 488999999999998765
Q ss_pred CCcccc-----cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 441 IDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 441 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 433211 123467999999999999999999999999999999999999998765433333222222111111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
. .+.... ...+.+++..||+.+|++||++.+|++.|+..
T Consensus 240 ~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 E-----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred H-----HHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 011112 24578899999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=355.00 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=192.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.++||+|+||.||+++... |+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4678899999999999999999754 889999998653 334456788999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999854 3458999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .+. ........
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~----~~i~~~~~----- 366 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----ELILMEEI----- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCC-----
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHHhCCC-----
Confidence 222 2233468999999999999999999999999999999999999997532211 111 11111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
...... ...+.+|+..||+.||++|| ++.++++
T Consensus 367 -~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -RFPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011112 24577899999999999999 9999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=339.39 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=191.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe----CCcEEEEEEccccc----ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
.++|.+.+.||+|+||.||+++.. .++.+|+|++.+.. ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467889999999999999999973 68999999997642 2344568899999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999854 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ........
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~----~~i~~~~~-- 238 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTI----DKILKCKL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHHTCC--
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhCCC--
Confidence 643222 1233467999999999999999999999999999999999999997543211 111 11111100
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
.+.. .....+.+++.+||+.+|++|| ++.++++
T Consensus 239 ----~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ----NLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111 1224677899999999999999 6677764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=330.87 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=201.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
..++|.+.+.||+|+||.||+|++.+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999999754 2369999987653 3346789999999999999999999999865 4568
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999642 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..... .......
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~----~~~~~~~-- 233 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGV----LEKGDRL-- 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHH----HHHTCCC--
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHH----HhcCCCC--
Confidence 443221 1223456889999999999999999999999999999998 99997543221 11111 1111000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+......+.+++..||+.+|++||++.++++.|+.+
T Consensus 234 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 -------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01111224577899999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.58 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=203.0
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999986 58999999986542 234578999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999953 445999999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .+ ......+..
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~----~~~i~~~~~------ 233 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TL----FKKICDGIF------ 233 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HH----HHHHHTTCC------
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HH----HHHHhcCCc------
Confidence 2 2234679999999999998776 78999999999999999999998643211 11 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...... ...+.+++..||+.||++|||+.++++
T Consensus 234 ~~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 YTPQYL----NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccC----CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 001111 235778999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.45 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=199.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
++|.....||+|+||.||+|.... ++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345556799999999999999754 7899999997776666788999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCCccccCCCcc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGla~~~~~~~~ 444 (606)
++++|.+++........+++..+..++.||+.||.|||+.+ |+|+||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999976544456789999999999999999999998 999999999999987 89999999999987643221
Q ss_pred cccccccccccCccCccccccCC--CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
......||..|+|||++.+.. ++.++||||||+++|||++|+.|+....... .......... ..+.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-----~~~~ 246 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFK-----VHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHC-----CCCC
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccc-----cccc
Confidence 223457899999999997654 8899999999999999999999975322110 0000000000 0111
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+ +......+.+++..||+.+|++||++.++++
T Consensus 247 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 I----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp C----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1122346778999999999999999999984
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=340.95 Aligned_cols=248 Identities=26% Similarity=0.321 Sum_probs=201.6
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 359 (606)
..++|...+.||+|+||.||+++... ++.||+|++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34688999999999999999999875 788999999754 234567788999999988 8999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999542 34899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+ .........
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~~~---- 238 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL----FQSIMEHNV---- 238 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC----
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HH----HHHHHhCCC----
Confidence 3221 2234468999999999999999999999999999999999999997542211 11 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVV 557 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl 557 (606)
..... ....+.+++..||+.+|++||+ +.+++
T Consensus 239 --~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 239 --AYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp --CCCTT----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred --CCCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 01111 2246778999999999999996 46665
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=345.61 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=191.3
Q ss_pred CCCcCCeecccCcccEEEEEEeCC----cEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEee-CCeeEEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIEG----QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDERMLI 361 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~g----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 361 (606)
.|...+.||+|+||.||+|.+.+. ..+|+|.+.... ....+.|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 456678999999999999997542 368999886543 3446789999999999999999999999765 4578999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999954 3345889999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc--ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 442 DQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 442 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
.... .......+|..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..... ...+.. .
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~----~~~~~~--~ 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY----LLQGRR--L 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHH----HHTTCC--C
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHH----HHcCCC--C
Confidence 3221 12233457889999999999999999999999999999999 55665433221 11111 111110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
. .+......+.+++..||+.+|++||++.++++.|+.+
T Consensus 316 ---~----~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 ---L----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ---C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0111224678899999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=340.14 Aligned_cols=259 Identities=29% Similarity=0.416 Sum_probs=202.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.++|.+.+.||+|+||.||+|++. .++.||+|++... ......++.+|+.++.+++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467899999999999999999842 3678999999654 334456789999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEe
Q 007361 359 MLIYEYLPNKSLNDFIFDVTR----SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKIS 431 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~ 431 (606)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975332 245899999999999999999999998 999999999999984 4569999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHh
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+ ....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~----~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EV----LEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH----HHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HH----HHHH
Confidence 9999986543333333344567899999999999999999999999999999998 88887532211 11 1111
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..... ...+......+.+++..||+.+|.+||++.+|++.|+..
T Consensus 259 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11110 011111234677899999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.83 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=197.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-----ccCHHHHHHHHHHHhhcc---CCCcceEEEEEeeC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQR 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 355 (606)
..++|.+.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999974 48899999986432 222456778888887775 99999999999876
Q ss_pred C-----eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEE
Q 007361 356 D-----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 430 (606)
Q Consensus 356 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki 430 (606)
. ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 59999986432 334899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh
Q 007361 431 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 431 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ..........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence 9999998764322 223467899999999999999999999999999999999999998543221 1111111111
Q ss_pred hhcC---cc---hhcccccC--CCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 511 IEER---PV---ELINKSLG--GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 511 ~~~~---~~---~l~d~~l~--~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... .. .+...... ..... .....+.+++..||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 00 00000000 00111 11246778999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=336.27 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=200.9
Q ss_pred hcCCCcCC-eecccCcccEEEEEEe---CCcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 286 TENFSDKN-KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 286 ~~~~~~~~-~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
.++|.+.+ .||+|+||.||+|.+. .++.||+|++..... ...+++.+|+.++.+++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999999653 267899999875532 2357899999999999999999999999 567789
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+|+||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999964 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 440 GIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 440 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
....... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ..........
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~-- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGER-- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCC--
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCC--
Confidence 5433221 1222456788999999999999999999999999999999 99997543221 0 1111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+......+.+++..||+.||++||++.+|++.|+..
T Consensus 239 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111112234678899999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.36 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=182.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467888999999999999999974 58999999986532 23457899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+++++|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999854 3356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+......... ..... .+.
T Consensus 165 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~------~~~ 229 (278)
T 3cok_A 165 PHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVL------ADY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS------SCC
T ss_pred CCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhh------ccc
Confidence 3221 22357899999999999999999999999999999999999997643321100 00000 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... ....+.+++.+||+.||++||++.++++
T Consensus 230 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11111 2246778999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=342.50 Aligned_cols=245 Identities=29% Similarity=0.455 Sum_probs=197.1
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
+.|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999974 588999999865432 23467899999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||++ |+|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 678887743 2345899999999999999999999998 999999999999999999999999999875422
Q ss_pred cccccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
....||+.|+|||++. +..++.++||||||+++|||++|+.|+..... ...... .........
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~-~~~~~~~~~- 273 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-IAQNESPAL- 273 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCCCCC-
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHH-HHhcCCCCC-
Confidence 2357899999999985 56799999999999999999999999753221 111111 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... ...+.+++..||+.+|++|||+.++++
T Consensus 274 ---~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 274 ---QSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ---CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCC----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 01112 235678999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.59 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=203.3
Q ss_pred HHHHHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC
Q 007361 280 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR 355 (606)
Q Consensus 280 ~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 355 (606)
.+.....++|.+.++||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 334445688999999999999999999986 48999999996532 23345688999999999999999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence 9999999999999999999642 235899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCccccc-------cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAI-------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 508 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 508 (606)
++....... ......+||+.|+|||++. +..++.++||||||+++|||++|+.||...... ........
T Consensus 209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~ 284 (412)
T 2vd5_A 209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVH 284 (412)
T ss_dssp CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT
T ss_pred heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence 987653322 1223468999999999997 457899999999999999999999998543211 11111100
Q ss_pred HhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCC---CCHHHHHH
Q 007361 509 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR---PNMSSVVL 558 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~~vl~ 558 (606)
. .. .+.-+...... ...+.+|+..||+ +|++| |++.++++
T Consensus 285 ~-~~----~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 Y-KE----HLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp H-HH----HCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred c-cc----CcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0 00 00001011112 2466789999999 99998 58888874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.01 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=203.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.+.|.+.+.||+|+||.||+++... |+.+|+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4678889999999999999999864 88999999865432 1367899999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----ceEEeecC
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG 434 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~ki~DFG 434 (606)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999953 345899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... ... .......
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANITSVS 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHTTC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhcc
Confidence 998765332 223457899999999999999999999999999999999999997532211 111 1111100
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. . ......... ...+.+++..||+.||++|||+.++++
T Consensus 235 ~-~-~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y-D-FDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C-C-CCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c-c-cChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0 000000111 235778999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.89 Aligned_cols=243 Identities=21% Similarity=0.314 Sum_probs=200.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc--------cCHHHHHHHHHHHhhccCCCcceEEEEEeeC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 355 (606)
..++|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999975 488999999865421 1344678899999999999999999999999
Q ss_pred CeeEEEEecCCCC-CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 356 DERMLIYEYLPNK-SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 356 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99998853 345999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.....
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 9987643322 233678999999999998877 8899999999999999999999753211
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.+...... +......+.+++..||+.+|++|||+.++++-
T Consensus 236 ----~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000100 00112357789999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.62 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=199.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
+.++|.+.+.||+|+||.||++.... ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34678889999999999999999765 678999998553 23345678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998543 34899999999999999999999998 9999999999999999999999999986543
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
... .....||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......... .
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~------~ 223 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRV------E 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHT------C
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------HHHHHHHhC------C
Confidence 221 23357899999999999999999999999999999999999997532211 011111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. .+......+.+++..||+.+|++||++.++++
T Consensus 224 ~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 FT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CC----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CC----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01 11112245678999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=330.88 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=203.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEee---------
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--------- 354 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 354 (606)
...+|...+.||+|+||.||+|+.. +++.||+|++.... +.+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467888999999999999999986 58999999986543 356789999999999999999998854
Q ss_pred -------CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc
Q 007361 355 -------RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 427 (606)
Q Consensus 355 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~ 427 (606)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44579999999999999999642 2346899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH
Q 007361 428 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 428 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 507 (606)
+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..|+... ...+
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~ 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFF 228 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence 99999999987654322 22356899999999999999999999999999999999998874210 0111
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
..... ..+....+ ..+.+++.+||+.||++||++.++++.|.....
T Consensus 229 ~~~~~--------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 229 TDLRD--------GIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHT--------TCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHhhc--------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 11111 11112222 356789999999999999999999999987543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.10 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=199.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCC----cEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEe-eCCeeE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEG----QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCT-QRDERM 359 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~ 359 (606)
...|...++||+|+||.||+|.+.++ ..+|+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45678889999999999999997542 358899886543 334577999999999999999999999865 456789
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999954 3455899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccC-CCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 440 GIDQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 440 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++|.. |+...... ..... ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~----~~~~~~- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY----LLQGRR- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHH----HHTTCC-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHH----HhcCCC-
Confidence 443221 22233567889999999999999999999999999999999554 44322211 11111 111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...... ....+.+++..||+.+|++||++.++++.|+.+
T Consensus 251 ----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 251 ----LLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000111 124578899999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=340.60 Aligned_cols=252 Identities=16% Similarity=0.124 Sum_probs=203.1
Q ss_pred HhcCCCcCCeecccCcccEEEEE------EeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc---CCCcceEEEEEeeC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQR 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 355 (606)
..++|.+.++||+|+||.||+|. ...++.||+|++... ...++..|+.++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35678889999999999999994 445889999999654 3567888888888886 99999999999999
Q ss_pred CeeEEEEecCCCCCchhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---------
Q 007361 356 DERMLIYEYLPNKSLNDFIFDV--TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------- 424 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~--------- 424 (606)
+..++||||+++|+|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999642 23456999999999999999999999998 999999999999998
Q ss_pred --CCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccch
Q 007361 425 --EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 502 (606)
Q Consensus 425 --~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 502 (606)
++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.|+.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999986643333334455789999999999999999999999999999999999999974322110
Q ss_pred hHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHhcCC
Q 007361 503 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR-PNMSSVVLMLSGE 563 (606)
Q Consensus 503 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Ps~~~vl~~L~~~ 563 (606)
..+...+..... ...+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 293 --------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 --------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 001111111122 2345578889999999998 5788888877653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=332.42 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=197.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457889999999999999999974 58999999987532 33456789999999999999999999999999999999
Q ss_pred EecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 362 YEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998542 23456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ...........
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~~--- 257 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCDYPP--- 257 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHH-HHHHHTTCSCC---
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHH-HHHhhcccCCC---
Confidence 3222 122356899999999999999999999999999999999999997532211 1111 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
+ ........+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 258 --~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 258 --L---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp --C---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0 001122467789999999999999999999999987643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=338.74 Aligned_cols=264 Identities=26% Similarity=0.362 Sum_probs=195.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHH--HhhccCCCcceEEEEEee-----CCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLL--IAKLQHRNLVKLIGCCTQ-----RDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~ 358 (606)
.++|.+.++||+|+||.||+|+. +++.||+|++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999977 78999999986433 3344444444 455899999999986543 2356
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeccCCCCCEEEcCCCceE
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD---------SRLRIIHRDLKASNVLLDNEMNPK 429 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~iiH~Dlk~~NIll~~~~~~k 429 (606)
++||||+++|+|.+++.. ...++..++.++.||++||.|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999943 2358999999999999999999998 6 99999999999999999999
Q ss_pred EeecCCccccCCCcc------cccccccccccCccCcccccc-------CCCCccccchhHHHHHHHHHhccCCCCCCCC
Q 007361 430 ISDFGMARAFGIDQT------EANTNRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA 496 (606)
Q Consensus 430 i~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~ 496 (606)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+-....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987653321 122234579999999999987 4577899999999999999999877533221
Q ss_pred C-CccchhHH----------HHHHhhhcCcchhcccccCC--CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 497 D-HHHNLLGH----------AWRLWIEERPVELINKSLGG--SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 497 ~-~~~~l~~~----------~~~~~~~~~~~~l~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
. ........ .......... .+.+.. .........+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1 11111100 0000000000 011111 11223455789999999999999999999999999875
Q ss_pred C
Q 007361 564 R 564 (606)
Q Consensus 564 ~ 564 (606)
.
T Consensus 317 l 317 (336)
T 3g2f_A 317 M 317 (336)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=328.77 Aligned_cols=262 Identities=17% Similarity=0.190 Sum_probs=198.1
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc---CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
..++|.+.+.||+|+||.||++... +++.||+|++...... ..+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999986 4889999998754322 34678999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999642 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
..... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... .......
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~-~~~~~~~-- 254 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHI-NQAIPRP-- 254 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHH-HSCCCCG--
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHh-ccCCCCc--
Confidence 33221 223357899999999999999999999999999999999999997542211 111111 1111100
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhcCCCCCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGERSLP 567 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~vl~~L~~~~~~~ 567 (606)
....... ...+.+++.+||+.||++|| ++.++++.|+......
T Consensus 255 ~~~~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 STVRPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GGTSTTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cccCCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0011111 23577899999999999999 9999999998764433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=330.23 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=204.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.+.|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456888999999999999999975 48899999986543 3456889999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999984 345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... . .......... ..+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~-----~~~ 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------K-VLFLIPKNNP-----PTL 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHSCC-----CCC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------H-HHHHhhcCCC-----CCC
Confidence 2 223457899999999999999999999999999999999999997533211 0 0011111111 111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.... ...+.+++..||+.+|++|||+.++++-
T Consensus 240 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1222 2457789999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=332.55 Aligned_cols=267 Identities=21% Similarity=0.292 Sum_probs=206.2
Q ss_pred HHHHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhh--ccCCCcceEEEEEeeCC-
Q 007361 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQRD- 356 (606)
Q Consensus 280 ~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~- 356 (606)
.......++|.+.+.||+|+||.||+|+. .++.||+|++... ....+..|++++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33445567899999999999999999998 6899999998643 34667888888887 78999999999998876
Q ss_pred ---eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCCCCEEEcCC
Q 007361 357 ---ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNE 425 (606)
Q Consensus 357 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiH~Dlk~~NIll~~~ 425 (606)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN 183 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred ccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence 78999999999999999953 34899999999999999999999 666 9999999999999999
Q ss_pred CceEEeecCCccccCCCcccc--cccccccccCccCccccccC------CCCccccchhHHHHHHHHHhc----------
Q 007361 426 MNPKISDFGMARAFGIDQTEA--NTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLEIVCG---------- 487 (606)
Q Consensus 426 ~~~ki~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~k~DV~S~Gvvl~elltG---------- 487 (606)
+.+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 999999999998764332211 23345789999999999876 345789999999999999999
Q ss_pred cCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC-CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 488 KRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS-YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 488 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
+.|+........ ............. ..+.+... .+......+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 264 ~~p~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 264 QLPYYDLVPSDP--SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCTTTTTSCSSC--CHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCccccCcCcc--cHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 455433221110 1111111111111 11111111 1235566788999999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.11 Aligned_cols=247 Identities=20% Similarity=0.235 Sum_probs=191.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHH-HhhccCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLL-IAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.++|...+.||+|+||.||+++... ++.+|+|++.+.. ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4678899999999999999999865 7889999997653 2234456667766 567899999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999854 345889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+ .........
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~~~----- 256 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM----YDNILNKPL----- 256 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HH----HHHHHHSCC-----
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HH----HHHHHhccc-----
Confidence 221 2234578999999999999999999999999999999999999997532211 11 111111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
.+.... ...+.+|+..||+.||.+||++.+.+
T Consensus 257 -~~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 -QLKPNI----TNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -CCCSSS----CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -CCCCCC----CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111112 23567899999999999999986433
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.01 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=205.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|...+.||+|+||.||+++.. +|+.||+|++.+. .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 457888899999999999999986 4899999999653 234567789999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999986532 334899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ........ . .
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~-~-----~ 406 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEV-P-----E 406 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHC-C-----C
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhcc-c-----c
Confidence 32 12335899999999999999999999999999999999999999865432211111 11111110 0 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
...... ...+.+|+..||+.||++|| ++.+|++
T Consensus 407 ~~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111112 24677899999999999999 6778763
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=342.65 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=190.8
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--------ccCHHHHHHHHHHHhhccCCCcceEEEEEee
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--------GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 354 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 354 (606)
...++|.+.++||+|+||.||+|.... ++.||+|++.+.. ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 356789999999999999999999765 7899999986532 122235889999999999999999999975
Q ss_pred CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CceEEe
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKIS 431 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~ki~ 431 (606)
.+..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 4568999999999999998853 345999999999999999999999998 9999999999999754 459999
Q ss_pred ecCCccccCCCcccccccccccccCccCcccccc---CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 508 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 508 (606)
|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+...
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~--- 356 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ--- 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH---
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH---
Confidence 999998764322 2234679999999999863 678999999999999999999999986432211 11111
Q ss_pred HhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 509 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 509 ~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...... ..... .... ....+.+++.+||+.||++||++.++++
T Consensus 357 -i~~~~~-~~~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 -ITSGKY-NFIPE-VWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHTTCC-CCCHH-HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HhcCCC-CCCch-hhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 011100 00000 0000 1246788999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.33 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=198.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..++|.+.+.||+|+||.||++.... ++.+|+|.+.+.... +.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45678999999999999999999864 889999999765433 35688888888 7999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC----CceEEeecCCccc
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA 438 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~----~~~ki~DFGla~~ 438 (606)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999854 345999999999999999999999998 9999999999998443 3599999999987
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....+....+. .....+...
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~-- 241 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS-- 241 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC--
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc--
Confidence 643322 223467899999999999888999999999999999999999998643222111111 111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+...........+.+|+..||+.||++||++.++++
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111112245678999999999999999999885
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=366.62 Aligned_cols=247 Identities=27% Similarity=0.391 Sum_probs=195.5
Q ss_pred CeecccCcccEEEEEEe---CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLI---EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+.++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 35789999997643 2346789999999999999999999999964 568899999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc-c
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-A 446 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~-~ 446 (606)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999953 345899999999999999999999998 999999999999999999999999999877543322 2
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......+|..|+|||++.+..++.++||||||+++|||++ |+.|+...... ........+. ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~---------~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGE---------RM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTC---------CC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC---------CC
Confidence 2223456789999999999999999999999999999998 99997543221 1111111111 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+......+.+|+..||+.||++||++.+|++.|+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112223567899999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=327.56 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=201.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++|.+.+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4688999999999999999999765 8899999986542 334567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc---eEEeecCCcccc
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAF 439 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~ki~DFGla~~~ 439 (606)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999988854 345899999999999999999999998 999999999999976655 999999999876
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ......... ...
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~----~~~~~~~~~-~~~ 227 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL----YAQIKAGAY-DYP 227 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCC-CCC
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HH----HHHHHhccc-cCC
Confidence 43322 23357899999999999999999999999999999999999997532211 11 111111110 000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+ ........+.+++..||+.+|++|||+.++++
T Consensus 228 ~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 00111245778999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=327.67 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=196.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|...++||+|+||.||++.... +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 4678889999999999999999754 8899999986653 3456889999999999999999999999999999999999
Q ss_pred cCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCceEEeecCCcccc
Q 007361 364 YLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAF 439 (606)
Q Consensus 364 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~ki~DFGla~~~ 439 (606)
|+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988542 23356999999999999999999999998 9999999999999 45688999999999876
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.|+...... ........ .......
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~-~~~~~~~ 246 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATY-KEPNYAV 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCCCCCC
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhcc-CCccccc
Confidence 4322 223457899999999875 56899999999999999999999997543211 00000000 0000000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ....+.+++..||+.||++|||+.++++
T Consensus 247 ---~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ---ECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 1245678999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=329.13 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=198.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 360 (606)
..++|.+.+.||+|+||.||+|... +++.||+|++.... .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567889999999999999999986 58999999987542 33456788999999999 99999999999999999999
Q ss_pred EEecCCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---------------
Q 007361 361 IYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------------- 424 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~--------------- 424 (606)
||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999996432 1255899999999999999999999998 999999999999984
Q ss_pred ----CCceEEeecCCccccCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCc
Q 007361 425 ----EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 499 (606)
Q Consensus 425 ----~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~ 499 (606)
...+||+|||++....... ...||..|+|||.+.+. .++.++||||||+++|||++|..++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 4479999999998764332 24589999999999876 67789999999999999999987642210
Q ss_pred cchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 500 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 500 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+......... .+.... ...+.+++..||+.||++|||+.++++
T Consensus 236 ------~~~~~~~~~~~-----~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ------QWHEIRQGRLP-----RIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------HHHHHHTTCCC-----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHcCCCC-----CCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111111111 111122 246778999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.17 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=195.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-CeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-DERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~ 364 (606)
.++|...+.||+|+||.||++.. .|+.+|+|.+.... ..+.+.+|+.++.+++||||+++++++.+. +..++|+||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788899999999999999987 58899999986543 457899999999999999999999997655 478999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999998542 1223789999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. .......
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~~~--------- 231 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PRVEKGY--------- 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH----HHHTTTC---------
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhcCC---------
Confidence 22356889999999999999999999999999999998 99987543221 111 1111110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....+......+.+++..||+.+|++||++.++++.|+.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0111112234677899999999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=335.23 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=201.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcE--EEEEEcccc-cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQE--IAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 361 (606)
++|...+.||+|+||.||+|+... +.. +|+|++... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 678889999999999999999765 554 488988653 334456789999999999 899999999999999999999
Q ss_pred EecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 362 YEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ...
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY 251 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHH
Confidence 99999999753221 11223456889999999999999999999999999999998 99997543211 011
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...... .....+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 252 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 00111112234678899999999999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.02 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=186.3
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ....+++.+|+.++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999965 58899999986543 344567889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 363 EYLPNKSLNDFIFDV-----TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 363 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998531 23456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc---cccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 438 AFGIDQT---EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 438 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .. .. ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~-~~~~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---ML-TLQN 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HH-HHTS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HH-Hhcc
Confidence 7643221 112234578999999999876 568999999999999999999999986543211 11 00 1111
Q ss_pred Ccchh----cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RPVEL----INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~~~l----~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... .+....... ...+.+++.+||+.||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111 111111122 245778999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.20 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=202.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|...+.||+|+||.||+++... |+.||+|++.+. .....+.+.+|+.++.+++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3678888999999999999999864 899999999654 234567889999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 362 YEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 446999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~~~i~~~~~----- 410 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRVLEQAV----- 410 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHHHHHHHCCC-----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHHHHHhhccc-----
Confidence 3322 223458999999999999999999999999999999999999998654321111 111111111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 553 (606)
..+......+.+++..||+.||++||++
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1111123466789999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=338.13 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=192.4
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|...++||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56888899999999999999986 4889999998654322 122456799999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 588888854 2346899999999999999999999998 99999999999999999999999999986543222
Q ss_pred cccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc---Ccchhcc
Q 007361 445 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE---RPVELIN 520 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~d 520 (606)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ............ .......
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence 2233578999999999876 568999999999999999999999986533211 111111110000 0000000
Q ss_pred c------ccC--CCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 K------SLG--GSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~------~l~--~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ... .... ......+.+|+..||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 000 0000 011235678999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.53 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=203.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||++...+ ++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4678889999999999999999865 7789999886542 23456789999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998854 245899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
... ......||..|+|||++.+..++.++||||||+++|||++|+.|+...... . .+........
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~~~~~~~------ 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIKKNEY------ 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTCC------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------H-HHHHHhcCCC------
Confidence 322 223467899999999999999999999999999999999999997543211 1 1111111110
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.... ...+.+++.+||+.||++||++.++++
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112 235678999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.79 Aligned_cols=250 Identities=20% Similarity=0.234 Sum_probs=189.3
Q ss_pred cCCCcC-CeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhh-ccCCCcceEEEEEee----CCeeE
Q 007361 287 ENFSDK-NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAK-LQHRNLVKLIGCCTQ----RDERM 359 (606)
Q Consensus 287 ~~~~~~-~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 359 (606)
++|... +.||+|+||.||++.... ++.||+|++.. ...+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456655 689999999999999864 88999999853 2467788888755 489999999999875 56789
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEeecCCc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMA 436 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~DFGla 436 (606)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999642 2345899999999999999999999998 999999999999987 789999999999
Q ss_pred cccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccc-hhHHHHHHhhhcCc
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN-LLGHAWRLWIEERP 515 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~ 515 (606)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .... ...+..
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~ 284 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc
Confidence 8754321 2234678999999999999999999999999999999999999986543322111 1111 111100
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.... .. .....+.+|+..||+.||++|||+.++++
T Consensus 285 -~~~~~~-~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 -EFPNPE-WS----EVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -CCCTTT-TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCCcc-cc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 01 11245778999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=332.36 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=202.1
Q ss_pred HHHHHHhcCCCcC-CeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhc-cCCCcceEEEEEee
Q 007361 280 MAIANATENFSDK-NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ 354 (606)
Q Consensus 280 ~~~~~~~~~~~~~-~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 354 (606)
.......+.|.+. +.||+|+||.||++.... ++.||+|++.... ......+.+|+.++.++ +||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344556667766 889999999999999864 8999999987542 34467899999999999 46999999999999
Q ss_pred CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEe
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKIS 431 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~ 431 (606)
.+..++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999999854 23456999999999999999999999998 999999999999988 7899999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ... ....
T Consensus 177 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~ 246 (327)
T 3lm5_A 177 DFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETY----LNIS 246 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHH
T ss_pred eCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHH----HHHH
Confidence 999998764322 123357899999999999999999999999999999999999997543211 000 0000
Q ss_pred hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... .............+.+++..||+.||++|||+.++++
T Consensus 247 ~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 QVNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HTCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0000 0001111112345778999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.03 Aligned_cols=203 Identities=26% Similarity=0.480 Sum_probs=163.5
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCC--e
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRD--E 357 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~ 357 (606)
...++|.+.++||+|+||.||+|.+.. |+.||+|++... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345789999999999999999999754 889999998654 2334567889999999997 999999999997544 6
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 589888853 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCc-------------------ccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 438 AFGIDQ-------------------TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 438 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
.+.... ........+||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 763211 1112234679999999999987 67999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.44 Aligned_cols=199 Identities=25% Similarity=0.353 Sum_probs=174.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.++||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999986 48899999987653 3345678999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|+++++|.+++... ..+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999543 3589999999999999999999986 6 999999999999999999999999999765321
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+...
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223357899999999999999999999999999999999999998643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.07 Aligned_cols=262 Identities=15% Similarity=0.146 Sum_probs=204.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC---------CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcce---------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE---------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK--------- 347 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 347 (606)
.++|.+.+.||+|+||.||+|+... ++.||+|.+... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678899999999999999999864 789999998644 36789999999999999988
Q ss_pred ------EEEEEee-CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 007361 348 ------LIGCCTQ-RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 420 (606)
Q Consensus 348 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI 420 (606)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 77899999999 99999999643 2356999999999999999999999998 99999999999
Q ss_pred EEcCCC--ceEEeecCCccccCCCccc-----ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCC
Q 007361 421 LLDNEM--NPKISDFGMARAFGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 493 (606)
Q Consensus 421 ll~~~~--~~ki~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~ 493 (606)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876533221 112335799999999999999999999999999999999999999865
Q ss_pred CCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 494 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 494 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..... .........+ ......+.+...... .....+.+++..||+.||++||++.+|+++|+.+
T Consensus 271 ~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNT--EDIMKQKQKF-VDKPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCH--HHHHHHHHHH-HHSCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCH--HHHHHHHHhc-cCChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 43221 1111111111 111222221111100 1124677899999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=337.26 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=201.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEe----CCcEEEEEEccccc----ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 356 (606)
.++|.+.+.||+|+||.||+++.. .++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 357888999999999999999983 58999999986532 23456678899999999 6999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999643 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
+.+...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+......... . ..........
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~-~~~~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--A-EISRRILKSE 282 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--H-HHHHHHHHCC
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--H-HHHHHHhccC
Confidence 876433222 2234679999999999986 34789999999999999999999998644322111 1 1111111110
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHHh
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLML 560 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~~L 560 (606)
. ..+......+.+|+.+||+.||++|| ++.++++-.
T Consensus 283 ------~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 11112224567899999999999999 899998644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=334.04 Aligned_cols=267 Identities=22% Similarity=0.344 Sum_probs=199.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEee--------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-------- 354 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 354 (606)
.++|.+.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++.+++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367889999999999999999985 58899999986543 3345678899999999999999999999977
Q ss_pred CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
.+..++||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 4468999999985 77776643 2345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcc--cccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 435 MARAFGIDQT--EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 435 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987653222 222344678999999999876 4589999999999999999999999864332111111100000000
Q ss_pred hcCcc-----hh---cccccCCCCCHHH-------HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EERPV-----EL---INKSLGGSYSLSE-------VLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~~~-----~l---~d~~l~~~~~~~~-------~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... +. +............ ...+.+|+.+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000 00 0000011111111 134778999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=326.09 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=203.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|...+.||+|+||.||++...+ ++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4678889999999999999999875 7789999886542 23456788999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998854 245899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... . ..........
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~------ 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIKKNEY------ 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTCC------
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhhccC------
Confidence 222 223357899999999999999999999999999999999999997543211 0 1111111110
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.... ...+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCcccc----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111112 245778999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=347.72 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=192.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------C
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------D 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 356 (606)
.++|.+.++||+|+||.||++.... ++.||+|++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4678999999999999999999764 889999999754 333456788999999999999999999999655 3
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++||||++++ |.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999865 555552 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHH--------
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR-------- 508 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-------- 508 (606)
+..... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 876432 22334689999999999999999999999999999999999999986432111 0000000
Q ss_pred ----------HhhhcCc-------chhcccccCCCCC---HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 509 ----------LWIEERP-------VELINKSLGGSYS---LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 509 ----------~~~~~~~-------~~l~d~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+..... ...+...+..... ......+.+|+.+||+.||++|||+.++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0000000000000 111446889999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=322.97 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=199.3
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
++|.+.+.||+|+||.||+++.. +++.+|+|.+..... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888899999999999999987 488999999865421 24678999999999999999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----ceEEeecCC
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFGM 435 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~ki~DFGl 435 (606)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999954 345899999999999999999999998 99999999999998877 899999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+....... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+...... . ..........
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---E----TLTNISAVNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---H----HHHHHHTTCC
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---H----HHHHhHhccc
Confidence 98764322 123356899999999999999999999999999999999999997543211 0 1111111100
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ........ ....+.+++.+||+.+|++||++.++++
T Consensus 229 -~-~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 -D-FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -C-CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -C-Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 00000001 1235778999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.05 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=191.1
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
...++|.+.++||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999975 488999999965432 234567899999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE-----cCCCceEEeecCC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL-----DNEMNPKISDFGM 435 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll-----~~~~~~ki~DFGl 435 (606)
||||++ |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999998 499998854 334899999999999999999999998 9999999999999 4555699999999
Q ss_pred ccccCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
++.+..... ......+|..|+|||++.+. .++.++||||||+++|||++|+.|+...... ..............
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCc
Confidence 987643322 22335679999999999875 4899999999999999999999998543211 11111111000000
Q ss_pred c---chhc-----ccccC--CCCCHH------HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 P---VELI-----NKSLG--GSYSLS------EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~---~~l~-----d~~l~--~~~~~~------~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. .... ..... ...... ....+.+|+..||+.||++|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0000 00000 000111 1246779999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.80 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=198.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++|...+.||+|+||.||+++... |+.||+|++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3578889999999999999999865 88999999865432 23456889999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999988643 335899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHHHHHhhhc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLWIEE 513 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~ 513 (606)
.. ......||..|+|||.+.+. .++.++||||||+++|||++|+.|+............ ......+...
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 22 22335789999999999875 7899999999999999999999998653321110000 0001111111
Q ss_pred Ccc-hhcccccCCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 RPV-ELINKSLGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~~~-~l~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ....+.+...... .....+.+|+.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000111111111 11346789999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.35 Aligned_cols=198 Identities=22% Similarity=0.394 Sum_probs=156.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----Ce
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 357 (606)
.++|.+.++||+|+||.||+|+.. .++.||||++.... ....+.+.+|+.++..++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999976 48899999986542 23456789999999999999999999999543 56
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 5789888843 345999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-------------------------ccccccccccCccCcccc-ccCCCCccccchhHHHHHHHHHhccCC
Q 007361 438 AFGIDQTE-------------------------ANTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKRN 490 (606)
Q Consensus 438 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DV~S~Gvvl~elltG~~p 490 (606)
........ ......+||+.|+|||++ .+..++.++|||||||+||||++|..+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 76432211 122345789999999986 466799999999999999999995443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.37 Aligned_cols=258 Identities=21% Similarity=0.359 Sum_probs=204.5
Q ss_pred HHHHHHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc--------CHHHHHHHHHHHhhc-cCCCcceE
Q 007361 279 WMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--------GMEEFENEVLLIAKL-QHRNLVKL 348 (606)
Q Consensus 279 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l 348 (606)
+.......++|.+.+.||+|+||.||+|++. +|+.||||++...... ..+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999986 5899999998654321 245678999999999 79999999
Q ss_pred EEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 349 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 349 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
++++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999864 245899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCcccccc------CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccch
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 502 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 502 (606)
||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... ..
T Consensus 240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~ 313 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LM 313 (365)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH
T ss_pred EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HH
Confidence 999999998765332 2234679999999999863 35889999999999999999999997532210 11
Q ss_pred hHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 503 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 503 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ......... ...+.. .. ....+.+++..||+.||++||++.++++
T Consensus 314 ~----~~i~~~~~~-~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 L----RMIMEGQYQ-FSSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H----HHHHHTCCC-CCHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H----HHHHhCCCC-CCCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111111100 000000 00 1235778999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=322.70 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=197.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc----ccCHHHHHHHHHHHhhccCCCcceEEEEEe--eCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIGCCT--QRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 358 (606)
.++|.+.+.||+|+||.||++.... ++.+|+|.+.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4689999999999999999999754 7899999986542 234678999999999999999999999984 45678
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 76766543 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccccccccccccCccCccccccCC--CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
..............||..|+|||++.+.. ++.++||||||+++|||++|+.|+...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhcCCC-
Confidence 65433333334467899999999997654 478999999999999999999997642211 11111111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.... ...+.+++.+||+.||++|||+.++++
T Consensus 231 -----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 -----AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -----CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111112 245678999999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=329.29 Aligned_cols=259 Identities=24% Similarity=0.292 Sum_probs=202.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEee--CCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 360 (606)
.++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999986 48899999986542 3345678999999999999999999998854 567899
Q ss_pred EEecCCCCCchhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 361 IYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996432 3445899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
....... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... .+ ......+...
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~i~~~~~~- 234 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFR- 234 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCCC-
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HH----HHHHhhcccc-
Confidence 7643221 122356899999999999999999999999999999999999997543211 11 1111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.+.. .....+.+++.+||+.+|++||++.+|++.+..
T Consensus 235 ----~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 ----RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----cCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111 123467789999999999999999999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=328.21 Aligned_cols=259 Identities=23% Similarity=0.330 Sum_probs=204.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
..++|.+.+.||+|+||.||+++.. +|+.||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467888999999999999999986 488999999976655556778999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCceEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~ki~DFGla~~~~ 440 (606)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ ++++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999998542 35899999999999999999999998 9999999999999 788999999999997643
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .+ ......... .. .
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~i~~~~~-~~-~ 227 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KL----FEKIKEGYY-EF-E 227 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH----HHHHHHCCC-CC-C
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHcCCC-CC-C
Confidence 22 223356899999999999999999999999999999999999997532211 11 111111110 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCCCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERSL 566 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~~~~~ 566 (606)
. .........+.+++..||+.||++||++.++++ .+++...+
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (304)
T 2jam_A 228 S----PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271 (304)
T ss_dssp T----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred c----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence 0 011112246778999999999999999999986 45554433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.09 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=205.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccC-CCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH-RNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.++||+|+||.||+|+.. +++.||||++..... ..++..|+.++..++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 467899999999999999999974 488999998754432 2357899999999987 556666677788888999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCceEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~ki~DFGla~~~~ 440 (606)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999542 345999999999999999999999998 9999999999999 688999999999998775
Q ss_pred CCcccc-----cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 441 IDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 441 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
...... ......||..|+|||.+.+..++.++||||||++||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 433221 223567999999999999999999999999999999999999998765443222222211111111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+. ..+ ...+.+|+..||+.+|++||++.+|+++|+.+
T Consensus 238 ~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1110 111 24678999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=323.16 Aligned_cols=246 Identities=23% Similarity=0.308 Sum_probs=202.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||+|+... ++.+|+|.+... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 3678889999999999999999865 778999998653 233457899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998643 35899999999999999999999998 99999999999999999999999999976543
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
.. .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... . ......... .
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~~~~~~------~ 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------E-THRRIVNVD------L 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTC------C
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------H-HHHHHhccc------c
Confidence 21 23357899999999999999999999999999999999999997543211 0 111111110 1
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...... ...+.+++..||+.+|.+||++.++++
T Consensus 230 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111112 245678999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.48 Aligned_cols=258 Identities=27% Similarity=0.363 Sum_probs=195.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC--Cc--EEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE--GQ--EIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~--g~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.++|.+.+.||+|+||.||+|++.. ++ .||+|.+... .....+.+.+|+.++.+++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3578889999999999999998643 33 6899988654 2344678999999999999999999999998765 8
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998642 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 439 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 439 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. ........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL----HKIDKEGE- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTSCC-
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHH----HHHHccCC-
Confidence 6543222 12233567889999999999999999999999999999999 99997543211 111 11111100
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
...........+.+++..||+.+|++||++.++++.|+...
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00011122346788999999999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=345.71 Aligned_cols=242 Identities=17% Similarity=0.179 Sum_probs=188.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHH---HHHhhccCCCcceEE-------EE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEV---LLIAKLQHRNLVKLI-------GC 351 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 351 (606)
.++|.+.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888899999999999999974 5899999999743 334457899999 555566899999998 66
Q ss_pred EeeCCe-----------------eEEEEecCCCCCchhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007361 352 CTQRDE-----------------RMLIYEYLPNKSLNDFIFDVT----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 410 (606)
Q Consensus 352 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 410 (606)
+.+.+. .++||||+ +|+|.+++.... ....+++..++.|+.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 689999996421 1223557889999999999999999998 9
Q ss_pred eeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccC-----------CCCccccchhHHH
Q 007361 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-----------LFSVKSDVFSFGV 479 (606)
Q Consensus 411 iH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DV~S~Gv 479 (606)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2233567 999999999887 8999999999999
Q ss_pred HHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 480 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 480 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
++|||++|+.|+......... ..+.. . ....+ ..+.+|+..||+.||++||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~---------------~~~~~-~-~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS---------------EWIFR-S-CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS---------------GGGGS-S-CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch---------------hhhhh-h-ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999997543221110 00100 0 01222 45778999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.69 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=195.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEee----CCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 359 (606)
..|.+.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 346777899999999999999865 778999988654 23345678999999999999999999999865 35589
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCceEEeecCCccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARA 438 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~ki~DFGla~~ 438 (606)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999954 245899999999999999999999875 3499999999999997 789999999999976
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.|+...... ...............
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccc
Confidence 4332 223357899999999876 45999999999999999999999997542211 111111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... .. ...+.+++..||+.+|++|||+.++++
T Consensus 251 ~~~----~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 FDK----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCC----CC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111 11 235788999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=325.40 Aligned_cols=256 Identities=18% Similarity=0.267 Sum_probs=197.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEee--CCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQ--RDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV 361 (606)
.++|.+.++||+|+||.||+|+.. +++.||+|++... ..+.+.+|+.++.+++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 367889999999999999999874 4889999998643 3577899999999997 9999999999987 6678999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCccccC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFG 440 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~~ 440 (606)
|||+++++|.+++.. +++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999998832 889999999999999999999998 99999999999999776 89999999998764
Q ss_pred CCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh---------
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW--------- 510 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------- 510 (606)
.... .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ..+.......
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHH
Confidence 3322 233578999999999987 679999999999999999999999974322211 0000000000
Q ss_pred hhcC--------------cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 511 IEER--------------PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 511 ~~~~--------------~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ....................+.+|+..||+.||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00000000111111112346789999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=330.47 Aligned_cols=265 Identities=23% Similarity=0.289 Sum_probs=196.3
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccccc-----CHHHHHHHHHHHhhccCCCcceEEEEEeeCCe
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-----GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 357 (606)
...++|...+.||+|+||.||+|+... |+.||+|++...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999999864 889999998653221 23468899999999999999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||+++ +|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 88888743 3346889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
.+..... ......+|+.|+|||++.+. .++.++||||||+++|||++|..|+..... .................
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTT
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChh
Confidence 7643322 22345789999999999764 589999999999999999999988754321 11111111111000000
Q ss_pred ------hhcccc---cCCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 007361 517 ------ELINKS---LGGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559 (606)
Q Consensus 517 ------~l~d~~---l~~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~ 559 (606)
.+.+.. .....+.. ....+.+++..||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 00011111 12467899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.45 Aligned_cols=262 Identities=22% Similarity=0.250 Sum_probs=201.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhcc--------CCCcceEEEEEe---
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--------HRNLVKLIGCCT--- 353 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 353 (606)
.++|.+.++||+|+||.||+|+... ++.||+|++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4679999999999999999998754 788999998643 344567889999999996 788999999987
Q ss_pred -eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCC-----
Q 007361 354 -QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEM----- 426 (606)
Q Consensus 354 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~----- 426 (606)
+....++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 56666666432 234589999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------ceEEeecCCccccCCCcccccccccccccCccCccc
Q 007361 427 --------------------------------------------NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462 (606)
Q Consensus 427 --------------------------------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 462 (606)
.+||+|||++...... .....||..|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 233578999999999
Q ss_pred cccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH--HHhhhcCcchh----------cccc--------
Q 007361 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--RLWIEERPVEL----------INKS-------- 522 (606)
Q Consensus 463 ~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--~~~~~~~~~~l----------~d~~-------- 522 (606)
+.+..++.++||||||+++|||++|+.||................ ........... +...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999987654433221111100 00000000000 0000
Q ss_pred -----------cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 -----------LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 -----------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
-....+......+.+|+.+||+.||++|||+.++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001234556678899999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.62 Aligned_cols=200 Identities=23% Similarity=0.380 Sum_probs=167.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----Ce
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 357 (606)
.++|.+.+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999765 7889999997542 23456789999999999999999999999776 56
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 599998853 345999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--------------------ccccccccccCccCcccc-ccCCCCccccchhHHHHHHHHHhccCCCC
Q 007361 438 AFGIDQTE--------------------ANTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKRNRG 492 (606)
Q Consensus 438 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DV~S~Gvvl~elltG~~p~~ 492 (606)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76433221 123457899999999986 55679999999999999999998766543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.86 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=203.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccC-----------------HHHHHHHHHHHhhccCCCcceE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG-----------------MEEFENEVLLIAKLQHRNLVKL 348 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 348 (606)
.++|.+.+.||+|+||.||++.. +++.||+|++....... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999999 99999999986542211 1889999999999999999999
Q ss_pred EEEEeeCCeeEEEEecCCCCCchhh------hcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEE
Q 007361 349 IGCCTQRDERMLIYEYLPNKSLNDF------IFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVL 421 (606)
Q Consensus 349 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIl 421 (606)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 432 225679999999999999999999999 77 999999999999
Q ss_pred EcCCCceEEeecCCccccCCCcccccccccccccCccCccccccC-CCCc-cccchhHHHHHHHHHhccCCCCCCCCCCc
Q 007361 422 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSV-KSDVFSFGVLVLEIVCGKRNRGFYHADHH 499 (606)
Q Consensus 422 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DV~S~Gvvl~elltG~~p~~~~~~~~~ 499 (606)
++.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.|+......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999876433 23346789999999999887 6766 999999999999999999998643321
Q ss_pred cchhHHHHHHhhhcCcchh------cccccC---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 500 HNLLGHAWRLWIEERPVEL------INKSLG---GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 500 ~~l~~~~~~~~~~~~~~~l------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+ ..........-. ...... ..........+.+++.+||+.||.+||++.++++
T Consensus 259 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VEL----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 111111111000 000000 0000112346788999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.76 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=198.2
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
..+.|.+.+.||+|+||.||+|.... ++.+|+|.+........+.+.+|+.++.+++||||+++++++.+.+..++|+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34678899999999999999999865 88999999987777778899999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999988542 345899999999999999999999998 999999999999999999999999987643211
Q ss_pred ccccccccccccCccCcccc-----ccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 444 TEANTNRVVGTYGYMPPEYA-----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
........||..|+|||++ .+..++.++||||||+++|||++|+.|+...... ..... .........
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~ 242 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSDPPTL 242 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCCC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHH-HhccCCccc
Confidence 1112235789999999998 4677899999999999999999999997543211 11111 111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. .+......+.+++..||+.+|++|||+.++++
T Consensus 243 ~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 L-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 01112246778999999999999999999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=325.53 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=185.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++|.+.++||+|+||.||+++.. +++.||+|++..... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999975 588999999865422 22334455566688889999999999999999999999
Q ss_pred ecCCCCCchhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 363 EYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 363 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||++ |+|.+++.. ......+++..+..++.||+.||.|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588887753 22345699999999999999999999997 7 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccCcccc----ccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYA----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.|+...... ... ..........
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~~ 232 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQ-LKQVVEEPSP 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHH-HHHHHHSCCC
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHH-HHHHhccCCC
Confidence 3322 2234689999999996 5667899999999999999999999997542211 011 1111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ........+.+++..||+.+|++|||+.++++
T Consensus 233 ~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 QL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11 11112245778999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=358.06 Aligned_cols=247 Identities=27% Similarity=0.336 Sum_probs=202.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 360 (606)
.++|.+.++||+|+||.||+++... ++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 4678999999999999999999865 788999999753 334567788999999988 79999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999643 35899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
... ......+||+.|+|||++.+..++.++||||||++||||++|+.||...... .+ .........
T Consensus 494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~----~~~i~~~~~----- 559 (674)
T 3pfq_A 494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL----FQSIMEHNV----- 559 (674)
T ss_dssp CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHSSCC-----
T ss_pred cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HH----HHHHHhCCC-----
Confidence 222 2234578999999999999999999999999999999999999998643211 11 111111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCH-----HHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM-----SSVV 557 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~vl 557 (606)
.++......+.+|+..||+.||++||++ .+|+
T Consensus 560 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 560 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 1111223467789999999999999997 6665
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.63 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=194.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhcc--CCCcceEEEEEeeCCeeEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~l 360 (606)
..++|.+.+.||+|+||.||++...+++.+|+|++... .....+.+.+|+.++.+++ |+||+++++++.+.+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 45678999999999999999999988999999998654 2344578899999999997 5999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||| +.+++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 668899999964 345899999999999999999999998 999999999999965 899999999998775
Q ss_pred CCcccccccccccccCccCcccccc-----------CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
............||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ... ...
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~-~~~ 251 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK-LHA 251 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHH-HHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHH-HHH
Confidence 4433333344678999999999875 47889999999999999999999997532211 000 011
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.++.......+......+.+++..||+.+|++||++.++++
T Consensus 252 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 252 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11111111111111246778999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=331.83 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=197.3
Q ss_pred HHHHHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEee---
Q 007361 280 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ--- 354 (606)
Q Consensus 280 ~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~--- 354 (606)
..+....++|.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344456788999999999999999999985 58899999986543 3457889999999999 79999999999977
Q ss_pred ---CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 355 ---RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 355 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999999643 2346899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 506 (606)
|||++........ ......||..|+|||++. +..++.++||||||+++|||++|+.|+...... ...
T Consensus 172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~ 243 (326)
T 2x7f_A 172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RAL 243 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH
T ss_pred eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHH
Confidence 9999987643221 223357899999999987 567899999999999999999999997532211 111
Q ss_pred HHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 507 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 507 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ........... .... ...+.+++..||+.+|++||++.++++
T Consensus 244 ~-~~~~~~~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 F-LIPRNPAPRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp H-HHHHSCCCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-HhhcCccccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 11111111110 1111 246778999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.69 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=194.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999986 5899999998653 234567899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999543 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.. ......+|+.|+|||.+.+..+ +.++||||||+++|||++|+.|+...... ...........
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~----- 228 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVF----- 228 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC-----
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCcc-----
Confidence 22 1223568999999999988765 68999999999999999999997532211 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.... ...+.+++.+||+.||++|||+.++++
T Consensus 229 -~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 -YIPEYL----NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cCchhc----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011111 245778999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=323.77 Aligned_cols=251 Identities=28% Similarity=0.412 Sum_probs=198.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
..+.|.+.+.||+|+||.||+|.... |+.||+|.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 45789999999999999999999865 8899999986543 45788999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++++|.+++.. ....+++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999853 2345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
. ......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ...........
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~~---- 246 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIF-MIPTNPPPTFR---- 246 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCCCCCS----
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHH-HHhcCCCcccC----
Confidence 2 223357899999999999999999999999999999999999997533211 1111 01111111100
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+......+.+++..||+.||.+|||+.++++
T Consensus 247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01111246778999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.89 Aligned_cols=253 Identities=10% Similarity=0.057 Sum_probs=180.7
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc---cCHHHHHHHHHHHhhc--cCCCcceEE-------EEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKL--QHRNLVKLI-------GCCT 353 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~~ 353 (606)
.+|...+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45788899999999999999976 588999999976542 3455678886655555 599988755 4544
Q ss_pred eC-----------------CeeEEEEecCCCCCchhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 007361 354 QR-----------------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR------CQIIGGIARGLLYLHQDSRLRI 410 (606)
Q Consensus 354 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 410 (606)
.. ...++||||++ |+|.+++... ...+.+..+ +.++.||+.||+|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 33 33799999999 8999999643 223455556 788899999999999998 9
Q ss_pred eeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhcc
Q 007361 411 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGK 488 (606)
Q Consensus 411 iH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~ 488 (606)
+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875422 113456799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 489 RNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 489 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.|+........... ........................+.+|+.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99875433211100 000000000000000000112346778999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=336.19 Aligned_cols=268 Identities=20% Similarity=0.257 Sum_probs=197.4
Q ss_pred HHHHHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEccccccc-----------CHHHHHHHHHHHhhccCCCcce
Q 007361 279 WMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ-----------GMEEFENEVLLIAKLQHRNLVK 347 (606)
Q Consensus 279 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~ 347 (606)
..++....++|.+.+.||+|+||.||+|...+|+.||+|++...... ..+.+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998653221 1378999999999999999999
Q ss_pred EEEEEeeC-----CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 348 LIGCCTQR-----DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 348 l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
+++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99998543 35799999998 688888753 3446999999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~ 501 (606)
+.++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.|+.......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 241 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--- 241 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---
Confidence 999999999999998543222 2233578999999999887 679999999999999999999999986432111
Q ss_pred hhHHHHHHhhhcC-----------cchhcccccCCC--CC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 502 LLGHAWRLWIEER-----------PVELINKSLGGS--YS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 502 l~~~~~~~~~~~~-----------~~~l~d~~l~~~--~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
............. ....+....... .. ......+.+|+..||+.||++|||+.++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111100000000 000000000000 00 011235778999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=323.08 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=193.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEe-----------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT----------- 353 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 353 (606)
.++|.+.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4678889999999999999999876 8899999997766666788999999999999999999999873
Q ss_pred ---eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCceE
Q 007361 354 ---QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPK 429 (606)
Q Consensus 354 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~k 429 (606)
+....++||||++ |+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 69999883 345899999999999999999999998 99999999999997 577999
Q ss_pred EeecCCccccCCCcc-cccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH
Q 007361 430 ISDFGMARAFGIDQT-EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 430 i~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 507 (606)
|+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 999999987643221 122233567899999998875 678999999999999999999999986433211 111000
Q ss_pred -----------HHhhhcCcchhcccccC-CCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 508 -----------RLWIEERPVELINKSLG-GSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 508 -----------~~~~~~~~~~l~d~~l~-~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... .....+..... ...+.. ....+.+++..||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 00000001000 111111 1246789999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.14 Aligned_cols=259 Identities=19% Similarity=0.260 Sum_probs=193.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe------eEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE------RML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 360 (606)
.+|...++||+|+||.||+|++..+..+|+|++....... .+|+.+++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~----~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK----NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC----CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH----HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4688899999999999999999888889999986543322 369999999999999999999965443 789
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCceEEeecCCcccc
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAF 439 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~ki~DFGla~~~ 439 (606)
||||++++.+............+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655444332233556999999999999999999999998 99999999999999 7999999999999876
Q ss_pred CCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc---
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP--- 515 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 515 (606)
..... .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||....... .+............
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 43322 2235789999999999765 58999999999999999999999986433211 11111110000000
Q ss_pred ----chhcccccCC--CCCH------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 ----VELINKSLGG--SYSL------SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ----~~l~d~~l~~--~~~~------~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.......... ..+. .....+.+|+.+||+.||++|||+.++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000000 0011 12246789999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=343.89 Aligned_cols=251 Identities=25% Similarity=0.309 Sum_probs=200.0
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
..++|.+.++||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567899999999999999999986 4889999998653 234567899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCceEEeecCCccc
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARA 438 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~ki~DFGla~~ 438 (606)
+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988543 45899999999999999999999998 99999999999995 456799999999987
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
+.... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||...... .+. ...........
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL----KRVETGKYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCCCSC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCCCCC
Confidence 64332 2234579999999999876 5999999999999999999999997543211 111 11111111000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.. ......+.+++..||+.+|++|||+.++++
T Consensus 243 -~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 243 -LPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -SGGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -Cccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 011235778999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=335.52 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=194.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------ 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 356 (606)
.++|...+.||+|+||.||+|... .|+.||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999985 48999999996542 233567889999999999999999999997653
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999854 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+..... .....+|+.|+|||++.+ ..++.++||||+|++++||++|+.||...... ..+...... .....
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~-~g~~~ 246 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKV-TGTPP 246 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHH-HCCCC
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHh-cCCCC
Confidence 875432 233578999999999987 67999999999999999999999998643221 111110000 00000
Q ss_pred chhc------------ccc--c-CC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCC
Q 007361 516 VELI------------NKS--L-GG---SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGE 563 (606)
Q Consensus 516 ~~l~------------d~~--l-~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~~ 563 (606)
.+.+ ... . .. .........+.+|+.+||+.||++|||+.++++ .++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0000 000 0 00 000111245778999999999999999999987 45443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=328.20 Aligned_cols=267 Identities=20% Similarity=0.234 Sum_probs=189.6
Q ss_pred HHHHHHhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe-
Q 007361 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE- 357 (606)
Q Consensus 280 ~~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 357 (606)
.......++|.+.+.||+|+||.||+|+... ++.||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 3455677899999999999999999999854 8899999985543 333456788889999999999999999976443
Q ss_pred ------eEEEEecCCCCCchhhhc-ccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeccCCCCCEEEcC-CCc
Q 007361 358 ------RMLIYEYLPNKSLNDFIF-DVTRSKFLDWSKRCQIIGGIARGLLYLH--QDSRLRIIHRDLKASNVLLDN-EMN 427 (606)
Q Consensus 358 ------~~lV~E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiH~Dlk~~NIll~~-~~~ 427 (606)
.++||||++++ |...+. .......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 78999999874 444332 2234566899999999999999999999 777 999999999999996 899
Q ss_pred eEEeecCCccccCCCcccccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH
Q 007361 428 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506 (606)
Q Consensus 428 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 506 (606)
+||+|||+++....... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||....... .....
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~ 244 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEI 244 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHH
Confidence 99999999987653322 22357899999999987654 8999999999999999999999986533211 11111
Q ss_pred HHHhhhcCcchhc----------ccccC---------CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 507 WRLWIEERPVELI----------NKSLG---------GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 507 ~~~~~~~~~~~l~----------d~~l~---------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.. .....+.+ +.... ..........+.+|+..||+.||++|||+.++++
T Consensus 245 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 245 VRVL-GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHH-CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHc-CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1100 00000000 00000 0111123457889999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=344.87 Aligned_cols=250 Identities=25% Similarity=0.324 Sum_probs=196.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.+.|...++||+|+||.||+++... +..+|+|++.+.. ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4578889999999999999999864 7899999987643 344678999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CceEEeecCCcccc
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAF 439 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~ki~DFGla~~~ 439 (606)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||++..+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999988543 45899999999999999999999998 9999999999999764 55999999999876
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||...... .+. ........ ...
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~-~~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EIL----RKVEKGKY-TFD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC-CCC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC-CCC
Confidence 5332 223467999999999876 56999999999999999999999998543211 111 11111110 000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+.. ... ...+.+++..||+.+|.+|||+.++++
T Consensus 258 ~~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-KNV----SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-ccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000 111 235778999999999999999999884
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=323.59 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=194.7
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--------ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--------GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 355 (606)
..++|.+.+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++.+++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34678999999999999999999865 7899999986532 12234588999999999999999999998765
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc---eEEee
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISD 432 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~ki~D 432 (606)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 8999999999999998843 446899999999999999999999998 999999999999987654 99999
Q ss_pred cCCccccCCCcccccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 433 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 433 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.|+....... .+....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~--- 232 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI--- 232 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH---
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH---
Confidence 99998764321 122356899999999974 5678999999999999999999999986433221 111111
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...... .. +..... ....+.+++..||+.||++||++.++++
T Consensus 233 -~~~~~~-~~-~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -TSGKYN-FI-PEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHTCCC-CC-HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhCccc-cC-chhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111000 00 000001 1246788999999999999999999983
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=344.29 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=198.5
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc-------------cCHHHHHHHHHHHhhccCCCcceEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-------------QGMEEFENEVLLIAKLQHRNLVKLIG 350 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 350 (606)
..+.|.+.++||+|+||.||+++... ++.+|+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999865 78999999865421 34578999999999999999999999
Q ss_pred EEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC---c
Q 007361 351 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---N 427 (606)
Q Consensus 351 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~---~ 427 (606)
++.+....++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999988543 45899999999999999999999998 99999999999998775 6
Q ss_pred eEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH
Q 007361 428 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 428 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 507 (606)
+||+|||++..+.... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||...... .+.
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---- 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DII---- 256 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH----
Confidence 9999999998765332 223457999999999886 56999999999999999999999998643211 111
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.......... ........ ...+.+++..||+.+|.+|||+.++++
T Consensus 257 ~~i~~~~~~~--~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYF--DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCC--CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCC--CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111000 00000011 245778999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.98 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=201.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|...++||+|+||.||+++.. .++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467888999999999999999986 58999999986542 34567899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---cCCCceEEeecCCccc
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARA 438 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll---~~~~~~ki~DFGla~~ 438 (606)
+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998854 345899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
+.... ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||...... .+. ......... .
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~-~ 246 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL----KKVEKGKYT-F 246 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCC-C
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCCC-C
Confidence 64332 2233579999999999876 6999999999999999999999998643211 111 111111110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+. .......+.+++..||+.+|++|||+.++++
T Consensus 247 ~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CSGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000 0011245778999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.05 Aligned_cols=262 Identities=20% Similarity=0.273 Sum_probs=193.1
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------ 355 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 355 (606)
....++|.+.+.||+|+||.||+|+.. +|+.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999975 4899999998654332 24799999999999999999998443
Q ss_pred --------------------------------CeeEEEEecCCCCCchhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHH
Q 007361 356 --------------------------------DERMLIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYL 402 (606)
Q Consensus 356 --------------------------------~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yL 402 (606)
...++||||++ ++|.+.+.. ......+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 588777753 12345699999999999999999999
Q ss_pred HhCCCCCeeeccCCCCCEEEc-CCCceEEeecCCccccCCCcccccccccccccCccCccccccC-CCCccccchhHHHH
Q 007361 403 HQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVL 480 (606)
Q Consensus 403 H~~~~~~iiH~Dlk~~NIll~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvv 480 (606)
|+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....+|..|+|||++.+. .++.++||||+|++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999997 689999999999987643322 2335789999999998875 48999999999999
Q ss_pred HHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc----------chhcccccCCC-----CCHHHHHHHHHHHhhcccC
Q 007361 481 VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP----------VELINKSLGGS-----YSLSEVLRCIQVGLLCVQQ 545 (606)
Q Consensus 481 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----------~~l~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~ 545 (606)
+|||++|+.||....... .+............ .+..-+.+... .+......+.+|+..||+.
T Consensus 232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999986432211 11111100000000 00000000000 0111224578999999999
Q ss_pred CCCCCCCHHHHHH
Q 007361 546 RPEDRPNMSSVVL 558 (606)
Q Consensus 546 ~P~~RPs~~~vl~ 558 (606)
||++|||+.++++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999983
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=320.51 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=191.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEee----------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ---------- 354 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 354 (606)
.++|.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467888999999999999999975 5889999998543 3445788999999999999999999999865
Q ss_pred ---CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 355 ---RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 355 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3567999999999999999964 2345788999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCcc------------cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCC
Q 007361 432 DFGMARAFGIDQT------------EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498 (606)
Q Consensus 432 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 498 (606)
|||++........ ........||..|+|||.+.+. .++.++||||||+++|||++ |+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--- 232 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--- 232 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---
Confidence 9999987643211 1122345689999999999865 68999999999999999998 322100
Q ss_pred ccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. .......... ........+......+.+++..||+.||++|||+.++++
T Consensus 233 --~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 --ER-VNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HH-HHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --hH-HHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 00 0011111110 011112222333456778999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=328.80 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=190.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------ 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 356 (606)
.++|...+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4678999999999999999999754 889999998653 2334567889999999999999999999997665
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 68999999975 7877773 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH----------
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA---------- 506 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---------- 506 (606)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 8754321 2233578999999999999999999999999999999999999986432210 00000
Q ss_pred --------HHHhhhcCc-------chhcccccCCCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 507 --------WRLWIEERP-------VELINKSLGGSY---SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 507 --------~~~~~~~~~-------~~l~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+..... ..++........ .......+.+|+.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000 000000000001 1122457889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=331.17 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=181.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------C
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------D 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 356 (606)
.++|...+.||+|+||.||+|.... |+.||+|++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999754 8899999996542 23456788999999999999999999999654 5
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899998843 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+..... .....||..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+...... .....
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~-~g~p~ 250 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRL-VGTPG 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH-HCSCC
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH-hCCCC
Confidence 875422 233678999999999987 679999999999999999999999986433211 11111110 00000
Q ss_pred ch------------hccccc-CCCCCHHH-----HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VE------------LINKSL-GGSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~------------l~d~~l-~~~~~~~~-----~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+ .+.... ........ ...+.+|+.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 000000 00111111 235788999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=336.28 Aligned_cols=198 Identities=22% Similarity=0.292 Sum_probs=171.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhc------cCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL------QHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 358 (606)
..+|.+.++||+|+||.||+|.... ++.||||++... ....+.+.+|+.++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4678999999999999999998765 789999998643 33446778899888887 567999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc--eEEeecCCc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMA 436 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~--~ki~DFGla 436 (606)
++||||+. ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6899988643 2334899999999999999999999998 999999999999999887 999999999
Q ss_pred cccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 764322 22357899999999999999999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=325.27 Aligned_cols=258 Identities=21% Similarity=0.284 Sum_probs=201.0
Q ss_pred hcCCCcCCeecccCcccEEEEEE-e-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCC------cceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVL-I-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN------LVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~-~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 357 (606)
.++|.+.+.||+|+||.||++.. . +++.||+|++... ....+.+.+|+.++..++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46788999999999999999987 3 5789999998643 334567889999999997654 9999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-------------
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------------- 424 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~------------- 424 (606)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999998643 2345899999999999999999999998 999999999999987
Q ss_pred ------CCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCC
Q 007361 425 ------EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498 (606)
Q Consensus 425 ------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 498 (606)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999864322 233578999999999999999999999999999999999999986543221
Q ss_pred ccchhHHHHHHhhhcCcchhcc----------ccc---------------------CCCCCHHHHHHHHHHHhhcccCCC
Q 007361 499 HHNLLGHAWRLWIEERPVELIN----------KSL---------------------GGSYSLSEVLRCIQVGLLCVQQRP 547 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d----------~~l---------------------~~~~~~~~~~~l~~l~~~Cl~~~P 547 (606)
....... .....+..... ... ...........+.+++..||+.||
T Consensus 242 ~~~~~~~----~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 242 HLAMMER----ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HHHHHHH----HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHHHHHH----HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 1111100 00000000000 000 001122345678899999999999
Q ss_pred CCCCCHHHHHH
Q 007361 548 EDRPNMSSVVL 558 (606)
Q Consensus 548 ~~RPs~~~vl~ 558 (606)
++|||+.++++
T Consensus 318 ~~Rpt~~ell~ 328 (339)
T 1z57_A 318 AKRITLREALK 328 (339)
T ss_dssp TTSCCHHHHTT
T ss_pred ccccCHHHHhc
Confidence 99999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=320.87 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=201.3
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc---------ccCHHHHHHHHHHHhhcc-CCCcceEEEEEe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---------GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCT 353 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 353 (606)
..++|.+.+.||+|+||.||++.... ++.||+|.+.... ....+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45789999999999999999999864 7899999986543 122456889999999995 999999999999
Q ss_pred eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeec
Q 007361 354 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433 (606)
Q Consensus 354 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DF 433 (606)
+....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999954 245899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCccccc------cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAI------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 507 (606)
|++....... ......+|..|+|||++. ...++.++||||||+++|||++|+.|+...... . ..
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~ 238 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---L----ML 238 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HH
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---H----HH
Confidence 9998764322 223357899999999985 456899999999999999999999997532211 0 11
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
......... . ...........+.+++..||+.||++||++.++++
T Consensus 239 ~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111110 0 00000122346789999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=329.86 Aligned_cols=261 Identities=20% Similarity=0.310 Sum_probs=199.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----Cee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 358 (606)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467899999999999999999976 47889999997543 23346789999999999999999999999765 368
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 589988843 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc-cccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 439 FGIDQTEA-NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 439 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+....... ......... .....
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~-~~~~~ 253 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGIL-GSPSQ 253 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHH-CSCCH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHh-CCCCH
Confidence 65432222 2344689999999998764 558999999999999999999999986543221 111111000 00000
Q ss_pred hhc------------ccc-cCCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 ELI------------NKS-LGGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~l~------------d~~-l~~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+.+ ... .....+.. ....+.+|+..||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000 00011111 1235789999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.29 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=201.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhcc-----------CCCcceEEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-----------HRNLVKLIGCCT 353 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 353 (606)
.++|.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357889999999999999999974 4889999998643 234567889999999886 899999999987
Q ss_pred eCC----eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEc-----
Q 007361 354 QRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 423 (606)
Q Consensus 354 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~----- 423 (606)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 899999986532 34589999999999999999999998 7 99999999999994
Q ss_pred -CCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccch
Q 007361 424 -NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 502 (606)
Q Consensus 424 -~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l 502 (606)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876432 2235789999999999999999999999999999999999999875432221111
Q ss_pred h---HHHHHHhhhcCcchh----------------ccc-------------ccCCCCCHHHHHHHHHHHhhcccCCCCCC
Q 007361 503 L---GHAWRLWIEERPVEL----------------INK-------------SLGGSYSLSEVLRCIQVGLLCVQQRPEDR 550 (606)
Q Consensus 503 ~---~~~~~~~~~~~~~~l----------------~d~-------------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 550 (606)
. ...... ....+..+ ... ......+......+.+|+..||+.||++|
T Consensus 247 ~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQIIEL-LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHH-HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHh-cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1 000000 00000000 000 00112345666788999999999999999
Q ss_pred CCHHHHHH--HhcCCC
Q 007361 551 PNMSSVVL--MLSGER 564 (606)
Q Consensus 551 Ps~~~vl~--~L~~~~ 564 (606)
||+.++++ .+.+..
T Consensus 326 pt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTL 341 (373)
T ss_dssp BCHHHHHTCGGGTTCT
T ss_pred CCHHHHhhChhhhccc
Confidence 99999987 455443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=328.96 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=198.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
..++|.+.+.||+|+||.||+|.... .+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35778899999999999999998743 5899988653 2334456788999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++ ++.+||+|||++......
T Consensus 109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999954 2345899999999999999999999998 99999999999998 679999999998765322
Q ss_pred c---ccccccccccccCccCcccccc---------CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHh
Q 007361 443 Q---TEANTNRVVGTYGYMPPEYAID---------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 443 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
. .........||..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ...+ ..
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~-~~ 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIW-QM 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHH-HH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-Hh
Confidence 1 1122233568999999999874 45789999999999999999999997543211 1111 11
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
.......... .. ....+.+++..||+.+|++|||+.+++++|+.+..
T Consensus 256 ~~~~~~~~~~----~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 GTGMKPNLSQ----IG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HTTCCCCCCC----SS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ccCCCCCCCc----CC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111111100 01 12357789999999999999999999999998643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=354.03 Aligned_cols=256 Identities=24% Similarity=0.323 Sum_probs=200.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
..++|.+.+.||+|+||.||+|.+.. +..+|+|++.... ....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678888999999999999999753 4579999986543 334578999999999999999999999985 45689
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999964 2345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..|+...... ... .........
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~----~~i~~~~~~-- 611 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI----GRIENGERL-- 611 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHHTCCC--
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHH----HHHHcCCCC--
Confidence 433221 2223456789999999999999999999999999999997 88887543211 111 111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
..+......+.+++..||+.||++||++.+|++.|+.+
T Consensus 612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11112234677899999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=322.12 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=198.3
Q ss_pred HhcCCCcCCeecccCcccEEEEEEe--CCcEEEEEEccccc--ccCHHHHHHHHHHHhhc---cCCCcceEEEEEe----
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKL---QHRNLVKLIGCCT---- 353 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 353 (606)
+.++|.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 57899999986432 22234567788777776 8999999999987
Q ss_pred -eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEee
Q 007361 354 -QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD 432 (606)
Q Consensus 354 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~D 432 (606)
.....++|+||++ |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 69999986532 344899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhh
Q 007361 433 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512 (606)
Q Consensus 433 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 512 (606)
||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ............
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence 99998764322 223467899999999999999999999999999999999999997643211 111111110000
Q ss_pred cCc----------chhcccccC---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 513 ERP----------VELINKSLG---GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 513 ~~~----------~~l~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ...+..... ..........+.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000000000 0001112245678999999999999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.15 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=190.4
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------CeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------DERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 359 (606)
..|...+.||+|+||.||+|++.. |+.||||++..... .+.+|+.++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 457888999999999999999865 89999999865432 234799999999999999999998542 2367
Q ss_pred EEEecCCCCCchhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-CceEEeecCCcc
Q 007361 360 LIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 437 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-~~~ki~DFGla~ 437 (606)
+||||+++ +|.+.+.. ......+++..+..++.||++||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 55555532 123456999999999999999999999998 9999999999999955 678999999998
Q ss_pred ccCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH-------
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------- 509 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------- 509 (606)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.. ....
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~-i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVE-IIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-HHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHHHhCCCCHH
Confidence 7643322 2235789999999999765 7999999999999999999999998643221 11111 1110
Q ss_pred -hhh--cCcchhcccccCCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 510 -WIE--ERPVELINKSLGGS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 510 -~~~--~~~~~l~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+.. ....+..-+.+... ........+.+|+.+||+.||++||++.++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000 00000000000000 01111246789999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=335.34 Aligned_cols=201 Identities=25% Similarity=0.380 Sum_probs=154.2
Q ss_pred CCCc-CCeecccCcccEEEEEEe---CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEee--CCeeEEE
Q 007361 288 NFSD-KNKLGEGGFGPVYKGVLI---EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLI 361 (606)
Q Consensus 288 ~~~~-~~~lG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 361 (606)
.|.+ .++||+|+||.||+|++. .++.||+|++.... ....+.+|+.++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 468999999999999976 47889999996542 33578899999999999999999999954 6789999
Q ss_pred EecCCCCCchhhhccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE----cCCCceEEe
Q 007361 362 YEYLPNKSLNDFIFDV------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKIS 431 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll----~~~~~~ki~ 431 (606)
|||+.+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999974 777776421 12235899999999999999999999998 9999999999999 778999999
Q ss_pred ecCCccccCCCcc-cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 432 DFGMARAFGIDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 432 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999987653322 1223446789999999999874 5899999999999999999999998644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.48 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=177.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHH-HHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVL-LIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++|...+.||+|+||.||++... +|+.||+|++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888899999999999999985 48899999996643 233345556665 777789999999999999999999999
Q ss_pred ecCCCCCchhhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 363 EYLPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 363 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 78777642 12245689999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccc----ccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYA----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
..... .....||..|+|||++ .+..++.++||||||+++|||++|+.|+......... .........
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~ 247 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhcCCC
Confidence 43221 2234689999999998 4667899999999999999999999998643211000 000000100
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. .+...........+.+++.+||+.||++||++.++++
T Consensus 248 ~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 P-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 1111111112346788999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=324.24 Aligned_cols=255 Identities=20% Similarity=0.309 Sum_probs=193.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee----
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER---- 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 358 (606)
.++|...+.||+|+||.||+|.... |+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4688889999999999999999764 8899999997543 23356788999999999999999999999877665
Q ss_pred --EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 359 --MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 359 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68887762 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ......... .....
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~-~~~~~ 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKV-TGVPG 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHH-HCCCC
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHH-hCCCc
Confidence 865322 233578999999999987 67999999999999999999999998643211 111100000 00000
Q ss_pred ch------------hcccccC-CCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VE------------LINKSLG-GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~------------l~d~~l~-~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+ .+..... ..... .....+.+|+..||+.||++|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 0000000 00011 11346789999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.84 Aligned_cols=262 Identities=22% Similarity=0.274 Sum_probs=196.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----Cee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 358 (606)
.++|.+.+.||+|+||.||+|.... |+.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4678899999999999999999864 8899999996543 23356788999999999999999999998764 678
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++|+||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 589988853 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc--------cccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 439 FGIDQTEA--------NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 439 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+....... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence 64322111 1223578999999998765 779999999999999999999999986432110 00000000
Q ss_pred hhhcC------------cchhccccc-CCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 510 WIEER------------PVELINKSL-GGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 510 ~~~~~------------~~~l~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... ..+.+.... ...... .....+.+++..||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 000000000 000011 11246778999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=322.30 Aligned_cols=201 Identities=23% Similarity=0.327 Sum_probs=170.4
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhcc-CC-----CcceEEEEEeeCCe
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HR-----NLVKLIGCCTQRDE 357 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~ 357 (606)
..++|.+.++||+|+||.||+|.... ++.||+|++... ....+++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 45789999999999999999999764 788999999643 334567788999998885 55 49999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCceEEeecCC
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGM 435 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~ki~DFGl 435 (606)
.++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++. .+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 59999986532 245899999999999999999999531 2399999999999994 578899999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876432 23367899999999999999999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.56 Aligned_cols=252 Identities=25% Similarity=0.308 Sum_probs=200.6
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
...++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 58899999986542 3456789999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC---CceEEeecCCcc
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMAR 437 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~---~~~ki~DFGla~ 437 (606)
|+||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999988543 35899999999999999999999998 9999999999999754 479999999998
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
....... .....+|..|+|||.+.+ .++.++||||||+++|+|++|+.|+...... .+ ...........
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~----~~~~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DI----LKRVETGKYAF 241 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCCCC
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCCCC
Confidence 7643321 223468899999998875 4899999999999999999999997543211 11 11111111100
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. + ..... ...+.+++.+||+.+|++|||+.++++
T Consensus 242 ~~-~-~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL-P-QWRTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS-G-GGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-h-hhhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 0 00111 245778999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.30 Aligned_cols=252 Identities=24% Similarity=0.283 Sum_probs=185.5
Q ss_pred CCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456889999999998776678999999998543 245678999999987 89999999999999999999999996
Q ss_pred CCCchhhhcccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCC-------------CceE
Q 007361 367 NKSLNDFIFDVTRSK----FLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-------------MNPK 429 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~-------------~~~k 429 (606)
|+|.+++....... ..++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996432211 1234456789999999999999998 9999999999999654 4899
Q ss_pred EeecCCccccCCCcccc--cccccccccCccCcccccc-------CCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCc
Q 007361 430 ISDFGMARAFGIDQTEA--NTNRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHH 499 (606)
Q Consensus 430 i~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~ 499 (606)
|+|||+++......... ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.|+.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999999875433221 2234679999999999976 678999999999999999999 899975322110
Q ss_pred cchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 500 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 500 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ....... .. ..............+.+++.+||+.||++|||+.+|++
T Consensus 248 ----~----~i~~~~~-~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----S----NIIRGIF-SL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----H----HHHHTCC-CC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----H----HHhcCCC-Cc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 0011100 00 00111123344567889999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=323.12 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=193.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe-----
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE----- 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 357 (606)
.++|...+.||+|+||.||+|.... |+.||+|++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3578888999999999999999854 8899999986542 2335678899999999999999999999987654
Q ss_pred -eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 358 -RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 358 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58888772 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .......... ....
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~-~~~~ 244 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVT-GVPG 244 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHH-CBCC
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh-CCCC
Confidence 865322 223578999999999887 67899999999999999999999998643211 1111110000 0000
Q ss_pred ch------------hccc---ccC---CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VE------------LINK---SLG---GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~------------l~d~---~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+ .+.. ... ..........+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0000 000 0011122356788999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=317.72 Aligned_cols=257 Identities=19% Similarity=0.209 Sum_probs=173.6
Q ss_pred HhcCCCcCC-eecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEee----CCee
Q 007361 285 ATENFSDKN-KLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDER 358 (606)
Q Consensus 285 ~~~~~~~~~-~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 358 (606)
..++|.+.+ .||+|+||.||++... +++.||+|++.... ....+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356788754 6999999999999987 48999999985432 222233334566799999999999876 4458
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEeecCC
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM 435 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~DFGl 435 (606)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999643 2346999999999999999999999998 999999999999976 45599999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
++..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.|+............ .......
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~-- 248 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG-- 248 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc--
Confidence 9865422 223357899999999999999999999999999999999999998543322110000 0000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcC
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSG 562 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~ 562 (606)
...............+.+++..||+.||++|||+.++++ .+..
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000000000112346778999999999999999999997 4444
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=319.86 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=198.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-C-cEEEEEEcccccccCHHHHHHHHHHHhhccCCC------cceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-G-QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN------LVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 357 (606)
.++|.+.+.||+|+||.||++.... + +.||+|.+... ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4688999999999999999999754 4 68999998643 344567889999999998766 9999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE---------------
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL--------------- 422 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll--------------- 422 (606)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66777766542 2345899999999999999999999998 9999999999999
Q ss_pred ----cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCC
Q 007361 423 ----DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498 (606)
Q Consensus 423 ----~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~ 498 (606)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999864322 233578999999999999999999999999999999999999986433211
Q ss_pred ccchhHHHHHHhhhcCcchhcc----------ccc---------------------CCCCCHHHHHHHHHHHhhcccCCC
Q 007361 499 HHNLLGHAWRLWIEERPVELIN----------KSL---------------------GGSYSLSEVLRCIQVGLLCVQQRP 547 (606)
Q Consensus 499 ~~~l~~~~~~~~~~~~~~~l~d----------~~l---------------------~~~~~~~~~~~l~~l~~~Cl~~~P 547 (606)
. ...... .....+..... ... ...........+.+|+..||+.||
T Consensus 247 ~---~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 247 H---LVMMEK-ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp H---HHHHHH-HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred H---HHHHHH-HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1 000000 00000000000 000 001122334578899999999999
Q ss_pred CCCCCHHHHHH
Q 007361 548 EDRPNMSSVVL 558 (606)
Q Consensus 548 ~~RPs~~~vl~ 558 (606)
++|||+.++++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=316.37 Aligned_cols=244 Identities=24% Similarity=0.423 Sum_probs=189.6
Q ss_pred HHHHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc------CHHHHHHHHHHHhhc----cCCCcceEEE
Q 007361 282 IANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ------GMEEFENEVLLIAKL----QHRNLVKLIG 350 (606)
Q Consensus 282 ~~~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g 350 (606)
.....++|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999875 4889999999654321 223456799999998 8999999999
Q ss_pred EEeeCCeeEEEEec-CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCce
Q 007361 351 CCTQRDERMLIYEY-LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNP 428 (606)
Q Consensus 351 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~ 428 (606)
++.+.+..++|+|+ +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999964 235899999999999999999999998 99999999999999 88999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||++....... .....||..|+|||++.+..+ +.++||||||+++|||++|+.|+.....
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------- 244 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence 999999998765332 233568999999999987766 4589999999999999999999753110
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... ..+.... ...+.+++.+||+.+|++||++.++++
T Consensus 245 --~~~~~------~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 --ILEAE------LHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HHHTC------CCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --Hhhhc------cCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0111112 245778999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.39 Aligned_cols=242 Identities=25% Similarity=0.396 Sum_probs=197.7
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc------CHHHHHHHHHHHhhcc--CCCcceEEEEEee
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ------GMEEFENEVLLIAKLQ--HRNLVKLIGCCTQ 354 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~ 354 (606)
...++|.+.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.++.+++ |+||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34578999999999999999999875 4889999998654321 2345678999999996 5999999999999
Q ss_pred CCeeEEEEecCCC-CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCceEEee
Q 007361 355 RDERMLIYEYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISD 432 (606)
Q Consensus 355 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~ki~D 432 (606)
.+..++|+|++.+ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 899999854 345899999999999999999999998 99999999999999 789999999
Q ss_pred cCCccccCCCcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 433 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 433 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+..... ..
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~ 256 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------II 256 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HH
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hh
Confidence 99998765322 223568999999999987765 7889999999999999999999753210 00
Q ss_pred hcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ...... ...+.+++.+||+.+|++||++.++++
T Consensus 257 ~~~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 RGQV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HCCC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 011112 245778999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.19 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=185.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
..+|...+.||+|+||+|+.....+++.||||++...... .+.+|+.+++++ +|||||++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4568888999999999976655668999999999654322 356899999999 799999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCceEEeecCCcccc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAF 439 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~ki~DFGla~~~ 439 (606)
+. |+|.+++.... ..+.+..+..++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 59999986432 22445566789999999999999998 999999999999953 346889999999876
Q ss_pred CCCcc-cccccccccccCccCccccc---cCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 440 GIDQT-EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 440 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
..... ........||+.|+|||++. ...++.++||||||+++|||++ |..|+...... . ........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~-~~~~~~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------Q-ANILLGAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------H-HHHHTTCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------H-HHHHhccC
Confidence 53322 12334467999999999997 4567889999999999999999 88887432211 0 00011110
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
..... .........+.+|+.+||+.||++|||+.+|+
T Consensus 246 ~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 246 SLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp CCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred Ccccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 10100 11122334577899999999999999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.35 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=177.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc--CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
.++|...+.||+|+||.||+|... +|+.||+|++...... ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999986 4889999998654322 2234455556788889999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
||+ ++.+..+... ....+++..+..++.||++||.|||+. + |+|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4445444422 234589999999999999999999985 7 99999999999999999999999999976543
Q ss_pred CcccccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
... .....+|+.|+|||++. ...++.++||||||+++|||++|+.|+...... . ............
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~----~~~~~~~~~~~~ 248 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--F----EVLTKVLQEEPP 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--H----HHHHHHHHSCCC
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--H----HHHHHHhccCCC
Confidence 221 22356899999999994 556899999999999999999999997642211 0 111111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. +.... .....+.+++.+||+.||.+||++.++++
T Consensus 249 ~-----~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 L-----LPGHM--GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-----CCSSS--CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-----CCccC--CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 11000 11245778999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=338.86 Aligned_cols=264 Identities=23% Similarity=0.295 Sum_probs=197.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEee------CCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ------RDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 357 (606)
.++|.+.++||+|+||.||+|.... |+.||+|++... .....+.+.+|+.++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 4689999999999999999999754 889999998654 33445679999999999999999999999765 667
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCc---eEEeecC
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFG 434 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~---~ki~DFG 434 (606)
.++||||+++|+|.+++........+++..++.++.+|+.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555556999999999999999999999998 999999999999987665 9999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCc--cchhHHHHHH-hh
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH--HNLLGHAWRL-WI 511 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~-~~ 511 (606)
++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+........ .......... ..
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998764332 22346789999999999999999999999999999999999999854211000 0000000000 00
Q ss_pred hcCcchh--cccc--cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 007361 512 EERPVEL--INKS--LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSS 555 (606)
Q Consensus 512 ~~~~~~l--~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 555 (606)
....... .... ............+.+++..||+.||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000 0000 011223345567889999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=339.95 Aligned_cols=237 Identities=21% Similarity=0.287 Sum_probs=190.3
Q ss_pred cCCCcCCeecccCcccEEEEEEe--CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCe-----e
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE-----R 358 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~--~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 358 (606)
++|.+.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999986 48899999986543 3345678999999999999999999999987665 6
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
++||||+++++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999987732 5899999999999999999999998 9999999999999986 899999999987
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
.... ....||+.|+|||++.+.. +.++||||||+++|||++|..|+........
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------- 284 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------- 284 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------
Confidence 6432 3467999999999987654 8999999999999999999877542111100
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHHhcC
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-MSSVVLMLSG 562 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~vl~~L~~ 562 (606)
............+.+|+.+||+.||++||+ +.++...|.+
T Consensus 285 ----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 ----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000001112246788999999999999995 5666665543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=292.64 Aligned_cols=231 Identities=10% Similarity=0.083 Sum_probs=181.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|.+.+.||+|+||.||+|.... ++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 578999999999999999999865 89999999976533 23477999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++++|.+++.. . ....++..++.||+.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999832 2 355678899999999999999998 9999999999999999999998543
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
|++| ++.++||||||+++|||++|+.||............. .. ........ ..
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~-~~~~~~~~--~~ 227 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RD-TAGQPIEP--AD 227 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BC-TTSCBCCH--HH
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HH-hccCCCCh--hh
Confidence 3333 6889999999999999999999986543321110000 00 00000000 00
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
..... ...+.+|+.+||+.||++| |+.++++.|+....
T Consensus 228 ~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 228 IDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 11111 2357789999999999999 99999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.62 Aligned_cols=240 Identities=17% Similarity=0.179 Sum_probs=177.8
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc---ccCHHHHHHHHHHHhhccC-CCc----------ceE---
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQH-RNL----------VKL--- 348 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-~ni----------v~l--- 348 (606)
..|...+.||+|+||.||+|++. +|+.||||++.... ....+.|.+|+.++..++| +|. +.+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45667789999999999999965 48999999987432 2346789999999999987 221 111
Q ss_pred --------EEEEee-----CCeeEEEEecCCCCCchhhhcc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 007361 349 --------IGCCTQ-----RDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 411 (606)
Q Consensus 349 --------~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 411 (606)
+.+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||.|||+.+ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111111 12346666655 6899988841 223456889999999999999999999998 99
Q ss_pred eccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCcccc----------ccCCCCccccchhHHHHH
Q 007361 412 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA----------IDGLFSVKSDVFSFGVLV 481 (606)
Q Consensus 412 H~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DV~S~Gvvl 481 (606)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||+++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999875432 334567 999999999 556688999999999999
Q ss_pred HHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 482 LEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 482 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
|||++|+.|+......... ...+... ...+ ..+.+|+..||+.+|++||++.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~---------------~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS---------------EWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS---------------GGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhhH---------------HHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999998643221110 0011100 1122 4577899999999999999976664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.37 Aligned_cols=227 Identities=20% Similarity=0.250 Sum_probs=176.5
Q ss_pred hcCCCcC-CeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHH-hhccCCCcceEEEEEee----CCee
Q 007361 286 TENFSDK-NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLI-AKLQHRNLVKLIGCCTQ----RDER 358 (606)
Q Consensus 286 ~~~~~~~-~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~ 358 (606)
.++|.+. +.||+|+||.||++... +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3566666 77999999999999985 488999999853 24677888888 55589999999999877 6778
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEeecCC
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM 435 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~DFGl 435 (606)
++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999653 2346899999999999999999999998 999999999999998 78999999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+.... +..++.++||||||+++|||++|+.|+.......... ...
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~ 211 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMK 211 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHH
Confidence 87532 2456789999999999999999999985432211000 000
Q ss_pred chhcccccCCCCCHH----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...... ....+.. ....+.+++..||+.||++|||+.++++
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 0011111 1346788999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=293.63 Aligned_cols=237 Identities=16% Similarity=0.167 Sum_probs=183.6
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEccccc--------ccCHHHHHHHHHHHhhcc---------CCCcceE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--------GQGMEEFENEVLLIAKLQ---------HRNLVKL 348 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 348 (606)
.++|.+.++||+|+||.||+|+. +|+.||+|++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999998 78999999997542 234478999999999986 8888888
Q ss_pred EEEEe------------------------------eCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHH
Q 007361 349 IGCCT------------------------------QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 398 (606)
Q Consensus 349 ~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 398 (606)
.+.+. +.+..++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 88753 26789999999999987777632 458999999999999999
Q ss_pred HHHHH-hCCCCCeeeccCCCCCEEEcCCC--------------------ceEEeecCCccccCCCcccccccccccccCc
Q 007361 399 LLYLH-QDSRLRIIHRDLKASNVLLDNEM--------------------NPKISDFGMARAFGIDQTEANTNRVVGTYGY 457 (606)
Q Consensus 399 L~yLH-~~~~~~iiH~Dlk~~NIll~~~~--------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y 457 (606)
|.||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999876422 35799999
Q ss_pred cCccccccCCCCccccchhHHHH-HHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc-cCCC----CCHHH
Q 007361 458 MPPEYAIDGLFSVKSDVFSFGVL-VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS-LGGS----YSLSE 531 (606)
Q Consensus 458 ~aPE~~~~~~~s~k~DV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~-l~~~----~~~~~ 531 (606)
+|||++.+.. +.++||||++++ .+++++|..|+.. ..|.... ...++... .... .....
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYL---TDKMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHH---HHHHHHTCCCSSCCCSHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHH---HHhhhhhhccCcccchhhhhhc
Confidence 9999998776 899999998777 7778888888521 1110000 00111000 0000 11234
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 532 VLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 532 ~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
...+.+|+.+||+.+ |+.+++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 557889999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-30 Score=281.32 Aligned_cols=185 Identities=18% Similarity=0.183 Sum_probs=131.1
Q ss_pred eecccCcccEEEEEE-eCCcEEEEEEccccc----------ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEE
Q 007361 294 KLGEGGFGPVYKGVL-IEGQEIAAKRLSKSS----------GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 294 ~lG~G~fG~Vy~g~~-~~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 361 (606)
.++.|++|.+..++. .-|+.+++|.+.+.. +...++|.+|+++|+++ .|+||+++++++.+.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677776666553 248899999986542 23356799999999999 799999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||++|++|.++|.. ...++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999954 3446654 48899999999999999 99999999999999999999999999987654
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCC
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN 490 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p 490 (606)
+.. .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 322 2334789999999999875 467789999999999988766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=254.21 Aligned_cols=185 Identities=18% Similarity=0.187 Sum_probs=145.9
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccccc--------cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG--------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
...++||+|+||.||+|.. .++.+++|+...... ...+.+.+|+.++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4457899999999999954 578888887644221 1134589999999999999999766666677888999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999853 5589999999999999998 999999999999999 999999999998754
Q ss_pred Ccccc-----cccccccccCccCcccccc--CCCCccccchhHHHHHHHHHhccCCC
Q 007361 442 DQTEA-----NTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNR 491 (606)
Q Consensus 442 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~k~DV~S~Gvvl~elltG~~p~ 491 (606)
..... ......||+.|||||++.. ..|+..+|+||..+-.++-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32221 1234689999999999987 66888999999999998888776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=208.29 Aligned_cols=151 Identities=18% Similarity=0.118 Sum_probs=120.4
Q ss_pred HHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccc------------------cCHHHHHHHHHHHhhccCC
Q 007361 282 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG------------------QGMEEFENEVLLIAKLQHR 343 (606)
Q Consensus 282 ~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~ 343 (606)
+......|.+.+.||+|+||.||+|...+|+.||+|.+..... .....+.+|+.++.+++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 3444556777799999999999999996699999999864321 124568999999999994
Q ss_pred CcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc
Q 007361 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 423 (606)
Q Consensus 344 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~ 423 (606)
+++.+++.. +..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|||++
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 555554433 55799999999999998 421 124479999999999999998 99999999999999
Q ss_pred CCCceEEeecCCccccCCCcccccccccccccCccCcccccc
Q 007361 424 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465 (606)
Q Consensus 424 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 465 (606)
++.+||+|||+|+. +..++|||++..
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999874 335788998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.5e-19 Score=175.15 Aligned_cols=136 Identities=15% Similarity=0.182 Sum_probs=106.0
Q ss_pred CCcCCeecccCcccEEEEEE-eCCcE--EEEEEccccccc------------------------CHHHHHHHHHHHhhcc
Q 007361 289 FSDKNKLGEGGFGPVYKGVL-IEGQE--IAAKRLSKSSGQ------------------------GMEEFENEVLLIAKLQ 341 (606)
Q Consensus 289 ~~~~~~lG~G~fG~Vy~g~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 341 (606)
|.+.+.||+|+||.||+|.. .+|+. ||||.+...... ....+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 999986443111 1136789999999998
Q ss_pred CCCc--ceEEEEEeeCCeeEEEEecCCC-C----CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeec
Q 007361 342 HRNL--VKLIGCCTQRDERMLIYEYLPN-K----SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH-QDSRLRIIHR 413 (606)
Q Consensus 342 H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~ 413 (606)
|+++ ..+++. ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8754 444543 357899999942 4 55554422 234567789999999999999 887 9999
Q ss_pred cCCCCCEEEcCCCceEEeecCCcccc
Q 007361 414 DLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 414 Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
||||+|||+++ .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=165.84 Aligned_cols=137 Identities=14% Similarity=0.196 Sum_probs=99.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccc--------------cCHHHH--------HHHHHHHhhccCCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG--------------QGMEEF--------ENEVLLIAKLQHRN 344 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--------------~~~~~~--------~~E~~~l~~l~H~n 344 (606)
.-|.+..+||+|+||.||+|...+|+.||||.++.... ...... ..|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999998999999998753210 011112 23555666664433
Q ss_pred c--ceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 345 L--VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 345 i--v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
+ ...+++ ...+|||||+++++|..+... .....++.||+.+|.|||+.+ ||||||||.|||+
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 3 222222 123799999999988775421 123567899999999999998 9999999999999
Q ss_pred cCCC----------ceEEeecCCcccc
Q 007361 423 DNEM----------NPKISDFGMARAF 439 (606)
Q Consensus 423 ~~~~----------~~ki~DFGla~~~ 439 (606)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8776 3899999977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=6.8e-12 Score=124.36 Aligned_cols=146 Identities=17% Similarity=0.096 Sum_probs=115.3
Q ss_pred HHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEE
Q 007361 283 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 283 ~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 361 (606)
......|.....++.|+.+.||+... .++.+++|............+.+|+.+++.+. |.++.++++++.+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456787778888899999999975 47899999986532233346889999999984 67888999999998999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS----------------------------------- 406 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------- 406 (606)
|||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999887641 11223478889999999999821
Q ss_pred ---------------------CCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 407 ---------------------RLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 407 ---------------------~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999887667899998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=5.6e-11 Score=117.20 Aligned_cols=138 Identities=14% Similarity=0.143 Sum_probs=102.0
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCC--cceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN--LVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~ 364 (606)
.++......+.|..+.||+....+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344433333456669999998766788999987543 2345788999999996544 55688988888889999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS-------------------------------------- 406 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 406 (606)
++|.+|. ... .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 211 11 2356778888888888753
Q ss_pred -----------------CCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 407 -----------------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 407 -----------------~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998877778999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=2e-09 Score=111.76 Aligned_cols=142 Identities=18% Similarity=0.264 Sum_probs=107.7
Q ss_pred cCCeecccCcccEEEEEEeCCcEEEEEEcc--ccc-ccCHHHHHHHHHHHhhcc--CCCcceEEEEEeeC---CeeEEEE
Q 007361 291 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSS-GQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQR---DERMLIY 362 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 362 (606)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3477999999999998874 4678888775 322 123456888999999997 45688999998776 4489999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS------------------------------------ 406 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 406 (606)
||++|..+.+.. ...++...+..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998885422 123678888999999999999999731
Q ss_pred -------------------CCCeeeccCCCCCEEEcCCCc--eEEeecCCccc
Q 007361 407 -------------------RLRIIHRDLKASNVLLDNEMN--PKISDFGMARA 438 (606)
Q Consensus 407 -------------------~~~iiH~Dlk~~NIll~~~~~--~ki~DFGla~~ 438 (606)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=3.1e-09 Score=107.67 Aligned_cols=186 Identities=19% Similarity=0.216 Sum_probs=121.5
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCC--cceEEEEEeeCC---eeEEEEecC
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRN--LVKLIGCCTQRD---ERMLIYEYL 365 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~~ 365 (606)
.+.++.|....||+.. ..+++|..... .....+.+|+.++..+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3668999999999853 56788875422 34567899999998883 332 445555543333 358899999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD---------------------------------------- 405 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 405 (606)
+|.+|.+... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 2267777888888888888888862
Q ss_pred ---------------CCCCeeeccCCCCCEEEcC--CCceEEeecCCccccCCCccccccc------------ccccccC
Q 007361 406 ---------------SRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGIDQTEANTN------------RVVGTYG 456 (606)
Q Consensus 406 ---------------~~~~iiH~Dlk~~NIll~~--~~~~ki~DFGla~~~~~~~~~~~~~------------~~~gt~~ 456 (606)
....++|+|++|.||++++ +..+.|+||+.+..-.......... ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1235899999999999998 5668899999886532110000000 0000111
Q ss_pred ccC-ccccccCCCCccccchhHHHHHHHHHhccCC
Q 007361 457 YMP-PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN 490 (606)
Q Consensus 457 y~a-PE~~~~~~~s~k~DV~S~Gvvl~elltG~~p 490 (606)
... |+.... .....+.|+++.++|.+.+|+.+
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 112 222111 11236899999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=3.9e-06 Score=84.76 Aligned_cols=136 Identities=21% Similarity=0.175 Sum_probs=94.8
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCC---CcceEEEEEe-eCCeeEEEEecCCC
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR---NLVKLIGCCT-QRDERMLIYEYLPN 367 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~ 367 (606)
.+.++.|....||+. |+.+++|+-. .......+..|+.++..+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888899987 5677888742 223456789999999999652 3566677664 44567899999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD------------------------------------------ 405 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 405 (606)
.+|.+.... .++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 134445555555566655555543
Q ss_pred ---------------CCCCeeeccCCCCCEEEcC---CCc-eEEeecCCccc
Q 007361 406 ---------------SRLRIIHRDLKASNVLLDN---EMN-PKISDFGMARA 438 (606)
Q Consensus 406 ---------------~~~~iiH~Dlk~~NIll~~---~~~-~ki~DFGla~~ 438 (606)
....++|+|+++.||+++. ++. ..|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 58999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4.7e-06 Score=85.98 Aligned_cols=80 Identities=9% Similarity=0.015 Sum_probs=57.6
Q ss_pred Cee-cccCcccEEEEEEe-------CCcEEEEEEccccc---ccCHHHHHHHHHHHhhcc-C--CCcceEEEEEeeC---
Q 007361 293 NKL-GEGGFGPVYKGVLI-------EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQ-H--RNLVKLIGCCTQR--- 355 (606)
Q Consensus 293 ~~l-G~G~fG~Vy~g~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~--- 355 (606)
+.| +.|....+|+.... +++.+++|...... ......+..|+.+++.+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88889999998765 26678888764432 112246788999998884 3 3577888887665
Q ss_pred CeeEEEEecCCCCCchh
Q 007361 356 DERMLIYEYLPNKSLND 372 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~ 372 (606)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.4e-06 Score=82.49 Aligned_cols=136 Identities=18% Similarity=0.155 Sum_probs=97.3
Q ss_pred CeecccCcc-cEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 293 NKLGEGGFG-PVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 293 ~~lG~G~fG-~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
+.+..|..| .||+..... +..+++|+-... ....+..|...|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556665 589877654 567888875432 3456888999998884 4457788999999999999999999988
Q ss_pred chhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 007361 370 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS------------------------------------------- 406 (606)
Q Consensus 370 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 406 (606)
+.+.... .......+..+++..|.-||+..
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765421 11223345566666666666431
Q ss_pred ------------CCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 407 ------------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 407 ------------~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
...++|+|+.+.||++++++.+-|.||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999887778999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=4.1e-05 Score=78.03 Aligned_cols=140 Identities=14% Similarity=0.189 Sum_probs=81.2
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc--CCCcceEEE------EEeeCCeeEEEEec
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--HRNLVKLIG------CCTQRDERMLIYEY 364 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g------~~~~~~~~~lV~E~ 364 (606)
+.|+.|..+.||+....+| .+++|+.... ..++..|+.++..|. .-.+.+++. +....+..++|+||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987544 5888888642 234455666666553 122333332 12345678999999
Q ss_pred CCCCCchh--------------hhcccC-----C------CCCCCHHHHH------------------------------
Q 007361 365 LPNKSLND--------------FIFDVT-----R------SKFLDWSKRC------------------------------ 389 (606)
Q Consensus 365 ~~~gsL~~--------------~l~~~~-----~------~~~l~~~~~~------------------------------ 389 (606)
++|..+.. .++... . .....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 111100 0 0112343211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 390 -QIIGGIARGLLYLHQ----------DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 390 -~i~~~ia~gL~yLH~----------~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.+...+..++.+|++ ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445667763 123569999999999999888899999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=5.5e-05 Score=79.20 Aligned_cols=75 Identities=11% Similarity=0.139 Sum_probs=50.6
Q ss_pred CCeecccCcccEEEEEEe-CCcEEEEEEcccccc-------cCHHHHHHHHHHHhhccC--CCc-ceEEEEEeeCCeeEE
Q 007361 292 KNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-------QGMEEFENEVLLIAKLQH--RNL-VKLIGCCTQRDERML 360 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~ni-v~l~g~~~~~~~~~l 360 (606)
.+.||.|.++.||++... +++.+++|....... ...+.+..|..++..+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 367999999999999764 467899997643221 234567789999988743 343 455544 3455789
Q ss_pred EEecCCCC
Q 007361 361 IYEYLPNK 368 (606)
Q Consensus 361 V~E~~~~g 368 (606)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.0002 Score=72.18 Aligned_cols=139 Identities=19% Similarity=0.149 Sum_probs=94.5
Q ss_pred cCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc---CCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 291 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 291 ~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
..+.|+.|....+|+... +++.+++|..... ....+..|+..|+.|. ...+.+++++....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346799999999999886 5678888876432 3567889999998884 36788899998888889999999999
Q ss_pred CCchh-----------hhcccCC-C------------------CCCCHHHHH---HHHH----------------HHHHH
Q 007361 368 KSLND-----------FIFDVTR-S------------------KFLDWSKRC---QIIG----------------GIARG 398 (606)
Q Consensus 368 gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~g 398 (606)
..+.. -|+.... . -.-+|.... ++.. .+...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 87632 1122111 0 012565432 1111 11111
Q ss_pred -HHHHHh-CCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 399 -LLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 399 -L~yLH~-~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
...|.. ..++.++|+|+.+.||+++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2356799999999999999887 8899973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00013 Score=72.80 Aligned_cols=80 Identities=18% Similarity=0.211 Sum_probs=59.9
Q ss_pred CCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccC---CCcceEEEEEeeCCeeEEEEec
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH---RNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.....+.+|.|..+.||+.++.+|+.+++|+-..........|..|+..|+.|.- -.+.++++.. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3445678999999999999999999999998765544445568899999998842 2345556542 34789999
Q ss_pred CCCCCch
Q 007361 365 LPNKSLN 371 (606)
Q Consensus 365 ~~~gsL~ 371 (606)
++++...
T Consensus 92 l~~~~~~ 98 (288)
T 3f7w_A 92 VDERPPT 98 (288)
T ss_dssp CCCCCCC
T ss_pred ecccCCC
Confidence 9877643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00041 Score=73.09 Aligned_cols=80 Identities=9% Similarity=0.000 Sum_probs=47.9
Q ss_pred CCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccC---CCCccccchhHHHHHHH
Q 007361 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLE 483 (606)
Q Consensus 407 ~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DV~S~Gvvl~e 483 (606)
...++|+|+++.|||++.++ ++|.||+.+..-.....-... ...-...|.+|+..... .-....++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34599999999999998876 999999988652110000000 00001245666554311 11223556688888888
Q ss_pred HHhcc
Q 007361 484 IVCGK 488 (606)
Q Consensus 484 lltG~ 488 (606)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.002 Score=64.87 Aligned_cols=157 Identities=13% Similarity=0.074 Sum_probs=86.9
Q ss_pred CHHHHHHHhcCCCc-----CCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCC--cceEEE
Q 007361 278 DWMAIANATENFSD-----KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN--LVKLIG 350 (606)
Q Consensus 278 ~~~~~~~~~~~~~~-----~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g 350 (606)
+..++......|.. .+.|+.|....+|+....+| .+++|..... ...+.+..|+.++..+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34444444444543 24566788899999987555 6778877542 12235567777777774212 233332
Q ss_pred E------EeeCCeeEEEEecCCCCCchhh--------------hcccC----CC-----CCCCHHHHHHH----------
Q 007361 351 C------CTQRDERMLIYEYLPNKSLNDF--------------IFDVT----RS-----KFLDWSKRCQI---------- 391 (606)
Q Consensus 351 ~------~~~~~~~~lV~E~~~~gsL~~~--------------l~~~~----~~-----~~l~~~~~~~i---------- 391 (606)
. ....+..++|++|++|..+... ++... .. ....|...+.-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1223567899999998765321 11110 00 01124331110
Q ss_pred --HHHHHHHHHHHHhC----CCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 392 --IGGIARGLLYLHQD----SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 392 --~~~ia~gL~yLH~~----~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
...+.+.+..++.. .+..++|+|+++.||+++++..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11234455555532 23459999999999999987666899998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0009 Score=70.68 Aligned_cols=73 Identities=19% Similarity=0.297 Sum_probs=51.0
Q ss_pred CeecccCcccEEEEEEeC--------CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCc-ceEEEEEeeCCeeEEEEe
Q 007361 293 NKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 363 (606)
+.|+.|....+|+....+ ++.+++|+.... ...+.+..|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 568888899999998753 467888876331 122566789999988853333 567776543 38999
Q ss_pred cCCCCCch
Q 007361 364 YLPNKSLN 371 (606)
Q Consensus 364 ~~~~gsL~ 371 (606)
|++|.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0023 Score=66.17 Aligned_cols=141 Identities=18% Similarity=0.225 Sum_probs=84.6
Q ss_pred CeecccCcccEEEEEEeC--------CcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEe
Q 007361 293 NKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 363 (606)
+.|..|-...+|+....+ ++.+++|+-.. .......+.+|..+++.+. +.-..++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567788889999988752 46788887532 2234667779999998884 3334567776654 29999
Q ss_pred cCCCCCchhh-----------------hccc--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 007361 364 YLPNKSLNDF-----------------IFDV--TRSKFLD--WSKRCQIIGGIAR-------------------GLLYL- 402 (606)
Q Consensus 364 ~~~~gsL~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~ia~-------------------gL~yL- 402 (606)
|++|..|..- |+.. .-.+... |.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 0111 1111222 3444444433321 22333
Q ss_pred ---HhC-CCCCeeeccCCCCCEEEcCC----CceEEeecCCccc
Q 007361 403 ---HQD-SRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA 438 (606)
Q Consensus 403 ---H~~-~~~~iiH~Dlk~~NIll~~~----~~~ki~DFGla~~ 438 (606)
... ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 23469999999999999876 7899999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0019 Score=64.50 Aligned_cols=72 Identities=8% Similarity=0.143 Sum_probs=45.8
Q ss_pred CCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCc-ceEEEEEeeCCeeEEEEecC-CCCC
Q 007361 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYL-PNKS 369 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gs 369 (606)
.+.|+.|....+|+. +.+++|+-....... ....+|+.+++.+....+ .++++. +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 567777765432221 223568888887753333 456554 344457899999 6655
Q ss_pred ch
Q 007361 370 LN 371 (606)
Q Consensus 370 L~ 371 (606)
|.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0036 Score=63.42 Aligned_cols=141 Identities=17% Similarity=0.133 Sum_probs=73.1
Q ss_pred CeecccCccc-EEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccC--CCcceEEEEEeeCCeeEEEEecCCCCC
Q 007361 293 NKLGEGGFGP-VYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRDERMLIYEYLPNKS 369 (606)
Q Consensus 293 ~~lG~G~fG~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 369 (606)
+.|+.|.... +|+....+++.+++|....... +.+..|+.++..+.. -.+.+++.+..+. .++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565554444 6677654467777776543221 234556777776642 3456677764433 378999998766
Q ss_pred chhhhcc---------------------cCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 007361 370 LNDFIFD---------------------VTR--SKFLDWSKRC-------Q-------------IIGGIARGLLYLH--- 403 (606)
Q Consensus 370 L~~~l~~---------------------~~~--~~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 403 (606)
+.+++.. ... ...++..... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6543311 000 0111111100 0 0011112222221
Q ss_pred hCCCCCeeeccCCCCCEEEcCC----CceEEeecCCccc
Q 007361 404 QDSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA 438 (606)
Q Consensus 404 ~~~~~~iiH~Dlk~~NIll~~~----~~~ki~DFGla~~ 438 (606)
......++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1223469999999999999875 6899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0041 Score=66.04 Aligned_cols=74 Identities=15% Similarity=0.084 Sum_probs=48.4
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCc-ceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
+.|+.|-...+|+....+ +..+++|+........ -+-..|..++..|...++ .++++.+. + .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 678889999999998765 4677787764332221 122578889998865445 56777763 2 359999998665
Q ss_pred h
Q 007361 371 N 371 (606)
Q Consensus 371 ~ 371 (606)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.011 Score=59.62 Aligned_cols=142 Identities=11% Similarity=0.123 Sum_probs=82.7
Q ss_pred CeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccC--CCcceEEEE-----EeeCCeeEEEEecC
Q 007361 293 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLIGC-----CTQRDERMLIYEYL 365 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~E~~ 365 (606)
..|+ |....||+....+|+.+++|...... .....+..|+.++..+.. -.+.+++.. ....+..++|+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877677789999875331 234567778888887742 223444433 12244567899999
Q ss_pred CCCCchh----h----------hcc----c--CCCCCCCHHHH----HHHH---------------HHHHHHHHHHHh--
Q 007361 366 PNKSLND----F----------IFD----V--TRSKFLDWSKR----CQII---------------GGIARGLLYLHQ-- 404 (606)
Q Consensus 366 ~~gsL~~----~----------l~~----~--~~~~~l~~~~~----~~i~---------------~~ia~gL~yLH~-- 404 (606)
+|..+.. . ++. . ......++... ..++ ..+...+..+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865431 0 111 0 01112233211 0010 011112222221
Q ss_pred --CCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 405 --DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 405 --~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
..+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.005 Score=63.40 Aligned_cols=73 Identities=14% Similarity=0.122 Sum_probs=44.8
Q ss_pred CeecccCcccEEEEEEeCC---------cEEEEEEcccccccCHHHHHHHHHHHhhccCCC-cceEEEEEeeCCeeEEEE
Q 007361 293 NKLGEGGFGPVYKGVLIEG---------QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN-LVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g---------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 362 (606)
..|+.|....+|+....++ +.+++|........ ..+...|..++..+...+ ..++++.. . -++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 5678888889999987542 67777776443222 123467888888885333 34666554 2 37899
Q ss_pred ecCCCCCc
Q 007361 363 EYLPNKSL 370 (606)
Q Consensus 363 E~~~~gsL 370 (606)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.015 Score=59.05 Aligned_cols=32 Identities=31% Similarity=0.416 Sum_probs=28.0
Q ss_pred CCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 407 ~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.09 E-value=0.01 Score=55.58 Aligned_cols=98 Identities=9% Similarity=0.044 Sum_probs=63.6
Q ss_pred CchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccccc
Q 007361 369 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 448 (606)
Q Consensus 369 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 448 (606)
||.+.|.. ...+++++++|.++.|.+.+|.-+-.... -..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----------
Confidence 67777743 45679999999999999999877622110 11333457899999999988764 1110
Q ss_pred cccccccCccCccccccCCCCccccchhHHHHHHHHHh
Q 007361 449 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC 486 (606)
Q Consensus 449 ~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt 486 (606)
.....+.|||... ...+.+.=|||+|++||.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888653 455678899999999999874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.56 E-value=0.25 Score=51.67 Aligned_cols=140 Identities=14% Similarity=0.138 Sum_probs=84.4
Q ss_pred CeecccCcccEEEEEEeC--------CcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeEEEEe
Q 007361 293 NKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 363 (606)
+.|..|-...+|+....+ ++.+++++-...... .-+-.+|..+++.+. +.-..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 567788889999998753 577888876443222 223467888888885 333455665432 378999
Q ss_pred cCCCCCchhh-h----------------cc--c-----C---CCCCCCHHHHHHHHHHH-------------------HH
Q 007361 364 YLPNKSLNDF-I----------------FD--V-----T---RSKFLDWSKRCQIIGGI-------------------AR 397 (606)
Q Consensus 364 ~~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a~ 397 (606)
|++|..|..- + +. . . ...+.-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998765321 0 10 0 0 11111244433333221 22
Q ss_pred HHHHHH---------------------hCCCCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 398 GLLYLH---------------------QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 398 gL~yLH---------------------~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
.+..|. ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 233332 112345899999999999 8888999999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.42 E-value=0.6 Score=48.31 Aligned_cols=30 Identities=23% Similarity=0.371 Sum_probs=25.1
Q ss_pred CeeeccCCCCCEEE------cCCCceEEeecCCccc
Q 007361 409 RIIHRDLKASNVLL------DNEMNPKISDFGMARA 438 (606)
Q Consensus 409 ~iiH~Dlk~~NIll------~~~~~~ki~DFGla~~ 438 (606)
.++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999988754
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=88.36 E-value=0.15 Score=34.18 Aligned_cols=24 Identities=33% Similarity=0.260 Sum_probs=9.6
Q ss_pred hhhhHHHHHHHHHHhhhhhhhccc
Q 007361 226 TSVLLVTGVILLGGFVYLWKRRHR 249 (606)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~rr~r 249 (606)
+++++++++++.+.+.++++||+.
T Consensus 17 ~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 17 AVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHhheehhhh
Confidence 333433333333344444444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.36 E-value=0.38 Score=32.40 Aligned_cols=27 Identities=26% Similarity=0.276 Sum_probs=10.5
Q ss_pred EEehhhh-HHHHHHHHHHhhhhhhhccc
Q 007361 223 IVITSVL-LVTGVILLGGFVYLWKRRHR 249 (606)
Q Consensus 223 i~~~~~~-~~~~~~~~~~~~~~~~rr~r 249 (606)
|++++++ +++++++++.+.++++||++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 4444444 23333333344444444433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.74 E-value=0.89 Score=30.54 Aligned_cols=15 Identities=20% Similarity=0.135 Sum_probs=6.1
Q ss_pred HHHHhhhhhhhcccc
Q 007361 236 LLGGFVYLWKRRHRK 250 (606)
Q Consensus 236 ~~~~~~~~~~rr~rk 250 (606)
+++.++++++||+++
T Consensus 26 i~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 26 VGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHTTCSS
T ss_pred HHHHHHHHhhhhhhh
Confidence 333444444444433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.17 E-value=2.5 Score=39.42 Aligned_cols=84 Identities=8% Similarity=0.012 Sum_probs=59.3
Q ss_pred cCCCcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeccCCCCC
Q 007361 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL-YLHQDSRLRIIHRDLKASN 419 (606)
Q Consensus 341 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~iiH~Dlk~~N 419 (606)
.||++ -...-.+.+...+.|+.-+++.=..-+ +.++...+++++..|+.... +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 344446667777777765433222222 23778889998888887766 5554 6888999999
Q ss_pred EEEcCCCceEEeecCCcc
Q 007361 420 VLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 420 Ill~~~~~~ki~DFGla~ 437 (606)
|+++.++.++|.-.|+-.
T Consensus 115 L~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EEECTTCCEEESCCEETT
T ss_pred EEEeCCCcEEEEEcCCcc
Confidence 999999999998877643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.96 E-value=2.2 Score=39.71 Aligned_cols=116 Identities=13% Similarity=0.069 Sum_probs=77.0
Q ss_pred cCCCcceEEEEEeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCE
Q 007361 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 420 (606)
Q Consensus 341 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NI 420 (606)
.||+.+.. .+-.+.+...+.|+.-++ ...|- .-+.++...+++++..|+....+++. -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcc--cCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57888876 455566666666665432 22222 12237889999999999988866654 57889999999
Q ss_pred EEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCC
Q 007361 421 LLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG 492 (606)
Q Consensus 421 ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~ 492 (606)
+++.++.++|.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999887764322 221 01111122346678888888887754
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=82.79 E-value=0.38 Score=31.38 Aligned_cols=31 Identities=35% Similarity=0.610 Sum_probs=23.5
Q ss_pred cCCcccccCCCcccccCCCCCCcccccCCCcc
Q 007361 68 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVP 99 (606)
Q Consensus 68 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 99 (606)
|.|. ...|...|.|.....+..|.|++||.-
T Consensus 4 d~C~-~~pC~ngg~C~~~~~~~~C~C~~G~~G 34 (39)
T 1edm_B 4 DQCE-SNPCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred ccCC-CCCCCCCCEeEcCCCceEeECCCCCcC
Confidence 6676 467888899975434568999999973
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 606 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-72
Identities = 63/286 (22%), Positives = 135/286 (47%), Gaps = 21/286 (7%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
+ ++G G FG VYKG + ++ + Q ++ F+NEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+G T + ++ ++ SL + + K I A+G+ YLH S
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA--- 463
IIHRDLK++N+ L ++ KI DFG+A ++ G+ +M PE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+S +SDV++FG+++ E++ G+ + + ++ ++ R ++ ++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRS--- 236
Query: 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG-ERSLPQ 568
+ + ++ ++ C++++ ++RP ++ + RSLP+
Sbjct: 237 ----NCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-66
Identities = 83/274 (30%), Positives = 132/274 (48%), Gaps = 22/274 (8%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
E +LG G FG V+ G ++A K L + S + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L TQ + +I EY+ N SL DF+ + K L +K + IA G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
IHRDL+A+N+L+ + ++ KI+DFG+AR ++ A + PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 467 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526
F++KSDV+SFG+L+ EIV R Y + ++ + R + RP
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMVRPDNCPE------ 237
Query: 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
Q+ LC ++RPEDRP + +L
Sbjct: 238 -------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 6e-64
Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 23/288 (7%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
E+ + KLG+G FG V+ G +A K L + E F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L ++ + ++ EY+ SL DF+ K+L + + IA G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
+ +HRDL+A+N+L+ + K++DFG+AR ++ A + PE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 467 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526
F++KSDV+SFG+L+ E+ R Y + +L R + P E
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPE------ 241
Query: 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK-QPG 573
+ C ++ PE+RP + L + +P+ QPG
Sbjct: 242 -------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 7e-64
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 24/276 (8%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
+ ++G G FG V+ G + ++A K + + + E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L G C ++ L++E++ + L+D++ + + + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
+IHRDL A N L+ K+SDFGM R DQ ++ + PE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 467 LFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525
+S KSDV+SFGVL+ E+ GK + +RL+
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST-------- 229
Query: 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
Q+ C ++RPEDRP S ++ L+
Sbjct: 230 --------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-63
Identities = 61/292 (20%), Positives = 113/292 (38%), Gaps = 28/292 (9%)
Query: 292 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 351
+ +G+G FG V++G G+E+A K S + E E+ L+H N++ I
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 352 CTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-- 405
+ + + L+ +Y + SL D++ + ++ A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 406 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPP 460
+ I HRDLK+ N+L+ I+D G+A D + N VGT YM P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 461 EYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH----NLLGHAWRLW 510
E D + ++D+++ G++ EI G + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 511 IEERPVELINKSLGGSYSLSEVLRCI-QVGLLCVQQRPEDRPNMSSVVLMLS 561
+ + + ++ + E LR + ++ C R + LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-61
Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 285 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQH 342
++F ++LG G G V+K G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
+V G E + E++ SL+ + ++ + ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
+ +I+HRD+K SN+L+++ K+ DFG++ ++ N VGT YM PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKR 489
+SV+SD++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-61
Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 24/275 (8%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
++ + +LG G FG V G ++A K + + S +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
+L G CT++ +I EY+ N L +++ + + ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 466
+ +HRDL A N L++++ K+SDFG++R + +D ++ + PPE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 467 LFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525
FS KSD+++FGVL+ EI GK + + RL+ E
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 228
Query: 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+ + C ++ ++RP ++ +
Sbjct: 229 --------KVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 5e-61
Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 22/275 (8%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
+ + K+KLG G +G VY+GV + +A K L + + + +EEF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
V+L+G CT+ +I E++ +L D++ + + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
+ IHRDL A N L+ K++DFG++R D A+ + PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 466 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525
FS+KSDV++FGVL+ EI + Y + EL+ K
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVY-------------ELLEKDYRM 235
Query: 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+ ++ C Q P DRP+ + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 7e-61
Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 56/321 (17%)
Query: 268 REEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSK 321
+ +E P N +GEG FG V++ +A K L +
Sbjct: 4 KLLSLEYP----------RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE 53
Query: 322 SSGQGME-EFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS 380
+ M+ +F+ E L+A+ + N+VKL+G C L++EY+ LN+F+ ++
Sbjct: 54 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113
Query: 381 KF---------------------LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 419
L +++ I +A G+ YL + + +HRDL N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170
Query: 420 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 479
L+ M KI+DFG++R +MPPE ++ +SDV+++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 480 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVG 539
++ EI Y+ H ++ + I P L +
Sbjct: 231 VLWEIFSYGLQ--PYYGMAHEEVIYYVRDGNILACPENC-------------PLELYNLM 275
Query: 540 LLCVQQRPEDRPNMSSVVLML 560
LC + P DRP+ S+ +L
Sbjct: 276 RLCWSKLPADRPSFCSIHRIL 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-59
Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 27/288 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQE-----IAAKRLSKSSGQGM-EEFENEVLLIAKL 340
+ + +G G FG VYKG+L +A K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
H N+++L G ++ M+I EY+ N +L+ F+ + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT-NRVVGTYGYMP 459
YL + +HRDL A N+L+++ + K+SDFG++R D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519
PE F+ SDV+SFG+++ E++ Y +H ++ + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVM-------------KAI 226
Query: 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 567
N + Q+ + C QQ RP + +V +L P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-59
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 27/282 (9%)
Query: 285 ATENFS-DKNKLGEGGFGPVYKGVLI---EGQEIAAKRLSKSSGQG-MEEFENEVLLIAK 339
+N +LG G FG V +GV + ++A K L + + + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 399
L + +V+LIG C Q + ML+ E L+ F+ + + + S +++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYM 458
YL + +HRDL A NVLL N KISDFG+++A G D + + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
PE FS +SDV+S+GV + E + + Y ++ + E P E
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRMECPPEC 237
Query: 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+ + C + EDRP+ +V +
Sbjct: 238 PPE-------------LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-59
Identities = 62/275 (22%), Positives = 106/275 (38%), Gaps = 28/275 (10%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
+ +G+G FG V G G ++A K + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 347 KLIGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
+L+G + + ++ EY+ SL D++ L + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
+HRDL A NVL+ + K+SDFG+ + Q + PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE 174
Query: 466 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525
FS KSDV+SFG+L+ EI R Y +++ + + + P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYKMDAPDGCPPA---- 228
Query: 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+V C RP+ + L
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 6e-59
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 37/301 (12%)
Query: 277 FDWMAIANATENFSDK---------NKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS- 322
F + A F+ + +G G FG V G L +A K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 323 SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF 382
+ + +F +E ++ + H N++ L G T+ M+I E++ N SL+ F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 383 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442
+ ++ GIA G+ YL + +HRDL A N+L+++ + K+SDFG++R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 443 QTEANTNRVVG---TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 499
++ +G + PE F+ SDV+S+G+++ E++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 500 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 559
+ + + I + + Q+ L C Q+ RP +V
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 560 L 560
L
Sbjct: 287 L 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-58
Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 26/279 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHR 343
E++ +G G +G K G+ + K L S + +EV L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 344 NLVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLL 400
N+V+ R L + EY L I T+ + +LD +++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 401 YLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
H+ D ++HRDLK +NV LD + N K+ DFG+AR D + A VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
PE ++ KSD++S G L+ E+ + A L G P
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557
S L+E++ + + RP++ ++
Sbjct: 239 -------SDELNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 3e-58
Identities = 80/320 (25%), Positives = 126/320 (39%), Gaps = 47/320 (14%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQ 341
+ FSD ++G G FG VY + + +A K++S S Q ++ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
H N ++ GC + L+ EY + + K L + + G +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH +IHRD+KA N+LL K+ DFG A A N VGT +M PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 462 YAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
+ +G + K DV+S G+ +E+ K + + L + L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSAL----YHIAQNESPAL 234
Query: 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTER 578
+ SE R C+Q+ P+DRP ++ K F
Sbjct: 235 QSG------HWSEYFR--NFVDSCLQKIPQDRPTSEVLL------------KHR-FVLRE 273
Query: 579 NPPESGSSSSKRSLLSTNEI 598
PP +R+ + E+
Sbjct: 274 RPPTVIMDLIQRTKDAVREL 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-58
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 23/273 (8%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRN 344
E++ LGEG +G V V + +A K + E + E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+VK G + + + L EY L D I + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
+ I HRD+K N+LLD N KISDFG+A F + E N++ GT Y+ PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 465 DGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
F + DV+S G+++ ++ G+ + + W E++ K +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
+ +L + + P R + +
Sbjct: 233 --DSAPLALLHK------ILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 5e-58
Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 48/316 (15%)
Query: 273 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEG---QEIAAKRLSK-SSGQGME 328
P+ DW + ++ +GEG FG V K + + + A KR+ + +S
Sbjct: 3 IYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 329 EFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI------------- 374
+F E+ ++ KL H N++ L+G C R L EY P+ +L DF+
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 375 FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434
+ + L + +ARG+ YL Q + IHRDL A N+L+ KI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172
Query: 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494
++R + +M E +++ SDV+S+GVL+ EIV Y
Sbjct: 173 LSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PY 227
Query: 495 HADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMS 554
L + + E+P+ ++ + C +++P +RP+ +
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFA 274
Query: 555 SVVLMLSGERSLPQPK 570
+++ L R L + K
Sbjct: 275 QILVSL--NRMLEERK 288
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-58
Identities = 64/279 (22%), Positives = 124/279 (44%), Gaps = 27/279 (9%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 342
N + + +LG+G FG VYK E AAK + S + +E++ E+ ++A H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N+VKL+ + ++ E+ +++ + + + L S+ + L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H +IIHRDLKA N+L + + K++DFG++ ++ +GT +M PE
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181
Query: 463 AI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517
+ D + K+DV+S G+ ++E+ + +H + +L ++ E P
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL---LKIAKSEPPTL 235
Query: 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
S + + L+ C+++ + R S +
Sbjct: 236 AQPSRW--SSNFKDFLKK------CLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 6e-58
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 28/276 (10%)
Query: 291 DKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQG--MEEFENEVLLIAKLQHRNL 345
+ +LG G FG V KG + +A K L + +E E ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
V++IG C + + ML+ E LN ++ +++ + +++ ++ G+ YL +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-RVVGTYGYMPPEYAI 464
+HRDL A NVLL + KISDFG+++A D+ + PE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
FS KSDV+SFGVL+ E + Y + ++ K
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT-------------AMLEKGER 228
Query: 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+ LC E+RP ++V L L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 64/278 (23%), Positives = 121/278 (43%), Gaps = 28/278 (10%)
Query: 292 KNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLV 346
+G G FG VY G L++ A K L++ + G + +F E +++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 347 KLIGCCTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
L+G C + + +++ Y+ + L +FI + + +A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGM---KFL 146
Query: 406 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR--VVGTYGYMPPEYA 463
+ + +HRDL A N +LD + K++DFG+AR + ++ N+ +M E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
F+ KSDV+SFGVL+ E++ Y + ++ + + +P +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP-- 262
Query: 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
+V L C + E RP+ S +V +S
Sbjct: 263 -----------LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-57
Identities = 64/302 (21%), Positives = 109/302 (36%), Gaps = 40/302 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQG-MEEFENEVLLIAK 339
S LG G FG V + +A K L S+ E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 340 L-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD---------------VTRSKFL 383
L H N+V L+G CT ++I EY L +F+ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 384 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443
D +A+G+ +L IHRDL A N+LL + KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 503
+M PE + +++ +SDV+S+G+ + E+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 504 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563
+ ++ + ++I + + C P RP +V ++ +
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 564 RS 565
S
Sbjct: 306 IS 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 5e-57
Identities = 76/326 (23%), Positives = 136/326 (41%), Gaps = 29/326 (8%)
Query: 280 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE-----IAAKRLSKS-SGQGMEEFENE 333
+ I TE F LG G FG VYKG+ I E +A K L ++ S + +E +E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 334 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 393
++A + + ++ +L+G C LI + +P L D++ + +
Sbjct: 62 AYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCV 118
Query: 394 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 453
IA+G+ YL R++HRDL A NVL+ + KI+DFG+A+ G ++ E +
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 454 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513
+M E + +++ +SDV+S+GV V E++ Y +
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEIS---------- 223
Query: 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPG 573
++ K + + + C + RP +++ S PQ
Sbjct: 224 ---SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280
Query: 574 FFTER-NPPESGSSSSKRSLLSTNEI 598
ER + P S+ R+L+ ++
Sbjct: 281 QGDERMHLPSPTDSNFYRALMDEEDM 306
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-56
Identities = 72/303 (23%), Positives = 130/303 (42%), Gaps = 33/303 (10%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVL------IEGQEIAAKRLSKS-SGQGMEEFENEVLLIAK 339
E + +LG+G FG VY+GV +A K ++++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQII 392
++V+L+G +Q ++I E + L ++ + SK Q+
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 393 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 452
G IA G+ YL+ + + +HRDL A N ++ + KI DFGM R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 453 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 512
+M PE DG+F+ SDV+SFGV++ EI Y + +L +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEGGLL 254
Query: 513 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQP 572
++P + ++ +C Q P+ RP+ ++ + E P ++
Sbjct: 255 DKPDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREV 300
Query: 573 GFF 575
F+
Sbjct: 301 SFY 303
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-56
Identities = 56/274 (20%), Positives = 109/274 (39%), Gaps = 31/274 (11%)
Query: 292 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKL 348
++G G F VYKG+ E E+A L + + F+ E ++ LQH N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 349 IGCC----TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+ +L+ E + + +L ++ R K + I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 405 DSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
+ IIHRDLK N+ + + KI D G+A V+GT +M PE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM- 184
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+ + DV++FG+ +LE+ + + + + ++ +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557
++ C++Q ++R ++ ++
Sbjct: 243 ------------KEIIEGCIRQNKDERYSIKDLL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 9e-56
Identities = 65/305 (21%), Positives = 109/305 (35%), Gaps = 45/305 (14%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQG-MEEFENEVLLIAK 339
EN LG G FG V ++A K L + + E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 340 L-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD--------------------VT 378
L H N+V L+G CT LI+EY L +++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 379 RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438
L + +A+G+ +L +HRDL A NVL+ + KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 498
D +M PE +G++++KSDV+S+G+L+ EI +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 499 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558
N + ++P + + C RP+ ++
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEE-------------IYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 559 MLSGE 563
L +
Sbjct: 320 FLGCQ 324
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-55
Identities = 63/276 (22%), Positives = 127/276 (46%), Gaps = 24/276 (8%)
Query: 282 IANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL 340
+ + + ++ K+G+G G VY + + GQE+A ++++ E NE+L++ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 341 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
++ N+V + DE ++ EYL SL D + + +D + + + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALE 130
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 460
+LH ++IHRD+K+ N+LL + + K++DFG +Q++ +T +VGT +M P
Sbjct: 131 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 185
Query: 461 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
E + K D++S G++ +E++ G+ Y ++ L + + P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL---YLIATNGTPELQNP 239
Query: 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
+ L S + L C+ E R + +
Sbjct: 240 EKL--SAIFRDFLNR------CLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-55
Identities = 73/286 (25%), Positives = 108/286 (37%), Gaps = 36/286 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAK 339
++ KLG+G FG V +G + +A K L S + M++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 340 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 399
L HRNL++L G +M + E P SL D + + +A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-ANTNRVVGTYGYM 458
YL R IHRDL A N+LL KI DFG+ RA + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
PE FS SD + FGV + E+ + WI ++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------------EPWIGLNGSQI 223
Query: 519 INKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 560
++K L C V + C +PEDRP ++ L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-55
Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 35/277 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 342
E+F LG+G FG VY + +A K L K+ + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N+++L G LI EY P ++ + +++ D + I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H R+IHRD+K N+LL + KI+DFG + + + GT Y+PPE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
+ K D++S GVL E + GK + E +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK-------------------PPFEANTYQETYKRI 216
Query: 523 LGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSVV 557
++ + + + ++ P RP + V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-51
Identities = 67/280 (23%), Positives = 112/280 (40%), Gaps = 27/280 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQ 341
E +GEG FG V++G+ + +A K + + E+F E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
H ++VKLIG T+ + +I E L F+ S LD + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
L R +HRD+ A NVL+ + K+ DFG++R D T ++ +M PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521
F+ SDV+ FGV + EI+ + +++++G P
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
+L ++ C P RP + + LS
Sbjct: 235 ----PPTLYSLMTK------CWAYDPSRRPRFTELKAQLS 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 9e-51
Identities = 69/297 (23%), Positives = 107/297 (36%), Gaps = 39/297 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQG--MEEFENEVLLIA 338
+ LG G FG V + + +A K L + + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 339 KLQHRNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIF-------------DVTRSKFLD 384
H N+V L+G CT+ M+I E+ +L+ ++ + FL
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 385 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444
+A+G+ +L + IHRDL A N+LL + KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 504
+M PE D +++++SDV+SFGVL+ EI +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244
Query: 505 HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
R E + + + Q L C P RP S +V L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-49
Identities = 62/274 (22%), Positives = 99/274 (36%), Gaps = 31/274 (11%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 342
E+F LGEG F V + +E A K L K + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
VKL ++ Y N L +I + D + I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H IIHRDLK N+LL+ +M+ +I+DFG A+ + +A N VGT Y+ PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
+ SD+++ G ++ ++V G + + K
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKI 222
Query: 523 LGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMS 554
+ Y E + + + R
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 70/298 (23%), Positives = 114/298 (38%), Gaps = 41/298 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSK-SSGQGMEEFENEVLLI 337
+ LGEG FG V I ++A K L ++ + + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 338 AKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFL 383
+ +H+N++ L+G CTQ +I EY +L +++ + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 384 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443
+ARG+ YL + IHRDL A NVL+ + KI+DFG+AR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 444 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 503
T +M PE D +++ +SDV+SFGVL+ EI + Y L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELF 247
Query: 504 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
++P N+ + C P RP +V L
Sbjct: 248 KLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (434), Expect = 9e-49
Identities = 52/274 (18%), Positives = 106/274 (38%), Gaps = 26/274 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
+++ +LG G FG V++ G AAK + E E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
V L +E ++IYE++ L + + D + + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 406 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
+H DLK N++ + + K+ DFG+ + + GT + PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+D++S GVL ++ G + ++ L + ++ + + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRN-----VKSCDWNMDDSAF 249
Query: 524 GG-SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
G S + +R + P R +
Sbjct: 250 SGISEDGKDFIRK------LLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (425), Expect = 2e-47
Identities = 55/273 (20%), Positives = 104/273 (38%), Gaps = 24/273 (8%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
+ + +LG G FG V++ V G+ AK ++ +NE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
+ L + E +LI E+L L D I + ++ + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 406 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
I+H D+K N++ + + KI DFG+A D+ T + PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+D+++ GVL ++ G + + L + R + E S+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKR--CDWEFDEDAFSSV 255
Query: 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
S + ++ +Q+ P R +
Sbjct: 256 --SPEAKDFIKN------LLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (406), Expect = 1e-45
Identities = 60/282 (21%), Positives = 112/282 (39%), Gaps = 28/282 (9%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQ 341
++ + LG GG V+ + +++A K L + F E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 342 HRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 397
H +V + ++ EY+ +L D + + + ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-ANTNRVVGTYG 456
L + H + IIHRD+K +N+++ K+ DFG+ARA T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516
Y+ PE A +SDV+S G ++ E++ G+ + D ++ + E P+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVA----YQHVREDPI 232
Query: 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558
+ G S L V+ + + PE+R ++ +
Sbjct: 233 PPSARHEGLSADLDAVVLK------ALAKNPENRYQTAAEMR 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 2e-45
Identities = 62/321 (19%), Positives = 119/321 (37%), Gaps = 24/321 (7%)
Query: 279 WMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLL 336
W + + + ++ LG G F V + +A K ++K + +G E ENE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 337 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 396
+ K++H N+V L LI + + L D I F ++I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117
Query: 397 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 456
+ YLH + + LD + ISDFG+++ + GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPG 174
Query: 457 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516
Y+ PE +S D +S GV+ ++CG ++ ++ L + E
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYEFDSP 231
Query: 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGERSLPQPKQPGF 574
+ S I+ +++ PE R + ++G+ +L +
Sbjct: 232 YWDDIS-------DSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ-S 280
Query: 575 FTERNPPESGSSSSKRSLLST 595
+E+ S K++ +T
Sbjct: 281 VSEQIKKNFAKSKWKQAFNAT 301
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-45
Identities = 51/278 (18%), Positives = 101/278 (36%), Gaps = 35/278 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
E + LG G FG V++ V ++ + K G + E+ ++ +HRN++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
L +E ++I+E++ + + I T + L+ + + + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 407 RLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
I H D++ N++ + KI +FG AR N + Y PE
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
+ S +D++S G LV ++ G ++ E ++I +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGI-------------------NPFLAETNQQIIENIMN 217
Query: 525 GSYSLSEVLR------CIQVGLLCVQQRPEDRPNMSSV 556
Y+ E + + + + R S
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-45
Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 21/291 (7%)
Query: 284 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQ 341
+ +++ + +GEG +G V +A K++S Q + E+ ++ + +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
H N++ + + YL + ++ + +++ L C + I RGL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT-NRVVGTYGYMPP 460
+H ++HRDLK SN+LL+ + KI DFG+AR D V T Y P
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 461 EYAIDGLFSVKS-DVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAWRLWIEERPVEL 518
E ++ KS D++S G ++ E++ + G ++ D +++LG E+ +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 519 INKSLGGSYS--------LSEVLRCIQVGLL-----CVQQRPEDRPNMSSV 556
K+ S + + L + P R +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 7e-44
Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 30/277 (10%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN----EVLLIAKLQ 341
E+F LG+G FG V+ + Q A K L K ++ E + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 342 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
H L + ++ + EYL L I D S+ I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
LH I++RDLK N+LLD + + KI+DFGM + + + NT GT Y+ PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521
+ ++ D +SFGVL+ E++ G+ +H L H+ R+ P L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELF-HSIRMDNPFYPRWL--- 226
Query: 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558
++L + PE R + +
Sbjct: 227 ----EKEAKDLLVK------LFVREPEKRLGVRGDIR 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (397), Expect = 2e-43
Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 32/275 (11%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQ- 341
+FS +G GGFG VY + G+ A K L K QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 342 --HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 399
+V + D+ I + + L+ + + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 400 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 459
++H +++RDLK +N+LLD + +ISD G+A F + + VGT+GYM
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 460 PEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518
PE G+ + +D FS G ++ +++ G + H + + +E
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--- 230
Query: 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 553
S S LR + GLL R
Sbjct: 231 ---------SFSPELRSLLEGLLQRD--VNRRLGC 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 3e-43
Identities = 54/276 (19%), Positives = 93/276 (33%), Gaps = 25/276 (9%)
Query: 294 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
K+G G FG +Y G I G+E+A K + + E + +Q + I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 353 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 412
+ ++ L SL D S+ + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 413 RDLKASNVL---LDNEMNPKISDFGMARAFGIDQTEAN-----TNRVVGTYGYMPPEYAI 464
RD+K N L I DFG+A+ + +T + + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524
S + D+ S G +++ G A P+E++ K
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISEKKMSTPIEVLCKGY- 244
Query: 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 560
+ L C R +D+P+ S + +
Sbjct: 245 -PSEFATYLNF------CRSLRFDDKPDYSYLRQLF 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (389), Expect = 3e-43
Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 39/287 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM---------EEFENEVLL 336
EN+ K LG G V + + +E A K + + G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 337 IAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 395
+ K+ H N+++L L+++ + L D++ T L + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 455
+ LH +L I+HRDLK N+LLD++MN K++DFG + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 456 GYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509
Y+ PE + + + D++S GV++ ++ G + +L
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSG 230
Query: 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
+ E + S V + + +P+ R
Sbjct: 231 NYQFGSPEWDDYS-------DTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (388), Expect = 1e-42
Identities = 54/271 (19%), Positives = 96/271 (35%), Gaps = 36/271 (13%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 342
++F LG G FG V+ G+ A K L K + +E +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
++++ G + +I +Y+ L + R + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
II+RDLK N+LLD + KI+DFG A+ + GT Y+ PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
++ D +SFG+L+ E++ G + + ++ K
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKI 213
Query: 523 LGGSYSLSEVL--RCIQVGLLCVQQRPEDRP 551
L + + + R
Sbjct: 214 LNAELRFPPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (378), Expect = 1e-41
Identities = 66/287 (22%), Positives = 112/287 (39%), Gaps = 27/287 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRN 344
E + K+GEG +G VYK G+ A K RL K E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+VKL + +L++E+L L+ + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 405 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 464
R++HRDLK N+L++ E KI+DFG+ARAFGI + +V + P
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174
Query: 465 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW----------IEER 514
+S D++S G + E+V G + + L +R+ + E
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 515 PVELINKSLGGSYSLSEVLRCIQVGLL-----CVQQRPEDRPNMSSV 556
P N ++ L+ + + ++ P R
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 61/295 (20%), Positives = 114/295 (38%), Gaps = 32/295 (10%)
Query: 285 ATENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQGM--EEFENEVLLIAKL 340
A + + ++GEG +G V+K ++ G+ +A KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 341 ---QHRNLVKLIGCCTQRDERMLIYEYLPNKSLN---DFIFDVTRSKFLDWSKRCQIIGG 394
+H N+V+L CT L + ++ D + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 395 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 454
+ RGL +LH R++HRDLK N+L+ + K++DFG+AR + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178
Query: 455 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL----- 509
Y PE + ++ D++S G + E+ K + + LG +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235
Query: 510 ---WIEERPVELINKSLGGSYSLSEVLRCIQVGLL-----CVQQRPEDRPNMSSV 556
W + + + + + + I C+ P R + S
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 65/315 (20%), Positives = 113/315 (35%), Gaps = 45/315 (14%)
Query: 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-----FENEVLLIAKLQHRNLV 346
+ LGEG F VYK Q +A K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 347 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 406
L+ + L+++++ S L S + +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 407 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID- 465
I+HRDLK +N+LLD K++DFG+A++FG V T Y PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175
Query: 466 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525
++ V D+++ G ++ E++ F D + L + + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 526 SYSLSEVLRCIQVGLL--------------CVQQRPEDRPNMSSVVLMLSGERSLPQPKQ 571
Y + I + + P R + + K
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL------------KM 280
Query: 572 PGFFTERNPPESGSS 586
+F+ R P G
Sbjct: 281 K-YFSNRPGPTPGCQ 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (369), Expect = 3e-40
Identities = 43/286 (15%), Positives = 95/286 (33%), Gaps = 27/286 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 345
++ ++GEG FG +++G + Q++A K + S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 346 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 405
+ + Q ++ L SL D + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 406 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGIDQTEAN-----TNRVVGTY 455
+++RD+K N L+ + + DFGM + + T+ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 456 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515
YM + S + D+ + G + + + G A + I E+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-----ERIGEKK 232
Query: 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561
+ L + E + + + P+ + + S
Sbjct: 233 QSTPLRELCAGFP-EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-40
Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 27/288 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 343
ENF K+GEG +G VYK G+ +A K++ + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
N+VKL+ ++ L++E+L D + + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
R++HRDLK N+L++ E K++DFG+ARAFG T+ VV + P
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILL 175
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
+S D++S G + E+V + + D + L +R V +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 524 GGSY----------SLSEVLRCIQVGLL-----CVQQRPEDRPNMSSV 556
Y S+V+ + + P R + +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 62/289 (21%), Positives = 111/289 (38%), Gaps = 29/289 (10%)
Query: 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 346
+++D +G G FG VY+ L + G+ +A K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 347 KLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 400
+L E+ L+ +Y+P + L + + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 401 YLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 459
Y+H I HRD+K N+LLD + K+ DFG A+ + E N + + Y P
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191
Query: 460 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKR----NRGFYHADHHHNLLGHAWRLWIEERP 515
++ DV+S G ++ E++ G+ + G +LG R I E
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 516 VELINKSLG--GSYSLSEVLR------CIQVGLLCVQQRPEDRPNMSSV 556
++ ++V R I + ++ P R
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-39
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 37/285 (12%)
Query: 287 ENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS------GQGMEEFENEVL 335
EN D +LG G F V K G + AAK + K G E+ E EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 336 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 395
++ ++QH N++ L + + +LI E + L DF+ + L + + + I
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQI 122
Query: 396 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRV 451
G+ YLH L+I H DLK N++L + P KI DFG+A +
Sbjct: 123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNI 176
Query: 452 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511
GT ++ PE +++D++S GV+ ++ G + D L + +
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAVNY 233
Query: 512 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
E N S + +R + + P+ R +
Sbjct: 234 EFEDEYFSNTSA----LAKDFIRR------LLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 51/271 (18%), Positives = 100/271 (36%), Gaps = 30/271 (11%)
Query: 295 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCC 352
LG G G V + ++ A K L + EV L + Q ++V+++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 353 ----TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 408
R +++ E L L I D + + +I+ I + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 409 RIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 465
I HRD+K N+L ++ K++DFG A+ + T Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 466 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525
+ D++S GV++ ++CG ++++H + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
S + ++R ++ P R ++
Sbjct: 245 SEEVKMLIRN------LLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (344), Expect = 7e-37
Identities = 62/313 (19%), Positives = 119/313 (38%), Gaps = 40/313 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 343
+ + K+GEG +G V+K E + +A KR+ E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
N+V+L + L++E+ F + LD + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
++HRDLK N+L++ K+++FG+ARAFGI + VV + P
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523
L+S D++S G + E+ R + + + L +RL + + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 524 GGSYSLSEVLRCIQVGLL---------------CVQQRPEDRPNMSSVVLMLSGERSLPQ 568
Y + + ++ P R + +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL----------- 281
Query: 569 PKQPGFFTERNPP 581
+ P +F++ PP
Sbjct: 282 -QHP-YFSDFCPP 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 9e-37
Identities = 60/274 (21%), Positives = 96/274 (35%), Gaps = 43/274 (15%)
Query: 294 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE------FENEVLLIAKLQ--HRN 344
LG GGFG VY G+ + +A K + K E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 345 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 404
+++L+ + D +LI E +T L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 405 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY- 462
++HRD+K N+L+D N K+ DFG + GT Y PPE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
+ V+S G+L+ ++VCG + D +R + LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQVFFRQRVSSECQHLIRW- 237
Query: 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 556
C+ RP DRP +
Sbjct: 238 -------------------CLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 62/314 (19%), Positives = 119/314 (37%), Gaps = 41/314 (13%)
Query: 272 MELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG--ME 328
+E P D + + K+G+G FG V+K + GQ++A K++ + +
Sbjct: 1 VECPFCDEV------SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 54
Query: 329 EFENEVLLIAKLQHRNLVKLIGCCTQRDERM--------LIYEYLPNKSLNDFIFDVTRS 380
E+ ++ L+H N+V LI C + L++++ + + +
Sbjct: 55 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 114
Query: 381 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440
+ + Q++ L L+ R +I+HRD+KA+NVL+ + K++DFG+ARAF
Sbjct: 115 TLSEIKRVMQML------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168
Query: 441 IDQTEANTNR--VVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKR----NRGF 493
+ + V T Y PPE + + + D++ G ++ E+ N
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228
Query: 494 YHADHHHNLLG----HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLL-------C 542
+ L G W E + G + + L+
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288
Query: 543 VQQRPEDRPNMSSV 556
+ P R +
Sbjct: 289 LVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 55/273 (20%), Positives = 94/273 (34%), Gaps = 33/273 (12%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 342
+F LG+G FG V G+ A K L K + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
L L D + EY L + +R + + I L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H +++RD+K N++LD + + KI+DFG+ + D GT Y+ PE
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
D + D + GV++ E++CG+ + + L
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR-------------------LPFYNQDHERLFELI 217
Query: 523 LGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNM 553
L L + +++ P+ R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 2e-34
Identities = 59/270 (21%), Positives = 95/270 (35%), Gaps = 32/270 (11%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 342
+ F LG G FG V E G A K L K + +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
LVKL ++ EY+ + + R I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H L +I+RDLK N+L+D + +++DFG A+ + + T + GT + PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 463 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522
+ ++ D ++ GVL+ E+ G + AD + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGKVRFPS------- 259
Query: 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 552
S L+ + LL V R
Sbjct: 260 -----HFSSDLKDLLRNLLQVD--LTKRFG 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-33
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 343
+ D +G G +G V V G ++A K+L + S + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 344 NLVKLIGCCTQRDERMLIYE-YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
N++ L+ T + + YL + + + + + L + ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 462
H IIHRDLK N+ ++ + KI DFG+AR Q ++ V T Y PE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 463 AIDGL-FSVKSDVFSFGVLVLEIVCGK 488
++ + ++ D++S G ++ E++ GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 7e-32
Identities = 49/241 (20%), Positives = 105/241 (43%), Gaps = 23/241 (9%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRN 344
+++ KLG G + V++ + I +++ K L ++ + E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 345 LVKLIGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
++ L R L++E++ N + L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 403 HQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
H + I+HRD+K NV++D+E ++ D+G+A + Q N V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 462 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520
+D ++ D++S G ++ ++ K F+H +++ L ++ E + I+
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 521 K 521
K
Sbjct: 258 K 258
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS----GQGMEEFENEVLLIA 338
ENF LG G +G V+ I G+ A K L K++ + E E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 339 KLQHR-NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 397
++ LV L + LI +Y+ L + R + +G I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 398 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 457
L +LH +L II+RD+K N+LLD+ + ++DFG+++ F D+TE GT Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 458 MPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515
M P+ G D +S GVL+ E++ G + D N R ++ P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEP 253
Query: 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP 551
+ + S ++++ + + P+ R
Sbjct: 254 P--YPQEM--SALAKDLIQR------LLMKDPKKRL 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 1e-29
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 9/205 (4%)
Query: 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 343
+ + + +G G G V + +A K+LS+ + + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 344 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 403
N++ L+ T + + L D LD + ++ + G+ +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 404 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 463
IIHRDLK SN+++ ++ KI DFG+AR G V T Y PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVI 190
Query: 464 IDGLFSVKSDVFSFGVLVLEIVCGK 488
+ + D++S G ++ E+V K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQH 342
E + + + +G G +G V + G +A K+LS+ S + E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 343 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 401
N++ L+ T YL + + ++ + + L +I I RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 402 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 461
+H IIHRDLK SN+ ++ + KI DFG+AR + T R + P
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEI 189
Query: 462 YAIDGLFSVKSDVFSFGVLVLEIVCGK 488
++ D++S G ++ E++ G+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 2e-26
Identities = 39/210 (18%), Positives = 77/210 (36%), Gaps = 18/210 (8%)
Query: 294 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 352
KLG G F V+ ++ +A K + E E+E+ L+ ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 353 TQRDERMLIYEYLPNKSL-------------NDFIFDVTRSKFLDWSKRCQIIGGIARGL 399
++L + + + + + QI + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 400 LYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 458
Y+H+ R IIH D+K NVL++ + + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 459 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 488
PE + + +D++S L+ E++ G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 31/155 (20%), Positives = 54/155 (34%), Gaps = 20/155 (12%)
Query: 293 NKLGEGGFGPVYKGVLIEGQEIAAK--RLSKSSGQ--------GMEEFENEVLLIAKLQH 342
+GEG V+ + E K ++ +S + G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 343 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 402
R L KL G + Y + N L + I + + +++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 403 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437
+ I+H DL NVL+ E I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.53 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.19 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.36 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.97 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 91.44 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 90.2 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.83 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.55 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 87.37 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.89 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 86.75 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.44 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.69 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.5 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 82.47 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 81.59 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 80.07 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=411.56 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=198.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|+..++||+|+||+||+|++.+++.||||++... ....++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467888999999999999999988999999999654 4456789999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|+|.+++.. ....++|..++.++.|||+||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999999854 3456899999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
......||..|+|||++.+..++.++|||||||++|||+|+..|+..... ...+... ...+.. ..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~----i~~~~~---------~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVED----ISTGFR---------LY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHH----HHHTCC---------CC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHhcCC---------CC
Confidence 22335789999999999999999999999999999999996555321111 1111111 111100 01
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.+.....++.+|+..||+.||++||||++|++.|+.+
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1111234678999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=409.55 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=201.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.++||+|+||+||+|++. ..||||++... .....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467888999999999999999864 46999998654 34556789999999999999999999999865 56899999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999964 2345999999999999999999999998 9999999999999999999999999998875544
Q ss_pred ccccccccccccCccCcccccc---CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 444 TEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.........||+.|||||++.+ ..|+.++|||||||+||||+||+.||....... .+ ......+.....+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~----~~~~~~~~~~p~~- 231 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QI----IFMVGRGYLSPDL- 231 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HH----HHHHHHTSCCCCG-
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HH----HHHHhcCCCCCcc-
Confidence 4444455789999999999864 358999999999999999999999986432211 11 1111111111000
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....... ...+.+|+.+||+.||++||||.+|++.|+.+
T Consensus 232 ~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 232 SKVRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp GGSCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0111122 24677899999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-51 Score=412.40 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=210.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|.+.++||+|+||+||+|++.. ++.||||++... ....++|.+|+.++++++|||||+++|++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4678888999999999999999865 889999998654 34567899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+++|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999998653 3456999999999999999999999998 99999999999999999999999999997654333
Q ss_pred cccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 445 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..|+..... . .........+ ..
T Consensus 171 ~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~----~~~~~~i~~~---------~~ 234 (287)
T d1opja_ 171 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--L----SQVYELLEKD---------YR 234 (287)
T ss_dssp EE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--H----HHHHHHHHTT---------CC
T ss_pred ee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--H----HHHHHHHhcC---------CC
Confidence 22 2335688999999999999999999999999999999998776432111 0 1111111111 11
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+......+.+|+..||+.||++||||.+|++.|+.+
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111122234678999999999999999999999999765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=406.91 Aligned_cols=255 Identities=30% Similarity=0.431 Sum_probs=205.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++|++.++||+|+||.||+|++.+++.||||++... ....++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578888999999999999999988899999999654 3456789999999999999999999998865 5679999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++|+|.+++... ....++|..++.|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999987542 2234899999999999999999999998 999999999999999999999999999987543322
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......||+.|+|||++.+..++.++|||||||++|||+||..|+..... ...+. .....+. ......
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~----~~i~~~~-----~~~~p~ 233 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI----QNLERGY-----RMVRPD 233 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHH----HHHHTTC-----CCCCCT
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHH----HHHHhcC-----CCCCcc
Confidence 23346789999999999999999999999999999999997766432211 11111 1111110 011111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.. ...+.+|+.+||+.||++||||.+|+++|+.
T Consensus 234 ~~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 234 NC----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cC----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 22 2467889999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=403.31 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=203.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357889999999999999999985 48999999986543 3345678999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+++|+|.+++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999984 3456999999999999999999999998 9999999999999999999999999999875544
Q ss_pred ccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.|+....... .. ............
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~----~~~~~~~~~~~~---- 227 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QE----YSDWKEKKTYLN---- 227 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HH----HHHHHTTCTTST----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HH----HHHHhcCCCCCC----
Confidence 4444455789999999999988876 678999999999999999999986432211 00 011111111000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.+|+.+||+.||++|||+.++++
T Consensus 228 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011235678899999999999999999854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=395.77 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=210.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|+..++||+|+||+||+|++.+++.||||++++. ....++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578899999999999999999988889999999654 3456789999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|+|.+++.. ....+++..+++++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999999754 3345899999999999999999999998 999999999999999999999999999876544332
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......||..|+|||.+.+..++.++||||||+++|||+| |+.|+...... .+.. ....+.. .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~----~i~~~~~---------~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE----HIAQGLR---------L 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH----HHHTTCC---------C
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH----HHHhCCC---------C
Confidence 2333678999999999999999999999999999999998 78887644321 1111 1111110 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+......+.+|+..||+.||++|||+.+|++.|.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1111222467899999999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-50 Score=407.41 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=195.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-C---cEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
++|++.++||+|+||+||+|++.. + ..||||++... .....++|.+|+.++++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456667899999999999999754 2 25889988654 334557899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.. ....++|.+++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998854 3446999999999999999999999998 99999999999999999999999999998754
Q ss_pred Ccccc---cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 442 DQTEA---NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 442 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
..... ......||+.|||||.+.+..++.++|||||||+||||+| |+.|+...... .+.. ....+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~----~i~~~---- 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVIN----AIEQD---- 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTT----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcC----
Confidence 33322 1222457899999999999999999999999999999998 89887543211 1111 11111
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
.....+......+.+|+.+||+.||++||||.+|++.|+.+
T Consensus 250 -----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 -----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111222335678899999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-50 Score=410.01 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=206.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEeCC------cEEEEEEcccc-cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIEG------QEIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~g------~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 357 (606)
.++|.+.++||+|+||+||+|++... ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 36788899999999999999997542 36899988654 344557899999999998 89999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTR--------------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA 417 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~ 417 (606)
.++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965321 235899999999999999999999998 99999999
Q ss_pred CCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCC
Q 007361 418 SNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHA 496 (606)
Q Consensus 418 ~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~ 496 (606)
+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655444444445678999999999999999999999999999999998 8999764332
Q ss_pred CCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 007361 497 DHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 561 (606)
Q Consensus 497 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~ 561 (606)
.. .+ ......+ .....+......+.+|+.+||+.||++|||+++|++.|.
T Consensus 273 ~~--~~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA--NF----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH--HH----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HH----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 11 1111111 111111122346789999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=394.71 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=206.6
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
++|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999975 48999999998776667788999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998743 35899999999999999999999998 99999999999999999999999999997643322
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .+
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~~------- 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL------- 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC-------
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-CC-------
Confidence 234468999999999999999999999999999999999999998532211 111111111111 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111245778999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=399.98 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=202.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 366 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 366 (606)
++|++.+.||+|+||.||+|++.+++.||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578899999999999999999988889999999644 4456889999999999999999999999855 56899999999
Q ss_pred CCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcccc
Q 007361 367 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 446 (606)
Q Consensus 367 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~~ 446 (606)
+|+|..++... ....++|..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 99999988643 2335999999999999999999999998 999999999999999999999999999876433322
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 526 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~ 526 (606)
......||+.|+|||++.++.++.++||||||+++|||++|..|+...... ..+... ...+. ...
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~----i~~~~---------~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQ----VERGY---------RMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTC---------CCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHH----HHhcC---------CCC
Confidence 223357899999999999999999999999999999999987764332211 111111 11111 111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 527 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 527 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
.+......+.+++.+||+.||++||+|.+|+++|+..-
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 11122346789999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=398.84 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=200.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeCC-----cEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEG-----QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
..|+..++||+|+||.||+|.+..+ ..||||++.... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999998653 369999986543 3345679999999999999999999999999999999
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
|+||+.+++|.+++.. ....++|..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999998754 3356999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
..... .......||+.|||||++.+..++.++|||||||++|||++|..|+...... ..+ ......+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~----~~~i~~~------ 229 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV----MKAINDG------ 229 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH----HHHHHTT------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHH----HHHHhcc------
Confidence 43222 2233456899999999999999999999999999999999977664322111 111 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
.....+......+.+|+.+||+.+|++||||.+|+++|+.+..
T Consensus 230 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1111222233567899999999999999999999999986543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=399.05 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=204.0
Q ss_pred cCCCcCC-eecccCcccEEEEEEeC---CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKN-KLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~-~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
++|...+ +||+|+||+||+|.+.. +..||||++.... ....++|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4455556 49999999999998643 4579999997653 3346789999999999999999999999865 568999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.. .+..+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 3456999999999999999999999998 99999999999999999999999999998754
Q ss_pred Cccc-ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 442 DQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 442 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. .....+...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~~~--- 231 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRM--- 231 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCCC---
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCC---
Confidence 4322 23334578999999999999999999999999999999998 89998643221 111 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+......+.+|+.+||+.+|++||||.+|++.|+.
T Consensus 232 ------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111223467789999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=395.11 Aligned_cols=245 Identities=26% Similarity=0.359 Sum_probs=204.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.+.||+|+||.||+|+... ++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 578889999999999999999864 889999998643 3345678999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999954 345999999999999999999999998 999999999999999999999999999875432
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
......||+.|||||++.+..++.++|||||||+||||++|+.||...... .+ ......... .
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~----~~~i~~~~~------~ 222 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ET----YKRISRVEF------T 222 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----HHHHHTTCC------C
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC------C
Confidence 223467999999999999999999999999999999999999998542211 11 111111110 1
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+.... ...+.+|+.+||+.||++|||+.|+++
T Consensus 223 ~p~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11112 245678999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=397.89 Aligned_cols=247 Identities=27% Similarity=0.394 Sum_probs=196.7
Q ss_pred CeecccCcccEEEEEEeC---CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecCCC
Q 007361 293 NKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 367 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~---g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 367 (606)
++||+|+||+||+|.+.+ ++.||||++.... ....++|.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998754 4689999996543 2335689999999999999999999999865 457899999999
Q ss_pred CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc-c
Q 007361 368 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-A 446 (606)
Q Consensus 368 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~-~ 446 (606)
|+|.+++.. ...+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999854 345999999999999999999999998 999999999999999999999999999977544332 2
Q ss_pred cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccCC
Q 007361 447 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 525 (606)
Q Consensus 447 ~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 525 (606)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+ ......+.. .
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~----~~~i~~~~~---------~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGER---------M 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCC---------C
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH----HHHHHcCCC---------C
Confidence 2334678999999999999999999999999999999998 89997643211 11 111111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 526 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 526 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
..+......+.+|+.+||+.||++|||+++|+++|+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1111223467789999999999999999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=398.06 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=193.1
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEee--CCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 361 (606)
++|++.+.||+|+||+||+|+... |+.||+|.+.... +...+.+.+|+.++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 678899999999999999999754 8899999986643 3345678999999999999999999999865 4557999
Q ss_pred EecCCCCCchhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 362 YEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 23456999999999999999999999864 23599999999999999999999999999998
Q ss_pred cCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 439 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 439 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
+..... ......||+.|||||++.+..++.++|||||||++|||+||+.||...... .+ ...........
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~----~~~i~~~~~~~- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFRR- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHTCCCC-
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HH----HHHHHcCCCCC-
Confidence 753322 233468999999999999999999999999999999999999998543211 11 11111121111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
+.... ...+.+|+.+||+.||++|||+.|+++
T Consensus 234 ----~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122 235778999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=397.52 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=205.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
+.|++.++||+|+||+||+|++.. ++.||||++........+.|.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 467888999999999999999864 8899999998777777788999999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++|+|.+++.+. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999987542 345999999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccccccccCccCccccc-----cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 446 ANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||....... ... .........+.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~----~i~~~~~~~~~- 236 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL----KIAKSEPPTLA- 236 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH----HHHHSCCCCCS-
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH----HHHcCCCCCCC-
Confidence 1223468999999999984 4568999999999999999999999986433211 111 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 ------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112246778999999999999999999865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=398.02 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=201.9
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999985 4889999998653 3445678999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998854 345999999999999999999999998 999999999999999999999999999987655
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ........ .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~----~~i~~~~~------~ 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIF----QKIIKLEY------D 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHTTCC------C
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHH----HHHHcCCC------C
Confidence 4444445578999999999999999999999999999999999999998642211 111 11111110 1
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 557 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl 557 (606)
+.... ...+.+|+.+||+.||++|||+.|++
T Consensus 229 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 FPEKF----FPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11122 24567899999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-49 Score=399.51 Aligned_cols=262 Identities=25% Similarity=0.396 Sum_probs=210.8
Q ss_pred HHhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccccc-CHHHHHHHHHHHhhccCCCcceEEEEEeeCC
Q 007361 284 NATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRD 356 (606)
Q Consensus 284 ~~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 356 (606)
...++|++.++||+|+||+||+|++.. ++.||||++...... ..++|.+|+.++++++||||+++++++.+.+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 346789999999999999999999752 578999999765433 4567999999999999999999999999999
Q ss_pred eeEEEEecCCCCCchhhhcccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVT---------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL 415 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl 415 (606)
..++|+||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.+ |+||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEE
Confidence 9999999999999999986422 1234899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccC-CCCCC
Q 007361 416 KASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFY 494 (606)
Q Consensus 416 k~~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~ 494 (606)
||+||||+.++.+||+|||+|+.+.............+|+.|+|||.+.+..++.++|||||||++|||++|.. |+...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999999987755444444455678999999999999999999999999999999999975 54332
Q ss_pred CCCCccchhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 495 HADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 495 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
... .+. .....+.... .+.....++.+|+..||+.+|++||||.+|+++|+.+.
T Consensus 247 ~~~---e~~----~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHE---EVI----YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHH---HHH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHH---HHH----HHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 211 111 1112221111 11122346789999999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=400.76 Aligned_cols=199 Identities=25% Similarity=0.354 Sum_probs=176.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc-cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|++.++||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999975 488999999876533 335678999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999643 3589999999999999999999975 6 999999999999999999999999999875322
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCC
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 494 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~ 494 (606)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 223468999999999999999999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=386.43 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=194.4
Q ss_pred CcCCeecccCcccEEEEEEeC-CcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEee----CCeeEEEE
Q 007361 290 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERMLIY 362 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 362 (606)
...++||+|+||+||+|++.. ++.||+|++... .....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 445689999999999999865 789999998654 33345679999999999999999999999865 34579999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc-CCCceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~-~~~~~ki~DFGla~~~~~ 441 (606)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999954 345899999999999999999999875 3599999999999996 578999999999986432
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||...... .........+.....++
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~- 235 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD- 235 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG-
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccC-
Confidence 2 2234689999999998865 6999999999999999999999998532211 11111111111111111
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ...+.+|+.+||+.||++|||+.|+++
T Consensus 236 ---~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ---KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 234678999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=394.47 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=201.4
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-Cc----EEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
++|++.++||+|+||+||+|.+.. |+ .||+|++... .....++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 468889999999999999999754 43 5899988654 445678899999999999999999999999875 5678
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
++||+.+|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998854 3456999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
............||+.|+|||++.++.++.++|||||||+||||+| |+.|+....... +... ...+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~----i~~~~----- 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGE----- 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHH----HHHTC-----
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCC-----
Confidence 5555444555678999999999999999999999999999999998 778865433221 1111 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
....+......+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 231 ----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1111122234678899999999999999999999988654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-48 Score=392.78 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=191.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
.+.|++.+.||+|+||+||+|+... ++.||||.+.+.. ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4668899999999999999999864 8899999997543 2334568899999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCceEEeecCCccccC
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFG 440 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~ki~DFGla~~~~ 440 (606)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999953 456999999999999999999999998 99999999999994 57899999999998764
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 520 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 520 (606)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+ ......... . ..
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~----~~~i~~~~~-~-~~ 229 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KL----FEQILKAEY-E-FD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHTTCC-C-CC
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HH----HHHHhccCC-C-CC
Confidence 322 223467999999999999999999999999999999999999998542211 11 111111111 0 00
Q ss_pred cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCC
Q 007361 521 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGER 564 (606)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~~~ 564 (606)
...... ....+.+|+..||+.||++|||+.|+++ .+.+..
T Consensus 230 ~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 230 SPYWDD----ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp TTTTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred CccccC----CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 001111 2245778999999999999999999987 455433
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-48 Score=393.23 Aligned_cols=245 Identities=29% Similarity=0.443 Sum_probs=199.2
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
+.|+..++||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888899999999999999975 478899999876532 33467899999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999876643 346999999999999999999999998 99999999999999999999999999986532
Q ss_pred cccccccccccccCccCcccccc---CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.|+..... ...... ........+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~-i~~~~~~~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-IAQNESPALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCCCCCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHH-HHhCCCCCCC
Confidence 223679999999999864 4689999999999999999999999753221 111111 1111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.... ...+.+|+.+||+.||++|||+.++++
T Consensus 236 ----~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ----SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112 246778999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=384.04 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=195.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-CeeEEEEecC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-DERMLIYEYL 365 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~ 365 (606)
++|+..++||+|+||.||+|++ .|..||||+++.. ...+.|.+|++++++++|||||+++|++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5677889999999999999998 5789999999653 3457899999999999999999999999654 5689999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++|+|.++|... ....++|..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999999642 2234899999999999999999999988 999999999999999999999999999865322
Q ss_pred ccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccccC
Q 007361 446 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 524 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 524 (606)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.|+...... .+... ...+ ..
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~----i~~~---------~~ 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKG---------YK 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH----HTTT---------CC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcC---------CC
Confidence 223567889999999999999999999999999999998 56665432211 11111 1111 11
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 525 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 525 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...+.....++.+|+.+||+.||++||||.+|+++|+.+
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111222234677999999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-47 Score=393.96 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=206.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|.+.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 4899999999877666677899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCceEEeecCCccccCCC
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGID 442 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~ki~DFGla~~~~~~ 442 (606)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999853 3345999999999999999999999998 99999999999995 4678999999999876533
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||...... .... ....... .. ...
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~----~i~~~~~-~~-~~~ 247 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLR----NVKSCDW-NM-DDS 247 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCC-CS-CCG
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCC-CC-Ccc
Confidence 2 223468999999999999999999999999999999999999998543211 1111 1111110 00 000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... .....+.+|+.+||+.||++|||+.++++
T Consensus 248 ~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 AFS----GISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 11235678999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=387.81 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=198.9
Q ss_pred HhcCCCcCCeecccCcccEEEEEEeC------CcEEEEEEccccc-ccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC-
Q 007361 285 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR- 355 (606)
Q Consensus 285 ~~~~~~~~~~lG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 355 (606)
..++|.+.++||+|+||.||+|++.. ++.||||++.... ....+.+..|+.++.++ +|+||+++++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 34678999999999999999999753 4689999997543 33456788888888887 689999999998765
Q ss_pred CeeEEEEecCCCCCchhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
...++||||+++|+|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 46899999999999999996422 2345899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccC-CCCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~ 501 (606)
++++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||.. |+...... .
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~---~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---E 244 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---H
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999998765555445556789999999999999999999999999999999999764 55432221 1
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
........+.... .+......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 245 ---~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 ---EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ---HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111111111 1111224678899999999999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=387.91 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=209.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 357 (606)
.++|++.++||+|+||.||+|++. .++.||||++..... ....+|.+|+.++.++ +|||||+++|++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467888899999999999999863 356899999976543 3455799999999999 79999999999999999
Q ss_pred eEEEEecCCCCCchhhhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 358 RMLIYEYLPNKSLNDFIFDVT---------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
.++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999996432 2235899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCC-CCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p-~~~~~~~~~~~ 501 (606)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|+..| +......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---- 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH----
Confidence 99999999999999987655544455567899999999999999999999999999999999995555 3322211
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
.........+ .....+......+.+|+.+||+.||++||||.+|+++|+.
T Consensus 255 --~~~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 255 --SKFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp --HHHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111111111 1111111223567899999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=389.06 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=211.8
Q ss_pred hcCCCcCCeecccCcccEEEEEEe------CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.++|...++||+|+||+||+|.+. .++.||||++.... ......|.+|+.++++++|||||+++|++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999874 25789999997543 33445789999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhccc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 359 MLIYEYLPNKSLNDFIFDV-------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
++||||+++|+|.+++... .....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998532 23345899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhcc-CCCCCCCCCCccchhHHHHHHh
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNLLGHAWRLW 510 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~ 510 (606)
|||+|+.+.............+|+.|+|||.+.+..++.++||||||+++|||+||. .|+..... .. .....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~----~~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQ----VLRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HH----HHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HH----HHHHH
Confidence 999999876555544455567899999999999999999999999999999999996 45432211 11 11111
Q ss_pred hhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCCC
Q 007361 511 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 565 (606)
Q Consensus 511 ~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~~ 565 (606)
..+.... .+......+.+|+.+||+.+|++||||.+|+++|+...+
T Consensus 249 ~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 111122468899999999999999999999999987644
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=385.36 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=207.9
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC--------CcEEEEEEcccccc-cCHHHHHHHHHHHhhc-cCCCcceEEEEEeeC
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR 355 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 355 (606)
.++|.+.++||+|+||.||+|+... +..||||++.+... ....++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578888999999999999998643 24799999976543 3457889999999998 899999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEE
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL 422 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll 422 (606)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999964321 245899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccc
Q 007361 423 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN 501 (606)
Q Consensus 423 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 501 (606)
+.++.+||+|||+++...............+|+.|+|||.+.++.|+.++||||||+++|||++ |..|+.....+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 9999999999999998866555555566789999999999999999999999999999999998 67776432211
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
..+..+..+... ..+......+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus 245 ---~~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ---ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ---HHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 112222222111 111112246789999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=380.43 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=194.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC----CcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 360 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 360 (606)
.++|.+.+.||+|+||.||+|++.. +..||+|++.... ....+.|.+|+.++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578888999999999999998754 3468999986543 334567999999999999999999999996 467899
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccC
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 440 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~ 440 (606)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998754 3446899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcchhc
Q 007361 441 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 519 (606)
Q Consensus 441 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 519 (606)
..... ......||+.|+|||.+.+..++.++|||||||++|||+| |..|+...... .+... ...+...
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~----i~~~~~~--- 228 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERL--- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCC---
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCCC---
Confidence 33222 2334678999999999999999999999999999999998 78887543321 11111 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 520 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 520 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
...... ...+.+|+..||+.||++|||+.+|++.|+.+
T Consensus 229 --~~~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 --PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111122 34678899999999999999999999988753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=380.16 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=203.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc------ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCee
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS------GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 358 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 358 (606)
.+.|++.++||+|+||+||+|+.. +|+.||||++.+.. ....+.|.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467899999999999999999985 48999999986532 22467899999999999999999999999999999
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC----ceEEeecC
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG 434 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~----~~ki~DFG 434 (606)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999954 245999999999999999999999998 99999999999998776 59999999
Q ss_pred CccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 435 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 435 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .......
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~----~~i~~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANVSAVN 232 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHTTC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHH----HHHHhcC
Confidence 998764332 223457899999999999999999999999999999999999998643211 111 1111110
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ... ...... ....+.+|+.+||+.||++|||+.++++
T Consensus 233 ~-~~~-~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y-EFE-DEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-CCC-HHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-CCC-chhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 000001 1235678999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=382.82 Aligned_cols=255 Identities=27% Similarity=0.369 Sum_probs=194.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC--C--cEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE--G--QEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~--g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
++|++.+.||+|+||.||+|++.. + ..||||++.+. .....++|.+|+.++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568888999999999999998753 2 37899998654 33445789999999999999999999999976 4678
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++|+|.+++.. +...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998754 3345999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCcccc-cccccccccCccCccccccCCCCccccchhHHHHHHHHHh-ccCCCCCCCCCCccchhHHHHHHhhhcCcch
Q 007361 440 GIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVE 517 (606)
Q Consensus 440 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 517 (606)
....... ......||..|+|||.+.+..++.++||||||+++|||+| |+.||...... ... ......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~---~~i~~~~~~-- 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL---HKIDKEGER-- 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHTSCCC--
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHH---HHHHhCCCC--
Confidence 5543332 3334567889999999999999999999999999999998 89987532211 111 111111100
Q ss_pred hcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 518 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 518 l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
...+......+.+|+.+||+.||++||||.+|+++|+.
T Consensus 234 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 01111122467789999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=385.25 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=198.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC----eeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----ERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 362 (606)
+.|...++||+|+||.||+|++ +|+.||||++..... ....++.|+..+.+++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778999999999999997 789999999854322 1222344555666789999999999998654 579999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
||+++|+|.++|.. ..++|..+++++.++|.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999954 34899999999999999999999741 2359999999999999999999999999998
Q ss_pred ccCCCccc--ccccccccccCccCccccccCC------CCccccchhHHHHHHHHHhccCCCCCCCCCCcc--------c
Q 007361 438 AFGIDQTE--ANTNRVVGTYGYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH--------N 501 (606)
Q Consensus 438 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~--------~ 501 (606)
........ .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 77443222 2334568999999999987653 678999999999999999998876542221110 0
Q ss_pred hhHHHHHHhhhcCcchhcccccCCCC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCC
Q 007361 502 LLGHAWRLWIEERPVELINKSLGGSY-SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 563 (606)
Q Consensus 502 l~~~~~~~~~~~~~~~l~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~ 563 (606)
............ .+++.+.... +.+....+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111111111111 1111111111 224456788999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-46 Score=389.41 Aligned_cols=252 Identities=21% Similarity=0.248 Sum_probs=206.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 4899999999776555567889999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc--CCCceEEeecCCccccCCC
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGID 442 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~--~~~~~ki~DFGla~~~~~~ 442 (606)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999987743 3345999999999999999999999998 99999999999997 6789999999999987543
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+.. ....... .
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~----~i~~~~~------~ 246 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ----NVKRCDW------E 246 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHHCCC------C
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCC------C
Confidence 2 233467899999999999999999999999999999999999998543211 1111 1111111 0
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
............+.+|+.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111112245678999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=385.82 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=202.3
Q ss_pred cCCCcCCeecccCcccEEEEEEeCC-c--EEEEEEcccc-cccCHHHHHHHHHHHhhc-cCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEG-Q--EIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g-~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 361 (606)
++|++.++||+|+||.||+|++.++ . .||||++... .....++|.+|++++.++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6788889999999999999998663 3 5788887543 344566899999999999 799999999999999999999
Q ss_pred EecCCCCCchhhhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCce
Q 007361 362 YEYLPNKSLNDFIFDV-------------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 428 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ 428 (606)
|||+++|+|.++|... .....+++..+++++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23456999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccC-CCCCCCCCCccchhHHHH
Q 007361 429 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAW 507 (606)
Q Consensus 429 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~ 507 (606)
||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|.. |+..... ..+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~---- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY---- 236 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHH----
Confidence 999999998654222 2234568999999999999999999999999999999999875 4432211 1111
Q ss_pred HHhhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 508 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 508 ~~~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
.....+. ....+......+.+|+.+||+.||++||||.+|++.|+.+.
T Consensus 237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 237 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111111 11111222346788999999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=381.40 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=201.1
Q ss_pred CCeecccCcccEEEEEEeCC----cEEEEEEcccc-cccCHHHHHHHHHHHhhccCCCcceEEEEEeeC-CeeEEEEecC
Q 007361 292 KNKLGEGGFGPVYKGVLIEG----QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-DERMLIYEYL 365 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~ 365 (606)
.++||+|+||+||+|++.++ ..||||++... .....++|.+|++++++++|||||+++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999998653 25899999753 444567899999999999999999999998764 5789999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999864 3445789999999999999999999998 999999999999999999999999999976543322
Q ss_pred --ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccccc
Q 007361 446 --ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 523 (606)
Q Consensus 446 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l 523 (606)
.......||..|+|||.+.+..++.++||||||+++|||+||+.|+...... ..+... ...+... ..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~----i~~g~~~-----~~ 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY----LLQGRRL-----LQ 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCCC-----CC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH----HHcCCCC-----CC
Confidence 2223357899999999999999999999999999999999988886432211 111111 1111110 01
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcCCC
Q 007361 524 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 564 (606)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~~~ 564 (606)
... ....+.+|+.+||+.||++||+|.||++.|+.+.
T Consensus 256 p~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 256 PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 1246778999999999999999999999998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=383.41 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=204.7
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 361 (606)
.++|.+.+.||+|+||.||+|+.. +|+.||+|++.+. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357889999999999999999975 4899999999754 344567899999999999999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...... .+ .........
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~----~~~i~~~~~------ 222 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL----FELILMEEI------ 222 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC------
T ss_pred CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HH----HHHHhcCCC------
Confidence 222 234478999999999999999999999999999999999999997643221 11 111111111
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
......+ ..+.+|+..||+.||++||+ +.++++
T Consensus 223 ~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1112222 35678999999999999995 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-45 Score=380.34 Aligned_cols=262 Identities=21% Similarity=0.251 Sum_probs=211.1
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.++||+|+||.||+|++. +|+.||||++.+. .....+.+.+|+.+++.++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999985 4899999998653 3345678999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+.+|+|..++... +.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998543 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... ..+.. ....... .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~----~i~~~~~------~ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE----KIVSGKV------R 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCCC------C
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHH----HHhcCCC------C
Confidence 2346899999999999999999999999999999999999999853221 11111 1111111 1
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH--HhcC-------CCCCCCCCCCCCcc
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL--MLSG-------ERSLPQPKQPGFFT 576 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~--~L~~-------~~~~~~p~~p~~~~ 576 (606)
..... ...+.+++.+||+.||.+|+ |+.++++ .+.+ .+.++.|..|.+..
T Consensus 257 ~p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~ 320 (350)
T d1rdqe_ 257 FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred CCccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCC
Confidence 11112 23567899999999999994 8999985 3322 23445555665543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-46 Score=379.17 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=202.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 362 (606)
++|++.++||+|+||+||+|+... |+.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 568889999999999999999854 899999998653 3345678999999999999999999999999999999999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 442 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~ 442 (606)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998854 345789999999999999999999998 999999999999999999999999999876432
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+ ......... .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~----~~~i~~~~~------~ 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KT----YEKILNAEL------R 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----HHHHHHCCC------C
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HH----HHHHHcCCC------C
Confidence 23468999999999999999999999999999999999999998542211 11 111111111 1
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~vl~ 558 (606)
..... ...+.+++.+||+.||.+|| |+.++++
T Consensus 220 ~p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11112 23567899999999999996 8999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=378.24 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=200.7
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHHHHHHh-hccCCCcceEEEEEeeCCeeEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIA-KLQHRNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 361 (606)
++|.+.++||+|+||+||+|+... |+.||||++.+. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578899999999999999999864 889999999653 2345566777777765 68999999999999999999999
Q ss_pred EecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCC
Q 007361 362 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 441 (606)
Q Consensus 362 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~ 441 (606)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999964 334899999999999999999999998 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhccc
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 521 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 521 (606)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ +........
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~----~~~i~~~~~------ 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL----FHSIRMDNP------ 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC------
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCC------
Confidence 322 233468999999999999999999999999999999999999998643211 11 111111111
Q ss_pred ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 007361 522 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMS-SVV 557 (606)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~vl 557 (606)
...... ...+.+|+.+||+.||++||++. +++
T Consensus 221 ~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 111112 24577899999999999999995 675
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-46 Score=371.32 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=198.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc---cCHHHHHHHHHHHhhccCCCcceEEEEEeeCC----e
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----E 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 357 (606)
.++|.+.+.||+|+||.||+|+.. .|+.||||.+.+... ...+.|.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467899999999999999999975 589999999976432 33457899999999999999999999987654 3
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||+++++|.+++.. .+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999998854 345999999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCc-ccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 438 AFGIDQ-TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 438 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence 654332 22234456899999999999999999999999999999999999999864321 11111111111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhcC
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-NMSSVVLMLSG 562 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~vl~~L~~ 562 (606)
. ....... ...+.+++.+||+.||++|| |+.++++.|..
T Consensus 234 ~---~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 P---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp G---GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C---chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0 0111112 24677899999999999999 89999887754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=371.09 Aligned_cols=256 Identities=23% Similarity=0.255 Sum_probs=193.8
Q ss_pred CCeecccCcccEEEEEEeC-CcEEEEEEccccccc-----CHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEecC
Q 007361 292 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-----GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 365 (606)
Q Consensus 292 ~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 365 (606)
.++||+|+||+||+|++.. |+.||||++...... ..+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 4789999999999999754 899999998654322 2346889999999999999999999999999999999999
Q ss_pred CCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCccc
Q 007361 366 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 445 (606)
Q Consensus 366 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~~ 445 (606)
.++++..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 988777665 34556899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc------hh
Q 007361 446 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV------EL 518 (606)
Q Consensus 446 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~l 518 (606)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....+........ ..
T Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhcc
Confidence 2336799999999998754 5799999999999999999999987543221 1111111111000000 00
Q ss_pred ccc---ccCCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 519 INK---SLGGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 519 ~d~---~l~~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ......+.. ....+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 000011111 1236788999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-45 Score=365.75 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=201.2
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccccc---------CHHHHHHHHHHHhhcc-CCCcceEEEEEeeC
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ---------GMEEFENEVLLIAKLQ-HRNLVKLIGCCTQR 355 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 355 (606)
++|++.+.||+|+||+||+|+.. +|+.+|||++.+.... ..+.+.+|+.++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67889999999999999999975 5889999998664321 2346889999999997 99999999999999
Q ss_pred CeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCC
Q 007361 356 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 435 (606)
Q Consensus 356 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGl 435 (606)
+..++||||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999964 345999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccCcccccc------CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHH
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAID------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 509 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 509 (606)
++.+..... .....||..|+|||++.+ ..++.++||||+||+||||++|+.||...... . ....
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~----~~~~ 226 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---L----MLRM 226 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---H----HHHH
Confidence 998754322 234679999999999853 34788999999999999999999998643211 1 1111
Q ss_pred hhhcCcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 510 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 510 ~~~~~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+... . ...........+.+|+.+||+.+|++|||+.+|++
T Consensus 227 i~~~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhCCCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111 0 00011112246778999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-45 Score=379.38 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=196.8
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccc---cccCHHHHHHH---HHHHhhccCCCcceEEEEEeeCCeeE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENE---VLLIAKLQHRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~ 359 (606)
++|++.++||+|+||.||+|+... |+.||||++.+. .......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 678999999999999999999864 899999998643 22233344444 66677778999999999999999999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999954 345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchh
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 518 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l 518 (606)
.... .....||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+ .......
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~----- 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM----- 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSSC-----
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccC-----
Confidence 5432 334679999999999975 5689999999999999999999999865433211111 0000000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 519 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 519 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
........ ...+.+|+..||+.||++||| +.++++
T Consensus 225 -~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00111122 235778999999999999999 577763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=373.30 Aligned_cols=251 Identities=18% Similarity=0.262 Sum_probs=202.0
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
.++|.+.+.||+|+||+||+|.... ++.||+|.+.... .....+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4678999999999999999999864 7899999996543 2345688999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC--CCceEEeecCCccccCCC
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGID 442 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~--~~~~ki~DFGla~~~~~~ 442 (606)
+++|+|.+++.. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999953 2335899999999999999999999998 999999999999985 458999999999876432
Q ss_pred cccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcchhcccc
Q 007361 443 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 522 (606)
Q Consensus 443 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 522 (606)
. ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...... .+. ........ .+ ...
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~----~~i~~~~~-~~-~~~ 225 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII----ENIMNAEY-TF-DEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHHTCC-CC-CHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC-CC-Chh
Confidence 2 223467899999999999999999999999999999999999998643211 111 11111100 00 000
Q ss_pred cCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 523 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..... ...+.+|+..||+.||++|||+.|+++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011 235678999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=370.60 Aligned_cols=252 Identities=19% Similarity=0.211 Sum_probs=195.8
Q ss_pred hcCCCcCC-eecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhc-cCCCcceEEEEEee----CCee
Q 007361 286 TENFSDKN-KLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ----RDER 358 (606)
Q Consensus 286 ~~~~~~~~-~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 358 (606)
.++|.+.. .||+|+||+||+|+.. +++.||||++.. ...+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46787765 5999999999999975 489999999854 34678899987665 89999999999865 4568
Q ss_pred EEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC---CCceEEeecCC
Q 007361 359 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM 435 (606)
Q Consensus 359 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~---~~~~ki~DFGl 435 (606)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999642 2346999999999999999999999998 999999999999975 56799999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
|+....... .....||+.|+|||++.+..|+.++|||||||+||||+||+.||............ .......
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~-- 232 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMG-- 232 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC--
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcC--
Confidence 987654322 33467999999999999999999999999999999999999998643322110000 0000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...............+.+|+.+||+.||++|||+.++++
T Consensus 233 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 ----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000000000112346789999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=365.09 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=197.7
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999975 48999999996543 3346789999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
|+.++.+ +++.. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 ~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchh-hhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9976544 44422 23456999999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC---cch--
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER---PVE-- 517 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~-- 517 (606)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||...... .............. ...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhccccc
Confidence 2233467999999999987766 588999999999999999999998643211 11111111000000 000
Q ss_pred -hcc--ccc--CCCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 -LIN--KSL--GGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 -l~d--~~l--~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
..+ ... ...... .....+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 000 000111 11235678999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-44 Score=362.60 Aligned_cols=261 Identities=24% Similarity=0.331 Sum_probs=199.2
Q ss_pred cCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 364 (606)
++|...++||+|+||+||+|++.+|+.||||++... .....+.+.+|+.++++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578889999999999999999988999999998654 334467899999999999999999999999999999999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCcc
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 444 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~~ 444 (606)
+.++.+..+.. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....+..
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98877777663 3456999999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC------cch
Q 007361 445 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER------PVE 517 (606)
Q Consensus 445 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 517 (606)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .............. ...
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhh
Confidence 22335689999999998764 5699999999999999999999998543211 11111111100000 000
Q ss_pred hc--ccccC--CC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 518 LI--NKSLG--GS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 518 l~--d~~l~--~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.. ..... .. ........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 00 00011235678999999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=358.44 Aligned_cols=239 Identities=25% Similarity=0.397 Sum_probs=193.9
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc------cCHHHHHHHHHHHhhcc--CCCcceEEEEEeeCCe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDE 357 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 357 (606)
++|.+.++||+|+||+||+|+.. +|+.||||++.+... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999975 489999999865321 12234678999999996 8999999999999999
Q ss_pred eEEEEecCCC-CCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-CCceEEeecCC
Q 007361 358 RMLIYEYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGM 435 (606)
Q Consensus 358 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-~~~~ki~DFGl 435 (606)
.++||||+.+ +++.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 577777743 345899999999999999999999998 999999999999985 57999999999
Q ss_pred ccccCCCcccccccccccccCccCccccccCCC-CccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC
Q 007361 436 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 514 (606)
Q Consensus 436 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 514 (606)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .....
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~ 220 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ 220 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhcc
Confidence 9875432 2234679999999999987765 6789999999999999999999753210 00110
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 515 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 515 ~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
.......+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 221 ------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01112222 35678999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=359.02 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=194.5
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-C-CcEEEEEEccccc--ccCHHHHHHHHHHHhhc---cCCCcceEEEEEee----
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-E-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKL---QHRNLVKLIGCCTQ---- 354 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 354 (606)
.++|++.++||+|+||+||+|++. . ++.||||++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 5679999986532 22334566788777766 79999999999853
Q ss_pred -CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeec
Q 007361 355 -RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 433 (606)
Q Consensus 355 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DF 433 (606)
....++++||++++++..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 346799999999887665442 34456899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 434 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 434 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
|+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||....... .+..........
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence 999865322 23345789999999999999999999999999999999999999986432211 111111100000
Q ss_pred C----------cchhcccccCC---CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 514 R----------PVELINKSLGG---SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 514 ~----------~~~l~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
. ........... .........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000000000 000011235678999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=355.93 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=196.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccc--cccCHHHHHHHHHHHhhccCCCcceEEEEEee--------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-------- 354 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 354 (606)
.++|++.++||+|+||+||+|++. +|+.||||++... .....+.+.+|+.+|++++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368899999999999999999985 5899999998554 34456788999999999999999999999855
Q ss_pred CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecC
Q 007361 355 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 434 (606)
Q Consensus 355 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFG 434 (606)
....++||||+.++.+..+. .....++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34579999999888776554 23455889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCccc--ccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhh
Q 007361 435 MARAFGIDQTE--ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 511 (606)
Q Consensus 435 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 511 (606)
+++.+...... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876543322 223335799999999999865 689999999999999999999999864322111111111000000
Q ss_pred hcC--------cchhcccccCCCCCHHH-------HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 512 EER--------PVELINKSLGGSYSLSE-------VLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 512 ~~~--------~~~l~d~~l~~~~~~~~-------~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
... ....+............ ...+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 00000000111111111 124578999999999999999999984
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-42 Score=346.56 Aligned_cols=259 Identities=20% Similarity=0.267 Sum_probs=195.9
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceE-EEEEeeCCeeEEEEec
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL-IGCCTQRDERMLIYEY 364 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~E~ 364 (606)
++|++.++||+|+||.||+|++.. |+.||||.+..... .+++..|++++++++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 568899999999999999999754 88999998765432 2457889999999987765554 5556778889999999
Q ss_pred CCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEc---CCCceEEeecCCccccCC
Q 007361 365 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGI 441 (606)
Q Consensus 365 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~---~~~~~ki~DFGla~~~~~ 441 (606)
+. ++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 94 566665533 3345899999999999999999999998 99999999999985 456799999999998754
Q ss_pred Cccc-----ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCcc
Q 007361 442 DQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 516 (606)
Q Consensus 442 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 516 (606)
.... .......||+.|||||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence 3322 2234468999999999999999999999999999999999999998765443222221111111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 517 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 517 ~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
+.+....+ ..+.+++..||+.+|++||++.++.+.|+.
T Consensus 238 ----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 ----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp ----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ----hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11111122 457789999999999999999999988875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=360.81 Aligned_cols=261 Identities=20% Similarity=0.241 Sum_probs=191.7
Q ss_pred CCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccCCCcceEEEEEeeC------CeeEE
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------DERML 360 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 360 (606)
+|+..++||+|+||+||+|++.. |+.||||++...... +.+|+.++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57778999999999999999864 899999999665432 24799999999999999999998543 34789
Q ss_pred EEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCcccc
Q 007361 361 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF 439 (606)
Q Consensus 361 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~ 439 (606)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655544433334556999999999999999999999998 99999999999999765 8999999999876
Q ss_pred CCCcccccccccccccCccCcccccc-CCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchh--------HHHHHHh
Q 007361 440 GIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLW 510 (606)
Q Consensus 440 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~ 510 (606)
..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||............ ...+...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 43322 233679999999998875 46899999999999999999999998643321100000 0001111
Q ss_pred hhcCcchhccc----ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 511 IEERPVELINK----SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 511 ~~~~~~~l~d~----~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........+.. .............+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 0000001112235778999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-41 Score=342.70 Aligned_cols=260 Identities=16% Similarity=0.193 Sum_probs=204.1
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEcccccccCHHHHHHHHHHHhhccC-CCcceEEEEEeeCCeeEEEEe
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH-RNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 363 (606)
.++|.+.++||+|+||+||+|++.. |+.||||.+..... ...+.+|++++..++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 3578899999999999999999764 88999998855432 2457889999999975 899999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcC-----CCceEEeecCCccc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARA 438 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~-----~~~~ki~DFGla~~ 438 (606)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6899998854 3345899999999999999999999998 999999999999964 57899999999998
Q ss_pred cCCCccc-----ccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhc
Q 007361 439 FGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 513 (606)
Q Consensus 439 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 513 (606)
+...... .......||+.|||||.+.+..++.++||||||+++|||++|+.||..................-...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7533221 22344689999999999999999999999999999999999999987544332221111111100001
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcC
Q 007361 514 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 562 (606)
Q Consensus 514 ~~~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~~L~~ 562 (606)
...+ +....+ ..+.+++..|++.+|++||++..+.+.|+.
T Consensus 236 ~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 112222 357788899999999999999999888865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=353.53 Aligned_cols=263 Identities=20% Similarity=0.296 Sum_probs=195.2
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc-ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC----eeE
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----ERM 359 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 359 (606)
+++|.+.++||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 456889999999999999999974 58999999997543 334567899999999999999999999997653 235
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcccc
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 439 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~ 439 (606)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677789999999953 34899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccccCccCccccc-cCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc--
Q 007361 440 GIDQTE-ANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP-- 515 (606)
Q Consensus 440 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 515 (606)
...... ......+||+.|+|||.+. +..++.++||||+|++++||++|+.||........ .............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence 543322 2234567999999999985 45679999999999999999999999854322110 0000000000000
Q ss_pred ---------chhcccc-cCCCCCHHH-----HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 516 ---------VELINKS-LGGSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 516 ---------~~l~d~~-l~~~~~~~~-----~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
....... .....+... ..++.+|+..||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000111111 135778999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=350.09 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=192.4
Q ss_pred hcCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCC------
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------ 356 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 356 (606)
.++|.+.++||+|+||+||+|+... |+.||||++.+.. ....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4678899999999999999999754 8999999997542 233567889999999999999999999997655
Q ss_pred eeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCc
Q 007361 357 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 436 (606)
Q Consensus 357 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla 436 (606)
..++||||+ +.+|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 566777663 235999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 437 RAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 437 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
+..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.|+....... ........ .....
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~-~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKV-TGTPP 239 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH-HCCCC
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhc-cCCCc
Confidence 876432 2346789999999998764 57899999999999999999999986432111 00000000 00000
Q ss_pred c-------------------hhcc---cccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCCC
Q 007361 516 V-------------------ELIN---KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGER 564 (606)
Q Consensus 516 ~-------------------~l~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~~~ 564 (606)
. +... ..+....+ ..+.+|+.+||+.||++|||+.++++ .|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 0000 00011112 35678999999999999999999997 355543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=341.52 Aligned_cols=262 Identities=22% Similarity=0.271 Sum_probs=200.9
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEeeCCeeEEEEe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 363 (606)
++|++.++||+|+||+||+|++. +++.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999975 48899999986543 3346789999999999999999999999999999999999
Q ss_pred cCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCccccCCCc
Q 007361 364 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 443 (606)
Q Consensus 364 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~~~~~~ 443 (606)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888774 3456899999999999999999999998 9999999999999999999999999998865433
Q ss_pred ccccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC---cc---
Q 007361 444 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER---PV--- 516 (606)
Q Consensus 444 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~--- 516 (606)
.. .....++..|+|||.+.+.. ++.++||||+||++|||++|+.|+-.... ................ ..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhh
Confidence 22 22346788999999988765 69999999999999999999999632111 1111111111111000 00
Q ss_pred hhccc--------cc-CCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 517 ELINK--------SL-GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 517 ~l~d~--------~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
...+. .. ...........+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00 00011111235678899999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=345.67 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=199.7
Q ss_pred cCCCcCCeecccCcccEEEEEEe----CCcEEEEEEcccc----cccCHHHHHHHHHHHhhccC-CCcceEEEEEeeCCe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS----SGQGMEEFENEVLLIAKLQH-RNLVKLIGCCTQRDE 357 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 357 (606)
++|++.++||+|+||+||+|+.. .|+.||||.+.+. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 66999999999999999999863 3789999998653 22345678899999999976 899999999999999
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++++||+.+|+|.+++... ..+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998543 34678899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccCccccccC--CCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcCc
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 515 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 515 (606)
.+....... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||......... ............
T Consensus 178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEP 253 (322)
T ss_dssp ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCCC
T ss_pred hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCCC
Confidence 765433322 3346799999999999765 4788999999999999999999998654332221 111111111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 007361 516 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL 558 (606)
Q Consensus 516 ~~l~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~vl~ 558 (606)
. .+......+.+++..||+.||++||| +.|+++
T Consensus 254 ------~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ------P----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------C----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------C----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 11122346778999999999999995 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-41 Score=345.82 Aligned_cols=257 Identities=18% Similarity=0.274 Sum_probs=194.6
Q ss_pred cCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeC--CeeEEEE
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQR--DERMLIY 362 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 362 (606)
++|++.++||+|+||+||+|+.. .|+.||||+++.. ..+.+.+|+.+|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999985 4889999998643 3567899999999995 99999999998744 5689999
Q ss_pred ecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCC-ceEEeecCCccccCC
Q 007361 363 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGI 441 (606)
Q Consensus 363 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~-~~ki~DFGla~~~~~ 441 (606)
||+++++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999998764 24899999999999999999999998 99999999999998654 699999999987653
Q ss_pred CcccccccccccccCccCccccccC-CCCccccchhHHHHHHHHHhccCCCCCCCCCCccch-hHH-----HHHHhhh--
Q 007361 442 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGH-----AWRLWIE-- 512 (606)
Q Consensus 442 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~-----~~~~~~~-- 512 (606)
... .....+|..|+|||.+.+. .++.++||||+|++++||++|+.|+........... ... ....+..
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 322 3346789999999998865 479999999999999999999999764432211100 000 0000000
Q ss_pred -cCcchhccc------------ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 513 -ERPVELINK------------SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 513 -~~~~~l~d~------------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
......... .............+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 0000001111235678999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=339.75 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=195.3
Q ss_pred hcCCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccc--cCHHHHHHHHHHHhhccCCCcceEEEEEeeC-----Ce
Q 007361 286 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DE 357 (606)
Q Consensus 286 ~~~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 357 (606)
.++|.+.++||+|+||+||+|+.. +|+.||||++.+... ...+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999975 589999999976532 3345788999999999999999999998643 34
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++|++|+.+|+|.+++. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788889999999984 235999999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCcccccccccccccCccCccccccCC-CCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHHHHHhhhcC--
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER-- 514 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 514 (606)
.... ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||......... ...........
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~---~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGAE 241 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHH
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChH
Confidence 6532 223467899999999877764 689999999999999999999998643221110 00000000000
Q ss_pred ---------cchhccccc-CCCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHH--HhcCC
Q 007361 515 ---------PVELINKSL-GGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGE 563 (606)
Q Consensus 515 ---------~~~l~d~~l-~~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~~vl~--~L~~~ 563 (606)
......... ....... ....+.+|+.+||+.||++|||+.|+++ .+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000000000 0011111 1235678999999999999999999986 45543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=341.93 Aligned_cols=260 Identities=23% Similarity=0.277 Sum_probs=187.5
Q ss_pred cCCCcCCeecccCcccEEEEEEeC-CcEEEEEEccccc--ccCHHHHHHHHHHHhhccCCCcceEEEEEee------CCe
Q 007361 287 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ------RDE 357 (606)
Q Consensus 287 ~~~~~~~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 357 (606)
++|.+.++||+|+||+||+|++.. |+.||||++.... ......+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999999864 8999999996542 3344578899999999999999999999964 367
Q ss_pred eEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 358 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 358 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.++||||+.++.+..+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999766554432 24899999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhH--------HHH--
Q 007361 438 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAW-- 507 (606)
Q Consensus 438 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~-- 507 (606)
..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||............. ..|
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 75432 22334678999999999999999999999999999999999999985432110000000 000
Q ss_pred -----HHhhhcCc-------chhcccccCCCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 007361 508 -----RLWIEERP-------VELINKSLGGSY---SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 558 (606)
Q Consensus 508 -----~~~~~~~~-------~~l~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~~vl~ 558 (606)
........ ...+........ .......+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00001100 011111111111 1123446789999999999999999999973
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=316.30 Aligned_cols=281 Identities=20% Similarity=0.230 Sum_probs=201.0
Q ss_pred CCCcCCeecccCcccEEEEEEe-CCcEEEEEEcccccccCHHHHHHHHHHHhhcc-----------CCCcceEEEEEee-
Q 007361 288 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-----------HRNLVKLIGCCTQ- 354 (606)
Q Consensus 288 ~~~~~~~lG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~- 354 (606)
+|.+.++||+|+||+||+|+.. +|+.||||++.+.. ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4889999999999999999975 58999999996543 23467788999988875 4789999988754
Q ss_pred -CCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCEEEcCCC------
Q 007361 355 -RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEM------ 426 (606)
Q Consensus 355 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlk~~NIll~~~~------ 426 (606)
....+++++++..+..............+++..+..++.||++||.|||+ .+ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 35567777777666555544444566678999999999999999999998 66 99999999999997655
Q ss_pred ceEEeecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHHHHHhccCCCCCCCCCCccchhHHH
Q 007361 427 NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 506 (606)
Q Consensus 427 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 506 (606)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+|++++||++|+.||...............
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999999865322 23467999999999999999999999999999999999999998654332211111110
Q ss_pred HHH--hhhcCc----------chhccc-------------------ccCCCCCHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 007361 507 WRL--WIEERP----------VELINK-------------------SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSS 555 (606)
Q Consensus 507 ~~~--~~~~~~----------~~l~d~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 555 (606)
... ...... ....+. .............+.+|+.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000 000000 000000 0011234455668899999999999999999999
Q ss_pred HHH--Hhc---CCCCCCCCCCCCCccc
Q 007361 556 VVL--MLS---GERSLPQPKQPGFFTE 577 (606)
Q Consensus 556 vl~--~L~---~~~~~~~p~~p~~~~~ 577 (606)
+++ .++ ...++..|..+-....
T Consensus 325 ~L~Hp~f~~~~~~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 325 LVNHPWLKDTLGMEEIRVPDRELYGSG 351 (362)
T ss_dssp HHTCGGGTTCTTCTTCCCTTSCTTCBS
T ss_pred HhcCcccCCCCCcccCCCCCcccCCCC
Confidence 987 243 2345555555555433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=2.5e-23 Score=195.14 Aligned_cols=170 Identities=19% Similarity=0.148 Sum_probs=121.7
Q ss_pred CcCCeecccCcccEEEEEEeCCcEEEEEEcccccc------------------cCHHHHHHHHHHHhhccCCCcceEEEE
Q 007361 290 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG------------------QGMEEFENEVLLIAKLQHRNLVKLIGC 351 (606)
Q Consensus 290 ~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 351 (606)
.+.++||+|+||+||+|+..+|+.||||.+..... .....+..|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999998899999998643210 012334568889999999999998876
Q ss_pred EeeCCeeEEEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCEEEcCCCceEEe
Q 007361 352 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 431 (606)
Q Consensus 352 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk~~NIll~~~~~~ki~ 431 (606)
.. .+++|||+++..+.. ++......++.|++++|.|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 32 379999998866544 233445678999999999999998 99999999999999654 8999
Q ss_pred ecCCccccCCCcccccccccccccCccCccccccCCCCccccchhHHHHHH
Q 007361 432 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVL 482 (606)
Q Consensus 432 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DV~S~Gvvl~ 482 (606)
|||+|.....+.........+. . -.+ +....|+.++|+||..--++
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~---~-~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR---N-IIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH---H-HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH---H-HHH-HHcCCCCCcccHHHHHHHHh
Confidence 9999987543322110000000 0 001 12356788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=2.3e-07 Score=89.06 Aligned_cols=149 Identities=17% Similarity=0.104 Sum_probs=104.6
Q ss_pred HHHHHhcCCCcCCeecccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc-CCCcceEEEEEeeCCeeE
Q 007361 281 AIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERM 359 (606)
Q Consensus 281 ~~~~~~~~~~~~~~lG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 359 (606)
++....+.|...+..+.+....||+... +++.+++|+...........+.+|+..+..+. +--+.+++.+..+.+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445556676555544455578999864 56778888887665555566788999888774 444678888888888999
Q ss_pred EEEecCCCCCchhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 007361 360 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS--------------------------------- 406 (606)
Q Consensus 360 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 406 (606)
+||+++++.++.+..... .....++.++++.|..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886654211 112234555666666666431
Q ss_pred -----------------------CCCeeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 407 -----------------------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 407 -----------------------~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
...++|+|+.|.||++++++.+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999877778999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=4.5e-05 Score=72.00 Aligned_cols=130 Identities=16% Similarity=0.152 Sum_probs=86.7
Q ss_pred eecccCc-ccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhcc--CCCcceEEEEEeeCCeeEEEEecCCCCCc
Q 007361 294 KLGEGGF-GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDERMLIYEYLPNKSL 370 (606)
Q Consensus 294 ~lG~G~f-G~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL 370 (606)
.+..|.. ..||+....++..+++|....... ..+..|+..++.+. .-.+.+++++..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 678999887777888887644332 34677888887774 33467788888888889999999998776
Q ss_pred hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 007361 371 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ---------------------------------------------- 404 (606)
Q Consensus 371 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~---------------------------------------------- 404 (606)
.+.. ... ..++.++++.|.-||+
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 5421 111 1112233333333332
Q ss_pred -----C----CCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 405 -----D----SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 405 -----~----~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
. .+..++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11237999999999999988778899998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=0.00035 Score=70.45 Aligned_cols=76 Identities=12% Similarity=0.157 Sum_probs=49.3
Q ss_pred CeecccCcccEEEEEEeC-CcEEEEEEcccc-------cccCHHHHHHHHHHHhhcc-C--CCcceEEEEEeeCCeeEEE
Q 007361 293 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-------SGQGMEEFENEVLLIAKLQ-H--RNLVKLIGCCTQRDERMLI 361 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~-g~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV 361 (606)
+.||.|....||+....+ ++.++||.-... .....+....|+..|..+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 568999999999998765 678888864321 1123344566888887663 3 235555544 45567899
Q ss_pred EecCCCCCc
Q 007361 362 YEYLPNKSL 370 (606)
Q Consensus 362 ~E~~~~gsL 370 (606)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987553
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.53 E-value=0.0026 Score=63.82 Aligned_cols=73 Identities=19% Similarity=0.278 Sum_probs=50.1
Q ss_pred CeecccCcccEEEEEEeCC--------cEEEEEEcccccccCHHHHHHHHHHHhhccCCCc-ceEEEEEeeCCeeEEEEe
Q 007361 293 NKLGEGGFGPVYKGVLIEG--------QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYE 363 (606)
Q Consensus 293 ~~lG~G~fG~Vy~g~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 363 (606)
+.|+.|-.=.+|+....++ +.++++.. .. ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~-g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY-FN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE-CS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEec-CC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 6788899999999987653 34555444 33 2334456789999988853344 577777753 68999
Q ss_pred cCCCCCch
Q 007361 364 YLPNKSLN 371 (606)
Q Consensus 364 ~~~~gsL~ 371 (606)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.19 E-value=0.0051 Score=59.77 Aligned_cols=136 Identities=11% Similarity=0.133 Sum_probs=79.1
Q ss_pred cccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCCc--ceEEE-----EEeeCCeeEEEEecCCCCCchh
Q 007361 300 FGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL--VKLIG-----CCTQRDERMLIYEYLPNKSLND 372 (606)
Q Consensus 300 fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL~~ 372 (606)
--.||++...+|+.+++|..... ....+++..|...+..|....+ +..+. .....+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999989999999887543 3356778889998888753222 22211 1234566788999998755431
Q ss_pred h----h----------cc------cCCCCCCCHHHH-------------------HHHHHHHHHHHHHHH----hCCCCC
Q 007361 373 F----I----------FD------VTRSKFLDWSKR-------------------CQIIGGIARGLLYLH----QDSRLR 409 (606)
Q Consensus 373 ~----l----------~~------~~~~~~l~~~~~-------------------~~i~~~ia~gL~yLH----~~~~~~ 409 (606)
. + +. ...+..+++... -.+...+.+.+..+. +..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 0 00 011122222211 111111222233332 223446
Q ss_pred eeeccCCCCCEEEcCCCceEEeecCCccc
Q 007361 410 IIHRDLKASNVLLDNEMNPKISDFGMARA 438 (606)
Q Consensus 410 iiH~Dlk~~NIll~~~~~~ki~DFGla~~ 438 (606)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.36 E-value=0.081 Score=50.37 Aligned_cols=157 Identities=13% Similarity=0.022 Sum_probs=81.2
Q ss_pred CHHHHHHHhcCCCcCCee-----cccCcccEEEEEEeCCcEEEEEEcccccccCHHHHHHHHHHHhhccCCC--cceEEE
Q 007361 278 DWMAIANATENFSDKNKL-----GEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN--LVKLIG 350 (606)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l-----G~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g 350 (606)
+..++.....+|.+++.. ..|---+.|+.+..+|+ +++|+..... ..+++..|+.++..|.+.+ +...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 445677777778765443 35555778998876654 7788775432 2244555666776664222 111111
Q ss_pred ------EEeeCCeeEEEEecCCCCCchhhh--------------cc------cCCCCCCCHH------------------
Q 007361 351 ------CCTQRDERMLIYEYLPNKSLNDFI--------------FD------VTRSKFLDWS------------------ 386 (606)
Q Consensus 351 ------~~~~~~~~~lV~E~~~~gsL~~~l--------------~~------~~~~~~l~~~------------------ 386 (606)
+..-......++.++.+......- +. ..........
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 112234566677777665443211 00 0000000000
Q ss_pred HHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCEEEcCCCceEEeecCCcc
Q 007361 387 KRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 437 (606)
Q Consensus 387 ~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlk~~NIll~~~~~~ki~DFGla~ 437 (606)
.....+..+...+.-.+.. -+..+||+|+.+.||+++++...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222221 23359999999999999998888899999875
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.97 E-value=0.0047 Score=37.21 Aligned_cols=34 Identities=32% Similarity=0.722 Sum_probs=26.7
Q ss_pred CcCCcccccCCCcccccCCCCCCcccccCCCccCC
Q 007361 67 LDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKS 101 (606)
Q Consensus 67 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~ 101 (606)
+|+|.+-..|| +|.|+.--....|.|-.||+|..
T Consensus 1 tdECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CCccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 37899999998 68897542335799999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.44 E-value=0.031 Score=35.94 Aligned_cols=31 Identities=29% Similarity=0.705 Sum_probs=25.3
Q ss_pred cCCcc-cccCCCcccccCCCCCCcccccCCCc
Q 007361 68 DQCDN-YALCGAYAVCNMNSNSAKCECLEGFV 98 (606)
Q Consensus 68 ~~C~~-~~~CG~~g~C~~~~~~~~C~C~~gf~ 98 (606)
|+|.. ...|..+|.|.....+..|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 67875 46899999998664557899999997
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.20 E-value=0.071 Score=33.52 Aligned_cols=32 Identities=38% Similarity=0.788 Sum_probs=24.4
Q ss_pred cCCcccccCCCcccccCCCCCCcccccCCCccC
Q 007361 68 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVPK 100 (606)
Q Consensus 68 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 100 (606)
|+|. ..-|...|.|........|.|++||+-+
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4565 4679999999876456789999999743
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.83 E-value=0.081 Score=34.23 Aligned_cols=35 Identities=20% Similarity=0.372 Sum_probs=25.2
Q ss_pred cCCcccccCCCcccccCCCCCCcccccCCCccCCC
Q 007361 68 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSP 102 (606)
Q Consensus 68 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~~ 102 (606)
|+|.....+-.++.|.....+..|.|++||+...+
T Consensus 4 dEC~~~~~~C~~~~C~Nt~Gsy~C~C~~Gy~~~~~ 38 (44)
T d1lmja1 4 DECRISPDLCGRGQCVNTPGDFECKCDEGYESGFM 38 (44)
T ss_dssp CTTTTCSSTTTTSCEEEETTEEEECCCSSEEECTT
T ss_pred cccCCCCCCCCCCEeEcCCCCeEEeCCCCCccCCC
Confidence 78876444335799987655678999999986543
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.55 E-value=0.13 Score=33.06 Aligned_cols=32 Identities=25% Similarity=0.590 Sum_probs=25.0
Q ss_pred CcCCcccccCCCcccccCCCCCCcccccCCCcc
Q 007361 67 LDQCDNYALCGAYAVCNMNSNSAKCECLEGFVP 99 (606)
Q Consensus 67 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 99 (606)
.|+|.... |+.++.|.....+-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47897654 557899987655678999999985
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.37 E-value=0.085 Score=33.15 Aligned_cols=32 Identities=34% Similarity=0.545 Sum_probs=25.5
Q ss_pred CcCCcccccCCCcccccCCCCCCcccccCCCcc
Q 007361 67 LDQCDNYALCGAYAVCNMNSNSAKCECLEGFVP 99 (606)
Q Consensus 67 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 99 (606)
.|+|. ..-|-..|.|........|.|++||+-
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 34 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCC
Confidence 36787 467999999987655679999999973
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.89 E-value=0.1 Score=32.74 Aligned_cols=31 Identities=23% Similarity=0.598 Sum_probs=23.9
Q ss_pred cCCcccccCCCcccccCCCCCCcccccCCCcc
Q 007361 68 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVP 99 (606)
Q Consensus 68 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 99 (606)
|+|.. .-|...|.|.....+..|.|++||.-
T Consensus 2 d~C~~-~PC~n~g~C~~~~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECVS-NPCQNDATCLDQIGEFQCICMPGYEG 32 (39)
T ss_dssp CTTTT-CCCCSSCEEEECSSCEEEECCTTEES
T ss_pred cCCcC-CCCCCCCEEECCCCCEEEeCCCCCcc
Confidence 56643 56999999986545678999999974
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.75 E-value=0.15 Score=32.34 Aligned_cols=31 Identities=32% Similarity=0.746 Sum_probs=23.9
Q ss_pred cCCcccccCCCcccccCCCCCCcccccCCCccC
Q 007361 68 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVPK 100 (606)
Q Consensus 68 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 100 (606)
|+|...+.| ..+|.....+-.|.|++||...
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678776666 4689776556789999999864
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.44 E-value=0.092 Score=33.79 Aligned_cols=32 Identities=22% Similarity=0.519 Sum_probs=25.2
Q ss_pred cCCcccccCCCcccccCCCCCCcccccCCCccC
Q 007361 68 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVPK 100 (606)
Q Consensus 68 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 100 (606)
|+|.....| -.+.|.....+..|.|++||+..
T Consensus 4 dEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLDPTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred cccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 789877666 57899876455789999999865
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.69 E-value=0.094 Score=33.57 Aligned_cols=32 Identities=34% Similarity=0.730 Sum_probs=23.4
Q ss_pred cCCcc-cccCCCcccccCCCCCCcccccCCCccC
Q 007361 68 DQCDN-YALCGAYAVCNMNSNSAKCECLEGFVPK 100 (606)
Q Consensus 68 ~~C~~-~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 100 (606)
|+|.. ...|. +|.|.....+-.|.|++||.+.
T Consensus 3 dEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 3 DECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp CHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred cccCCCCCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 45644 45664 7899876556789999999965
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.50 E-value=0.22 Score=30.36 Aligned_cols=30 Identities=30% Similarity=0.635 Sum_probs=22.1
Q ss_pred CCcccccCCCcccccCCCCCCcccccCCCcc
Q 007361 69 QCDNYALCGAYAVCNMNSNSAKCECLEGFVP 99 (606)
Q Consensus 69 ~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 99 (606)
+|. ..-|...|.|........|.|++||.-
T Consensus 2 ~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 31 (35)
T d2vj3a3 2 ECA-SSPCLHNGRCLDKINEFQCECPTGFTG 31 (35)
T ss_dssp TTT-TCCSTTTCEEEECSSCEEEECCTTEES
T ss_pred CCC-CCCCCCCcEEECCCCCeEEECCCCCCC
Confidence 453 356888889976545578999999973
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.47 E-value=0.099 Score=32.84 Aligned_cols=32 Identities=25% Similarity=0.564 Sum_probs=24.0
Q ss_pred cCCcccccCCCcccccCCCCCCcccccCCCccC
Q 007361 68 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVPK 100 (606)
Q Consensus 68 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~ 100 (606)
+.|. ..-|...|.|........|.|++||.-+
T Consensus 2 ~~C~-~~pC~ngg~C~~~~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 2 AACT-NTSCSGHGECVETINNYTCKCDPGFSGL 33 (39)
T ss_dssp CCCC-TTGGGGSEEEEEETTEEEEEECTTEEST
T ss_pred Cccc-CCcCCCCcEEECCCCCEEEeCCCCCcCc
Confidence 4565 3679999999765455789999999743
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=81.59 E-value=0.15 Score=31.48 Aligned_cols=31 Identities=32% Similarity=0.584 Sum_probs=24.0
Q ss_pred cCCcccccCCCcccccCCCCCCcccccCCCcc
Q 007361 68 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVP 99 (606)
Q Consensus 68 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~ 99 (606)
|+|. ..-|-..|.|........|.|++||+-
T Consensus 3 d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 33 (37)
T d2c4fl1 3 DQCA-SSPCQNGGSCKDQLQSYICFCLPAFEG 33 (37)
T ss_dssp CGGG-GCCCCTTCEEEEETTEEEEECCTTEES
T ss_pred ccCC-CCCCCCCCEEECCCCCeEEECCCCCcC
Confidence 5675 567888999976545578999999973
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=80.07 E-value=0.19 Score=31.63 Aligned_cols=25 Identities=20% Similarity=0.573 Sum_probs=20.0
Q ss_pred ccCCCcccccCCCCCCcccccCCCc
Q 007361 74 ALCGAYAVCNMNSNSAKCECLEGFV 98 (606)
Q Consensus 74 ~~CG~~g~C~~~~~~~~C~C~~gf~ 98 (606)
..|.+++.|.....+..|.|.+||.
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~ 31 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANYT 31 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEE
T ss_pred CCCCCCCEeecCCCCeEeECCCCCc
Confidence 3588889997654567899999997
|